bibliografia sui danni da vaccini

BIBLIOGRAFIA SUI DANNI DA VACCINI Alcuni riferimenti per eventuali approfondimenti (Dal 1926 al dicembre 2009) 1926 Turnbull, H M. Encephalomyelitis Following Vaccination. Brit Jour Exper Path, 7:181, 1926. 1938 Finley, K H. Pathogenesis of Encephalitis Occurring With Vaccination, Variola and Measles, Arch Neur and Psychologist, 1938; 39:1047­1054. 1958 Berg, J M. Neurological Complications of Pertussis Immunization. Brit Med Jour, July 5,1958; p 24. 1960 Aragona, F. Fatal Acute Adrenal Insufficiency Caused by Bilateral Apoplexy of the Adrenal Glands (WFS) following Anti­poliomyelitis Vaccination. Minerva Medicolegale, Aug 1960; 80:167­173. Pathel JC. Tetanus following smallpox vaccine. J Pediatr, July 1960; 27:251­263. Reynolds, E. Fatal Outcome of a Case of Eczema Vaccinatum. Lancet, 24 Sept 1960, 2:684­686. 1961 Apostolov. et al. Death of an Infant in Hyperthermia After Vaccination. J Clin Path, Mar 1961, 14:196­197.
Goetzeler, A. Fatal Encephalitis after Poliomyelitis Vaccination. 22 Jun 1961, Muenchen Med Wschr, 102:1419­1422.
1962 Connolly, J H, Dick, G W, Field, CM. A Case of Fatal Progressive Vaccinia. Brit Med Jour, 12 May 1962; 5288:1315­1317.
Kompier, A J. Some Skin Diseases caused by Vaccinia Virus [Smallpox. Ned Milt Geneesk T, 15:149­157, May 1962.
Perez Diaz R, et al. Post­vaccinal Pericarditis. Report of 2 Cases. Rev Cuba Med, 1:49­54, Jul­Aug 1962.
Provvidenza G. Un caso di benigna atassia acuta del cervelletto nell'infanzia. Arch Ital Sci Med Trop, 43:189­194, aprile 1962.
1963 Katsilambros L. Il fenomeno di apatia in uomini ed animali dopo l'iniezione di virus in dosi molto elevate. Rev Med Moyen Orient, 20:539­546, nov.­dic. 1963. Pialoux, P et al. Vaccinations and Deafness. Ann Otolaryng (Paris), Dec 1963, 80:1012­1013. Weber, G et al. Skin Lesions Following Vaccinations. Deutsch Med Wschr, 88:1878­1886, S7 Sept 1963. 1965 Aubertin J. Diabetes and vaccination. J Med Bord. 1965 Apr;142(4):702­5. Cherry JD, Jahn CL. Concomitant enterovirus infecton, smallpox vaccination, and exanthem. J Pediatr. 1965 Oct;67(4):679­81. Delaveleye R, Filipe­Lourenco A. Neuro­psychiatric sequelae, principally epileptic, of vaccinal and, serological immunizations. Study of 24 cases. Rev Neuropsychiatr Infant. 1965 Jun­Jul;13(6):419­38. Drouhet V, Leventis F, Netter R, Celers J. Multiplication, in the digestive tract, of 3 attenuated poliomyelitic strains (Sabin type) following oral vaccination. Its relation to the preexisting immunologic status and serologic response. Rev Fr Etud Clin Biol. 1965 Apr;10(4):381­93. Dyczkowska M, Szczeklik A. Myocarditis following smallpox vaccination. Pol Tyg Lek. 1965 May 24;20(21):760­2. Germano G, Borselli L. On possible minor neurologic complications of smallpox vaccination. Riv Clin Pediatr. 1965 Jan­Jun;75(1):59­68. Grasser R. Reactions to diphtheria­tetanus­pertussis vaccines and their causes. Arch Exp Veterinarmed. 1965 Apr;19(1):311­5. Hall RD. Reactions to diphtheria­tetanus­pertussis antigen. Public Health. 1965 Sep;79(6):332­9. Hofele U. Abdominal purpura following smallpox vaccination. Arch Kinderheilkd. 1965 Nov;173(2):175­8. Krupina TN. The clinical picture of postvaccinal affections of the nervous system in children. Vopr Okhr Materin Det. 1965 Sep;10(9):23­7. Migdalska­Kassurowa B, Obodowska­Zysk W. Neurological disorders and peripheral blood picture in complications of smallpox vaccination. (Preliminary report). Przegl Epidemiol. 1965;19(2):167­8. Pantazopoulos, PE. Perceptive Deafness Following Prophylactic use of Tetanus anittoxin. Laryngoscope, Dec 1965, 75:1832­1836. Schedifka R. On the disease picture of post­vaccinal brain disease following smallpox vaccination (with special regard to damage compensation regulations valid in the German Democratic Republic. Z Arztl Fortbild (Jena). 1965 Mar 1;59(5):237­42. Stewart, AM, et al. Aetiology of Childhood Leukaemia. Lancet, 16 Oct, 1965, 2:789­790. Zablocka I, Straczkowski W, Furmanowa K. Renal complications after smallpox vaccination in adults. Przegl Lek. 1965;21(11):685­7. Zimmerman, W. Observation of a case of Acute Bilateral Hearing Impairment Following Preventive Poliomyelitis Vaccination (type 3). Arch Ohr Nas Kehlkopfheilk, 1965, 185:723­725. 1966 Anderson JA, Daly FT Jr, Kidd JC. Human rabies after antiserum and vaccine postexposure treatment. Case report and review. Ann Intern Med. 1966 Jun;64(6):1297­302. Andreoni G, Curatolo D, Cervini E, Provvidenza G, Rocchi G, Velli V. Isolation of poliovirus in poliomyelitic patients vaccinated with Sabin vaccine. G Mal Infett Parassit. 1966 Oct;18(10):662­3. Bhagwat SM, Samuel MR. Oral polio vaccine (Sabin): Vaccine­associated poliolike illnesses. Indian J Med Sci. 1966 Dec;20(12):903­6. Calomiirescu A, Lucian M, Mihal I. Postvaccinal reaction in children vaccinated with DPT trivaccine. Microbiol Parazitol Epidemiol (Bucur). 1966 Mar­
Apr;11(2):163­72. Chang TW, Weinstein L, MacMahon HE. Paralytic poliomyelitis in a child with hypogammaglobulinemia: probable implication of type I vaccine strain. Pediatrics. 1966 Apr;37(4):630­6. Checinska Z, Galazka A, Smolik R. A case of diabetes insipidus after smallpox vaccination. Przegl Lek. 1966;22(6):454­5. Collomb H, Rey M, Dumas M, Berne C. Neuro­psychic syndromes during postvaccinal encephalitis (yellow fever vaccination). Bull Soc Med Afr Noire Lang Fr. 1966;11(3):575­86. Copeman, P W. Skin Complications of Smallpox Vaccination. Practitioner, 197:793­800, Dec 1966. De la Plaza N, Isola MB. Infrequent complication of oral anti­poliomyelitis vaccination. Prensa Med Argent. 1966 Jul 29;53(30):1680­3. Duverne J, Volle H, Gogue Y. Hyperergic accidents of the Sanarelli­Shwartzman type caused by DT­polio vaccination in children. Bull Soc Fr Dermatol Syphiligr. 1966 Mar­Apr;73(2):221­3. Duvina PL, Bini R. Reactions caused by the Sabin poliovirus vaccine in infants. (Considerations on 134 cases hospitalized in 1965). Riv Clin Pediatr. 1966 Jul;78(1):400­11. Ekbom K. A case of asthma after vaccination against smallpox. Acta Med Scand Suppl. 1966;464:170­1. Goldman II. Allergic rhinosinus bronchopathy in a patient after the use of dry anti­influenza serum. Vestn Otorinolaringol. 1966 Mar­Apr;28(2):98­9. Goldman II. Allergic rhinosinusbronchopathy in a patient after the use of dry anti­influenza serum. Vestn Otorinolaringol. 1966 Mar­Apr;28(2):98­9. Goncalves JC. Malignant change in smallpox vaccination scars. Arch Dermatol. 1966 Feb;93(2):229­30. Holmgren B, Lindblom U. Neurological complications after smallpox vaccination. Acta Med Scand Suppl. 1966;464:105­12. Kollmannsberger A. Neurological complications following rabies vaccination. Munch Med Wochenschr. 1966 Feb 4;108(5):259­62. Kringelbach J, Senstius J. Hypsarrhythmia after triple vaccination. Nord Med. 1966 Dec 8;76(49):1433­6. Larbre F, Thivolet J, Hermier M, Cotton JB, Gaudin G, Richoux. Fatal acute myocarditis after smallpox vaccination. Pediatrie. 1966 Apr­May;21(3):345­50. Larbre, F et al. Fatal Acute Myocarditis After Smallpox Vaccination. Pediatrie, Apr­May 1966, 21:345­350. Larsen AA. A severe complication of smallpox vaccination. Can Med Assoc J. 1966 Jun 18;94(25):1316­7. Osterland CK, Miller EJ, Karakawa WW, Krause RM. Characteristics of streptococcal group­specific antibody isolated from hyperimmune rabbits. J Exp Med. 1966 Apr 1;123(4):599­614. Polster H. Mastocytosis (Urticaria pigmentosa) and small pox vaccination. Kinderarztl Prax. 1966 Jun;34(6):241­7. Polster, H. Diabetes insipidus after Smallpox vaccination. Z Aerztl Fortbild (Jena), 1 Apr 1966, 60:429­432. Royer P. Problems raised by vaccination in diabetic children. Pediatrie. 1966 Sep;21(6):729­32. Sankale M, Bourgeade A, Wade F, Beye B. Contribution to the study of vaccinal reactions observed outside Dakar. Bull Soc Med Afr Noire Lang Fr. 1966;11(3):617­23. Stickl H, Helming M. Purulent meningitides following smallpox vaccination. On the problem of post­vaccinal decrease of resistance. Dtsch Med Wochenschr. 1966 Jul 22;91(29):1307­10. Swaak AJ. Local reactions following booster injections with DWTP­vaccine (diphtheria­whooping cough­tetanus­poliovirus vaccine) in children born in 1960 and 1961. Ned Tijdschr Geneeskd. 1966 Feb 12;110(7):332­4. Tidstrom B. Eczema vaccinatum. Ugeskr Laeger. 1966 Jan 6;128(1):18­20. Zablocki B, Skalba D. An attempt to induce the production of rheumatoid factor­like substance in rabbits by prolonged immunization with killed bacterial suspension. Bull Acad Pol Sci Biol. 1966;14(1):23­4. 1967 Annamalai A, Shreekumar S, Manoharan V. Neurological complications following antirabies vaccination. Trans R Soc Trop Med Hyg. 1967;61(6):839­41. Arevalo. Vaccinia Necrosum. Report on a Fatal Case. Bol Ofoc Sanit Panamer, Aug 1967, 63:106­110. Balduzzi P, Glasgow LA. Paralytic poliomyelitis in a contact of a vaccinated child. N Engl J Med. 1967 Apr 6;276(14):796­7. Chandra RK. Reactions following measles vaccination. Indian J Pediatr. 1967 Nov;34(238):423­4. Ebert H. Smallpox vaccination and myocarditis? Dtsch Gesundheitsw. 1967 Dec 28;22(52):2465­8. Fabiani F, Cioffi P. On some neurologic complications during vaccination with the Sabin vaccine. Riv Neurobiol. 1967 Jan­Mar;13(1):127­30. Fedotova AM. The pathogenesis of manifestations of nonspecific allergy during vaccinations. Pediatriia. 1967 Jan;46(1):56­60. Galili S. A mild form of Stevens­Johnson syndrome following measles vaccination. Isr J Med Sci. 1967 Nov­Dec;3(6):903­5. Giovannucci M. Convulsive syndrome following anti­poliomyelitis vaccination (Salk). Riv Sper Freniatr Med Leg Alien Ment. 1967 Oct 31;91(5):1185­94. Kahana D, Berant M. Diabetes in an infant following inapparent mumps. Clin Pediatr (Phila). 1967 Feb;6(2):124­5. Kitani Y, Akita J. A case of postvaccinal chorioretinitis. Nippon Ganka Kiyo. 1967 Dec;18(12):1142­6. Matsuki, A. Recent studies on Goroji Nakagawa, pioneer of vaccination in Japan. On the bicentenary of his birth Nippon Ishigaku.Zasshi. 1967, 13 (3): 26­32. Miller H, Cendrowski W, Shapira K. Multiple sclerosis and vaccination. Br Med J. 1967 Apr 22;2(546):210­3. Okinaka S, Toyokura Y, Tsukagoshi H, Kuriowa Y, Araki S. Physical reactions following vaccination against Japanese B encephalitis­­with special reference to neurological complications. Shinkei Kenkyu No Shimpo. 1967 Aug;11(2):410­24. Pathak R, Khare KC. Disseminated sclerosis syndrome following antirabic vaccination, J. Indian Med Assoc. 1967 Nov 16;49(10):484­5. Pazdyga R, Szestakowska­Pazdyga K. General severe postvaccination reactions in pregnant women vaccinated against typhoid fever. Wiad Lek. 1967 Apr 1;20(7):655­7. Petrilli FL, Crovari P. On the possible consequences of the diffusion of the virus after poliomyelitis vaccination with attenuated poliovirus vaccine. G Ig Med Prev. 1967 May­Jun;8(3):313­23. Sedan J. 2 points to emphasize in the matter of vaccinal ophthalmic complications. Ophthalmologica. 1967;153(3):198­9. Strom J. Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959­
65. Br Med J. 1967 Nov 11;4(575):320­3. Swanson PD, McAlister R, Peterson DR. Poliomyelitis associated with type 2 virus. Paralytic disease in the father of a recently immunized child. JAMA. 1967 Sep 4;201(10):771­3. Terragna A, Cottafava F. Thrombcytopenic purpura during viral infections. Minerva Pediatr. 1967 Apr 21;19(16):816­25. Trump RC, White TR. Cerebellar ataxia presumed due to live, attenuated measles virus vaccine. JAMA. 1967 Jan 9;199(2):129­30. Trump, R C, White, T R. Cerebellar Ataxia Presumed Due To Live Attenuated Measles Virus Vaccine. JAMA, 1967, 199:165­166. Wilhelm DJ, Paegle RD. Thrombocytopenic purpura and pneumonia following measles vaccination. Am J Dis Child. 1967 May;113(5):534­7. 1968 Albrecht RM. Poliomyelitis from a vaccinee. Lancet. 1968 Jun 22;1(7556):1371. Alter HJ, Scanlon RT, Schechter GP. Thrombocytopenic purpura following vaccination with attenuated measles Virus. Am J Dis Child. 1968 Jan;115(1):111­
3. Ammundsen E. Complications of polio vaccination with Sabin vaccine. Fra Sundhedsstyr. 1968 Mar.25;4(25):337­8. Badalian LO, Krupina TN, Kalinina LV, Sandukovskaia SI. Vaccinal lesions of the nervous system in children. Vopr Okhr Materin Det. 1968 Dec;13(12):54­
9. Bazex A, Dupre A, Christol B. Cancer on a smallpox vaccination scar. Bull Soc Fr Dermatol Syphiligr. 1968;75(6):743­6. Bierschenk H, Knabe J. Psoriasis vulgaris in expert testimony on vaccination damage. Z Gesamte Hyg. 1968 Oct;14(10):768­70. Breton J, Caroff J, Hadengue A, Derobert L. Malignant postvaccinal syndrome: 2 cases. Med Leg Dommage Corpor. 1968 Apr;1(2):172­6. Briantseva VV. On vaccine reactions in children. Vopr Okhr Materin Det. 1968 Sep;13(9):87. Colon, VF, et al. Vaccinia Necrosum as a Clue to Lymphatic Lymphoma. Geriatrics, Dec 1968, 23:81­82. Egorova NB. Anaphylactic reaction and antitoxin titer following aerosol and subcutaneous immunization against tetanus. Zh Mikrobiol Epidemiol Immunobiol. 1968 Apr;45(4):63­8. Feldman RA, Kamath DK, Christopher S. Oral poliovaccine and paralysis. Indian Pediatr. 1968 Oct;5(10):475­8. Gathier JC, Bruyn GW. Peripheral neuropathies following the administration of heterologous immune sera. A critical evaluation. Psychiatr Neurol Neurochir. 1968 Jul­Aug;71(4):351­71. Goldman, A. Ocular Vaccinia: A Case Report and Review of Treatment. Med J Aust, Nov 30, 1968, 2:921­922. Hartstock,. Post­vaccinial Lymphadenitis: Hyperplasia of Lymphoid Tissue That Simulates Malignant Lymphomas. Apr 1968, Cancer, 21(4):632­649. Hugoson, G et al. The Occurrence of Bovine Leukosis Following the Introduction of Babesiosis Vaccination. Bibl Haemat, 1968, 30:157­161. Iakunin IA, Iampol'skaia EI, Sysoeva IM, Kipis SL. Nervous system complications in children after preventive vaccinations. Pediatriia. 1968 Nov;47(11):19­
26. Ivanus IA. On disorders of the nervous system after vaccination. Voen Med Zh. 1968 Mar;3:67­8. Jimenez EL, Dorrington HJ. Vaccination and Henoch­Schoenlein purpura. N Engl J Med. 1968 Nov 21;279(21):1171. Kuwert E, Klosterkotter W, Linzenmeier G. Neurological complications following rabies vaccination. Med Klin. 1968 Aug 23;63(34):1326­8. Linchevskii GL. Effect of immunization with whooping cough­diphtheria­tetanus vaccine on the condition of several factors of blood coagulation in children. Pediatriia. 1968 Jun;6:30­3. Marmelzat WL. Malignant tumors in smallpox vaccination scars: a report of 24 cases. Arch Dermatol. 1968 Apr;97(4):400­6. Maszkiewicz W, Penar S. Neurological complications in children of the Wroclaw district following smallpox vaccination during the 1963 epidemic. Przegl Lek. 1968 May 31;24(5):476­8. Morse LJ. Poliomyelitis from a vaccine. Lancet. 1968 Jun 15;1(7555):1312­3. Nedar P R, and Warren, R J. Reported Neurological Disorders Following Live Measles Vaccine. 1968, Ped, 41:997­1001. Park­Dincsoy, H et al. Lymphoid Depletion in a case of Vaccinia Gangrenosa. Laval Med, Jan 1968, 39:24­26. Patan BD. Postvaccinal severe diabetes mellitus. Ter Arkh. 1968 Jul;40(7):117­8. Piriatinskaia RG. Vaccination eczema in a child. Vestn Dermatol Venerol. 1968 Aug;42(8):73. Reed CE. Pertussis sensitization as an animal model for the abnormal bronchial sensitivity of asthma. Yale J Biol Med. 1968 Apr­Jun;40(5):507­21. Reed WB, Wilson­Jones E. Malignant tumors as a late complication of vaccination. Arch Dermatol. 1968 Aug; 98(2):132­5. Rudenko MI, Koldoba LG, Velichko VP. Disorder of the nervous system and the heart following smallpox vaccination. Vrach Delo. 1968 Mar;3:134­5. Scolari R. Unexpected vestibulopathy caused by a vaccine. Riv Otoneurooftalmol. 1968 Mar­Apr;43(2):213­22. Silina EM, et al. Some diseases of the kidneys in children during the 1st year of life, following primary smallpox vaccination and administration of pertusis­
diphtheria­tetanus vaccine. Vopr Okhr Materin Det 1968 Mar; 13(3):79­80. Article in Russian. Zelickson AS. Basal cell epithelioma at site and following smallpox and vaccination. Arch Dermatol. 1968 Jul;98(1):35­6. 1969 Anatomo­clinical study. Acta Neurol (Napoli). 1969 Mar­Apr;24(2):248­58. Bondarev VN, Dadiomova MA. The changes of the nervous system in children after vaccination. Pediatriia. 1969 Jun;48(6):20­4. Candeias JA. Isolation and subtype identification of poliovirus strains following the administration of Sabin vaccine. Rev Saude Publica. 1969;3(2):183­201. Casteles­Van Daele M. Vaccination and Henoch­Schoenlein purpura. N Engl J Med. 1969 Apr 3;280(14):781. Cesario TC, Nakano JH, Caldwell GG, Youmans RA. Paralytic poliomyelitis in an unimmunized child. Apparent result of a vaccine­derived poliovirus. Am J Dis Child. 1969 Dec;118(6):895­8. Del Campo A. Physiological changes of the vaccinated organism: a basis for the interpretation of the clinical complications due to prophylactic vaccines. Prog Immunobiol Stand. 1969;3:280­4. Farkas E, Nyerges G, Kiss S. Late dermal complication of smallpox vaccination. Orv Hetil. 1969 Jul. 20;110(29):1690­2. Feyling T, Hestetun S. Thrombocytopenic purpura after smallpox vaccination. Tidsskr Nor Laegeforen. 1969 May 15;89(10):725­6. Franczak T. Diabetes following virus hepatitis. Pol Tyg Lek. 1969 Oct 3;24(44):1705­6. Gold JA. Arthritis after rubella vaccination of women. N Engl J Med. 1969 Jul 10;281(2):109. Goswamy BM. Neurological complication after smallpox vaccination. J Assoc Physicians India. 1969 Jan;17(1):41­3. Holtzman CM. Postvaccination arthritis. N Engl J Med. 1969 Jan 9;280(2):111­2. Hopkins CC, Dismukes WE, Glick TH, Warren RJ. Surveillance of paralytic poliomyelitis in the United States. 1966 and 1967 cases, and 1965­1967 cases associated with oral poliovirus vaccine. JAMA. 1969 Oct 27;210(4):694­700. Katz SL. The effect of live attenuated measles­virus vaccine on the central nervous System. Int Arch Allergy Appl Immunol. 1969;36:Suppl:125­33. Kitamura I, Hirai S, Kurashige T. Poliomyelitis from a vaccine. Lancet. 1969 Mar 1;1(7592):465. Koval'skaia SI. Anaphylactogenic properties of ADT­, PDT­and APDT vaccines under experimental conditions. Zh Mikrobiol Epidemiol Immunobiol. 1969 Jan;46(1):65­71. Lane JM. Vaccination and Henoch­Schoenlein purpura. N Engl J Med. 1969 Apr 3;280(14):781. Lorentz IT, McLeod JG. Post­vaccinial sensory polyneuropathy with myoclonus, Proc Aust Assoc Neurol. 1969;6:81­6. Monnet P, Lauras B. Acute thrombopenia in the child. Pediatrie. 1969 Dec;24(8):885­909. Myking OL. Myocarditis after smallpox vaccination. Tidsskr Nor Laegeforen. 1969 Jan 15;89(2):87­9. Nicolopoulos D, Matsaniotis N, Kattamis C, Athanassiades T. Post­vaccinial complications. Report of 45 cases. Helv Paediatr Acta. 1969 Aug;24(4):378­89. Poser CM. Disseminad vasculomyelinopathy. A review of the clinical and pathologic, reactions of the nervous system in hyperergic diseases. Acta Neurol Scand. 1969;:Suppl 37:3­44. Sourreil P, Battin JP, Beylot C. Postvaccinal erythemato­purpuric acrodermatitis. Bull Soc Fr Dermatol Syphiligr. 1969;76(1):79­80. Supino V. Critical episode of an epileptic nature as complications of antipoliomyelitis vaccination with Sabin oral vaccine. Acta Neurol (Napoli). 1969 Jan­
Feb;24(1):62­5. Wasser S, Schone D, Hauschild G. Schoenlein­Henoch syndrome after smallpox vaccination. Kinderarztl Prax. 1969 Jul;37(7):299­303. 1970 Delaney JJ. Problems of rubella vaccination in adult women. Rocky Mt Med J. 1970 Oct;67(10):53­6. Eichmann K, Braun DG, Feizi T, Krause RM. The emergence of antibodies with either identical or unrelated individual antigenic specificity during repeated immunizations with streptococcal vaccines. J Exp Med. 1970 Jun 1;131(6):1169­89. Geiser JD. Malignant tumors­­complications of scars caused by smallpox vaccinations. Schweiz Rundsch Med Prax. 1970 Aug 11;59(32):1158­61. Hardy, GE, Jr, et al. The Failure of a School Immunization Campaign to Terminate an Urban Epidemic of Measles. Amer J Epidem, Mar 1970; 91:286­293. Kilroy AW, Schaffner W, Fleet WF Jr, Lefkowitz LB Jr, Karzon DT, Fenichel GM. Two syndromes following rubella immunization. Clinical observations and epidemiological studies. JAMA. 1970 Dec 28;214(13):2287­92. Obodowska­Zysk W. Reaction after vaccination against poliomyelitis and discussion of 3 cases. Przegl Epidemiol. 1970;24(2):249­54. Petrovic R. Study of reactions to the Di­Te­A1 vaccine for adults. Srp Arh Celok Lek. 1970 Apr;98(4):569­76. Riley KA. Basal cell epithelioma in smallpox vaccination scar. Report of a case. Arch Dermatol. 1970 Apr;101(4):416­7. Shaw EB, Cesario TC. Vaccine­derived poliomyelitis. Am J Dis Child. 1970 Jun;119(6):546. Study of reactions to the Di­Te­A1 vaccine for adults. Srp Arh Celok Lek. 1970 Apr;98(4):569­76. Uragami, G. Japanese pioneers in the vaccination. (Jpn) Igakushi.Kenkyu. 1970, 34:201­8. (): 201­208. 1971 Berger K, Ehrengut W. Vaccination lesions and vaccinia­strains. Dtsch Med Wochenschr. 1971 Sep 17;96(38):1511. Braginskaia VP, Sokolova AF, Livanova LV. Complications following immunization of children with several vaccines. Vopr Okhr Materin Det. 1971 Aug;16(8):18­24. Braginskaia VP, Sokolova AF. Postinoculation complications in smallpox vaccination of children. Sov Med. 1971 Jun;34(6):121­5. Chin J, Werner SB. Neuritis and arthritis following rubella immunization. JAMA. 1971 Jan 18;215(3):485­6. Deliyannakis E. Peripheral nerve and root disturbances following active immunization against smallpox and tetanus. Mil Med. 1971 May;136(5):458­62. Doutlik S, Vacek Z, Havrankova D. Evaluation of side­effects of Hempt's vaccine using electroencephalography. Cas Lek Cesk. 1971 Jan;110(3):59­61. Duenwald JC, Holland JM, Gorham JR, Ott RL. Feline panleukopenia: experimental cerebellar hypoplasia produced in neonatal ferrets with live virus vaccine. Res Vet Sci. 1971 Jul;12(4):394­6. Kuwert E, Thraenhart O, Hoher PG, Dorndorf W, Voit D, Blumenthal W. Spinal poliomyelitis due to contact with polio vaccine virus. Dtsch Med Wochenschr. 1971 Oct;96(40):1562­8. Leonida D. Complications of Rubella vaccine inoculation among 8,051 school children. Wis Med J. 1971 Oct;70(10):217­8. Levenbuk IS, Chebotareva SV, Chertkova FA. Clinical­anatomical analysis of some post­vaccinal complications in children. Zh Mikrobiol Epidemiol Immunobiol. 1971 Sep;48:55­60. Marennikova SS, Matsevich GR. Neurological complications following smallpox vaccination. Zh Mikrobiol Epidemiol Immunobiol. 1971 Sep;48:3­7. Melchior JC. Infantile spasms and immunisation in the first year of life. Neuropadiatrie. 1971 Jul;3(1):3­10. Orstavik I, Flugsrud LB, Lahelle O. Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study. Bull World Health Organ. 1971;45(6):733­9. Pitzurra M, Iorio A. Etiological studies in cases of anterior acute poliomyelitis (AAP) verified in Umbria and in the Marche since the year 1964. Ann Sclavo. 1971 May­Jun;13(3):299­304. Wilkins J, Leedom JM, Salvatore MA, Portnoy B. Transmission of rubella vaccine virus from vaccinees to contacts. Calif Med. 1971 Nov;115(5):16­22. Wong KY. Anaphylactoid purpura associated with smallpox vaccination. Hawaii Med J. 1971 Sep­Oct;30(5):388­9. Zakharova MS, Vares AM, Vorob'eva AI, Ustinova VG. Reactions to adsorbed pertussis­diphtheria­tetanus vaccine. Pediatriia. 1971 Jan;50(1):65­8. 1972 Bartos HR. Thrombocytopenia associated with rubella vaccination. N Y State J Med. 1972 Feb 15;72(4):499. Cherry JD. Peripheral pain syndromes following rubella immunization. J Pediatr. 1972 Mar;80(3):541­2. Forrest JM, Menser MA, Honeyman MC, Stout M, Murphy AM. Clinical rubella eleven months after vaccination. Lancet. 1972 Aug 26;2(7774):399­400. Friedman MM, Miller­Cranko JA. Malignancy in a smallpox vaccination scar. Report on another case. Cent Afr J Med. 1972 Jul;18(7):142. Granel B, Disdier P, Devin F, Swiader L, Riss JM, Coupier L, Harle JR, Jouglard J, Weiller PJ. Healy CE. Mumps vaccine and nerve deafness. Am J Dis Child. 1972 Jun;123(6):612. Haneberg B, Orstavik I. Poliomyelitis associated with oral poliovaccine. Report on two cases. Acta Paediatr Scand. 1972 Jan;61(1):105­8. Healy. Mumps Vaccine and Nerve Deafness. Am J Disorder Child, 1972 Jun; 123(6):612. Held JR, Adaros HL. Neurological disease in man following administration of suckling mouse brain antirabies vaccine. Bull World Health Organ. 1972;46(3):321­7. Henry P, Vital C, Du Pasquier P, Loiseau P, Barat M. Subacute anterior poliomyelitis after oral polio vaccination. Anatomo­clinical study. Rev Neurol (Paris). 1972 Sep;127(3):364­70. Mobius G, Wiedersberg H, Wunscher W, Backer F. Pathological­anatomical findings in cases of death following poliomyelitis and diphtheria­pertusis­tetanus vaccination. Dtsch Gesundheitsw. 1972 Jul 20;27(29):1382­6. Nosov SD, Braginskaia VP. Systematization of reactions developing after prophylactic vaccination. Pediatriia. 1972 Feb;51(2):10­5. Palmar I, Kaljalovic R, Popovic M, Marcetic V. Encephalopathy after vaccination against smallpox with permanent sequel­­diabetes insipidus. Vojnosanit Pregl. 1972 May;29(5):242­4. Porter D, Earle J. Jadassohn tumour arising at smallpox vaccination site. Br J Dermatol. 1972 Feb;86(2):177­9. Richter KH, Hoffmann F, Schwenen M. Smallpox: vaccination and incubation vaccination. Fortschr Med. 1972 Sep 14; 90(25):902­6. Tomasevic M, Petrovic B, Kamenkovic J, Purisic S. Incidence and variations of proteinuria following TABT vaccination. Vojnosanit Pregl. 1972 Jan;29(1):11­3. Vasil'eva IG, Semenov VF, Grachev VP, Popova VD. Possibilities of using the phenomenon of autoantibody formation for evaluating the quality of vaccines. Lab Delo. 1972;6:368­9. Wallace RB, Libert P, Ibrahim M, Isacson P. Joint symptoms following an area­wide rubella immunization campaign­­report of a survey. Am J Public Health. 1972 May;62(5):658­61. 1973 Ballerini Ricci B, Bilancia G, Cherubini E, Maccagnani F, Ricci G. On the neurological complications of vaccination, with special reference to epileptic syndromes. Riv Neurol. 1973 Jul­Aug;43(4):254­8. Basa, SN. Paralytic Poliomyelitis Following Inoculation With Combined DTP Prophylactic. A review of Sixteen cases with Special Reference to Immunization Schedules in Infancy. J Indian Med Assoc, Feb 1, 1973, 60:97­99. Brown RC, Blecher TE, French EA, Toghill PJ. Thrombotic thrombocytopenic purpura after influenza vaccination. Br Med J. 1973 May 5;2(5861):303. Cherry, JD, et al. A Clinical and Serologic Study of 103 Children With Measles Vaccine Failure. J Pediatr, May 1973; 82:801­808. Chiappo GF, Licata D, Mignone F, Remogna M. The Schonlein­Henoch syndrome in childhood. I. Nosographical classification. Minerva Pediatr. 1973 Oct 13;25(35):1465­72. Editorial. Vaccine­associated poliomyelitis. Med J Aust. 1973 Oct 27;2(17):795­6. Grachev VP, Popova VD, Vasilyeva IG, Avdeyeva LI. Formation of autoantibodies in laboratory animals after inoculation of viruses with different virulence. I. Results of studies on vaccine and wild strains of polio and measles viruses in guinea pigs. Acta Virol. 1973 Jul;17(4):319­26. Hale MS, Ruderman JE. Carpal tunnel syndrome associated with rubella immunization. Am J Phys Med. 1973 Aug;52(4):189­94. Klemparskaya N. Autohaemolysin­producing cells in mice injected with bacterial vaccines. Immunology. 1973 Jul;25(1):11­5. Krapp R, Holzmann H. Revaccination and primary psoriatic manifestation­­expert opinion. Berufsdermatosen. 1973;21(6):254­61. Landrigan PJ, Witte JJ. Neurologic disorders following live measles­virus vaccination. JAMA. 1973 Mar 26;223(13):1459­62. Mazurenko GI, Deliagina EM. Periarteritis nodosa, developing after vaccination. Vrach Delo. 1973 Oct;10:128­9. Multiple sclerosis and vaccinations. British Medical Journal, aprile 1967 Adams, JM et al. Neuromyelitis Optica: Severe Demyelination Occurring Years After Primary Smallpox Vaccinations. Rev Roum Neurol, 1973, 10:227­231. Plotkin, SA. Failures of Protection by Measles Vaccine. J Pediatr, May 1973; 82:798­801. Richter KH, Buchwald G. Smallpox, purpura and incubation vaccination. Simultaneously a reply and correction to Buchwald's article. Incubation vaccinations". Med Welt. 1973 Nov 9;24(45):1765­74. Symmers WS. Thrombocytopenic purpura and haemolytic anaemia after influenza vaccination. Br Med J. 1973 Jun 9;2(5866):614. Tilgner S, Meyer W, Hempel E, Schroder KD. Experimental allergic chorioretinitis in rabbits following immunization to homologous retina. Exp Eye Res. 1973 Jan 1;15(1):71­3. Tilz GP, Heschl R. Anaphylactic reactions following vaccinations. Dtsch Med Wochenschr. 1973 May 18;98(20):1047. Vaccine­Associated Poliomyelitis. Med J Aust, Oct 1973, 2:795­796. Walter Z, Walter T. 6 cases of poliomyelitis associated with oral immunization. Wiad Lek. 1973 May 15;26(10):901­5. Wilson J. Proceedings: Neurological complications of DPT inoculation in infancy. Arch Dis Child. 1973 Oct;48(10):829­30. 1974 Aasted B. Characterization of the antibody production in rabbits induced by streptococcal group A and C carbohydrate antigens. II. Evidence that the appearance of an antibody response of restricted heterogeneity is accompanied by an anti­antibody production. Scand J Immunol. 1974;3(5):553­8. Apostolski A, Stankovic M, Romano M, Anicic S, Popovic D. Myocarditis following administration of antivariola vaccine. Vojnosanit Pregl. 1974 Mar­
Apr;31(2):122­5. Bessard G, Marchal A, Avezou F, Pont J, Rambaud P. A new case of myocarditis following smallpox vaccination. Pediatrie. 1974 Mar;29(2):179­84. Bolotovskii, V, et al. Measles Incidence Among Children Properly Vaccinated Against This Infection. ZH Mikrobiol Epidemiol Immunobiol, 1974; 00(5):32­
35. Braginskaia VP, Gurvich EB, Dzagurov SG, Ozeretskovskii NA. Neurological complications after immunization of children against smallpox. Pediatriia. 1974 Jan;(1):39. Dolinova L. Bilateral uveoretinoneuritis following DITEPE vaccination. Cesk Oftalmol. 1974 Mar;30(2):114­6. Felix JK, Schwartz RH, Myers GJ. Isolated hypoglossal nerve paralysis following influenza vaccination. Am J Dis Child 1976 Jan;130(1):82­3. Donadon W, Pagnan A, Dal Palu C. Case of acute benign myocarditis caused by smallpox vaccination. Minerva Cardioangiol. 1974 Sep;22(9):642­5. Ducloux M, Robin Y, Chaffaut A. A further case of neuropathy following rabies vaccination. Bull Soc Med Afr Noire Lang Fr. 1974;19(3):247­50. Eggers C. Postvaccinal polyneuritis as a complication of smallpox vaccination. Monatsschr Kinderheilkd. 1974 Jul;122(7):681. Eggers C. The post­vaccinal polyneuritis as complication following smallpox­vaccination (author's transl). Monatsschr Kinderheilkd. 1974 Apr;122(4):169­71. Greshilo MS, Gorchitsa LV. Postvaccinal complications in children inoculated against smallpox. Pediatr Akus Ginekol. 1974 Sep­Oct;(5):14­5. Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child. 1974 Jan;49(1):46­9. Laitinen O, Vaheri A, University Central Hospital and Department of Virology, University of Helsinki, Finland. Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus, and infectious mononucleosis. The Lancet, vol. 1, February 9, 1974, pp. 194­7. Landrigan, PJ et al. Measles in Previously Vaccinated Children in Illinois. Ill Med J, Arp 1974, 141:367­372. Landrigan, PJ, et al. Measles in Previously Vaccinated Children in Illinois. Ill Med J, Apr 1974; 141:367­372. Rennie AG. Ocular Vaccinia. The Lancet, 3 august 1974, 2:273­275. Rohde W. Possibilities of reactions and complications from the part of CNS in vaccinations. Z Arztl Fortbild (Jena). 1974 Feb 15;68(4):202­8. Schaffner W, Fleet WF, Kilroy AW, Lefkowitz LB, Herrmann KL, Thompson J, Karzon DT. Polyneuropathy following rubella immunization. A follow­up study and review of the problem. Am J Dis Child. 1974 May;127(5):684­8. Ullrich E, Schmutzler R. Skin manifestations following smallpox vaccination. Padiatr Grenzgeb. 1974;13(2­3):119­25. Vesper J, Dietze RA. Clinical and legal aspects of the prevention, recognition and assessment of neurogenic vaccination complications in childhood. 1. Clinical problems associated with the definition, recognition and prevention of vaccination complications in childhood. Psychiatr Neurol Med Psychol (Leipz). 1974 Nov;26(11):685­92. Wharton CF, Pietroni R. Letter: Polyarteritis after influenza vaccination. Br Med J. 1974 May 11;2(914):331­2. Wilson J, Robinson R. Letter: Poliomyelitis after contact with recently vaccinated infant. Br Med J. 1974 Apr 6;2(909):53. Zayid I, Farraj S. Granuloma pyogenicum ­ a hitherto unrecognized complication of smallpox vaccination. Br J Dermatol. 1974 Mar;90(3):293­9. 1975 Aicardi J, Chevrie JJ. Neurologic manifestations following pertussis vaccination. Arch Fr Pediatr 1975 Apr;32(4):309­17. Cooverji ND, D'Sa JA. Reactions to adsorbed triple vaccine. Indian Pediatr. 1975 Sep;12(9):875­7. Corvaglia E. Jennerian vaccination. 2 unusual complications. Minerva Pediatr. 1975 Apr 7;27(12):708­13. Kulwin MH. Basal cell epithelioma in smallpox vaccination scar­fifty years later. IMJ Ill Med J. 1975 Dec;148(6):612­3. Lery L, Gaillard L, Delphin D. Benign neurologic accident following anti­rabies vaccination. Unforeseen clinical and biological aspects. Arch Fr Pediatr 1975 Jun­Jul;32(6):563­7. Movsesiants AA, Gurvich EB, Dzagurov SG, Grachev VP, Avdeeva LI. Experimental study of the ability of different strains of vaccinia virus to induce autoantibody formation. Vopr Virusol 1975 May­Jun;(3):297­302. Ogra PL, Chiba Y, Ogra SS, Dzierba JL, Herd JK. Rubella­virus infection in juvenile rheumatoid arthritis. Lancet 1975 May 24;1(7917):1157­61. Oyrl, A, et al. Can Vaccinations Harm the Kidney? Clin Nephrol, 1975, 3(5):204­205. Radvila P. Prevention of tetanus in man and animal following injury. Arch Exp Veterinarmed 1975 Jun;29(3):469­81. Schmidt GW. Tuberous sclerosis as cause of neuropathological symptoms allegedly due to smallpox vaccination. Monatsschr Kinderheilkd 1975 Sep;123(9):664­6. Schneider H. Manifestation of diabetes after smallpox vaccination. Kinderarztl Prax. 1975 Mar;43(3):101­7. Schrader H. A case of Guillain­Barre syndrome following cholera vaccination. J Neurol 1975;209(1):69­74. Sinaniotis CA, Daskalopoulou E, Lapatsanis P, Doxiadis S. Letter: Diabetes mellitus after mumps vaccination. Arch Dis Child. 1975 Sep;50(9):749­50. 1976 Bichel. Post­vaccinial Lymphadenitis Developing into Hodgkin’s Disease. Acta Med Scand, 1976, Vol 199, p523­525. Bolognesi, DP. Potential Leukemia Virus Subunit Vaccines: Discussion. Can Research, Feb 1976, 36(2 pt 2):655­656. Castrow FF, Williams TE. Basal­cell epithelioma occurring in a smallpox vaccination scar. J Dermatol Surg. 1976 May;2(2):151­2. De Jong MC, Monnens LA. Recurrent haemolytic uraemic syndrome. Padiatr Padol 1976;11(3):521­7. De Kozak Y, FRE, Usui M, Faure JP. Experimental autoimmune uveoretinitis. Ultrastructure of chorioretinal lesions induced in guinea pigs by immunization against the outer rods of the bovine retina, Arch Ophtalmol (Paris). 1976 Mar;36(3):231­48. Deutsch J. Temperature changes after triple­immunization in infant age. Padiatr Grenzgeb. 1976;15(1):3­6. Dietzsch HJ, Kiehl W. Central nervous complications following measles vaccination. Dtsch Gesundheitsw. 1976 Dec 4;31(52):2489­91. Erdos Z, Romhanyi J, Szemenyei C. Fatal BCG vaccination. Acta Paediatr Acad Sci Hung 1976;17(4):287­92. Gatta AM, Pieroni P. Acute fatal myocarditis following smallpox vaccination. Minerva Pediatr. 1976 Sep 8;28(27):1691­6. Gerth HJ. Letter: Influenza following influenza vaccination. Dtsch Med Wochenschr. 1976 Jul 2;101(27):1043. Hempel E, Tilgner S, Meyer W, Schroder KD. Experimental chorioretinitis in rabbits following injection of autologous retina in Freund's complete adjuvant. Exp Eye Res. 1976 Oct;23(4):399­401. Johnson, RH, et al. Nosocomial Vaccinia Infection. West J Med, Oct 1976, 125(4):266­270. Luster MI, Leslie GA. Erythrocyte antinuclear antibodies in sera of chickens hyperimmunized with group A streptococcal vaccine. Infect Immun 1976 Mar;13(3):825­9. Mastroiacovo P. Measles vaccination and Schonlein­Henoch purpura. Minerva Pediatr. 1976 Aug 4;28(25):1591. Mittermayer CH. Lethal complications of typhoid­cholera­vaccination. (Case report and review of the literature). Beitr Pathol 1976 Jul;158(2):212­24. Moschos A, Papaioannou AC, Nicolopoulos D, Anagnostakis D. Cardiac complications after vaccination for smallpox. Helv Paediatr Acta 1976 OCT;31(3):257­60. Rosenthal T, Michaeli D. Vaccine­associated poliomyelitis. Harefuah. 1976 Jan 1;90(1):25­6. Ryzhova TP, Dadiomova MA. Neurologic complications of APDT vaccination (immediate and remote outcomes). Pediatriia. 1976 Jan;(1):64­7. Schlenska GK. Neurological complications following rabies duck embryo vaccination. J Neurol. 1976 Nov 26;214(1):71­4. Schonberger LB, McGowan JE Jr, Gregg MB. Vaccine­associated poliomyelitis in the United States, 1961­1972. Am J Epidemiol 1976 Aug;104(2):202­11. Schumm F. Letter: Neurologic complications following influenza vaccination? Dtsch Med Wochenschr. 1976 Apr 30;101(18):720­1. Stohr M, Mayer K. Neurologic diseases following influenza vaccination. Med Welt. 1976 May 7;27(19):912­4. Stopfkuchen H, Jungst BK, Wilutzky H. Purpura fulminans associated with varicella and polyvalent protective inoculations. Klin Padiatr. 1976 Mar;188(2):190­3. Sudden death among Finnish conscripts [following cardiac damage from vaccine. British Med Journal, 1976. Zaludko J, Vrbova O. Acute myocarditis as complication of smallpox vaccination in adulthood. Bratisl Lek Listy. 1976;66(3):345­8. 1977 Barnard BJ, Geyer HJ, De Koker WC. Neurological symptoms in a cat following vaccination with high egg passage Flury rabies vaccine of chicken embryo origin. Onderstepoort J Vet Res 1977 Sep;44(3):195­6. Bensasson M, Lanoe R, Assan R. A case of algodystrophic syndrome of the upper limb following tetanus vaccination. Sem Hop. 1977 Oct 23;53(36):1965­6. Caspary EA. Effect of live attenuated vaccines on the course of experimental allergic encephalomyelitis. A pilot study. Eur Neurol 1977;16(1­6):176­80. Davis LE, Bodian D, Price D, Butler IJ, Vickers JH. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med 1977 Aug 4;297(5):241­5. Ehrengut W, Allerdist H. Neurological complications after influenza vaccination. MMW Munch Med Wochenschr 1977 May 20;119(20):705­10. Ehrengut W. Neurological complications following whooping­cough vaccination. Monatsschr Kinderheilkd 1977 Nov;125(11):908­11. Forrest, JM, et al. Failure of Rubella Vaccination to Prevent Congenital Rubella. Med J Aust, 1977 Jan 15; 1(3): 77. Furlow TW Jr. Neuropathy after influenza vaccination. Lancet. 1977 Jan 29;1(8005):253­4. Glathe, H et al. Evidence of Tumorigenic Activity of Candidate Cell Substrate in Vaccine Production by the Use of Anti­Lymphocyte Serum. Development Biol Std, 1977, 34:145­148. Kumbar UN, Varkey B. Urticarial rash, periorbital edema following influenza (bivalent) vaccination. Can Med Assoc J. 1977 Apr 9;116(7):724. Onica D, Mihalcu F, Lenkei R, Gherman M, Tudor M. Autoantibodies detected in rabbits hyperimmunized with group A, C, and G streptococcal vaccines. Infect Immun 1977 Dec;18(3):624­8. Oszczak A, Kaniak AA. Case of hepato­renal syndrome following vaccination against smallpox. Wiad Lek. 1977 Oct 1;30(19):1519­21. Ressler P. Evaluation of cerebral function disturbances following smallpox vaccination. Z Arztl Fortbild (Jena). 1977 Mar 15;71(6):289­93. Seiferth, LB. Deafness after Oral Poliomyelitis Vaccination ­a Case Report and Review. HNO, 1977 Aug; 25(8): 297­300. Shasby, DM, et al. Epidemic Measles in Highly Vaccinated Population. NEJM, Mar 1977, 296(11): 585­589. Stewart GT. Vaccination against whooping­cough. Efficacy versus risks. Lancet 1977 Jan 29;1(8005):234­7. Stohr M. Para­infectious cerebral nerve mononeuritis and mononeuritis multiplex: a selectively located type of para­infectious, postvaccination, serogenetic neuritis. Nervenarzt. 1977 Jul;48(7):359­64. Wecht CH. The swine flu immunization program: scientific venture or political folly? Am J Law Med 1977­78 Winter;3(4):425­45. Weintraub MI, Chia DT. Paralytic brachial neuritis after swine flu vaccination. Arch Neurol. 1977 Aug;34(8):518. Wright PF, Hatch MH, Kasselberg AG, Lowry SP, Wadlington WB, Karzon DT. Vaccine­associated poliomyelitis in a child with sex­linked agammaglobulinemia. J Pediatr 1977 Sep;91(3):408­12. 1978 Basillico FC, Bernat JL. Vaccine­associated poliomyelitis in a contact. JAMA. 1978 May 26;239(21):2275. Burkholder JN. Severe vaccine reaction. Can Med Assoc J. 1978 May 6;118(9):1027. Dyro FM. Vaccination mononeuropathy. Ann Neurol. 1978 May;3(5):468. Ehrengut W. Dermatomyositis and vaccination. Lancet. 1978 May 13;1(8072):1040­1. Froissart, M et al. Acute Meningoencephalitis Immediately after an Influenza Vaccination. Lille Med, Oct 1978, 23(8):548­551. Haneberg B, Matre R, Winsnes R, Dalen A, Vogt H, Finne PH. Acute hemolytic anemia related to diphtheria­pertussis­tetanus vaccination. Acta Paediatr Scand 1978 May;67(3):345­50. Hazelrigg DE. Basal cell epithelioma in a vaccination scar. Int J Dermatol. 1978 Nov;17(9):723­5. Helle EP, Koskenvuo K, Heikkila J, Pikkarainen J, Weckstrom P. Myocardial complications of immunisations. Ann Clin Res 1978 Oct;10(5):280­7. Hennessen W, Jacob H, Quast U. Neurologic affections after influenza inoculation (author's transl). Nervenarzt. 1978 Feb;49(2):90­6. Kazarian EL, Gager WE. Optic neuritis complicating measles, mumps, and rubella vaccination. Am J Ophthalmol 1978 Oct;86(4):544­7. Knuutila, S et al. An Increased Frequency of Chromosomal Changes and SCE’s in Cultured Lymphocytes of 12 Subjects Vaccinated Against Smallpox. Hum Genet, 1978 Feb 23; 41(1):89­96. Mathias, R G. Whooping Cough In Spite of Immunization. Can J Pub Health, 1978 Mar/Apr; 69(2):130­132. Mel'man NI. Renal lesions after use of vaccines and sera. Vrach Delo. 1978 Oct;(10):67­9. Myocardic complications from vaccines. Annals of Clinical Research 1978 Vol 10. Pokrovskaia NI, Gurvich EB, Ozeretskovskii NA. Neurological complications in children from smallpox vaccination. Pediatriia. 1978 Dec;(12):45­9. Prandota J, Zwolinska D. 2 cases of acute renal failure in children following Di­Te­Per vaccination. Pediatr Pol. 1978 Feb;53(2):215­7. Scholl R, Wolf R, Dieckhofer K. Neurologic disorders following influenza vaccination. A case report. Med Welt. 1978 Nov 3;29(44):1707­9. Senatore S, Tedeschi F. Uremic­hemolytic syndrome: clinical and pathological observations of a case (author's transl). Ateneo Parmense Acta Biomed 1978;49(4):377­87. Silina ZM, Galaktionova TI, Shabunina NR. Causes of postvaccinal complications in the kidneys in young infants. Pediatriia. 1978 Dec;(12):59­61. Smith JW, Wherry PJ. Poliomyelitis surveillance in England and Wales, 1969­1975. J Hyg (Lond) 1978 Feb;80(1):155­67. Smith, T. Vaccination/immunisation and compensation J.Med.Ethics. 1978, 4 (3): 152. 1979 Allerdist, H. Neurological Complications Following Measles Virus Vaccination. Evaluation of the Cases seen Between 1971­1977. Monatsschr Kinderheilkd, Jan 1979, 127(1): 23­28. Bowman, I. A. Smallpox vaccination in the nineteenth century Bookman. 1979, 6 (1): 1­12. Buimovici­Klein E, Cooper LZ. Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines. Infect Immun 1979 Jul;25(1):352­6. Cherkeziia, SE, et al. Disorders in the Murine Chromosome Apparatus Induced By Immunization with a Complex of Anti­viral Vaccines. Vopr Virusol, 1979 Sept Oct, (5):547­550. Colling RG, Brown JC. The appearance of IgM and IgG cold agglutinins in rabbits hyperimmunized with group C streptococcal vaccine. J Immunol. 1979 Jan;122(1):202­8. Cupic V,et al. Role of DTP vaccine in the convulsive syndromes in children. Lijec Vjesn 1978 Jun; 100(6):345­348. Article in Serbo­Croatian (Roman). Ehrengut W, Ehrengut J. Convulsions following oral polio immunisation. Dev Biol Stand 1979;43:165­71. Damjanov J, Amato JA. Progression of renal disease in Henoch­Schonlein purpura after influenza Vaccination. JAMA. 1979 Dec 7;242(23):2555­6. Ehrengut, W et al. On Convulsive Reactions Following Oral vaccination Against Polio. Klin Paediatr, May 1979, 191(3):261­270. Eisinger, AJ et al. Acute Renal Failure after TAB and Cholera Vaccination. B Med J, Feb 10, 1979, 1(6160):381­382. Hennessen W, Quast U. Side effects of whooping cough inoculation. Fortschr Med 1979 Oct 25;97(40):1772­4. Kass E, Straume S, Mellbye OJ, Munthe E, Solheim BG. Dermatomyositis associated with BCG vaccination. Scand J Rheumatol 1979;8(3):187­91. Muller I, Haupt M. Vaccination complications following triple vaccination. Kinderarztl Prax. 1979 May;47(5):269­75. Naumova, R P, et al. Encephalitis Developing After Vaccination without a Local Skin Reaction. Vrach Delo, Jul 1979, (7):114­115. Pembroke AC, Marten RH. Unusual cutaneous reactions following diphtheria and tetanus immunization. Clin Exp Dermatol. 1979 Sep;4(3):345­8. Perry HD, Mallen FJ, Grodin RW, Cossari AJ. Reversible blindness in optic neuritis associated with influenza vaccination. Ann Ophthalmol 1979 Apr;11(4):545­50. Quast U, Hennessen W, Widmark RM. Vaccine induced mumps­like diseases. Dev Biol Stand 1979;43:269­72. Schonberger LB, Bregman DJ, Sullivan­Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA.Guillain­Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976­1977. Am J Epidemiol 1979 Aug;110(2):105­23. Shirasawa K, Akai K, Kawaguchi Y, Maeda S, Nagahara S, Toyoda H, Kurata T. Widespread eczema vaccinatum acquired by contacts. A report of an autopsy case. Acta Pathol Jpn 1979 May;29(3):435­55. Stewart GT. Deaths of infants after triple vaccine. Lancet. 1979 Aug 18;2(8138):354­5. Tingle AJ, Ford DK, Price GE, Kettyls DW. Prolonged arthritis in identical twins after rubella immunization. Ann Intern Med. 1979 Feb;90(2):203­4. Tritschler JL, Delouvrier JJ, Khoury M, Dehen H, Masson M. Multiple sclerosis manifested by paralysis of the great hypoglossal nerve. Nouv Presse Med. 1979 Sep 10;8(34):2756. 1980 Bayer AS. Arthritis related to rubella: a complication of natural rubella and rubella immunization. Postgrad Med. 1980 May;67(5):131­4. Beikin IB, Erman BA, Vlasova LV, Vaserin II, Livshits AA. Poliovirus infection in monkeys vaccinated with live Sabin vaccine. Zh Mikrobiol Epidemiol Immunobiol1980;(2):84­9. Blumberg S, Bienfang D, Kantrowitz FG. A possible association between influenza vaccination and smallvessel vasculitis. Arch Intern Med 1980 Jun;140(6):847­8. Boling HL. An adult's reaction to measles vaccine. Am J Nurs. 1980 Aug;80(8):1442­3. Curran, W. J. Health department legal liability for injuries in vaccination programs Am.J.Public Health Nations.Health. 1980, 70 (11): 1215­1216. Cutting, W. Cost­benefit evaluations of vaccination programmes Lancet. 1980, %20;2 (8195): 634­635. Fukase, Y. [On the foundation of Otamagaike Vaccination Infirmary part 2: Toshiakira Kawaji and Genzo Saito] (Jpn) Nippon Ishigaku.Zasshi. 1980, 26 (4): 420­431. Gorshunova LP, Maksimova­Todorova VA, Vanag KA, Nabokokova AV, Sadogurskaia EM. Persistence of attenuated poliomyelitis virus in the organs of vaccinated animals. Vopr Virusol 1980 May­Jun;(3):338­41. Gurvich EB, Lakotkina EA, Kossova ET, Stepanenkova LP, Pozdnyakova IS, Ozeretskovskij NA. Lack of correlation between complications after smallpox vaccination and the ABO blood­group system. J Hyg Epidemiol Microbiol Immunol 1980;24(2):200­5. Keenlyside RA, Schonberger LB, Bregman DJ, Bolyai JZ. Fatal Guillain­Barre syndrome after the national influenza immunization program. Neurology 1980 Sep;30(9):929­33. Li J, Zhang LB, Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Hara M, Nomura T, Yoshikura H, Minor PD. Comparative biochemical studies of type 3 poliovirus. J Virol 1980 Apr;34(1):73­84. Lozovskaia LS, Desiatskova RG, Mitchenko AF, Pokryshkina EL, Shigina OM. Antibodies to rubella virus in the blood sera and in the synovial fluid of children with rheumatoid arthritis. Vopr Virusol 1980 Jul­Aug;(4):468­73. Mandal GS, Mukhopadhyay M, Bhattacharya AR. Adverse reactions following tetanus toxoid injection. J Indian Med Assoc. 1980 Jan 16;74(2):35­7. Negina IP. Comparative study of autoantibody formation following immunization with different types of typhoid vaccines. Zh Mikrobiol Epidemiol Immunobiol. 1980 May;(5):69­72. Neumann G. Relation of vaccination to childhood malignancy. Med Klin. 1980 Jan 18;75(2):72­5. Panizzon R. Basal cell epithelioma in a BCG vaccination scar. Arch Dermatol. 1980 Apr;116(4):381. Rich JD, Shesol BF, Horne DW 3rd. Basal cell carcinoma arising in a smallpox vaccination site. J Clin Pathol. 1980 Feb;33(2):134­5. Russo F, Piro E, Frugiuele PL, Buffone E, Palma B, Greco LM. Problems of rubella prevention: vaccination of 51 fertile young women with the Wister Ra 27/3 virus strain. Ann Sclavo. 1980 Jan­Feb;22(1):57­62. 1981 Burianova B, Hegerova H, Hybaskova J, Malicky J, Pruchova J, Puzanova L, Vlcek J. Reactions after immunization with the triple vaccine against diphtheria, tetanus, and pertussis. Cesk Pediatr. 1981 Nov;36(11):646­7. Cannata J, Cuesta V, Peral V, Maisueche I, Herrera J. Reactivation of vasculitis after influenza vaccination. Br Med J 1981 Aug 22;283(6290):526. Cizewska S, Huber Z, Sluzewski W. Prophylactic inoculations and seizure activity in the EEG. Neurol Neurochir Pol 1981 Sep­Dec;15(5­6):553­7. Dittman S. Atypical reactions after vaccination. Beitr Hyg Epidemiol. 1981;25:1­274. Douglas SD, Anolik R.,Postvaccination paralysis in a 20­month­old child. Hosp Pract (Off Ed). 1981 Sep;16(9):40A, 40F. Drozdz M, Kucharz E, Felus E. Antiglobulin antibodies in blood serum of rabbits hyperimmunized with bovine albumin and treated chronically with hydrazinophtalazines. Arch Immunol Ther Exp (Warsz). 1981;29(2):167­73. Experimental myocarditis. II. Cardiac lesions in rats induced by immunization with heterologous heart extracts. Jpn Circ J 1981 Dec;45(12):1399­402. Fellat­Hamdouch R, Mouhadden F, Jorio M, Malki­Tazi A. Rabies in supposedly vaccinated children, cases of long incubation (apropos of 2 cases). Maroc Med. 1981 Dec;3(4):793­803. Fukuta S, Kimura Y, Yamakawa K, Iwamoto S, Wada K, Kusukawa R. Experimental myocarditis. II. Cardiac lesions in rats induced by immunization with heterologous heart extracts. Jpn Circ J 1981 Dec;45(12):1399­402. Goodwin CS. Smallpox vaccination: risks are involved. Med J Aust. 1981 Feb 7;1(3):139. Grahame R, Armstrong R, Simmons NA, Mims CA, Wilton JM, Laurent R. Isolation of rubella virus from synovial fluid in five cases of seronegative arthritis. Lancet 1981 Sep 26;2(8248):649­51. Gross TP, Milstien JB, Kuritsky JN. Bulging fontanelle after immunization with diphtheria­tetanus­pertussis vaccine and diphtheria­tetanus vaccine. J Pediatr. 1989 Mar;114(3):423­5. Mathur R, Kumari S. Bulging fontanel following triple vaccine. Indian Pediatr. 1981 Jun;18(6):417­8. Hall WN, Goodman RA, Noble GR, Kendal AP, Steece RS. An outbreak of influenza B in an elderly population. J Infect Dis 1981 Oct;144(4):297­302. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain­Barre syndrome and the 1978­1979 influenza Vaccine. N Engl J Med 1981 Jun 25;304(26):1557­61. Kelton JG. Vaccination­Associated relapse of immune thrombocytopenia. JAMA 1981 Jan 23­30;245(4):369­70. Kew OM, Nottay BK, Hatch MH, Nakano JH, Obijeski JF. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol 1981 Oct;56(Pt 2):337­47. Laude TA. Herald patch in a DPT injection site. J Am Acad Dermatol. 1981 Oct;5(4):475­6. Mathur R, Kumari S. Bulging fontanel following triple vaccine. Indian Pediatr. 1981 Jun;18(6):417­8. Omokoku B, Castells S. Post­DPT inoculation cervical lymphadenitis in children. N Y State J Med. 1981 Oct;81(11):1667­8. Omokoku B, Castells S. Post­DPT inoculation cervical lymphadenitis in children. N Y State J Med 1981 Oct;81(11):1667­1668. Robinson IG. Unusual reaction to tetanus toxoid. N Z Med J. 1981 Nov 11;94(695):359. Shi OS. Observations on immune persistence after vaccination with attenuated polio vaccine. Zhonghua Yu Fang Yi Xue Za Zhi. 1981 May;15(3):148­50. Smith MF, Haycock GB, Grahame R. Rubella and juvenile chronic arthritis. Arch Dis Child 1981 Apr;56(4):310­1. Stewart GT, Wilson J. Pertussis vaccine and serious acute neurological illness in children. Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1968­9. Stickl, H. Iatrogenic Immuno­suppression as a Result of Vaccination. Fortschr Med, Mar 5, 1981, 99(9);289­292. Streifler JJ, Dux S, Garty M, Rosenfeld JB. Recurrent pericarditis: a rare complication of influenza vaccination. Br Med J (Clin Res Ed). 1981 Aug 22;283(6290):526­7. Vadot E. Chorioretinitis induced by vaccination. Bull Soc Ophtalmol Fr. 1981 Apr­May;81(4­5):501­3. Zabicka J. Vaccines and vaccination against mumps. Przegl Epidemiol. 1981;35(3):399­401. 1982 Anderson, R. and May, R. The logic of vaccination New Sci. 11­18­1982, 96 (1332): 410­415. Champsaur HF, Bottazzo GF, Bertrams J, Assan R, Bach C. Virologic, immunologic, and genetic factors in insulin­dependent diabetes mellitus. J Pediatr 1982 Jan;100(1):15­20. Connor IM. Neurological reactions to pertussis vaccination. Arch Dis Child. 1982 Mar;57(3):241. Fenichel GM. Neurological complications of immunization. Ann Neurol 1982 Aug;12(2):119­28. Ford DK, da Roza DM, Reid GD, Chantler JK, Tingle AJ. Synovial mononuclear cell responses to rubella antigen in rheumatoid arthritis and unexplained persistent knee arthritis. J Rheumatol 1982 May­Jun; 9(3):420­3. Giudicelli, et al. Renal Risk in Vaccination. Presse Med, Jun 11, 1982, 12(25):1587­1590. Jacquot, C et al. Renal Risk in Vaccination. Nouv Presse Med, Nov 6, 1982, 11(44):3237­3238. Johnstone T, Arcand TA. Adverse reactions associated with DTP immunizations. Pediatrics. 1982 Nov;70(5):829. Kline LB, Margulies SL, Oh SJ. Optic neuritis and myelitis following rubella vaccination. Arch Neurol. 1982 Jul;39(7):443­4. Kucharska Z, Sramova H, Zdrazilek J. Excretion of attenuated polioviruses in children vaccinated with live oral poliovirus vaccine. J Hyg Epidemiol Microbiol Immunol 1982;26(1):74­82. Loffel M, Meienberg O, Diem P, Mombelli G. Vaccine poliomyelitis in an adult undergoing chemotherapy for non­Hodgkin lymphoma. Schweiz Med Wochenschr 1982 Mar 20;112(12):419­21. Macoul KL. Bilateral optic nerve atrophy and blindness following swine influenza Vaccination. Ann Ophthalmol. 1982 Apr;14(4):398­9. Nielsen LJ, Karup Pedersen F, Ellegaard J. Failure of pneumococcal vaccination in a splenectomized child. Acta Paediatr Scand 1982 Mar;71(2):331­3. Orlans D, Verbov J. Skin reactions after triple vaccine. Practitioner. 1982 Jul;226(1369):1295­6. Rajagopalan P, Kumar R, Malaviya AN. A study of humoral and cell­mediated immune response following typhoid vaccination in human volunteers. Clin Exp Immunol 1982 Feb;47(2):275­82. Soekawa, M. [Was the vaccinia virus, which was introduced into Japan by Dr. Otto G. J. Mohnike, used for vaccination in Japan] (Jpn) Nippon Ishigaku.Zasshi. 1982, 28 (1): 1­14. Yoneyama T, Hagiwara A, Hara M, Shimojo H. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients. Infect Immun 1982 Jul;37(1):46­53. 1983 Albert JM, Ott HJ. Calcifying dermatomyositis following antitetanus vaccination. Arch Intern Med 1983 Jul;143(7):1457­8. Baraff, LJ, et al. Possible Temporal Association Between Diphtheria­tetanus toxoid­Pertussis Vaccination and Sudden Infant Death Syndrome. Pediatr Infect Disorder, Jan­Feb 1983, 2(1): 5­6. Bator, P. A. The health reformers versus the common Canadian: the controversy over compulsory vaccination against smallpox in Toronto and Ontario, 1900­
1920 Ont.Hist. 1983, 75 (4): 348­373. Coplan J. Seizures following immunizations. J Pediatr. 1983 Sep;103(3):496. Foo D, Rossier AB. Anterior spinal artery syndrome and its natural history. Paraplegia 1983 Feb;21(1):1­10. Friedland ML, Wittels EG. An unusual neurologic reaction following polyvalent pneumococcal vaccine in a patient with hairy cell leukemia. Am J Hematol. 1983 Apr;14(2):189­91. Fulginiti, V. Sudden Infant Death Syndrome, Diphtheria­Tetanus Toxoid­Pertussis Vaccination and Visits to the Doctor: Chance Association or Cause and Effect? Pediatr Infect Disorder, Jan­Feb 1983, 2(1): 7­11. Graham DR. Reactions to tetanus toxoid. JAMA. 1983 Sep 9;250(10):1273­4. Guillevin L, Levy Y. Hypersensitivity reaction following vaccination against influenza. Presse Med. 1983 Jun 18;12(26):1668­9. Hirschel BJ, Hirschel­Scholz S, Luthy R, Bonetti A. Abdominal typhus following vaccination with the live vaccine Vivotif. Schweiz Med Wochenschr. 1983 Apr 23;113(16):605­7. Hirtz DG, Nelson KB, Ellenberg JH. Seizures following childhood immunizations. J Pediatr 1983 Jan;102(1):14­8. Holliday PL, Bauer RB. Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids. Arch Neurol. 1983 Jan;40(1):56­7. Houston TP. Small­vessel vasculitis following simultaneous influenza and pneumococcal vaccination. N Y State J Med. 1983 Oct­Nov;83(11­12):1182­3. Kruppenbacher JP, Mertens T, Adrian M, Smolenski S, Leidel J, Eggers HJ. Vaccine poliomyelitis as a complication of oral vaccination. Offentl Gesundheitswes. 1983 Oct;45(10):528­31. Ledermann JA, Hoffbrand BI. Dapsone in allergic vasculitis: its use in Henoch­Schonlein disease following Vaccination. J R Soc Med. 1983 Jul;76(7):613­4. Matsuki, A. [Studies on G. Nakagawa's vaccination­­new evidence of Nakagawa's vaccination] (Jpn) Nippon Ishigaku.Zasshi. 1983, 29 (1): 35­41. McEwen J. Early­onset reaction after measles vaccination. Further Australian reports. Med J Aust 1983 Nov 12;2(10):503­5. Mortimer EA Jr, Jones PK, Adelson L. DTP and SIDS. Pediatr Infect Dis. 1983 Nov­Dec;2(6):492­3. Openshaw H, Lieberman JS. Vaccine­related poliomyelitis: serum IgM and cerebrospinal fluid antibodies. West J Med. 1983 Mar;138(3):420­2. Park JM, Ledbetter EO, South MA, Sridaromont S, Mirkovic RR. Paroxysmal supraventricular tachycardia precipitated by pertussis vaccine. J Pediatr. 1983 Jun;102(6):883­5. Pokrovskaia NIa. Convulsive syndrome in DPT vaccination (a clinico­experimental study). Pediatriia 1983 May;(5):37­39. Problems of live virus vaccine­associated poliomyelitis a paralytic case with isolation of all three poliovirus types. Med Microbiol Immunol (Berl) 1983;172(1):13­21. Procaccia S, Borroni G, Lanzanova D, Papini E, Perego R, Ferrante P. IgG rheumatoid factors behaviour in young normal subjects following vaccination. Boll Ist Sieroter Milan 1983 Nov 30;62(5):451­61. Sawada Y, Ogawa S. Case of skin ulcer due to influenza HA vaccination. Nippon Hifuka Gakkai Zasshi. 1983 Nov;93(12):1297­301. Soboleva VD, Lozovskaia LS, Mitchenko AF. Viremia in children with rheumatoid arthritis. Vopr Virusol. 1983 Mar­Apr;(2):207­10. Russian. Straumann A, Gyr N, Thommen A, Muller R. Abdominal typhoid following vaccination with the attenuated vaccine Vivotif. Schweiz Med Wochenschr. 1983 Aug 27;113(34):1205. Suda, K. and Soekawa, M. Smallpox mortality in a mountainous district in Japan where neither variolation nor vaccination had been performed Nippon Ishigaku.Zasshi. 1983, 29 (1): 83­94. Von Wehren U, von Torklus D. Arthritis following rubella immunization. Z Orthop Ihre Grenzgeb 1983 Nov­Dec;121(6):749­50. Waight PA, Pollock TM, Miller E, Coleman EM. Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Arch Dis Child. 1983 Nov;58(11):921­3. Watkins SM, Williams JR, Turnbull AL. Latent period of 9 years in the presentation of a myeloproliferative disorder. Scand J Haematol 1983 Sep;31(3):280­
2. Welch MJ, Fong S, Vaughan J, Carson D. Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol 1983 Feb;51(2):299­304. Ziegler DW, Gardner JJ, Warfield DT, Walls HH. Experimental allergic neuritis­like disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants. Infect Immun 1983 Nov;42(2):824­30. 1984 Bader M. Risks from polio vaccination. JAMA. 1984 Feb 10;251(6):728­9. Buddle, BM et al. Contagious Ecthyma Virus­Vaccination Failures. Am J Vet Research, Feb 1984, 45(2):263­266. Cruickshank JG, Orme RL, Haas L, Gill NO, Roebuck MO, Magrath DI, Chamberlain R. Two cases of vaccine­associated paralytic poliomyelitis linked in time and place. Lancet. 1984 Oct 6;2(8406):804­5. Czech. Cherry JD, Shields WD. Recurrent seizures after diphtheria, tetanus, and pertussis immunization, Cause and effect v temporal association. Am J Dis Child. 1984 Oct;138(10):904­7. Driehorst J, Laubenthal F. Acute myocarditis after cholera vaccination. Dtsch Med Wochenschr. 1984 Feb 3;109(5):197­8. Ferne M, Schlossberg M, Michel J. Antibody formation in rabbits after vaccination with Streptococcus pyogenes cultured in the presence of subinhibitory concentrations of erythromycin. Pathol Biol (Paris). 1984 May;32(5):369­71. Geraghty KC. A call for clinical prudence in use of DTP and other vaccines. Pediatrics. 1984 Nov;74(5):902­3. Geraghty KC. DTP immunization and SIDS. J Pediatr. 1984 Jul;105(1):169­71. Hjorth RN, Bonde GM, Piner E, Hartzell RW, Rorke LB, Rubin BA. Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. A possible model for Guillain­Barre syndrome. J Neuroimmunol 1984 Feb;6(1):1­8. Leung A. Congenital heart disease and DPT vaccination. Can Med Assoc J. 1984 Sep 15;131(6):541. Leung AK. Erythema multiforme following DPT vaccination. J R Soc Med. 1984 Dec;77(12):1066­7. Lin, P. [From human­pox vaccination to cowpox vaccination] (Chi) Zhonghua Yi.Shi Za Zhi. 1984, 14 (3): 168­169. Mall T, Gyr K. Episode resembling immune complex disease after cholera vaccination. Trans R Soc Trop Med Hyg 1984;78(1):106­7. Mertens T, Schurmann W, Kruppenbacher JP, Eggers HJ, Rheingans K, Kellermann K, Leidel J. Two cases of vaccine­induced poliomyelitis. Acta Paediatr Scand. 1984 Jan;73(1):133­4. Murphy JV, Sarff LD, Marquardt KM. Recurrent seizures after diphtheria, tetanus, and pertussis vaccine immunization. Onset less than 24 hours after vaccination. Am J Dis Child 1984 Oct;138(10):908­11. Otten A, Helmke K, Stief T, Mueller­Eckhard G, Willems WR, Federlin K. Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I. Behring Inst Mitt. 1984 Jul;(75):83­8. Peters ME, Horowitz S. Bone changes after rubella vaccination. AJR Am J Roentgenol. 1984 Jul;143(1):27­8. Reinert P, Lemerle S, Kohout G, Bernaudin F. Complications of measles and antimeasles vaccination. Ann Pediatr (Paris). 1984 Jun;31(6):477­80. Serban O, Toacsen E. Treatment failures and accidents following rabies vaccination. Postvaccinal reactivity. Reconsiderations and updating. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Para29. 1984 Jan­Mar;29(1):27­40. Soekawa, M. [Propaganda bills for vaccination distributed during the Kaei Period in Japan] (Jpn) Nippon Ishigaku.Zasshi. 1984, 30 (1): 62­84. Tingle AJ, Pot CH, Chantler JK. Prolonged arthritis, viraemia, hypogammaglobulinaemia, and failed seroconversion following rubella immunisation. Lancet. 1984 Jun 30;1(8392):1475­6. Wutzler P, Sprossig M, Schneider J, Ullrich K, Bothig B. Complications following preventive oral poliomyelitis vaccination. Padiatr Grenzgeb. 1984;23(5):289­97. Zabel J, Karas Z. Malherbe's calcifying epithelioma of the skin of the arm at the site of Di­Per­Te vaccination. Przegl Dermatol. 1984 May­Jun;71(3):269­72. 1985 Brodsky, Stanievich. Sensorineural Hearing Loss Following Live Measles Virus Vaccination. Int J Ped Oto, 1985 Nov; 10(2):159­163. Burova LA, Christensen P, Grubb R, Schalen C, Svensson ML, Beltukov PP, Totolian AA. Antiimmunoglobulins in experimental streptococcal immunization; relation to bacterial growth conditions and Fcreceptors. Acta Pathol Microbiol Immunol Scand. 1985 Feb;93(1):19­23. De Silva L, Rogers M. Hepatitis B vaccine: urticarial reaction. Med J Aust. 1985 Sep 30;143(7):323­4. Greco D, et al. Case­control study on encephalopathy associated with diphtheria­tetanus immunization in Campania, Italy. Bull World Health Organ 1985;63(5):919­925. Heidel G, Demmler M. Neurologic yndromes as atypical courses of vaccination following preventive influenza A vaccination. Z Gesamte Hyg. 1985 Apr; 31(4):218­20. Hu XM. Recent advance in research on the incidence of paralysis following immunization with live oral polio vaccine. Zhonghua Liu Xing Bing Xue Za Zhi. 1985 Apr;6(2):125­7. Huerkamp, C. The history of smallpox vaccination in Germany: a first step in the medicalization of the general public J.Contemp.Hist. 1985, 20 (4): 617­635. Leung AK. Anaphylaxis to DPT vaccine. J R Soc Med. 1985 Feb;78(2):175. Marshall GS, Wright PF, Fenichel GM, Karzon DT. Diffuse retinopathy following measles, mumps, and rubella vaccination. Pediatrics. 1985 Dec;76(6):989­
91. Mercer, A. J. Smallpox and epidemiological­demographic change in Europe: the role of vaccination Popul.Stud.(Camb.). 1985, 39 (2): 287­307. Mirkovic RR, Lamberts DW, Dolen J. Recovery of vaccinal poliovirus type 1 from conjunctiva of an infant with transient, unilateral conjunctivitis. Eur J Pediatr. 1985 Jul;144(2):210­1. Pollock TM, Miller E, Mortimer JY, Smith G. Post­vaccination symptoms following DTP and DT vaccination. Dev Biol Stand 1985;61:407­10. Poser CM. Swine influenza vaccination. Truth and consequences. Arch Neurol. 1985 Nov;42(11):1090­2. Prensky AL, et al. History of convulsions and use of pertussis vaccine. J Pediatr 1985 Aug; 107(2):244­255. Snider GB, Gogate SA. A possible systemic reaction to hepatitis B vaccine. JAMA. 1985 Mar 1;253(9):1260­1. Tarkowski A, Czerkinsky C, Nilsson LA. Simultaneous induction of rheumatoid factor­and antigen­specific antibody­secreting cells during the secondary immune response in man. Clin Exp Immunol 1985 Aug;61(2):379­87. Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis 1985 Sep;152(3):606­12. Vogel R. AIDS transmission by hepatitis b vaccine. Br Dent J. 1985 Dec 21;159(12):391. Wehrle PF. Injury associated with the use of vaccines. Clin Ther. 1985;7(3):282­4. 1986 Amsel SG, Hanukoglu A, Fried D, Wolyvovics M. Myocarditis after triple immunisation. Arch Dis Child. 1986 Apr; 61(4):403­5. Barkin RM, Jabhour JT. Reactions to pertussis immunization. J Pediatr. 1986 Jun;108(6):1041­3. Basu SN. A review of paralytic poliomyelitis cases occurring after polio vaccination. J Indian Med Assoc. 1986 Jul;84(7):203­6. Blattner RJ, Feigin RD. Diphtheria, pertussis, and tetanus (DTP) immunization local reactions do not predict central nervous system reactions. Pediatrics. 1986 Dec;78(6):1168­9. Burova LA, Christensen P, Grubb R, Shalen K, Ogurtsov RP. Induction of anti­immunoglobulin synthesis during the immunization of rabbits with streptococci group A. Vestn Akad Med Nauk SSSR. 1986;(7):63­71. Courrier A, Stenbach G, Simonnet P, Rumilly P, Lopez D, Coquillat G, Scherer C, Chopin J. Peripheral neuropathy following fetal bovine cell rabies vaccine. Lancet. 1986 May 31;1(8492):1273. Di Giusto CA, Bernhard JD. Erythema nodosum provoked by hepatitis B vaccine. Lancet. 1986 Nov 1;2(8514):1042. Ehrengut W. Central nervous sequelae of vaccinations. Lancet. 1986 May 31;1(8492):1275­6. Ishizaki A, Noda Y. Neurological complications of immunization. No To Hattatsu. 1986 Mar;18(2):105­13. Kolata G. Litigation causes huge price increases in childhood vaccines. Science. 1986 Jun 13;232(4756):1339. Kowal P. Neurological complications after vaccination against rabies as exemplified by 4 cases from Poznan province. Neurol Neurochir Pol 1986 Mar­
Apr;20(2):132­6. Kurokawa T, Mizuno Y, Tomita S, Ueda K, Mitsudome A, Yokota K, Hanai T, Narasaki O. Neurological complications related to immunization. No To Hattatsu. 1986 Mar;18(2):98­104. Lee SY, Komp DM, Andiman W. Thrombocytopenic purpura following varicella­zoster vaccination. Am J Pediatr Hematol Oncol 1986 Spring;8(1):78­80. Lewis K, Jordan SC, Cherry JD, Sakai RS, Le CT. Petechiae and urticaria after DTP vaccination: detection of circulating immune complexes containing vaccine­specific antigens. J Pediatr. 1986 Dec;109(6):1009­12. Radeff B, Harms M. Acute febrile neutrophilic dermatosis (Sweet's syndrome) following BCG vaccination. Acta Derm Venereol 1986;66(4):357­8. Thoman M. The toxic shot syndrome. Vet Hum Toxicol. 1986 Apr;28(2):163­6. Urokawa T, Mizuno Y, Tomita S, Ueda K, Mitsudome A, Yokota K, Hanai T, Narasaki O. Neurological complications related to immunization. No To Hattatsu. 1986 Mar;18(2):98­104. Vaandrager GJ, Molenaar JL, Bruining GJ, Plantinga AD, Ruitenberg EJ. Islet cell antibodies, mumps infection and mumps vaccination. Diabetologia. 1986 Jun; 29(6):406­7. 1987 Arlazoroff A, Bleicher Z, Klein C, Vure E, Lahat E, Gross B, Handsher R. Vaccine­associated contact paralytic poliomyelitis with atypical neurological presentation. Acta Neurol Scand 1987 Sep;76(3):210­4. Barkin RM, Jabhour JT, Samuelson JS. Immunizations, seizures, and subsequent evaluation. JAMA. 1987 Jul 10;258(2):201. Christau B, Helin P. Reactive arthritis following vaccination against hepatitis B. Ugeskr Laeger. 1987 Jul 6;149(28):1882. Denning, DW, et al. Skin Rashes After Triple Vaccine. Arch Disorder Child, May 1987, 62(5): 510­511. Fried M, Conene D, Conzelmann M, Steinemann E. Uveitis following hepatitis B vaccine. The Lancet, 1987; 2: 631­32. Graus F, Ribalta T, Ribera G, Condom E, Nadal P. Acute necrotic myelopathy associated with influenza vaccination. Lancet. 1987 Jun 6;1(8545):1311­2. Greenspan NS, Monafo WJ, Davie JM. Interaction of IgG3 anti­streptococcal group A carbohydrate (GAC) antibody with streptococcal group A vaccine: enhancing and inhibiting effects of anti­GAC, anti­isotypic, and anti­idiotypic antibodies. J Immunol. 1987 Jan 1;138(1):285­92. Gross TP, Khurana RK, Higgins T, Nkowane BS, Hirsch RL. Vaccine­associated poliomyelitis in a household contact with Netherton's syndrome receiving long­term steroid therapy. Am J Med 1987 Oct;83(4):797­800. Illingsworth R. Skin rashes after triple vaccine. Arch Dis Child. 1987 Sep;62(9):979. Ipp MM, Gold R, Greenberg S, Goldbach M, Kupfert BB, Lloyd DD, Maresky DC, Saunders N, Wise SA. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria­pertussis­tetanus toxoids­polio vaccine. Pediatr Infect Dis J. 1987 Aug;6(8):721­5. Leung AK, Szabo TF. Erythema multiforme following diphtheria­pertussis­tetanus vaccination. Kobe J Med. Sci. 1987 Aug;33(4):121­4. Lupton GP. Discoid lupus erythematosus occurring in a smallpox vaccination scar. J Am Acad Dermatol, 1987 Oct; 17(4):688­690. Mortimer EA Jr. DTP and SIDS: when data differ. Am J Public Health 1987 Aug; 77(8):925­926. Munk ME. Vaccines with anti­idiotypic antibodies. AMB Rev Assoc Med Bras. 1987 Nov­Dec;33(11­12):241­4. Nkowane BM, Wassilak SG, Orenstein WA, Bart KJ, Schonberger LB, Hinman AR, Kew OM. Vaccine­associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 1987 Mar 13;257(10):1335­40. Novello F, Lombardi F, Amato C, Santoro R, Fiore L, Grandolfo ME, Pasquini P. Paralytic poliomyelitis in Italy (1981­85). Eur J Epidemiol 1987 Mar;3(1):54­60. Reizis Z, Frank J, Sikuler E. Allergic vasculitis and bronchial asthma following influenza vaccination. Harefuah. 1987 Jan 15;112(2):70­1. Scholz E, Wietholter H. Postvaccinal neuritis following prophylactic vaccination against early­summer meningo­encephalitis. Dtsch Med Wochenschr 1987 Apr 3;112(14):544­6. Schutze MP, LeClerc C, Jolivet M, Deriaud E, Audibert F, Chang CC, Chedid L. A potential anti­pregnancy vaccine built by conjugation of the beta­subunit of human chorionic gonadotropin to adjuvant­active muramyl peptide. Am J Reprod Immunol Microbiol 1987 Jul;14(3):84­90. Siddiqui MA, Lin FY, Trostel B, Israel E, Dwyer DM. Adverse events following DTP immunization in Maryland, 1987. Md Med J 1989 Jul;38(7):556­9. Smith CA, Petty RE, Tingle AJ.Rubella virus and arthritis. Rheum Dis Clin North Am 1987 Aug;13(2):265­74. Uveoretinitis in rabbits following immunization with interphotoreceptor retinoid­binding protein. Exp Eye Res 1987 Mar;44(3):425­38. Wilkins J. Circulating immune complexes after DTP vaccination. J Pediatr. 1987 Jul;111(1):162. 1988 Asindi AA, Bell EJ, Browning MJ, Stephenson JB. Vaccine­induced polioencephalomyelitis in Scotland. Scott Med J 1988 Aug;33(4):306­7. Baraff LJ. Infants and children with convulsions and hypotonic­hypo­responsive episodes following diphtheria­tetanus­pertussis immunization: follow­up evaluation. Pediatrics 1988 Jun; 81(6):789­794. Bergmannova V, Stehlikova J, Domorazkova E, Dankova E. Follow­up of a group of children with severe reactions to mixed vaccine against diphtheria, tetanus and whooping cough from the aspect of their immunological profile. Cesk Pediatr. 1988 Oct;43(10):599­601. Biron P, Montpetit P, Infante­Rivard C, Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med 1988 Dec;148(12):2685. Brauer H. Are we sweeping DTP contraindications under the rug? Am J Dis Child. 1988 Jul;142(7):698. Buchner H, Ferbert A, Hundgen R. Polyneuritis cranialis? Brain stem encephalitis and myelitis following preventive influenza vaccination. Nervenarzt. 1988 Nov;59(11):679­82. De Juan Frigola J, Rodriguez Fernandez LM, Orejas Rodriguez­Arango G, Valdes­Hevia y Villa J, Crespo Hernandez M. Isolated paralysis of the hypoglossal nerve in a child. An Esp Pediatr. 1988 Oct;29(4):341­2. Elidrissy AT, Abdurrahman MB, Ramia S, Lynch JB. Hepatitis B surface antigen associated nephrotic Syndrome. Ann Trop Paediatr 1988 Sep;8(3):157­61. Flahault A. Sudden infant death syndrome and diphtheria/tetanus toxoid/pertussis/poliomyelitis immunisation. Lancet 1988 Mar 12;1(8585):582­583. Gonzalez E, Cordero J. Poliomyelitis associated with a vaccine: 2 clinical cases. Rev Med Chil. 1988 May;116(5):461­4. Hanrahan A, Waters J. Adverse local reactions to fourth and fifth doses of DPT vaccine­Alberta. Can Dis Wkly Rep. 1988 Mar 19;14(11):45­7. Jacobson V, Nielsen C, Buch D, Shields WD, Christenson P, Zachau­Christiansen B, Cherry JD. Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study. Tokai J Exp Clin Med 1988;13 Suppl:137­42. Kimura M, Kuno­Sakai H. Reports on cases of neurological illnesses occurring after administration of acellular pertussis vaccines in Japan. Tokai J Exp Clin Med. 1988;13 Suppl:165­70. Le Goff P, Fauquert P, Youinou P, Hoang S. Periarteritis nodosa following vaccination against hepatitis B. Presse Med. 1988 Oct 8;17(34):1763. Leads from the MMWR. Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine ­ Thailand. JAMA. 1988 Jan 1;259(1):25­6. Levinson AI, Tar L. In vitro IgM rheumatoid­factor production induced by tetanus toxoid. J Allergy Clin Immunol 1988 Apr;81(4):730­6. Miller D, Wadsworth J, Ross E. Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study. Tokai J Exp Clin Med. 1988;13 Suppl:145­55. Mumps meningitis, possibly vaccine related. Canada Disease Weekly Report, vol. 14­40, 1988, pp. 209­11. Nabe­Nielsen, Walter. Unilateral Total Deafness as a Complication of the Measles­Mumps­Rubella Vaccination. Scan Audio Suppl, 1988, 30:69­70. Olin P, Romanus, V, Storsaeter, J. Invasive Bacterial Infections During an Efficiacy Trial of Acellular Pertussis Vaccines ­ Implications For Future Surveilance In Pertussis Vaccine Programmes. Tokai J Exp Clin Med, 1988; 13 Suppl: 143­144. Orenstein WA. DTP vaccine litigation, 1988. Am J Dis Child. 1990 May;144(5):517. Osterholm, MT, et al. Lack of Efficacy of Haemophilus b Polysacharide Vaccine in Minnesota. JAMA, 1988 Sept 9; 260(10:1423­1428. Patel U, Bradley JR, Hamilton DV. Henoch­Schonlein purpura after influenza vaccination. Br Med J (Clin Res Ed). 1988 Jun 25;296(6639):1800. Scheifele DW. Pertussis vaccine and encephalopathy after the Loveday trial. CMAJ. 1988 Dec 1;139(11):1045­6. Shields WD, et al. Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study. J Pediatr 1988 Nov; 113(5):801­805. Storsaeter, J, et al. Mortality and Morbidity From Invasive Bacterial Infections During a Clinical Trial of Acellular Pertussis Vaccines in Sweden. Pediatr Infect Disorder J, 1988 Sept; 7(9):637­645. Tsilimigras CW, Schoub BD. Characterisation of two different types of poliovirus isolated from a patient. J Infect 1988 Sep;17(2):159­61. Walker AM, Jick H, Perera DR, Knauss TA, Thompson RS. Neurologic events following diphtheria­tetanus­pertussis Immunization. Pediatrics 1988 Mar;81(3):345­9. Wattiaux MJ, Moulonguet­Doleris L, Cabane J, Lebas J, Imbert JC. Rheumatoid purpura following influenza vaccination. Presse Med. 1988 Apr 9;17(13):649­50. 1989 Aseptic meningitis after vaccination against measles and mumps. Paediatric Infectious Diseases, vol. 8, 1989, pp. 302­8. Casoli P, Tumiati B. Acute idiopathic thrombocytopenic purpura after anti­influenza vaccination. Medicina (Firenze) 1989 Oct­Dec;9(4):417­8. Cizman M, Mozetic M, Radescek­Rakar R, Pleterski­Rigler D, Susec­Michieli M. Aseptic meningitis after vaccination against measles and mumps. Pediatr Infect Dis J 1989 May;8(5):302­8. Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine. N Engl J Med. 1989 Oct 26;321(17):1198­9. Gray JA, Burns SM. Mumps vaccine meningitis. Lancet. 1989 Oct 14;2(8668):927. Gross TP, Milstien JB, Kuritsky JN. Bulging fontanelle after immunization with diphtheria­tetanus­pertussis vaccine and diphtheria­tetanus vaccine. J Pediatr. 1989 Mar;114(3):423­5. Hood DA, Edwards IR. Meningococcal vaccine­­do some children experience side effects? N Z Med J 1989 Feb 22;102(862):65­7. Katafuchi Y, Aida K, Shiotsuki Y, Yamashita Y, Horikawa M, Andou H. Acute cerebellar ataxia and facial palsy after DPT immunization. No To Hattatsu 1989 Sep;21(5):465­9. Koroleva IV, Burova LA, Shalen K. Streptococcal immunoglobulin Fc receptors as inductors of antiimmunoglobulins. Vestn Akad Med Nauk SSSR 1989;(11):37­41. Leviton A. Neurologic sequelae of pertussis immunization 1989. J Child Neurol. 1989 Oct;4(4):311­4. Local adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine, adsorbed, in Surrey, BC. CMAJ. 1989 Aug 15;141(4):312­3. Majchrowicz H. Post­vaccination reactions to diploid rabies vaccine. Przegl Epidemiol 1989;43(3):259­62. Mumps meningitis following measles, mumps, and rubella immunisation. The Lancet, vol. 2, July 8, 1989, p. 98; comments in vol. 2, August 12, 1989, pp. 394­5; vol. 2, September 16, 1989, p. 677. Saito H, Yanagisawa T. Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy. Tohoku J Exp Med 1989 May;158(1):95­103. Schabet M, Wiethoelter H, Grodd W, Vallbracht A, Dichgans J, Becker W, Berg PA. Neurological complications after simultaneous immunisation against tick­borne encephalitis and tetanus. Lancet. 1989 Apr 29;1(8644):959­60. Sepkowitz S. Adverse reactions of medical organizations to DTP vaccine: the vaccine­related compensation bill. J Okla State Med Assoc. 1989 Jan;82(1):21­
4. Sutter RW, Brink EW, Cochi SL, Kew OM, Orenstein WA, Biellik RJ, Hinman AR. A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health 1989 Apr;79(4):495­8. Unrau, W. E. Fur trader and Indian office obstruction to smallpox vaccination in the St. Louis Indian superintendency, 1831­1834 Plains.Anthropol. 1989, 34 (124 pt 2): 33­39. Von Muhlendahl KE. Side effects and complications of measles­mumps vaccination. Monatsschr Kinderheilkd 1989 Aug;137(8):440­6. Wolf SM, Forsythe A. Epilepsy and mental retardation following febrile seizures in childhood. Acta Paediatr Scand 1989 Mar;78(2):291­295. 1990 Bryder, L. BCG vaccination: comparative perspectives Occas.Pap.Med.Hist Aust. 1990, 4:193­9. (): 193­199. De Ritis L, Pecorari R. Thrombopenic purpura following measles vaccination. Pediatr Med Chir 1990 Mar­Apr;12(2):161­3. Devey ME, Major PJ, Bleasdale­Barr KM, Holland GP, Dal Canto MC, Paterson PY. Experimental allergic encephalomyelitis (EAE) in mice selectively bred to produce high affinity (HA) or low affinity (LA) antibody responses. Immunology 1990 Apr; 69(4):519­24. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Pediatrics, vol. 85, number 4 part 2, April 1990, pp. 698­704. Ehrengut W. BCG­induced inflammation during childhood and in pregnancy. Additionally a contribution to BCG­induced necrotising cerebral arteritis. Klin Padiatr. 1990 Sep­Oct;202(5):303­7. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures and encephalopathy after immunization with the diphtheria­tetanus­pertussis vaccine. JAMA 1990 Mar 23­30;263(12):1641­5. Heller J, Holzer G, Schimrigk K. Immunological differentiation between neuroborreliosis and multiple sclerosis. J Neurol 1990 Dec;237(8):465­70. Huttenlocher PR, Hapke RJ. A follow­up study of intractable seizures in childhood. Ann Neurol 1990 Nov; 28(5):699­705. Iwase K, Fujii Y, Nakashima I, Kato N, Fujino Y, Kawashima H, Mochizuki M. A new method for induction of experimental autoimmune uveoretinitis (EAU) in mice. Curr Eye Res 1990 Mar;9(3):207­16. Jilg, W, et al. Inoculation Failure Following Hepatitis B Vaccination. Dtsch Med wochenschr, 1990 Oct 12; 115(41):1514­1548. Jilg, W. Unsuccessful Vaccination against Hepatitis B. Dtsch Med Wochenschr, Nov 16, 1990, 115(46):1773. Kan VK. Systemic vasculitis as a complication of hepatitis B. Sov Med. 1990;(12):114. Maddox PR, Motley RJ. Sweet's syndrome: a severe complication of pneumococcal vaccination following emergency splenectomy. Br J Surg. 1990 Jul;77(7):809­10. Masse I, Descoffres MC. Hypersensitivity vasculitis after hepatitis B vaccination. Presse Med. 1998 Jun 6;27(20):965­6. Molina M, Ortega G, Galvez J, Munoz L. Leukocytoclastic vasculitis secondary to flu vaccination. Med Clin (Barc). 1990 Jun 9;95(2):78. Molina M, Ortega G, Galvez J, Munoz L. Leukocytoclastic vasculitis secondary to flu vaccination. Med Clin (Barc). 1990 Jun 9;95(2):78. Paradiso G. Neuropatia multifocale demielinizzante a seguito di vaccino anti­tetano. Medicina (B Aires), 1990, 50(1):52­54. Pear, R. Vaccination of children tied to welfare in U.S. proposal NY Times (Print.). 11­29­1990, :A1, B16. (): A1, B16. Querfurth H, Swanson PD. Vaccine­associated paralytic poliomyelitis. Regional case series and review. Arch Neurol 1990 May;47(5):541­4. Reutens DC, Dunne JW, Leather H. Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination. Muscle Nerve. 1990 May;13(5):461. Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ. 1990 Aug 11;301(6747):345. Schchelkunov, SN et al. The Role of Viruses in the Induction of Allergic Encephalomyelitis. Dokl Akad Nauk SSSR, 1990,315(1):252­255. Vaccines contain viruses, too. Toblli JE, Chirife AM, Budani AM, Marcuzzi A, Digioia MC, Collado H. Membranoproliferative glomerulonephritis with semilunar forms and massive deposits of IgA associated with HBsAg. Medicina (B Aires) 1990;50(1):57­60. Tornatore CS, Richert JR. CNS demyelination associated with diploid cell rabies vaccine. Lancet 1990 Jun 2;335(8701):1346­1347. Vial T, Laine V, Delcombel M, Goubier C, Galland MC, Mallaret M, Descotes J. Vasculitis after antiinfluenza vaccination. Report of 5 cases. Therapie 1990 Nov­Dec;45(6):509­12. Von Muhlendahl KE. Side­effects of measles­mumps vaccination. Lancet. 1990 Mar 3;335(8688):540­1. 1991 Allerberger, F. An Outbreak of Suppurative Lymphadenitis Connected with BCG Vaccination in Austria­1990/1991. Am Rev Respir Disorder, Aug 1991, 144(2) 469. Benjamin CM, Silman AJ. Adverse reactions and mumps, measles and rubella vaccine. J Public Health Med. 1991 Feb;13(1):32­4. Blumberg DA, Mink CM, Lewis K, Chatfield P, Leach C, Smith LP, Christenson PD, Guravitz L, Steinfeld MB, Marcy SM, et al. Pathophysiology of reactions associated with pertussis Vaccine. Dev Biol Stand 1991;73:289­95. Ehrengut W. Bias in evaluating CNS complications following pertussis immunization. Acta Paediatr Jpn, 1991 Aug; 33(4):421­427. Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture­wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J 1991 Mar;10(3):204­9. Green, C et al. A Case of Hepatitis Related to Etretinate Therapy and Hepatitis B Vaccine. Dermatologica, 1991, 182(2):119­120. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles­mumps­rubella immunization. Pediatrics 1991 Nov;88(5):881­
5. Hartmann, G et al. Unsuccessful Inoculation against Hepatitis B. Dtsch Med Wochenschr, May 17, 1991, 116(20): 797. Herroelen, L et al. Central­Nervous­System Demyelination After Immunization with Recombinant Hepatitis B Vaccine. Lancet, Nov 9, 1991, 338(8776):1174­1175. Hulbert, et al. Bilateral Hearing Loss after Measles and Rubella Vaccination in an Adult. NEJM, 1991 July, 11;325(2):134. Int J Ped Oto, Feb 1998, 43(1):73­73 Koga, et al. Bilateral Acute Profound Deafness After MMR Vaccination­Report of a Case. Nippon Jibiin Gakkai Kai, 1991 Aug;94(8):1142­5. Knopf HL. Recurrent uveitis after influenza vaccination. Ann Ophthalmol. 1991 Jun;23(6):213­4. Levi GC, de Mendonca JS, Granato C. Hepatitis B virus infection in a successfully immunized patient. Vaccine. 1991 Mar; 9(3):216. Levine S, Saltzman A. Inhibition of experimental allergic encephalomyelitis by lithium chloride: specific effect or nonspecific stress? Immunopharmacology 1991 Nov­Dec;22(3):207­13. Lipskaya GY, Muzychenko AR, Kutitova OK, Maslova SV, Equestre M, Drozdov SG, Bercoff RP, Agol VI. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine­associated polio cases. J Med Virol 1991 Dec;35(4):290­6. Mori I, Torii S, Hamamoto Y, Kanda A, Tabata Y, Nagafuji H. Virological evaluation of mumps meningitis following vaccination against mumps. Kansenshogaku Zasshi. 1991 Feb;65(2):226­33. Pawlowski B, Gries FA. Mumps vaccination and type­I diabetes. Dtsch Med Wochenschr. 1991 Apr 19;116(16):635. Strebel, P et al. An Outbreak of Whooping Cough in a Highly Vaccinated Urban Community. J Trop Pediatr, Mar 1991, 37(2): 71­76. Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps Vaccination. Pediatr Infect Dis J 1991 Mar;10(3):209­13. Wiersbitzky S, Bruns R. Febrile exanthema following measles vaccination­­risk of recurrence in the 2d measles vaccination? Kinderarztl Prax. 1991 Dec;59(12):384­5. Wiersbitzky S, Schroder C, Burtzlaff C. Vaccination encephalopathy after measles vaccination simulating recurrent cardiovascular dysregulation? The pediatric vaccination counseling unit. Kinderarztl Prax. 1991 Jun;59(6):187­8. Yen MY, Liu JH. Bilateral optic neuritis following bacille Calmette­Guerin (BCG) vaccination. J Clin Neuroophthalmol 1991 Dec;11(4):246­9. Yeolekar ME. Rabies vaccine and its complications. J Assoc Physicians India. 1991 Sep;39(9):663­4. 1992 Alves RS, Barbosa ER, Scaff M. Postvaccinal parkinsonism. Mov Disord 1992;7(2):178­80. Arnup, K. "Victims of vaccination?": opposition to compulsory immunization in Ontario, 1900­90 Bull.Can.Hist Med. 1992, 9 (2): 159­176. Coles, FB, et al. An Outbreak of Influenza A (H3N2) in a Well­Immunized Nursing home Population. J Am ger Sociologist, Jun 1992, 40(6):589­592. Duclos P. Adverse events after hepatitis B vaccination. CMAJ. 1992 Oct 1;147(7):1023­6. Herroelen L, de Keyser J, Ebinger G. Central­nervous­system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991 Nov 9;338(8776):1174­5 ­Comment in: Lancet. 1992 Jan 18;339(8786):178­9. Howson CP, Fineberg HV. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. JAMA 1992 Jan 15;267(3):392­6. Huang YP, Gauthey L, Michel M, Loreto M, Paccaud M, Pechere JC, Michel JP. The relationship between influenza vaccine­induced specific antibody responses and vaccine­induced nonspecific autoantibody responses in healthy older women. J Gerontol 1992 Mar;47(2):M50­5. Joce R, Wood D, Brown D, Begg N. Paralytic poliomyelitis in England and Wales, 1985­91. BMJ 1992 Jul 11;305(6845):79­82. Malengreau, M. Reappearance of Post­Vaccination Infection of Measles, Rubella, and Mumps. Should Adolescents be re­vaccinated? Pediatric, 1992;47(9):597­601 (25 ref). Martinez E, Domingo P. Evans's syndrome triggered by recombinant hepatitis B vaccine. Clin Infect Dis. 1992 Dec;15(6):1051. Mori, O. [Supplement report of "The first vaccination by cowpox in Inaba and Hoki"­­Eiji Harada's memories] Nippon Ishigaku.Zasshi. 1992, 38 (3): 501­505. Nelson, M. C. and Rogers, J. The right to die? Anti­vaccination activity and the 1874 smallpox epidemic in Stockholm Soc.Hist Med. 1992, 5 (3): 369­388. Pohl KR, Farley JD, Jan JE, Junker AK. Ataxia­telangiectasia in a child with vaccine­associated paralytic poliomyelitis. J Pediatr 1992 Sep;121(3):405­7. Scarpelli, G. "Nothing in nature that is not useful". The anti­vaccination crusade and the idea of 'harmonia naturae' in Alfred Russel Wallace Nuncius. 1992, 7 (1): 109­130. Shields WD, Nielsen C, Buch D, Jacobsen V, Christenson P, Zachau­Christiansen B, Cherry JD. Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study. Skovrankova J, Komarek V, Domorazkova E. Neurologic complications after vaccination against diphtheria, tetanus and whooping cough. Cesk Pediatr 1992 Feb;47(2):122­4. Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus­associated disease. Clin Infect Dis 1992 Feb;14(2):568­79. Sutter RW, Patriarca PA, Suleiman AJ, Brogan S, Malankar PG, Cochi SL, Al­Ghassani AA, el­Bualy MS. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J Infect Dis 1992 Mar;165(3):444­9. Topaloglu H, Berker M, Kansu T, Saatci U, Renda Y. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet. 1992 Jan 18;339(8786):178­
9. Trier H. Ronne T. Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella. Ugeskr Laeger, vo. 154, no. 29, July 13, 1992, pp. 2008­13. Wiersbitzky S, Bruns R, Schroder C, Warmuth M. Thrombocytopenic purpura following immunization with a live vaccine (mumps­measles­rubella vaccination)? Kinderarztl Prax. 1992 Feb;60(1):28­9. 1993 Allen MB, Cockwell P, Page RL. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax. 1993 May;48(5):580­1. Alves RS, Barbosa ER, Scaff M. Postvaccinal parkinsonism. Mov Disord 1992;7(2):178­80 Comment in: Mov Disord. 1993 Apr;8(2):253. Arya LS, Ghai OP, Saraya AK. Thrombocytopenic purpura following DPT vaccination. Pediatr Hematol Oncol. 1993 Oct­Dec;10(4):381­3. Beijer WE, Sprenger MJ, Masurel N. Polymyalgia rheumatica and influenza vaccination. Dtsch Med Wochenschr. 1993 Feb 5;118(5):164­5. Blain JG, Osterman JW, Baghdadllan H, Lambert L. Paralytic polio in an adult female following OPV vaccination of her infant. Can Commun Dis Rep. 1993 Aug 15;19(15):118­9. Blumberg DA, Lewis K, Mink CM, Christenson PD, Chatfield P, Cherry JD. Severe reactions associated with diphtheria­tetanus­pertussis vaccine: detailed study of children with seizures, hypotonic­hyporesponsive episodes, high fevers, and persistent crying. Pediatrics 1993 Jun;91(6):1158­65. Blumberg DA. Gravi reazioni associate al vaccino difteria.­tetano­pertosse: dettagliato studio di bambini con epilessia, episodi ipotonici iporesponsivi , elevati febbri e pianto continuo. Pediatrics, giugno 1993; 91(6): 1158­1165. Bohus M, Glocker FX, Jost S, Deuschl G, Lucking CH. Myelitis after immunisation against tick­borne encephalitis. Lancet. 1993 Jul 24;342(8865):239­40. Brezin A, Lautier­Frau M, Hamedani M, Rogeaux O, Hoang PL. Visual loss and eosinophilia after recombinant hepatitis B vaccine. Lancet. 1993 Aug 28;342(8870):563­4. Carmeli Y, De­Medina T. Serious hepatitis B vaccine adverse reactions, are they immune­mediated? Vaccine. 1993 Oct;11(13):1358­9. Castresana­Isla CJ, Herrera­Martinez G, Vega­Molina J. Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol. 1993 Aug;20(8):1417­8. Cherry JD, Holtzman AE, Shields WD, Buch D, Nielsen C, Jacobsen V, Christenson PD, Zachau­Christiansen B. Pertussis immunization and characteristics related to first seizures in infants and children. J Pediatr 1993 Jun;122(6):900­3. Dokheel, T M. An Epidemic of Childhood Diabetes in the United States? Evidence from. Diabetes Care, 1993, 16:1606­1611. Eggers HJ, Weyer J. Provocation paralysis. Lancet. 1993 Jan 2;341(8836):62. Frias, Nunez M. [Plans for the establishment of central vaccination committees in the institutionalization of Medicine in Colombia] Cuad.Complut.Hist Med.Cienc. 1993, 1:89­102: 89­102. Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R. Polioviruses with natural recombinant genomes isolated from vaccine­associated paralytic poliomyelitis. Virology 1993 Sep;196(1):199­208. Gavaghan T, Webber CK. Severe systemic vasculitic syndrome post influenza vaccination. Aust N Z J Med. 1993 Apr;23(2):220. German. Wu VH,. Measles virus­specific cellular immunity in patients with vaccine failure. J Clin Microbiol 1993 Jan; 31(1):118­22. Giampietro PG, Bruno G, Grandolfo M, Businco L. Adverse reaction to measles immunization. Eur J Pediatr. 1993 Jan;152(1):80. Hughes PJ, Saadeh IK, Cox JP, Illis LS. Probable post­hepatitis A vaccination encephalopathy. Lancet. 1993 Jul 31;342(8866):302. Hyoty H, Hiltunen M, Reunanen A, Leinikki P, Vesikari T, Lounamaa R, Tuomilehto J, Akerblom HK. Decline of mumps antibodies in type 1 (insulin­
dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps­measles­rubella vaccine in Finland. Childhood Diabetes in Finland Study Group.,m Diabetologia 1993 Dec;36(12):1303­8. Iizuka H, Amano N, Izeki E, Sakai M, Harada K. A case of antirabies inoculation encephalitis with a long clinical course. Jpn J Psychiatry Neurol 1993 Sep;47(3):603­8. Mader R, Narendran A, Lewtas J, Bykerk V, Goodman RC, Dickson JR, Keystone EC. Systemic vasculitis following influenza vaccination­­report of 3 cases and literature review. J Rheumatol. 1993 Aug;20(8):1429­31. Mermel L, Sanchez de Mora D, Sutter RW, Pallansch MA. Vaccine­associated paralytic poliomyelitis. N Engl J Med. 1993 Sep 9;329(11):810­1. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L, Tettmar R. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet 1993 Apr 17;341(8851):979­82. Mitchell LA, Tingle AJ, Shukin R, Sangeorzan JA, McCune J, Braun DK. Chronic rubella vaccine­associated arthropathy. Arch Intern Med 1993 Oct 11;153(19):2268­74. Muhlemann K; Alexander ER; Weiss NS; Pepe M; Schopfer K. Risk factors for invasive Haemophilus influenzae disease among children 2­16 years of age in the vaccine era, Switzerland 1991­1993. Nadler JP. Multiple sclerosis and hepatitis B vaccination. Clin Infect Dis. 1993 Nov;17(5):928­9. Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr 1993 Mar;82(3):267­70. Nisini R, Biselli R, Matricardi PM, Fattorossi A, D'Amelio R. Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits. Vaccine 1993;11(5):582­6. Pillai, JJ, et al. Renal Involvement in Association with Post­vaccination Varicella. Clin Infect Disorder, Dec 1993, 17(6): 1079­1080. Ramis Pedromingo M, Canete Diaz A, Torres Rubio J, Magro Rodriguez R. Pancreatitis following vaccination against measles, mumps, and rubella in a young adult. Aten Primaria. 1993 Feb 1;11(2):105. Reactions to DTP and DT vaccines. Med J Aust. 1983 Apr 30;1(9):405­6. Olsen OF. Complications of MMR vaccinations. Ugeskr Laeger. 1993 Jul 26;155(30):2359­60. Rejjal AL, Britten G, Nazer H. Thrombocytopenic purpura following measles­mumps­rubella vaccination. Ann Trop Paediatr. 1993;13(1):103­4. Sackey AH, Broadhead RL. Hemiplegia after measles, mumps, and rubella vaccination. BMJ. 1993 May 1;306(6886):1169. Sawada H, Yano S, Oka Y, Togashi T. Transmission of Urabe mumps vaccine between siblings. Lancet. 1993 Aug 7;342(8867):371. Slater PE. Role of EIPV in 1988 Israel polio outbreak. Vaccine. 1993 Sep;11(12):1269. Tan, SY, et al. Vaccine Related Glomerulonephritis. BMJ, Jan 23, 1993, 306(6872):248. Tesovic, G et al. Aseptic Meningitis after Measles, Mumps and Rubella Vaccine. Lancet, Jun 12, 1993, 341(8859):1541. Trevisani F, Gattinara GC, Caraceni P, Bernardi M, Albertoni F, D'Alessandro R, Elia L, Gasbarrini G. Transverse myelitis following hepatitis B vaccination. J Hepatol. 1993 Sep;19(2):317­8. Tulchinsky TH, Birkhead G. More on vaccine­associated paralytic poliomyelitis. N Engl J Med. 1993 Dec 23;329(26):1968­9. Vuolo AM, Lustigman B. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine­sensitizing factor. Biologicals 1993 Mar;21(1):45­52. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL­4 suggests induction of a Th2 response. Clin Immunol Immunopathol 1993 May; 67(2):171­7. Wiersbitzky S, Bruns R, Mentel R. Increased risk of invasive bacterial infections after preventive mumps­measles­rubella vaccination? Kinderarztl Prax. 1993 Jun;61(4­5):170­1. Wiersbitzky S, Burtzlaff C, Weinke I, Wiersbitzky H, Herrmann H. BNS epilepsy after the second triple (DPT) vaccination? Kinderarztl Prax. 1993 Aug;61(6):229­31. Wolf JE, Eisen JE, Fraimow HS. Symptomatic rubella reinfection in an immune contact of a rubella vaccine recipient. South Med J. 1993 Jan;86(1):91­3. 1994 Bate, C.; Kwiatkowski, D. P.; Taverne, J.; Playfair, J. H. Immunizing Against Toxic Malarial Antigens: Reply. Parasitol.Today. 10 (1): 24; 1994. Beausoleil JL, Nordgren RE, Modlin JF. Vaccine­associated paralytic poliomyelitis. J Child Neurol. 1994 Jul;9(3):334­5. Biasi D, Carletto A, Caramaschi P, Frigo A, Pacor ML, Bezzi D, Bambara LM. Rheumatological manifestations following hepatitis B vaccination. A report of 2 clinical cases. Recenti Prog Med 1994 Sep;85(9):438­40. Blanche P, Decrette C, Sicard D. Development of uveitis following vaccination for influenza. Clin Infect Dis. 1994 Nov;19(5):979. Bodokh I, Lacour JP, Bourdet JF, Rodot S, Botcazou V, Ortonne JP. Reactivation of bullous pemphigoid after influenza vaccination. Therapie. 1994 Mar­
Apr;49(2):154. Brown MA, Bertouch JV. Rheumatic complications of influenza vaccination. Aust N Z J Med. 1994 Oct;24(5):572­3. Cebria L, Perez Roldan F, Sanchez E, Rodriguez­Laiz JM, Casado M, Robles J, Gonzalez­Lara V, Cos E. Acute pancreatitis caused by parotiditis vaccine. Pancreas. 1994 May;9(3):390­1. Clark, I. A.; Rockett, K. A. Immunizing Against Toxic Malarial Antigens. Parasitol.Today. 10 (1): 6; 1994. Deisenhammer F, Pohl P, Bosch S, Schmidauer C. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurol Scand. 1994 Jun;89(6):462­3. Georgescu MM, Delpeyroux F, Tardy­Panit M, Balanant J, Combiescu M, Combiescu AA, Guillot S, Crainic R. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccineassociated paralytic poliomyelitis. J Virol 1994 Dec;68(12):8089­101. Groom SN, Clewley J, Litton PA, Brown DW. Vaccine­associated poliomyelitis. Lancet. 1994 Mar 5;343(8897):609­10. Guillot S, Otelea D, Delpeyroux F, Crainic R. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site­specific polymerase chain reaction. Vaccine 1994 May;12(6):503­7. Hassan W, Oldham R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ. 1994 Jul 9;309(6947):94. Helies P, Crepy P, Mve Mengome E, Batisse JL, Maille M. Oculo­palpebral complication of vaccination. Review of the literature. J Fr Ophtalmol 1994;17(1):62­6. Ion­Nedelcu N, Dobrescu A, Strebel PM, Sutter RW. Vaccine­associated paralytic poliomyelitis and HIV infection. Lancet. 1994 Jan 1;343(8888):51­2. Jani FM, Gray JP, Lanham J. Influenza vaccine and dermatomyositis. Vaccine. 1994 Nov;12(15):1484. Lachgar T, Soupison T, Roche­Sicot J. Immuno­allergic meningeal reaction following anti­flavivirus vaccination. Presse Med. 1994 Oct 22;23(32):1493. Mashikian MV, Stollerman GH. Vaccine­associated polio: a case and its lessons. Hosp Pract (Off Ed). 1994 Sep 15;29(9):69­73, 76­7. Masson P, Rigot A, Cecile W. Brachial plexus neuropathy following pyogenic cervical adenophlegmon. Arch Pediatr 1994 Aug;1(8):735­7. Miller D, Madge N, Diamond J, Wadsworth J, Ross E. Pertussis immunisation and serious acute neurological illnesses in children. BMJ 1993 Nov 6;307(6913):1171­6 & Comment in: BMJ. 1994 Jan 29;308(6924):343. Monafo WJ, Haslam DB, Roberts RL, Zaki SR, Bellini WJ, Coffin CM. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr 1994 Feb;124(2):273­6. Odent, MR et al. Pertussis Vaccination and Asthma : is there a link? JAMA 1994­Vol. 272, No. 8 pag. 592­593. Olague, de Ros and Astrain, Gallart M. [An unpublished letter by Ignacio Maria Ruiz de Luzuriaga (1763­1822) on the spread of vaccination in Spain (1801)] Dynamis. 1994, 14:305­37. (): 305­337. Sepkowitz S. Pertussis immunization and neurological illness. BMJ. 1994 Mar 5;308(6929):655. Smedman L, Joki A, da Silva AP, Troye­Blomberg M, Aronsson B, Perlmann P. Immunosuppression after measles vaccination. Acta Paediatr 1994 Feb;83(2):164­8. Stratton KR, Howe CJ, Johnston RB Jr. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 1994 May 25;271(20):1602­5. Stratton KR, Howe CJ, Johnston RB Jr. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 1994 May 25;271(20):1602­9. Evidence for a high risk of vaccine­associated disease and reintroduction of wild­virus infection. Am J Epidemiol 1994 Dec 15;140(12):1111­24. Taraszkiewicz F, Bogus­Parafieniuk W, Oldak E, Sulik A. Adverse events following immunization: AEFI in 17 children between 0 and 2 years of age. Przegl Epidemiol 1994;48(4):505­9. Vautier G, Carty JE. Acute sero­positive rheumatoid arthritis occurring after hepatitis Vaccination. Br J Rheumatol. 1994 Oct;33(10):991. Wyatt HV. Vaccine­associated poliomyelitis. Lancet. 1994 Mar 5;343(8897):610. Zeigler, M et al. Autoantibodies in type 1 diabetes mellitus. Z Arztl Fortbild (Jena). 1994 Aug; 88(7­8):561­5. 1995 Angerstein, W, et al. Solitary Hearing and Equilibrium Damage After Vaccinations. Gesundheitswesen, May 1995, 57(5): 264­268. Bouvier­Colle, MH. Sex­Specific Differences in Mortality After High­Titre Measles Vaccination. Rev Epidemiol Sante Publique, 1995; 43(1): 97. Brezin AP, Massin­Korobelnik P, Boudin M, Gaudric A, LeHoang P. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol 1995 Mar;113(3):297­300. Dalakas MC, Illa I, Leon­Monzon M. Intramuscular injections and vaccine­associated poliomyelitis. N Engl J Med. 1995 Jul 6;333(1):62;. De Moraes­Pinto MI, Oruamabo RS, Igbagiri FP, Chan MC, Prado SM, Vancetto MD, Johnson PM, Hart CA. Neonatal tetanus despite immunization and protective antitoxin antibody. J Infect Dis. 1995 Apr;171(4):1076­7. Driesel G, Diedrich S, Kunkel U, Schreier E. Vaccine­associated cases of poliomyelitis over a 30 year period in East Germany. Eur J Epidemiol 1995 Dec;11(6):647­54. Escudero Nafs FJ, Guarch Troyas R, Perez Montejano­Sierra M, Colas San Juan C. Basal cell carcinoma in a vaccination scar. Plast Reconstr Surg. 1995 Jan;95(1):199­200. Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan­Capner P, Rush M, Miller E. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995 Mar 4;345(8949):567­9. Fescharek R, Dass H. Transverse myelitis unlikely to be due to measles, mumps, and rubella vaccine. BMJ. 1995 Dec 16;311(7020):1642. Friedrich F, Filippis AM, Ferreira FC, Schatzmayr HG, Da­Silva EE. Genomic characterization of type 2 polioviruses isolated from vaccine­associated cases in Brazil. Braz J Med Biol Res 1995 Jul;28(7):733­42. Friedrich F, Filippis AM, Ferreira FC, Schatzmayr HG, Da­Silva EE. Genomic characterization of type 3 polioviruses isolated from vaccine­associated poliomyelitis cases in Brazil. Braz J Med Biol Res 1995 Feb;28(2):195­200. Geiger R, Fink FM, Solder B, Sailer M, Enders G. Persistent rubella infection after erroneous vaccination in an immunocompromised patient with acute lymphoblastic leukemia in remission. J Med Virol 1995 Dec;47(4):442­4. Gross K, Combe C, Kruger K, Schattenkirchner M. Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol 1995;24(1):50­2. Herderschee D, Rensing JC, Ottervanger JP. Myelopathy following influenza vaccination. Ned Tijdschr Geneeskd. 1995 Oct 21;139(42):2152­4. Jayarajan, Sedler. Hearing Loss Following Measles Vaccination. J Infect, 1995 Mar; 30(2):184­185. Kaplanski G, Retornaz F, Durand J, Soubeyrand J. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):758­9. Kobune F, Funatu M, Takahashi H, Fukushima M, Kawamoto A, Iizuka S, Sakata H, Yamazaki S, Arita M, Xu W. Characterization of measles viruses isolated after measles vaccination. Vaccine 1995 Mar;13(4):370­2. Kothari SS. Aetiopathogenesis of Takayasu's arteritis and BCG vaccination: the missing link? Med Hypotheses 1995 Sep;45(3):227­30. Macario F, Freitas L, Correia J, Campos M, Marques A. Nephrotic syndrome after recombinant hepatitis B vaccine. Clin Nephrol. 1995 May;43(5):349. Maillefert JF, Farge P, Gazet­Maillefert MP, Tavernier C,.Mental nerve neuropathy as a result of hepatitis B vaccination. Matyszak MK, Perry VH. Demyelination in the central nervous system following a delayed­type hypersensitivity response to bacillus Calmette­Guerin. Neuroscience 1995 Feb;64(4):967­977. Measles Encephalomyelitis in a Patient With a History of Vaccination. Acta Paediatrica Japonica, vol. 37, number 3, June 1995, pp. 374­376. Meyboom RH, Fucik H, Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet. 1995 Jun 24;345(8965):1638. Meynell, E. French reactions to Jenner's discovery of smallpox vaccination: the primary sources Soc.Hist Med. 1995, 8 (2): 285­303. Owda AK, Turney JH. Typhoid vaccination and IgA nephropathy. Nephrol Dial Transplant. 1995;10(8):1477­8. Riikonen RS. Retinal vasculitis caused by rubella. Neuropediatrics 1995 Jun;26(3):174­6. Ross RT. Intramuscular injections and vaccine­associated poliomyelitis. N Engl J Med. 1995 Jul 6;333(1):63;. Sander D, Scholz C, Eiben P, Klingelhofer J. Plexus neuropathy following vaccination against tick­borne encephalitis and tetanus due to a sports related altered immune state. Neurol Res 1995 Aug;17(4):316­9. Sepkowitz S. Intramuscular injections and vaccine­associated poliomyelitis. N Engl J Med. 1995 Jul 6;333(1):64. Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 1995 Apr;20(4):1010­36. Stachowski J, Runowski D, Kramer J, Madalinski K, Maciejewski J, Baldamus CA. Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf). Przegl Lek 1995;52(9):445­54. Strebel PM, Ion­Nedelcu N, Baughman AL, Sutter RW, Cochi SL. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine ­a risk factor for vaccine­associated paralytic poliomyelitis. N Engl J Med 1995 Feb 23;332(8):500­6. Sullivan AA, Boyle RS, Whitby RM. Vaccine­associated paralytic poliomyelitis. Med J Aust. 1995 Oct 16;163(8):423­4. Sunaga Y, Hikima A, Ostuka T, Morikawa A. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatr Neurol 1995 Nov;13(4):340­2. Ueda K, Miyazaki C, Hidada Y, Osaka K, Kusuhara K. Kadoya R. Aseptic meningitis caused by measles­mumps­rubella vaccine in Japan. Lancet. 1995 Sep 9;346(8976):701­2. Van de Loo AA, Arntz OJ, Bakker AC, van Lent PL, Jacobs MJ, van den Berg WB. Role of interleukin 1 in antigen­induced exacerbations of murine arthritis. Am J Pathol. 1995 Jan;146(1):239­49. Vlasimska H, Smejkalova H. Reactions after vaccination against tick­borne encephalitis. Epidemiol Mikrobiol Imunol 1995 Mar;44(1):26­8. Ward, M. Immunization Administration and Disease Reporting in the Emergency Department. Semin Pediatr Infect Dis; 6 (4): 255­264; October, 1995. Wiechers D. Electrophysiology of acute polio revisited. Utilizing newer EMG techniques in vaccine­associated disease. Ann N Y Acad Sci. 1995 May 25;753:111­9. Wiersbitzky S, Bruns R, Muller C, Wiersbitzky H, Mentel R, Seidel W. Postvaccinal thrombocytopenia: fact or myth?, Pediatr Hematol Oncol. 1995 Sep­
Oct;12(5):503­5. 1996 Autret E, Jonville­Bera AP, Galy­Eyraud C, Hessel L. Thrombocytopenic purpura after single or combined vaccination against measles, mumps and rubella. Arch Pediatr. 1996 Apr;3(4):393­4. Auwaerter PG. Changes within T cell receptor V beta subsets in infants following measles vaccination. Clin Immunol Immunopathol 1996 May;79(2):163­70. Baglivo E, Safran AB, Borruat FX. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol 1996 Sep;122(3):431­2. Bahri F, Letaief A, Ernez M, Elouni J, Chekir T, Ben Ammou S, Jemni L. Neurological complications in adults following rabies vaccine prepared from animal brains. Presse Med 1996 Mar 23;25(10):491­3. Bani­Sadr F, Gueit I, Humbert G. Vasculitis related to hepatitis A vaccination. Clin Infect Dis. 1996 Mar;22(3):596. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J. 1996 Jan;15(1):88­90. Berkman N, Benzarti T, Dhaoui R, Mouly P. Bilateral neuro­papillitis after hepatitis B vaccination. Presse Med. 1996 Sep 28;25(28):1301. Cathebras P, Cartry O, Lafage­Proust MH, Lauwers A, Acquart S, Thomas T, Rousset H.Arthritis, hypercalcemia, and lytic bone lesions after hepatitis B vaccination. J Rheumatol 1996 Mar;23(3):558­60. Chang SK, Farrell DL, Dougan K, Kobayashi B. Acute idiopathic thrombocytopenic purpura following combined vaccination against measles, mumps, and rubella. J Am Board Fam Pract. 1996 Jan­Feb; 9(1):53­5. Classen JB. Childhood immunisation and diabetes mellitus. N Z Med J, 109(1022):195 1996 May 24. Classen JB. The diabetes epidemic and the hepatitis B vaccines. N Z Med J, 109(1030):366 1996 Sep 27. Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996;24(3):137­45. Cohen AD, Shoenfeld Y. Vaccine­induced autoimmunity. J Autoimmun. 1996 Dec;9(6):699­703. Devin F, Roques G, Disdier P, Rodor F, Weiller PJ. Occlusion of central retinal vein after hepatitis B vaccination. Lancet. 1996 Jun 8;347(9015):1626. Fiore L, Novello F, Simeoni P, Amato C, Vellucci L, De Stefano D, Grandolfo ME, Luzzi I. Surveillance of acute flaccid paralysis in Italy: 1996­1997. AFP Study Group. Acute flaccid paralysis. Eur J Epidemiol 1999 Sep;15(8):757­63. Fournier B, Descamps V, Bouscarat F, Crickx B, Belaich S. Bullous pemphigoid induced by vaccination. Br J Dermatol. 1996 Jul;135(1):153­4. Frenkel LM, Nielsen K, Garakian A, Jin R, Wolinsky JS, Cherry JD. A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clin Infect Dis 1996 Feb;22(2):287­94. Friedrich F, Da­Silva EF, Schatzmayr HG. Type 2 poliovirus recombinants isolated from vaccine­associated cases and from healthy contacts in Brazil. Acta Virol 1996 Feb;40(1):27­33. Friedrich F, Filippis AM, Ferreira FC, Oliveira MJ, Schatzmayr HG, Da­Silva EE. Poliovirus type 1 isolated from a vaccine­associated case of paralytic poliomyelitis in Brazil. Braz J Med Biol Res 1996 Jan;29(1):15­8. Friedrich F. Genomic modifications in Sabin vaccine strains isolated from vaccination­associated cases, healthy contacts and healthy vaccinees. Acta Virol 1996 Jun;40(3):157­70. Genereau T, Koeger AC, Chaibi P, Bourgeois P. Polymyalgia rheumatica with temporal arteritis following intravesical Calmette­Guerin bacillus immunotherapy (antitubercolar vaccine) for bladder cancer. Clin Exp Rheumatol. 1996 Jan­Feb;14(1):110. Hummel M, Ziegler AG. Vaccines and the appearance of islet cell antibodies in offspring of diabetic parents. Results from the BABY­DIAB Study. Diabetes Care. 1996 Dec;19(12):1456­7. Hussey GD, Goddard EA, Hughes J, Ryon JJ, Kerran M, Carelse E, Strebel PM, Markowitz LE, Moodie J, Barron P, Latief Z, Sayed R, Beatty D, Griffin DE. The effect of Edmonston­Zagreb and Schwarz measles vaccines on immune response in infants. J Infect Dis 1996 Jun;173(6):1320­6. Lear JT, Tan BB, English JS. Bullous pemphigoid following influenza vaccination. Clin Exp Dermatol. 1996 Sep;21(5):392. Mahoney RT. Developing vaccines against HIV: options for accelerated progress. AIDS Public Policy J 1996 Spring;11(1):28­35. Miyamura T, Hagiwara A. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine­associated paralytic patients. Arch Virol 1996;141(6):1047­54. Muhlemann K, Alexander ER; Weiss NS; Pepe M; Schopfer K. Risk factors for invasive Haemophilus influenzae disease among children 2­16 years of age in the vaccine era, Switzerland 1991­1993. The Swiss H. Influenzae Study Group. Int J Epidemiol 1996 Dec;25(6):1280­5. Polychronopoulou­Androulakaki S, Panagiotou JP, Kostaridou S, Kyratzopoulou A, Haidas S. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine. Pediatr Hematol Oncol 1996 Sep­1996 Oct 31;13(5):425­31. Polymerase chain reaction detection of the hemagglutinin gene from an attenuated measles vaccine strain in the peripheral mononuclear cells of children with autoimmune hepatitis. Archives of Virology volume 141, 1996, pages 877­884. Poutasi K. Immunisation and diabetes. N Z Med J. 1996 Jul 26;109(1026):283. Ramanathan S, de Kozak Y, Saoudi A, Goureau O, Van der Meide PH, Druet P, Bellon B.Recombinant IL­4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996 Sep 1;157(5):2209­15. Ray CL, Dreizin IJ. Bilateral optic neuropathy associated with influenza vaccination. J Neuroophthalmol 1996 Sep;16(3):182­4. Resik Aguirre S, Sariol Curbelo CA, Alvarez Vega M, Marrero Suarez M. Anomalous response of antibodies in rash­causing viral infections. Rev Cubana Med Trop 1996;48(1):56­8. Schmitt HJ, Schuind A, Knuf M, Beutel K, Schulte­Wissermann H, Gahr M, Schult R, Folkens J, Rauh W, Bogaerts H, Bork HL, Clemens R. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr 1996 Nov;129(5):695­701. Sepkowitz S. Perverse reactions to pertussis vaccine by government medical agencies. J Okla State Med. Assoc. 1996 Apr;89(4):135­8. Skold, P. From inoculation to vaccination: smallpox in Sweden in the eighteenth and nineteenth centuries Popul.Stud.(Camb.). 1996, 50 (2): 247­262. The Swiss H. Influenzae Study Group. Int J Epidemiol 1996 Dec;25(6):1280­5. Vlacha V, Forman EN, Miron D, Peter G. Recurrent thrombocytopenic purpura after repeated measles­mumps­rubella Vaccination. Pediatrics. 1996 May;97(5):738­9. Waldvogel K, Bossart W, Huisman T, Boltshauser E, Nadal D. Severe tick­borne encephalitis following passive immunization. Eur J Pediatr 1996 Sep;155(9):775­9. Weibel RE, Benor DE. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program. Arthritis Rheum 1996 Sep;39(9):1529­34. Weibel RE, Benor DE. Reporting vaccine­associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program. Am J Public Health 1996 May;86(5):734­7. Wu T, Wang SL, Xiang YZ. Study on the subclinical infection of the recipients of measles vaccine. Zhonghua Liu Xing Bing Xue Za Zhi 1996 Apr;17(2):70­
2. Yamamoto T, Kino T, Yagi K, Miyata H, Yoshioka K. Acute thrombocytopenic purpura following rubella vaccination. Rinsho Ketsueki. 1996 Nov;37(11):1328­30. 1997 Arya SC. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophthalmol. 1997;21(3):177­8. Berkman N. A case of segmentary unilateral occlusion of the central retinal vein following hepatitis B vaccination. Presse Med. 1997 Apr 26;26(14):670. Biellik RJ, Allies T, Woodfill CJ, Lobanov A. Polio outbreaks in Namibia, 1993­1995: lessons learned. J Infect Dis 1997 Feb;175 Suppl 1:S30­6. Bracci M, Zoppini A. Polyarthritis associated with hepatitis B vaccination. Br J Rheumatol. 1997 Feb;36(2):300­1. Braun MM, Ellenberg SS. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991­1994. J Pediatr 1997 Oct;131(4):529­35. Burova LA, Nagornev VA, Pigarevsky PV, Gladilina MM, Seliverstova VG, Schalen C, Totolian AA. Circulating anti­IgG and glomerular damage in rabbits immunized with IgG Fc­receptor positive group A streptococci. Adv Exp Med Biol. 1997;418:531­5. Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB Jr, Adelman DC. Use of an anti­IgE humanized monoclonal antibody in ragweed­induced allergic rhinitis. J Allergy Clin Immunol 1997 Jul;100(1):110­21. Confino I, Passwell JH, Padeh S. Erythromelalgia following influenza vaccine in a child. Clin Exp Rheumatol 1997 Jan­Feb;15(1):111­3. Daoud MS, Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Am Acad Dermatol. 1997 May;36(5 Pt 1):779­80. De Meester A, Luwaert R, Chaudron JM. Symptomatic pericarditis after influenza vaccination: report of two cases. Desson JF, Leprevost M, Vabret F, Davy A. Acute benign pericarditis after anti­influenza vaccination. Presse Med. 1997 Mar 22;26(9):415. Ehrengut W. Role of provocation poliomyelitis in vaccine­associated poliomyelitis. Acta Paediatr Jpn 1997 Dec;39(6):658­62. Fescharek R, Arras­Reiter C, Arens ER, Quast U, Maass G. Oral vaccines against poliomyelitis and vaccination­related paralytic poliomyelitis in Germany. Do we need a new immunization strategy? Wien Med Wochenschr 1997;147(19­20):456­61. Fescharek R, Budde RK, Arras C. OPV vs IPV­­could placental immunity reduce the number of vaccineassociated paralytic poliomyelitis? Vaccine. 1997 Nov;15(16):1707­8. Friedrich F. Rare adverse events associated with oral poliovirus vaccine in Brazil. Braz J Med Biol Res 1997 Jun;30(6):695­703. Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine­associated paralytic poliomyelitis. J Virol 1997 Oct;71(10):7758­68. Hamati­Haddad A, Fenichel GM. Brachial neuritis following routine childhood immunization for diphtheria, tetanus, and pertussis (DTP): report of two cases and review of the literature. Pediatrics. 1997 Apr;99(4):602­3. Hazir T, Saleem M, Abbas KA. Stevens­Johnson syndrome following measles vaccination. J Pak Med Assoc. 1997 Oct;47(10):264­5. Henderson, D. A. The miracle of vaccination Notes Rec.R.Soc.Lond. 1997, 51 (2): 235­245. House DV, Winter WE. Autoimmune diabetes. The role of auto­antibody markers in the prediction and prevention of insulin­dependent diabetes mellitus. Clin Lab Med 1997 Sep; 17(3):499­545. Hull TP, Bates JH. Optic neuritis after influenza vaccination. Am J Ophthalmol 1997 Nov;124(5):703­4. Izurieta, H. S., Sutter, R. W., Strebel, P. M., Bardenheier, B., Prevots, D. R., Wharton, M., and Hadler, S. C. Tetanus Surveillance­­United States, 1991­1994 MMWR CDC Surveill Summ. 2­21­1997, 46 (2): 15­25 Kanra G, Ozon A, Vajsar J, Castagna L, Secmeer G, Topaloglu H. Intravenous immunoglobulin treatment in children with Guillain­Barre syndrome [see comments]. Europ J Paediatr Neurol 1997; 1(1):7­12. Kelsall JT, Chalmers A, Sherlock CH, Tron VA, Kelsall AC. Microscopic polyangiitis after influenza vaccination. J Rheumatol 1997 Jun;24(6):1198­202. Kemp T; Pearce N; Fitzharris P; Crane J; Fergusson D; St. George I; Wickens K; Beasley R. Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology 1997 Nov;8(6):678­80. Kerleau JM, Levesque H, Lair G, Lecomte F, Carrara O, Courtois H. Is hepatitis B vaccination a new cause of necrotizing vasculitis? Rev Med Interne. 1997;18(6):491­2. Mahassin F, Algayres JP, Valmary J, Bili H, Coutant G, Bequet D, Daly JP. Acute myelitis after vaccination against hepatitis B. Presse Med 1993 Dec 18;22(40):1997­8. Measles, Mumps, Rubella Vaccine Induced Subacute Sclerosing Panencephalitis. Journal of the Indian Medical Association, November 1997, vol. 95 no. 11, page 594. Merican I. Typhoid fever: present and future. Med J Malaysia 1997 Sep;52(3):299­308; quiz 309. MMWR. Prolonged poliovirus excretion in an immunodeficient person with vaccine­associated paralytic poliomyelitis. MMWR Morb Mortal Wkly Rep 1997 Jul 18;46(28):641­3. Mortiere MD, Falcone AL. An acute neurologic syndrome temporally associated with postexposure treatment of rabies. Pediatrics 1997 Oct;100(4):720­1. Noble JP, de Gennes C, Bousquet O. Skin diseases related to hepatitis B vaccine. Gastroenterol Clin Biol. 1997;21(1):87. Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases. Presse Med 1997 Feb 1;26(2):62­5. Ohno M, Egawa T, Yamano T, Shimada M. Multiple abnormal magnetic resonance imaging signals in a patient with minimal neurological symptoms. Europ J Paediatr Neurol 1997; 1(1):39­40. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 Jun;83(6):663­4. Palao Sanchez A, Leiva­Santana C, Munoz­Ruiz C, Sanchez­Paya J. Neurological involvement following triple virus vaccine. Rev Neurol 1997 Jan;25(137):75­7. Parent ME, et al. Bacille Calmette­Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 1997 May; 20(5):767­772. Peyriere H, Hillaire­Buys D, Pons M, Navarre C, Davy JM, Blayac JP. Acute pericarditis after vaccination against hepatitis B: a rare effect to be known. Rev Med Interne. 1997;18(8):675­6. Pool V, Chen R, Rhodes P. Indications for measles­mumps­rubella vaccination in a child with prior thrombocytopenia purpura. Pediatr Infect Dis J. 1997 Apr;16(4):423­4. Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, Hadler S, Chen R, Cochi S, Wassilak S. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA 1997 Aug 20;278(7):551­6 con comment in: JAMA. 1997 Aug 20;278(7):594­5. Reijneveld JC, Taphoorn MJ, Hoogenraad TU, van Gijn J. Severe but transient parkinsonism after tetanus vaccination. J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):258. Reinert, P. The role of pneumococcal and haemophilus type B vaccination in the prevention of acute otitis media Clin.Microbiol.Infect. 1997, 3 Suppl 3:S59­
S61. (): S59­S61. Shorer Z. Current treatment in acute demyelinating polyneuropathy (Guillain­Barre syndrome) [editorial; comment]. Europ J Paediatr Neurol 1997; 1(1):3­5. Song HK, Kim HC, Yun YH. Acute Myelitis after hepatitis B vaccination. J Korean Med Sci 1997 Jun;12(3):249­51. Soubrier M, Dubost JJ, Bielsa C, Ristori JM, Bussiere JL.,[Erosive polyarthritis triggered by vaccination against hepatitis B. Presse Med. 1997 Feb 1;26(2):75. Tate CA, Johnson GD. Case report: acute vaccine­associated paralytic poliomyelitis. Muscle Nerve. 1997 Feb;20(2):253­4. Thurairajan G, Hope­Ross MW, Situnayake RD, Murray PI. Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine. Br J Rheumatol 1997 Jan;36(1):120­3. Transmission of vaccine strain varicella­zoster virus from a healthy adult with vaccine­associated rash to susceptible household contacts. Journal of Infectious Disease, vol. 176, no. 4, October 1997, pp. 1072­5. Treves R, Lacoste L, Bontoux D, Pitrou E, Bertin P, Bonnet C. Erosive nodular rheumatoid arthritis triggered by hepatitis B vaccination. Presse Med. 1997 Apr 26;26(14):670. Vines, J. [An Appraisal of the Pros and Cons of Mass Vaccination]. An Sist.Sanit.Navar. 20 (3): 391­394; September, 1997. Wanschitz J, Hainfellner JA, Simonitsch I, Schnizer M, Deisenhammer E, Terunuma H, Iwasaki Y, Budka H. Non­HTLV­I associated pleomorphic T­cell lymphoma of the brain mimicking post­vaccinal acute inflammatory demyelination. Neuropathol Appl Neurobiol 1997 Feb;23(1):43­9. Warrell, D. A. The success of vaccination in tropical countries Proc.R.Coll.Physicians Edinb. 1997, 27 (1): 22­29. Watson JM, Cordier JF, Nicholson KG. Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma? Thorax. 1997 Feb;52(2):190­4. Willbanks GA, Rootman DS, Jay V, Wiggert B, Chamberlain J, Inman RD. Experimental autoimmune uveitis in HLA­B27 transgenic mice. Hum Immunol 1997 Apr 1;53(2):188­94. 1998 Ajithkumar K, Anand U, Pulimood S, Chandi SM, George S, Jacob CK, Thomas PP. Vaccine­induced necrobiotic granuloma. Clin Exp Dermatol. 1998 Sep;23(5):222­4. Allen, A. Injection rejection: the dangerous backlash against vaccination New Repub. 3­23­1998, 218 (12): 20­23. Ashmarin IP, Danilova RA, Obukhova MF, Belopol'skaia MV. Induction of long­term depression (with anxiety and fear components) by immunization of rats against pargyline. Vestn Ross Akad Med Nauk 1998;(8):27­32. Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. Antivir Ther 1998; 3(Suppl 3):1­9. Bui­Quang D, Thomas E, Riols M, Levillain P, Picaud D, Sechet A, Baron M, Verove C. Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant patient. Presse Med. 1998 Sep 12;27(26):1321­3. Campins Marti M, Moraga Llop FA. Hepatitis B vaccine and multiple sclerosis. An Esp Pediatr. 1998 Dec;49(6):555­7. Cernescu C, Ruta S, Diaconu C, Bleotu C, Grancea C, Truica C, Craciun D, Nedelcu IN. Low rates of seroconversion after hepatitis B vaccination in orphanges with high prevalence of virus carriers. Rom J Virol 1998 Jan­1998 Dec 31;49(1­4):73­81. Cottrell BH, Carter CC. Health care professionals: have you had the chicken pox? AWHONN.Lifelines. 1998;33­8. Downs AM, Lear JT, Bower CP, Kennedy CT. Does influenza vaccination induce bullous pemphigoid? A report of four cases. Br J Dermatol. 1998 Feb;138(2):363. Drago F, Rampini P, Lugani C, Rebora A. Generalized morphoea after antitetanus vaccination. Clin Exp Dermatol. 1998 May;23(3):142. Durand JM. Arthritis after intravesicular BCG therapy. Presse Med. 1998 May 23­30;27(19):918. Epidemics of aseptic meningitis due to enteroviruses following national immunization days in Bahrain. Annals of Tropical Paediatrics, vol. 18, no. 2, June 1998, pp. 101­9. Fanutti C, Del Pozzo G, De Berardinis P, Guardiola J, Deng LW, Perham RN. Phage­display of antigenic peptides applied to vaccine design. Biochem Soc Trans 1998 Feb;26(1):S8. Fernandez­Funez A, Polo Romero FJ. Juvenile dermatomyositis concomitant with hepatitis B vaccination. Med Clin (Barc). 1998 Nov 21;111(17):675. Freed GL, Pathman DE, Konrad TR, Freeman VA, Clark SJ. Adopting immunization recommendations: a new dissemination model. Matern Child Health J 1998; 2(4):231­239. Friedrich F. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. Acta Virol 1998 Jun;42(3):187­94. Fry M, Edwards G, Taylor A. Tetanus­­the silent killer: how safe are you? Aust.Crit Care 1998;82­5. Grasland A, Le Maitre F, Pouchot J, Hazera P, Bazin C, Vinceneux P. Adult­onset Still's disease after hepatitis A and B vaccination? Rev Med Interne 1998 Feb;19(2):134­6. Grey M. The impact of the "Put Prevention into Practice" initiative on pediatric nurse practitioner practices. J.Pediatr.Health Care 1998;171­5. Hanson KL, Fairbrother G, Kory P, Butts GC, Friedman S. The transition from Medicaid fee­for­service to managed care among private practitioners in New York City: effect on immunization and screening rates. Matern Child Health J 1998; 2(1):5­14. Hegde, B. M. Vaccination in India J.Assoc.Physicians India. 1998, 46 (5): 472­473. Hennock, E. P. Vaccination policy against smallpox, 1835­1914: a comparison of England with Prussia and Imperial Germany Soc.Hist Med. 1998, 11 (1): 49­
71. Kawasaki A, Purvin VA, Tang R. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol 1998 Mar;18(1):56­9. Kemp T; Pearce N; Fitzharris P; Crane J; Fergusson D; St. George I; Wickens K; Beasley R; Lewis SA, Britton JR. Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever. Clin Exp Allergy 1998 Dec;28(12):1493­500. Khalfan S, Aymard M, Lina B, Thouvenot D, Schuffenecker I, Foray S, Fernandes E, Baig B. Epidemics of aseptic meningitis due to enteroviruses following national immunization days in Bahrain. Ann Trop Paediatr 1998 Jun;18(2):101­9. Lacour JP. Hepatitis, the vaccine, multiple sclerosis and lichen": the story and its morale. Ann Dermatol Venereol. 1998 Jul;125(6­7):395­7. Leaver M. Measles (rubeola) virus. Collegian. 1998;40­1. Lehmann D, Kakazo M, Yarsley S, Javati A, Taime J, Saleu G, Namuigi P, Alpers MP, Mendelman PM, Staub T. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children. P N G Med J 1998 Sep­1998 Dec 31;41(3­4):102­11. Lonnrot M, Knip M, Roivainen M, Koskela P, Akerblom HK, Hyoty H. Onset of type 1 diabetes mellitus in infancy after enterovirus infections. Diabet Med 1998 May;15(5):431­4. McIntyre PB, O'Brien ED, Heath TC. Immunisation and asthma. Commun Dis Intell. 1998 Mar 19;22(3):38. Megel ME, Houser CW, Gleaves LS. Children's responses to immunizations: lullabies as a distraction. Issues Compr.Pediatr.Nurs. 1998;129­45. Miller E. Collapse reactions after whole cell pertussis vaccination. BMJ. 1998 Mar 21;316(7135):876. Neau D, Bonnet F, Michaud M, Perel Y, Longy­Boursier M, Ragnaud JM, Guillard JM. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis. 1998;30(2):115­8. Osborne, K., Valenciano, M., Veldhuijzen, I., Levy­Bruhl, D., and Pebody, R. ESEN : A Comparison of Vaccination Programmes Part One: Diphtheria. Euro.Surveill 1998, 3 (10): 93­96. Osborne, K., Valenciano, M., Veldhuijzen, I., Levy­Bruhl, D., and Pebody, R. ESEN : A Comparison of Vaccination Programmes Part Two : Pertussis. Euro.Surveill 1998, 3 (11): 107­110. Osborne, K., Valenciano, M., Veldhuijzen, I., Levy­Bruhl, D., and Pebody, R. ESEN: A Comparison of Vaccination Programmes ­ Part Three : Measles Mumps and Rubella. Euro.Surveill 1998, 3 (12): 115­119. Ozdemir S, Bakkaloglu A, Oran O. Nephrotic syndrome associated with recombinant hepatitis B vaccination: a causal relationship or just a mere association? Nephrol Dial Transplant. 1998 Jul;13(7):1888­9. Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998 Sep;25(9):1687­93. Prevots DR, Ciofi degli Atti ML, Sallabanda A, Diamante E, Aylward RB, Kakariqqi E, Fiore L, Ylli A, van der Avoort H, Sutter RW, Tozzi AE, Panei P, Schinaia N, Genovese D, Oblapenko G, Greco D, Wassilak SG. Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis 1998 Feb;26(2):419­25. Ramakrishnan N, Parker LP. Thrombotic thrombocytopenic purpura following influenza vaccination­­a brief case report. Conn Med. 1998 Oct;62(10):587­8. Ridgway D. Disputed claims for pertussis vaccine injuries under the National Vaccine Injury Compensation Program. J Investig Med 1998 Apr;46(4):168­74. Rokicka­Milewska, R., Machala, M., Klukowska, A., Laguna, P., and Sikorska­Fic, B. Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia Clin.Microbiol.Infect. 1998, 4 (10): 589­593. Rose V. MMR immunisation: what advice should we give to parents? Prof.Care Mother.Child 1998;58­9. Sakaguchi M, Nakayama T, Inouye S. Cases of systemic immediate­type urticaria associated with acellular diphtheria­tetanus­pertussis vaccination. Vaccine 1998 Jul;16(11­12):1138­40. Scheig R. Acute and chronic viral hepatitis. Lippincotts.Prim.Care Pract. 1998;390­7. Schuil J, van de Putte EM, Zwaan CM, Koole FD, Meire FM. Retinopathy following measles, mumps, and rubella vaccination in an immuno­incompetent girl. Int Ophthalmol 1998;22(6):345­7. Sebag O, Bolla G, Bebin B, Sebag F. Exacerbation of chronic juvenile arthritis induced by hepatitis B vaccination. Arch Pediatr. 1998 Sep;5(9):1046. Selvaraj N, Moonis M, Ravin P. Hemiparesis following influenza vaccination. Postgrad Med J. 1998 Oct;74(876):633­5. Skowron F, Grezard P, Berard F, Balme B, Perrot H. Persistent nodules at sites of hepatitis B vaccination due to aluminium Sensitization.!, Contact Dermatitis. 1998 Sep;39(3):135­6. Smith, B. Camphor, cabbage leaves and vaccination: the career of Johnie "Notions" Williamson, of Hamnavoe, Eshaness, Shetland Proc.R.Coll.Physicians Edinb. 1998, 28 (3): 395­406. Toft J, Larsen S, Toft H. Subacute thyroiditis after hepatitis B vaccination. Endocr J. 1998 Feb;45(1):135. Van Amsterdam JG, te Biesebeek JD, van de Kuil T, van der Laan JW, Wemer J, de Wildt DJ, Vleeming W. The effect of pertussis toxin and whole­cell pertussis vaccine on haemodynamics and autonomic responsiveness in the rat depends on route of administration and age. Vaccine 1998 Apr;16(7):666­71. Van Essen, G. A. Monitoring the Introduction of Universal Influenza Vaccination for the Elderly People in the Netherlands. Euro.Surveill 1998, 3 (3): 32. Vanoli M, Gambini D, Scorza R. A case of Churg­Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis. 1998 Apr;57(4):256­7. Wolf F, Grezard P, Berard F, Clavel G, Perrot H,.Generalized granuloma annulare and hepatitis B vaccination. Eur J Dermatol 1998 Sep;8(6):435­6. Wood DW, Block KP. Helicobacter pylori: a review. Am.J.Ther. 1998;253­61. Zuberi BF, Rajput MR, Muzaffar L, Jatoi N, Shaikh WM. Efficacy of low dose intra­dermal hepatitis B vaccination schedule. JPMA J.Pak.Med.Assoc. 1998;377­8. 1999 Aaberge IS. Pneumococcal vaccine in the elderly: the Norwegian experience. Drugs Aging 1999; 15 Suppl 1:37­41. Abbott G, Farmer K, Grimwood K, Hill S, Lennon D, Moyes C, Reid S, Stanley T, Teele D, Tsang B, Voss L. Childhood immunisation in Rotorua [letter]. N.Z.Med.J. 1999;454­5. Adegbola RA, Usen SO, Weber M, Lloyd­Evans N, Jobe K, Mulholland K, McAdam KP, Greenwood BM, Milligan PJ. Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine [letter]. Lancet 1999;1091­2. Agarwal RK, John TJ. Intervals between different vaccines. Indian Pediatr 1999 Jun;36(6):608­10. Agarwal RK. Measles vaccination and risk of SSPE. Indian Pediatr. 1999 Mar;36(3):317. Agarwal, S. K., Irshad, M., and Dash, S. C. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure. J Assoc Physicians India 1999 Feb;47(2):183­5 Ahmad N, Akhtar T, Roghani MT, Ilyas HM, Ahmad M. Immunization coverage in three districts of North West Frontier Province (NWFP). JPMA J.Pak.Med.Assoc. 1999;301­5. Allen HF, Klingensmith GJ, Jensen P, Simoes E, Hayward A, Chase HP. Effect of Bacillus Calmette­Guerin vaccination on new­onset type 1 diabetes. A randomized clinical study. Diabetes Care 1999;1703­7. Alm JS; Swartz J; Lilja G; Scheynius A; Pershagen G ; Atopy in children of families with an anthroposophic lifestyle [see comments. Lancet 1999 May 1; 353(9163):1485­8 ­Comment in: Lancet 1999 May 1;353(9163):1457­8. Arita I. Standardization of smallpox vaccines and the eradication programme­­a WHO perspective. Dev.Biol.Stand. 1999;31­7. Arya SC. Therapeutic failures with rabies vaccine and rabies immunoglobulin [letter]. Clin.Infect.Dis. 1999;1605. Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 1999;57­67. Austrian R. A brief history of pneumococcal vaccines. Drugs Aging 1999; 15 Suppl 1:1­10. Austrian R. Pneumococcal vaccines for the world. Drugs Aging 1999; 15 Suppl 1:4. Ayuk F, Li Z, Kuhlcke K, Lindemann C, Schade U, Eckert HG et al. Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements. Gene Ther 1999; 6(10):1788­1792. Baillie LW, Fowler K, Turnbull PC. Human immune responses to the UK human anthrax vaccine. J.Appl.Microbiol. 1999;306­8. Ballou WR, Kester KE, Stoute JA, Heppner DG. Malaria vaccines: triumphs or tribulations? Parassitologia 1999; 41(1­3):403­408. Bardazzi F, Landi C, Orlandi C, Neri I, Varotti C. Graham Little­Piccardi­Lasseur syndrome following HBV vaccination. Acta Derm Venereol. 1999 Jan;79(1):93. Bardi J. Aftermath of a hypothetical smallpox disaster. Emerg.Infect.Dis. 1999;547­51. Barlow GD, Nathwani D. Meningococcal disease: hope on the horizon. Scott.Med.J. 1999;132­3. Barnes G. Intussusception and rotavirus vaccine [news]. J.Pediatr.Gastroenterol.Nutr. 1999;375. Baxby D. Edward Jenner's unpublished cowpox inquiry and the Royal Society: Everard Home's report to Sir Joseph Banks. Med Hist 1999 Jan;43(1):108­10. Begg N. Policies for public health management of meningococcal disease [editorial; comment]. J.Epidemiol.Community Health 1999;516. Beierle JW. A viewpoint on the coming impact of emerging diseases. J.Calif.Dent.Assoc. 1999;369­75. Bennett JV, Cutts FT, Katz SL. Edmonston­Zagreb measles vaccine: A good vaccine with an image problem. Pediatrics 1999;1123­4. Bergfors E, Trollfors B, Taranger J, ard T, Sundh V, Zackrisson G. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int.J.Infect.Dis. 1999;140­6. Bonanni P, Colombai R, Gasparini R, Lo NA, Tiscione E, Tomei A, Montomoli E, Comodo N. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy. Pediatr.Infect.Dis.J. 1999;677­82. Boraschi D, Tagliabue A. Interleukin­1 and interleukin­1 fragments as vaccine adjuvants. Methods 1999;108­13. Borgiel AE, Williams JI, Davis DA, Dunn EV, Hobbs N, Hutchison B, Wilson CR, Jensen J, O'Neil JJ, Bass MJ. Evaluating the effectiveness of 2 educational interventions in family practice. CMAJ. 1999;965­70. Bowen AM, Dammeyer MM. Reducing children's immunization distress in a primary care setting. J.Pediatr.Nurs. 1999;296­303. Boyce TG, Gruber WC, Coleman­Dockery SD, Sannella EC, Reed GW, Wolff M, Wright PF. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999;82­8. Bradbury, J. To vaccinate or not? Lancet North Am.Ed. 8­21­1999, 354 (9179): 655. Bradley SF. Prevention of influenza in long­term­care facilities. Long­Term­Care Committee of the Society for Healthcare Epidemiology of America. Infect.Control Hosp.Epidemiol. 1999;629­37. Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol 1999; 9(6):431­444. Brennan MJ, Collins FM, Morris SL. Propelling novel vaccines directed against tuberculosis through the regulatory process. Tuber.Lung Dis. 1999;145­51. Broder CC, Earl PL. Recombinant vaccinia viruses. Design, generation, and isolation. Mol Biotechnol 1999 Dec 15;13(3):223­45. Brown GV. Progress in the development of malaria vaccines: context and constraints. Parassitologia 1999; 41(1­3):429­432. Bryder L. 'We shall not find salvation in inoculation': BCG vaccination in Scandinavia, Britain and the USA, 1921­1960. Soc.Sci.Med. 1999;1157­67. Burgess MA, McIntyre PB. Vaccine­associated paralytic poliomyelitis. Commun Dis Intell. 1999 Mar 18;23(3):80­1. Butler JC, Schuchat A. Epidemiology of pneumococcal infections in the elderly. Drugs Aging 1999; 15 Suppl 1:11­19. Cain M. Raising awareness of legal risks. Nurs N Z 1999; 5(6):22. Cardenas­Freytag L, Cheng E, Mirza A. New approaches to mucosal immunization. Adv Exp Med Biol 1999; 473:319­337. Carlin JB, Jackson T, Lane L, Bishop RF, Barnes GL. Cost effectiveness of rotavirus vaccination in Australia. Aust.N.Z.J.Public Health 1999;611­6. Carter R. Epidemiological considerations for malaria reduction by transmission blocking vaccination. Parassitologia 1999; 41(1­3):415­420. Casadevall A. Passive antibody therapies: progress and continuing challenges. Clin.Immunol. 1999;5­15. Casal JI, Rueda P, Hurtado A. Parvovirus­like particles as vaccine vectors. Methods 1999;174­86. Casals JL, Vazguez MA. Arthritis induced by antihepatitis B vaccine. An Med Interna. 1999 Nov;16(11):601­2. Cassidy WM. School­based adolescent hepatitis B vaccination. J.La State Med.Soc. 1999;622­6. Castillo dF, Chacon dP, Casanova dE, Naveda O, Naveda M, Estopinan M, Bordones G, Zambrano B, Garcia A, Dumas R. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children. Vaccine 1999;656­64. Cecille A, Schuster H, Hansmann Y, Wendling MJ, Christmann D, Gut JP. A case report of post­rubella myelitis in an adult. Pathol Biol (Paris) 1999 May;47(5):531­3. Chakravarti A, Yadav S, Berry N, Rastogi A, Mathur MD. Evaluation of serological status of rubella & mumps in children below five years. Indian J Med Res 1999; 110:1­3. Chapman GB, Coups EJ. Predictors of influenza vaccine acceptance among healthy adults. Prev.Med. 1999;249­62. Chen D, McMichael JC, VanDerMeid KR, Masi AW, Bortell E, Caplan JD, Chakravarti DN, Barniak VL. Evaluation of a 74­kDa transferrin­binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate. Vaccine 1999;109­18. Chen MK, Wang CC, Chu ML, Pan TM. Prospective surveillance of children with invasive Haemophilus influenzae disease in Taiwan. Chung Hua Min Kuo Wei Sheng Wu Chi Mien I.Hsueh Tsa Chih 1999;257­60. Chen, Z. and Zheng, H. [Qiu Xi and vaccination] Zhonghua Yi.Shi Za Zhi. 1999, 29 (3): 157­161. Cheng E, Cardenas­Freytag L, Clements JD. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat­labile enterotoxin (LT). Vaccine 1999;38­49. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin.Infect.Dis. 1999;S112­S117. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin.Infect.Dis. 1999;S107­S111. Chevalet P, Foulc P, De Faucal P, Pottier P, Cassagnau E, Pistorius MA, Hamidou M, Planchon B. Disclosure of Behcet disease by concomitant dental infection. Presse Med 1999 Oct 9;28(30):1635­7. Chippaux JP, Campagne G, Djibo S, Cisse L, Hassane A, Kanta I. Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt. Ann.Trop.Med.Parasitol. 1999;505­10. Chisholm CJ, Nair P. Route of administration of BCG in a school population: outcome of an audit of clinical practice in North Bedfordshire. Public Health 1999;177­9. Chitsike I, van Furth R. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report. BMJ 1999 Mar 27;318(7187):841­3. Chumakov KM. Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines. Dev.Biol.Stand. 1999;67­74. Cichutek K. Development and standardisation of DNA vaccines. Dev.Biol.Stand. 1999;119­29. Classen JB, Classen DC. Association between type 1 diabetes and hib vaccine. Causal relation is likely. BMJ. 1999 Oct 23;319(7217):1133. Classen JB, Classen DC. Immunisation and type 1 diabetes mellitus: is there a link? Drug Saf. 1999 Nov;21(5):423­5. Classen JB, Classen DC. Vertically transmitted enteroviruses and the benefits of neonatal immunization [letter]. Diabetes Care 1999;1760­1. Clayton MF, Boegel E. Missed immunization opportunities: a comparison of nurse practitioners and physicians. J Am Acad Nurse Pract 1999; 11(10):423­
429. Clemens J, Keckich N, Naficy A, Glass R, Rao M. Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus­based reassortant vaccine. Epidemiol.Rev. 1999;24­42. Coen PG, Heath PT, Garnett GP. The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease. Epidemiol.Infect. 1999;389­402. Coiffier B. Monoclonal antibodies in the treatment of non­Hodgkin's lymphoma patients. Haematologica 1999 Jun;84:14­8. Conry RM, Khazaeli MB, Saleh MN, Allen KO, Barlow DL, Moore SE, Craig D, Arani RB, Schlom J, LoBuglio AF. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration. Clin.Cancer Res. 1999;2330­7. Conway SP. Opportunistic immunisation in hospital. Arch.Dis.Child 1999;422­5. Cooper PJ, Espinel I, Wieseman M, Paredes W, Espinel M, Guderian RH, Nutman TB. Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect.Immun. 1999;5951­7. Corazza M, Bertelli G, Altieri E, Strumia R. Mediterranean spotted fever: a case report [letter]. J.Eur.Acad.Dermatol.Venereol. 1999;229­30. Cornford CS, Morgan M. Elderly people's beliefs about influenza vaccination. Br J Gen Pract 1999; 49(441):281­284. Corrigan EM, Clancy RL. Is there a role for a mucosal influenza vaccine in the elderly? Drugs Aging 1999;169­81. Costello CA. The varicella vaccine. Inching toward universal use. Adv Nurse Pract 1999 Dec;7(12):47­50. Cox NJ, Subbarao K. Influenza. Lancet 1999;1277­82. Craig SC, Pittman PR, Lewis TE, Rossi CA, Henchal EA, Kuschner RA, Martinez C, Kohlhase KF, Cuthie JC, Welch GE, Sanchez JL. An accelerated schedule for tick­borne encephalitis vaccine: the American Military experience in Bosnia. Am.J.Trop.Med.Hyg. 1999;874­8. Creange A, Temam G, Lefaucheur JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999;30(3):143­6. Cresswell J. The real horrors [news]. Community Nurse 1999; 5(9):10. Cunningham SJ. Providing immunizations in a pediatric emergency department: underimmunization rates and parental acceptance. Pediatr.Emerg.Care 1999;255­9. Cutts FT, Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int.J.Epidemiol. 1999;1176­84. Dalgleish AG. Immunotherapy with Mycobacterium vaccae [letter]. Lancet 1999;1388­9. D'Alonzo GE. Make patients' immunizations Y2K compliant [editorial]. J.Am.Osteopath.Assoc. 1999;606­7. Das K, Jain A, Gupta RK, Kar P. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults. Natl Med J India 1999; 12(6):268­
269. De Melker HE, van den HS, Berbers GA, Nagelkerke NJ, Rumke HC, Conyn­van Spaendonck MA. A population­based study on tetanus antitoxin levels in The Netherlands. Vaccine 1999;100­8. Del Giudice G, Pizza M, Rappuoli R. Mucosal delivery of vaccines. Methods 1999;148­55. Desselberger U. Rotavirus infections: guidelines for treatment and prevention. Drugs 1999;447­52. Deuson RR, Hoekstra EJ, Sedjo R, Bakker G, Melinkovich P, Daeke D, Hammer AL, Goldsman D, Judson FN. The Denver school­based adolescent hepatitis B vaccination program: a cost analysis with risk simulation. Am.J.Public Health 1999;1722­7. Diego Nunez MA, Gonzalez Menendez AE. Vaccination against hepatitis B and multiple sclerosis. An Esp Pediatr. 1999 Jan;50(1):97. Dille JH. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending. AAOHN.J. 1999;301­9. Dille JH. Worksite influenza immunization. Successful program. AAOHN.J. 1999;292­300. Dlugovitzky D, Bottasso O, Dominino JC, Valentini E, Hartopp R, Singh M, Stanford C, Stanford J. Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). Respir.Med. 1999;557­62. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti­HBc positive donors. Transplantation 1999;1058­61. Dolan TT. Dogmas and misunderstandings in East Coast fever. Trop.Med.Int.Health 1999;A3­11. Dolo A, Modiano D, Doumbo O, Bosman A, Sidibe T, Keita MM et al. Thrombospondin related adhesive protein (TRAP), a potential malaria vaccine candidate. Parassitologia 1999; 41(1­3):425­428. Drabick JJ, Brandt BL, Moran EE, Saunders NB, Shoemaker DR, Zollinger WD. Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers. Vaccine 1999;160­72. Dranoff G. Interpreting cancer vaccine clinical trials. J Gene Med 1999; 1(2):80­83. Drobeniuc J, Hutin YJ, Harpaz R, Favorov M, Melnik A, Iarovoi P, Shapiro CN, Woodruff BA. Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants. Epidemiol.Infect. 1999;463­7. Dunn C, Wilde M, Paterson R. Agents in development for the treatment of hepatitis C. Summary and table. Drugs R.D. 1999;259­64. Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost­effectiveness of vaccination programmes: a dynamic perspective. Stat.Med. 1999;3263­82. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. The Lancet, vol. 353, January 9, 1999, pp. 98­
102. Ellett ML. Hepatitis A, B, and D. Gastroenterol Nurs 1999 Nov­1999 Dec 31;22(6):236­44. Encke J, zu PJ, Wands JR. DNA vaccines. Intervirology 1999;117­24. Enjuanes L, Sola I, Izeta A, Sanchez­Morgado JM, Gonzalez JM, Alonso S et al. Interference with virus and bacteria replication by the tissue specific expression of antibodies and interfering molecules. Adv Exp Med Biol 1999; 473:31­45. Erdmann C. Child immunization. Stuck on service [news]. Hosp.Health Netw. 1999;22, 24. Esmaeli­Gutstein B, Winkelman JZ. Uveitis associated with varicella virus vaccine. Am J Ophthalmol 1999 Jun;127(6):733­4. Evans AA, London WT. Hepatitis B vaccine and liver problems in U.S. children less than 6 years old [letter]. Epidemiology 1999;790­1. Exp Clin Endocrinol Diabetes. 1999;107 Suppl 3:S93­100. Fagerberg J, Askelof P, Wigzell H, Mellstedt H. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides. Cell Immunol. 1999;110­21. Feder HM, Jr., Beran J, Van Hoecke C, Abraham B, De Clercq N, Buscarino C, Parenti DL. Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children [see comments]. J.Pediatr. 1999;575­9. Fedson DS. Pneumococcal vaccination for older adults: the first 20 years. Drugs Aging 1999; 15 Suppl 1:21­30. Feldman C. Pneumonia in the elderly. Clin.Chest Med. 1999;563­73. Feng H, Sandlow JI, Sparks AE, Sandra A. Development of an immunocontraceptive vaccine. Current status. J.Reprod.Med. 1999;759­65. Fenner F. Nature, nurture and my experience with smallpox eradication. Med J Aust 1999; 171(11­12):638­641. Fernandez S, Arreaza L, Santiago I, Malvar A, Berron S, Vazquez JA, Hervada X, Gestal JJ. Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol.Infect. 1999;349­57. Findley SE, Irigoyen M, Schulman A. Children on the move and vaccination coverage in a low­income, urban Latino population. Am.J.Public Health 1999;1728­31. Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of pneumococcal polysaccharide vaccine for preschool­age children with chronic disease. Emerg.Infect.Dis. 1999;828­31. Flanagan JR, Doebbeling BN, Dawson J, Beekmann S. Randomized study of online vaccine reminders in adult primary care. Proc.AMIA.Symp. 1999;755­9. Flanagan JR, Walker KP. Tracking vaccine compliance in a primary care setting: online history, reminders, order entry, and charting. Proc.AMIA.Symp. 1999;760­4. Fledelius HC. Unilateral papilloedema after hepatitis B vaccination in a migraine patient. A case report including forensic aspects. Acta Ophthalmol.Scand. 1999;722­4. Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE. Response to early measles­mumps­rubella vaccination in infants with chronic renal failure and/ or receiving peritoneal dialysis. Adv Perit Dial 1999; 15:269­272. Ford­Jones A. Practice Tips. Immunization tracker for primary care physicians. Can.Fam.Physician 1999;2875­6. Forleo­Neto E, de Oliveira CF, Maluf EM, Bataglin C, Araujo JM, Kunz Jr LF, Pustai AK, Vieira VS, Zanella RC, Brandileone MC, Mimica LM, Mimica IM. Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with hib polyribosylribitol phosphate polysaccharide­tetanus toxoid conjugate vaccine in combination with diphtheria­tetanus toxoids­pertussis vaccine. J.Infect.Dis. 1999;1153­8. Freedman DA, Stark PB. The swine flu vaccine and Guillain­Barre syndrome. A case study in relative risk and specific causation. Eval Rev 1999 Dec;23(6):619­47. Freis PC. DNA vaccines [letter]. N.Engl.J.Med. 1999;1623­4. Frick KD, Simonsick EM. SES, Medicare coverage, and flu shot utilization among vulnerable women in the women's health and aging study. Ann.N.Y.Acad.Sci. 1999;493­6. Gabrieli R, Divizia M, El Ghazzawi E, Kader OA, El Gawhary Z, Renganathan E, Pana A. Serum antibodies to polioviruses in Alexandria, Egypt. Eur.J.Epidemiol. 1999;267­70. Gardner MJ, Tettelin H, Carucci DJ, Cummings LM, Smith HO, Fraser CM et al. The malaria genome sequencing project: complete sequence of Plasmodium falciparum chromosome 2. Parassitologia 1999; 41(1­3):69­75. Gardner P. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations. Clin.Infect.Dis. 1999;S131­
S135. Garrity RR. Targeted immune design using RNA immunization. Ann.N.Y.Acad.Sci. 1999;124­9. Gelbart M. Measles: the child slayer. Nurs Times 1999 Nov 3­1999 Nov 9;95(44):46­7. Gelbart M. Polio strikes back. Nurs.Times 1999;24­6. Gelbart M. Whooping cough: how the west was won. Nurs Times 1999; 95(40):52­54. Gelbart, M. Influenza: the mutating assassin waiting to strike. Nurs Times 1999 Nov 10­17;95(45):52­3 Gharavi EE, Chaimovich H, Cucurull E, Celli CM, Tang H, Wilson WA, Gharavi AE. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 1999;449­55. Gillespie SH. The role of the molecular laboratory in the investigation of Streptococcus pneumoniae infections. Semin.Respir.Infect. 1999;269­75. Glennie L. Meningitis: a new vaccine but the vigilance must go on. Prof Care Mother Child 1999;9(5):121­3. Glick M. Know thy hepatitis: A through TT. J.Calif.Dent.Assoc. 1999;376­85. Goettsch W, de Graaf R, Dorigo­Zetsma JW, van Zessen G, Houweling H. Broader vaccination of expatriates against HBV infection: do we reach those at highest risk? Int.J.Epidemiol. 1999;1161­6. Goh KT. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain [letter]. Lancet 1999;1355­6. Gold M, Kempe A, Osbourn M. A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in South Australia [letter]. Med.J.Aust. 1999;331­2. Goncalves G, Cutts F, Forsey T, Andrade HR. Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement. Rev.Inst.Med.Trop.Sao Paulo 1999;21­6. Goodwin H, Nash M, Gold M, Heath TC, Burgess MA. Vaccination of children following a previous hypotonic­hyporesponsive episode. J.Paediatr.Child Health 1999;549­52. Grabenstein JD, Bonasso J. Health­system pharmacists' role in immunizing adults against pneumococcal disease and influenza. Am.J.Health Syst.Pharm. 1999;S3­22. Grabenstein JD. Influenza vaccination increases productivity and reduces misery. J.Am.Pharm.Assoc.(Wash.) 1999;574. Granel B, Berbis P, Serratrice J, Pelletier J, Disdier P, Weiller PJ. An unusual cause of long­term fever: Behcet disease. Presse Med 1999 Dec 18­
25;28(40):2221­2. Granel B, Berbis P, Serratrice J, Pelletier J, Disdier P, Weiller PJ. An unusual cause of long­term fever: Behcet disease. Presse Med 1999 Dec 18­
25;28(40):2221­2. Graves PM, Barriga KJ, Norris JM, Hoffman MR, Yu L, Eisenbarth GS, Rewers M. Lack of association between early childhood immunizations and beta­cell autoimmunity. Diabetes Care 1999;1694­7. Gray RH. The changing face of paediatrics in the English­speaking Caribbean. West Indian Med.J. 1999;106­9. Greby SM, Singleton JA, Walker FJ, Strikas RA. Observations from the CDC: promoting women's health through age­appropriate vaccination. J.Womens Health Gend.Based.Med. 1999;1225­31. Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans.R.Soc.Trop.Med.Hyg. 1999;341­53. Greig JR. Chickenpox in pregnancy [letter]. Br J Gen Pract 1999; 49(442):401. Griffiths PD. Defending vaccines from the enemy within [editorial]. Rev.Med.Virol. 1999;145­6. Grossman DW, Hans LM, Glazier R. Geographic origin and risk for congenital infection in a Canadian inner city: findings and implications for policy. Can.J.Public Health 1999;385­8. Gubser M, Blumberg A, Donati F. Febrile convulsions: assessment of current status. Schweiz Med Wochenschr 1999 May 1;129(17):649­57. Gupte MD. Vaccine trials in leprosy­­Venezuela, Malawi and India. Int.J.Lepr.Other Mycobact.Dis. 1999;S32­S37. Gust I. Standardisation and licensing of combination vaccines based on DTP. Dev.Biol.Stand. 1999;137­41. Gutteridge WE. New tools for malaria therapy. Parassitologia 1999; 41(1­3):449­452. Gyhrs A, Lyngholm E, Larsen SO, Aggerbeck H, Heron I. Immunogenicity and safety of a tetravalent diphtheria­tetanus­acellular pertussis­inactivated poliovirus vaccine. Scand.J.Infect.Dis. 1999;579­85. Hall A, Kane M, Roure C, Meheus A. Multiple sclerosis and hepatitis B vaccine? Vaccine. 1999 Jun 4;17(20­21):2473­5. Hallander HO, Gnarpe J, Gnarpe H, Olin P. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand.J.Infect.Dis. 1999;281­6. Hallander, H. O. and Olin, P. Marked Decline in Pertussis Followed Reintroduction of Pertussis Vaccination in Sweden. Euro.Surveill 1999, 4 (12): 128­129. Halloran ME, Longini IM, Jr., Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol.Rev. 1999;73­88. Halsey NA, Duclos P, Van Damme P, Margolis H. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Pediatr Infect Dis J. 1999 Jan;18(1):23­4. Hampshire M. Meningitis: a village holds its breath. Nurs.Times 1999;15. He J, Binn LN, Caudill JD, Asher LV, Longer CF, Innis BL. Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity­capture RT­PCR. Virus Res. 1999;59­65. Heiligenhaus A, Bauer D. Herpes simplex virus type 1 infection of the cornea. Dev.Ophthalmol. 1999;141­66. Heineman TC, Clements­Mann ML, Poland GA, Jacobson RM, Izu AE, Sakamoto D, Eiden J, Van Nest GA, Hsu HH. A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant. Vaccine 1999;2769­78. Heinz FX. Tick­borne encephalitis virus: advances in molecular biology and vaccination strategy in the next century. Zentralbl.Bakteriol. 1999;506­10. Helfand RF, Kebede S, Mercader S, Gary HE, Jr., Beyene H, Bellini WJ. The effect of timing of sample collection on the detection of measles­specific IgM in serum and oral fluid samples after primary measles vaccination. Epidemiol.Infect. 1999;451­5. Henderson DA. Smallpox: clinical and epidemiologic features. Emerg.Infect.Dis. 1999;537­9. Henderson L. Fighting the flu. Nurs.Stand. 1999;22­3. Hennessy TW, Singleton RJ, Butler JC. Respiratory syncytial virus: current status and hope for the future. Alaska Med 1999; 41(4):86­93, 101. Herr W, Ranieri E, Gambotto A, Kierstead LS, Amoscato AA, Gesualdo L, Storkus WJ. Identification of naturally processed and HLA­presented Epstein­Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. Proc.Natl.Acad.Sci.U.S.A 1999;12033­8. Hess J, Kaufmann SH. Development of novel tuberculosis vaccines. C.R.Acad.Sci.III 1999;953­8. Hessel L, Debois H, Fletcher M, Dumas R. Experience with Salmonella typhi Vi capsular polysaccharide vaccine. Eur.J.Clin.Microbiol.Infect.Dis. 1999;609­
20. Hewlett EL. A commentary on the pathogenesis of pertussis. Clin.Infect.Dis. 1999;S94­S98. Hill AV. Genetics and genomics of infectious disease susceptibility. Br Med Bull 1999; 55(2):401­413. Hiltunen M, Lonnrot M, Hyoty H. Immunisation and type 1 diabetes mellitus: is there a link? Drug Saf 1999 Mar;20(3):207­12. Hinman AR. Economic aspects of vaccines and immunizations. C.R.Acad.Sci.III 1999;989­94. Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di R, I, Carbone M, Linnainmaa K. Simian virus 40 (SV40)­
like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40­contaminated polio vaccines. Mol.Carcinog. 1999;93­9. Hochman JA, Balistreri WF. Viral hepatitis: expanding the alphabet. Adv.Pediatr. 1999;207­43. Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott­Finnigan T et al. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia 1999; 41(1­3):409­414. Holzel H, Jumaa P. Varicella zoster virus immunisation [letter]. Lancet 1999;1207. Hong R. Evaluation of toxic assault on the immune system. Mutat.Res. 1999;109­14. Horlander JC, Boyle N, Manam R, Schenk M, Herring S, Kwo PY, Lumeng L, Chalasani N. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am.J.Med.Sci. 1999;304­7. Hotez PJ, Ghosh K, Hawdon JM, Narasimhan S, Jones B, Shuhua X, Sen L, Bin Z, Haechou X, Hainan R, Heng W, Koski RA. Experimental approaches to the development of a recombinant hookworm vaccine. Immunol.Rev. 1999;163­71. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999;1312­7. Huber S, Kappos L, Fuhr P, Wetzel S, Steck AJ. Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylobacter jejuni [letter]. J.Neurol. 1999;1204­6. Hull HF, Tangermann RH, Aylward RB, Andrus JK. Eradication of poliomyelitis [letter]. Lancet 1999;1910. Hutchins SS, Rosenthal J, Eason P, Swint E, Guerrero H, Hadler S. Effectiveness and cost­effectiveness of linking the special supplemental program for women, infants, and children (WIC) and immunization activities. J.Public Health Policy 1999;408­26. Hutchison BG, Oxman AD, Shannon HS, Lloyd S, Altmayer CA, Thomas K. Clinical effectiveness of pneumococcal vaccine. Meta­analysis [see comments]. Can.Fam.Physician 1999;2381­93. Huth MM. Children's responses to immunizations: lullabies as distraction. J Child Fam Nurs 1999 Nov­1999 Dec 31;2(6):432­3. Hutton J, Iglesias C, Jefferson TO. Assessing the potential cost effectiveness of pneumococcal vaccines in the US: methodological issues and current evidence. Drugs Aging 1999; 15 Suppl 1:31­36. Ishikawa T, Ogino C, Chang S. Lennox­Gastaut syndrome after a further attenuated live measles vaccination. Brain Dev 1999 Dec;21(8):563­5. Jacobson SH, Sewell EC, Deuson R, Weniger BG. An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot study. Health Care Manag Sci 1999 Jan;2(1):1­9. Jaffar S, Leach A, Hall AJ, Obaro S, McAdam KP, Smith PG, Greenwood BM. Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation? Vaccine 1999;633­40. Jain R, Kumar TA, Singh S. Polio eradication in India: are we on the correct path? [letter]. Natl Med J India 1999; 12(6):299­300. Jain, S.; Chopra, H.; Singh, J. V., et al. Need for strengthening immunization services in villages [letter]. Indian Pediatr 1999 Jun;36(6):619. Janes GR, Blackman DK, Bolen JC, Kamimoto LA, Rhodes L, Caplan LS, Nadel MR, Tomar SL, Lando JF, Greby SM, Singleton JA, Strikas RA, Wooten KG. Surveillance for use of preventive health­care services by older adults, 1995­1997. Mor Mortal.Wkly.Rep.CDC Surveill Summ. 1999;51­88. Jenders RA, Dasgupta B, Mercedes D, Fries F, Stambaugh K. Use of a hospital practice management system to provide initial data for a pediatric immunization registry. Proc.AMIA.Symp. 1999;286­90. Jochmus I, Schafer K, Faath S, Muller M, Gissmann L. Chimeric virus­like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine. Arch.Med.Res. 1999;269­74. Johnston LJ, Horning SJ. Autologous hematopoietic cell transplantation in non­Hodgkin's lymphoma. Hematol.Oncol.Clin.North Am. 1999;889­918. Kabakus N, Aydinoglu H, Bakkaloglu SA, Yekeler H. Mumps interstitial nephritis: a case report. Pediatr.Nephrol. 1999;930­1. Kaithamana S. Fan J. Osuga Y. Liang S. Prabhakar BS. Induction of Experimental Autoimmune Graves’ Disease in BALB/c Mice. The Journal of Immunology, 1999, 163: 5157­5164. Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A, Legocki AB. A plant­derived edible vaccine against hepatitis B virus. FASEB J. 1999;1796­9. Kato H, Nakata K, Hamasaki K, Hida D, Ishikawa H, Aritomi T, Nakao K, Kato Y, Yano M, Eguchi K. Long­term efficacy of immunization against hepatitis B virus in infants at high­risk analyzed by polymerase chain reaction. Vaccine 1999;581­7. Kaufmann SH, Fensterle J, Hess J. The need for a novel generation of vaccines. Immunobiology 1999;272­82. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin.Infect.Dis. 1999;S118­S123. Kerse NM, Flicker L, Jolley D, Arroll B, Young D. Improving the health behaviours of elderly people: randomised controlled trial of a general practice education programme. BMJ 1999;683­7. Keywords: Dental Care for Chronically Ill/ Dentistry/ Diagnosis/ Disease Transmission/ Kieseier BC, Archelos JJ, Storch M, Gold R, Hartung HP. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy. Wien.Klin.Wochenschr. 1999;728­37. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics­­a novel approach in the management of food allergy. Allergy 1999;909­15. Knutson KL, Schiffman K, Rinn K, Disis ML. Immunotherapeutic approaches for the treatment of breast cancer. J Mammary Gland Biol Neoplasia 1999; 4(4):353­365. Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2­ to 4­year­old children in Vietnam. Infect.Immun. 1999;5806­10. Kotra LP, Ojcius DM. 'Infectious web'. Microbes.Infect. 1999;1239. Kozlowski J. This month in investigative urology: Immunotherapy of bladder cancer [comment]. J.Urol. 1999;1581. Krcmery V, Gould IM. Antibiotic policies in Central/ Eastern Europe (CEE) after 1990. J.Hosp.Infect. 1999;S269­S274. Krieg AM. Direct immunologic activities of CpG DNA and implications for gene therapy. J Gene Med 1999; 1(1):56­63. Kristensen K. Haemophilus influenzae type b. Epidemiology of invasive diseases, antimicrobial resistance of clinical isolates, and response to a conjugate vaccine in selected risk groups. Dan.Med.Bull. 1999;303­12. Kyaw MH, Nguyen­Van­Tam JS, Pearson JC. Family doctor advice is the main determinant of pneumococcal vaccine uptake. J.Epidemiol.Community Health 1999;589­90. Lalumiere ML, Harris GT, Rice ME. Birth order and fluctuating asymmetry: a first look. Proc.R.Soc.Lond B Biol.Sci. 1999;2351­4. Lang J, Wood SC. Development of orphan vaccines: an industry perspective. Emerg.Infect.Dis. 1999;749­56. Le Hello C, Cohen P, Bousser MG, Letellier P, Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol 1999 Jan;26(1):191­4. Le Hello C, Cohen P, Bousser MG, Letellier P, Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol 1999 Jan;26(1):191­4. LeDuc JW, Becher J. Current status of smallpox vaccine [letter]. Emerg.Infect.Dis. 1999;593­4. Lee A, Cheng F, Lau L, Lo A, Fabb WE. Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: what are the implications? Public Health 1999;185­8. Lee LH, Burg E, III, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect.Immun. 1999;5799­805. Legge A. Killer in the house. Nurs Times Nurs Homes 1999 Nov­1999 Dec 31;1(4):7. Legge A. Nurses will face challenge of meningitis campaign [news]. Community Nurse 1999; 5(8):13­14. Leggiadro RJ, Schaberg DR. Nosocomial pneumococcal infection: an outbreak. Hosp Pract 1999 Sep 15;34(10):77­8, 81­2, 86­92. Lehmann D, Michael A, Omena M, Clegg A, Lupiwa T, Sanders RC, Marjen B, Wai'in P, Rongap A, Saleu G, Namuigi P, Kakazo M, Lupiwa S, Lewis DJ, Alpers MP. Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua New Guinea. Pediatr.Infect.Dis.J. 1999;S42­S49. Liashenko VA, Krasnova VP, Youminova NV. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L­16. Hum Antibodies 1999; 9(3):143­148. Lifson AR, Aitchison­Olson R, Ramesh A. New threats from an old enemy. A physician update on pneumococcus. Minn.Med. 1999;29­31. Lindberg J, Fangel S. Recurrent endocarditis caused by Streptococcus pneumoniae. Scand.J.Infect.Dis. 1999;409­10. Linder N, Raz M, Sirota L, Reichman B, Lubin D, Kuint J, Cohen AH, Barzilai A. Unexplained fever in neonates may be associated with hepatitis B vaccine. Arch.Dis.Child Fetal Neonatal Ed 1999;F206­F207. Lindfors A, Hage­Hamsten M, Rietz H, Wickman M, Nordvall SL. Influence of interaction of environmental risk factors and sensitization in young asthmatic children. J.Allergy Clin.Immunol. 1999;755­62. Liu MA. Vaccines timeline [interview by Philip Cohen]. BMJ 1999;1301. Lloyd JS, Milstien JB. Auto­disable syringes for immunization: issues in technology transfer. Bull.World Health Organ 1999;1001­7. Lockwood CM, Elliott JD, Brettman L, Hale G, Rebello P, Frewin M, Ringler D, Merrill C, Waldmann H. Anti­adhesion molecule therapy as an interventional strategy for autoimmune inflammation. Clin.Immunol. 1999;93­106. Lodi G, Carrassi A, Scully C, Porter SR. Hepatitis G virus: relevance to oral health care. Oral Surg.Oral Med.Oral Pathol.Oral Radiol.Endod. 1999;568­72. Lohse A, Michel F, Auge B, Toussirot E, Wendling D. Vascular purpura and cryoglobulinemia after influenza vaccination. Case­report and literature review. Rev Rhum Engl Ed. 1999 Jun;66(6):359­60. Lopatin DE, Shelburne CE, Van Poperin N, Kowalski CJ, Bagramian RA. Humoral immunity to stress proteins and periodontal disease. J.Periodontol. 1999;1185­93. Lu CY, Lee CY, Lee PI, Tsai HY, Chiu TF, Lin HC, Huang LM. Immunogenicity of oral poliovirus vaccine in Taiwan. J.Formos.Med.Assoc. 1999;859­62. Lucas AH, Reason DC. Polysaccharide vaccines as probes of antibody repertoires in man. Immunol.Rev. 1999;89­104. Lucher LA, Singleton R, Parkinson AJ, Butler JC. The challenge of ongoing Haemophilus influenzae type B carriage and transmission in Alaska. Alaska Med. 1999;61­8. Madhi SA, Klugman KP. Pneumococcal conjugate vaccine­­prospects for intervention in children. Semin.Respir.Infect. 1999;285­94. Madore DV, Johnson­Kraines CL, Rothstein EP, Smith DH. Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates. Curr.Med.Res.Opin. 1999;105­12. Maes RF. Tuberculosis II: the failure of the BCG vaccine. Med.Hypotheses 1999;32­9. Maichomi MW, Mugambi TJ. Evaluation of microtitre spin agglutination assay in the diagnosis of bovine brucellosis [letter]. East Afr Med J 1999; 76(12):713. Maizels RM, Holland MJ, Falcone FH, Zang XX, Yazdanbakhsh M. Vaccination against helminth parasites­­the ultimate challenge for vaccinologists? Immunol.Rev. 1999;125­47. Markham MH, Darville T. Morbidity and cost of vaccine­preventable varicella in previously healthy children in Arkansas. J.Ark.Med.Soc. 1999;260­2. Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HG, Heuvelman K, Stefanelli P, Mooi FR. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 1999;2069­75. Matsuki, A. On the circumstances of the publication of the 1855 edition of "Roshia Gyuto Zensho" (Russian Vaccination Book) Nippon Ishigaku.Zasshi. 1999, 45 (3 Pt 1495): 401­412. Maurin M, Raoult D. Q fever. Clin.Microbiol.Rev. 1999;518­53. Mautino, K. S. Vaccination Requirements for Immigrants to the United States. J Immigr Health; 1 (2): 61­63; April, 1999. Mayr GA, Chinsangaram J, Grubman MJ. Development of replication­defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot­and­mouth disease virus as a vaccine candidate. Virology 1999;496­506. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J.Infect.Dis. 1999;1171­6. McCarthy GM, Koval JJ, MacDonald JK. Compliance with recommended infection control procedures among Canadian dentists: results of a national survey. Am.J.Infect.Control 1999;377­84. McManus DP. The search for a vaccine against schistosomiasis­­a difficult path but an achievable goal. Immunol.Rev. 1999;149­61. Mehrotra J, Mittal A, Rastogi AK, Jaiswal AK, Bhandari NK, Sinha S. Antigenic definition of plasma membrane proteins of Bacillus Calmette­Guerin: predominant activation of human T cells by low­molecular­mass integral proteins. Scand.J.Immunol. 1999;411­9. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL. The role of B lymphocytes in coxsackievirus B3 infection. Am.J.Pathol. 1999;1205­15. Menta R. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps: comments [letter]. Vaccine 1999;1­2. Merieux C. The IABS supporting the work of the World Health Organization­­the eradication of poliomyelitis. Dev.Biol.Stand. 1999;9­10. Meriste S, Tamm E, Willems P, Lutsar I. Safety and immunogenicity of combined Dtpa­IPV vaccine for primary and booster vaccination. Scand.J.Infect.Dis. 1999;587­91. Miller JL. CDC issues recommendations on use of Lyme disease vaccine [news]. Am.J.Health Syst.Pharm. 1999;1484, 1486. Miller JL. CDC says upcoming doses of rotavirus vaccine should be delayed [news]. Am.J.Health Syst.Pharm. 1999;1589. Miller JL. Elimination of thimerosal from vaccines set as goal [news]. Am.J.Health Syst.Pharm. 1999;1589, 1593. Miller JL. Rotavirus, poliovirus top 1999 immunization changes [news]. Am.J.Health Syst.Pharm. 1999;303. Miller JL. Task force 'grades' strategies for boosting vaccination rates [news]. Am.J.Health Syst.Pharm. 1999;1480, 1482. Miller PL, Frawley SJ, Sayward FG. Exploring three approaches for handling incomplete patient histories in a computer­based guideline for childhood immunization. Proc.AMIA.Symp. 1999;878­82. Minor, P. D. Poliovirus Vaccination: Current Understanding of Poliovirus Interactions in Humans and Implications for the Eradication of Poliomyelitis. Expert.Rev Mol.Med. 1:1­17. (): 1­17; September 23, 1999. Miravitlles M, de Gracia J, Rodrigo MJ, Cruz MJ, Vendrell M, Vidal R, Morell F. Specific antibody response against the 23­valent pneumococcal vaccine in patients with alpha(1)­antitrypsin deficiency with and without bronchiectasis. Chest 1999;946­52. Modiano D, Petrarca V, Sirima BS, Luoni G, Nebie I, Diallo DA et al. Different response to Plasmodium falciparum in west African sympatric ethnic groups: possible implications for malaria control strategies. Parassitologia 1999; 41(1­3):193­197. Montgomery VA, Makuch RS, Brown JE, Hack DC. The immunogenicity in humans of a botulinum type F vaccine. Vaccine 1999;728­35. Monto AS. Francis field trial of inactivated poliomyelitis vaccine: background and lessons for today. Epidemiol.Rev. 1999;7­23. Morag M, Morag A, Reichenberg A, Lerer B, Yirmiya R. Psychological variables as predictors of rubella antibody titers and fatigue­­a prospective, double blind study. J.Psychiatr.Res. 1999;389­95. Morozova OV, Maksimova TG, Bakhvalova VN. Tick­borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge. Viral Immunol 1999;12(4):277­80. Muderhwa JM, Matyas GR, Spitler LE, Alving CR. Oil­in­water liposomal emulsions: characterization and potential use in vaccine delivery. J.Pharm.Sci. 1999;1332­9. Mudido PM, Guwatudde D, Nakakeeto MK, Bukenya GB, Nsamba D, Johnson JL, Mugerwa RD, Ellner JJ, Whalen CC. The effect of bacille Calmette­Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int.J.Tuberc.Lung Dis. 1999;891­5. Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiol.Rev. 1999;43­55. Muller A, Kertzscher F, Kiefel V, Lenk H. Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles­
mumps­rubella­vaccine) and after therapy with Co­trimoxazole. Eur.J.Pediatr. 1999;S209­S210. Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS. Pre­erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. Parassitologia 1999; 41(1­3):397­402. Nates SV, Cumino A, Isa MB, Martinez LC, Naretto E, Medeot SI, Giordano MO, de Wolff CD. Measles antibody in pregnant Argentinian women relative to vaccine­induced immunity and natural infection. Pediatr.Infect.Dis.J. 1999;937­9. Navarrete­Navarro S, Aguilar­Setien A, Avila­Figueroa C, Hernandez­Sierra F, Santos­Preciado JI. Improved serological response to human diploid cell rabies vaccine when given simultaneously with antirabies hyperimmune globulin. Arch.Med.Res. 1999;332­7. Naz RK. Vaccine for contraception targeting sperm. Immunol.Rev. 1999;193­202. Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J.Allergy Clin.Immunol. 1999;775­85. Ngui SL, Hallet R, Teo CG. Natural and iatrogenic variation in hepatitis B virus. Rev.Med.Virol. 1999;183­209. Nguyen­Van­Tam J, Granfield R, Pearson J, Fleming D, Keating N. Do influenza epidemics affect patterns of sickness absence among British hospital staff? Infect.Control Hosp.Epidemiol. 1999;691­4. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch.Intern.Med. 1999;2437­42. Nichol KL. Influenza vaccination for healthy working adults. Minn.Med. 1999;24­6. Nicoara C, Zach K, Trachsel D, Germann D, Matter L. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses. Clin.Diagn.Lab Immunol. 1999;868­71. Northrop­Clewes CA, Ahmad N, Paracha PI, Thurnham DI. Impact of health service provision on mothers and infants in a rural village in North West Frontier Province, Pakistan. Public Health Nutr. 1998;51­9. O'Dowd A. A shot in the dark. Nurs.Times 1999;16­7. Oettinger T, Jorgensen M, Ladefoged A, Haslov K, Andersen P. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber.Lung Dis. 1999;243­50. Oggioni MR, Medaglini D, Maggi T, Pozzi G. Engineering the gram­positive cell surface for construction of bacterial vaccine vectors. Methods 1999;163­73. Ogun TC, Uzumcu AU, Arazi M, Kapicioglu MI. Accidental Salmonella enteritidis vaccine injection leading to finger necrosis­­a report of 4 cases. Acta Orthop.Scand. 1999;629­31. Oh, J. KePRO priming for adult vaccination campaign Pa Med. 1999, 102 (11): 6. Olin P. Vaccination programmes out of pace with vaccine development: a call for national vaccination registers. Acta Paediatr. 1999;800­2. Omer MI. Measles: a disease that has to be eradicated. Ann.Trop.Paediatr. 1999;125­34. O'Neill T, Kydd JH, Allen GP, Wattrang E, Mumford JA, Hannant D. Determination of equid herpesvirus 1­specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet.Immunol.Immunopathol. 1999;43­54. Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination. Clin.Infect.Dis. 1999;S147­S150. O'Shea S, Dunn H, Palmer S, Banatvala JE, Best JM. Automated rubella antibody screening:a cautionary tale [letter]. J.Med.Microbiol. 1999;1047. O'Toole T. Smallpox: An attack scenario. Emerg.Infect.Dis. 1999;540­6. Ozaki T, Morishima T, Hirota T, Sugiyama K, Asano Y. Pediatric admission for vaccine preventable diseases: a 5­year survey from 1994 to 1998 in Aichi Prefecture. Jpn.J.Infect.Dis. 1999;208­13. Palombo EA. Genetic and antigenic diversity of human rotaviruses: potential impact on the success of candidate vaccines. FEMS Microbiol.Lett. 1999;1­8. Pang T. Vaccination in the Third World. Contemporary issues. C.R.Acad.Sci.III 1999;995­7. Papania M, Baughman AL, Lee S, Cheek JE, Atkinson W, Redd SC, Spitalny K, Finelli L, Markowitz L. Increased susceptibility to measles in infants in the United States. Pediatrics 1999;e59. Pardigon N, Laouini D. New millenium. The need for new vaccines. C.R.Acad.Sci.III 1999;913­7. Parenti D. Lyme disease vaccine­­LYMErix [letter]. Conn.Med. 1999;570. Parkman PD. Making vaccination policy: the experience with rubella. Clin.Infect.Dis. 1999;S140­S146. Pass RF, Duliege AM, Boppana S, Sekulovich R, Percell S, Britt W, Burke RL. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J.Infect.Dis. 1999;970­5. Passwell JH. MMR vaccination, Crohn's disease and autism: a real or imagined "stomach ache/ headache?" [editorial; comment]. Isr Med Assoc J 1999; 1(3):176­177. Pebody RG, Ruutu P, Nohynek H, Leinikki P. Changing epidemiology of hepatitis B infection in Finland. Scand.J.Infect.Dis. 1999;251­4. Peetermans WE, Lacante P. Pneumococcal vaccination by general practitioners: an evaluation of current practice. Vaccine 1999;612­7. Peleman RA, Peetermans WE, Van Laethem Y, Bachez PG, Vanatoru J, Van Wassenhove K, Struelens MJ, Verhaegen JL. Prevention of pneumococcal disease: an update on the Belgian Consensus Report. Acta Clin.Belg. 1999;321­7. Pelton SI, Klein JO. The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr.Infect.Dis.J. 1999;926­35. Pennie RA. Pneumococcal vaccine [editorial; comment]. Can.Fam.Physician 1999;2271­7. Perez­Cuevas R, Reyes H, Pego U, Tome P, Ceja K, Flores S, Gutierrez G. Immunization promotion activities: are they effective in encouraging mothers to immunize their children? Soc.Sci.Med. 1999;921­32. Peters S. Into the woods. New weapons against Lyme disease. Adv Nurse Pract 1999 Oct;7(10):53­4, 82. Peterson EM, You JZ, Motin V, de la Maza LM. Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar. Vaccine 1999;2901­7. Petousis­Harris H, Turner N. Hepatitis B vaccination and diabetes. N Z Med J. 1999 Aug 13;112(1093):303­4. Pichichero ME, Voloshen T, Zajac D, Passador S. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria­
tetanus­acellular pertussis­hib­hepatitis B combined vaccine in infants. J.Infect.Dis. 1999;1390­3. Pieters R, Albers R. Screening tests for autoimmune­related immunotoxicity. Environ Health Perspect 1999 Oct;107 Suppl 5:673­7. Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12­year experience. Vaccine 1999;181­9. Plotkin SA. Vaccination against the major infectious diseases. C.R.Acad.Sci.III 1999;943­51. Poltera AA. Aluminium chelation in chronic haemodialysis and aluminium adjuvanted vaccines [letter]. Vaccine 1999;577­8. Pramoolsinsap C, Poovorawan Y, Hirsch P, Busagorn N, Attamasirikul K. Acute, hepatitis­A super­infection in HBV carriers, or chronic liver disease related to HBV or HCV. Ann Trop Med Parasitol 1999; 93(7):745­751. Press R, Solders G. A case report. A vaccine against tick­borne encephalitis caused polyneuritis. Lakartidningen. 1999 Jul 28;96(30­31):3341­2. Prober CG, Sullender WM. Advances in prevention of respiratory syncytial virus infections. J.Pediatr. 1999;546­58. Puolakkainen M, Makela PH. Vaccination against infections by Chlamydia pneumoniae. C.R.Acad.Sci.III 1999;973­8. Rabaud C, Barbaud A, Trechot P. First case of erythermalgia related to hepatitis B vaccination. J Rheumatol. 1999 Jan;26(1):233­4. Rabbani F, Merchant AT. Economic development and health status among the poor in squatter settlements of Karachi. JPMA J.Pak.Med.Assoc. 1999;117­21. Rabinovich NR, Orenstein WA. Vaccines. Overview. Epidemiol.Rev. 1999;1­6. Rahman MM, Gu XX, Tsai CM, Kolli VS, Carlson W. The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non­typeable Haemophilus influenzae strain NTHi 9274. Glycobiology 1999;1371­80. Rao MN, Joshi N, Habibullah CM. Immunogenicity of a low dose of indigenously developed recombinant hepatitis­B vaccine in neonates and infants. Indian Pediatr 1999 Jun;36(6):581­3. Ravenscroft N, Averani G, Bartoloni A, Berti S, Bigio M, Carinci V, Costantino P, D'Ascenzi S, Giannozzi A, Norelli F, Pennatini C, Proietti D, Ceccarini C, Cescutti P. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines. Vaccine 1999;2802­16. Reflecting the extraordinary pace of change. Canadian Immunization Guide. Laboratory Centre for Disease Control, Health Protection Branch, Health Canada. Can Fam Physician 1999 Jan;45:135­8. Rehermann B. Cellular immune response to the hepatitis C virus. J Viral Hepat 1999; 6 Suppl 1:31­35. Reid G. Potential preventive strategies and therapies in urinary tract infection. World J.Urol. 1999;359­63. Renard JL, Guillamo JS, Ramirez JM, Taillia H, Felten D, Buisson Y. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti­
HBs antibodies. Presse Med 1999 Jul 3­10;28(24):1290­2. Review. Creange A, Temam G, Lefaucheur JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity. 1999;30(3):143­6. Rich M. It's your shot! Immunization by basketball [editorial; comment]. Ann.Epidemiol. 1999;394­6. Richey, W. A vaccination war erupts in military Christ.Sci.Monitor. 1­28­1999, :2. (): 2. Richmond P, Goldblatt D, Fusco PC, Fusco JD, Heron I, Clark S, Borrow R, Michon F. Safety and immunogenicity of a new Neisseria meningitidis serogroup C­tetanus toxoid conjugate vaccine in healthy adults. Vaccine 1999;641­6. Robbins JB. Pertussis in adults: introduction. Clin.Infect.Dis. 1999;S91­S93. Rodrigues LC, Smith PG. Use of the case­control approach in vaccine evaluation: efficacy and adverse effects. Epidemiol.Rev. 1999;56­72. Roggero MA, Weilenmann C, Bonelo A, Audran R, Renggli J, Spertini F et al. Plasmodium falciparum CS C­terminal fragment: preclinical evaluation and phase I clinical studies. Parassitologia 1999; 41(1­3):421­424. Rogier C, Tall A, Diagne N, Fontenille D, Spiegel A, Trape JF. Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal. Parassitologia 1999; 41(1­3):255­259. Rose VL. Advisory committee on immunization practices updates recommendations for the prevention of varicella. Am.Fam.Physician 1999;1849. Rosenthal SL, Lewis LM, Succop PA, Bernstein DI, Stanberry LR. College students' attitudes regarding vaccination to prevent genital herpes. Sex Transm.Dis. 1999;438­43. Rubins JB, Alter M, Loch J, Janoff EN. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect.Immun. 1999;5979­84. Russell PK. Vaccines in civilian defense against bioterrorism. Emerg.Infect.Dis. 1999;531­3. Salmond CE, Bandaranayake DR, Tobias M. Immunity to hepatitis B in two birth cohorts given plasma­derived or yeast­derived vaccine. N.Z.Med.J. 1999;331­3. Sato H, Sato Y. Experience with diphtheria toxoid­tetanus toxoid­acellular pertussis vaccine in Japan. Clin.Infect.Dis. 1999;S124­S130. Sawhney KK. Looking back on the 20th century. Mich.Med. 1999;56. Schallert D, Gold JA, Spurlin D. Health professionals represent 'front line' for vaccine­preventable diseases. WMJ. 1999;61­2. Schmutz JL, Barbaud A, Trechot P. Does influenza vaccination induce bullous pemphigoid? Ann Dermatol Venereol. 1999 Oct;126(10):765. Schneerson R. Similarities between the pathogenesis of and immunity to diphtheria and pertussis: the complex nature of serum antitoxin­induced immunity to these two diseases. Clin.Infect.Dis. 1999;S136­S139. Schwartz B, Rabinovich NR. Stimulating the development of orphan (and other) vaccines. Emerg.Infect.Dis. 1999;832. Scrimgeour EM, Mehta FR, Suleiman AJ. Infectious and tropical diseases in Oman: a review. Am.J.Trop.Med.Hyg. 1999;920­5. Scuffham P, Devlin N, Eberhart­Phillips J, Wilson­Salt R. The cost­effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule. Soc.Sci.Med. 1999;763­79. Sela M. Specific vaccines against autoimmune diseases. C.R.Acad.Sci.III 1999;933­8. Shahabuddin M, Vinetz JM. Chitinases of human parasites and their implications as antiparasitic targets. EXS 1999;87:223­34. Shann F, Steinhoff MC. Vaccines for children in rich and poor countries. Lancet 1999;SII7­11. Shefer A, Briss P, Rodewald L, Bernier R, Strikas R, Yusuf H, Ndiaye S, Wiliams S, Pappaioanou M, Hinman AR. Improving immunization coverage rates: an evidence­based review of the literature. Epidemiol.Rev. 1999;96­142. Shimoni Z, Dobrousin A, Cohen J, Pitlik S. Tetanus in an immunised patient. BMJ 1999;1049. Silvestri M, Rossi GA, Cozzani S, Pulvirenti G, Fasce L. Age­dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann.Allergy Asthma Immunol. 1999;335­40. Simon MM, Bauer Y, Zhong W, Hofmann H, Wallich R. Lyme disease: pathogenesis and vaccine development. Zentralbl.Bakteriol. 1999;690­5. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system () as a surveillance system. Working Group. Vaccine 1999;2908­17. Sirard JC, Niedergang F, Kraehenbuhl JP. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol.Rev. 1999;5­26. Siriwardena AN. Targeting pneumococcal vaccination to high­risk groups: a feasibility study in one general practice. Postgrad Med J 1999; 75(882):208­212. Slack MH, Schapira D. Severe apnoeas following immunisation in premature infants. Arch Dis Child Fetal Neonatal Ed 1999; 81(1):F67­F68. Slobodkin D, Kitlas JL, Zielske PG. A test of the feasibility of pneumococcal vaccination in the emergency department. Acad.Emerg.Med. 1999;724­7. Smith C, Vyas H. Pertussis is increasing in unimmunised infants: is a change of policy needed? [letter]. Arch.Dis.Child 1999;460. Smith I, Lehmann AK, Lie L, Digranes A, Caugant DA, Hoiby EA, Froholm LO, Halstensen A. Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET­5 clone: effect of vaccination and selective carriage eradication. Epidemiol.Infect. 1999;373­82. Solomon A, Siganos CS, Frucht­Pery J. Adverse ocular effects following influenza vaccination. Eye. 1999 Jun;13 (Pt 3a):381­2. Spicer PE, Phillips D, Pike A, Johansen C, Melrose W, Hall RA. Antibodies to Japanese encephalitis virus in human sera collected from Irian Jaya. Follow­up of a previously reported case of Japanese encephalitis in that region. Trans.R.Soc.Trop.Med.Hyg. 1999;511­4. Spickett GP, Bullimore J, Wallis J, Smith S, Saunders P. Northern region asplenia register­­analysis of first two years. J.Clin.Pathol. 1999;424­9. Spiegelberg HL, Raz E. DNA vaccines. Allergy 1999;47­8. Steven ID, Thomas SA, Eckerman E, Browning C, Dickens E. The provision of preventive care by general practitioners measured by patient completed questionnaires. J.Qual.Clin.Pract. 1999;195­201. Stevenson AM. Immunizations for women and infants. J.Obstet.Gynecol.Neonatal Nurs. 1999;534­44. Stockton JD, Zambon MC. The influenza virus. Hosp.Med. 1999;724­30. Streefland PH, Chowdhury AM, Ramos­Jimenez P. Quality of vaccination services and social demand for vaccinations in Africa and Asia. Bull.World Health Organ 1999;722­30. Sudarshan MK, Madhusudana SN, Mahendra BJ. Post­exposure prophylaxis with purified vero cell rabies vaccine during pregnancy­­safety and immunogenicity. J Commun Dis 1999 Dec;31(4):229­36. Suzuki H, Katsushima N, Konno T. Rotavirus vaccine put on hold [letter]. Lancet 1999;1390. Takahashi I, Kiyono H. Gut as the largest immunologic tissue. JPEN J.Parenter.Enteral Nutr. 1999;S7­12. Talwar GP, Diwan M, Razvi F, Malhotra R. The impact of new technologies on vaccines. Natl Med J India 1999; 12(6):274­280. Tan EK, Chee MW, Chan LL, Lee YL. Culture positive tuberculous meningitis: clinical indicators of poor prognosis. Clin.Neurol.Neurosurg. 1999;157­60. Tang C, Holden D. Pathogen virulence genes­­implications for vaccines and drug therapy. Br Med Bull 1999; 55(2):387­400. Targett G. Vaccine efficacy, and immunity affecting transmission. Parassitologia 1999; 41(1­3):433­436. Taylor DN, Cardenas V, Perez J, Puga R, Svennerholm AM. Safety, immunogenicity, and lot stability of the whole cell/ recombinant B subunit (WC/ rCTB) cholera vaccine in Peruvian adults and children. Am.J.Trop.Med.Hyg. 1999;869­73. Taylor­Robinson AW, Smith EC. A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection. Immunol.Rev. 1999;105­23. Temte JL. Prevention and control of influenza by Wisconsin family physicians: a WReN supported study. WMJ. 1999;40­4. Thayyil­Sudhan S, Kumar A, Singh M, Paul VK, Deorari AK. Safety and effectiveness of BCG vaccination in preterm babies. Arch Dis Child Fetal Neonatal Ed 1999; 81(1):F64­F66. Thomas PS, Ng C, Elsing M, Yates DH. Influenza vaccination: changes in exhaled nitric oxide levels and sputum cytology. Respirology. 1999;355­8. Thomson J, Hilditch A, Pirkis J, Dunt D. Immunisation initiatives in general practice. Important lessons from division projects. Aust.Fam.Physician 1999;1290­7. Tiwari RR, Kulkarni PN. Delayed immunization against vaccine preventable diseases­­factors responsible among children under 5 years of age. Indian J.Med.Sci. 1999;212­5. Toniolo­Neto J, Weckx LW, Halker E, Lopes CH, Menezes Succi RC, de Paiva TM et al. Safety of simultaneous pneumococcal and influenza vaccination in elderly patients in Brazil. Drugs Aging 1999; 15 Suppl 1:43­45. Torzillo P, Dixon J, Manning K, Hutton S, Gratten M, Hueston L, Leinonen M, Morey F, Forsythe S, Num R, Erlich J, Asche V, Cunningham A, Riley I. Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children. Pediatr.Infect.Dis.J. 1999;714­21. Tourbah A, Gout O, Liblau R, Lyon­Caen O, Bougniot C, Iba­Zizen MT, Cabanis EA.,.Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999 Jul 22;53(2):396­401. Toyota M, Kudo K, Sumiya M, Kobori O. High frequency of individuals with strong reaction to tuberculin among clinical trainees. Jpn.J.Infect.Dis. 1999;128­
9. Treanor J, Falsey A, Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Res. 1999;79­102. Tsai HY, Huang LM, Shih YT, Chen JM, Jiang TM, Tsai CH, Lee CY. Immunogenicity and safety of standard­titer AIK­C measles vaccine in nine­month­old infants. Viral Immunol. 1999;343­8. Tu HT, Kemper P, Wong HJ. Do HMOs make a difference? Use of health services. Inquiry 1999; 36(4):400­410. Tu SW, Musen MA. A flexible approach to guideline modeling. Proc.AMIA.Symp. 1999;420­4. Tucker R. Hepatitis and typhoid vaccine: killing two birds with one stone. Community Nurse 1999; 5(10):41­42. Tuohy PG. Immunisation coverage in New Zealand [letter]. N.Z.Med.J. 1999;454. Uilenberg G. Immunization against diseases caused by Theileria parva: a review. Trop.Med.Int.Health 1999;A12­A20. Umene K. Mechanism and application of genetic recombination in herpesviruses. Rev.Med.Virol. 1999;171­82. Valiante NM, Rappuoli R, Insel RA, McInnes P, Hoeveler A. The challenges of vaccinating the very young: lessons from a very old system of host defense. Vaccine 1999;2757­62. Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995­7. Epidemiol.Infect. 1999;403­11. van Hattum J, Chen XQ. Hepatitis A: infection, detection, vaccination and immunity. Neth.J.Med. 1999;142­50. Van Herck K, Van Damme P, Collard F, Thoelen S. Two­dose combined vaccination against hepatitis A and B in healthy subjects aged 11­18 years. Scand.J.Gastroenterol. 1999;1236­40. Van Steenbergen, J. E., Spanjaard, L., and Kraayeveld, A. G. Vaccination Campaign for Meningococcal Disease in a Rural Area in the Netherlands ­ January 1998. Euro.Surveill 1999, 4 (2): 18­21. Vellinga A, Van Damme P, Meheus A. Hepatitis B and C in institutions for individuals with intellectual disability. J.Intellect.Disabil.Res. 1999;445­53. Vyas SP, Sihorkar V. Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization. J.Clin.Pharm.Ther. 1999;259­72. Wadsworth L. Polio immunization: dealing with new recommendations and helping parents understand the changes. J Pediatr Health Care 1999 Nov­1999 Dec 31;13(6 Pt 2):S21­30. Wagstaff A, Brooke G. Prophylactic anti­infective vaccines in clinical development. Summary and table. Drugs R.D. 1999;185­91. Wakefield AJ, Montgomery SM. Autism, viral infection and measles­mumps­rubella vaccination [comment]. Isr Med Assoc J 1999; 1(3):183­187. Wang D, Jenders RA, Dasgupta B. Translating national childhood immunization guidelines to a computer­based reminder recall system within an immunization registry. Proc.AMIA.Symp. 1999;994­8. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin.Microbiol.Rev. 1999;633­53. Warner J. Immunising children is difficult for parents, but it is worse for nurses. Nurs.Times 1999;17. Watanabe M. PACHA adopts more lenient stance to government efforts [news]. Nat.Med. 1999;1220­1. Watson DA, Musher DM. A brief history of the pneumococcus in biomedical research. Semin.Respir.Infect. 1999;198­208. Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T. Introduction of Hib conjugate vaccines in the non­industrialized world: experience in four 'newly adopting' countries. Vaccine 1999;736­42. Whang W, Sisk JE, Heitjan DF, Moskowitz AJ. Probabilistic sensitivity analysis in cost­effectiveness. An application from a study of vaccination against pneumococcal bacteremia in the elderly. Int J Technol Assess Health Care 1999 Summer;15(3):563­72. White F. Prior use of killed vaccine as a factor in measles incidence in Canada [letter]. Int.J.Epidemiol. 1999;1185­6. White F. Prior use of killed vaccine as a factor in measles incidence in Canada. Int J Epidemiol. 1999 Dec;28(6):1185­6. White H. Association between type 1 diabetes and Hib vaccine. More research is still needed. BMJ. 1999 Oct 23;319(7217):1133. Whittle HC, Aaby P, Samb B, Jensen H, Bennett J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 1999 Jan 9;353(9147):98­102. Widdus R. Introduction of vaccines into the Third World. C.R.Acad.Sci.III 1999;999­1010. Williams CH. Durban Malaria Conference­­a short report [letter]. S Afr Med J 1999; 89(12):1240. Wood JM, Major D, Daly J, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC, Lee­Lin YN. Vaccines against H5N1 influenza [letter]. Vaccine 1999;579­80. Wynter SH, O'Gilvie CR, Khan C, Brown MG, Lindo JF, King SD. Rubella susceptibility in Jamaican women, 1996. West Indian Med.J. 1999;123­5. Yalcin SS, Yurdakok K. Sex­specific differences in serum vitamin A values after measles immunization [letter]. Pediatr.Infect.Dis.J. 1999;747­8. Yan J, Provost GP. North Carolina vaccine program linked to improved childhood immunization rates [news]. Am.J.Health Syst.Pharm. 1999;2019. Yarbough PO. Hepatitis E virus. Advances in HEV biology and HEV vaccine approaches. Intervirology 1999;179­84. Yusuf HR, Coronado VG, Averhoff FA, Maes EF, Rodewald LE, Battaglia MP, Mahoney FJ. Progress in coverage with hepatitis B vaccine among US children, 1994­1997. Am.J.Public Health 1999;1684­9. Zahner SJ. Public health nursing and immunization surveillance. Public Health Nurs. 1999;384­9. Zarzuela­Ramirez M, Cordoba­Dona JA, Perea­Milla E, Benitez­Rodriguez E, Escolar­Pujolar A, Lopez­Fernandez FJ. Factors associated with tuberculin conversion among staff at a university­affiliated hospital [letter]. Infect.Control Hosp.Epidemiol. 1999;589­90. Zegers ND, Kluter E, van Der SH, van Dura E, van Dalen P, Shaw M, Baillie L. Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax. J.Appl.Microbiol. 1999;309­14. Zimmerman RK, Ahwesh ER. Using problem­based learning to target public health problems. Acad.Med. 1996;543. Zoon KC. Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration. Emerg.Infect.Dis. 1999;534­6. Zotti C, Ossola O, Barberis R, Castella A, Ruggenini AM. Mumps: a current epidemiologic pattern as a necessary background for the choice of a vaccination strategy. Eur.J.Epidemiol. 1999;659­63. 2000 Feikema SM, Klevens RM, Washington ML, Barker L. Extraimmunization among US children [see comments]. JAMA 2000;1311­7. Abrunzo T, Gerardi M, Dietrich A, Lampell M, Sanford WC, Smith DM. The role of emergency physicians in the care of the child in school. Ann.Emerg.Med. 2000;155­61. Accidental exposure to smallpox vaccine, Russian Federation. Wkly Epidemiol Rec 2000 Jun 23;75(25):202. Adams, W. G., Conners, W. P., Mann, A. M., and Palfrey, S. Immunization entry at the point of service improves quality, saves time, and is well­accepted. Pediatrics 2000 Sep;106(3):489­92 Adolescent immunization. Wkly Epidemiol Rec 2000 Jun 2;75(22):183­7. Age threshold lowered for influenza immunisation and target for coverage introduced. Commun Dis Rep CDR Wkly 2000 Aug 11;10(32):285, 288. Aggarwal R, Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000; 15(1):9­20. Al Khalifa M, Elfving P, ansson W, Colleen S, Hellsten S, Duchek M et al. The effect of isoniazid on BCG­induced toxicity in patients with superficial bladder cancer. Eur Urol 2000; 37 Suppl 1:26­30. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000 Jul 8;321(7253):78­82. Altmann D. Autism and measles, mumps, and rubella vaccine [letter]. Lancet 2000;409­10. Ambati BK, Ambati J, Azar N, Stratton L, Schmidt EV. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology 2000 Aug;107(8):1450­3. American Academy of Pediatrics. Committee on Infecious Diseases. Prevention of Lyme disease. Pediatrics 2000;142­7. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000 Aug;106(2 Pt 1):362­6. American Academy of Pediatrics. Committee on Infectious Diseases. Recommended childhood immunization schedule­United States, January­December 2000. Pediatrics 2000;148­51. American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update. Pediatrics 2000;136­41. Anandh U, Bastani B, Ballal S. Granulocyte­macrophage colony­stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients. Am.J.Nephrol. 2000;53­6. Andersen O. Myelitis. Curr Opin Neurol 2000 Jun;13(3):311­6. Andre, M., Morgeaux, S., and Fuchs, F. Quantitative detection of RT activity by PERT assay: feasibility and limits to a standardized screening assay for human vaccines. Biologicals 2000 Jun;28(2):67­80 Antonen, J. A., Hannula, P. M., Pyhala, R., Saha, H. H., Ala­Houhala, I. O., and Pasternack, A. I. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 2000 Sep;86(1):56­61 Araga S, Xu L, Nakashima K, Villain M, Blalock JE. A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help. FASEB J. 2000;185­96. Araujo, O. O., Forleo­Neto, E., Vespa, G. N., Puccini, R. F., Weckx, L. W., Carvalho, E. S., and Farhat, C. K. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria­tetanus­whole­cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. Vaccine 2000 Sep 15;19(2­3):367­75 Arden NH. Control of influenza in the long­term­care facility: a review of established approaches and newer options. Infect.Control Hosp.Epidemiol. 2000;59­
64. Armstrong E. Time to switch from whole cell to acellular pertussis vaccines? [letter]. BMJ 2000; 320(7238):875. Arslan M, Wiesner RH, Poterucha JJ, Gross JB, Jr., Zein NN. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Liver Transpl 2000; 6(2):191­195. Artimos de Oliveira S, Jin L, Siqueira MM, Cohen BJ. Atypical measles in a patient twice vaccinated against measles: transmission from an unvaccinated household contact. Vaccine 2000 Dec 8;19(9­10):1093­6 Arya S, Chellani H, Pandey J. Evaluation of Safety of Oral Vitamin A Megadose Co­Administered with Measles Vaccination. Indian Pediatr 2000 Dec 7;37(12):1341­7 Arya, S. C. Poliomyelitis or acute flaccid paralysis in future [letter]. Vaccine 2000 Jun 15; 18(25): 2773­4. Asplund, L. Flu preparedness. Germ warfare [news] Hosp Health Netw 2000 Sep;74(9):22­4 Assa'ad A, Lierl M. Effect of acellular pertussis vaccine on the development of allergic sensitization to environmental allergens in adults. J.Allergy Clin.Immunol. 2000;170­5. Atabani S, Landucci G, Steward MW, Whittle H, Tilles JG, Forthal DN. Sex­associated differences in the antibody­dependent cellular cytotoxicity antibody response to measles vaccines. Clin.Diagn.Lab Immunol. 2000;111­3. Atkins GJ, McQuaid S, Morris­Downes MM, Galbraith SE, Amor S, Cosby SL, Sheahan BJ. Transient virus infection and multiple sclerosis. Rev Med Virol 2000 Sep­Oct;10(5):291­303. Attena, F., Serpieri, B., Trinchese, N. M., and Panico, M. G. Italy s New Vaccination Schedule Reduced Coverage of Poliomyelitis Vaccine in Naples. Euro.Surveill 2000, 5 (6): 73­74. Auvinen, A., Hakulinen, T., and Groves, F. Haemophilus influenzae type B vaccination and risk of childhood leukaemia in a vaccine trial in Finland. Br J Cancer 2000 Oct;83(7):956­8 Aycock, R. Cost effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 2000 Oct; 32(4 pt 1):873; discussion 874­5. Babiuk S, Baca­Estrada M, Babiuk LA, Ewen C, Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 2000 May 15;66(2­3):199­214. Bahmanyar M, Fayaz A, Nour­Salehi S, Mohammadi M, Koprowski H. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. 1976 [classical article]. Wilderness Environ Med 2000; 11(1):42­46. Baker JP. Immunization and the American way: 4 childhood vaccines. Am.J.Public Health 2000;199­207. Balas EA, Weingarten S, Garb CT, Blumenthal D, Boren SA, Brown GD. Improving preventive care by prompting physicians. Arch.Intern.Med. 2000;301­8. Balasanian M, McNabb SJ. Epidemic investigation of diphtheria in the Republic of Armenia, 1990­1996. J Infect Dis 2000; 181 Suppl 1:S69­S72. Baldini G, Bani E. Cardiac complications in Jennerian vaccination (clinical and electrocardiographic studies). Minerva Pediatr. 1979 Jan 15;31(1):35­9. Chest 2000 Jun;117(6):1803­5. Banzhoff A, Schwenke C, Febbraro S. Preservative­free influenza vaccine. Immunol Lett 2000; 71(2):91­96. Barnfield, C., Brew, R., Tilling, R., Rae, A., Wheeler, C., and Klavinskis, L. S. The cellular basis of immune induction at mucosal surfaces by DNA vaccination Dev.Biol.(Basel). 2000, 104:159­64. (): 159­164. Bassi P, Spinadin R, Carando R, Balta G, Pagano F. Modified induction course: a solution to side­effects? Eur Urol 2000; 37 Suppl 1:31­32. Bauer M, Wagner H, Lipford GB. HPV type 16 protein E7 HLA­A2 binding peptides are immunogenic but not processed and presented. Immunol Lett 2000; 71(1):55­59. Bautista­Lopez N, Ward BJ, Mills E, McCormick D, Martel N, Ratnam S. Development and durability of measles antigen­specific lymphoproliferative response after MMR vaccination. Vaccine 2000;1393­401. Beck JG, Low KH, Burnett M, Xu L, Suleyman S, Thompson KM, Sullivan L, Natvig JB, George V, Pinchuk. Analysis of 'natural' and vaccine­induced haemophilus influenzae type B capsular polysaccharide serum antibodies for 3H1, a V3­23­associated idiotope. Immunol Lett 2000 Jun 1;72(3):171­7. Bedford H, Elliman D. Concerns about immunisation. BMJ 2000;240­3. Bell BP. Hepatitis A vaccine. Pediatr Infect Dis J 2000 Dec;19(12):1187­8 Belloni C, Pistorio A, Tinelli C, Komakec J, Chirico G, Rovelli D, Gulminetti R, Comolli G, Orsolini P, Rondini G. Early immunisation with hepatitis B vaccine: a five­year study. Vaccine 2000;1307­11. Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M. Efficacy of vaccination with live attenuated, cold­adapted, trivalent, intranasal influenza virus vaccine against a variant (A/ Sydney) not contained in the vaccine [see comments]. J.Pediatr. 2000;168­75. Belshe RB, Gruber WC. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 2000 May;19(5 Suppl):S66­71. Bennett, J. L. Schistosomiasis vaccineswhat parasitology can do for immunology [letter] Parasitol Today 2000 Aug. 16(8): 356;discussion 357­8 Beran J, De Clercq N, Dieussaert I, Van Hoecke C. Reactogenicity and Immunogenicity of a Lyme Disease Vaccine in Children 2­5 Years Old. Clin Infect Dis 2000 Dec;31(6):1504­7 Berge JJ, Drennan DP, Jacobs RJ, Jakins A, Meyerhoff AS, Stubblefield W, Weinberg M. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 2000;469­73. Bergman, B. P., Hayton, J. C., and Green, A. D. Effectiveness of the meningococcal vaccination programme for British Armed Forces recruits Commun.Dis.Public Health. 2000, 3 (4): 298­299. Bermudes P. Health consequences of exemptions from immunization laws [letter]. JAMA 2000;1140­2. Berstad AK, Holst J, Froholm LO, Haugen IL, Wedege E, Oftung F, Haneberg B. A nasal whole­cell pertussis vaccine induces specific systemic and cross­
reactive mucosal antibody responses in human volunteers. J.Med.Microbiol. 2000;157­63. Bertrand, T. E. Adult vaccinations: 2000­2001 flu season update. Med Health R I 2000 Sep;83(9):291 Betts RF, Treanor JJ. Approaches to improved influenza vaccination. Vaccine 2000; 18(16):1690­1695. Beyer WE. Routine influenza vaccination for healthy children­old concept, new technologies. Arch Dis Child 2000 Dec;83(6):461­2 Bhamarapravati N, Sutee Y. Live attenuated tetravalent dengue vaccine. Vaccine 2000 May 26;18 Suppl 2:44­7. Birmingham K. Another attempt at creating a global vaccine initiative [news]. Nat.Med. 2000;238. Birmingham K. HIV vaccine trials planned for Africa [news]. Nat Med 2000 Aug;6(8):844. Birmingham K. Industry outlines its perspective on new third­world vaccine development [news]. Nat Med 2000 Jul;6(7):723­4. Bisgard KM, Rhodes P, Hardy IR, Litkina IL, Filatov NN, Monisov AA et al. Diphtheria toxoid vaccine effectiveness: A case­control study in Russia. J Infect Dis 2000; 181 Suppl 1:S184­S187. Black S. Varicella vaccination: to test or not to test [comment] [editorial]. Am J Med 2000 Jun 15;108(9):746­7. Blanck, R. R. Anthrax vaccination is based on medical evidence [letter]. Am J Public Health 2000 Aug;90(8):1326­7 Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. Anticancer Res 2000 Jul­2000 Aug 31;20(4):2665­76. Bohle A. BCG's mechanism of action ­ increasing our understanding. For the EBIN Group. Eur Urol 2000; 37 Suppl 1:1­8. Booth LV, Coppin R, Dunleavey J, Smith H. Implementation of influenza immunisation policy in general practice: 1997 to 1998. Commun Dis Public Health 2000; 3(1):39­42. Borrow R, Fox AJ, Richmond PC, Clark S, Sadler F, Findlow J, Morris R, Begg NT, Cartwright KA. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine. Epidemiol Infect 2000 Jun;124(3):427­32. Borrow R, Joseph H, Andrews N, Acuna M, Longworth E, Martin S, Peake N, Rahim R, Richmond P, Kaczmarski E, et al. Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults. Vaccine 2000 Dec 8;19(9­10):1129­32 Borrow R, Longworth E, Gray SJ, Kaczmarski EB. Prevalence of de­O­acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom. FEMS Immunol Med Microbiol 2000 Jul;28(3):189­91. Bower H. Arming the population against polio in Somalia [news]. Lancet 2000 Jul 15;356(9225):229. Bowers D. Children and youth new to Canada. Canadian Paediatric Society's health care guide. Can.Fam.Physician 2000;143­7. Boyce, T. G. and Poland, G. A. Promises and challenges of live­attenuated intranasal influenza vaccines across the age spectrum: a review. Biomed Pharmacother 2000 May;54(4):210­8 Boyce, T. G., Hsu, H. H., Sannella, E. C., Coleman­Dockery, S. D., Baylis, E., Zhu, Y., Barchfeld, G., DiFrancesco, A., Paranandi, M., Culley, B., Neuzil, K. M., and Wright, P. F. Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine 2000 Sep 15;19(2­3):217­26 Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 2000; 32(1 Suppl):98­112. Boyer­Chuanroong L, Deaver P. Meeting the preteen vaccine law: a pilot program in urban middle schools. J Sch Health 2000; 70(2):39­44. Bratcher DF, Stover BH, Lane NE, Paul RI. Compliance with national recommendations for tuberculosis screening and immunization of healthcare workers in a children's hospital. Infect Control Hosp Epidemiol 2000 May;21(5):338­40. Breiman, R. F., Keller, D. W., Phelan, M. A., Sniadack, D. H., Stephens, D. S., Rimland, D., Farley, M. M., Schuchat, A., and Reingold, A. L. Evaluation of effectiveness of the 23­valent pneumococcal capsular polysaccharide vaccine for HIV­infected patients. Arch Intern Med 2000 Sep 25;160(17):2633­8 Brennan M, Strebel P, George H, Yih WK, Tachdjian R, Lett SM, Cassiday P, Sanden G, Wharton M. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed­field gel electrophoresis studies. J.Infect.Dis. 2000;210­5. Brennan M, Vitek C, Strebel P, Wattigney W, Bisgard K, Brisgalov S et al. How many doses of diphtheria toxoid are required for protection in adults? Results of a case­control study among 40­ to 49­year­old adults in the Russian Federation. J Infect Dis 2000; 181 Suppl 1:S193­S196. Brennan MJ. Moving new vaccines for tuberculosis through the regulatory process. Clin Infect Dis 2000 Jun;30 Suppl 3:S247­9. Bridges, C. B., Thompson, W. W., Meltzer, M. I., Reeve, G. R., Talamonti, W. J., Cox, N. J., Lilac, H. A., Hall, H., Klimov, A., and Fukuda, K. Effectiveness and cost­benefit of influenza vaccination of healthy working adults: A randomized controlled trial [see comments] JAMA 2000 Oct 4;284(13):1655­63 Brigden ML, Pattullo A, Brown G. Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist. Am J Hematol 2000 Sep;65(1):25­9. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 2000 Jun 15;18(25):2775­8. Brocke S. T cell receptor peptides for the vaccination therapy of multiple sclerosis. Ernst Schering Res Found Workshop 2000;(30):167­79. Brockerhoff M, Hewett P. Inequality of child mortality among ethnic groups in sub­Saharan Africa. Bull.World Health Organ 2000;30­41. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP. Cross­species interactions between malaria parasites in humans. Science 2000;845­8. Brunell PA, Argaw T. Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster. Pediatrics 2000 Aug;106(2):E28. Brunham RC, Zhang DJ, Yang X, McClarty GM. The potential for vaccine development against chlamydial infection and disease. J Infect Dis 2000 Jun;181 Suppl 3:S538­43. Brydak LB, Roszkowska­Blaim M, Machala M, Leszczynska B, Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 2000 Aug 1;18(28):3280­6. Buckoke C. Unexpected beneficial effects of measles immunisation. Other conditions with reduced mortality could have been specified [letter]. BMJ 2000; 320(7239):938­940. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000 Jun;30(6):857­69. Burton DR, Parren PW. Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection? Nat.Med. 2000;123­5. Butcher GA, Sinden RE, Curtis C. Malaria: new ideas, old problems, new technologies [news]. Parasitol.Today 2000;43­4. Butler D. Analysis of polio vaccine could end dispute over how AIDS originated [news]. Nature 2000; 404(6773):9. Buxton BC, Fukuda K, Holman RC, De Guzman AM, Hodder RA, Gomolin IH, Galligan GK, Leib HB, Gallo RJ, Regnery HL, Arden NH, Cox NJ. Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996­97. Vaccine 2000;1103­9. Buxton J, Weatherill S, Hockin J, Daly P. Influenza and pneumococcal immunization 'blitz' in an inner city area: downtown eastside of Vancouver, British Columbia. Can Commun Dis Rep 2000 Jul 15;26(14):117­22. Camacho MT, Outschoorn I, Kovacova E, Tellez A. Distribution of immunoglobulin G (IgG) and A (IgA) subclasses following Q fever vaccination with soluble phase I Coxiella burnetii extract. Vaccine 2000; 18(17):1773­1777. Camargo MC, de Moraes JC, Souza VA, Matos MR, Pannuti CS. Predictors related to the occurrence of a measles epidemic in the city of Sao Paulo in 1997. Rev Panam Salud Publica 2000 Jun;7(6):359­65. Campagnoli S, Bensi G, Capo S, Coates S, Crawford K, Dong C, Wininger M, Baker G, Cousens L, Chien D, et al. J Virol 2000 Aug;74(15):6885­92. Campbell JB, Busse JW, Injeyan HS. Chiropractors and vaccination: A historical perspective. Pediatrics 2000; 105(4):E43. Canas LC, Lohman K, Pavlin JA, Endy T, Singh DL, Pandey P, Shrestha MP, Scott RM, Russell KL, Watts D, et al. The Department of Defense laboratory­
based global influenza surveillance system. Mil Med 2000 Jul;165(7 Suppl 2):52­6. Caporali R, Rossi S, Epis O, Montecucco C. Influenza may influence rheumatoid arthritis [letter]. J Rheumatol 2000; 27(2):553­554. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, Stott DJ. Effects of influenza vaccination of health­care workers on mortality of elderly people in long­term care: a randomised controlled trial [see comments]. Lancet 2000;93­7. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A. Malaria transmission­blocking vaccines­­how can their development be supported? Nat.Med. 2000;241­4. Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A. Genotypic stability of cold­adapted influenza virus vaccine in an efficacy clinical trial. J.Clin.Microbiol. 2000;839­45. Chaisson RE. New developments in the treatment of latent tuberculosis. Int J Tuberc Lung Dis 2000 Dec;4(12 Suppl 2):S176­81 Chartrand SA. Varicella vaccine. Pediatr Clin North Am 2000; 47(2):373­394. Chaudhry R, Kottke TE, Naessens JM, Johnson TJ, Nyman MA, Cornelius LA, Petersen JD. Busy physicians and preventive services for adults. Mayo Clin.Proc. 2000;156­62. Chen H. Recent advances in mucosal vaccine development. J Control Release 2000 Jul 3;67(2­3):117­28. Chen RT, Hardy IR, Rhodes PH, Tyshchenko DK, Moiseeva AV, Marievsky VF. Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union. J Infect Dis 2000; 181 Suppl 1:S178­S183. Chen, W. N.; Oon, C. J. Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti­hepatitis B virus antibody levels but negative for HBsAg [letter]. J Clin Microbiol 2000 Jul 38(7): 2793­42. Chiao JW, Villalon P, Schwartz I, Wormsera GP. Modulation of lymphocyte proliferative responses by a canine Lyme disease vaccine of recombinant outer surface protein A (OspA). FEMS Immunol Med Microbiol 2000 Jul;28(3):193­6. Chien JW, Johnson JL. Viral pneumonias. Epidemic respiratory viruses. Postgrad Med 2000; 107(3):41­7, 51. Chien JW, Johnson JL. Viral pneumonias. Infection in the immunocompromised host. Postgrad Med 2000; 107(2):67­4, 77. Chin J, Turner B, Barchia I, Mullbacher A. Immune response to orally consumed antigens and probiotic bacteria. Immunol.Cell Biol. 2000;55­66. Cholera, 1999. Wkly Epidemiol Rec 2000 Aug 4;75(31):249­56. Christenson B, Hellstrom U, Sylvan SP, Henriksson L, Granstrom M. Impact of a vaccination campaign on adult immunity to diphtheria. Vaccine 2000 Dec 8;19(9­10):1133­40 Christiansen G, Pedersen AS, Hjerno K, Vandahl B, Birkelund S. Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine. J Infect Dis 2000 Jun;181 Suppl 3:S528­37. Chu NR, Wu HB, Wu T, Boux LJ, Siegel MI, Mizzen LA. Immunotherapy of a human papillomavirus (HPV) type 16 E7­expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette­Guerin (BCG) hsp65 and HPV16 E7. Clin Exp Immunol 2000 Aug;121(2):216­25. Chweiz Med Wochenschr 2000 Nov 4;130(44):1685­8. Cieslak TJ, Christopher GW, Kortepeter MG, Rowe JR, Pavlin JA, Culpepper RC, Eitzen EM Jr. Immunization against potential biological warfare agents. Clin Infect Dis 2000 Jun;30(6):843­50. Ciment J. US drug companies announce vaccine initiative [news]. BMJ 2000; 320(7237):736. Classen, J. B.; Classen, D. C. Hemophilus vaccine associated with increased risk of diabetescausality likely [letter] Diabetes Care 2000 Jun;23(6): 872­3. Cline MK, Bailey­Dorton C, Cayelli M. Maternal infections: diagnosis and management. Prim Care 2000; 27(1):13­33. Cohen D, Orr N, Haim M, Ashkenazi S, Robin G, Green MS, Ephros M, Sela T, Slepon R, Ashkenazi I, et al. Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli­cholera toxin B subunit vaccine in Israeli young adults. Infect Immun 2000 Aug;68(8):4492­7. Cohen, J. Forensic epidemiology. Vaccine theory of AIDS origins disputed at Royal Society [news] Science 2000 Sep 15;289(5486):1850­1 Collins DM. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex. Immunol Cell Biol 2000 Aug;78(4):342­8. Compendium of animal rabies prevention and control, 2000. National Association of State Public Health Veterinarians, Inc. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(RR­8):21­30. Compendium of animal rabies prevention and control, 2000. National Association of State Public Health Veterinarians, Inc. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(RR­8):21­30. Comstock GW. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine. Clin Infect Dis 2000 Jun;30 Suppl 3:S250­3. Conrad DA. Why changes in administration of polio vaccine? Postgrad.Med. 2000;33, 36. Corrah T, Byass P, Jaffar S, Thomas V, Bouchier V, Stanford JL, Whittle HC. Prior BCG vaccination improves survival of Gambian patients treated for pulmonary tuberculosis. Trop Med Int Health 2000 Jun;5(6):413­7. Couch RB. Influenza: Prospects for Control. Ann Intern Med 2000 Dec 19;133(12):992­8 Crooy P, Lobet Y. An effective vaccine against Lyme disease. J.Biotechnol. 2000;261­3. Crovari P, Gabutti G, Giammanco G, Dentico P, Moiraghi AR, Ponzio F, Soncini R. Reactogenicity and immunogenicity of a new combined measles­mumps­
rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines. Vaccine 2000 Jun 15;18(25):2796­803. Csatary LK, Csatary E, Moss RW. Re: Scientific interest in newcastle disease virus is reviving [letter]. J Natl Cancer Inst 2000; 92(6):493­494. Cutts FT, Abebe A, Messele T, Dejene A, Enquselassie F, Nigatu W, Nokes DJ. Sero­epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiol Infect 2000 Jun;124(3):467­79. Czeschinski PA, Binding N, Witting U. Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. Vaccine 2000;1074­80. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic­resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J 2000 May;19(5 Suppl):S79­87; discussion S88. Dagan R, Gradstein S, Belmaker I, Porat N, Siton Y, Weber G et al. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis 2000; 30(2):319­321. Dalby DM, Sellors JW, Fraser FD, Fraser C, van Ineveld C, Howard M. Effect of preventive home visits by a nurse on the outcomes of frail elderly people in the community: a randomized controlled trial [see comments]. CMAJ. 2000;497­500. Dalton C. Unexpected beneficial effects of measles immunisation. Measles vaccination may be marker for other health seeking behaviours [letter]. BMJ 2000; 320(7239):938­940. Daniel­Ribeiro CT. Is there a role for autoimmunity in immune protection against malaria? Mem Inst Oswaldo Cruz 2000 Mar­2000 Apr 30;95(2):199­207. Danovaro­Holliday MC, LeBaron CW, Allensworth C, Raymond R, Borden TG, Murray AB, Icenogle JP, Reef SE. A large rubella outbreak with spread from the workplace to the community. JAMA 2000 Dec 6;284(21):2733­9 Darden PM. Assessing immunization rates: the importance of denominators [editorial]. Pediatrics 2000 Jul;106(1 Pt 2):169­70. Dargan JM, Coplan PM, Kaplan KM, Nikas A. Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP­OMPC) or failure to vaccinate with PRP­OMPC? [letter]. J Infect Dis 2000; 181(2):806­809. D'Argenio, P.; Arigliani, R.; Selvaggi, T. M. ReField evaluation of the clinical effectiveness of vaccines against pertusis, measles, rubella, and mumps [letter]. Vaccine 2000 Jul 1;18(26):2925­6. Davidkina I, Peltolab H, Leinikkia P, Vallea M. Duration of rubella immunity induced by two­dose measles, mumps and rubella (MMR) vaccination. A 15­
year follow­up in Finland. Vaccine 2000 Jul 15;18(27):3106­12. Davidson RN. Childhood tuberculosis­­problems ahead. Trans R Soc Trop Med Hyg 2000; 94(1):5­6. Davies MK, Mayne AJ. Stamps in paediatrics. Immunisation. Arch Dis Child 2000; 82(4):282. Davis ID. An overview of cancer immunotherapy. Immunol Cell Biol 2000 Jun;78(3):179­95. Davis RL. Vaccine extraimmunization­­too much of a good thing? [editorial; comment]. JAMA 2000;1339­40. De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I et al. Immune­mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea­like drug eruption. Clin Exp Rheumatol 2000; 18(1):81­85. De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, Praet M, Veys E. Immunemediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea­like drug eruption. Clin Exp Rheumatol 2000 Jan­Feb;18(1):81­5. De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, Praet M, Veys E. Immunemediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea­like drug eruption. Clin Exp Rheumatol 2000 Jan­Feb;18(1):81­5. De Kleijn ED, de Groot R, Labadie J, Lafeber AB, van den DG, van Alphen L, van Dijken H, Kuipers B, van Omme GW, Wala M, Juttmann R, Rumke HC. Immunogenicity and safety of a hexavalent meningococcal outer­membrane­vesicle vaccine in children of 2­3 and 7­8 years of age. Vaccine 2000;1456­66. de Kleijn ED, de Groot R, Lafeber AB, Labadie J, van Limpt KC, Visser J, Berbers GA, van Alphen L, Rumke HC. Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations. Vaccine 2000 Dec 8;19(9­10):1141­8 De La Rosa JM, Escobedo M. Tuberculosis and other infectious diseases in the adolescent immigrant. Adolesc Med 2000 Jun;11(2):453­66. De Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn­van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000 Jul­2000 Aug 31;6(4):348­57. De Moraes, Jd, Barata, R., Ribeiro, M. C., and de Castro, P. C. [Vaccination coverage in the first year of life in 4 cities of the state of Sao Paulo, Brazil] Rev.Panam.Salud Publica. 2000, 8 (5): 332­341. De Oliveira LH, Struchiner CJ. Vaccine­associated paralytic poliomyelitis in Brazil, 1989­1995. Rev Panam Salud Publica 2000 Apr;7(4):219­24. De Oliveira LH, Struchiner CJ. Vaccine­associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil. Int J Epidemiol 2000 Aug;29(4):757­63. De Serres G. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine. Can Commun Dis Rep 2000 May 1;26:1­8. De Wals P. Does informing patients of the risk of acquiring Guillain­Barre syndrome following influenza vaccination have an effect on their willingness to be vaccinated? Can Commun Dis Rep 2000 Dec 1;26(23):205­7 Dearman, C.; Lazenby, R. B. Community Partnerships: A Win­Win Situation. Nurse Educ; 25 (6): 287; November, 2000. Decker MD, Edwards KM. Acellular pertussis vaccines. Pediatr Clin North Am 2000; 47(2):309­335. Decker, M. D. and Edwards, K. M. Combination vaccines: problems and promise [comment] [editorial] J Pediatr 2000 Sep;137(3):291­5 Del Rey, Calero J. [Current interest of antipneumococcal vaccination] An R.Acad.Nac.Med. (Madr.). 2000, 117 (1): 163­178. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000­01 influenza season. Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(27):619­22. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000­01 influenza season. Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(27):619­22. Delpeyroux F, Guillot S, Szendroi A, Balanant J, Caro V, Cuervo N, Chevaliez S, Dahourou G, Crainic R. Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world? Bull Soc Pathol Exot 2000 Jul;93(3):193­7. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;957­1030. DeStefano F, Chen RT. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. J.Pediatr. 2000;125­6. Dickson, D. Tests fail to support claims for origin of AIDS in polio vaccine [news] Nature 2000 Sep 14;407(6801):117 Dietz VJ, Baughman AL, Dini EF, Stevenson JM, Pierce BK, Hersey JC. Vaccination practices, policies, and management factors associated with high vaccination coverage levels in Georgia public clinics. Georgia Immunization Program Evaluation Team. Arch.Pediatr.Adolesc.Med. 2000;184­9. Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000;798­803. Dini EF, Linkins RW, Sigafoos J. The impact of computer­generated messages on childhood immunization coverage. Am.J.Prev.Med. 2000;132­9. Dittmann S, Wharton M, Vitek C, Ciotti M, Galazka A, Guichard S et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 181 Suppl 1:S10­S22. D'Lugoff, M. I. and Schalla, K. M. Vaccine Verification Guide: Demystifying Childhood Immunizations for Inpatient and Other Nurses Pediatr.Nurs. 2000, 26 (1): 69­75. Doganci, L.; Saracli, M. A.; Guney, C. Am J Gastroenterol 2000 Aug;95(8):2137. Donald PR. Preventing tuberculosis in childhood. Indian J Pediatr 2000 May;67(5):383­5. Donovan RJ, Jalleh G. Positive versus negative framing of a hypothetical infant immunization: the influence of involvement. Health Educ Behav 2000; 27(1):82­95. Douglas, R. G. Will a new vaccine be used? J Hum Virol 2000 Mar­Apr;3(2):77­80 Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML. Outbreak of aseptic meningitis associated with mass vaccination with a urabe­containing measles­mumps­rubella vaccine: implications for immunization programs. Am.J.Epidemiol. 2000;524­30. Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML. Outbreak of aseptic meningitis associated with mass vaccination with a urabe­containing measles­mumps­rubella vaccine: implications for immunization programs. Am J Epidemiol 2000 Mar 1;151(5):524­30. Dove A. Sanctions programs expand despite failure to increase vaccination [news]. Nat.Med. 2000;119. Drogari­Apiranthitou M, Fijen CA, Van De BD, Hensen EF, Dankert J, Kuijper EJ. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement­deficient patients. Clin.Exp.Immunol. 2000;311­6. D'Souza RM, Campbell­Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F et al. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. Commun Dis Intell 2000; 24(2):27­33. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch.Intern.Med. 2000;113­5. Durbach, N. 'They might as well brand us': working­class resistance to compulsory vaccination in Victorian England Soc.Hist Med. 2000, 13 (1): 45­62. Durbin AP, Skiadopoulos MH, McAuliffe JM, Riggs JM, Surman SR, Collins PL, Murphy BR. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy. J Virol 2000 Aug;74(15):6821­31. Durek C, Rusch­Gerdes S, Jocham D, Bohle A. Sensitivity of BCG to modern antibiotics. Eur Urol 2000; 37 Suppl 1:21­25. Duval B, Boulianne N, De Serres G, Laflamme N, De Wals P, Masse R, Trudeau G, Delage G, Desjardins L. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8­10­year­old children. Vaccine 2000;1467­72. Earn DJ, Rohani P, Bolker BM, Grenfell BT. A simple model for complex dynamical transitions in epidemics [see comments]. Science 2000;667­70. Eder JP, Kantoff PW, Roper K, Xu GX, Bubley GJ, Boyden J, Gritz L, Mazzara G, Oh WK, Arlen P, et al. A phase I trial of a recombinant vaccinia virus expressing prostate­specific antigen in advanced prostate cancer. Clin Cancer Res 2000 May;6(5):1632­8. Edmunds W, Dejene A, Mekonnen Y, Haile M, Alemnu W, Nokes D. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa. Health Policy Plan 2000 Dec;15(4):408­16 Edmunds WJ, Gay NJ. Health professionals do not understand mathematical models [letter]. BMJ 2000; 320(7234):581­582. Edwards EA, Grant CC, Huang QS, Powell KF, Croxson MC. A case of vaccine­associated paralytic poliomyelitis. J Paediatr Child Health 2000 Aug;36(4):408­11. Edwards, E. A., Grant, C. C., Huang, Q. S., Powell, K. F., and Croxson, M. C. A case of vaccine­associated paralytic poliomyelitis. J Paediatr Child Health 2000 Aug;36(4):408­11 Ehresmann KR, Mills WA, Loewenson PR, Moore KA. Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider education. Am J Public Health 2000 Dec;90(12):1917­20 Ekwueme DU, Strebel PM, Hadler SC, Meltzer MI, Allen JW, Livengood JR. Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole­cell pertussis vaccine in the United States, 1997. Arch Pediatr Adolesc Med 2000 Aug;154(8):797­803. El Kasmi KC, Fillon S, Theisen DM, Hartter H, Brons NH, Muller CP. Neutralization of measles virus wild­type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies. J Gen Virol 2000; 81 Pt 3:729­735. Elliman, D.; Bedford, H. Perhaps it is not time to switch from whole cell to acellular pertussis vaccine [letter]. BMJ 2000 Aug 12;321(7258):451­2. Ellner JJ, Hirsch CS, Whalen CC. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis 2000 Jun;30 Suppl 3:S279­82. Elphinstone, P. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161. Emerton D. Unexpected beneficial effects of measles immunization. Socioeconomic confounding may also play a part [letter]. BMJ 2000; 320(7239):938­940. Engels EA, Bennish ML, Falagas ME, Lau J. Typhoid fever vaccines [letter]. Vaccine 2000;1433­4. Engler T. Unexpected beneficial effects of measles immunisation. Who brought measles? [letter]. BMJ 2000; 320(7239):939­940. Enserink M. Global health. Group urges action on Third World drugs [news]. Science 2000;1571. Erramouspe J, Heyneman CA. treatment and prevention of otitis media. Ann Pharmacother 2000 Dec;34(12):1452­68 Eskola J, Kilpi T. Potential of bacterial vaccines in the prevention of acute otitis media. Pediatr Infect Dis J 2000 May;19(5 Suppl):S72­8. Fabrizi F, Martin P. Hepatitis B virus infection in dialysis patients. Am.J.Nephrol. 2000;1­11. Feavers IM. ABC of meningococcal diversity [news; comment]. Nature 2000; 404(6777):451­452. Fee E, Brown TM. The microbial menace, then and now [editorial]. Am.J.Public Health 2000;184­5. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000 Dec 27;284(24):3145­50 Felt BT, Mollen E, Diaz S, Renaud E, Zeglis M, Wheatcroft G, Mendelow D. Behavioral interventions reduce infant distress at immunization. Arch Pediatr Adolesc Med 2000 Jul;154(7):719­24. Ferson MJ. Adult vaccination: old needs, new challenges and opportunities [editorial; comment]. Med J Aust 2000 Jul 17;173(2):72­3. Filonov VP, Zakharenko DF, Vitek CR, Romanovsky AA, Zhukovski VG. Epidemic diphtheria in Belarus, 1992­1997. J Infect Dis 2000; 181 Suppl 1:S41­
S46. Finlay R. Unexpected beneficial effects of measles immunisation. Number of squint operations has decreased [letter]. BMJ 2000; 320(7239):939­940. Fischman J. Vaccinating against paralysis. US News World Rep 2000 Dec 25;129(25):66­7 FitzGerald JM, Wang L, Elwood RK. Tuberculosis: 13. Control of the disease among aboriginal people in Canada. CMAJ. 2000;351­5. FitzGerald, D. and Mrsny, R. J. New approaches to antigen delivery. Crit Rev Ther Drug Carrier Syst 2000;17(3):165­248 Flehmig B, Normann A, Bohnen D. Transmission of hepatitis A virus infection despite vaccination. N Engl J Med. 2000 Jul 27;343(4):301­2. Frank­Peterside, N. Response of laboratory staff to vaccination with an inactivated rift valley fever vaccine­­TSI­GSD 200 Afr.J.Med.Med.Sci. 2000, 29 (2): 89­92. Franzen D. Clinical Efficacy of Pneumococcal Vaccination ­ A Prospective Study in Patients with Longstanding Emphysema and / or Bronchitis. Eur J Med Res 2000 Dec 29;5(12):537­40 Franzini L, Rosenthal J, Spears W, Martin HS, Balderas L, Brown M, Milne G, Drutz J, Evans D, Kozinetz C, et al. Cost­effectiveness of childhood immunization reminder/recall systems in urban private practices. Pediatrics 2000 Jul;106(1 Pt 2):177­83. Frasch CE, Concepcion NF. Specificity of human antibodies reactive with pneumococcal C polysaccharide. Infect Immun 2000; 68(4):2333­2337. French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. 23­valent pneumococcal polysaccharide vaccine in HIV­1­infected Ugandan adults: double­blind, randomised and placebo controlled trial. Lancet 2000 Jun 17;355(9221):2106­11. Fried RG. Health consequences of exemptions from immunization laws [letter]. JAMA 2000;1140­2. Friedman HM. Immunologic strategies for herpes vaccination [letter]. JAMA 2000;746­7. Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men. Am J Public Health 2000 Dec;90(12):1942­6 Friedrich F. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus. Acta Virol 2000 Apr;44(2):109­17. From the Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000­01 influenza season. Advisory Committee on Immunization Practices. JAMA 2000 Aug 9;284(6):687­8. From the Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000­01 influenza season. Advisory Committee on Immunization Practices. JAMA 2000 Aug 9;284(6):687­8. From the Centers for Disease Control and Prevention. Global measles control and regional elimination, 1998­1999. JAMA 2000;472­4. From the Centers for Disease Control and Prevention. National, state and urban area vaccination coverage levels among children aged 19­35 months­­United States, 1999. JAMA 2000 Aug 9;284(6):690. From the Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication­­European Region 1998­June 2000. JAMA 2000 Aug 16;284(7):824­5. From the Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication­­Eastern Mediterranean Region, 1998­October 1999. JAMA 2000;195­6. From the Centers for Disease Control and Prevention. Update: expanded availability of thimerosal preservative­free hepatitis B vaccine. JAMA 2000 Aug 23­
2000 Aug 30;284(8):954. Fry DE. Hepatitis: risks for the surgeon. Am.Surg. 2000;178­83. Galama, J. M. Vaccinations as risk factors for Type I diabetes mellitus [letter]. Diabetologia 2000 May;43(5):684. Gallup, R. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161­2. Garpenholt O, Hugosson S, Fredlund H, Giesecke J, Olcen P. Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children [see comments]. Acta Paediatr 2000 Apr;89(4):471­4. Gavrilin GV, Cherkasova EA, Lipskaya GY, Kew OM, Agol VI. Evolution of circulating wild poliovirus and of vaccine­derived poliovirus in an immunodeficient patient: a unifying model. J Virol 2000 Aug;74(16):7381­90. Gay, N. J. Eliminating measles­­no quick fix [editorial; comment] Bull World Health Organ 2000;78(8):949 Gdalevich M, Ephros M, Mimouni D, Grotto I, Shpilberg O, Eldad A, Ashkenazi I. Measles epidemic in israel­successful containment in the military. Prev Med 2000 Dec;31(6):649­51 Gershon A. Varicella: to vaccinate or not vaccinate? [letter]. Arch.Dis.Child 2000;88. Gershon, A. A.; Perkin, R. T. Herpes zoster [letter]. N Engl J Med 2000 Jul 20;343(3):222; discussion 223. Gessner BD. The cost­effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly. Vaccine 2000;1485­94. Gherardi MM, Ramirez JC, Esteban M. Interleukin­12 (IL­12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL­12 boost are mediated by nitric oxide. J Virol 2000 Jul;74(14):6278­86. Ghosh, A. K. Evidence­based nephrology: efficacy of hepatitis B vaccine in hemodialysis patients. Int J Artif Organs 2000 Apr;23(4):282­3 Ginsberg AM. A proposed national strategy for tuberculosis vaccine development. Clin Infect Dis 2000 Jun;30 Suppl 3:S233­42. Glassroth J. Clinical considerations in designing trials of vaccines for tuberculosis. Clin Infect Dis 2000 Jun;30 Suppl 3:S229­32. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;499­505. Glinyenko VM, Abdikarimov ST, Firsova SN, Sagamonjan EA, Kadirova R, Nuorti JP et al. Epidemic diphtheria in the Kyrgyz Republic, 1994­1998. J Infect Dis 2000; 181 Suppl 1:S98­S103. Golaz A, Hardy IR, Glushkevich TG, Areytchiuk EK, Deforest A, Strebel P et al. Evaluation of a single dose of diphtheria­tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J Infect Dis 2000; 181 Suppl 1:S203­S207. Golaz A, Hardy IR, Strebel P, Bisgard KM, Vitek C, Popovic T et al. Epidemic diphtheria in the Newly Independent States of the Former Soviet Union: implications for diphtheria control in the United States. J Infect Dis 2000; 181 Suppl 1:S237­S243. Golaz A, Lance­Parker S, Welty T, Schaefer L, Volmer L, LaFromboise C, Dixon J, Haase T, Kim C, Popovic T, et al. Epidemiology of diphtheria in South Dakota. S D J Med 2000 Jul;53(7):281­5. Gold M, Goodwin H, Botham S, Burgess M, Nash M, Kempe A. Re­vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Arch Dis Child 2000 Aug;83(2):128­31. Goldblatt D. Conjugate vaccines [editorial]. Clin.Exp.Immunol. 2000;1­3. Gomi Y, Imagawa T, Takahashi M, Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J Med Virol 2000 Aug;61(4):497­503. Gonik B, Jones T, Contreras D, Fasano N, Roberts C. The obstetrician­gynecologist's role in vaccine­preventable diseases and immunization. Obstet Gynecol 2000 Jul;96(1):81­4. Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child 2000 Dec;83(6):488­91 Goodman, K. J.; Wu, J. S.; Frerichs, R. R. Compliance With Childhood Immunizations in Kern County, California. J Immigr Health; 2 (4): 213­222; October, 2000. Gotch F, Rutebemberwa A, Jones G, Imami N, Gilmour J, Kaleebu P, Whitworth J. Vaccines for the control of HIV/AIDS. Trop Med Int Health 2000 Jul;5(7):A16­21. Grabenstein JD. How hard is it to learn to vaccinate? J Am Pharm Assoc (Wash) 2000; 40(2):268. Grabenstein JD. Smoking and the need for vaccination. J Am Pharm Assoc 2000 Jul­2000 Aug 31;40(4):562. Gray­Grant D. Beware of all types of bat exposure, BC MDs warned [news]. CMAJ 2000 Jun 27;162(13):1862­3. Green, M. S. Compliance with influenza vaccination and the health belief model Isr.Med.Assoc.J. 2000, 2 (12): 912­913. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 Jul;162(1):167­73. Greenberg SB. 'Bacilli and bullets': William Osler and the antivaccination movement. South Med J 2000 Aug;93(8):763­7. Greenberg, D. S. Short of vaccine, the Pentagon slows anthrax inoculations [news] Lancet 2000 Aug 5;356(9228):491 Greensfelder L. Infectious diseases. Polio outbreak raises questions about vaccine. Science. 2000 Dec 8;290(5498):1867­9. Griffin DD, Kirkwood CD, Parashar UD, Woods PA, Bresee JS, Glass RI, Gentsch JR. Surveillance of rotavirus strains in the United States: identification of unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories. J Clin Microbiol 2000 Jul;38(7):2784­7. Griskevica A, Ching P, Russo G, Kreysler J. Diphtheria in Latvia, 1986­1996. J Infect Dis 2000; 181 Suppl 1:S60­S64. Grubeck­Loebenstein B, Blasko I, Marx FK, Trieb I. Immunization with beta­amyloid: could T­cell activation have a harmful effect? [letter]. Trends Neurosci. 2000;114. Gruber T, Marada R. Improving pneumococcal vaccination rates for elderly patients. N.J.Med. 2000;35­9. Gryseels B. Schistosomiasis vaccines: a devils' advocate view. Parasitol.Today 2000;46­8. Guillemin, J. Anthrax: the investigation of a deadly outbreak [letter] N Engl J Med 2000 Oct 19;343(16):1198 Guillot S, Caro V, Cuervo N, Korotkova E, Combiescu M, Persu A, Aubert­Combiescu A, Delpeyroux F, Crainic R. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 2000 Sep;74(18):8434­43. Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert­Combiescu, A., Delpeyroux, F., and Crainic, R. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 2000 Sep;74(18):8434­43 Gurunathan, S., Wu, C. Y., Freidag, B. L., and Seder, R. A. DNA vaccines: a key for inducing long­term cellular immunity. Curr Opin Immunol 2000 Aug;12(4):442­7 Habib, S., Rishpon, S., and Rubin, L. Influenza vaccination among healthcare workers Isr.Med.Assoc.J. 2000, 2 (12): 899­901. Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis 2000; 181 Suppl 1:S116­S120. Hagan H. Vaccination could improve overall health in a high risk population [comment]. West J Med 2000; 172(1):21. Hagan P, Doenhoff MJ, Wilson RA, Al­Sherbiny M, Bergquist R. Schistosomiasis vaccines: a response to a devils' advocate's view. Parasitol Today 2000 Aug;16(8):322­3. Haller AA, Miller T, Mitiku M, Coelingh K. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J Virol 2000 Dec;74(24):11626­35 Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L. An adult formulation of a five­
component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000;1312­
9. Halpern­Felsher BL, Ozer EM, Millstein SG, Wibbelsman CJ, Fuster CD, Elster AB, Irwin CE, Jr. Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients? Arch.Pediatr.Adolesc.Med. 2000;173­9. Hampton HL. Examination of the adolescent patient. Obstet.Gynecol.Clin.North Am. 2000;1­18. Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P et al. Recognition and management of Kawasaki disease. CMAJ 2000; 162(6):807­812. Handal GA. Adolescent immunization. Adolesc Med 2000 Jun;11(2):439­52. Hanke, W. [Efficacy of vaccination against influenza among working people­­results of epidemiological studies] Med.Pr. 2000, 51 (5): 475­484. Hanlon M, Nambiar R, Kakakios A, McIntyre P, Land M, Devine P. Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole­cell pertussis ELISA. Immunol Cell Biol 2000 Jun;78(3):254­8. Hanna, J., Richards, A., Young, D., Hills, S., and Humphreys, J. Measles in health care facilities: some salutary lessons. Commun Dis Intell 2000 Jul;24(7):211­2 Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA, Takeshita K. Measles virus­specific T helper 1/T helper 2­cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000 Apr;6(2):121­6. Harbarth, S., Szucs, T., Berger, K., and Jilg, W. The economic burden of hepatitis B in Germany. Eur J Epidemiol 2000 Feb;16(2):173­7 Hardy A. "Straight back to barbarism": antityphoid inoculation and the Great War, 1914. Bull Hist Med 2000 Summer;74(2):265­90. Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 2000; 181(2):413­418. Harries AD. Applying advances to the developing world for TB and HIV control. Int J Tuberc Lung Dis 2000; 4(2 Suppl 1):S65­S70. Harris BD, Adal KA, Tomecki KJ. New and emerging therapies in infectious diseases. Dermatol.Clin. 2000;31­5, viii. Harrison LH, Dwyer DM, Billmann L, Kolczak MS, Schuchat A. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Arch.Intern.Med. 2000;89­94. Harrison LH. Preventing meningococcal infection in college students. Clin Infect Dis 2000 Apr;30(4):648­51. Hartigan­Go, K., Roces, M. C., Habacon, C. A., Mansoor, O., and Shin, S. Developing an immunization safety surveillance system in the Philippines. Bull World Health Organ 2000;78(9):1166 Hartley C. Immunologic strategies for herpes vaccination [letter]. JAMA 2000;746­7. Hassan I, Reen DJ. T­cell function in the human newborn [letter]. Immunol.Today 2000;107­8. Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cell Mol Life Sci 2000; 57(2):323­332. Hauri AM, Ehrhard I, Frank U, Ammer J, Fell G, Hamouda O et al. Serogroup C meningococcal disease outbreak associated with discotheque attendance during carnival. Epidemiol Infect 2000; 124(1):69­73. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin.Infect.Dis. 2000;122­40. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin.Infect.Dis. 2000;100­21. Haviv YS, Sharkia M, Galun E, Safadi R. Pancreatitis following hepatitis A vaccination. Eur J Med Res 2000 May 23;5(5):229­30. Hawk DL. Tick, tick, ticking away.... Pa Med 2000 Summer;Suppl:9. Hedlund, J., Ortqvist, A., Konradsen, H. B., and Kalin, M. Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle­aged and elderly adults. Scand J Infect Dis 2000;32(3):281­6 Heijtink RA, van Bergen P, Paulij WP, de Man RA, Osterhaus AD. Anti­HBs characteristics after hepatitis B immunisation with plasma­derived and recombinant DNA­derived vaccines. Vaccine 2000;1531­8. Heikkinen T, Chonmaitree T. Increasing importance of viruses in acute otitis media. Ann Med 2000 Apr;32(3):157­63. Heininger U, Schmidt­Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000;E31. Heininger, U. Coincidence is not causality­a principle which needs regular rediscovery. Arch Dis Child 2000 Oct;83(4):355 Hennessey KA, Marx A, Hafiz R, Ashgar H, Hadler SC, Jafari H, Sutter RW. Widespread paralytic poliomyelitis in Pakistan: A case­control study to determine risk factors and implications for poliomyelitis eradication. J Infect Dis 2000 Jul;182(1):6­11. Hensrud DD. Clinical preventive medicine in primary care: background and practice: 2. Delivering primary preventive services. Mayo Clin Proc 2000; 75(3):255­264. Hepatitis B vaccination coverage among Asian and Pacific Islander children­­United States, 1998. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(27):616­9. Hepatitis B vaccination coverage among Asian and Pacific Islander children­­United States, 1998. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(27):616­9. Hermans G, Medaer R, Raus J, Stinissen P. Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations. J.Neuroimmunol. 2000;79­84. Herremans T, Reimerink JH, Kimman TG, Der Avoort HG, Koopmans MP. Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure. Clin.Diagn.Lab Immunol. 2000;40­4. Herrera, G. A., Smith, P., Daniels, D., Klevens, R. M., Coronado, V., McCauley, M., Stokley, S., Maes, E. F., Ezzati­Rice, T. M., Wright, R. A., and Cordero, J. F. National, state, and urban area vaccination coverage levels among children aged 19­35 months­­United States, 1998. Mor Mortal Wkly Rep CDC Surveill Summ 2000 Sep 22;49(9):1­26 Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J et al. Population­based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92(6):464­474. Hewson R. RNA viruses: emerging vectors for vaccination and gene therapy. Mol.Med.Today 2000;28­35. Hill AG, MacLeod WB, Joof D, Gomez P, Walraven G. Decline of mortality in children in rural Gambia: the influence of village­level primary health care. Trop Med Int Health 2000; 5(2):107­118. Hilleman MR. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine 2000;1436­47. Hilleman, M. R. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. J Hum Virol 2000 Mar­Apr;3(2):63­76 Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, et al. Acute systemic inflammation impairs endothelium­dependent dilatation in humans. Circulation 2000 Aug 29;102(9):994­9. Hinman, A. R. How should physicians and nurses deal with people who do not want immunizations? Can J Public Health 2000 Jul­Aug;91(4):248­51 Hodge JW, Schlom J. Costimulatory molecules in vaccine design. Ernst Schering Res Found Workshop 2000;(30):23­52. Hoft DF, Brown RM, Belshe RB. Mucosal bacille calmette­Guerin vaccination of humans inhibits delayed­type hypersensitivity to purified protein derivative but induces mycobacteria­specific interferon­gamma responses. Clin Infect Dis 2000 Jun;30 Suppl 3:S217­22. Holgate ST. Science, medicine, and the future. Allergic disorders. BMJ 2000;231­4. Holl JL, Szilagyi PG, Rodewald LE, Shone LP, Zwanziger J, Mukamel DB, Trafton S, Dick AW, Barth R, Raubertas RF. Evaluation of New York State's Child Health Plus: access, utilization, quality of health care, and health status. Pediatrics 2000;711­8. Holt PG, Rudin A, Macaubas C, Holt BJ, Rowe J, Loh R, Sly PD. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria­tetanus­pertussis vaccine in atopic versus nonatopic children. J Allergy Clin Immunol 2000 Jun;105(6 Pt 1):1117­22. Homer MJ, Aguilar­Delfin I, Telford SR 3rd, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev 2000 Jul;13(3):451­69. Horne, A. D., Lachenbruch, P. A., and Goldenthal, K. L. Intent­to­treat analysis and preventive vaccine efficacy. Vaccine 2000 Sep 15;19(2­3):319­26 Horsburgh CR Jr. A large, simple trial of a tuberculosis vaccine. Clin Infect Dis 2000 Jun;30 Suppl 3:S213­6. Houston S. From Livingstone to ecotourism. What's new in travel medicine? Can.Fam.Physician 2000;121­8. Hueston WJ, Mainous AG, III, Brauer N. Predicting cost­benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections. J.Community Health 2000;23­33. Hull BP, McIntyre PB. A re­evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register. Commun Dis Intell 2000 Jun;24(6):161­4. Hurwitz EL, Morgenstern H. Effects of diphtheria­tetanus­pertussis or tetanus vaccination on allergies and allergy­related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther 2000; 23(2):81­90. Hurwitz EL, Morgenstern H. Effects of diphtheria­tetanus­pertussis or tetanus vaccination on allergies and allergy­related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther 2000 Feb;23(2):81­90. Hurwitz, E. S., Haber, M., Chang, A., Shope, T., Teo, S., Ginsberg, M., Waecker, N., and Cox, N. J. Effectiveness of influenza vaccination of day care children in reducing influenza­related morbidity among household contacts. JAMA 2000 Oct 4;284(13):1677­82 Hutchins SS, Sherrod J, Bernier R. Assessing immunization coverage in private practice. J Natl Med Assoc 2000 Apr;92(4):163­8. Iizuka, M.; Itou, H.; Chiba, M., et al. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161. Antigens, Viral/ Analysis/ Immunology/ Autistic Disorder/ Etiology/ Bias (Epidemiology)/ Ikewaki J, Nishizono A, Goto T, Fujioka T, Mifune K. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long­term Helicobacter pylori infection. Microbiol Immunol 2000; 44(1):29­39. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes: American Diabetes Association. Diabetes Care 2000 Jan;23(1):109­11. Immunization of college students against meningococcal disease. Med Lett Drugs Ther 2000 Aug 7;42(1084):69. Immunization of college students against meningococcal disease. Med Lett Drugs Ther 2000 Aug 7;42(1084):69. Impicciatore P, Bosetti C, Schiavio S, Pandolfini C, Bonati M. Mothers as active partners in the prevention of childhood diseases: maternal factors related to immunization status of preschool children in Italy. Prev Med 2000 Jul;31(1):49­55. Innes A, Beresford E, Bedford J. Influenza vaccination in asthma: a primary care experience. Br J Gen Pract 2000; 50(450):27­30. Irons, B., Lewis, M. J., Dahl­Regis, M., Castillo­Solorzano, C., Carrasco, P. A., and de Quadros, C. A. Strategies to eradicate rubella in the English­speaking Caribbean. Am J Public Health 2000 Oct;90(10):1545­9 Islam SM, El­Sheikh HF, Tabbara KF. Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases. Acta Ophthalmol Scand 2000 Oct;78(5):590­2. Islek I, Cengiz K, Cakir M, Kucukoduk S. Nephrotic syndrome following hepatitis B vaccination [letter]. Pediatr.Nephrol. 2000;89­90. Islek I, Cengiz K, Cakir M, Kucukoduk S. Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol. 2000 Jan;14(1):89­90. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N.Engl.J.Med. 2000;232­9. Jacobs RJ, Grover SF, Meyerhoff AS, Paivana TA. Cost effectiveness of vaccinating food service workers against hepatitis A infection. J Food Prot 2000 Jun;63(6):768­74. Jacobs RJ, Margolis HS, Coleman PJ. The cost­effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates. Arch Pediatr Adolesc Med 2000 Aug;154(8):763­70. Jacobs, R. J. and Koff, R. S. Cost­effectiveness of hepatitis A vaccination in patients with chronic hepatitis C [letter]. Hepatology 2000 Oct;32(4 Pt 1):873­4; discussion 874­5 Jenson HB. Nonresponders to hepatitis B vaccine. Postgrad Med 2000; 107(3):97­98. Jiles, R. B., Fuchs, C., and Klevens, R. M. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school. Mor Mortal Wkly Rep CDC Surveill Summ 2000 Sep 22;49(9):27­38 Jodar, L., Cartwright, K., and Feavers, I. M. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines. Biologicals 2000 Sep;28(3):193­7 Jogiste A, Ching P, Trei T, Kreysler J. Diphtheria in Estonia, 1991­1996. J Infect Dis 2000; 181 Suppl 1:S65­S68. John TJ. The final stages of the global eradication of polio [comment] [editorial]. N Engl J Med 2000 Sep 14;343(11):806­7. Juma, A., Evans, M. F., and Bloom, J. Influenza immunizations in the elderly: a continuous quality improvement project. Methods Inf Med 2000 Aug;39(3):217­22 Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis 2000; 181 Suppl 1:S110­S115. Kahn, J. S. Respiratory syncytial virus vaccine development. Curr Opin Pediatr 2000 Jun;12(3):257­62 Kallinowski, B., Knoll, A., Lindner, E., Sanger, R., Stremmel, W., Vollmar, J., Zieger, B., and Jilg, W. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course? Vaccine 2000 Aug 15;19(1):16­22 Kaly­Ibala R, Mabiala­Babela JR, Senga P. Post­vaccination encephalopathy. Arch Pediatr. 2000 Feb;7(2):216­7. Kane B. HIV vaccines: inch by inch. Ann Intern Med 2000 Sep 19;133(6):489. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM. Illnesses among United States veterans of the Gulf War: a population­based survey of 30,000 veterans. J Occup Environ Med 2000 May;42(5):491­501. Kanra G, Yalcin SS, Ceyhan M, Yurdakok K. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2­month­
old children. Turk J Pediatr 2000 Apr­2000 Jun 30;42(2):105­8. Kato Y, Horikawa Y, Nishimura Y, Shimoda H, Shigeto E, Ueda K. Sternal tuberculosis in a 9­month­old infant after BCG vaccination. Acta Paediatr 2000 Dec;89(12):1495­7. Kaufman, Z., Cohen­Manheim, I., and Green, M. S. Compliance with influenza vaccination in Israel in two successive winters, 1998/1999 and 1999/2000 Isr.Med.Assoc.J. 2000, 2 (10): 742­745. Kaur H, Mani A. Seroprotection following Enivac­HB, a recombinant hepatitis B vaccine [letter]. Indian J.Gastroenterol. 2000;41. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 2000; 45(4):723­729. Kazancioglu R, Sever MS, Yuksel­Onel D, Eraksoy H, Yildiz A, Celik AV, Kayacan SM, Badur S. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin.Transplant. 2000;61­5. Kembabanova G, Askarova J, Ivanova R, Deshevoi S, Vitek C, McNabb SJ. Epidemic investigation of diphtheria, Republic of Kazakhstan, 1990­1996. J Infect Dis 2000; 181 Suppl 1:S94­S97. Kendal, A. P., Neville, L. J., and Manning, C. C. Optimal immunization practices for the special supplemental nutrition program for women, infants, and children [letter]. Am J Public Health 2000 Oct;90(10):1640­1 Khakoo GA, Lack G. Guidelines for measles vaccination in egg­allergic children. Clin.Exp.Allergy 2000;288­93. Khakoo GA, Lack G. Recommendations for using MMR vaccine in children allergic to eggs. BMJ 2000; 320(7239):929­932. Khetsuriani N, Imnadze P, Dekanosidze N. Diphtheria epidemic in the Republic of Georgia, 1993­1997. J Infect Dis 2000; 181 Suppl 1:S80­S85. Khetsuriani N, Music S, Deforest A, Sutter RW. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis 2000; 181 Suppl 1:S208­S212. Kielstein JT, Termuhlen L, Sohn J, Kliem V. Minimal change nephrotic syndrome in a 65­year­old patient following influenza vaccination. Clin Nephrol. 2000 Sep;54(3):246­8. Klein DL. From pertussis to tuberculosis: what can be learned? Clin Infect Dis 2000 Jun;30 Suppl 3:S302­8. Kobel DE, Friedl A, Cerny T, Muhlemann K, Cerny A. Pneumococcal vaccine in patients with absent or dysfunctional spleen. Mayo Clin Proc 2000 Jul;75(7):749­53. Kodihalli S, Kobasa DL, Webster RG. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 2000 May 22;18(23):2592­9. Kohl S, Charlebois ED, Sigouroudinia M, Goldbeck C, Hartog K, Sekulovich RE, Langenberg AG, Burke RL. Limited antibody­dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. J.Infect.Dis. 2000;335­9. Kohlstadt I. Lyme disease vaccine [letter]. JAMA 2000;200. Kolasa MS, Desai SN, Bisgard KM, Dibling K, Prevots DR. Impact of the sequential poliovirus immunization schedule: a demonstration project. Am.J.Prev.Med. 2000;140­5. Kollaritsch H, Cryz SJ Jr, Lang AB, Herzog C, Que JU, Wiedermann G. Local and systemic immune responses to combined vibrio cholerae CVD103­HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization. Vaccine 2000 Jul 1;18(26):3031­9. Korkeila M, Lehtonen H, Ahman H, Leroy O, Eskola J, Kayhty H. Salivary anti­capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine 2000;1218­26. Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch Fam Med 2000 Jul;9(7):617­ Krause I, Blank M, Shoenfeld Y. The induction of experimental vascular diseases by immunization with pathogenic autoantibodies. Clin Exp Rheumatol. 2000 Mar­Apr;18(2):257­61. Krieg AM. CpG oligonucleotides as immune adjuvants. Ernst Schering Res Found Workshop 2000;(30):105­18. Krieger JW, Castorina JS, Walls ML, Weaver MR, Ciske S. Increasing influenza and pneumococcal immunization rates: a randomized controlled study of a senior center­based intervention. Am.J.Prev.Med. 2000;123­31. Kroger L, Korppi M, Pelkonen J, Pietikainen M, Katila ML. Development of tuberculin reactivity and sensitization to M. scrofulaceum and M. fortuitum in children BCG­vaccinated at birth. Eur Respir J 2000; 15(2):382­387. Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R. Antibody response after influenza vaccination in HIV­infected individuals: a consecutive 3­year study. Vaccine 2000 Jul 1;18(26):3040­9. Kuehnert MJ, Cardo DM. Infections Associated with Health­care Personnel: Vaccine­preventable Diseases and Bloodborne Pathogens. Curr Infect Dis Rep 2000 Dec;2(6):475­83 Kumagai T, Ozaki T, Kamada M, Igarashi C, Yuri K, Furukawa H, Wagatuma K, Chiba S, Sato M, Kojima H, Saito A, Okui T, Yano S. Gelatin­containing diphtheria­tetanus­pertussis (DTP) vaccine causes sensitization to gelatin in the recipients. Vaccine 2000;1555­61. Kumar G, Anand K, Kant S, Kapoor SK. Scale for identification of "at risk" families for underfive deaths. Indian J Pediatr 2000 Jun;67(6):411­7. Kuppermann M, Nease RF, Jr., Ackerson LM, Black SB, Shinefield HR, Lieu TA. Parents' preferences for outcomes associated with childhood vaccinations. Pediatr.Infect.Dis.J. 2000;129­33. Kurane I, Takasaki T. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Vaccine 2000 May 26;18 Suppl 2:33­5. Kutukculer N, Akil T, Egemen A, Kurugol Z, Aksit S, Ozmen D, Turgan N, Bayindir O, Caglayan S. Adequate immune response to tetanus toxoid and failure of vitamin A and E supplementation to enhance antibody response in healthy children. Vaccine 2000 Jul 1;18(26):2979­84. Laan MP, Baert MR, Bijl AM, Vredendaal AE, De Waard­van der Spek FB, Oranje AP, Savelkoul HF, Neijens HJ. Markers for early sensitization and inflammation in relation to clinical manifestations of atopic disease up to 2 years of age in 133 high­risk children. Clin Exp Allergy 2000 Jul;30(7):944­53. Lagrange, P. H. [Vaccinations. Immunological and microbiological bases, indications, contra­indications, adverse effects, efficacy (schedule and mandatory character of excluded vaccinations] Rev.Prat. 12­15­2000, 50 (20): 2275­2283. Laheru DA, Jaffee EM. Potential role of tumor vaccines in GI malignancies. Oncology (Huntingt) 2000; 14(2):245­256. Lai JC, Hamid PN, Cheng ST. Health beliefs and optimism as predictors of preventive health decisions in Hong Kong Chinese. Psychol Rep 2000 Jun;86(3 Pt 2):1059­70. Lakhiani, C. N., Vivier, P. M., Alario, A. J., Simon, P., Diana, B. J., and Peter, G. Analysis of the transition from oral polio vaccine to inactivated polio vaccine for primary immunization in a hospital­based primary care practice. Pediatr Infect Dis J 2000 Jun;19(6):575­6 Lakshman R, Finn A. MMR vaccine and allergy. Arch.Dis.Child 2000;93­5. Lamm DL. Preventing progression and improving survival with BCG maintenance. Eur Urol 2000; 37 Suppl 1:9­15. Langridge, W. H. Edible vaccines. Sci Am 2000 Sep;283(3):66­71 Larsen CE, Xu J, Lee S, Dubey DP, Uko G, Yunis EJ, Alper CA. Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen. Vaccine 2000 Jul 1;18(26):3021­30. Laskey AL, Johnson TR, Dagartzikas MI, Tobias JD. Endocarditis attributable to group A beta­hemolytic streptococcus after uncomplicated varicella in a vaccinated child. Pediatrics 2000 Sep;106(3):E40. Law B, Scheifele D, MacDonald N, Halperin S, Dery P, Jadavji T, Lebel M, Mills E, Morris R, Vaudry W, et al. The Immunization Monitoring Program­
active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991­1996. Can Commun Dis Rep 2000 Aug 1;26(15):125­31. Lawson, F., Baker, V., Au, D., and McElhaney, J. E. Standing orders for influenza vaccination increased vaccination rates in inpatient settings compared with community rates. J Gerontol A Biol Sci Med Sci 2000 Sep;55(9):M522­6 Leask, J. A.; Chapman, S.; Hawe, P. Concerns about immunisation. Facts are not enough [letter]. BMJ 2000 Jul 8;321(7253):109. LeBaron CW, Massoudi M, Stevenson J, Dang H, Lyons B. The status of immunization measurement and feedback in the United States. Arch Pediatr Adolesc Med 2000 Aug;154(8):832­6. Lee AC, Li DH, Kemper KJ. Chiropractic care for children. Arch Pediatr Adolesc Med 2000; 154(4):401­407. Lee N, Ahn B, Jung SB, Kim YG, Kim H, Park WJ. Conformation­dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans. FEMS Immunol.Med.Microbiol. 2000;79­85. Leef M, Elkins KL, Barbic J, Shahin RD. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med 2000 Jun 5;191(11):1841­52. Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health 2000 May­2000 Jun 30;91(3):168­70. Leitch HA, Palepu A, Fernandes CM. Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high. Can Fam Physician 2000 Jul;46:1460­6. Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM. Incidence, risk factors and outcome of varicella­zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant. 2000;167­72. Levine MJ, Ellison MC, Zerbe GO, Barber D, Chan C, Stinson D, Jones M, Hayward AR. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella­specific immune response in seropositive people 55 years of age and older. Vaccine 2000 Jun 15;18(25):2915­20. Lewis LS, Hardy I, Strebel P, Tyshchenko DK, Sevalnyev A, Kozlova I. Assessment of vaccination coverage among adults 30­49 years of age following a mass diphtheria vaccination campaign: Ukraine, April 1995. J Infect Dis 2000; 181 Suppl 1:S232­S236. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann.Intern.Med. 2000;296­305. Liccardi, G.; Szepfalusi, Z.; Noschese, P., et al. The significance of chicken meat allergy without sensitization to egg proteins [letter]. Ann Allergy Asthma Immunol 2000 Jul;85(1):84. Licciardone JC, Herron KM, Marshall MA, Woodworth RM. Factors associated with the vaccination of international travelers: a multivariate analysis. J Am Osteopath Assoc 2000 Jul;100(7):423­4, 427­31. Lietman T, Blower SM. Potential impact of tuberculosis vaccines as epidemic control agents. Clin Infect Dis 2000 Jun;30 Suppl 3:S316­22. Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF et al. Projected cost­effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000; 283(11):1460­1468. Lieu, T. A., Black, S. B., Ray, G. T., Martin, K. E., Shinefield, H. R., and Weniger, B. G. The hidden costs of infant vaccination. Vaccine 2000 Aug 15;19(1):33­41 Lifson, A. R., Roddy, M., and Ehresmann, K. R. The association of poverty and low immunization rates in ZIP code areas. A retrospective survey of Minnesota kindergartners. Minn Med 2000 Aug;83(8):51­5 Limcangco MR, Salole EG, Armour CL. Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996. Pediatr.Infect.Dis.J. 2000;7­11. Lina, B., Fletcher, M. A., Valette, M., Saliou, P., and Aymard, M. A TritonX­100­split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly. Biologicals 2000 Jun;28(2):95­103 Lindenburg K, Langendam MW, Veenstra J, Miedema F, Coutinho R. Long­term effects of therapeutic vaccination with rgp 120 [letter]. AIDS 2000; 14(2):203­204. Linnemann T, Wiesmuller KH, Gellrich S, Kaltoft K, Sterry W, Walden P. A T­cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T­cell lymphoma. Ann Oncol 2000; 11 Suppl 1:95­99. Liozon E, Ittig R, Vogt N, Michel JP, Gold G. Polymyalgia rheumatica following influenza vaccination. J Am Geriatr Soc. 2000 Nov;48(11):1533­4. Liu MA, Ulmer JB. Gene­based vaccines. Mol Ther 2000 Jun;1(6):497­500. Ljungberg K, Wahren B, Almqvist J, Hinkula J, Linde A, Winberg G. Effective construction of DNA vaccines against variable influenza genes by homologous recombination. Virology 2000; 268(2):244­250. Loche F, Schwarze HP, Thedenat B, Carriere M, Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000 Mar;25(2):167­8. Lodha R, Dash NR, Kapil A, Kabra SK. Diphtheria in urban slums in north India [letter]. Lancet 2000;204. Lok AS. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32(1 Suppl):89­97. Lonergan, G. and Rivest, P. What is a safe vaccine? [letter]. Vaccine 2000 Aug 15;19(1):1 Lutwick LI, Abramson JM. Pediatric immunization for the future. Lyme disease vaccine and beyond. Pediatr Clin North Am 2000; 47(2):465­79, viii. Lutwick LI, Rubin LG. Childhood immunizations 2000. Introduction. Pediatr Clin North Am 2000; 47(2):xi­xiv. Lutwick SM. Pediatric vaccine compliance. Pediatr Clin North Am 2000; 47(2):427­434. MacDonald NE, Halperin SA, Law BJ, Danzig LE, Granoff DM. Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? [letter]. JAMA 2000; 283(14):1826­1827. Macedo G, Maia JC, Gomes A, Teixeira A, Ribeiro T. Efficacy of a reinforced protocol of HBV vaccination in cirrhotic patients waiting for orthotopic liver transplantation. Transplant Proc 2000 Dec;32(8):2641 Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000 Jul;61(3):362­6. Magdei M, Melnic A, Benes O, Bukova V, Chicu V, Sohotski V et al. Epidemiology and control of diphtheria in the Republic of Moldova, 1946­1996. J Infect Dis 2000; 181 Suppl 1:S47­S54. Maillefert JF, Tavernier C, Sibilia J, Vignon E. Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senecal et al [letter]. Arthritis Rheum. 2000;468­9. Makela PH. Vaccines, coming of age after 200 years. FEMS Microbiol.Rev. 2000;9­20. Malay S, Tizer K, Lutwick LI. Current update of pediatric hepatitis vaccine use. Pediatr Clin North Am 2000; 47(2):395­406, vii. Malhotra A, Krilov LR. Influenza and respiratory syncytial virus. Update on infection, management, and prevention. Pediatr Clin North Am 2000; 47(2):353­
vii. Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schodel F, Mendelman P, Hessel L, Chryssomalis G, Vidor E, et al. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Hexavalent Vaccine Trial Study Group. Pediatr Infect Dis J 2000 Dec;19(12):1119­27 Malmstrom P. Improved patient outcomes with BCG immunotherapy vs. chemotherapy ­ Swedish and worldwide experience. Eur Urol 2000; 37 Suppl 1:16­
20. Manzano E, Grau A, Sequeira E, Valles JA. Possible toxicoderma secondary to influenza vaccination. Aten Primaria. 2000 Oct 15;26(6):429. Maple, P. A., Jones, C. S., Wall, E. C., Vyseb, A., Edmunds, W. J., Andrews, N. J., and Miller, E. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2000 Sep 15;19(2­3):167­73 Margolis HS, Handsfield HH, Jacobs RJ, Gangi JE. Evaluation of office­based intervention to improve prevention counseling for patients at risk for sexually acquired hepatitis B virus infection. Hepatitis B­WARE Study Group. Am.J.Obstet.Gynecol. 2000;1­6. Markina SS, Maksimova NM, Vitek CR, Bogatyreva EY, Monisov AA. Diphtheria in the Russian Federation in the 1990s. J Infect Dis 2000; 181 Suppl 1:S27­S34. Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine 2000 May 26;18 Suppl 2:26­32. Marques AR, Straus SE. Herpes simplex type 2 infections­­an update. Adv.Intern.Med. 2000;175­208. Marshall E. Bioterrorism. DOD retreats on plan for anthrax vaccine [news]. Science 2000 Jul 21;289(5478):382­3. Martin G, Lazarus A. Epidemiology and diagnosis of tuberculosis. Recognition of at­risk patients is key to prompt detection. Postgrad Med 2000 Aug;108(2):42­4, 47­50, 53­4. Martin J, Dunn G, Hull R, Patel V, Minor PD. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637­day period of virus excretion. J Virol 2000; 74(7):3001­3010. Martin J, Ferguson GL, Wood DJ, Minor PD. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in poland. Virology 2000 Dec 5;278(1):42­9 Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, Salvaneschi L, Rondini G, Avanzini MA, Cuccia M. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000 Dec;97(3):234­40 Martinez, F., Sanchez, C., Gonzalez, L., Galmes, A., Pachon, I., Pelayo, T., and Pons, C. Two Outbreaks of Mumps in Children Vaccinated With the Rubini Strain in Spain Indicate Low Vaccine Efficacy. Euro.Surveill 2000, 5 (7): 80­84. Marwick C. Calling the shots: IOM report calls for immunization revisions. Institute of Medicine [news]. JAMA 2000 Aug 9;284(6):683­4. Marwick C. Clearing the way for new combination vaccine use [news]. JAMA 2000;1280­1. Marwick C. FDA calls bovine­based vaccines currently safe [news]. JAMA 2000 Sep 13;284(10):1231­2. Marwick C. Merits, flaws of live virus flu vaccine debated [news]. JAMA 2000; 283(14):1814­1815. Mason BW, Donnelly PD. Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial. Commun Dis Public Health 2000; 3(1):67­68. Mastrangelo, G., Rossi, C. R., Pfahlberg, A., Marzia, V., Barba, A., Baldo, M., Fadda, E., Milan, G., and Kolmel, K. F. Is there a relationship between influenza vaccinations and risk of melanoma? A population­based case­control study Eur.J.Epidemiol. 2000, 16 (9): 777­782. Mathe, G. Influenza and its vaccination in HIV1­AIDS patients [editorial] Biomed Pharmacother 2000 May;54(4):175­7 Matheson AJ, Goa KL. Diphtheria­tetanus­acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3­CB): a review of its use in the prevention of Bordetella pertussis infection. Paediatr Drugs 2000 Mar­2000 Apr 30;2(2):139­59. Mathew A, Ennis FA, Rothman AL. Transient decreases in human T cell proliferative responses following vaccinia immunization. Clin Immunol 2000 Aug;96(2):100­7. Matsunga T, Akimoto K. Vaccines not containing human albumin and vaccines to avoid the risk of Creutzfeldt­Jakob disease [letter]. Eur J Pediatr 2000; 159(3):222. Matter HC, Wandeler AI, Neuenschwander BE, Harischandra LP, Meslin FX. Study of the dog population and the rabies control activities in the Mirigama area of Sri Lanka. Acta Trop 2000; 75(1):95­108. Maxim, R. Controversies in adult immunization. Med Health R I 2000 Aug;83(8):255­6 May R. Perspectives: epidemiology. Simple rules with complex dynamics [comment]. Science 2000;601­2. Mayans, M. V., Robertson, S. E., and Duclos, P. Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry. Bull World Health Organ 2000;78(9):1167 Mazon A, Nieto A, Linana JJ, Montoro J, Estornell F, Garcia­Ibarra F. Latex sensitization in children with spina bifida: follow­up comparative study after two years. Ann Allergy Asthma Immunol 2000; 84(2):207­210. Mazzuchi JF, Claypool RG, Hyams KC, Trump D, Riddle J, Patterson RE et al. Protecting the health of U.S. military forces: a national obligation. Aviat Space Environ Med 2000; 71(3):260­265. McCarthy, M. Conflict of interest taints vaccine approval process, charges US report [news] Lancet 2000 Sep 2;356(9232):838 McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 2000; 181(2):757­760. McCulley JP, Alizadeh H, Niederkorn JY. The diagnosis and management of Acanthamoeba keratitis. CLAO J. 2000;47­51. McIntosh K, Lieu T. Is it time to give influenza vaccine to healthy infants? [editorial; comment]. N.Engl.J.Med. 2000;275­6. McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, Turnbull F, Burgess M. Vaccine preventable diseases and vaccination coverage in Australia, 1993­1998. Commun Dis Intell. 2000 Jun;Suppl:v­83. McIntyre PB, Gidding HF, Gilbert GL. Measles in an era of measles control [editorial; comment]. Med J Aust 2000; 172(3):103­104. McIntyre, P. B., Burgess, M. A., and Lester, R. Immunisation in the age of the human genome [editorial] Aust N Z J Public Health 2000 Aug;24(4):351­2 McIntyre, P., Amin, J., Gidding, H., Hull, B., Torvaldsen, S., Tucker, A., Turnbull, F., and Burgess, M. Vaccine Preventable Diseases and Vaccination Coverage in Australia, 1993­1998 Commun.Dis.Intell. 2000, Suppl:v­83. (): v­83. McMillan CS, Spouge AR, Hammerberg O, Thain LM. Magnetic resonance imaging for differentiating delayed­onset sterile abscess complicating vaccination from soft­tissue neoplasm: case report. Can Assoc Radiol J 2000; 51(1):28­29. Means­Markwell M, O'Neil KM. Prevention of tuberculosis. Vigilance and infection control strategies are mainstays of efforts. Postgrad Med 2000 Aug;108(2):87­90, 93­6. Measles­­United States, 1999. MMWR Morb Mortal Wkly Rep 2000 Jun 30;49(25):557­60. Mehta N, Levin M. Management and prevention of meningococcal disease. Hosp Pract 2000 Aug 15;35(8):75­6, 79­82, 85­6. Melman ST, Ehrlich ES, Klugman D, Anbar RD. Compliance with initiation of a sequential schedule for polio immunization. Clin.Pediatr.(Phila) 2000;51­3. Meral A, Sevinir B, Gunay U. Efficacy of immunization against hepatitis B virus infection in children with cancer. Med Pediatr Oncol 2000 Jul;35(1):47­51. Meyer, P. A., Seward, J. F., Jumaan, A. O., and Wharton, M. Varicella mortality: trends before vaccine licensure in the United States, 1970­1994. J Infect Dis 2000 Aug;182(2):383­90 Michaeli, D. Influenza vaccination Isr.Med.Assoc.J. 2000, 2 (12): 914­915. Michielsen PP, Van Damme P. Hepatitis vaccination in patients with chronic liver diseases. Acta Gastroenterol Belg 2000 Jan­2000 Mar 31;63(1):1­4. Mignogna MD, Muzio LL, Ruocco E. Pemphigus induction by influenza vaccination. Int J Dermatol. 2000 Oct; 39(10):800. Mikula, C. Measles vaccination a risk factor for inflammatory bowel disease? Gastroenterol.Nurs. 2000, 23 (4): 168­171. Millar JS, McCauley D, Mitchell L, Winston T, Hays C. Immunization rate comparison for Oklahoma Medicaid managed care population by age two: 1995­
1998. J.Okla.State Med.Assoc. 2000;20­4. Millar, E. V., O'Brien, K. L., Levine, O. S., Kvamme, S., Reid, R., and Santosham, M. Toward elimination of Haemophilus influenzae type B carriage and disease among high­risk American Indian children. Am J Public Health 2000 Oct;90(10):1550­4 Miller KE, Graves JC. Update on the prevention and treatment of sexually transmitted diseases. Am.Fam.Physician 2000;379­86. Miller KE, Zylstra RG, Standridge JB. The geriatric patient: a systematic approach to maintaining health [see comments]. Am.Fam.Physician 2000;1089­104. Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b­, Streptococcus pneumoniae­conjugate and rotavirus vaccines in national immunization schedules. Health Econ 2000; 9(1):19­35. Miller MA. Introducing a novel model to estimate national and global measles disease burden. Int.J.Infect.Dis. 2000;14­20. Miller PL, Frawley SJ, Sayward FG. IMM/Scrub: a domain­specific tool for the deduplication of vaccination history records in childhood immunization registries. Comput Biomed Res 2000 Apr;33(2):126­43. Milne LM. Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood. Vaccine 2000 Dec 8;19(9­
10):1018­25 Minor PD. Eradication of polio by vaccination. Virology 2000; 268(2):231­232. Minutello, M., Zotti, C., Orecchia, S., Di Martino, E., Bastianoni, I., Ypma, E., Ruggenini Moiraghi, A., and Podda, A. Dose range evaluation of a new inactivated hepatitis A vaccine administered as a single dose followed by a booster. Vaccine 2000 Aug 15;19(1):10­5 Mitchell LA, Tingle AJ, Grace M, Middleton P, Chalmers AC. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations. J Rheumatol 2000; 27(2):418­423. Mitchell, E. A. SIDS: facts and controversies [editorial] Med J Aust 2000 Aug 21;173(4):175­6 Mlot C. Public health. Bat researchers dispute rabies policy [news]. Science 2000; 287(5462):2391­2392. Mohammed, I., Nasidi, A., Alkali, A. S., Garbati, M. A., Ajayi­Obe, E. K., Audu, K. A., Usman, A., and Abdullahi, S. A severe epidemic of meningococcal meningitis in Nigeria, 1996. Trans R Soc Trop Med Hyg 2000 May­Jun;94(3):265­70 Montalto NJ, Gum KD, Ashley JV. Updated treatment for influenza A and B. Am Fam Physician 2000 Dec 1;62(11):2467­76 Monto, A. S. Preventing influenza in healthy adults: the evolving story [comment] [editorial] JAMA 2000 Oct 4;284(13):1699­701 Moraga Llop, F. A. and Campins, Marti M. [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?] An Esp.Pediatr. 2000, 53 (4): 299­304. Moran GJ, Talan DA, Mower W, Newdow M, Ong S, Nakase JY, Pinner RW, Childs JE. Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group. JAMA 2000 Aug 23­2000 Aug 30;284(8):1001­7. Moreton, J. Childhood vaccination programmes: what's new? Community Nurse 2000 Oct;6(9):47­9 Morrell, P. Concerns about immunisation. Is vaccination cause celebe or bete noir? [letter]. BMJ 2000 Jul 8;321(7253):108­9; discussion 109. Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 2000 Dec;95(12):3507­12 Morrow AL, Crews RC, Carretta HJ, Altaye M, Finch AB, Sinn JS. Effect of method of defining the active patient population on measured immunization rates in predominantly Medicaid and non­Medicaid practices. Pediatrics 2000 Jul;106(1 Pt 2):171­6. Mosier DE. Human xenograft models for virus infection. Virology 2000 Jun 5;271(2):215­9. Moulton, L. H., Chung, S., Croll, J., Reid, R., Weatherholtz, R. C., and Santosham, M. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol 2000 Aug;29(4):753­6 Mulholland K. Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials. Clin Infect Dis 2000 Jun;30 Suppl 3:S206­9. Munoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am 2000; 47(2):449­463. Munoz FM, Galasso GJ, Gwaltney JM Jr, Hayden FG, Murphy B, Webster R, Wright P, Couch RB. Current research on influenza and other respiratory viruses: II international symposium. Antiviral Res 2000 May;46(2):91­124. Murphy LA, Buckley C. Gianotti­Crosti syndrome in an infant following immunization. Pediatr Dermatol 2000 May­2000 Jun 30;17(3):225­6. Murphy LA, Buckley C. Gianotti­Crosti syndrome in an infant following immunization. Pediatr Dermatol 2000 May­Jun;17(3):225­6. Murphy, E. Hepatitis B, vaccination and healthcare workers. Occup Med (Lond) 2000 Aug;50(6):383­6 Murray KO, Arguin PM. Decision­based evaluation of recommendations for preexposure rabies vaccination. J.Am.Vet.Med.Assoc. 2000;188­91. Murray M, Rasmussen Z. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness. Am J Epidemiol 2000 Apr 15;151(8):811­
9. Myers RP, Gregor JC, Marotta PJ. The cost­effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 2000; 31(4):834­839. Nabors GS, Braun PA, Herrmann DJ, Heise ML, Pyle DJ, Gravenstein S et al. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross­reactive antibodies to heterologous PspA molecules. Vaccine 2000; 18(17):1743­1754. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation (Online) 2000 Dec 19;102(25):3039­45 Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB. Evasion of host defenses by measles virus: wild­type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol 2000 Aug;74(16):7478­84. Nasir L. Reconnoitering the antivaccination web sites: news from the front. J Fam Pract 2000 Aug;49(8):731­3. Nasir, K., Khan, K. A., Kadri, W. M., Salim, S., Tufail, K., Sheikh, H. Z., and Ali, S. A. Hepatitis B vaccination among health care workers and students of a medical college. JPMA J Pak Med Assoc 2000 Jul;50(7):239­43 Nasr JT, Andriola MR, Coyle PK. ADEM: literature review and case report of acute psychosis presentation. Pediatr Neurol 2000 Jan;22(1):8­18. Nassif X. Microbiology. A furtive pathogen revealed [comment]. Science 2000; 287(5459):1767­1768. National, state, and urban area vaccination coverage levels among children aged 19­35 months­­United States, 1999. MMWR Morb Mortal Wkly Rep 2000 Jul 7;49(26):585­9. Nekrassova LS, Chudnaya LM, Marievski VF, Oksiuk VG, Gladkaya E, Bortnitska II et al. Epidemic diphtheria in Ukraine, 1991­1997. J Infect Dis 2000; 181 Suppl 1:S35­S40. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children [see comments]. N.Engl.J.Med. 2000;225­31. Nicholson KG. Should staff in long­stay hospitals for elderly patients be vaccinated against influenza? [comment]. Lancet 2000;83­4. Nicolay, U., Girgsdies, O. E., Banzhoff, A., Hundt, E., Kondler­Budde, R., Lober, R., Hainz, R., and Jilg, W. [Diphtheria antitoxin level 2 years after booster vaccination] Wien.Med.Wochenschr. 2000, 150 (22): 435­439. Nielsen C. Coping with vaccine manufacturing delays. Cleve Clin J Med 2000 Dec;67(12):898­900, 902 Niyazmatov BI, Shefer A, Grabowsky M, Vitek CR. Diphtheria epidemic in the Republic of Uzbekistan, 1993­1996. J Infect Dis 2000; 181 Suppl 1:S104­
S109. Nolan P. Primary care: the backbone of prevention. Med.Health R.I. 2000;7­8. Nordstrand A, Barbour AG, Bergstrom S. Borrelia pathogenesis research in the post­genomic and post­vaccine era. Curr Opin Microbiol 2000; 3(1):86­92. Nossal GJ. Vaccination and autoimmunity. J.Autoimmun. 2000;13­5. Obaro SK. Prospects for pneumococcal vaccination in African children. Acta Trop 2000; 75(2):141­153. Offit, P. Maintaining the public's trust in immunizations. Del Med J 2000 Aug;72(8):361­5 Ohgaki H, Huang H, Haltia M, Vainio H, Kleihues P. More about: cell and molecular biology of simian virus 40: implications for human infections and disease [letter]. J Natl Cancer Inst 2000; 92(6):495­497. Ohsaki M, Tsutsumi H, Takeuchi R, Seki K, Chiba S. Recent increase in the frequency of infant measles in Japan. Pediatr Int 2000 Jun;42(3):233­5. Olin P. Direct and indirect protection from Hib disease: may immunization of a target group lead to eradication of the disease in a population? [comment]. Acta Paediatr 2000 Apr;89(4):394­7. Olowokure, B., Hawker, J., Blair, I., and Spencer, N. Decrease in effectiveness of routine surveillance of Haemophilus influenzae disease after introduction of conjugate vaccine: comparison of routine reporting with active surveillance system. BMJ 2000 Sep 23;321(7263):731­2 Opare C, Nsiire A, Awumbilla B, Akanmori BD. Human behavioural factors implicated in outbreaks of human anthrax in the Tamale municipality of northern Ghana. Acta Trop 2000 Jul 21;76(1):49­52. Orenstein, W. A., Strebel, P. M., Papania, M., Sutter, R. W., Bellini, W. J., and Cochi, S. L. Measles eradication: is it in our future? Am J Public Health 2000 Oct;90(10):1521­5 Ormerod LP. BCG vaccination by multipuncture method [letter]. Thorax 2000; 55(4):345. Ortega AN, Stewart DC, Dowshen SA, Katz SH. The impact of a pediatric medical home on immunization coverage. Clin.Pediatr.(Phila) 2000;89­96. Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000 Aug;106(2 Pt 1):367­76. Paas­Rozner M, Dayan M, Paas Y, Changeux JP, Wirguin I, Sela M et al. Oral administration of a dual analog of two myasthenogenic T cell epitopes down­
regulates experimental autoimmune myasthenia gravis in mice. Proc Natl Acad Sci U S A 2000; 97(5):2168­2173. Paganini H, Gonzalez F, Santander C, Casimir L, Berberian G, Rosanova MT. Tuberculous meningitis in children: clinical features and outcome in 40 cases. Scand J Infect Dis 2000; 32(1):41­45. Page D, Eason P, Humiston S, Barker W. Notes from the Association of Teachers of Preventive Medicine: vaccine risk/ benefit communication project. Am.J.Prev.Med. 2000;176­7. Page, R. C. Vaccination and Periodontitis: Myth or Reality. J Int.Acad.Periodontol. 2000, 2 (2): 31­43. Pandey P, Cave W, Shlim DR. Hepatitis A post hepatitis A vaccination? J Travel Med. 2000 Jul­Aug;7(4):213­4. Paneth N, Kort EJ, Jurczak D, Havlichek DA Jr, Braunlich K, Moorer G, Vanderjagt D, Sienko D, Leiby P, Gibbons C. Predictors of vaccination rates during a mass meningococcal vaccination program on a college campus. J Am Coll Health 2000 Jul;49(1):7­11. Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, et al. Trends in intussusception­associated hospitalizations and deaths among US infants. Pediatrics 2000 Dec;106(6):1413­21 Pareek, M. and Pattison, H. M. The two­dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate Br.J.Gen.Pract. 2000, 50 (461): 969­971. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles­mumps­rubella vaccination during a fourteen­year prospective follow­up. Pediatr Infect Dis J 2000 Dec;19(12):1127­34 Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB. V and C proteins of measles virus function as virulence factors in vivo. Virology 2000;80­9. Patti AM, Santi AL, Fiore L, Vellucci L, De Stefano D, Bellelli E, Barbuti S, Fara GM; The Study Group. Enterovirus surveillance of Italian healthy children. Eur J Epidemiol 2000;16(11):1035­8. Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G et al. Granulocyte­macrophage colony­stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30(2):342­348. Paul, J. R. The case for live poliovirus vaccination. 1960 [classical article] Yale J.Biol.Med. 2000, 73 (1­6): 159­165. Paunio M, Heinonen OP, Virtanen M, Leinikki P, Patja A, Peltola H. Measles history and atopic diseases: a population­based cross­sectional study [see comments]. JAMA 2000;343­6. Paz JA, Vallada MG, Marques SN, Casella EB, Marques HH, Marques­Dias MJ. Vaccine­associated paralytic poliomyelitis: a case report of domiciliary transmission. Rev Hosp Clin Fac Med Sao Paulo 2000 May­Jun;55(3):101­4. Pearson L. Medical errors hit home [editorial]. Nurse Pract 2000 May;25(5):11­3. Pemberton MN, Sloan P, Thakker NS. Oral lichenoid lesions after hepatitis B vaccination. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 Jun;89(6):717­9. Perez C, Loza E, Tinture T. Giant cell arteritis after influenza vaccination. Arch Intern Med. 2000 Sep 25;160(17):2677. Perez C, Maravi E. Polymyalgia rheumatica following influenza vaccination. Muscle Nerve. 2000 May;23(5):824­5. Peters, T. R. and Edwards, K. M. The pneumococcal protein conjugate vaccines. J Pediatr 2000 Sep;137(3):416­20 Pinching AJ. Live attenuated vaccine trials in medically informed volunteers: a special case? J.Med.Ethics 2000;44­6. Pittman, P. R., Mangiafico, J. A., Rossi, C. A., Cannon, T. L., Gibbs, P. H., Parker, G. W., and Friedlander, A. M. Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans. Vaccine 2000 Sep 15;19(2­3):213­6 Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M et al. Identification of vaccine candidates against serogroup B meningococcus by whole­genome sequencing [see comments]. Science 2000; 287(5459):1816­1820. Plesner A, Ronne T, Wachmann H. Case­control study of allergic reactions to Japanese encephalitis vaccine. Vaccine 2000; 18(17):1830­1836. Plesner AM, Hansen FJ, Taudorf K, Nielsen LH, Larsen CB, Pedersen E. Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: a follow­up study. Acta Paediatr 2000 Jan;89(1):58­63. Poland GA, Jacobson RM. Vaccine safety: injecting a dose of common sense [editorial]. Mayo Clin.Proc. 2000;135­9. Porter RW, Steinglass R, Kaiser J, Olkhovsky P, Rasmuson M, Dzhatdoeva FA et al. Role of health communications in Russia's diphtheria immunization program. J Infect Dis 2000; 181 Suppl 1:S220­S227. Preboth M. ACIP issues recommendations for the 2000­2001 influenza season. Advisory Committee on Immunization Practices. Am Fam Physician 2000 Jul 1;62(1):233­6. Progress toward poliomyelitis eradication­­European region, 1998­June 2000. MMWR Morb Mortal Wkly Rep 2000 Jul 28;49(29):656­60. Progress toward poliomyelitis eradication­­South­East Asia Region, 1998­1999. MMWR Morb Mortal Wkly Rep 2000 Jun 30;49(25):568­72. Pywell, S. Vaccination and Other Altruistic Medical Treatments: Should Autonomy or Communitarianism Prevail? Med.Law Int. 4 (3­4): 223­243; 2000. Quast, U. and Maass, G. [Vaccination record. Patient data series] MMW.Fortschr.Med. 12­7­2000, 142 (49­50): 50­52. Quiambao BP, Lang J, Vital S, Montalban CG, Le M, V, Wood SC et al. Immunogenicity and effectiveness of post­exposure rabies prophylaxis with a new chromatographically purified Vero­cell rabies vaccine (CPRV): a two­stage randomised clinical trial in the Philippines. Acta Trop 2000; 75(1):39­52. Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Nakashidze R, Murvanidze S et al. Risk factors for diphtheria: a prospective case­control study in the Republic of Georgia, 1995­1996. J Infect Dis 2000; 181 Suppl 1:S121­S129. Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Strebel PM, Nakashidze R et al. Epidemic diphtheria in the Republic of Georgia, 1993­1996: risk factors for fatal outcome among hospitalized patients. J Infect Dis 2000; 181 Suppl 1:S130­S137. Raeder CK, Hayney MS. Immunology of Varicella Immunization in the elderly. Ann.Pharmacother. 2000;228­34. Rahman F, Dahmen A, Herzog­Hauff S, Bocher WO, Galle PR, Lohr HF. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000;521­7. Raitio M, Tala E. Tuberculosis among health care workers during three recent decades. Eur Respir J 2000; 15(2):304­307. Rajan E, Shattock AG, Fielding JF. Cost­effective analysis of hepatitis A prevention in Ireland. Am.J.Gastroenterol. 2000;223­6. Ramon, S. and Junquera, C. Ramon y Cajal, microbiologist. Int Microbiol 2000 Mar;3(1):59­61 Ramsay ME, Balogun MA, Teo CG, Mortimer PP. Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis B [letter]. BMJ 2000;512. Rennels MB. The rotavirus vaccine story: a clinical investigator's view. Pediatrics 2000 Jul;106(1 Pt 1):123­5. Resources for teaching and learning prevention. Acad Med 2000 Jul;75(7 Suppl):S95­8. Restifo NP, Ying H, Hwang L, Leitner WW. The promise of nucleic acid vaccines. Gene Ther. 2000;89­92. Richmond P, Kaczmarski E, Borrow R, Findlow J, Clark S, McCann R et al. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis 2000; 181(2):761­764. Riddell SR, Warren EH, Lewinsohn D, Mutimer H, Topp M, Cooper L, de Fries R, Greenberg PD. Application of T cell immunotherapy for human viral and malignant diseases. Ernst Schering Res Found Workshop 2000;(30):53­73. Ridgway D. The logic of causation and the risk of paralytic poliomyelitis for an American child. Epidemiol Infect 2000; 124(1):113­120. Rimmelzwaan GF, Nieuwkoop N, Brandenburg A, Sutter G, Beyer WE, Maher D, Bates J, Osterhaus AD. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 2000 Dec 8;19(9­10):1180­7 Riordan, F. A. Recommendations for using MMR vaccine in children allergic to egg should be consistent [letter]. Arch Dis Child 2000 Sep;83(3):276. Rischmann P, Desgrandchamps F, Malavaud B, Chopin DK. BCG intravesical instillations: recommendations for side­effects management. Eur Urol 2000; 37 Suppl 1:33­36. Robb­Nicholson, C. By the way, doctor. I recently read that this year's flu vaccine is recommended for anyone over the age of 50. Why has the age changed from 65 to 50? Harv Womens Health Watch 2000 Sep;8(1):8 Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82(7):1261­1265. Rodriguez F, Whitton JL. Enhancing DNA immunization. Virology 2000; 268(2):233­238. Roger, J. H. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):160­1. Rohani P, Earn DJ, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales [letter]. Lancet 2000;285­6. Ronne T, Valentelis R, Tarum S, Griskevica A, Wachmann CH, Aggerbeck H et al. Immune response to diphtheria booster vaccine in the Baltic states. J Infect Dis 2000; 181 Suppl 1:S213­S219. Roome, A., Rak, M., and Hadler, J. Follow­up of infants of hepatitis B­infected women after hepatitis B vaccination, Connecticut, 1994 to 1997. Pediatr Infect Dis J 2000 Jun;19(6):573­5 Rose NR. Immunologic hazards associated with vaccination of humans. J.Autoimmun. 2000;11­3. Rosenstein NE, Perkins BA. Update on Haemophilus influenzae serotype b and meningococcal vaccines. Pediatr Clin North Am 2000; 47(2):337­52, vi. Rovner J. Pharmaceutical companies pledge vaccines for developing countries [news]. Lancet 2000; 355(9207):908. Rua EC, Blacarce N, Drut R. Early bacille de Calmette­Guerin vaccination and Crohn's disease: possible relationship? Pediatr Dev Pathol 2000 Sep­2000 Oct 31;3(5):501­3. Rudenko, L. G., Arden, N. H., Grigorieva, E., Naychin, A., Rekstin, A., Klimov, A. I., Donina, S., Desheva, J., Holman, R. C., DeGuzman, A., Cox, N. J., and Katz, J. M. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine 2000 Sep 15;19(2­3):308­18 Rudolph, K. M., Parkinson, A. J., Reasonover, A. L., Bulkow, L. R., Parks, D. J., and Butler, J. C. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991­1998. J Infect Dis 2000 Aug;182(2):490­6 Ryan EJ, Nilsson L, Kjellman N, Gothefors L, Mills KH. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol 2000 Aug;121(2):193­200. Ryu DD, Nam DH. Recent progress in biomolecular engineering. Biotechnol.Prog. 2000;2­16. Saab, S., Martin, P., and Yee, H. F. Jr A simple cost­decision analysis model comparing two strategies for hepatitis A vaccination. Am J Med 2000 Aug 15;109(3):241­4 Sadovnick AD, Scheifele DW. School­based hepatitis B vaccination programme and adolescent multiple sclerosis [letter]. Lancet 2000;549­50. Safety of meningitis vaccine. Commun Dis Rep CDR Wkly 2000 Jun 16;10(24):213, 216. Sagar, S. and Pirofski, L. A. Pneumococcal vaccine with unknown vaccination status. Semin Dial 2000 May­Jun;13(3):207­8 Sakaguchi M, Miyazawa H, Inouye S. Sensitization to gelatin in children with systemic non­immediate­type reactions to varicella vaccines. Ann Allergy Asthma Immunol 2000; 84(3):341­344. Salleras, L., Dominguez, A., Vidal, J., Plans, P., Salleras, M., and Taberner, J. L. Seroepidemiology of varicella­zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 2000 Sep 15;19(2­3):183­8 Salmaso, S., Gabutti, G., Rota, M. C., Giordano, C., Penna, C., Mandolini, D., and Crovari, P. Pattern of susceptibility to measles in Italy. Serological Study Group [see comments] Bull World Health Organ 2000;78(8):950­5 Sanchez­Fructuoso AI, Prats D, Naranjo P, Fernandez­Perez C, Gonzalez MJ, Mariano A, Gonzalez J, Figueredo MA, Martin JM, Paniagua V, Fereres J, Gomez dlC, Barrientos A. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple­drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000;436­9. Santoshkumar A. Transmission of live vaccine viruses from vaccinated persons to others. Indian Pediatr. 2000 Jul;37(7):794­5. Sarangi J, Cartwright K, Stuart J, Brookes S, Morris R, Slack M. Invasive Haemophilus influenzae disease in adults. Epidemiol Infect 2000 Jun;124(3):441­7. Schadendorf D, Belardelli F, Ferrantini M, Parmiani G, Colombo MP. Conference on cancer vaccines. Cancer Immunol Immunother 2000 Jul;49(4­5):281­4. Schafer H, Ewig S. Pneumonia in the elderly­­what makes the difference? Wien Klin Wochenschr 2000 Jul 7;112(13):566­75. Schamhart DH, de Boer EC, de Reijke TM, Kurth K. Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use. Eur Urol 2000;37 Suppl 3:16­23. Scheifele D, Halperin S. Haemophilus influenzae type B disease control using PENTACEL, Canada, 1998­1999. Can Commun Dis Rep 2000 Jun 1;26(11):93­
6. Schijns, V. E. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000 Aug;12(4):456­63 Schmitt, H. J., Knuf, M., Ortiz, E., Sanger, R., Uwamwezi, M. C., and Kaufhold, A. Primary vaccination of infants with diphtheria­tetanus­acellular pertussis­
hepatitis B virus­ inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections [see comments] J Pediatr 2000 Sep;137(3):304­12 Schmutz JL, Posth M, Granel F, Trechot P, Barbaud A. Localized scleroderma after hepatitis B vaccination. Presse Med. 2000 May 27­Jun 3;29(19):1046. Schneeberg NG. Death of a president [letter]. N Engl J Med 2000; 342(16):1222. Schofield DH, Parenti D. Lyme disease vaccine [letter]. JAMA 2000;199. Schrijver IA, Melief MJ, van Meurs M, Companjen AR, Laman JD. Pararosaniline fixation for detection of co­stimulatory molecules, cytokines, and specific antibody. J.Histochem.Cytochem. 2000;95­103. Schuchat A. Microbes without borders: infectious disease, public health, and the journal [editorial; comment]. Am.J.Public Health 2000;181­3. Schulte JM, Burkham S, Squires JE, Doran T, Hamaker DW, Pelosi J, Graper J, Davis R, Caldwell MB. Immunization status of children born to human immunodeficiency virus (HIV)­infected mothers in two Texas cities. South.Med.J. 2000;48­52. Seder RA, Hill AV. Vaccines against intracellular infections requiring cellular immunity. Nature 2000 Aug 17;406(6797):793­8. Selander B, Kayhty H, Wedege E, Holmstrom E, Truedsson L, Soderstrom C, Sjoholm AG. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2­deficient sisters: alternative pathway­mediated bacterial killing and evidence for a novel type of blocking IgG. J Clin Immunol 2000 Mar;20(2):138­49. Seltsam A, Shukry­Schulz S, Salama A. Vaccination­associated immune hemolytic anemia in two children. Transfusion 2000 Aug;40(8):907­9. Sethuraman G, Thappa DM, Karthikeyan K. Images in Medicine. Cutaneous anthrax. Postgrad Med J 2000 Aug;76(898):472. Shata MT, Stevceva L, Agwale S, Lewis GK, Hone DM. Recent advances with recombinant bacterial vaccine vectors. Mol.Med.Today 2000;66­71. Shefer, A., Webb, E., and Wilmoth, T. Determination of up­to­date vaccination status for preschool­aged children: how accurate is manual assessment conducted by paraprofessional staff? Pediatrics 2000 Sep;106(3):493­6 Sheffield JV, Root RK. Smoking and pneumococcal infection [editorial; comment]. N.Engl.J.Med. 2000;732­4. Sheikh, N. A., al Shamisi, M., and Morrow, W. J. Delivery systems for molecular vaccination Curr.Opin.Mol.Ther. 2000, 2 (1): 37­54. Shin BM, Jeong KW. Distribution of anti­HBs levels in Korean adults. Yonsei Med J 2000; 41(1):40­48. Shlim, D. R. and Innis, B. L. Hepatitis E vaccine for travelers? [editorial; comment] J Travel Med 2000 Jul­Aug;7(4):167­9 Shoenfeld Y, Aron­Maor A. Vaccination and autoimmunity­'vaccinosis': a dangerous liaison? J Autoimmun 2000 Feb;14(1):1­10. Shoenfeld Y. Vaccination and autoimmunity­'vaccinosis': a dangerous liaison? J. Autoimmun. 2000 Feb; 14 (1), pag.1­10. Shohat T, Marva E, Sivan Y, Lerman I, Mates A, Cohen A. Immunologic response to a single dose of tetanus toxoid in older people. J Am Geriatr Soc 2000 Aug;48(8):949­51. Shohat T, Marva E, Sivan Y, Lerman I, Mates A, Cohen A. Immunologic response to a single dose of tetanus toxoid in older people. J Am Geriatr Soc 2000 Aug;48(8):949­51. Shouval D. Is universal vaccination against hepatitis B sufficient for control of HBV infection? Lessons from the immunization campaign in Italy. J Hepatol 2000 Dec;33(6):1009­11 Shovein JT, Damazo RJ, Hyams I. Hepatitis A: how benign is it? Am J Nurs 2000; 100(3):43­47. Singh B. Stimulation of the developing immune system can prevent autoimmunity. J.Autoimmun. 2000;15­22. Singh M. Influenza vaccination and asthma. Indian Pediatr. 2000 Apr;37(4):459­60. Singhal V, Reddy BS. Common contact sensitizers in Delhi. J Dermatol 2000 Jul;27(7):440­5. Singleton, J. A., Greby, S. M., Wooten, K. G., Walker, F. J., and Strikas, R. Influenza, pneumococcal, and tetanus toxioid vaccination of adults­­United States, 1993­7. Mor Mortal Wkly Rep CDC Surveill Summ 2000 Sep 22;49(9):39­62 Singleton, R., Bulkow, L. R., Levine, O. S., Butler, J. C., Hennessy, T. W., and Parkinson, A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage [see comments] J Pediatr 2000 Sep;137(3):313­20 Siscovick, D. S., Raghunathan, T. E., Lin, D., Weinmann, S., Arbogast, P., Lemaitre, R. N., Psaty, B. M., Alexander, R., and Cobb, L. A. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000 Oct 1;152(7):674­7 Skinner SR, Imberger A, Nolan T, Lester R, Glover S, Bowes G. Randomised controlled trial of an educational strategy to increase school­based adolescent hepatitis B vaccination. Aust N Z J Public Health 2000 Jun;24(3):298­304. Skinner SR, Imberger A, Nolan T, Lester R, Glover S, Bowes G. Randomised controlled trial of an educational strategy to increase school­based adolescent hepatitis B vaccination. Aust N Z J Public Health 2000 Jun;24(3):298­304. Skogen, V., Jenum, P. A., Danilov, E., Korolev, V. N., Halvorsen, D. S., and Sjursen, H. Immunity to diphtheria among children in Northern Norway and North­Western Russia. Vaccine 2000 Sep 15;19(2­3):197­203 Slater JE, Pastor RW. The determination of equivalent doses of standardized allergen vaccines. J Allergy Clin Immunol 2000; 105(3):468­474. Smith D, Inskip­Paulk E. Adolescent infectious disease challenges. Adolesc Med 2000 Jun;11(2):211­24. Smith KJ, Roberts MS. Cost effectiveness of vaccination strategies in adults without a history of chickenpox [see comments]. Am J Med 2000 Jun 15;108(9):723­9. Smith KJ, Roberts MS. Cost effectiveness of vaccination strategies in adults without a history of chickenpox [see comments]. Am J Med 2000 Jun 15;108(9):723­9. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000 Jan;23(1):95­108. Sohn YM, Rho HO, Park MS, Park JH, Choi BY, Ki M et al. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei Med J 2000; 41(1):34­39. Sohn YM. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg.Infect.Dis. 2000;17­24. Somodevilla­Torres MJ, Hillyard NC, Morton H, Alewood D, Halliday JA, Alewood PF et al. Preparation and characterization of polyclonal antibodies against human chaperonin 10. Cell Stress Chaperones 2000; 5(1):14­20. Sonnenberg P, Silber E, Ho KC, Koornhof HJ. Meningococcal disease in South African goldmines­­epidemiology and strategies for control. S Afr Med J 2000 May;90(5):513­7. Sonnenberg P, Silber E, Ho KC, Koornhof HJ. Meningococcal disease in South African goldmines­­epidemiology and strategies for control. S Afr Med J 2000 May;90(5):513­7. Sood SK. Immunization for children traveling abroad. Pediatr Clin North Am 2000; 47(2):435­48, viii. Soong W, Schultz JC, Patera AC, Sommer MH, Cohen JI. Infection of human T lymphocytes with varicella­zoster virus: an analysis with viral mutants and clinical isolates. J.Virol. 2000;1864­70. SoRelle R. Influenza vaccine shortages threaten those with chronic diseases [news]. Circulation 2000 Aug 22;102(8):E9014­5. Soubeyrand B, Boisnard F, Bruel M, Debois H, Delattre D, Gauthier A, Soum S, Thebault C. Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989­1998). Presse Med 2000 Apr 15;29(14):775­80. Squires, S. G. and Pelletier, L. Publicly­funded influenza and pneumococcal immunization programs in Canada: a progress report. Can Commun Dis Rep 2000 Sep 1;26(17):141­8 Stange, K. C., Flocke, S. A., Goodwin, M. A., Kelly, R. B., and Zyzanski, S. J. Direct observation of rates of preventive service delivery in community family practice. Prev Med 2000 Aug;31(2 Pt 1):167­76 Starr M. A rash of exanthems. How they affect children and pregnant women. Aust Fam Physician 2000 Jul;29(7):631­3, 636­7. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS­5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:19­20. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS­5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:19­20. Statement on immunization for Lyme disease (ACS­3). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:1­ Statement on influenza vaccination for the 2000­2001 season. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jun 1;26:1­16. Stenzel M. Hepatitis B: the only vaccine­preventable bloodborne pathogen. Med Health R I 2000 Jul;83(7):201­4. Stille, C. J. and Christison­Lagay, J. Determining immunization rates for inner­city infants: statewide registry data vs medical record review. Am J Public Health 2000 Oct;90(10):1613­5 Stojanov, S., Liese, J. G., Bendjenana, H., Harzer, E., Barrand, M., Jow, S., Dupuy, M., and Belohradsky, B. H. Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group. Pediatr Infect Dis J 2000 Jun;19(6):516­21 Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ. Cost­utility analyses of clinical preventive services: published ratios, 1976­1997. Am J Prev Med 2000 Jul;19(1):15­23. Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ. Cost­utility analyses of clinical preventive services: published ratios, 1976­1997. Am J Prev Med 2000 Jul;19(1):15­23. Stone S. Pneumococcal vaccine and the elderly [letter]. Lancet 2000;578­9. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000 Aug;55 Suppl 1:S2­10. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000 Aug;55 Suppl 1:S2­10. Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000 Dec;33(6):980­5 Subbarao K. As good as the real thing [editorial; comment]. J.Pediatr. 2000;139­41. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Maki M, Suzuki H, Ojika K, Ueda R. Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis. J Med Virol 2000 Dec;62(4):456­62 Sunbul, M., Leblebicioglu, H., Esen, S., Eroglu, C., and Barut, S. Response to hepatitis B vaccine in HBsAg/anti­HBs negative and anti­HBc positive subjects. Scand J Infect Dis 2000;32(3):315­6 Supplementary statement on hepatitis A vaccine (ACS­4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:12­8. Sutter RW, Hardy IR, Kozlova IA, Tchoudnaia LM, Gluskevich TG, Marievsky V et al. Immunogenicity of tetanus­diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union. J Infect Dis 2000; 181 Suppl 1:S197­S202. Sutter RW, Prevots DR, Cochi SL. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Pediatr Clin North Am 2000; 47(2):287­308. Sutter RW, Suleiman AJ, Malankar P, Al­Khusaiby S, Mehta F, Clements GB, Pallansch MA, Robertson SE. Trial of a supplemental dose of four poliovirus vaccines [see comments]. N Engl J Med 2000 Sep 14;343(11):767­73. Swanson ER, Fosnocht DE. Anthrax threats: a report of two incidents from Salt Lake City. J Emerg Med 2000; 18(2):229­232. Szilagyi PG, Holl JL, Rodewald LE, Shone LP, Zwanziger J, Mukamel DB, Trafton S, Dick AW, Raubertas RF. Evaluation of children's health insurance: from New York State's CHild Health Plus to SCHIP. Pediatrics 2000;687­91. Szilagyi, P. G., Bordley, C., Vann, J. C., Chelminski, A., Kraus, R. M., Margolis, P. A., and Rodewald, L. E. Effect of patient reminder/recall interventions on immunization rates: A review. JAMA 2000 Oct 11;284(14):1820­7 Takahashi H, Pool V, Tsai1 TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post­marketing surveillance data from Japan and the United States. The Working Group. Vaccine 2000 Jul 1;18(26):2963­9. Takahashi H, Pool V, Tsai1 TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post­marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000 Jul 1;18(26):2963­9. Takahashi M. Development of a live varicella vaccine­­past and future. Jpn J Infect Dis 2000 Apr;53(2):47­55. Takayama N, Takayama M, Takita J. Herpes zoster in healthy children immunized with varicella vaccine. Pediatr.Infect.Dis.J. 2000;169­70. Tarkowski A. Preventing staphylococcal disease by disarming the immune responses to infection. Arch Immunol Ther Exp (Warsz) 2000; 48(1):21­26. Tatochenko V, Mitjushin IL. Contraindications to vaccination in the Russian Federation. J Infect Dis 2000; 181 Suppl 1:S228­S231. Taylor A, Fisk NM, Glover V. Mode of delivery and subsequent stress response [letter]. Lancet 2000;120. Taylor JA, Newman RD. Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research Network. Arch.Pediatr.Adolesc.Med. 2000;302­
6. Taylor­Robinson, A. W.; Smith, E. C. Naturally acquired versus vaccine­induced immunity to malariaa dual role for TGF­beta and IL­12? [letter]. Parasitol Today 2000 Terada K, Niizuma T, Kataoka N, Niitani Y. Testing for rubella­specific IgG antibody in urine. Pediatr.Infect.Dis.J. 2000;104­8. Terkeltaub RA. Lyme disease 2000. Emerging zoonoses complicate patient work­up and treatment. Geriatrics 2000 Jul;55(7):34­5, 39­40, 43­4 passim. Termorshuizen F, Dorigo­Zetsma JW, de Melker HE, van den Hof S, Conyn­Van Spaendonck MA. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population­based survey. Epidemiol Infect 2000 Jun;124(3):459­66. Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000; 132(8):661­668. Theiler M, Smith HH. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787­800 (1937) [classical article]. Rev.Med.Virol. 2000;6­16. Thisyakorn U, Pancharoen C, Ruxrungtham K, Ubolyam S, Khawplod P, Tantawichien T, Phanuphak P, Wilde H. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin.Infect.Dis. 2000;218. Thoelen, S. An overview on a novel adjuvanted prophylactic hepatitis B vaccine. Acta Gastroenterol Belg 2000 Apr­Jun;63(2):185­6 Thomas PF, McIntyre PB, Jalaludin BB. Survey of pertussis morbidity in adults in western Sydney [see comments]. Med J Aust 2000 Jul 17;173(2):74­6. Thomas RE. Preparing patients to travel abroad safely. Part 1: Taking a travel history and identifying special risks. Can.Fam.Physician 2000;132­8. Thomson J, Pirkis J, Dunt D. Local register­reminder systems for immunisation in general practice [letter]. Aust Fam Physician 2000; 29(1):16­17. Thrower, D. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161. Tischer A, Gerike E. Immune response after primary and re­vaccination with different combined vaccines against measles, mumps, rubella. Vaccine 2000;1382­92. Tollman SM, Zwi AB. Health system reform and the role of field sites based upon demographic and health surveillance. Bull.World Health Organ 2000;125­
34. Toussirot E, Lohse A, Wendling D, Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum. 2000 Sep;43(9):2139­40. Toussirot, E., Lohse, A., Wendling, D., and Mougin, C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum 2000 Sep;43(9):2139­40 Touze E, Gout O, Verdier­Taillefer MH, Lyon­Caen O, Alperovitch A. The first episode of central nervous system demyelinization and hepatitis B virus vaccination. Rev Neurol (Paris) 2000 Mar;156(3):242­6. Trevejo RT. Rabies preexposure vaccination among veterinarians and at­risk staff. J Am Vet Med Assoc 2000 Dec 1;217(11):1647­50 Trubatch BN, Fisher DG, Cagle HH, Fenaughty AM. Vaccination strategies for targeted and difficult­to­access groups :letter. Am.J.Public Health 2000;447. Trujillo C. Meningococcal disease in healthcare workers. Vaccine is available in Latin America [letter]. BMJ 2000;247­9. Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13­15 October 1998. Vaccine 2000 May 26;18 Suppl 2:1­25. Tsai, C. H., Chiu, H. H., and Abe, T. Epidemiologic features of rotavirus infection in Taiwan: a review. Pediatr Int 2000 Aug;42(4):411­4 Tschantz, K. and Foley, L. A. Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza Issue.Brief.(Public Policy Inst.(Am.Assoc.Retired.Pers.)). 2000, IB45): 1­9. Tsu V, Tyshchenko DK. Case­control evaluation of an adult diphtheria immunization program in Ukraine. J Infect Dis 2000; 181 Suppl 1:S188­S192. Tsuru T, Mizuguchi M, Ohkubo Y, Itonaga N, Momoi MY. Acute disseminated encephalomyelitis after live rubella vaccination. Brain Dev 2000 Jun;22(4):259­61. Tun KM, Win H, Oo AK, Myint SS, Hla SK, Naing H. Tuberculin conversion after BCG vaccination: comparison by gestation and by age at immunization in Myanmar. Trans R Soc Trop Med Hyg 2000 Mar­2000 Apr 30;94(2):219­20. Turner JC. Meningococcal vaccine for college freshmen [editorial]. Am Fam Physician 2000 Aug 1;62(3):501­2, 505. Umble KE, Cervero RM, Yang B, Atkinson WL. Effects of traditional classroom and distance continuing education: a theory­driven evaluation of a vaccine­
preventable diseases course. Am J Public Health 2000 Aug;90(8):1218­24. Update: expanded availability of thimerosal preservative­free hepatitis B vaccine. MMWR Morb Mortal Wkly Rep 2000 Jul 21;49(28):642, 651. Ushijima, H. Rotavirus infection in Asia. Pediatr Int 2000 Aug;42(4):392­4 Usmanov I, Favorov MO, Chorba TL. Universal immunization: the diphtheria control strategy of choice in the Republic of Tajikistan, 1993­1997. J Infect Dis 2000; 181 Suppl 1:S86­S93. Usonis V, Bakasenas V, Morkunas B, Valentelis R, Ching P, Kreysler J. Diphtheria in Lithuania, 1986­1996. J Infect Dis 2000; 181 Suppl 1:S55­S59. Vafai A, Forghani B, Kilpatrick D, Ling J, Shankar V. Stability of a varicella­zoster virus glycoprotein E epitope. Arch Virol 2000; 145(1):85­97. Van Der Most RG, Murali­Krishna K, Ahmed R, Strauss JH. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus­specific CD8 T­cell response. J Virol 2000 Sep;74(17):8094­101. Vellinga A, Van Damme P, Joossens E, Goossens H. Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ 2000;217. Viallard JF, Boiron JM, Parrens M, Moreau JF, Ranchin V, Reiffers J, Leng B, Pellegrin JL. Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol 2000 Jul;110(1):230­3. Villeneuve, E., Vincelette, J., and Villeneuve, J. P. Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation. Can J Gastroenterol 2000 Jul­Aug;14 Suppl B:59B­62B Vinson DR. Immunisation does not rule out tetanus [letter]. BMJ 2000;383. Vitek CR, Bogatyreva EY, Wharton M. Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis 2000; 181 Suppl 1:S23­S26. Vitek CR, Velibekov AS. Epidemic diphtheria in the 1990s: Azerbaijan. J Infect Dis 2000; 181 Suppl 1:S73­S79. Vogel FR. Improving vaccine performance with adjuvants. Clin Infect Dis 2000 Jun;30 Suppl 3:S266­70. Vold PP, Owens DK. Cost­effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps. Clin.Infect.Dis. 2000;157­64. Von der Hardt K, Jungert J, Beck JD, Heininger U. Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents­­a retrospective analysis. Vaccine 2000 Jul 1;18(26):2999­3004. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000 Dec 8;19(9­10):1026­37 Vuotto ML, Ielpo MT, Liguori G, Benedetto RD, Moscatiello V, Maselli R. Activation of peripheral phagocytes in BCG­vaccinated subjects. Luminescence 2000 May­2000 Jun 30;15(3):153­7. Wade CF. Keeping Lyme disease at bay. An integrated approach to prevention. Am J Nurs 2000 Jul;100(7):26­31; quiz 32. Walt G, Buse K. Partnership and fragmentation in international health: threat or opportunity? [editorial]. Trop Med Int Health 2000 Jul;5(7):467­71. Walter R, Hartmann K, Pool V, Gargiullo P, Kuhn M. Reactivation of herpes virus infections by vaccination: evidence or coincidence?, Schweiz Med Wochenschr. 2000 Nov 4;130(44):1685­8. Wangoo A, Brown IN, Marshall BG, Cook HT, Young DB, Shaw RJ. Bacille Calmette­Guerin (BCG)­associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon­gamma (IFN­gamma). Clin.Exp.Immunol. 2000;92­8. Waters AP, Sauerwein R, Arnot D. Malaria vaccine research­­setting the record straight [letter]. Nat.Med. 2000;234. Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, Orlin S, Levenson R. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;84­8. Weijer, C. The future of research into rotavirus vaccine [editorial] BMJ 2000 Sep 2;321(7260):525­6 Weingart CL, Keitel WA, Edwards KM, Weiss AA. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun 2000 Dec;68(12):7175­9 Weir, E. Anthrax: of bison and bioterrorism. CMAJ 2000 Sep 5;163(5):608 Weitzel KW, Goode JV. Implementation of a pharmacy­based immunization program in a supermarket chain. J Am Pharm Assoc (Wash) 2000; 40(2):252­
256. Wiedermann U, Kundi M, Vollmann U, Kollaritsch H, Ebner C, Wiedermann G. Different HBs Antibody versus Lymphoproliferative Responses after Application of a Monovalent (Hepatitis B) or Combined (Hepatitis A + Hepatitis B) Vaccine. Int Arch Allergy Immunol 2000 Dec;123(4):349­53 Wierzba J, Irga N, Balcerska A, Borzych D. A severe adverse event after vaccine for diphtheria, tetanus, pertussis and poliomyelitis (DTP + polio) in a 4.5 month old infant. Przegl Lek 2000;57(7­8):436­8. Wijdicks EF, Fletcher DD, Lawn ND. Influenza vaccine and the risk of relapse of Guillain­Barre syndrome. Neurology 2000 Aug 8;55(3):452­3. Wilkerson JA. Initiation of contemporary rabies postexposure therapy­­a commentary. Wilderness Environ Med 2000; 11(1):40­41. Wilkerson JA. Rabies update. Wilderness Environ Med 2000; 11(1):31­39. Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR. Postlicensure safety surveillance for varicella vaccine. JAMA 2000 Sep 13;284(10):1271­9. Wright PJ, Fortinsky RH, Covinsky KE, Anderson PA, Landefeld CS. Delivery of preventive services to older black patients using neighborhood health centers. J.Am.Geriatr.Soc. 2000;124­30. Yoshida H, Horie H, Matsuura K, Miyamura T. Characterisation of vaccine­derived polioviruses isolated from sewage and river water in Japan. Lancet 2000 Oct 28;356(9240):1461­3. Yousuf, M. and Nadeem, A. Meningococcal infection among pilgrims visiting Madinah Al­Munawarah despite prior A­C vaccination. JPMA J Pak Med Assoc 2000 Jun;50(6):184­6 Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 2000 Aug 23­2000 Aug 30;284(8):978­83. Zeitlin L, Cone RA, Moench TR, Whaley KJ. Preventing infectious disease with passive immunization. Microbes Infect 2000 May;2(6):701­8. Zeuzem S. Hepatitis C virus: kinetics and quasispecies evolution during anti­viral therapy. Forum (Genova) 2000; 10(1):32­42. Zhao, S., Xu, Z., and Lu, Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. Int J Epidemiol 2000 Aug;29(4):744­52 Zielen S, Buhring I, Strnad N, Reichenbach J, Hofmann D. Immunogenicity and tolerance of a 7­valent pneumococcal conjugate vaccine in nonresponders to the 23­valent pneumococcal vaccine. Infect.Immun. 2000;1435­40. Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm.Dis. 2000;49­52. Zimet GD, Mays RM, Winston Y, Kee R, Dickes J, Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000; 9(1):47­50. Zuckerman, J. N. and Steffen, R. Risks of hepatitis B in travelers as compared to immunization status. J Travel Med 2000 Jul­Aug;7(4):170­4 2001 Aaby, P. and Jensen, H. Routine vaccination and child survival in Guinea­Bissau. Author's reply to commentary BMJ. 2­10­2001, 322 (7282): 360. Adamo, B., Coluccio, R., D'Apice, A., D'Argenio, P., Ferrara, M. A., Giugliano, F., Parrella, R., Peluso, F., Romeo, V., Ronga, C., and Simonetti, A. Influenza vaccination coverage in elderly people, Campania (Italy), 1999 Euro.Surveill. 2001, 6 (2): 26­30. Adhiyaman, V., Oke, A., Cefai, C., Adhiyaman, V., Oke, A., and Cefai, C. Effects of yellow fever vaccination. Lancet 2001; 358(9296): 1907­1908. Ahmed, F., Singleton, J. A., and Franks, A. L. Clinical practice. Influenza vaccination for healthy young adults N.Engl.J.Med. 11­22­2001, 345 (21): 1543­
1547. Allsup, S. J., Gosney, M., Regan, M., Haycox, A., Fear, S., and Johnstone, F. C. Side Effects of Influenza Vaccination in Healthy Older People: A Randomised Single­Blind Placebo­Controlled Trial Gerontology. 2001, 47 (6): 311­314. Ament, A., Fedson, D. S., and Christie, P. Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost­effective Clin.Infect.Dis. 12­15­2001, 33 (12): 2078­2079. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000­2001 season Can.Commun.Dis.Rep. 1­15­2001, 27 (15­16): 1­3. Andrews, N. J. Statistical assessment of the association between vaccination and rare adverse events post­licensure Vaccine. 10­15­2001, 20 Suppl 1:S49­53. (): S49­S53. Andrianarivelo, M. R., Boisier, P., Rabarijaona, L., Ratsitorahina, M., Migliani, R., and Zeller, H. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme. Trop Med Int Health 2001; 6(12): 1032­1039. Artz, A. S. and Ershler, W. B. Pneumococcal vaccination in adults JAMA. 7­11­2001, 286 (2): 166­167. Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J Immunol 2001 Jan 1;166(1):226­31 Arya, S. C. Effects of yellow fever vaccination. Lancet 2001; 358(9296): 1908. Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001 Feb 1;344(5):327­32. Avigan, D., Pirofski, L. A., and Lazarus, H. M. Vaccination against infectious disease following hematopoietic stem cell transplantation Biol.Blood Marrow Transplant. 2001, 7 (3): 171­183. Bahta, L. M., Wexler, D. L., and Atkinson, W. L. A screening questionnaire for contraindications to vaccination Pediatr.Ann. 2001, 30 (7): 418­421. Bakir, M.; El Khadir, A.; Devadas, K.; Farrukh, A. S.; Uduman, S. A. Haemophilus Influenzae Type b Diseases in Children: a Pre­Vaccination Study. East Mediterr.Health J. 7 (4­5): 597­603; July, 2001. Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., and Salive, M. E. Stevens­Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system Pediatr.Infect.Dis.J. 2001, 20 (2): 219­223. Baron, G., De Wals, P., and Milord, F. Vaccination practices of Quebec family physicians. Influenza vaccination status and professional practices for influenza vaccination Can.Fam.Physician. 2001, 47:2261­6. (): 2261­2266. Bartlett, D. L., Ezzati­Rice, T. M., Stokley, S., and Zhao, Z. Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates(1) Am.J.Prev.Med. 2001, 20 (4 Suppl): 25­27. Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001 Feb;44(2Suppl):348­50. Berner, Y. and Feldman, J. Disbelief or non­compliance of the elderly in influenza vaccination? Isr.Med.Assoc.J. 2001, 3 (1): 74. Berry, B. B., Ehlert, D. A., Battiola, R. J., and Sedmak, G. Influenza vaccination is safe and immunogenic when administered to hospitalized patients Vaccine. 5­14­2001, 19 (25­26): 3493­3498. Bigham M, Hoefer M. Comparing benefits and risks of immunization. Can J Public Health 2001 May­Jun;92(3):173­7. Boccara F, Benhaiem­Sigaux N, Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest 2001 Aug;120(2):671­2. Bolton, J. P., Lee, H. A., and Gabriel, R. Vaccinations as risk factors for ill health in veterans of the Gulf war. Conclusion may be flawed by inadequate data BMJ. 2­10­2001, 322 (7282): 361­362. Bonaccorsi G, Papini D, Bonanni P, Lo NA, Comodo N. Effects of a booster dose of tetanus toxoid after different primary courses of vaccination: implications on the use of immune globulin. Ann Ig 2001; 13(1):3­10. Bordet, A. L., Michenet, P., Cohen, C., Arbion, F., Ekindi, N., Bonneau, C., Kerdraon, R., and Coville, M. [Post­vaccination granuloma due to aluminium] Ann.Pathol. 2001, 21 (2): 149­152. Borrow, R., Goldblatt, D., Andrews, N., Richmond, P., Southern, J., and Miller, E. Influence of prior meningococcal c polysaccharide vaccination on the response and generation of memory after meningococcal c conjugate vaccination in young children J.Infect.Dis. 8­1­2001, 184 (3): 377­380. Borrow, R., Southern, J., Andrews, N., Peake, N., Rahim, R., Acuna, M., Martin, S., Miller, E., and Kaczmarski, E. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine­
naive controls Vaccine. 4­30­2001, 19 (23­24): 3043­3050. Bos, J. M., Rumke, H. C., Welte, R., Postma, M. J., and Jager, J. C. Health economics of a hexavalent meningococcal outer­membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program Vaccine. 10­12­2001, 20 (1­2): 202­207. Boulianne, N., De Serres, G., Duval, B., Shadmani, R., and Rochette, L. Clinical manifestations and incidence of oculo­respiratory syndrome following influenza vaccination­­Quebec, 2000 Can.Commun.Dis.Rep. 5­15­2001, 27 (10): 85­90. Bradbury, J. USA to increase smallpox vaccine stockpile Lancet Infect.Dis. 2001, 1 (5): 290. Brayden, R. and France, E. K. Efficient vaccination practices Pediatr.Ann. 2001, 30 (5): 284­288. Brearley MJ. Vaccine­associated feline sarcomas. Vet Rec. 2001 May 5;148(18):580. Breithaupt, T., Harris, K., Ellis, J., Purcell, E., Weir, J., Clothier, M., and Boesler, D. Thoracic lymphatic pumping and the efficacy of influenza vaccination in healthy young and elderly populations J.Am.Osteopath.Assoc. 2001, 101 (1): 21­25. Bretscher, P., Menon, J., Power, C., Uzonna, J., and Wei, G. A case for a neonatal, low­dose BCG vaccination trial Scand.J.Infect.Dis. 2001, 33 (4): 253­257. Broker, M. Meningococcal vaccination for college freshmen Cleve.Clin.J.Med. 2001, 68 (10): 879. Brouns, R., Verlinde, P., Lagae, L., De Koster, J., Lemmens, F., and Van de, Casseye W. Subacute sclerosing panencephalitis in a vaccinated, internationally adopted child Acta Neurol.Belg. 2001, 101 (2): 128­130. Brunton, D. Practitioners versus legislators: the shaping of the Scottish vaccination act Proc.R.Coll.Physicians Edinb. 1993, 23 (2): 193­201. Brydak, L. B., Roszkowska­Blaim, M., Machala, M., Leszczy&nacute, ska, B., and Sieniawska, M. Burkhard C, Choi M, Wilhelm H. Optic neuritis as a complication in preventive tetanus­diphtheria­poliomyelitis vaccination: a case report. Klin Monatsbl Augenheilkd 2001 Jan;218(1):51­4. Burton, A. Spain says good­bye to measles Lancet Infect.Dis. 2001, 1 (3): 142. Buxton, J. A., Skowronski, D. M., Ng, H., Marion, S. A., Li, Y., King, A., and Hockin, J. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks J.Infect.Dis. 7­15­2001, 184 (2): 188­191. Campos, J. Haemophilus influenzae: from the post­vaccination era to antibiotic resistance Clin.Microbiol.Infect. 2001, 7 (6): 287­290. Ceyhan, M., Kanra, G., Erdem, G., and Kanra, B. Immunogenicity and efficacy of one dose measles­mumps­rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age Vaccine. 8­14­2001, 19 (31): 4473­4478. Chee, C. B., Soh, C. H., Boudville, I. C., Chor, S. S., and Wang, Y. T. Interpretation of the Tuberculin Skin Test in Mycobacterium bovis BCG­vaccinated Singaporean Schoolchildren Am.J.Respir.Crit Care Med. 9­15­2001, 164 (6): 958­961. Cochi, S. L., Sutter, R. W., and Aylward, R. B. Possible global strategies for stopping polio vaccination and how they could be harmonized Dev.Biol.(Basel). 2001, 105:153­8; discussion 159. (): 153­158. Cohen, J. Bioterrorism. Smallpox vaccinations: how much protection remains? Science. 11­2­2001, 294 (5544): 985. Cohn, D. L. The Effect of BCG Vaccination on Tuberculin Skin Testing. Does it matter? Am.J.Respir.Crit Care Med. 9­15­2001, 164 (6): 915­916. Conyn­Van Spaendonck MA M, de Melker HE H, Abbink F, Elzinga­Gholizadea N, Kimman TG, van Loon T T. Immunity to Poliomyelitis in the Netherlands. Am J Epidemiol 2001 Feb 1;153(3):207­14 Cook, I. F. and Murtagh, J. Paediatric vaccination practice in a division of general practice Aust.Fam.Physician. 2001, 30 (12): 1185­1189. Cook, I. Paediatric vaccination: the orange hub needle is acceptable Aust.Fam.Physician. 2001, 30 (4): 311­312. Cookson, C. Benefit and risk of vaccination as seen by the general public and the media Vaccine. 10­15­2001, 20 Suppl 1:S85­8. (): S85­S88. Courtney PA, Patterson RN, Lee RJ. Henoch­Schonlein purpura following meningitis C vaccination. Rheumatology (Oxford). 2001 Mar;40(3):345­6. Courtney, P. A., Patterson, R. N., and Lee, R. J. Henoch­Schonlein purpura following meningitis C vaccination Rheumatology.(Oxford). 2001, 40 (3): 345­
346. Cox, R. J., Mykkeltvedt, E., Sjursen, H., and Haaheim, L. R. The effect of zanamivir treatment on the early immune response to influenza vaccination Vaccine. 9­14­2001, 19 (32): 4743­4749. Crocetti, E., Arniani, S., Bordoni, F., Maciocco, G., Zappa, M., and Buiatti, E. Cui, X. W., Nagao, M. M., and Effler, P. V. Influenza and pneumococcal vaccination coverage levels among Hawaii statewide long­term­care facilities Infect.Control Hosp.Epidemiol. 2001, 22 (8): 519­521. Cuthbert JA. Hepatitis A: Old and New. Clin Microbiol Rev 2001 Jan;14(1):38­58 Dagan, R., Amir, J., Ashkenazi, S., Hardt, K., and Kaufhold, A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria­tetanus­pertussis­polio­Haemophilus influenzae type b primary vaccination Pediatr.Infect.Dis.J. 2001, 20 (6): 587­592. Dalpke, A., Zimmermann, S., and Heeg, K. CpG­oligonucleotides in vaccination: signaling and mechanisms of action Immunobiology. 2001, 204 (5): 667­
676. Danovaro­Holliday, M. C., Zimmerman, L., and Reef, S. E. Preventing Congenital Rubella Syndrome (CRS) through Vaccination of Susceptible Women of Childbearing Age J.Womens Health Gend.Based.Med. 2001, 10 (7): 617­619. Daum, R. S., Zenko, C. E., Given, G. Z., Ballanco, G. A., Parikh, H., and Germino, K. Magnitude of Interference after Diphtheria­Tetanus Toxoids­Acellular Pertussis/Haemophilus influenzae Type b Capsular Polysaccharide­Tetanus Vaccination Is Related to the Number of Doses Administered J.Infect.Dis. 11­
15­2001, 184 (10): 1293­1299. Davis, J. W., Lee, E., Taira, D. A., and Chung, R. S. Influenza vaccination, hospitalizations, and costs among members of a medicare managed care plan Med.Care. 2001, 39 (12): 1273­1280. Davis, R. L. and Bohlke, K. Measles Vaccination and Inflammatory Bowel Disease: Controversy Laid to Rest? Drug Saf 2001; 24(13): 939­946. Davis, R. L., Lieu, T. A., Mell, L. K., Capra, A. M., Zavitkovsky, A., Quesenberry, C. P., Jr., Black, S. B., Shinefield, H. R., Thompson, R. S., and Rodewald, L. E. Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations Pediatrics. 2001, 107 (4): 671­676. Dayan, G. H., Nguyen, V. H., Debbag, R., Gomez, R., and Wood, S. C. Cost­effectiveness of influenza vaccination in high­risk children in Argentina Vaccine. 2001, %20;19 (30): 4204­4213. De Kleijn, E., van Eijndhoven, L., Vermont, C., Kuipers, B., van Dijken, H., Rumke, H., de Groot, R., van Alphen, L., and van den, Dobbelsteen G. Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine Vaccine. 11­12­2001, 20 (3­4): 352­358. De Los Rios, Martin R., Garcia, Marin N., Sanz, Moreno J., and Ballester, Orcal E. [Mumps in an urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures] Aten.Primaria. 6­15­2001, 28 (1): 10­16. De Swart, R. L., El Mubarak, H. S., Vos, H. W., Mustafa, O. M., Abdallah, A., Groen, J., Mukhtar, M. M., Zijlstra, E. E., El Hassan, A. M., Wild, T. F., Ibrahim, S. A., and Osterhaus, A. D. Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiology Vaccine. 3­21­2001, 19 (17­19): 2254­2257. Desguerre I, Ponsot G. Hepatitis B vaccination and neurologic manifestations in children. Arch Pediatr. 2001 May; 8 Suppl 2:325s­326s. DeStefano, F. and Chen, R. T. Autism and measles­mumps­rubella vaccination: controversy laid to rest? CNS.Drugs. 2001, 15 (11): 831­837. DeStefano, F. More evidence to reassure physicians and parents about vaccination West J.Med. 2001, 174 (6): 390­391. DeWilde, S., Carey, I. M., Richards, N., Hilton, S. R., and Cook, D. G. Do children who become autistic consult more often after MMR vaccination? Br.J.Gen.Pract. 2001, 51 (464): 226­227. Diez­Domingo, J., Pereiro, I., Morant, A., Gimeno, C., San Martin, M., and Gonzalez, A. Impact of non­routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain J.Infect. 2001, 42 (4): 257­260. Dionne, M., Boulianne, N., Duval, B., Lavoie, F., Laflamme, N., Carsley, J., Valiquette, L., Gagnon, S., Rochette, L., and De Serres, G. [Lack of conviction about vaccination in certain Quebec vaccinators] Can.J.Public Health. 2001, 92 (2): 100­104. Donnelly S, Loscher CE, Lynch MA, Mills KH. Whole­cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin­induced interleukin­1beta in a new murine model for analysis of neuronal side effects of vaccination. Infect Immun 2001 Jul;69(7):4217­23. Downes, K. A., Domen, R. E., McCarron, K. F., and Bringelsen, K. A. Acute autoimmune hemolytic anemia following DTP vaccination: report of a fatal case and review of the literature Clin.Pediatr.(Phila). 2001, 40 (6): 355­358. Doyle, daNM, Dauterive, R., Chuang, K. H., and Ellrodt, A. G. Translating evidence into practice: pursuing perfection in pneumococcal vaccination in a rural community Respir.Care. 2001, 46 (11): 1258­1275. Earhart, K. C., Beadle, C., Miller, L. K., Pruss, M. W., Gray, G. C., Ledbetter, E. K., and Wallace, M. R. Outbreak of influenza in highly vaccinated crew of u.s. navy ship Emerg.Infect.Dis. 2001, 7 (3): 463­465. Eason, E., Naus, M., Sciberras, J., and Oppenheimer, L. Evaluation of an institution­based protocol for postpartum rubella vaccination CMAJ. 11­13­2001, 165 (10): 1321­1323. Edmunds, W. J., Gay, N. J., Henao Restrepo, A. M., Olive, J., and Bele, O. Measles vaccination in Africa: by how much could routine coverage be improved? Vaccine. 10­12­2001, 20 (1­2): 16­18. Effectiveness of influenza vaccination in the elderly in a community in Italy Eur.J.Epidemiol. 2001, 17 (2): 163­168. Egemen, A., Aksit, S., Ozacar, T., Kurugol, Z., Keskinoglu, P., Pehlivan, T., and Mutlu, S. Measles seroprevalence in Izmir with special emphasis on measles vaccination policy for Turkey Pediatr.Int. 2001, 43 (4): 379­384. Eicken C, Sharma V, Klabunde T, Owens RT, Pikas DS, Hook M, Sacchettini JC. Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J Biol Chem 2001 Jan 3; El Kasmi, K. C. and Muller, C. P. New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules Vaccine. 3­21­2001, 19 (17­19): 2238­2244. Engers, H. D. [Anti­Malarial Vaccination Today]. Bull Soc Pathol Exot; 94 (2 Pt 2): 147­148; July, 2001. Ernst, E. Rise in popularity of complementary and alternative medicine: reasons and consequences for vaccination Vaccine. 10­15­2001, 20 Suppl 1:S90­3. (): S90­S93. Exner, M. Successful vaccination for Lyme disease: a novel mechanism? Expert Opin Biol Ther 2001; 1(5): 783­93. Faustini, A., Franco, E., Sangalli, M., Spadea, T., Calabrese, R. M., Cauletti, M., and Perucci, C. A. Persistence of anti­HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy Vaccine. 4­6­2001, 19 (20­22): 2812­2818. Feldman, R. Group B Streptococcus. Prevention of Infection in the Newborn Pract.Midwife. 2001, 4 (3): 16­18. Fiechtner, H. B. and Falls, S. Vaccination myths and misconceptions S D.J.Med. 2001, 54 (5): 165­166. Finsterer J, Artner C, Kladosek A, Kalchmayr R, Redtenbacher S. Cavernous sinus syndrome due to vaccination­induced giant cell arteritis. Arch Intern Med. 2001 Apr 9;161(7):1008­9. Finsterer, J., Artner, C., Kladosek, A., Kalchmayr, R., and Redtenbacher, S. Comments, Opinions and Brief Case Reports: Cavernous Sinus Syndrome Due to Vaccination­Induced Giant Cell Arteritis Arch.Intern.Med. 4­9­2001, 161 (7): 1008­1009. Fisher MA, Eklund SA, James SA, Lin X. Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994. Ann Epidemiol 2001 Jan;11(1):13­21. Fjallbrant, H., Ridell, M., and Larsson, L. O. The tuberculin skin test in reaction to immunological in vitro reactions in BCG­vaccinated healthcare workers Eur.Respir.J. 2001, 18 (2): 376­380. Folb, P. I. Routine vaccination and child survival in Guinea­Bissau. WHO responds to Guinea­Bissau report BMJ. 2­10­2001, 322 (7282): 361. Fulton, J. P. Asthma and flu vaccination Med.Health R.I. 2001, 84 (10): 343. Funada, H. and Abe, Y. [Two­step tuberculin testing and BCG vaccination in the personnel of a medical and pharmaceutical university] Kekkaku. 2001, 76 (8): 563­569. Gaillat, J. and Leophonte, P. [Pneumococcal vaccination: renewed awarness?] Rev.Pneumol.Clin. 2001, 57 (1): 3­5. Gans, H., Yasukawa, L., Rinki, M., DeHovitz, R., Forghani, B., Beeler, J., Audet, S., Maldonado, Y., and Arvin, A. M. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months J.Infect.Dis. 10­1­2001, 184 (7): 817­826. Garcia­Doval, I., Roson, E., Feal, C., De la, Torre C., Rodriguez, T., and Cruces, M. J. Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid Acta Derm.Venereol. 2001, 81 (6): 450­451. Gardner, E. M., Bernstein, E. D., Dran, S., Munk, G., Gross, P., Abrutyn, E., and Murasko, D. M. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population Vaccine. 9­14­2001, 19 (32): 4610­4617. Garly, M. L., Bale, C., Martins, C. L., Balde, M. A., Hedegaard, K. L., Whittle, H. C., and Aaby, P. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria­tetanus antigens Vaccine. 11­12­2001, 20 (3­4): 468­474. Gasior­Chrzan, B. Delayed granulomatous lesion at the bacillus Calmette­Guerin vaccination site Acta Derm.Venereol. 2001, 81 (4): 302­304. George­Chandy, A., Mielcarek, N., Nordstrom, I., Holmgren, J., and Eriksson, K. Vaccination with Bordetella pertussis­Pulsed Autologous or Heterologous Dendritic Cells Induces a Mucosal Antibody Response In Vivo and Protects against Infection Infect.Immun. 2001, 69 (6): 4120­4124. Georgitis, J. W. and Fasano, M. B. Allergenic components of vaccines and avoidance of vaccination­related adverse events Curr.Allergy Rep. 2001, 1 (1): 11­
17. Ghani, S. Convincing an Asian Community of the Importance of Flu Vaccination Prof.Nurse 2001, 17 (2): 130. Ghosh, C. Periorbital and orbital cellulitis after H. influenza B vaccination Ophthalmology. 2001, 108 (9): 1514­1515. Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., and Weyand, C. M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals J.Virol. 2001, 75 (24): 12182­12187. Gout O. Vaccinations and multiple sclerosis. Neurol Sci 2001 Apr;22(2):151­4. Griffin, J. P. MMR vaccination: how reassuring is reassurance? Adverse Drug React.Toxicol.Rev. 2001, 20 (1): 1­2. Grime, P. BCG re­vaccination Thorax. 2001, 56 (9): 741­742. Gutierrez, E. B., Li, H. Y., Santos, A. C., and Lopes, M. H. Effectiveness of influenza vaccination in elderly outpatients in Sao Paulo city, Brazil Rev.Inst.Med.Trop.Sao Paulo. 2001, 43 (6): 317­320. Hall, G. H. Antiflu, or antideath vaccination? Lancet. 6­30­2001, 357 (9274): 2141. Hamilton, M. The MMR vaccination and autism: a lay person's contribution West Indian Med.J. 2001, 50 (1): 87­89. Handjani, F., Delir, S., Sodaifi, M., and Kumar, P. V. Lupus vulgaris following bacille Calmette­Guerin vaccination Br.J.Dermatol. 2001, 144 (2): 444­445. Hanna, J. N., Young, D. M., Brookes, D. L., Dostie, B. G., and Murphy, D. M. The initial coverage and impact of the pneumococcal and influenza vaccination program for at­risk indigenous adults in Far North Queensland Aust.N.Z.J.Public Health. 2001, 25 (6): 543­546. Harel Z, Ipp L, Riggs S, Vaz R, Flanagan P. Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. J Adolesc Health 2001 Jan;28(1):26­9 Hassler, D., Braun, R., and Kimmig, P. [Vaccinations. Meningococci] Dtsch.Med.Wochenschr. 12­7­2001, 126 (49): A1120. Havinga, W. Vaccinations as risk factors for wheezing disorders Lancet. 10­6­2001, 358 (9288): 1186. Hedlund, J., Langer, B., Konradsen, H. B., and Ortqvist, A. Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL­
12 treatment in humans vaccinated with pneumococcal polysaccharide Vaccine. 10­12­2001, 20 (1­2): 164­169. Heller, D. Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine? BMJ. 10­13­
2001, 323 (7317): 839­840. Hernandez­Suarez, C. M. A note on the distribution of the number of vaccinated infected under non­random mixing conditions Stat.Med. 7­15­2001, 20 (13): 1983­1986. Herrera, G. A., Zhao, Z., and Klevens, R. M. Variation in vaccination coverage among children of Hispanic ancestry(2) Am.J.Prev.Med. 2001, 20 (4 Suppl): 69­74. Heyderman, R. Commentary: Should programmes for community­level meningococcal vaccination be considered in Australia­an economic evaluation Int.J.Epidemiol. 2001, 30 (3): 578­579. Higson, N. Health professionals' attitudes to MMR vaccine. Doctors must understand reasons behind vaccination BMJ. 5­5­2001, 322 (7294): 1121. Hodge, J. G.; Gostin, L. O. School Vaccination Requirements: Historical, Social, and Legal Perspectives. KY Law J; 90 (4): 831­890; 2001. Hoglund, D. and Stenqvist, K. [More elderly persons should be informed about the importance of vaccination against influenza. Extensive needs of information also among the health personnel] Lakartidningen. 1­17­2001, 98 (3): 156­158. Holdiness, M. R. Adverse cutaneous reactions to influenza vaccinations and chemotherapy Int.J.Dermatol. 2001, 40 (7): 427­430. Houcke­Bruge, C., Delaporte, E., Catteau, B., Martin, De Lassalle, and Piette, F. [Granuloma annulare following BCG vaccination] Ann.Dermatol.Venereol. 2001, 128 (4): 541­544. Howe, M. Pneumoccocal vaccination programme begins in Australia Lancet Infect.Dis. 2001, 1 (2): 69. Hull, H. F. The future of polio eradication Lancet Infect.Dis. 2001, 1 (5): 299­303. Humiston, S. G. and Strikas, R. A. Routine childhood vaccination update: educating the office staff Pediatr.Ann. 2001, 30 (6): 329­341. Hutchins, S. S., Dezayas, A., Blond, K. L., Heath, J., Bellini, W., Audet, S., Beeler, J., Wattigney, W., and Markowitz, L.Evaluation of an Early Two­Dose Measles Vaccination Schedule. Am J Epidemiol 2001; 154(11): 1064­1071. Ii, M. and Ohkusa, Y. [An empirical research for demand of influenza vaccination] Nippon Koshu Eisei Zasshi. 2001, 48 (1): 16­27. Immunological response to influenza vaccination in children with renal failure Nephrol.Dial.Transplant. 2001, 16 (3): 643­644. Iwane, M. K. and Schwartz, B. Pediatric influenza immunization: should healthy children be vaccinated? Pediatr.Ann. 2001, 30 (6): 354­357. Jacobson, R. M., Adegbenro, A., Pankratz, V. S., and Poland, G. A. Adverse events and vaccination­the lack of power and predictability of infrequent events in pre­licensure study Vaccine. 3­21­2001, 19 (17­19): 2428­2433. Jefferys, R. T cells and vaccination Lancet. 5­5­2001, 357 (9266): 1451. Jha, N., Kannan, A.T., Paudel, I.S., Niraula, S. EPI vaccination in Nepal. Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):547­52. Johansson, E. L., Wassen, L., Holmgren, J., Jertborn, M., and Rudin, A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans Infect.Immun. 2001, 69 (12): 7481­7486. Johnson, A. and Joynes, E. V. MMR vaccination uptake in a rural setting Br.J.Gen.Pract. 2001, 51 (466): 408. Jonville­Bera, A. P., Autret­Leca, E., Barbeillon, F., and Llado, J. P. [Relationship between vaccination for diphtheria­tetanus­pertussis +/­ Haemophilus influenzae b and sudden infant death before three months of age: a case­control study] Arch.Pediatr. 2001, 8 (11): 1272­1273. Jonville­Bera, A. P., Autret­Leca, E., Barbeillon, F., and Paris­Llado, J. Sudden unexpected death in infants under 3 months of age and vaccination status ­ a case­control study Br.J.Clin.Pharmacol. 2001, 51 (3): 271­276. Juretzko, P., Fabian­Marx, T., Haastert, B., Giani, G., von Kries, R., and Wirsing von Konig, C. H. Kaji, M., Tsuru, T., and Oizumi, K. [Efficacy and safety of influenza vaccination to elderly patients with neurological diseases] Kansenshogaku Zasshi. 2001, 75 (5): 411­415. Kakurai, M., Kiyosawa, T., Ohtsuki, M., and Nakagawa, H. Multiple lesions of granuloma annulare following BCG vaccination: case report and review of the literature. Int J Dermatol 2001; 40(9): 579­581. Kalinowski, P. The influence of prophylactic vaccination on epidemic situation of infectious diseases illustrated by the epidemiology of measles in Poland in the years 1968­1998. Ann Univ Mariae Curie Sklodowska [Med]. 2001;56:327­32. Kanakoudi­Tsakalidou, F., Trachana, M., Pratsidou­Gertsi, P., Tsitsami, E., and Kyriazopoulou­Dalaina, V. Influenza vaccination in children with chronic rheumatic diseases and long­term immunosuppressive therapy Clin.Exp.Rheumatol. 2001, 19 (5): 589­594. Keiholz, U., Scheibenbogen, C., Theil, E., and Schadendorf, D. Rational development of peptide vaccination in clinical oncology Onkologie. 2001, 24 (2): 174. Kent, S. J., Dale, C. J., Preiss, S., Mills, J., Campagna, D., and Purcell, D. F. Vaccination with attenuated simian immunodeficiency virus by DNA inoculation J.Virol. 2001, 75 (23): 11930­11934. Khalfan SA, Chomel JJ, Mallet L, Fernandes E, Lahlou AI, Lina B, Aymard M. Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain. Ann Trop Paediatr 2001 Sep;21(3):223­9. Khalil, M. K.; Al Mazrou, Y. Y.; Al Jeffri, M.; Al Ghamdy, Y. S. Measles Immunization in Saudi Arabia: the Need for Change. East Mediterr.Health J. 7 (4­
5): 829­834; July, 2001. Kharabsheh, S., Al Otoum, H., Clements, J., Abbas, A., Khuri­Bulos, N., Belbesi, A., Gaafar, T., and Dellepiane, N. Mass psychogenic illness following tetanus­diphtheria toxoid vaccination in Jordan Bull.World Health Organ. 2001, 79 (8): 764­770. Khetsuriani, N., Bisgard, K., Prevots, D. R., Brennan, M., Wharton, M., Pandya, S., Poppe, A., Flora, K., Dameron, G., and Quinlisk, P. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J 2001; 20(12): 1108­1112. Kim, J., Jeong, E., Lee, J., Yang, S., Shin, Y., Yoon, Y., and Chun, B. C. A Web­Based Interactive Education Programme on Vaccination for Public Health Officials Asia Pac.J.Public Health 2001, 13 Suppl:S7­12. (): S7­12. Kimball, P., Verbeke, S., and Tolman, D. Influenza vaccination among heart transplant recipients Transplant.Proc. 2001, 33 (1­2): 1785­1786. Klugman, K. P. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance Lancet Infect.Dis. 2001, 1 (2): 85­91. Konstantinou D, Paschalis C, Maraziotis T, Dimopoulos P, Bassaris H, Skoutelis A. Two episodes of leukoencephalitis associated with recombinant hepatitis b vaccination in a single patient. Clin Infect Dis 2001 Nov 15;33(10):1772­3. Kovarik, J. and Siegrist, C. A. The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way? Arch.Immunol.Ther.Exp.(Warsz.). 2001, 49 (3): 209­215. Kramarz, P., Destefano, F., Gargiullo, P. M., Chen, R. T., Lieu, T. A., Davis, R. L., Mullooly, J. P., Black, S. B., Shinefield, H. R., Bohlke, K., Ward, J. I., and Marcy, S. M. Does influenza vaccination prevent asthma exacerbations in children? J.Pediatr. 2001, 138 (3): 306­310. Kramarz, P., France, E. K., DeStefano, F., Black, S. B., Shinefield, H., Ward, J. I., Chang, E. J., Chen, R. T., Shatin, D., Hill, J., Lieu, T., and Ogren, J. M. Population­based study of rotavirus vaccination and intussusception Pediatr.Infect.Dis.J. 2001, 20 (4): 410­416. Kreager, A. M.; Cicerone, J.; Hella, S.; Johnson, A. N.; Matthews, L.; Richards, N. L.; Sinishtaj, L.; Tobin, A.; Veltigian, S. A Case Management Approach to Immunizing Patients at High Risk for Influenza. Lippincotts Case Manag; 6 (4): 138­142; July, 2001. Kreft, B., Fischer, A., Kruger, S., Sack, K., Kirchner, H., and Rink, L. The impaired immune response to diphtheria vaccination in elderly chronic hemodialysis patients is related to zinc deficiency Biogerontology. 2000, 1 (1): 61­66. Kumar, V., Sercarz, E., Zhang, J., and Cohen, I. T­cell vaccination: from basics to the clinic Trends Immunol. 2001, 22 (10): 539­540. Kyaw, M. H., Bramley, J. C., Chalmers, J., Jones, I. G., and Campbell, H. Pneumococcal vaccination: opinion of general practitioners and hospital doctors in Scotland, 1999­2000 Commun.Dis.Public Health. 2001, 4 (1): 42­48. Larzelere, R. E. We need the full picture on both smacking and vaccinations Arch.Dis.Child. 2001, 84 (5): 452. Law, B. J. Chickenpox vaccination, not chickenpox, should be routine for Canadian children CMAJ. 5­15­2001, 164 (10): 1454­1455. LeBaron, C. W., Massoudi, M., Stevenson, J., and Lyons, B. Vaccination coverage and physician distribution in the united states, 1997 Pediatrics. 2001, 107 (3): E31. Leggat, P. A. Book Review: The Traveller's Pocket Medical Guide and International Certificate of Vaccination,3rd edition. J Travel Med 2001; 8(6): 336. Lehmann, D., Kakazo, M., Saleu, G., Taime, J., Javati, A., Namuigi, P., Alpers, M. P., Wegmuller, B., Zellmeyer, M., Furer, E., Que, J. U., and Herzog, C. Safety and Immunogenicity of Two Haemophilus Influenzae Type b Polysaccharide­Tetanus Toxoid Conjugate Vaccines (PRP­T) Given With Diphtheria­
Tetanus­Pertussis Vaccine to Young Papua New Guinean Children P N.G.Med.J 2001, 44 (1­2): 6­16 Lehrke, P., Nuebling, M., Hofmann, F., and Stoessel, U. Attitudes of homoeopathic physicians towards vaccination Vaccine. 9­14­2001, 19 (32): 4859­4864. Levy­Bruhl, D. and Guerin, N. The use of smallpox virus as a biological weapon: the vaccination situation in France Euro.Surveill. 2001, 6 (11): 171­178. Lewis, P. R., Reimer, R. F., and Dixon, A. J. Evaluating the efficacy of vaccine storage in the general practice setting Aust.N.Z.J.Public Health. 2001, 25 (6): 547­550. Liddle, B. J. and Jennings, R. Influenza vaccination in old age Age Ageing. 2001, 30 (5): 385­389. Linde, A. [Sweden behind when it comes to influenza vaccination. Better vaccination programs in many western countries] Lakartidningen. 1­17­2001, 98 (3): 154­155. Lopez, J. A., Weilenman, C., Audran, R., Roggero, M. A., Bonelo, A., Tiercy, J. M., Spertini, F., and Corradin, G. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies Eur.J.Immunol. 2001, 31 (7): 1989­1998. Luman, E. T., Stokley, S., Daniels, D., and Klevens, R. M. Vaccination visits in early childhood(3)(3). Just one more visit to be fully vaccinated Am.J.Prev.Med. 2001, 20 (4 Suppl): 32­40. MacLennan J, Obaro S, Deeks J, Lake D, Elie C, Carlone G, Moxon ER, Greenwood B. Immunologic Memory 5 Years after Meningococcal A/C Conjugate Vaccination in Infancy. J Infect Dis 2001 Jan;183(1):97­104 Mahony, C. Vaccination. Nurse anxiety after GMC charges doctor over single­dose MMR jabs. Nurs Times. 2001 Aug 16­22;97(33):9. Mak, D. B., Plant, A. J., and Louise, Rushworth R. Where the data are deficient: a field evaluation of the effectiveness of pneumococcal vaccination in remote Australia Aust.J.Rural.Health. 2001, 9 (1): 38­46. Mandl S, Hix L, Andino R. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors. J Virol 2001 Jan;75(2):622­7 Manning, A. Referral of Dr. Peter Mansfield to the GMC. Should decision on vaccination be best for you or us? BMJ. 12­1­2001, 323 (7324): 1304. Maral, I., Baykan, Z., Aksakal, F. N., Kayikcioglu, F., and Bumin, M. A. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage Public Health. 2001, 115 (5): 359­364. Marianneau, P., Georges­Courbot, M., and Deubel, V. Rarity of adverse effects after 17D yellow­fever vaccination Lancet. 7­14­2001, 358 (9276): 84­85. Marth, E. and Kleinhappl, B. Albumin is a necessary stabilizer of TBE­vaccine to avoid fever in children after vaccination Vaccine. 11­12­2001, 20 (3­4): 532­537. Martin, M., Tsai, T. F., Cropp, B., Chang, G. J., Holmes, D. A., Tseng, J., Shieh, W., Zaki, S. R., Al Sanouri, I., Cutrona, A. F., Ray, G., Weld, L. H., and Cetron, M. S. Fever and multisystem organ failure associated with 17D­204 yellow fever vaccination: a report of four cases Lancet. 7­14­2001, 358 (9276): 98­104. Martin, M., Weld, L. H., Tsai, T. F., Mootrey, G. T., Chen, R. T., Niu, M., and Cetron, M. S. Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination. Emerg Infect Dis 2001; 7(6): 945­951. Martin, S., Sadler, F., Borrow, R., Dawson, M., Fox, A., and Cartwright, K. IgG antibody subclass responses determined by immunoblot in infants' sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine Vaccine. 8­14­2001, 19 (31): 4404­4408. Marufu, T. and Siziya, S. Impact of multiple dose measles vaccination on measles transmission patterns in Gweru, Zimbabwe J.Trop.Pediatr. 2001, 47 (6): 335­338. Mas, Lago P., Caceres, V. M., Galindo, M. A., Gary, H. E., Jr., Valcarcel, M., Barrios, J., Sarmiento, L., Avalos, I., Bravo, J. A., Palomera, R., Bello, M., Sutter, R. W., Pallansch, M. A., and de Quadros, C. A. Persistence of vaccine­derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication Int.J.Epidemiol. 2001, 30 (5): 1029­1034. Mazzone, P. J., Mossad, S. B., Mawhorter, S. D., Mehta, A. C., Schilz, R. J., and Maurer, J. R. The humoral immune response to influenza vaccination in lung transplant patients Eur.Respir.J. 2001, 18 (6): 971­976. McCarthy, M. Closing vaccination's "window of vulnerability" Lancet. 3­31­2001, 357 (9261): 1022. McCormick, A., Dinakaran, S., Bhola, R., and Rennie, I. G. Recurrent sixth nerve palsy following measles mumps rubella vaccination Eye. 2001, 15 (Pt 3): 356­357. McDade, T. W., Beck, M. A., Kuzawa, C., and Adair, L. S. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence Am.J.Clin.Nutr. 2001, 74 (4): 543­548. McDaid, D. and Maynard, A. Translating evidence into practice. The case of influenza vaccination Eur.J.Public Health. 2001, 11 (4): 453­455. Michiels, B., Coenen, S., Avonts, D., Van Royen, P., and Denekens, J. Who benefits from an influenza vaccination of GPs? Vaccine. 10­12­2001, 20 (1­2): 1­
2. Mihalopoulos, N. L., Khan, A., and Wiese, J. Influenza: recommendations for vaccination and treatment J.La State Med.Soc. 2001, 153 (12): 596­602. Miller, P. L., Frawley, S. J., and Sayward, F. G. Exploring the utility of demographic data and vaccination history data in the deduplication of immunization registry patient records J.Biomed.Inform. 2001, 34 (1): 37­50. Miller, P. L., Frawley, S. J., and Sayward, F. G. Exploring the utility of demographic data and vaccination history data in the deduplication of immunization registry patient records J.Biomed.Inform. 2001, 34 (1): 37­50. MMWR. Acute flaccid paralysis associated with circulating vaccine­derived poliovirus­­Philippines, 2001. MMWR Morb Mortal Wkly Rep. 2001 Oct 12;50(40):874­5. Mollenkopf, H., Dietrich, G., and Kaufmann, S. H. Intracellular bacteria as targets and carriers for vaccination Biol.Chem. 2001, 382 (4): 521­532. Mooi, F. R., van Loo, I. H., and King, A. J. Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence? Emerg.Infect.Dis. 2001, 7 (3 Suppl): 526­528. Moreno, S., Blazquez, R., Novoa, A., Carpena, I., Menasalvas, A., Ramirez, C., and Guerrero, C. The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees Arch.Intern.Med. 7­23­2001, 161 (14): 1760­1765. Moreton, J. MMR vaccination: the case for evidence­based practice Br.J.Community Nurs. 2001, 6 (4): 199­200. Mori, O. [The first vaccination by cowpox in Inaba and Hoki] (Jpn) Nippon Ishigaku.Zasshi. 1991, 37 (4): 513­533. Moriabadi, N. F., Niewiesk, S., Kruse, N., Jung, S., Weissbrich, B., ter, Meulen, V, Toyka, K. V., and Rieckmann, P. Influenza vaccination in MS: absence of T­cell response against white matter proteins Neurology. 4­10­2001, 56 (7): 938­943. Morimoto, N. The relationship between poliovirus multiplication, the sIgA antibody response and the serum neutralizing antibody titers after trivalent oral polio vaccination Kansenshogaku Zasshi. 2001, 75 (12): 1030­1039. Mortimer, E. A. Jr, Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., and Salive, M. E. Mrozek­Budzyn, D. [Performance of vaccinations against poliomyelitis and measles in Malopolska province versus the plan for eradication and elimination of these diseases.] Przegl.Epidemiol. 2001, 55 (3): 355­363. Mrozek­Budzyn, D. [The reasons of low performance and delaying in the compulsory vaccinations of children. The methods of research.] Przegl.Epidemiol. 2001, 55 (3): 343­353. Muennig, P. A. and Khan, K. Cost­Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults Clin.Infect.Dis. 12­1­2001, 33 (11): 1879­1885. Mulholland, K. and Barreto, M. L. Routine vaccination and child survival in Guinea­Bissau. Lessons can be learnt from this study BMJ. 2­10­2001, 322 (7282): 360. Mysliwski, A., Trzonkowski, P., Szmit, E., Dobyszuk, A., Mysliwska, J., and Foerster, J. Anti­influenza vaccination changes expression of CD45 isoforms on peripheral blood NK cells of the elderly Adv.Exp.Med.Biol. 2001, 495:311­4. (): 311­314. Nakase, H., Okazaki, K., Tabata, Y., Uchida, K., Uose, S., Ohana, M., Nishi, T., Watanabe, T., Matsuura, M., Hisatsune, H., Matsumura, K., Itoh, T., Kawanami, C., and Chiba, T. Rectal immunization with antigen­containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination Vaccine. 11­12­2001, 20 (3­4): 377­384. Nettleman, M. D., White, T., Lavoie, S., and Chafin, C. Nichol, K. L. Cost­Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza Arch.Intern.Med. 3­12­2001, 161 (5): 749­759. Niu, M. T., Erwin, D. E., and Braun, M. M. Data mining in the US Vaccine Adverse Event Reporting System (): early detection of intussusception and other events after rotavirus vaccination Vaccine. 9­14­2001, 19 (32): 4627­4634. Noped, J. C. and Schomberg, R. Implementing an inpatient pharmacy­based pneumococcal vaccination program Am.J.Health Syst.Pharm. 10­1­2001, 58 (19): 1852­1855. Ogra, P. L., Faden, H., and Welliver, R. C. Vaccination strategies for mucosal immune responses Clin.Microbiol.Rev. 2001, 14 (2): 430­445. Ogura, M. and Ichimura, H. [Measles epidemic and investigation of the vaccination history in Chiba Prefecture in 2000. A report from Chiba epidemiological surveillance of tuberculosis and infectious diseases] Kansenshogaku Zasshi. 2001, 75 (8): 686­691. Olson, A. D., Shope, T. C., and Flynn, J. T. Pretransplant varicella vaccination is cost­effective in pediatric renal transplantation Pediatr.Transplant. 2001, 5 (1): 44­50. Opstelten, W., Hak, E., Verheij, T. J., and van Essen, G. A. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance Am.J.Med. 10­15­2001, 111 (6): 474­479. Orellana, C. Mexican vaccine against typhoid fever in phase I trial Lancet Infect.Dis. 2001, 1 (5): 292. Orient, J. M. Public health risks of not vaccinating children JAMA. 3­28­2001, 285 (12): 1573. Osterholm, M. T. How to vaccinate 30,000 people in three days: realities of outbreak management Public Health Rep. 2001, 116 Suppl 2:74­8. (): 74­78. Parkkali, T., Vakevainen, M., Kayhty, H., Ruutu, T., and Ruutu, P. Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine Bone Marrow Transplant. 2001, 27 (2): 207­211. Paterson, R. Human trials start for new tuberculosis vaccine Lancet Infect.Dis. 2001, 1 (5): 291. Patja A, Makinen­Kiljunen S, Davidkin I, Paunio M, Peltola H. Allergic Reactions to Measles­Mumps­Rubella Vaccination. Pediatrics 2001 Feb;107(2):E27 Pattison, H. and Pareek, M. Health professionals' attitudes to MMR vaccine. Advice in primary care affects parents' decision to take up MMR vaccination BMJ. 5­5­2001, 322 (7294): 1121. Pattison, S. Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine? BMJ. 10­
13­2001, 323 (7317): 840. Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases Epidemiol.Infect. 2001, 127 (1): 63­71. Pesanti, E. L. Immunologic defects and vaccination in patients with chronic renal failure Infect.Dis.Clin.North Am. 2001, 15 (3): 813­832. Peters, P. H., Jr., Gravenstein, S., Norwood, P., De, Bock, V, Van Couter, A., Gibbens, M., von Planta, T. A., and Ward, P. Long­term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population J.Am.Geriatr.Soc. 2001, 49 (8): 1025­1031. Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ 2001 Jan 13;322(7278):82­5 Pichichero, M. E., Anderson, E. L., Rennels, M. B., Edwards, K. M., and England, J. A. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four­ to six­year­olds Pediatr.Infect.Dis.J. 2001, 20 (4): 427­433. Plotkin, S. A. Vaccination against cytomegalovirus Arch.Virol.Suppl. 2001, 17): 121­134. Poehling, K. A., Speroff, T., Dittus, R. S., Griffin, M. R., Hickson, G. B., and Edwards, K. M. Predictors of influenza virus vaccination status in hospitalized children. Pediatrics 2001; 108(6): 99. Pokorn, M., Kopac, S., Neubauer, D., and Cizman, M. Economic evaluation of Haemophilus influenzae type b vaccination in Slovenia Vaccine. 5­14­2001, 19 (25­26): 3600­3605. Pollard, A. J. and Scheifele, D. Meningococcal disease and vaccination in North America J.Paediatr.Child Health. 2001, 37 (5): S20­S27. Pollard, A. J. and Scheifele, D. Meningococcal disease and vaccination in North America. J Paediatr Child Health 2001; 37(5): 20­27. Ponnuraj EM, John TJ, Levin MJ, Simoes EA. Sabin attenuated LSc/2ab strain of poliovirus spreads to the spinal cord from a peripheral nerve in bonnet monkeys (Macaca radiata). J Gen Virol 2001 Jun;82(Pt 6):1329­. Postma, M. J., Heijnen, M. L., and Jager, J. C. Cost­effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands Pharmacoeconomics. 2001, 19 (2): 215­222. Pronsati, M. P. Facts Support Immunization Adv.Nurse Pract. 2001, 9 (2): 11 Pyhala, R., Haanpaa, M., Kleemola, M., Tervahauta, R., Visakorpi, R., and Kinnunen, L. Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match Vaccine. 4­30­2001, 19 (23­24): 3253­3260. Pyhala, R., Ikonen, N., Santanen, R., Haanpaa, M., Visakorpi, R., Jappinen, P., and Valle, M. Vaccination­induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996­1997 epidemic season J.Med.Virol. 2001, 65 (3): 584­589. Quail, P. Flu vaccination in Alberta long­term care facilities CMAJ. 11­13­2001, 165 (10): 1299. Raaska, K., Raitasuo, V., and Neuvonen, P. J. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia Eur.J.Clin.Pharmacol. 2001, 57 (10): 705­708. Rahman, M., Sekimoto, M., Takamatsu, I., Hira, K., Shimbo, T., Toyoshima, K., and Fukui, T. Economic evaluation of universal BCG vaccination of Japanese infants Int.J.Epidemiol. 2001, 30 (2): 380­385. Ramsay, M., Slack, M., and Kaczmarski, E. Surveillance of Haemophilus influenzae infection. Surveillance data for assessing impact of vaccination are valid BMJ. 3­10­2001, 322 (7286): 613­614. Reeder, J. C. Towards a Malaria Vaccine for Papua New Guinea P N.G.Med.J 2001, 44 (1­2): 17­23 Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., and Tashiro, M. The Japanese experience with vaccinating schoolchildren against influenza N.Engl.J.Med. 3­22­2001, 344 (12): 889­896. Riddell, M. A., Leydon, J. A., Ugoni, A., and Kelly, H. A. A serosurvey evaluation of the school­based measles 'catch­up' immunisation campaign in Victorian school­aged children Aust.N.Z.J.Public Health. 2001, 25 (6): 529­533. Rodewald, L. E. and Santoli, J. M. The challenge of vaccinating vulnerable children J.Pediatr. 2001, 139 (5): 613­615. Roos­Van Eijndhoven, D. G., Cools, H. J., Westendorp, R. G., Cate­Hoek, A. J., Knook, D. L., and Remarque, E. J. Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects J.Med.Virol. 2001, 63 (4): 293­298. Russell, M. L. and Ferguson, C. A. Using epidemiology to target staff influenza vaccination programs Infect.Control Hosp.Epidemiol. 2001, 22 (8): 525­526.
Russell, M. L. Influenza vaccination in Alberta long­term care facilities CMAJ. 5­15­2001, 164 (10): 1423­1427.
Ryan, E. J., Daly, L. M., and Mills, K. H. Immunomodulators and delivery systems for vaccination by mucosal routes Trends Biotechnol. 2001, 19 (8): 293­
304. Saadoun D, Cacoub P, Mahoux D, Sbai A, Piette JC. Postvaccine vasculitis: a report of three cases. Rev Med Interne 2001 Feb;22(2):172­6. Saha, S. K., Baqui, A. H., Hanif, M., Darmstadt, G. L., Ruhulamin, M., Nagatake, T., Santosham, M., and Black, R. E. Typhoid fever in Bangladesh: implications for vaccination policy Pediatr.Infect.Dis.J. 2001, 20 (5): 521­524. Salleras, L., Dominguez, A., Prats, G., Parron, I., and Munoz, P. Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people J.Epidemiol.Community Health. 2001, 55 (4): 283­287. Salmon DA, Siegel AW. Religious and philosophical exemptions from vaccination requirements and lessonslearned from conscientious objectors from conscription. Public Health Rep. 2001 Jul­Aug;116(4):289­95. Sasmaz, R., Altinyazar, H. C., Tatlican, S., Eskioglu, F., and Yurtsever, P. Recurrent lupus vulgaris following repeated BCG (Bacillus Calmette Guerin) vaccination J.Dermatol. 2001, 28 (12): 762­764. Schaberg, T. [Protective Vaccination Against Pneumococci]. Pneumologie 2001; 55(12): 543­545. Schellenberg, D., Menendez, C., Kahigwa, E., Aponte, J., Vidal, J., Tanner, M., Mshinda, H., and Alonso, P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo­controlled trial Lancet. 5­12­2001, 357 (9267): 1471­1477. Schmitt, H. J. and Habermehl, P. [Your most important duty concerning vaccinations in childhood. Instruct the parents!] MMW.Fortschr.Med. 11­15­2001, 143 (46): 36­39. Schneider, E. C., Cleary, P. D., Zaslavsky, A. M., and Epstein, A. M. Racial Disparity in Influenza Vaccination: Does Managed Care Narrow the Gap Between African Americans and Whites? JAMA. 9­26­2001, 286 (12): 1455­1460. Schnorr JJ, Cutts FT, Wheeler JG, Akramuzzaman SM, Alam MS, Azim T, Schneider­Schaulies S, ter­Meulen V. Immune modulation after measles vaccination of 6­9 months old Bangladeshi infants. Vaccine 2001 Jan 8;19(11­12):1503­10. Schofield I. Influenza vaccination. Nurs Older People. 2000 Dec­2001 Jan;12(9):21­4; quiz 25. School absenteeism, parental work loss, and acceptance of childhood influenza vaccination Am.J.Med.Sci. 2001, 321 (3): 178­180. Schunk, M., Wachinger, W., and Wachinger, H. Vaccination status and prophylactic measures of travelers from Germany to subtropical and tropical areas: results of an airport survey J.Travel.Med. 2001, 8 (5): 260­262. Schwartz M, Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med 2001 Jun;7(6):252­8. Schwartz, B. and Orenstein, W. A. Vaccination Policies and Programs: The Federal Government's Role in Making the System Work. Prim Care 2001; 28(4): 697­711. Scrimgeour, E. M. and Mehta, F. R. Rabies in Oman: failed postexposure vaccination in a lactating woman bitten by a fox. Int J Infect Dis 2001; 5(3): 160­2. Sen S, Cloete Y, Hassan K, Buss P. Adverse events following vaccination in premature infants. Acta Paediatr 2001 Aug;90(8):916­20. Sen, S., Cloete, Y., Hassan, K., and Buss, P. Adverse events following vaccination in premature infants Acta Paediatr. 2001, 90 (8): 916­920. Shadick, N. A., Liang, M. H., Phillips, C. B., Fossel, K., and Kuntz, K. M. The Cost­effectiveness of Vaccination Against Lyme Disease Arch.Intern.Med. 2­
26­2001, 161 (4): 554­561. Shah, S., Raman, S., Moreira, C., and MacIntyre, C. R. School immunisation certificates­­a review over time in a disadvantaged community Aust.N.Z.J.Public Health. 2001, 25 (6): 534­538. Shefer, A. M., Luman, E. T., Lyons, B. H., Coronado, V. G., Smith, P. J., Stevenson, J. M., and Rodewald, L. E. Vaccination status of children in the Women, Infants, and Children (WIC) Program(2). Are we doing enough to improve coverage? Am.J.Prev.Med. 2001, 20 (4 Suppl): 47­54. Silverman, N. S. and Greif, A. Influenza vaccination during pregnancy. Patients' and physicians' attitudes J.Reprod.Med. 2001, 46 (11): 989­994. Simonsen, L., Morens, D., Elixhauser, A., Gerber, M., Van Raden, M., and Blackwelder, W. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception Lancet. 10­13­2001, 358 (9289): 1224­1229. Singh, D., Sutton, C., and Woodcock, A. Repeat Tuberculin Testing in BCG­vaccinated Subjects in the United Kingdom. The booster effect varies with the time of reading Am.J.Respir.Crit Care Med. 9­15­2001, 164 (6): 962­964. Sinisalo, M., Aittoniemi, J., Oivanen, P., Kayhty, H., Olander, R. M., and Vilpo, J. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia Br.J.Haematol. 2001, 114 (1): 107­110. Skull, S. A. and Butler, J. R. Meningococcal vaccination for adolescents? An economic evaluation in Victoria J.Paediatr.Child Health. 2001, 37 (5): S28­S33. Skull, S. A. and Wang, E. E. Varicella vaccination­a critical review of the evidence Arch.Dis.Child. 2001, 85 (2): 83­90. Skull, S. A., Andrews, R. M., Gorrie, G. J., Riddell, M. A., and Street, A. C. Healthcare workers continue to be at risk of measles: a case for better vaccination coverage Med.J.Aust. 6­18­2001, 174 (12): 662­663. Skull, S. and Butler, J. Meningococcal vaccination for adolescents? An economic evaluation in Victoria. J Paediatr Child Health 2001; 37(5): 28­33. Skull, S., Butler, J., Robinson, P., and Carnie, J. Should programmes for community­level meningococcal vaccination be considered in Australia? An economic evaluation Int.J.Epidemiol. 2001, 30 (3): 571­578. Slee DS, Lagro SW, Frenkel J. Acute hemorrhagic edema in children: excellentprognosis. Ned Tijdschr Geneeskd 2001 Apr 28;145(17):830­4. Sleeman K, Knox K, George R, Miller E, Waight P, Griffiths D, Efstratiou A, Broughton K, Mayon­White RT, Moxon ER, et al. Invasive Pneumococcal Disease in England and Wales: Vaccination Implications. J Infect Dis 2001 Jan;183(2):239­46 Smeeth, L., Hall, A. J., Fombonne, E., Rodrigues, L. C., Huang, X., and Smith, P. G. A case­control study of autism and mumps­measles­rubella vaccination using the general practice research database: design and methodology BMC.Public Health. 2001, 1 (1): 2. Sparkes, A. H. Towards a more rational and scientific approach to vaccination J.Feline.Med.Surg. 2001, 3 (2): 45­46. Stambos V, Brussen KA, Turnbull A, Thorley B, Kennett M. Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000. Commun Dis Intell 2001 Apr;25(2):54­8. Stephenson, J. The World in Medicine: Smallpox Vaccination and the WHO JAMA. 11­14­2001, 286 (18): 2225. Stevens­Johnson Syndrome After Vaccination. Pediatr Infect Dis J 2001; 20(8): 818­819. Stokley S, Rodewald LE, Maes EF. The impact of record scattering on the measurement of immunization coverage. Pediatrics 2001 Jan;107(1):91­6 Stokley, S., Smith, P. J., Klevens, R. M., and Battaglia, M. P. Vaccination status of children living in rural areas in the United States(2). Are they protected? Am.J.Prev.Med. 2001, 20 (4 Suppl): 55­60. Strauss, B. and Bigham, M. Does measles­mumps­rubella (MMR) vaccination cause inflammatory bowel disease and autism? Can.Commun.Dis.Rep. 4­15­
2001, 27 (8): 65­72. Suker, J. and Feavers, I. M. Prospects offered by genome studies for combating meningococcal disease by vaccination Pharmacogenomics. 2001, 2 (3): 273­
283. Swan, R. Public health risks of not vaccinating children JAMA. 3­28­2001, 285 (12): 1573­1574. Takao, S., Ishida, T., Shimazu, Y., Fukuda, S., Noda, M., and Miyazaki, K. Genetic differentiation of a measles virus isolated from a case occurring 15 days after measles vaccination Jpn.J.Infect.Dis. 2001, 54 (3): 119­120. Talani, P., Nzaba, P., Bolanda, D., Ambedet, A., and Moyen, G. [Anti­tetanus vaccination protection on the Kouilou region of Congo­Brazzaville] Med.Trop.(Mars.). 2001, 61 (2): 195. Tantawichien, T., Tantawichien, T., Supit, C., Khawplod, P., and Sitprija, V. Three­year experience with 4­site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis Clin.Infect.Dis. 12­15­2001, 33 (12): 2085­2087. Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Lagergard, T., Schneerson, R., and Robbins, J. B. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Pediatrics 2001; 108(6): 115. Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Sundh, V., Lagergard, T., Lind­Brandberg, L., Zackrisson, G., White, J., Cicirello, H., Fusco, J., and Robbins, J. B. Mass vaccination of children with pertussis toxoid­decreased incidence in both vaccinated and nonvaccinated persons Clin.Infect.Dis. 10­1­
2001, 33 (7): 1004­1010. Tillmann, B. U., Tillmann, H. C., Nars, P. W., and Weber, P. Vaccination rate and age of premature infants weighing <1500 g: a pilot study in north­western Switzerland Acta Paediatr. 2001, 90 (12): 1421­1426. Traynor, K. CDC has anthrax, smallpox vaccination guidelines available Am.J.Health Syst.Pharm. 11­1­2001, 58 (21): 2008. Troillet, N. and Laurencet, F. Effects of yellow fever vaccination. Lancet 2001; 358(9296): 1908­1909. Tukuitonga, C. Meningococcal vaccine N.Z.Med.J. 12­14­2001, 114 (1145): 557. Tunstall­Pedoe, S. The role of opportunistic vaccination should not be forgotten Fam.Pract. 2001, 18 (4): 464. Umeed, M. Vaccinating against influenza and pneumococcus. Nurs Times. 2001 Oct 18­24;97(42):32­4. Van Amburgh, J. A., Waite, N. M., Hobson, E. H., and Migden, H. Improved influenza vaccination rates in a rural population as a result of a pharmacist­
managed immunization campaign Pharmacotherapy. 2001, 21 (9): 1115­1122. Van Den Hof S, de Melker HE, Berbers GA, van Der Kraak PH, Spaendonck MA. Antibodies to Haemophilus influenzae Serotype b in The Netherlands a Few Years after the Introduction of Routine Vaccination. Clin Infect Dis 2001 Jan;32(1):2­8 Van den, Hof S., Wallinga, J., Widdowson, M. A., and Conyn­van Spaendonck, M. A. E. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules Epidemiol.Infect. 2001, 128 (1): 47­57. Van der Velden, A. M., Mulder, A. H., Hartkamp, A., Diepersloot, R. J., Velzen­Blad, H., and Biesma, D. H. Influenza virus vaccination and booster in B­cell chronic lymphocytic leukaemia patients European Journal of Internal Medicine 2001, 12 (5): 420­424. Van Herck K, Van Damme P. Inactivated hepatitis A vaccine­induced antibodies: follow­up and estimates of long­term persistence. J Med Virol 2001 Jan;63(1):1­7 Van, der Lubben, I, Verhoef, J. C., Borchard, G., and Junginger, H. E. Chitosan for mucosal vaccination Adv.Drug Deliv.Rev. 11­5­2001, 52 (2): 139­144. Verstraeten, T., Baughman, A. L., Cadwell, B., Zanardi, L., Haber, P., Chen, R. T., and the Vaccine Adverse Event Reporting System Team Enhancing Vaccine Safety Surveillance: A Capture­Recapture Analysis of Intussusception after Rotavirus Vaccination. Am J Epidemiol 2001; 154(11): 1006­1012. Verweij, M. Individual and Collective Considerations in Public Health: Influenza Vaccination in Nursing Homes Bioethics. 2001, 15 (5­6): 536­546. Vessey, S. J., Chan, C. Y., Kuter, B. J., Kaplan, K. M., Waters, M., Kutzler, D. P., Carfagno, P. A., Sadoff, J. C., Heyse, J. F., Matthews, H., Li, S., and Chan, I. S. Childhood vaccination against varicella: Persistence of antibody, duration of protection, and vaccine efficacy J.Pediatr. 2001, 139 (2): 297­304. Vigni, L. [Smallpox Vaccination in Siena During the Napoleonic Era]. Infez.Med. 2001, 9 (2): 115­118. Vlasich, C. Pneumococcal infection and vaccination in the elderly Vaccine. 3­21­2001, 19 (17­19): 2233­2237. Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever. Klin Monatsbl Augenheilkd 2001Oct;218(10):688­90. Wahid, S. T., Nag, S., Bilous, R. W., Marshall, S. M., and Robinson, A. C. Audit of influenza and pneumococcal vaccination uptake in diabetic patients attending secondary care in the Northern Region Diabet.Med. 2001, 18 (7): 599­603. Wallinga, J., Levy­Bruhl, D., Gay, N. J., and Wachmann, C. H. Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries Epidemiol.Infect. 2001, 127 (2): 281­295. Ward, B. M., Lambert, S. B., and Lester, R. A. Rubella vaccination in prenatal and postnatal women: why not use MMR? Med.J.Aust. 3­19­2001, 174 (6): 311­312. Watanabe T, Onda H. Henoch­Schonlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatr Nephrol. 2001 May;16(5):458­
9; discussion 460­2. Watanabe, T. and Onda, H. Henoch­Schonlein purpura with antiphospholipid antibodies following an influenza vaccination Pediatr.Nephrol. 2001, 16 (5): 458­459. Wattigney, W. A., Mootrey, G. T., Braun, M. M., and Chen, R. T. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine Pediatrics. 2001, 107 (5): E83. Weaver M, Krieger J, Castorina J, Walls M, Ciske S. Cost­effectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med 2001 Jan 8;161(1):111­20 Weir, E. Yellow fever vaccination: be sure the patient needs it CMAJ. 10­2­2001, 165 (7): 941. Werfel, U. and Popp, W. Effects of yellow fever vaccination. Lancet 2001; 358(9296): 1909. Yamazaki, T., Suzuki, T., and Yamamoto, K. Vaccinating Japanese schoolchildren against influenza N.Engl.J.Med. 6­21­2001, 344 (25): 1947­1948. Yenicesu, I., Yetgin, S., and Ozyurek, E. Vaccination­associated immune thrombocytopenic purpura in five children Pediatr.Hematol.Oncol. 2001, 18 (8): 547­549. Zaas A, Scheel P, Venbrux A, Hellmann DB.Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. J Rheumatol 2001 May;28(5):1116­20. Zanetta, R. A., Amaku, M., Azevedo, R. S., Zanetta, D. M., Burattini, M. N., and Massad, E. Optimal age for vaccination against measles in the State of Sao Paulo, Brazil, taking into account the mother's serostatus Vaccine. 10­12­2001, 20 (1­2): 226­234. Zhang, J. T­cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy Crit Rev.Immunol. 2001, 21 (1­3): 41­55. Zimmerman, R. K. and Ball, J. A. Adult Vaccinations. Prim Care 2001; 28(4): 763­790. Zuber, P. L., Conombo, K. S., Traore, A. D., Millogo, J. D., Ouattara, A., Ouedraogo, I. B., and Valian, A. Mass measles vaccination in urban Burkina Faso, 1998 Bull.World Health Organ. 2001, 79 (4): 296­300. 2002 Aaby, P., Jensen, H., Garly, M. L., Bale, C., Martins, C., and Lisse, I. Routine Vaccinations and Child Survival in a War Situation With High Mortality: Effect of Gender Vaccine 11­22­2002, 21 (1­2): 15­20 Abbey, D. M. Antivaccination Web Sites. JAMA 10­9­2002, 288 (14): 1717. Ahmad, K. Vaccination With Varicella Protects Against Zoster Infection Lancet Oncol. 2002, 3 (9): 523. Ahmed, F., Elbasha, E. E., Thompson, B. L., Harris, J. R., and Sneller, V. P. Cost­Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination. Med.Decis.Making 2002, 22 (5 Suppl): S58­S66. Aller Blanco A, Garjon Parra F, Buisan Giral M, Palacin Arbues J. Is vaccination for pneumococci in the over­65s justified? Aten Primaria. 2002 Apr 30;29(7):433­437. Spanish. Allsup, S.J., Gosney, M.A. Difficulties of recruitment for a randomized controlled trial involving influenza vaccination in healthy older people. Gerontology. 2002 May­Jun;48(3):170­3. Alm, J.S., Sanjeevi, C.B., Miller, E.N., Dabadghao, P., Lilja, G., Pershagen, G., Blackwell, J.M., Scheynius, A. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun. 2002 Apr;3(2):71­7. Alpay, H., Yildiz, N., Onar, A., Temizer, H., Ozcay, S. Varicella vaccination in children with steroid­sensitive nephrotic syndrome. Pediatr Nephrol. 2002 Mar;17(3):181­3. Apuzzio, J., Ganesh, V., Iffy, L., and Al Khan, A. Varicella Vaccination During Early Pregnancy: A Cause of in Utero Miliary Fetal Tissue Calcifications and Hydrops? Infect.Dis.Obstet.Gynecol. 2002, 10 (3): 159­160. Aribas, O. K., Kanat, F., Gormus, N., and Turk, E. Cold abscess of the chest wall as an unusual complication of BCG vaccination Eur.J.Cardiothorac.Surg. 2002, 21 (2): 352­354. Arita, I. Duration of Immunity After Smallpox Vaccination: A Study on Vaccination Policy Against Smallpox Bioterrorism in Japan. Jpn.J Infect.Dis. 2002, 55 (4): 112­116. Arthur, A. J., Matthews, R. J., Jagger, C., Clarke, M., Hipkin, A., and Bennison, D. P. Improving Uptake of Influenza Vaccination Among Older People: a Randomised Controlled Trial Br.J.Gen.Pract. 2002, 52 (482): 717­2. Atkinson, W. L., Pickering, L. K., Schwartz, B., Weniger, B. G., Iskander, J. K., and Watson, J. C. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP) MMWR Morb.Mortal.Wkly.Rep. 2­8­2002, 51 (RR­2): 1­35. Baleta, A. "Urgent global response" needed to vaccinate the world's children. Lancet. 2002 Apr 20;359(9315):1414. No abstract available. Barker, L. E., Luman, E. T., McCauley, M. M., and Chu, S. Y. Assessing Equivalence: an Alternative to the Use of Difference Tests for Measuring Disparities in Vaccination Coverage Am.J Epidemiol. 12­1­2002, 156 (11): 1056­1061 Barker, L., Luman, E., Zhao, Z., Smith, P., Linkins, R., Santoli, J., Rodewald, L., and McCauley, M. National, State, and Urban Area Vaccination Coverage Levels Among Children Aged 19­35 Months­­United States, 2001 MMWR Morb.Mortal.Wkly.Rep. 8­2­2002, 51 (30): 664­666. Barton, L. L. Immunology series: vaccines N.Engl.J.Med. 3­14­2002, 346 (11): 864­866. Batayneh, N. and Bdour, S. Mumps: Immune Status of Adults and Epidemiology As a Necessary Background for Choice of Vaccination Strategy in Jordan. APMIS 2002, 110 (7­8): 528­534. Baudier, F., Allemand, H., and Lancry, P. J. [Threats on Vaccination?]. Rev.Epidemiol.Sante Publique 2002, 50 (6): 505­508. Baxby, D. Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine. 2002 May 15;20(16):2140­9. Baxby, Rb R. Studies in Smallpox and Vaccination Rev.Med.Virol. 2002, 12 (4): 201­209. Beach, J. and Hobson, J. Influenza Vaccination Occup.Med.(Lond) 2002, 52 (5): 237­238. Berg, A. T. Seizure Risk With Vaccination. Epilepsy Curr. 2 (1): 15­16; January, 2002. Beverley, P. C. Immunology of Vaccination Br.Med.Bull. 2002, 62 (1): 15­28. Bhatt, K. M. and Bhatt, S. M. Anthrax Revisited. East Afr.Med.J 2002, 79 (7): 364­367. Bhrolchain CN. Do children who become autistic consult more often after MMR vaccination? Child Care Health Dev. 2002 May;28(3):268­9. Birchmeier, M., Favrat, B., Pecoud, A., Abetel, G., Karly, M., Landry, P., Mancini, M., Verdon, F., and Genton, B. Improving Influenza Vaccination Rates in the Elderly. J Fam.Pract. 2002, 51 (10): 856. Black, G.F., Weir, R.E., Floyd, S., Bliss, L., Warndorff, D.K., Crampin, A.C., Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J.M., Branson, K., Chaguluka, S.D., Donovan, L., Jarman, E., King, E., Fine, P.E., Dockrell, H.M. BCG­induced increase in interferon­gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002 Apr 20;359(9315):1393­401. Bode, G., Piechotowski, I., Rothenbacher, D., and Brenner, H. Helicobacter Pylori­Specific Immune Responses of Children: Implications for Future Vaccination Strategy Clin.Diagn.Lab Immunol. 2002, 9 (5): 1126­1128. Bond, L., Davie, G., Carlin, J. B., Lester, R., and Nolan, T. Increases in vaccination coverage for children in child care, 1997 to 2000: an evaluation of the impact of government incentives and initiatives Aust.N.Z.J.Public Health. 2002, 26 (1): 58­64. Borrow, R., Goldblatt, D., Andrews, N., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K., and Miller, E. Antibody Persistence and Immunological Memory at Age 4 Years After Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom. J Infect.Dis. 11­1­2002, 186 (9): 1353­1357. Bradshaw, J. and Wright, P. F. Cold­adapted influenza vaccines Curr.Opin.Pediatr. 2002, 14 (1): 95­98. Brammer, T. L., Murray, E. L., Fukuda, K., Hall, H. E., Klimov, A., and Cox, N. J. Surveillance for Influenza­­United States, 1997­98, 1998­99, and 1999­00 Seasons MMWR Surveill Summ. 10­25­2002, 51 (7): 1­10 Bramson, J. L. and Wan, Y. H. The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen Expert.Opin.Biol.Ther. 2002, 2 (1): 75­85. Bratzler, D. W., Houck, P. M., Jiang, H., Nsa, W., Shook, C., Moore, L., and Red, L. Failure to Vaccinate Medicare Inpatients: a Missed Opportunity Arch.Intern.Med. 11­11­2002, 162 (20): 2349­2356 Braun, R. and Hassler, D. Vaccination. Hepatitis A Dtsch.Med.Wochenschr. 2002, 127 (16): 835. [Article in German] Braun, R., Kimmig, P., and Hassler, D. Vaccination. Hepatitis B Dtsch.Med.Wochenschr. 5­17­2002, 127 (20): 1062. [Article in German] Breukels, M. A., Zijde, E. M., van Tol, M. J., and Rijkers, G. T. Concentration and Avidity of Anti­Haemophilus influenzae Type b (Hib) Antibodies in Serum Samples Obtained from Patients for Whom Hib Vaccination Failed. Clin Infect Dis 2002; 34(2): 191­197. Brisson, M. and Edmunds, W. J. The cost­effectiveness of varicella vaccination in Canada Vaccine. 1­15­2002, 20 (7­8): 1113­1125. Bunout, D., Hirsch, S., Pia, de la Maza, Munoz, C., Haschke, F., Steenhout, P., Klassen, P., Barrera, G., Gattas, V., and Petermann, M. Effects of Prebiotics on the Immune Response to Vaccination in the Elderly. JPEN J Parenter.Enteral Nutr. 2002, 26 (6): 372­376. Burns, V. E., Drayson, M., Ring, C., and Carroll, D. Perceived Stress and Psychological Well­Being Are Associated With Antibody Status After Meningitis C Conjugate Vaccination Psychosom.Med. 2002, 64 (6): 963­970 Burrage, M., Robinson, A., Borrow, R., Andrews, N., Southern, J., Findlow, J., Martin, S., Thornton, C., Goldblatt, D., Corbel, M., Sesardic, D., Cartwight, K., Richmond, P., and Miller, E. Effect of Vaccination With Carrier Protein on Response to Meningococcal C Conjugate Vaccines and Value of Different Immunoassays As Predictors of Protection Infect.Immun. 2002, 70 (9): 4946­4954. Burton, A. Vaccine vanquishes varicella. Lancet. 2002 Apr 20;359(9315):1393­401. Buschard, K. and Funda, D. Vaccination Studies in Type 1 Diabetes Lancet 8­10­2002, 360 (9331): 488. Cale, C. M. and Klein, N. J. The link between rotavirus vaccination and intussusception: implications for vaccine strategies Gut. 2002, 50 (1): 11­12. Campbell, M. J. and Jiwa, M. Educational Outreach to Improve Vaccination Uptake Br.J Gen.Pract. 2002, 52 (485): 1021­1022. Campos, W. and Jalaludin, B. B. Predictors of Influenza Vaccination Amongst Australian Nurses Aust.J Adv.Nurs. 12­20­2002, 20 (2): 19­21. Carabin, H., John, Edmunds W., Kou, U., Van Den, Hof S., and Hung, Nguyen, V The Average Cost of Measles Cases and Adverse Events Following Vaccination in Industrialised Countries BMC.Public Health 2002, 19;2 (1): Carter, R. Spatial Simulation of Malaria Transmission and Its Control by Malaria Transmission Blocking Vaccination Int.J Parasitol. 2002, 32 (13): 1617­1624 Casadevall, A., Feldmesser, M., and Pirofski, L. Induced Humoral Immunity and Vaccination Against Major Human Fungal Pathogens Curr.Opin.Microbiol. 2002, 5 (4): 386. Chaloner, J. H. and Ormerod, L. P. Assessment of the Impact of BCG Vaccination on Tuberculosis Incidence in South Asian Adult Immigrants Commun.Dis.Public Health 2002, 5 (4): 338­340. Chan, L., Maclehose, R. F., and Houck, P. M. Impact of physician reminders on the use of influenza vaccinations: A randomized trial Arch.Phys.Med.Rehabil. 2002, 83 (3): 371­375. Charatan, F. US Health Officials Recommend Offering Smallpox Vaccination to All. BMJ 10­12­2002, 325 (7368): 794. Chen, M., Hu, K. F., Rozell, B., Orvell, C., Morein, B., and Liljestrom, P. Vaccination With Recombinant Alphavirus or Immune­Stimulating Complex Antigen Against Respiratory Syncytial Virus J.Immunol. 9­15­2002, 169 (6): 3208­3216. Choudhri, Y., Walop, W., Squires, S., Tam, T., King, A., Skowronski, D., Warrington, R., and Wood, J. ORS During the 2000­2001 Influenza Vaccination Season Can.Commun.Dis.Rep. 9­1­2002, 28:2­8: 2­8. Christensen, L. S., Scholler, S., Schierup, M. H., Vestergaard, B. F., and Mordhorst, C. H. Sequence Analysis of Measles Virus Strains Collected During the Pre­ and Early­Vaccination Era in Denmark Reveals a Considerable Diversity of Ancient Strains APMIS 2002, 110 (2): 113­122. Christenson, B. and Lundbergh, P. Comparison Between Cohorts Vaccinated and Unvaccinated Against Influenza and Pneumococcal Infection Epidemiol.Infect. 2002, 129 (3): 515­524. Ciriminna, S. and Cuccia, M. ["Herd Immunity" After Administration of Pneumococcal Conjugate Vaccine and Its Impact on Vaccination Campaigns]. Ann.Ig 2002, 14 (6 Suppl 7): 39­42. Clark, J. Mandela Calls for Greater Investment in Global Vaccination BMJ 11­23­2002, 325 (7374): 1193 Cohen, R., Aujard, Y., Bingen, E., Boucherat, M., Bourrillon, A., Foucaud, P., Francois, M., Garnier, J. M., Guillot, M., Ovetchkine, P., Ployet, M. J., Quinet, B., and Gaudelus, J. [Therapeutic approaches in children immunized with vaccine Prevenar] Arch.Pediatr. 2002, 9 (1): 4­6. Cook, I.F., Murtagh, J. Needle length required for intramuscular vaccination of infants and toddlers. An ultrasonographic study. Aust Fam Physician. 2002 Mar;31(3):295­7. Cooper E, O'Reilly M. A novel staff vaccination strategy. Infect Control Hosp Epidemiol. 2002 May;23(5):232­3. Coughlan, S., Connell, J., Cohen, B., Jin, L., and Hall, W. W. Suboptimal Measles­Mumps­Rubella Vaccination Coverage Facilitates an Imported Measles Outbreak in Ireland Clin.Infect.Dis. 7­1­2002, 35 (1): 84­86. Cozzani, E., Cacciapuoti, M., Parodi, A., and Rebora, A. Pemphigus Following Tetanus and Diphtheria Vaccination Br.J.Dermatol. 2002, 147 (1): 188­189. Cremer, R. and Plum, C. Vaccination Rate and Age of Premature Infants Weighing Less Than 1500 GramsActa Paediatr. 2002, 91 (6): 724­725. Cummings, M. L. Informed Consent and Investigational New Drug Abuses in the U.S. Military. Account.Res. 2002, 9 (2): 93­103. Da Cunha, S. S., Rodrigues, L. C., Barreto, M. L., and Dourado, I. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad­Zagreb mumps strain Vaccine. 1­15­2002, 20 (7­8): 1106­1112. Da Silveira, C. M., Kmetzsch, C. I., Mohrdieck, R., Sperb, A. F., and Prevots, D. R. The Risk of Aseptic Meningitis Associated With the Leningrad­Zagreb Mumps Vaccine Strain Following Mass Vaccination With Measles­Mumps­Rubella Vaccine, Rio Grande Do Sul, Brazil, 1997 Int.J Epidemiol. 2002, 31 (5): 978­982 D'Amelio, R., Biselli, R., Cali, G, and Peragallo, M. S. Vaccination Policies in the Military: an Insight on Influenza Vaccine 2002 Dec 20; 20 (S5): B36­B39. Davies, P. Antivaccination Web Sites. JAMA 10­9­2002, 288 (14): 1717. De Wals, P., Allard, M.A., Guindon, K., Mayrand, L., Simard, S., Black, R. [Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec.] Can Commun Dis Rep. 2002 Apr 15;28(8):61­3. Desai, V. K., Kapadia, S. J., Kumar, P., and Nirupam, S. Impact Assessment of Mass Measles Vaccination Indian J Pediatr. 2002, 69 (12): 1037­1040. DeStefano, F., Gu, D., Kramarz, P., Truman, B. I., Iademarco, M. F., Mullooly, J. P., Jackson, L. A., Davis, R. L., Black, S. B., Shinefield, H. R., Marcy, S. M., Ward, J. I., and Chen, R. T. Childhood Vaccinations and Risk of Asthma Pediatr.Infect.Dis.J. 2002, 21 (6): 498­504. Devlin HR. Smallpox still poses a threat. CMAJ. 2002 Apr 16;166(8):1012; D'heilly, S., Bauman, W. L., and Nichol, K. L. Safety and Acceptability of Pneumococcal Vaccinations Administered in Nontraditional Settings Am.J.Infect.Control 2002, 30 (5): 261­268. Diodati, C. Mandatory vaccination of health care workers CMAJ. 2­5­2002, 166 (3): 301­302. Donlin, J. The influenza vaccine NCSL.Legisbrief. 2002, 10 (17): 1­2. Dubois, H. F. The synergistic role TQM and reengineering could play in standardizing the European vaccination policy Qual.Manag.Health Care. 2002, 10 (2): 47­57. Dvornikov, V. S. Diphtheria in the Republic of North Ossetia (Alania) Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2: 79­81. Eason, E., Graham, I. D., Sabourin, M., Salvador, A., and Ranger, L. Introducing Printed Postpartum Orders for Measles­Mumps­Rubella Vaccination: a Qualitative Study J.Obstet.Gynaecol.Can. 2002, 24 (5): 410­414. Eaton, L. New research on autism and measles "proves nothing" BMJ. 2­9­2002, 324 (7333): 315. Edmunds, W. J. and Brisson, M. The Effect of Vaccination on the Epidemiology of Varicella Zoster Virus J.Infect. 2002, 44 (4): 211­219. Edmunds, W. J., Brisson, M., Gay, N. J., and Miller, E. Varicella Vaccination: a Double­Edged Sword? Commun.Dis.Public Health 2002, 5 (3): 185­186 Eibl, N., Spatz, M., Fischer, G. F., Mayr, W. R., Samstag, A., Wolf, H. M., Schernthaner, G., and Eibl, M. M. Impaired Primary Immune Response in Type­1 Diabetes: Results From a Controlled Vaccination Study Clin.Immunol. 2002, 103 (3 Pt 1): 249­259. Eichner, M., Diebner, H. H., Schubert, C., Kreth, H. W., and Dietz, K. Estimation of the Time­Dependent Vaccine Efficacy From a Measles Epidemic Stat.Med. 8­30­2002, 21 (16): 2355­2368. Elkayam, O., Paran, D., Caspi, D., Litinsky, I., Yaron, M., Charboneau, D., and Rubins, J. B. Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus. Clin Infect Dis 2002; 34(2): 147­153. Engler, R. J., Kenner, J., and Leung, D. Y. Smallpox Vaccination: Risk Considerations for Patients With Atopic Dermatitis J.Allergy Clin.Immunol. 2002, 110 (3): 357­365. Enserink, M. Bioterrorism. How Devastating Would a Smallpox Attack Really Be? Science 5­31­2002, 296 (5573): 1592­1595. Enserink, M. Bioterrorism. In Search of a Kinder, Gentler Vaccine Science 5­31­2002, 296 (5573): 1594. Ermolovich, M. A., Fel'dman, E. V., Samoilovich, E. O., Kuzovkova, N. A., and Levin, V. I. Characterization of the Immune Status of Patients With Vaccine­
Associated Poliomyelitis Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 42­50. [Article in Russian] Fair, E., Murphy, T. V., Golaz, A., and Wharton, M. Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years Pediatrics. 2002, 109 (1): E2. Fasth, A. Infection Protection Requires Maintenance in a "Over­Hygienic" Surrounding World Lakartidningen 5­2­2002, 99 (18): 2069. [Article in Swedish] Fletcher, M. A., Tetelboum, R., and Fritzell, B. Time to Recommend Pneumococcal Vaccination for All Children in Europe: Experience in France Eur.J Pediatr. 2002, 161 Suppl 2: S132­4. Froome, J., Badcock, K. Should vaccination be compulsory for all preschool children? Nurs Times. 2002 Mar 21­27;98(12):16. Galil, K., Lee, B., Strine, T., Carraher, C., Baughman, A. L., Eaton, M., Montero, J., and Seward, J. Outbreak of Varicella at a Day­Care Center Despite Vaccination N.Engl.J Med. 12­12­2002, 347 (24): 1909­1915. Gallo, G., Ciofi degli Atti, M. L., Cerquetti, M., Piovesan, C., Tozzi, A. E., and Salmaso, S. Impact of a regional Hib vaccination programme in Italy Vaccine. 1­15­2002, 20 (7­8): 993­995. Gasparini, R., Lucioni, C., Lai, P., Maggioni, P., Sticchi, L., Durando, P., Morelli, P., Comino, I., Calderisi, S., and Crovari, P. Cost­Benefit Evaluation of Influenza Vaccination in the Elderly in the Italian Region of Liguria Vaccine 2002 Dec 20; 20 Suppl 5:B50­4. Getsios, D., Caro, J. J., Caro, G., De Wals, P., Law, B. J., Robert, Y., and Lance, J. M. Instituting a Routine Varicella Vaccination Program in Canada: an Economic Evaluation Pediatr.Infect.Dis.J. 2002, 21 (6): 542­547. Glass, T. A. and Schoch­Spana, M. Bioterrorism and the People: How to Vaccinate a City against Panic. Clin Infect Dis 2002; 34(2): 217­223. Glezen WP. Influenza vaccination for healthy children. Curr Opin Infect Dis. 2002 Jun;15(3):283­7. Gold, M. S. Hypotonic­hyporesponsive episodes following pertussis vaccination: a cause for concern? Drug Saf. 2002, 25 (2): 85­90. Goldman, R. D. and Koren, G. Influenza Vaccination During Pregnancy Can.Fam.Physician 2002 Nov, 48:1768­9: 1768­1769. Gomes­Solecki, M. J., Wormser, G. P., Schriefer, M., Neuman, G., Hannafey, L., Glass, J. D., and Dattwyler, R. J. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status J.Clin.Microbiol. 2002, 40 (1): 193­197. Grabenstein, J. D., Guess, H. A., Hartzema, A. G., Koch, G. G., and Konrad, T. R. Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated J.Clin.Epidemiol. 2002, 55 (3): 279­284. Graham­Rowe, D. and MacKenzie, D. Tough Choices: Would a Separate Measles Vaccination Be a Disaster for Britain?. New Sci. 2­16­2002, 173 (2330): 12­13. Greene, A. Vaccination Fears: What the School Nurse Can Do. J Sch Nurs. 2002, Suppl:31­5. (): 31­35. Grossl, N.A. The reluctant acceptance of new ideas in medicine. Pharos Alpha Omega Alpha Honor Med Soc. 2002 Winter;65(1):18­22. Gruber, C., Meinlschmidt, G., Bergmann, R., Wahn, U., and Stark, K. Is Early BCG Vaccination Associated With Less Atopic Disease? An Epidemiological Study in German Preschool Children With Different Ethnic Backgrounds Pediatr.Allergy Immunol. 2002, 13 (3): 177­181. Guala, A., Garipoli, V., Pastore, G., and Pagani, L. Familial adverse events after measles­mumps­rubella (MMR) vaccination Vaccine. 1­15­2002, 20 (7­8): 991. Gurfinkel, E. and Mautner, B. Secondary Prevention of Coronary Artery Disease. Flu Vaccinations and New Evidence of the Role of Infection in Acute Coronary Syndromes. Rev.Esp.Cardiol. 2002, 55 (10): 1009­1012. Habeck, M. Staphylococcal vaccine one step closer to reality. Lancet Infect Dis 2002 Apr;2(4):201 Hackley, B. K. Controversies in immunization practices: vaccine safety and implications for midwifery practice J.Midwifery Womens Health. 2002, 47 (1): 16­27. Hahne, S. J., Gray, S. J., Jean, Francois, Aguilera, Crowcroft, N. S., Nichols, T., Kaczmarski, E. B., and Ramsay, M. E. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001 Lancet. 2­16­2002, 359 (9306): 582­583. Hak, E., Hoes, A. W., and Verheij, T. J. Influenza Vaccinations: Who Needs Them and When? Drugs 2002, 62 (17): 2413­2420 Hak, E., Nordin, J., Wei, F., Mullooly, J., Poblete, S., Strikas, R., and Nichol, K. L. Influence of High­Risk Medical Conditions on the Effectiveness of Influenza Vaccination Among Elderly Members of 3 Large Managed­Care Organizations Clin.Infect.Dis. 8­15­2002, 35 (4): 370­377. Hall, J., Kenny, P., King, M., Louviere, J., Viney, R., and Yeoh, A. Using Stated Preference Discrete Choice Modelling to Evaluate the Introduction of Varicella Vaccination Health Econ. 2002, 11 (5): 457­465. Halsey, N. A. The Science of Evaluation of Adverse Events Associated With Vaccination Semin.Pediatr.Infect.Dis. 2002, 13 (3): 205­214. Harrison, J. and Abbott, P. Vaccination Against Influenza: UK Health Care Workers Not on­Message Occup.Med.(Lond) 2002, 52 (5): 277­279. Hasanain, F. H. and Jan, M. M. Delays in Primary Vaccination of Infants Living in Western Saudi Arabia. Saudi.Med.J 2002, 23 (9): 1087­1089. Havinga, W. Too Many Vaccinations? Pediatrics 2002, 110 (3): 648­649. Hino, M., Ono, Y., Kokubo, Y., Soma, T., Tanaka, Y., Omata, M., Ichino, K., Uehara, T., Kudoh, S., and Hayama, N. The Frequency Profiles of Size of Two­
Step Tuberculin Skin Tests With Histories of BCG Vaccinations and Tuberculin Tests Among Hospital Employees Kekkaku 2002, 77 (4): 347­354. [Article in Japanese] Hoey, J. Smallpox Vaccination Advice CMAJ. 11­12­2002, 167 (10): 1148 Hopkins, R. H., Ridout, S., and Heft, M. Influenza and pneumococcal vaccination J.Ark.Med.Soc. 2002, 98 (7): 230­231. Hopkins, Tanne J. Old Smallpox Vaccination May Still Protect BMJ 9­7­2002, 325 (7363): 513. Humair, J. P., Buchs, C. R., and Stalder, H. Promoting Influenza Vaccination of Elderly Patients in Primary Care Fam.Pract. 2002, 19 (4): 383­389. Huo, Z., Miles, J., Harris, T., and Riches, P. Effect of Pneumovax((R)) II Vaccination in High­Risk Individuals on Specific Antibody and Opsonic Capacity Against Specific and Non­Specific Antigen Vaccine 10­4­2002, 20 (29­30): 3532. Husain, S., Slobodkin, D., and Weinstein, R. A. Pneumococcal Vaccination: Analysis of Opportunities in an Inner­City Hospital Arch.Intern.Med. 9­23­2002, 162 (17): 1961­1965. Hussell, T. and Humphreys, I. R. Nasal Vaccination Induces Protective Immunity Without Immunopathology Clin.Exp.Immunol. 2002, 130 (3): 359­362 Imbimbo, B. P. Toxicity of Beta­Amyloid Vaccination in Patients With Alzheimer's Disease Ann.Neurol. 2002, 51 (6): 794. Isa, M.B., Martinez, L., Giordano, M., Passeggi, C,. De Wolff M.C., Nates S. Comparison of Immunoglobulin G Subclass Profiles Induced by Measles Virus in Vaccinated and Naturally Infected Individuals. Clin Diagn Lab Immunol 2002 May;9(3):693­697 Isaacs, S. N. Critical Evaluation of Smallpox Vaccination for Laboratory Workers Occup.Environ.Med. 2002, 59 (9): 573­574. Itoh, M., Okuno, Y., Hotta, H. Comparative Analysis of Titers of Antibody against Measles Virus in Sera of Vaccinated and Naturally Infected Japanese Individuals of Different Age Groups. J Clin Microbiol. 2002 May;40(5):1733­1738. Jackson, L. A., Yu, O., Heckbert, S. R., Slobodkin, D., and Weinstein, B. M., Malais, D., Barlow, W. E., and Thompson, W. W. Influenza Vaccination Is Not Associated With a Reduction in the Risk of Recurrent Coronary Events Am.J.Epidemiol. 10­1­2002, 156 (7): 634­640. James, J. S. Smallpox Vaccination Followup: IOM Suggests Changes, Widespread Civilian Vaccinations to Begin. AIDS Treat.News 12­27­2002, 387): 4­5. Javitt, G. H. Drugs and Vaccines for the Common Defense: Refining FDA Regulation to Promote the Availability of Products to Counter Biological Attacks. J Contemp.Health Law Policy 2002, 19 (1): 37­116. Jentoft, H. F., Omenaas, E., Eide, G. E., and Gulsvik, A. Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults Allergy. 2002, 57 (4): 336­340. Jessop, A. B.; Hausman, A. J. Pneumococcal Vaccination in Pennsylvania Nursing Homes: Factors Associated With Vaccination Level. J Am.Med.Dir.Assoc. 3 (6): 347­351; November 2002. Jonsson, S., Vidarsson, G., Valdimarsson, H., Schiffman, G., Schneerson, R., and Jonsdottir, I. Vaccination of COPD Patients With a Pneumococcus Type 6B Tetanus Toxoid Conjugate Vaccine. Eur.Respir.J 2002, 20 (4): 813­818. Josefson, D. US encourages flu jabs for infants aged under 2 BMJ. 3­2­2002, 324 (7336): 502. K secik, M., Emiroglu, H., Tatli, M.M., Koc, A., Atas, A. Prevalence of Tuberculous Infection and the Impact of BCG Vaccination on Tuberculin Testing Among Primary Schoolchildren in Turkey. Indian Pediatr. 2002 Apr;39(4):362­5. Kaji M, Watanabe A, Aizawa H. [Influenza vaccination for elderly patients with neurological disease] Kansenshogaku Zasshi. 2002 Apr;76(4):263­8. Japanese Kaji, M., Watanabe, A., and Aizawa, H. Influenza Vaccination for Elderly Patients With Neurological Disease Kansenshogaku Zasshi 2002, 76 (4): 263­268. [Article in Japanese] Kalda, R., Sarapuu, H., Lember, M., Sontak, G., and Hapunova, M. Family Physicians and Pediatricians Vaccinate Children With Same Quality Fam.Med. 2002, 34 (10): 714­715 Kanesa­Thasan, N., Putnak, J. R., Mangiafico, J. A., Saluzzo, J. E., and Ludwig, G. V. Short Report: Absence of Protective Neutralizng Antibodies to West Nile Virus in Subjects Following Vaccination With Japanese Encephalitis or Dengue Vaccines Am.J.Trop.Med.Hyg. 2002, 66 (2): 115­116. Kapikian, A.Z. Ecological studies, rotavirus vaccination, and intussusception. Lancet. 2002 Mar 23;359(9311):1065­6; discussion 1066. Kaplan, E. H., Craft, D. L., and Wein, L. M. Emergency Response to a Smallpox Attack: The Case for Mass Vaccination Proc.Natl.Acad.Sci.U.S A 7­12­
2002. Karim, Y., Masood, A. Haemolytic uraemic syndrome following mumps, measles, and rubella vaccination. Nephrol Dial Transplant. 2002 May;17(5):941­2. Karma P. Vaccination and Otitis media. ORL J Otorhinolaryngol Relat Spec. 2002 Mar­Apr;64(2):80­5. Katona, S.J. Vaccination to prevent varicella and shingles. J Clin Pathol 2002 May;55(5):399 Katz, S.L. Measles prevention­­ just vaccinate. J Pediatr. 2002 Mar;140(3):382; discussion 382. Kaur, S., Faridi, M. M., and Agarwal, K. N. BCG Vaccination Reaction in Low Birth Weight Infants Indian J Med.Res. 2002, 116:64­9. (): 64­69. Keith, L. S., Jones, D. E., and Chou, C. H. Aluminum Toxicokinetics Regarding Infant Diet and Vaccinations Vaccine 5­31­2002, 20 Suppl 3:S13­7. (): S13­
S17. Kelly, H.A., Riddell, M.A., Andrews, R.M. Measles transmission in healthcare settings in Australia. Med J Aust. 2002 Jan 21;176(2):50­1. Kerrison, J. B., Lounsbury, D., Thirkill, C. E., Lane, R. G., Schatz, M. P., and Engler, R. M. Optic neuritis after anthrax vaccination Ophthalmology. 2002, 109 (1): 99­104. Khanal, P. Nepal's Childhood Mortality Falls by Half As Vaccinations Rise Tenfold Bull.World Health Organ 2002, 80 (12): 988­989. Konishi, E. and Suzuki, T. Ratios of Subclinical to Clinical Japanese Encephalitis (JE) Virus Infections in Vaccinated Populations: Evaluation of an Inactivated JE Vaccine by Comparing the Ratios With Those in Unvaccinated Populations Vaccine 11­22­2002, 21 (1­2): 98­107 Korang, K., Ghohestani, R., Krieg, T., Uitto, J., and Hunzelmann, N. Exacerbation of Pemphigus Foliaceus After Tetanus Vaccination Accompanied by Synthesis of Auto­Antibodies Against Paraneoplastic Pemphigus Antigens Acta Derm.Venereol. 2002, 82 (6): 482­483. Kosuwon, P., Wasi, C., Sutra, S., Kositanont, U., Hutagalung, Y., and Bock, H. L. Flexibility in the Administration Schedule of Varicella Vaccination in Healthy Adolescents and Young Adults. Asian Pac.J Allergy Immunol. 2002, 20 (4): 241­245. Krause, G., Blackmore, C., Wiersma, S., Lesneski, C., Gauch, L., and Hopkins, R. S. Mass Vaccination Campaign Following Community Outbreak of Meningococcal Disease Emerg.Infect.Dis. 2002 Dec, 8 (12): 1398­1403. Kribs­Zaleta, C.M., Martcheva, M. Vaccination strategies and backward bifurcation in an age­since­infection structured model. Math Biosci. 2002 May­
Jun;177­178:317­32. Krishna, M. T. and Salvi, S. S. BCG vaccination and prevention of allergic disease Pediatrics. 2002, 109 (2): 346­347. Krishna, M. T. and Salvi, S. S. Could Administration of Bacille Calmette­Guerin Vaccination at Birth Protect From the Development of Asthma and Allergic Diseases in the Western World? Has This Question Been Adequately Investigated? Pediatr.Allergy Immunol. 2002, 13 (3): 172­176. Kudesia, G., Partridge, S., Farrington, C. P., and Soltanpoor, N. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy J.Clin.Pathol. 2002, 55 (2): 154­155. Kunz, C. Vaccination Against TBE in Austria: the Success Story ContinuesInt.J.Med.Microbiol. 2002, 291 Suppl 33:56­7. (): 56­57. Kuvakina, V. I., Golovina, L. I., Mishina, A. I., Skirda, T. A., Bobyleva, G. V., Mikheeva, N. G., Chernyshova, T. F., Temper, R. M., and Ermolenko, Z. N. Evaluation of the Immunological Activity and Safety of Group B Meningococcal Vaccine Prepared From a Natural Complex of Specific Polysaccharide and Outer Membrane Proteins Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 33­37. [Article in Russian] Kyaw, M. H., Holmes, E. M., Chalmers, J., Jones, I. G., and Campbell, H. A Survey of Vaccine Coverage and Antibiotic Prophylaxis in Splenectomised Patients in Scotland J.Clin.Pathol. 2002, 55 (6): 472­474. Lacson, A. G., D'Cruz, C. A., Gilbert­Barness, E., Sharer, L., Jacinto, S., and Cuenca, R. Aluminum Phagocytosis in Quadriceps Muscle following Vaccination in Children: Relationship to Macrophagic Myofasciitis Pediatr.Dev.Pathol. 2002, 5 (2): 151­158. Lane, J. M. Smallpox and Smallpox Vaccination N.Engl.J.Med. 8­29­2002, 347 (9): 691­692. Lathrop, S. L., Ball, R., Haber, P., Mootrey, G. T., Braun, M. M., Shadomy, S. V., Ellenberg, S. S., Chen, R. T., and Hayes, E. B. Adverse event reports following vaccination for Lyme disease: December 1998­­July 2000 Vaccine. 2­22­2002, 20 (11­12): 1603­1608. Lau, C.; Sisson, J. The Effectiveness of Intradermal Pre­Exposure Rabies Vaccination in an Australian Travel Medicine Clinic. J Travel.Med. 9 (6): 285­288; November, 2002. Laubereau B, Hermann M, Schmitt HJ, Weil J, von Kries R. Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect. 2002 Apr;128(2):185­92. Laubereau, B., Grote, V., Holscher, G., Holscher, B., Frye, C., Wichmann, H. E., and Heinrich, J. Vaccination Against Haemophilus Influenzae Type b and Atopy in East German Schoolchildren Eur.J Med.Res. 9­30­2002, 7 (9): 387­392 Leask J. Vaccination and risk communication: Summary of a workshop, Arlington Virginia, USA, 5­6 October 2000. J Paediatr Child Health. 2002 Apr;38(2):124­8 Leask, J. and Chapman, S. 'The cold hard facts' immunisation and vaccine preventable diseases in Australia's newsprint media 1993­1998 Soc.Sci.Med. 2002, 54 (3): 445­457. Leask, J. Vaccination and Risk Communication: Summary of a Workshop, Arlington Virginia, USA, 5­6 October 2000 J.Paediatr.Child Health 2002, 38 (2): 124­128. Lee MS, Nokes DJ, Wu YC, Huang YH, Lu CF. Measles IgG seroprevalence prior to mass vaccination in Taiwan. Int J Infect Dis. 2002;6(1):42­47. Lee, P. Y., Matchar, D. B., Clements, D. A., Huber, J., Hamilton, J. D., and Peterson, E. D. Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults Ann.Intern.Med. 2002, %20;137 (4): 225­231. Levenson, D. Infant Immunizations Don't Increase Risk of Certain Illnesses, Panel Says Rep.Med.Guidel.Outcomes.Res. 3­8­2002, 13 (5): 1­2, 5 Levenson, D. Pneumonia Vaccine Protocol Could Save Money and Lives Rep.Med.Guidel.Outcomes.Res. 3­8­2002, 13 (5): 5­7 Levitsky, J., Te, H. S., Faust, T. W., and Cohen, S. M. Varicella Infection Following Varicella Vaccination in a Liver Transplant Recipient. Am.J Transplant. 2002, 2 (9): 880­882. Levy­Bruhl, D. [What place for BCG vaccination in France?] Arch.Pediatr. 2002, 9 (1): 1­3. Levy­Bruhl, D., Perrocheau, A., Mora, M., Taha, M., Dromell­Chabrier, S., and Quatresous, I. Vaccination Campaign Following an Increase in Incidence of Serogroup C Meningococcal Diseases in the Department of Puy­De­Dome (France). Euro.Surveill 2002, 7 (5): 74­76. Libman, M. D., Ibrahim, S. A., Omer, M. I., Adlan, I. A., Bellavance, F., Hoskins, E., Bertley, F., and Ward, B. J. No evidence for short or long term morbidity after increased titer measles vaccination in Sudan Pediatr.Infect.Dis.J. 2002, 21 (2): 112­119. Lista, F., Faggioni, G., Peragallo, M. S., Tontoli, F., Stella, A., Salvatori, P., Pusino, M., Germani, M. A., Contreas, V., and D'Amelio, R. Molecular analysis of early postvaccine mumps­like disease in Italian military recruits JAMA. 3­6­2002, 287 (9): 1114­1115. Liu, T. C., Chen, C. S., and Chen, L. M. The Impact of National Health Insurance on Neonatal Care Use and Childhood Vaccination in Taiwan Health Policy Plan. 2002, 17 (4): 384­392 Luman, E. T., Barker, L. E., Simpson, D. M., Rodewald, L. E., Szilagyi, P. G., and Zhao, Z. National, State and Urban­Area Vaccination­Coverage Levels Among Children Aged 19­35 Months, United States, 1999 Am.J.Prev.Med. 2001, 20 (4 Suppl): 88­153. Lyratzopoulos, G., Aston, R., Bailey, K., Flitcroft, J., and Clarke, H. Accuracy of Routine Data on MMR Vaccination Coverage and Validity of Parental Recall of Vaccination Commun.Dis.Public Health 2002, 5 (4): 305­310. Lyratzopoulos, G., Aston, R., Bailey, K., Flitcroft, J., and Clarke, H. Accuracy of Routine Data on MMR Vaccination Coverage and Validity of Parental Recall of Vaccination Commun.Dis.Public Health 2002, 5 (4): 305­310. Mack, T. A Different View of Smallpox and Vaccination N.Engl.J Med. 2002 Dec 19, epub 1056/NEJMsb022994. Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., and Melbye, M. A Population­Based Study of Measles, Mumps, and Rubella Vaccination and Autism N.Engl.J Med. 11­7­2002, 347 (19): 1477­1482 Maiden MC, Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate olysaccharide vaccination. Lancet. 2002 May 25;359(9320):1829­31. Maiden, M. C. and Stuart, J. M. Carriage of Serogroup C Meningococci 1 Year After Meningococcal C Conjugate Polysaccharide Vaccination Lancet 5­25­
2002, 359 (9320): 1829­1831. Makela, A., Nuorti, J. P., and Peltola, H. Neurologic Disorders After Measles­Mumps­Rubella Vaccination Pediatrics 2002, 110 (5): 957­963 Makela, A., Nuorti, J. P., and Peltola, H. Neurologic Disorders After Measles­Mumps­Rubella Vaccination. Pediatrics 2002, 110 (5): 957­963. Maldonado, Y. A. Current Controversies in Vaccination: Vaccine Safety JAMA 12­25­2002, 288 (24): 3155­3158. Manuel, D. G., Henry, B., Hockin, J., and Naus, M. Health Behavior Associated With Influenza Vaccination Among Healthcare Workers in Long­Term­Care Facilities. Infect.Control Hosp.Epidemiol. 2002, 23 (10): 609­614. Mariat, C., Alamartine, E., Sabido, O., and Berthoux, F. Use of Mature Dendritic Cells for Anti­Human Papillomavirus Peptide­Based Vaccination in Transplant Patients Transplant.Proc. 2002, 34 (7): 2836­2837 Marshall, B.C., Henshaw, C., Evans, D.A., Bleyl, K., Alder, S., T.G. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics 2002 May;109(5):E80­0 Matsui, M., Kawano, H., Matsukura, M., Otani, Y., Miike, T. Acute transverse myelitis after Japanese B encephalitis vaccination in a 4­year­old girl. Brain Dev. 2002 Apr;24(3):187­9. Mauri, I. Puig JM [Which Child Population Between 2 Months and 2 Years of Age Needs to Be Vaccinated Against Pneumococci?] Aten.Primaria 7­30­2002, 30 (3): 176­178. Mayer M, Blanco Urzaiz F, Martin Martin S, Morato M. [Vaccination: information, precautions and technique] Aten Primaria. 2002 Apr 30;29(7):438­442. Spanish. Mayor, S. Chief Medical Officer Confirms Key Health Workers Will Be Vaccinated Against Smallpox. BMJ 2002, 19; 325 (7369): 855B. McElhaney, J. E. Guest Editorial: Nutrition, Exercise, and Influenza Vaccination J.Gerontol.A Biol.Sci.Med.Sci. 2002, 57 (9): M555­M556. McIntyre, P., Gidding, H., Gilmour, R., Lawrence, G., Hull, B., Horby, P., Wang, H., Andrews, R., and Burgess, M. Vaccine Preventable Diseases and Vaccination Coverage in Australia, 1999 to 2000 Commun.Dis.Intell. 2002, Suppl:i­xi, 1­111. McVernon, J., Maclennan, J., Buttery, J., Oster, P., Danzig, L., and Moxon, E. R. Safety and Immunogenicity of Meningococcus Serogroup C Conjugate Vaccine Administered As a Primary or Booster Vaccination to Healthy Four­Year­Old Children Pediatr.Infect.Dis.J. 2002, 21 (8): 747­753. Medic­Stojanac, S., Petrovic, R., and Radulovic, T. Vaccination of Women During Pregnancy and Lactation Srp.Arh.Celok.Lek. 2002, 130 (3­4): 131­135. Meeker, J. Meningococcal Disease­­Prevention and Intervention. Ohio.Nurses Rev. 77 (6): 15­18; July, 2002. Meyers, D. G. and Jurisich, P. D. Could vaccinations prevent myocardial infarction? Am.J.Cardiol. 3­15­2002, 89 (6): 723­725. Michaeli, D. Smallpox: a Possible Comeback Isr.Med.Assoc.J. 2002, 4 (7): 487­488. Mixeu, M. A., Vespa, G. N., Forleo­Neto, E., Toniolo­Neto, J., and Alves, P. M. Impact of Influenza Vaccination on Civilian Aircrew Illness and Absenteeism Aviat.Space Environ.Med. 2002, 73 (9): 876­880. Monath, T. P. Editorial: Jennerian Vaccination Against West Nile Virus Am.J.Trop.Med.Hyg. 2002, 66 (2): 113­114. Montes, M., Cilla, G., Artieda, J., Vicente, D., and Basterretxea, M. Mumps Outbreak in Vaccinated Children in Gipuzkoa (Basque Country), Spain Epidemiol.Infect. 2002, 129 (3): 551­556. Moreton, J. MMR Vaccination: Answers to Some Parents' Questions. J Fam.Health Care 2002, 12 (6): 151­153. Moreton, J. MMR Vaccination: Protecting Our Children J Fam.Health Care 2002, 12 (2): 31 Morfin, F., Beguin, A., Lina, B., and Thouvenot, D. Detection of measles vaccine in the throat of a vaccinated child Vaccine. 2­22­2002, 20 (11­12): 1541­
1543. Mostowy, S. and Behr, M. A. Comparative Genomics in the Fight Against Tuberculosis: Diagnostics, Epidemiology, and BCG Vaccination. Am.J Pharmacogenomics. 2002, 2 (3): 189­196. Mrsny, R. J., Daugherty, A. L., McKee, M. L., and FitzGerald, D. J. Bacterial toxins as tools for mucosal vaccination Drug Discov.Today. 2­15­2002, 7 (4): 247­258. Murphy, T. V., Gargiullo, P. M., and Wharton, M. More on rotavirus vaccination and intussusception N.Engl.J.Med. 1­17­2002, 346 (3): 211­212. Musharrafieh, U. M., Nuwayhid, I. A., Hamadeh, G. N., Steitieh, S. W., and Bizri, A. R. Immunity to Chickenpox Among School Adolescents in Lebanon and Options for Vaccination Epidemiol.Infect. 2002, 129 (3): 607­615. Nakatani, H., Sano, T., and Iuchi, T. Development of Vaccination Policy in Japan: Current Issues and Policy Directions. Jpn.J Infect.Dis. 2002, 55 (4): 101­
111. Nasir, L. Antivaccination Web Sites. JAMA 10­9­2002, 288 (14): 1718. Neff, J. M., Lane, J. M., Fulginiti, V. A., and Henderson, D. A. Contact Vaccinia­­Transmission of Vaccinia From Smallpox Vaccination. JAMA 10­16­2002, 288 (15): 1901­1905. Nichol, K. L. and Goodman, M. Cost Effectiveness of Influenza Vaccination for Healthy Persons Between Ages 65 and 74 Years Vaccine 5­15­2002, 20 Suppl 2:S21­4. (): S21­S24. Nicol, M., Eley, B., Kibel, M., Hussey, G. Intradermal BCG vaccination­­adverse reactions and their management. S Afr Med J. 2002 Jan;92(1):39­42. Review. Obaro, S. and Adegbola, R. The pneumococcus: carriage, disease and conjugate vaccines J.Med.Microbiol. 2002, 51 (2): 98­104. Ogunbanjo, G. A., Durrheim, D. N., Gouws, A., and Grobler, S. Intradermal BCG Vaccination­­Limiting Local Adverse Reactions. S Afr.Med.J 2002, 92 (9): 665­666. Oliveira MI, Curti SP, Figueiredo CA, Afonso AM, Theobaldo M, Azevedo RS, Durigon EL. Rash after measles vaccination: laboratory analysis of cases reported in Sao Paulo, Brazil. Rev Saude Publica. 2002 Apr;36(2):155­159. O'Reilly, D., Gormley, G., Gilliland, A., Cuene­Grandidier, H., Rafferty, C., Reilly, P., Steele, K., Stevenson, M., and Smyth, B. Influenza Vaccinations in Northern Ireland: Are Older Patients Missing Out? Age Ageing 2002, 31 (5): 385­390. Orr, P. Supplementary Statement for the 2002­2003 Influenza Season: Update on Oculo­Respiratory Syndrome in Association With Influenza Vaccination Can.Commun.Dis.Rep. 9­1­2002, 28:1: 1. Ortolon, K. Short on Shots Tex.Med. 2002, 98 (5): 30­32. Otagiri, T., Mitsui, T., Kawakami, T., Katsuura, M., Maeda, K., Ikegami, T., Sendo, D., and Hayasaka, K. Haemophagocytic Lymphohistiocytosis Following Measles Vaccination Eur.J.Pediatr. 2002, 161 (9): 494­496. Overturf, G. D. Pneumococcal Vaccination of Children Semin.Pediatr.Infect.Dis. 2002, 13 (3): 155­164. Pance, A., Reisser, D., and Jeannin, J. F. Antitumoral Effects of Lipid A: Preclinical and Clinical Studies J.Investig.Med. 2002, 50 (3): 173­178. Pasinetti, G. M., Ho, L., and Pompl, P. AN1792 Vaccination Immunotherapy in Alzheimer's Disease: the Case of a Therapy Before Its Time. Neurobiol.Aging 2002, 23 (5): 683. Patterson KB, Runge T. Smallpox and the Native American. Am J Med Sci. 2002 Apr;323(4):216­22. Review. Patterson, P. and Reinarz, J. A. Smallpox: Mass Vaccinations or Not? Tex.Med. 2002, 98 (6): 43­44. Pelton, S. I. Vaccination for the Prevention of Acute Otitis Media: Proof of Concept and Current Challenges Pediatr.Ann. 2002, 31 (12): 804­809. Perez­Trallero, E., Vicente, D., Montes, M., and Cisterna, R. Positive Effect of Meningococcal C Vaccination on Serogroup Replacement in Neisseria Meningitidis Lancet 9­21­2002, 360 (9337): 953. Persaude, D., Teape­Humphrey, L., Adelstein, R., Domb, S., and Jaakkimainen, L. Peril of the pox. Are primary care providers aware of varicella vaccination guidelines? Can.Fam.Physician. 2002, 48:316­23. (): 316­323. Peterson, D. C., Bahta, L., and Ehresmann, K. Vaccinating adults for vaccine­preventable diseases Minn.Med. 2002, 85 (2): 37­39. Petousis­Harris, H. Needle Angle When Giving i.m. Vaccinations Nurs.Prax.N.Z. 2002, 18 (2): 52­53. Pfahlberg, A., Botev, I. N., Kolmel, K. F., and Gefeller, O. Vaccination and Melanoma Risk Int.J.Cancer 11­1­2002, 102 (1): 96­97. Pfahlberg, A., Kolmel, K. F., Grange, J. M., Mastrangelo, G., Krone, B., Botev, I. N., Niin, M., Seebacher, C., Lambert, D., Shafir, R., Schneider, D., Kokoschka, E. M., Kleeberg, U. R., Uter, W., and Gefeller, O. Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM Study J.Invest Dermatol. 2002, 119 (3): 570­575. Pietsch, M., Michels, H., Diwo, J., Martens, H., Jacob, R., Lossen­Geissler, E., and Bussmann, H. [Influence of information campaigns on the vaccination immunity among the population of a small town area ­ seroepidemiological results of the 'Wittlich Vaccination Study'] Gesundheitswesen. 2002, 64 (1): 60­
64. Plans, P. [Cost­Effectiveness of 23­Valent Antipneumococcical Vaccination in Catalonia, Spain]. Gac.Sanit. 2002, 16 (5): 392­400. Pleis, J. R. and Gentleman, J. F. Using the National Health Interview Survey: Time Trends in Influenza Vaccinations Among Targeted Adults Eff.Clin.Pract. 2002, 5 (3 Suppl): E3. Poland GA, Jacobson RM, Vierkant RA, Colbourne SA, Thampy AM, Pankratz VS, Jacobsen SJ. Effect of differing immunization policies on circulating measles antibody levels in US and Canadian children. Mayo Clin Proc. 2002 May;77(5):446­52. Poli D, Chiarugi L, Capanni M, Antonucci E, Abbate R, Gensini GF, Prisco D. Need of more frequent International Normalized Ratio monitoring in elderly patients on long­term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis. 2002 Jun;13(4):297­300. Pool, V.; Braun, M. M.; Kelso, J. M.; Mootrey, G.; Chen, R. T.; Yunginger, J. W.; Jacobson, R. M.; Gargiullo, P. M. Prevalence of Anti­Gelatin IgE Antibodies in People With Anaphylaxis After Measles­Mumps Rubella Vaccine in the United States. Pediatrics. 110 (6): e71; December, 2002. Portaels, F., Aguiar, J., Debacker, M., Steunou, C., Zinsou, C., Guedenon, A., and Meyers, W. M. Prophylactic Effect of Mycobacterium Bovis BCG Vaccination Against Osteomyelitis in Children With Mycobacterium Ulcerans Disease (Buruli Ulcer). Clin.Diagn.Lab Immunol. 2002, 9 (6): 1389­1391. Postma, M.J., Jansema, P., Van Genugten, M.L., Heijnen, M.L., Jager, J.C., De Jong­Van Den Berg, L.T. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence. Drugs 2002;62(7):1013­24 Quirk, M. Home­grown Vietnamese cholera vaccine "completely safe". Lancet Infect Dis 2002 Apr;2(4):198 Quirk, M. Varicella Vaccination Reduces Risk of Herpes Zoster Lancet Infect.Dis. 2002, 2 (8): 454. Ramsay, M., White, J., and Crowcroft, N. MMR Uptake Data Are Unlikely to Be Subject to Manipulation BMJ 6­8­2002, 324 (7350): 1394. Rangel, M. C., Schoenbach, V., Hogan, V., and Weigle, K. #72­S Racial/Ethnic Disparities in Influenza Vaccination in Elderly Adults. The Role of Access to Care. Ann.Epidemiol. 2002, 12 (7): 516. Rappuoli, R., Miller, H. I., and Falkow, S. Medicine. The Intangible Value of Vaccination Science 8­9­2002, 297 (5583): 937­939. Rayner, J. O., Dryga, S. A., and Kamrud, K. I. Alphavirus Vectors and Vaccination Rev.Med.Virol. 2002, 12 (5): 279­296. Razum, O. Editorial: A Farewell to Polio Vaccination? Not Anytime Soon Trop.Med.Int.Health 2002, 7 (10): 811­812. Reading, R. Measles, Mumps, and Rubella Vaccination and Bowel Problems or Developmental Regression in Children With Autism: Population Study Child Care Health Dev. 2002, 28 (4): 337. Redondo, Granado M. [Vaccination schedule of the Spanish Association of Pediatrics 2001­2002] An Esp.Pediatr. 2002, 56 (1): 78. Rehme, P. A., Williams, R., and Grabenstein, J. Ambulatory medical visits among anthrax­vaccinated and unvaccinated personnel after return from southwest Asia Mil.Med. 2002, 167 (3): 205­210. Rehmet, S., Ammon, A., Pfaff, G., Bocter, N., and Petersen, L. R. Cross­Sectional Study on Influenza Vaccination, Germany, 1999­2000 Emerg.Infect.Dis. 2002, 8 (12): 1442­1447. Reichert, T. A. The Japanese Program of Vaccination of Schoolchildren Against Influenza: Implications for Control of the Disease Semin.Pediatr.Infect.Dis. 2002, 13 (2): 104­111. Reynolds, P., Linton, C., and Warner, N. Influenza Vaccination of People With Dementia in Long­Stay Wards in the United Kingdom: What Is Going on? Int.J.Geriatr.Psychiatry 2002, 17 (7): 681­682. Ring, A., Marx, G., Steer, C., and Harper, P. Influenza Vaccination and Chemotherapy: a Shot in the Dark? Support.Care Cancer 2002, 10 (6): 462­465. Robb­Nicholson, C. By the Way Doctor. I Was Relieved to Read That the United States Will Soon Have Enough Smallpox Vaccine for Everyone. Should My Family and I Be Vaccinated? Harv.Womens Health Watch. 2002, 9 (11): 8. Robb­Nicholson, C. By the Way, Doctor. I'm 50 Years Old, and Like Everybody Else My Age, I Was Vaccinated Against Smallpox Before First Grade. Do I Still Have Some Immunity? Harv.Womens Health Watch. 2002, 10 (4): 8. Roche, P. and Spencer, J. Polio Eradication in Australia and the World Commun.Dis.Intell. 2002, 26 (2): 113­117. Rothberg, M., Bennish, M. L., Kao, J. S., and Wong, J. B. Do the benefits of varicella vaccination outweigh the long­term risks? A decision­analytic model for policymakers and pediatricians Clin.Infect.Dis. 4­1­2002, 34 (7): 885­894. Rush, C., Mitchell, T., and Garside, P. Efficient Priming of CD4(+) and CD8(+) T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways. J Immunol. 11­1­2002, 169 (9): 4951­4960. Saffle, J. R. A Comprehensive Practice Guideline Is Needed to Make Vaccination Practices More Consistent J Trauma 2002, 53 (5): 1026­1027 Salgado, C.D., Farr, B.M., Hall, K.K., Hayden, F.G. Influenza in the acute hospital setting. Lancet Infect Dis 2002 Mar;2(3):145­55 Saray, Y., Seckin, D., Sarifakioglu, E., Gulec, A. T., and Demirhan, B. Acute Infantile Haemorrhagic Oedema: Measles Vaccination As Possible Triggering Factor Acta Derm.Venereol. 2002, 82 (6): 471­472. Scanlon­Kohlroser, C. A., Fan, P. Y., Primack, W., and Stoff, J. S. Primary Varicella After Transplantation Am.J.Kidney Dis. 2002, 39 (6): 1310­1312. Scherer, A. and McLean, A. Mathematical Models of Vaccination Br.Med.Bull. 2002, 62 (1): 187­199. Schlafly, R. Antivaccination Web Sites. JAMA 10­9­2002, 288 (14): 1717. Schofield, C. Who Should Receive the Influenza Vaccine? Nursing 2002, 32 (11 Pt 1): 24. Schraeder, T. L. and Campion, E. W. Smallpox Vaccination ­­ The Call to Arms N.Engl.J Med. 2002, 19. epub 10.1056/NEJMp020177. Schwartz, M. and Hauben, E. T Cell­Based Therapeutic Vaccination for Spinal Cord Injury Prog.Brain Res. 2002, 137:401­6. (): 401­406 Scott, R. D., Meltzer, M. I., Erickson, L. J., De Wals, P., and Rosenstein, N. E. Vaccinating First­Year College Students Living in Dormitories for Meningococcal Disease. an Economic Analysis Am.J.Prev.Med. 2002, 23 (2): 98­105. Seibil', V. B. How Poliomyelitis Is to Be Eradicated Completely Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 107­113. [Article in Russian] Seward, J. F., Watson, B. M., Peterson, C. L., Mascola, L., Pelosi, J. W., Zhang, J. X., Maupin, T. J., Goldman, G. S., Tabony, L. J., Brodovicz, K. G., Jumaan, A. O., and Wharton, M. Varicella disease after introduction of varicella vaccine in the United States, 1995­2000 JAMA. 2­6­2002, 287 (5): 606­
611. Shatz, D. V. Vaccination Practices Among North American Trauma Surgeons in Splenectomy for Trauma J Trauma 2002, 53 (5): 950­956 Shinefield, H. R., Black, S. B., Staehle, B. O., Matthews, H., Adelman, T., Ensor, K., Li, S., Chan, I., Heyse, J., Waters, M., Chan, C. Y., Vessey, S. J., Kaplan, K. M., and Kuter, B. J. Vaccination With Measles, Mumps and Rubella Vaccine and Varicella Vaccine: Safety, Tolerability, Immunogenicity, Persistence of Antibody and Duration of Protection Against Varicella in Healthy Children Pediatr.Infect.Dis.J. 2002, 21 (6): 555­561. Shlush, L. I., Behar, D. M., Zelazny, A., Keller, N., Lupski, J. R., Beaudet, A. L., and Bercovich, D. Molecular Epidemiological Analysis of the Changing Nature of a Meningococcal Outbreak Following a Vaccination Campaign J.Clin.Microbiol. 2002, 40 (10): 3565­3571. Sibley, C. L. Smallpox Vaccination Revisited. Am.J Nurs. 2002, 102 (9): 26­32. Siedler, A., Hermann, M., Schmitt, H. J., and Von Kries, R. Consequences of Delayed Measles Vaccination in Germany Pediatr.Infect.Dis.J. 2002, 21 (9): 826­830. Sigal, L. H. Vaccination for Lyme Disease: Cost­Effectiveness Versus Cost and Value Arthritis Rheum. 2002, 46 (6): 1439­1442. Silvers, L. E., Varricchio, F. E., Ellenberg, S. S., Krueger, C. L., Wise, R. P., and Salive, M. E. Pediatric deaths reported after vaccination: the utility of information obtained from parents Am.J.Prev.Med. 2002, 22 (3): 170­176. Simonsen, L., Morens, D.M., Blackwelder, W.C. Ecological studies, rotavirus vaccination, and intussusception. Lancet. 2002 Mar 23;359(9311):1066­7; discussion 1066. Sinsalo, M., Aittoniemi, J., Kayhty, H., and Vilpo, J. Haemophilus Influenzae Type b (Hib) Antibody Concentrations and Vaccination Responses in Patients With Chronic Lymphocytic Leukaemia: Predicting Factors for Response Leuk.Lymphoma 2002, 43 (10): 1967­1969. Skowronski DM, De Serres G, Hebert J, Stark D, Warrington R, Macnabb J, Shadmani R, Rochette L, MacDonald D, Patrick DM, Duval B. Skin testing to evaluate oculo­respiratory syndrome (ORS) associated with influenza vaccination during the 2000­2001 season. Vaccine. 2002 Jun 21;20(21­22):2713­9. Slater, P. E., Anis, E., and Leventhal, A. Preparation for an Outbreak of Smallpox in Israel Isr.Med.Assoc.J. 2002, 4 (7): 507­512. Sleigh, K. M.; Marra, F. H.; Stiver, H. G. Influenza Vaccination: Is It Appropriate in Chronic Fatigue Syndrome? Am.J.Respir.Med. 1 (1): 3­9; 2002. Smithson, R. Varicella Vaccination—An Ethical Issue Commun.Dis.Public Health 2002, 5 (4): 343. Smits AJ, Hak E, Stalman WA, van Essen GA, Hoes AW, Verheij TJ. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect. 2002 Apr;128(2):205­11. Spier, R. E. On the 2002 Measles Vaccination Furore in the UK Vaccine 7­26­2002, 20 (23­24): 2845­2847. St, S., Jacobson, R. M., Vierkant, R. A., Jacobsen, S. J., Green, E. M., and Poland, G. A. Association of parental vaccination reports with measles, mumps, and rubella protective antibody levels: comparison of Somali immigrant, Hispanic migrant, and US children in Rochester, Minn Mayo Clin.Proc. 2002, 77 (3): 241­245. Staff, M. P. and Angel, P. A. Vaccination Among Household Contacts of Chronic Hepatitis B Carriers by General Practitioners Aust.Fam.Physician 2002, 31 (5): 491­493. Steiner, M., Vermeulen, L. C., Mullahy, J., and Hayney, M. S. Factors Influencing Decisions Regarding Influenza Vaccination and Treatment: a Survey of Healthcare Workers. Infect.Control Hosp.Epidemiol. 2002, 23 (10): 625­627. Stephenson, I., Roper, J. P., and Nicholson, K. G. Healthcare Workers and Their Attitudes to Influenza Vaccination Commun.Dis.Public Health 2002, 5 (3): 247­252 Stephenson, J. Experts focus on infective agents of bioterrorism JAMA. 2­6­2002, 287 (5): 575­576. Stevenson, J., Massoudi, M., Stokley, S., and Bulim, I. Clinical assessment software application (CASA) and immunization coverage rates Am.J.Public Health. 2002, 92 (3): 333­334. Stevenson, M., Beard, S., Finn, A., and Brennan, A. Estimating the potential health gain and cost consequences of introducing a pre­school DTPa pertussis booster into the UK child vaccination schedule Vaccine. 3­15­2002, 20 (13): 1778­1786. Stewart, S., Murray, S. B., and Skull, S. A. Evaluation of Health­Care Worker Vaccination in a Tertiary Australian Hospital Intern.Med.J 2002, 32 (12): 585­
592. Strine, T. W., Barker, L. E., Jain, R. B., Washington, M. L., Chu, S. Y., and Mokdad, A. H. Extraimmunization in children through 2000 JAMA. 2­6­2002, 287 (5): 588­589. Strine, T. W., Barker, L. E., Mokdad, A. H., Luman, E. T., Sutter, R. W., and Chu, S. Y. Vaccination Coverage of Foreign­Born Children 19 to 35 Months of Age: Findings From the National Immunization Survey, 1999­2000 Pediatrics 2002, 110 (2 Pt 1): e15. Su, S. B. and Guo, H. R. Seroprevalence of Rubella Among Women of Childbearing Age in Taiwan After Nationwide Vaccination Am.J Trop.Med.Hyg. 2002, 67 (5): 549­553. Suarez, V. R. and Hankins, G. D. Smallpox and Pregnancy: From Eradicated Disease to Bioterrorist Threat Obstet.Gynecol. 2002, 100 (1): 87­93. Suzuki, M., Takizawa, A., Furuta, A., Yanada, S., Iwamuro, S., and Tashiro, K. A Case of Orchitis Following Vaccination With Freeze­Dried Live Attenuated Mumps Vaccine Nippon Hinyokika Gakkai Zasshi 2002, 93 (4): 577­579. [Article in Japanese] Szabo, J. HHS Proposes Smallpox Vaccination for Medical Workers MLO.Med.Lab Obs. 2002, 34 (11): 41 Tacken, M., Braspenning, J., Spreeuwenberg, P., van den, Hoogen H., van Essen, G., de Bakker, D., and Grol, R. Patient Characteristics Determine Differences in the Influenza Vaccination Rate More So Than Practice Features Prev.Med. 2002, 35 (4): 401­406 Tan, H. H. and Seow, C. S. A Review of Cutaneous Granulomas and Lupus Vulgaris Following BCG Vaccination in a Skin Hospital in Singapore. Ann.Acad.Med.Singapore 2002, 31 (5): 663­665. Tarjan, P., Sipka, S., Marodi, L., Nemes, E., Lakos, G., Gyimesi, E., Kiss, E., Ujj, G., and Szegedi, G. No Short­Term Immunological Effects of Pneumococcus Vaccination in Patients With Systemic Lupus Erythematosus. Scand.J Rheumatol. 2002, 31 (4): 211­215. Taylor, B., Lingam, R., Simmons, A., Stowe, J., Miller, E., and Andrews, N. Autism and MMR Vaccination in North London; No Causal RelationshipMol.Psychiatry 2002, 7 Suppl 2:S7­8. (): S7­S8. Taylor, B., Miller, E., Lingam, R., Andrews, N., Simmons, A., and Stowe, J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study BMJ. 2­16­2002, 324 (7334): 393­396. Taylor, J. A., Darden, P. M., Brooks, D. A., Hendricks, J. W., Wasserman, R. C., and Bocian, A. B. Association Between Parents' Preferences and Perceptions of Barriers to Vaccination and the Immunization Status of Their Children: a Study From Pediatric Research in Office Settings and the National Medical Association Pediatrics 2002, 110 (6): 1110­1116 Tefanova, V. T., Tallo, T. G., Priimiagi, L. S., Kikosh, G. V., Krupskaia, L. M., Lisitsyna, S. A., and Noorlind, IuP Hepatitis A in Estonia (1990­1999) Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 22­26. [Article in Russian] Terada, K., Niizuma, T., Ogita, S., Kataoka, N. [Alterations in epidemics and vaccination for measles during a 20 year period and a strategy for elimination in Kurashiki City, Japan] Kansenshogaku Zasshi. 2002 Mar;76(3):180­4. Japanese. Thjodleifsson, B., Davidsdottir, K., Agnarsson, U., Sigthorsson, G., Kjeld, M., and Bjarnason, I. Effect of Pentavac and Measles­Mumps­Rubella (MMR) Vaccination on the Intestine Gut 2002, 51 (6): 816­817 Thornjoethleifsson, B.; Daviethsdottir, K.; Agnarsson, U.; Theodors, A.; Gunnarsdottir, A.; Moeller, E.; Jonsdottir, A.; Sigthornorsson, G.; Kjeld, M.; Bjarnason, I. [Effect of Pentavac and MMR Vaccination on the Intestine.]. Laeknabladid; 88 (6): 491­494; June, 2002. Timmer, S. J., Amundson, D. E., and Malone, J. D. Hypersensitivity Pneumonitis Following Anthrax Vaccination Chest 2002, 122 (2): 741­745. Tom, B., Moutou, F., Dufour, B., and Durand, B. Ring Vaccination Against Foot­and­Mouth Disease. Comp Immunol.Microbiol.Infect.Dis. 2002, 25 (5­6): 365­372. Traynor, K. Groups revise general vaccination recommendations. Am J Health Syst Pharm. 2002 Apr 1;59(7):598. Trotter, C. L., Ramsay, M. E., and Kaczmarski, E. B. Meningococcal Serogroup C Conjugate Vaccination in England and Wales: Coverage and Initial Impact of the Campaign Commun.Dis.Public Health 2002, 5 (3): 220­225 Trotter, C.L., Edmunds, W.J. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ. 2002 Apr 6;324(7341):809. Tugumisirize, F., Tumwine, J. K., and Mworozi, E. A. Missed Opportunities and Caretaker Constraints to Childhood Vaccination in a Rural Area in Uganda. East Afr.Med.J 2002, 79 (7): 347­354. Turnbull, F. M., McIntyre, P. B., Achat, H. M., Wang, H., Stapledon, R., Gold, M., and Burgess, M. A. National study of adverse reactions after vaccination with bacille calmette­guerin Clin.Infect.Dis. 2­15­2002, 34 (4): 447­453. Uhari, M. Review: varicella vaccination is effective in children ACP J.Club. 2002, 136 (1): 25. Uzicanin, A., Eggers, R., Webb, E., Harris, B., Durrheim, D., Ogunbanjo, G., Isaacs, V., Hawkridge, A., Biellik, R., and Strebel, P. Impact of the 1996­1997 Supplementary Measles Vaccination Campaigns in South Africa Int.J Epidemiol. 2002, 31 (5): 968­976 Vancikova, Z. Mucosal Immunity­­Basic Principles, Ontogeny, Cystic Fibrosis and Mucosal Vaccination Curr.Drug Targets.Immune.Endocr.Metabol.Disord. 2002, 2 (1): 83­95. Vazquez, J. A. [Development of Vaccinations Against Meningococcus: a Long, Winding, and Still Unfinished Road] Enferm.Infecc.Microbiol.Clin. 2002, 20 (7): 313­315. Vazquez, J. A. [Inmunisation: Leaps into the Future. Vaccination for Bacterial Meningitis: Reality or Myth?] Aten.Primaria 12­15­2002, 30 (10): 643­647. Verweij, M. and van Den, Hoven M. Influenza vaccination rates and informed consent in Dutch nursing homes: survey of nursing home physicians BMJ. 2­9­
2002, 324 (7333): 328. Vidyashankar, C. Optimal Age for Measles Vaccination J.Indian Med.Assoc. 2002, 100 (1): 24­26. Virk, G. Keep an open mind on MMR vaccination. Nurs Stand 2002 Apr 10­16;16(30):25 Von Herrath, M. G. Vaccination to Prevent Type 1 Diabetes. Expert.Rev Vaccines. 1 (1): 25­28; June, 2002. Vyse, A. J., Gay, N. J., White, J. M., Ramsay, M. E., Brown, D. W., Cohen, B. J., Hesketh, L. M., Morgan­Capner, P., and Miller, E. Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence­Based Vaccination Policy. Epidemiol.Rev. 2002, 24 (2): 125­
136. Waldrop, T. B. Childhood Vaccination Update. A New Weapon Against Pneumococcal Bacteria Adv.Nurse Pract. 2001, 9 (2): 34­6, 39 Wallich, R., Jahraus, O., and Simon, M. M. Prophylactic Vaccination Against Lyme Borreliosis for Man and Dogs and New Strategies to Treat Established B. Burgdorferi Infections Int.J.Med.Microbiol. 2002, 291 Suppl 33:147­9. (): 147­149. Wallinga, J. Modelling the Impact of Vaccination Strategies Neth.J Med. 2002, 60 (7 Suppl): 67­75 Walsh, M. Smallpox: the Disease and Strategies for Its Control Nurs.Times 12­17­2002, 98 (51): 26­27. Wang, L., Smith, D., Bot, S., Dellamary, L., Bloom, A., and Bot, A. Noncoding RNA Danger Motifs Bridge Innate and Adaptive Immunity and Are Potent Adjuvants for Vaccination. J Clin.Invest 2002, 110 (8): 1175­1184. Wanyama, C. Africa's Largest Measles Vaccination Campaign Could Reduce Childhood Mortality by 20% Bull.World Health Organ 2002, 80 (12): 989. Wei, K. X., Xie, Y. F., and Yao, Z. F. [Analysis of HFRS Vaccination Against Hemorrhagic Fever With Renal Syndrome During 1999­2000 in Laiwu City]. Zhonghua Shi Yan.He.Lin.Chuang.Bing.Du Xue.Za Zhi. 2002, 16 (3): 283­285. Weightman, G. W. Scientific Evidence Supports Anthrax Vaccination. Am.J Public Health 2002, 92 (11): 1707­1708. Weir, E. Streptococcus pneumoniae infection in children: vaccine implications CMAJ. 1­22­2002, 166 (2): 220. Wettendorff, M. Therapeutic vaccination Virus Res. 1­30­2002, 82 (1­2): 133­140. White, S. R., Henretig, F. M., and Dukes, R. G. Medical Management of Vulnerable Populations and Co­Morbid Conditions of Victims of Bioterrorism Emerg.Med.Clin.North Am. 2002, 20 (2): 365­92, xi. Wiesen, A. R. and Littell, C. T. Relationship Between Prepregnancy Anthrax Vaccination and Pregnancy and Birth Outcomes Among US Army Women JAMA. 3­27­2002, 287 (12): 1556­1560. Wilder­Smith, A., Paton, N.I. Crossover Vaccination with Quadrivalent Meningococcal Vaccine (against A/C/Y/W­135) Following Recent Application of Bivalent Meningococcal Vaccine (against A/C): Assessment of Safety and Side Effect Profile. J Travel Med. 2002 Jan­Feb;9(1):20­3. Wilton, P., Smith, R., Coast, J., Millar, M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost­
effectiveness. J Health Serv Res Policy 2002 Apr;7(2):111­7. Wise, R. P., Braun, M. M., Seward, J. F., Mootrey, G. T., Shields, K. E., Salive, M. E., and Krause, P. R. Pharmacoepidemiologic Implications of Erroneous Varicella Vaccinations in Pregnancy Through Confusion With Varicella Zoster Immune Globulin Pharmacoepidemiol.Drug Saf 2002, 11 (8): 651­654. Wolfe, R. M. and Sharp, L. K. Anti­Vaccinationists Past and Present BMJ 8­24­2002, 325 (7361): 430­432. Wong, G. Educational Outreach to Improve Vaccination Uptake Br.J Gen.Pract. 2002, 52 (485): 1021. Wutzler, P., Neiss, A., Banz, K., Goertz, A., and Bisanz, H. Can Varicella Be Eliminated by Vaccination? Potential Clinical and Economic Effects of Universal Childhood Varicella Immunisation in Germany. Med.Microbiol.Immunol.(Berl) 2002, 191 (2): 89­96. Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T. Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc. 2002 Mar;34(2):572­5. Yang, H. M. The Effects of Re­Infection in Directly Transmitted Infections Modelled With Vaccination. IMA J Math.Appl.Med.Biol. 2002, 19 (2): 113­135. Yazbak, F. and Yazbak, K. Live Virus Vaccination Near a Pregnancy: Flawed Policies, Tragic Results Med.Hypotheses 2002, 59 (3): 283. Yoshiyama, T. [Comparison of effectiveness of BCG vaccination and preventive therapy in Japanese settings, with special emphasis on the sensitivity and specificity of tuberculin testing] Kekkaku. 2002, 77 (1): 11­22. Zanoni, G., Nguyen, T. M., Destefani, E., Masala, L., Nardelli, E., and Tridente, G. Transverse Myelitis After Vaccination Eur.J Neurol. 2002, 9 (6): 696­697 Zent, O., Arras­Reiter, C., Broeker, M., and Hennig, R. Immediate allergic reactions after vaccinations­­a post­marketing surveillance review Eur.J.Pediatr. 2002, 161 (1): 21­25. Zinkernagel, R. M. On Natural and Artificial Vaccinations Annu.Rev.Immunol. 12­6­2002. epub 10.1146/annurev.immunol.21.120601.141045. 2003 Aaby, P.; Garly, M. L.; Bale, C.; Martins, C.; Jensen, H.; Lisse, I.; Whittle, H. Survival of Previously Measles­Vaccinated and Measles­Unvaccinated Children in an Emergency Situation: An Unplanned Study. Pediatr Infect Dis J. 22 (9): 798­805; September, 2003. Aaby, P.; Jensen, H.; Simondon, F.; Whittle, H. High­Titer Measles Vaccination Before 9 Months of Age and Increased Female Mortality: Do We Have an Explanation? Semin Pediatr Infect Dis. 14 (3): 220­232; July 2003. Abinader, E. G. Influenza Vaccination and Reduced Risk of Myocardial Infarction. Isr.Med Assoc J. 5 (11): 839; November, 2003. Abramson, J. S.; McMillan, J. A.; Baltimore, R. S. The US Smallpox Vaccination Plan. Pediatrics. 111 (6 Pt 1): 1431­1432; June 2003. Achtman, M. Successful Prevention of Meningitis in Africa Will Need More Than a Vaccination Strategy. Bull.World Health Organ. 81 (10): 754­755; 2003. Ada, G. Progress Towards Achieving New Vaccine and Vaccination Goals. Intern.Med.J. 33 (7): 297­304; July, 2003. Ada, G. Progress Towards Achieving New Vaccine and Vaccination Goals. Intern.Med.J. 33 (7): 297­304; July 2003. Adamkiewicz, T. V.; Sarnaik, S.; Buchanan, G. R.; Iyer, R. V.; Miller, S. T.; Pegelow, C. H.; Rogers, Z. R.; Vichinsky, E.; Elliott, J.; Facklam, R. R.; O'brien, K. L.; Schwartz, B.; Van Beneden, C. A.; Cannon, M. J.; Eckman, J. R.; Keyserling, H.; Sullivan, K.; Wong, W. Y.; Wang, W. C. Invasive Pneumococcal Infections in Children With Sickle Cell Disease in the Era of Penicillin Prophylaxis, Antibiotic Resistance, and 23­Valent Pneumococcal Polysaccharide Vaccination. J Pediatr. 143 (4): 438­444; October, 2003. Ahmad, K. WHO Steps Up Fight Against Poliomyelitis. Lancet Neurol. 2 (10): 586; October, 2003. Ali, M., Canh, do G., Clemens, J. D., Park, J. K., Seidlein, L., Thiem, V. D., Tho, le H., and Trach, D. D. The Vaccine Data Link in Nha Trang, Vietnam: A Progress Report on the Implementation of a Database to Detect Adverse Events Related to Vaccinations. Vaccine 4­2­2003, 21 (15): 1681­1686. Alswede, M. An Analysis of the Proposed National Strategy for Smallpox Vaccination of Health Care Workers Air Med.J 2003, 22 (1): 22­25. Aragon, T. J.; Fernyak, S. E. The Risks and Benefits of Pre­Event Smallpox Vaccination: Where You Stand Depends on Where You Sit. Ann Emerg.Med. 42 (5): 681­684; November, 2003. Aragon, T. J.; Ulrich, S.; Fernyak, S. E.; Rutherford, G. W. Risks of Serious Complications and Death From Smallpox Vaccination: A Systematic Review of the United States Experience, 1963­1968. BMC Public Health. 3 (1): 26; August 11, 2003. Archibald, L. K., Nwanyanwu, O., Kazembe, P. N., Mwansambo, C., Bell, M., Dobbie, H., Reller, L. B., and Jarvis, W. R. Detection of Bloodstream Pathogens in a Bacille Calmette­Guerin (BCG)­Vaccinated Pediatric Population in Malawi: A Pilot Study. Clin.Microbiol.Infect. 2003, 9 (3): 234­238. Archibald, L. K.; Kazembe, P. N.; Nwanyanwu, O.; Mwansambo, C.; Reller, L. B.; Jarvis, W. R. Epidemiology of Bloodstream Infections in a Bacille Calmette­Guerin­Vaccinated Pediatric Population in Malawi. J Infect.Dis. 188 (2): 202­208; July 15, 2003. Artenstein, A. W. Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1925. Artz, A. S., Ershler, W. B., and Longo, D. L. Pneumococcal Vaccination and Revaccination of Older Adults. Clin.Microbiol.Rev. 2003, 16 (2): 308­318. Arya, S. C. Smallpox Vaccination to Combat Bioterrorism. Clin.Infect.Dis. 37 (1): 150­151; July 1, 2003. Asikainen, T.; Giesecke, J.; Svensson, A. [Measles Takes Root in Sweden Again. Reduced Vaccination Will Result in Epidemics, About 25 000 Cases Are Expected to Occur Annually Within a 15­Year Period]. Lakartidningen. 100 (40): 3126­3130; October 2, 2003. Atlas, R. M.; Clover, R. Commentary on Implications of the 1971 Outbreak in Aralsk, Kazakhstan, for U.S. Smallpox Vaccination Policy (No. 1). Crit Rev Microbiol. 29 (2): 159­161; 2003. Augey, F.; Legoff, D.; Chouvet, B. [Bullous Eruption After Influenza Virus Vaccination]. Ann.Dermatol.Venereol. 130 (11): 1058­1060; November, 2003. Ault, A. US Advisory Panel Urges Government to Subsidise Vaccine Costs. Recommendations Would Increase Vaccination Rates and Stimulate Research and Development. Lancet. 362 (9383): 539; August 16, 2003. Bager, P.; Rostgaard, K.; Nielsen, N. M.; Melbye, M.; Westergaard, T. Age at Bacille Calmette­Guerin Vaccination and Risk of Allergy and Asthma. Clin Exp Allergy. 33 (11): 1512­1517; November, 2003. Bager, P.; Westergaard, T.; Rostgaard, K.; Nielsen, N. M.; Melbye, M.; Aaby, P. Smallpox Vaccination and Risk of Allergy and Asthma. J Allergy Clin.Immunol. 111 (6): 1227­1231; June 2003. Baize, S.; Deubel, V. [Accelerated Vaccination for Ebola Hemorrhagic Fever]. Med Sci (Paris). 19 (12): 1183­1184; December, 2003. Baleta, A. Sri Lanka Opens Vaccine­Safety Centre. Lancet. 362 (9377): 49; July 5, 2003. Balinska, M. A. Vaccination in Tomorrow's Society. Lancet Infect.Dis. 3 (7): 443­447; July, 2003. Baltimore, R. S. and Jenson, H. B. Editorial Review: New Recommendations for Influenza Vaccination for Children and Pregnant Women Curr.Opin.Pediatr. 2003, 15 (1): 74­76. Banz, K., Wagenpfeil, S., Neiss, A., Goertz, A., Staginnus, U., Vollmar, J., and Wutzler, P. The Cost­Effectiveness of Routine Childhood Varicella Vaccination in Germany Vaccine 3­7­2003, 21 (11­12): 1256­1267. Barbero, Gonzalez A.; Alvarez de Toledo, Saavedra F.; Esteban, Fernandez J.; Pastor­Sanchez, R.; Gil, de Miguel; Rodriguez Barrios, J. M.; Garcia, Cebrian F.; Capdevilla, Prim C. [Management of Vaccinations and Prophylaxis of International Travellers From Community Pharmacy (VINTAF Study)]. Aten.Primaria. 32 (5): 276­281; September 30, 2003. Bartlett, J., Borio, L., Radonovich, L., Mair, J. S., O'Toole, T., Mair, M., Halsey, N., Grow, R., and Inglesby, T. V. Smallpox Vaccination in 2003: Key Information for Clinicians. Clin.Infect.Dis. 4­1­2003, 36 (7): 883­902. Bauch, C. T.; Galvani, A. P.; Earn, D. J. Group Interest Versus Self­Interest in Smallpox Vaccination Policy. Proc Natl Acad Sci U S A. 100(18): 10564­
10567, September 2, 2003. Baumhackl, U., Franta, C., Retzl, J., Salomonowitz, E., and Eder, G. A Controlled Trial of Tick­Borne Encephalitis Vaccination in Patients With Multiple Sclerosis. Vaccine 4­1­2003, 21 (S1): S56­S61. Bearman, G.; Fuentes, L.; Van Vorenkamp, J. L.; Drusin, L. M. Vaccination Without Documentation: Influenza Immunization Among Medical Residents at a Tertiary­Care Medical Center. Infect Control Hosp.Epidemiol. 24 (8): 626­628; August 2003. Begue, P. [Vaccination in France]. Arch Pediatr. 10 (6): 571­578; June, 2003. Bellaby, P. Communication and Miscommunication of Risk: Understanding UK Parents' Attitudes to Combined MMR Vaccination. BMJ. 327 (7417): 725­
728; September 27, 2003. Benjamin, G. C. Smallpox Vaccination Policy: Part II­Preparedness Begins. Physician Exec. 2003, 29 (2): 61­63. Bennett, M. E.; Ledell, K. Current Infection­Control Issues for Smallpox Disease and Vaccinia Vaccine. J Lab Clin Med. 142 (4): 239­245; October, 2003. Beran, J.; Moravik, J. Effectiveness of Vaccination Against Influenza in SkodaAuto Company Employees During the Influenza Season 2000­2001. Cent.Eur.J.Public Health. 11 (4): 209­212; December, 2003. Berg, H. F., Van Gendt, J., Rimmelzwaan, G. F., Peeters, M. F., and Van Keulen, P. Nosocomial Influenza Infection Among Post­Influenza­Vaccinated Patients With Severe Pulmonary Diseases. J Infect. 2003, 46 (2): 129­132. Bernsen, R. M.; de Jongste, J. C.; van der Wouden, J. C. Lower Risk of Atopic Disorders in Whole Cell Pertussis­Vaccinated Children. Eur Respir J. 22 (6): 962­964; December, 2003. Bernstein, D. I., Yan, L., Treanor, J., Mendelman, P. M., and Belshe, R. Effect of Yearly Vaccinations With Live, Attenuated, Cold­Adapted, Trivalent, Intranasal Influenza Vaccines on Antibody Responses in Children Pediatr.Infect.Dis.J 2003, 22 (1): 28­34. Beutels, P. and Gay, N. J. Economic Evaluation of Options for Measles Vaccination Strategy in a Hypothetical Western European Country. Epidemiol Infect. 2003, 130 (2): 273­283. Bidat, E.; Rance, F.; Gaudelus, J. [Vaccination in Children With Egg Allergy]. Arch.Pediatr. 10 (3): 251­253; March 2003. Billittier, A. J.; Lupiani, P.; Masterson, G.; Masterson, T.; Zak, C. Electronic Patient Registration and Tracking at Mass Vaccination Clinics: a Clinical Study. J.Public Health Manag.Pract. 9 (5): 401­410; September, 2003. Birmingham, M. E.; Lewis, R. F.; Perea, W.; Nelson, C. B.; Kabore, A.; Tarantola, D. Routine Vaccination With Polysaccharide Meningococcal Vaccines Is an Ineffective and Possibly Harmful Strategy. Bull.World Health Organ. 81 (10): 751­752; 2003. Bishaia, D., Koenig, M., and Khan, M. A. Measles Vaccination Improves the Equity of Health Outcomes: Evidence From Bangladesh. Health Econ. 2003, 12 (5): 415­419. Blakeney, B. Statement of Barbara Blakeney, MS, APRN, BC, ANP President, American Nurses Association. Regarding National Network for Immunization Information (NNii) Smallpox Vaccination Survey Findings­­January 22, 2003. Ala Nurse 2003, 30 (1): 12. Bodkin, C.; Klopper, H. C. Self­Care Practices and the Need for Influenza Vaccination in Healthy Individuals. Int.J.Nurs.Pract. 9 (6): 382­388; December, 2003. Bohlke, K.; Galil, K.; Jackson, L. A.; Schmid, D. S.; Starkovich, P.; Loparev, V. N.; Seward, J. F. Postpartum Varicella Vaccination: Is the Vaccine Virus Excreted in Breast Milk? Obstet Gynecol. 102 (5 Pt 1): 970­977; November, 2003. Bonilla­Guerrero, R.; Poland, G. A. Smallpox Vaccines: Current and Future. J Lab Clin Med. 142 (4): 252­257; October, 2003. Booss, J. and Davis, L. E. Smallpox and Smallpox Vaccination: Neurological Implications. Neurology 4­22­2003, 60 (8): 1241­1245. Boran, C.; Coban, Y. K.; Sasmaz, S.; Parmaksiz, G. Huge Keloid Formation After BCG Vaccination. Pediatr Dermatol. 20 (5): 460; September, 2003. Borner, N. Tolerability of Multiple Vaccinations in Travel Medicine. J Travel.Med. 2003, 10 (2): 112­116. Bos, J. M.; Rumke, H.; Welte, R.; Postma, M. J. Epidemiologic Impact and Cost­Effectiveness of Universal Infant Vaccination With a 7­Valent Conjugated Pneumococcal Vaccine in the Netherlands. Clin Ther. 25 (10): 2614­2630; October, 2003. Bothamley, G. H.; Cooper, E.; Shingadia, D.; Mellanby, A. Tuberculin Testing Before BCG Vaccination. BMJ. 327 (7409): 243­244; August 2, 2003. Bourdet, S. V.; Kelley, M.; Rublein, J.; Williams, D. M. Effect of a Pharmacist­Managed Program of Pneumococcal and Influenza Immunization on Vaccination Rates Among Adult Inpatients. Am J Health Syst Pharm. 60 (17): 1767­1771; September 1, 2003. Bray, M. and Wright, M. E. Progressive Vaccinia. Clin.Infect.Dis. 3­15­2003, 36 (6): 766­774. Bray, M. Pathogenesis and Potential Antiviral Therapy of Complications of Smallpox Vaccination. Antiviral Res. 2003, 58 (2): 101­114. Breen, D. Pneumococcal Vaccination Programme in Over 65s and at­Risk Groups: the Dumfries and Galloway Experience. Commun.Dis.Public Health. 6 (3): 228­230; September, 2003. Bridges, C. B., Harper, S. A., Fukuda, K., Uyeki, T. M., Cox, N. J., and Singleton, J. A. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 4­25­2003, 52 (RR­8): 1­34. Bridges, M. J.; Coady, D.; Kelly, C. A.; Hamilton, J.; Heycock, C. Factors Influencing Uptake of Influenza Vaccination in Patients With Rheumatoid Arthritis. Ann.Rheum.Dis. 62 (7): 685; July, 2003. Bridges, M. J.; Coady, D.; Kelly, C. A.; Hamilton, J.; Heycock, C. Factors Influencing Uptake of Influenza Vaccination in Patients With Rheumatoid Arthritis. Ann.Rheum.Dis. 62 (7): 685; July 2003. Brinkman, D. M.; Jol­van der Zijde, C. M.; ten Dam, M. M.; Vossen, J. M.; Osterhaus, A. D.; Kroon, F. P.; van Tol, M. J. Vaccination With Rabies to Study the Humoral and Cellular Immune Response to a T­Cell Dependent Neoantigen in Man. J.Clin.Immunol. 23 (6): 528­538; November, 2003. Brisson, M. and Edmunds, W. J. Economic Evaluation of Vaccination Programs: the Impact of Herd­Immunity Med.Decis.Making 2003, 23 (1): 76­82. Brisson, M., Edmunds, W. J., and Gay, N. J. Varicella Vaccination: Impact of Vaccine Efficacy on the Epidemiology of VZV. J Med.Virol. 2003, 70 Suppl 1:S31­7. (): S31­S37. Brisson, M.; Edmunds, W. J. Varicella Vaccination in England and Wales: Cost­Utility Analysis. Arch Dis Child. 88 (10): 862­869; October, 2003. Brodkin, H. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 4­1­2003, 138 (7): 607­609. Brotherton, J. M., Delpech, V. C., Gilbert, G. L., Hatzi, S., Paraskevopoulos, P. D., and McAnulty, J. M. A Large Outbreak of Influenza A and B on a Cruise Ship Causing Widespread Morbidity. Epidemiol Infect. 2003, 130 (2): 263­271. Brotherton, J.; McAnulty, J. A Pertussis Epidemic in NSW: How Epidemiology Reflects Vaccination Policy. N.S W.Public Health Bull. 14 (4­5): 77­81; April 2003. Brydak, L. B.; Machala, M.; Mysliwska, J.; Mysliwski, A.; Trzonkowski, P. Immune Response to Influenza Vaccination in an Elderly Population. J Clin.Immunol. 23 (3): 214­222; May 2003. Buchwald, U. K. and Pirofski, L. Immune Therapy for Infectious Diseases at the Dawn of the 21(St) Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers. Curr.Pharm.Des 2003, 9 (12): 945­968. Buchwald, U. K. and Pirofski, L. Immune Therapy for Infectious Diseases at the Dawn of the 21(St) Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers. Curr.Pharm.Des 2003, 9 (12): 945­968. Bueving, H. J.; Bernsen, R. M.; de Jongste, J. C.; Suijlekom­Smit, L. W.; Rimmelzwaan, G. F.; Osterhaus, A. D.; Rutten­Van Molken, M. P.; Thomas, S.; van der Wouden, J. C. Influenza Vaccination in Asthmatic Children: Randomised Double­Blind Placebo­Controlled Trial. Am J Respir Crit Care Med. December 4, 2003. Bugiani, M., Borraccino, A., Migliore, E., Carosso, A., Piccioni, P., Cavallero, M., Caria, E., Salamina, G., and Arossa, W. Tuberculin Reactivity in Adult BCG­Vaccinated Subjects: a Cross­Sectional Study. Int J Tuberc Lung Dis. 2003, 7 (4): 320­326. Bugri, S. Meningococcal Meningitis Vaccination: More Information Needed. Bull.World Health Organ. 81 (10): 755; 2003. Burns, V. E., Carroll, D., Ring, C., and Drayson, M. Antibody Response to Vaccination and Psychosocial Stress in Humans: Relationships and Mechanisms. Vaccine 6­2­2003, 21 (19­20): 2523­2534. Burns, V. E.; Carroll, D.; Drayson, M.; Whitham, M.; Ring, C. Life Events, Perceived Stress and Antibody Response to Influenza Vaccination in Young, Healthy Adults. J Psychosom.Res. 55 (6): 569­572; December, 2003. Butler, D. WHO Prepares for Final Push to Rid the World of Polio. Nature. 424 (6949): 604; August 7, 2003. Campins, Marti M., Casal, Lombos J., Tarrago, Asensio D., Rodrigo Anoro Mf, M. J., Allepuz, Palau A., and C7llis, Bracons L. [Persistence of Antibodies Three Years After Vaccination With the 23­Valent Pneumococcal Vaccine]. An Pediatr.(Barc.) 2003, 58 (2): 184­187. Campins, Marti M.; Alemany, Vilches L. [Influenza Vaccination: Only Advantages?]. Med Clin (Barc.). 121 (18): 703­704; November 22, 2003. Cardenosa, N.; Dominguez, A.; Martinez, A.; Alvarez, J.; Panella, H.; Godoy, P.; Minguell, S.; Camps, N.; Vazquez, J. A. Meningococcal Disease in Catalonia 1 Year After Mass Vaccination Campaign With Meningococcal Group C Polysaccharide Vaccine. Infection. 31 (6): 392­397; December, 2003. Cavdar, C., Sayan, M., Sifil, A., Artuk, C., Yilmaz, N., Bahar, H., and Camsari, T. The Comparison of Antibody Response to Influenza Vaccination in Continuous Ambulatory Peritoneal Dialysis, Hemodialysis and Renal Transplantation Patients. Scand J Urol Nephrol. 2003, 37 (1): 71­76. Chapman, R. S., Cross, K. W., and Fleming, D. M. The Incidence of Shingles and Its Implications for Vaccination Policy. Vaccine 6­2­2003, 21 (19­20): 2541­2547. Charatan, F. US Panel Advises Caution Over Smallpox Vaccination. BMJ. 327 (7412): 414; August 23, 2003. Cherian, T., Varkki, S., Raghupathy, P., Ratnam, S., and Chandra, R. K. Effect of Vitamin A Supplementation on the Immune Response to Measles Vaccination. Vaccine 6­2­2003, 21 (19­20): 2418­2420. Cherry, J. D. Risks to Children of Health Care Personnel Receiving Smallpox Vaccination. Pediatr.Infect.Dis J. 22 (6): 574­575; June 2003. Chowdhury, A. M.; Bhuiya, A.; Mahmud, S.; Abdus Salam, A. K.; Karim, F. Immunization Divide: Who Do Get Vaccinated in Bangladesh? J.Health Popul.Nutr. 21 (3): 193­204; September, 2003. Chu, N. R. Therapeutic Vaccination for the Treatment of Mucosotropic Human Papillomavirus­Associated Disease. Expert.Opin.Biol.Ther. 3 (3): 477­486; June 2003. Claes, C. and Graf Von Der Schulenburg, JM Cost Effectiveness of Pneumococcal Vaccination for Infants and Children With the Conjugate Vaccine PnC­7 in Germany. Pharmacoeconomics. 2003, 21 (8): 587­600. Classen, J. B.; Classen, D. C. Clustering of Cases of Type 1 Diabetes Mellitus Occurring 2­4 Years After Vaccination Is Consistent With Clustering After Infections and Progression to Type 1 Diabetes Mellitus in Autoantibody Positive Individuals. J Pediatr.Endocrinol.Metab. 16 (4): 495­508; April 2003. Clements, C. Mass Psychogenic Illness After Vaccination. Drug Saf. 26 (9): 599­604; 2003. Cochran, C. E., Smith, D. R., Reid, G., Morrow, H., and Ramirez, J. Protecting Texas Children: Evidence­Based Recommendations for Improving Childhood Vaccination Rates. Tex.Med. 2003, 99 (3): 52­60. Cohen, R. [Antipneumococcal Vaccines in Sickle­Cell Anemia and Asplenia]. Presse Med. 32 (28 Suppl): S12­S14; September 6, 2003. Colino, J. and Snapper, C. M. Dendritic Cells, New Tools for Vaccination. Microbes.Infect. 2003, 5 (4): 311­319. Conti, R. Smallpox Vaccinations: the Risks and the Benefits. Issue.Brief.(Commonw.Fund.) 2003, 620): 1­9. Cooper, P. J.; Chico, M. E.; Gaus, D.; Griffin, G. E. Relationship Between Bacille Calmette­Guerin Vaccination, Mantoux Test Positivity, and Geohelminth Infection. Trans.R.Soc.Trop.Med.Hyg. 97 (4): 473­476; July, 2003. Cotter, B., Bremer, V., Stroh, G., Msambichaka, K., Mabuzane, E., Munyoro, M., Shirehwa, F., Biellik, R., and Birmingham, M. Assessment of Neonatal Tetanus Elimination in an African Setting by Lot Quality Assurance Cluster Sampling (LQA­CS). Epidemiol Infect. 2003, 130 (2): 221­226. Coudeville, L. Measles Dynamics and Vaccination DiffusionA Model and an Application. Eur J Health Econ; 4 (4): 319­326; December, 2003. Crabb, C. Developing Countries Overstate Vaccination Coverage. Bull.World Health Organ. 81 (11): 851; 2003. Crotty, S.; Felgner, P.; Davies, H.; Glidewell, J.; Villarreal, L.; Ahmed, R. Cutting Edge: Long­Term B Cell Memory in Humans After Smallpox Vaccination. J Immunol. 171 (10): 4969­4973; November 15, 2003. Crump, S. C. and Oxley, M. Society of Homeopaths Does Not Advise Against Vaccination BMJ 1­18­2003, 326 (7381): 164. Culley, F. J.; Olszewska, W. Physical Trauma of Vaccination Acts As a Wake­Up Call to Dangers in the Skin. Immunology. 110 (3): 291­292; November, 2003. Daly, A. D.; Nxumalo, M. P.; Biellik, R. J. Missed Opportunities for Vaccination in Health Facilities in Swaziland. S Afr Med J. 93 (8): 606­610; August, 2003. D'Amelio, R.; Biselli, R.; Natalicchio, S.; Lista, F.; Peragallo, M. S. Vaccination Programmes in the Italian Military. Vaccine. 21 (25­26): 3530­3533; September 8, 2003. Dannetun, E.; Tegnell, A.; Normann, B.; Garpenholt, O.; Giesecke, J. Influenza Vaccine Coverage and Reasons for Non­Vaccination in a Sample of People Above 65 Years of Age, in Sweden, 1998­2000. Scand.J Infect Dis. 35 (6­7): 389­393; 2003. Darling, R. G.; Waeckerle, J. F.; Grabenstein, C. O.; Koenig, K. L. Removing Health Care Workers From Clinical Duties After Smallpox Vaccination: Is It Really Necessary? Ann Emerg.Med. 42 (5): 685­688; November, 2003. Das, J. and Das, S. Trust, Learning, and Vaccination: a Case Study of a North Indian Village. Soc Sci Med. 2003, 57 (1): 97­112. Das, J.; Das, S. Trust, Learning, and Vaccination: A Case Study of a North Indian Village. Soc.Sci Med. 57 (1): 97­112; July, 2003. Dasgupta, S.; Bhinge, A.; Chandran, V.; Sewlikar, S.; Nimbkar, A.; Datta, D. Role of L­Lysine HCl in Immunopotentiation Towards Development of Suitable Tuberculosis Vaccination. Vaccine. 21 (32): 4722­4727; December 1, 2003. De Serres, G., Boulianne, N., Duval, B., Rochette, L., Grenier, J. L., Roussel, R., Donaldson, D., Tremblay, M., Toth, E., Menard, S., Landry, M., and Robert, Y. Oculo­Respiratory Syndrome Following Influenza Vaccination: Evidence for Occurrence With More Than One Influenza Vaccine. Vaccine 6­2­2003, 21 (19­20): 2346­2353. De Serres, G., Grenier, J. L., Toth, E., Menard, S., Roussel, R., Tremblay, M., Fradet, M. D., Landry, M., Robert, Y., and Skowronski, D. M. The Clinical Spectrum of the Oculo­Respiratory Syndrome After Influenza Vaccination. Vaccine 6­2­2003, 21 (19­20): 2354­2361. de Vries, P. A., Oei­Reyners, A. K., Moller, A. V., Timens, W., Tulleken, J. E., and van der Werf, T. S. [Fulminant Pneumococcal Sepsis in Two Splenectomized Patients]. Ned.Tijdschr.Geneeskd. 3­8­2003, 147 (10): 450­454. Deem, M. W.; Lee, H. Y. Sequence Space Localization in the Immune System Response to Vaccination and Disease. Phys.Rev Lett. 91 (6): 068101; August 8, 2003. Degefie, T. Tuberculous Meningitis in a District Hospital From Southern Ethiopia. Ethiop.Med.J. 41 (4): 311­318; October, 2003. Del Giudice, G. Vaccination Strategies. An Overview. Vaccine 6­1­2003, 21 Suppl 2:S83­8: S83­S88. Delgado, Rubio A. [Vaccination Schedule 2003]. An Pediatr.(Barc.) 2003, 58 (3): 207. Delhaye, M.; Clavreul, A.; Garcion, E.; Menei, P. [Anti­Glioma Vaccination]. Neurochirurgie. 49 (4): 459­463; September, 2003. Dervaux, B.; Leleu, H.; Valdmanis, V.; Walker, D. Parameters of Control When Facing Stochastic Demand: a DEA Approach Applied to Bangladeshi Vaccination Sites. Int J Health Care Finance.Econ. 3 (4): 287­299; December, 2003. DeStefano, F.; Thompson, W. W. MMR Vaccination and Autism: Is There a Link? Expert.Opin.Drug Saf. 1 (2): 115­120; July, 2002. Dhiman, N.; Ovsyannikova, I. G.; Pinsky, N. A.; Vierkant, R. A.; Jacobsen, S. J.; Jacobson, R. M.; Poland, G. A. Lack of Association Between Transporter Associated With Antigen Processing (TAP) and HLA­DM Gene Polymorphisms and Antibody Levels Following Measles Vaccination. Eur.J Immunogenet. 30 (3): 195­200; June 2003. Diabate, V. [Why Not Include an Anti­Pneumococcal Vaccination in the Anti­Influenza Program?]. Presse Med. 1­18­2003, 32 (2): 51­52. Dilber, E.; Karagoz, T.; Aytemir, K.; Ozer, S.; Alehan, D.; Oto, A.; Celiker, A. Acute Myocarditis Associated With Tetanus Vaccination. Mayo Clin Proc. 78 (11): 1431­1433; November, 2003. Dili, Z. The IOM Committee on Smallpox Vaccination. Am.J Nurs. 2003, 103 (4): 27. Dodart, J. C., Bales, K. R., and Paul, S. M. Immunotherapy for Alzheimer's Disease: Will Vaccination Work? Trends Mol.Med. 2003, 9 (3): 85­87. Dodds, W. J. Advocate for Serologic Testing After Vaccination J Am.Vet.Med.Assoc. 1­15­2003, 222 (2): 149­150. Donnelly, M. J.; Herold, B. C.; Jenkins, S. G.; Daum, R. S. Obstacles to the Elimination of Haemophilus Influenzae Type b Disease: Three Illustrative Cases. Pediatrics. 112 (6 Pt 1): 1465­1466; December, 2003. Dourado, I., Rios, M. H., Pereira, S. M., Cunha, S. S., Ichihara, M. Y., Goes, J. C., Rodrigues, L. C., Bierrenbach, A. L., and Barreto, M. L. Rates of Adverse Reactions to First and Second Doses of BCG Vaccination: Results of a Large Community Trial in Brazilian Schoolchildren. Int J Tuberc Lung Dis. 2003, 7 (4): 399­402. Dropulic, L. K., Rubin, R. H., and Bartlett, J. G. Smallpox Vaccination and the Patient With an Organ Transplant. Clin.Infect.Dis. 3­15­2003, 36 (6): 786­788. du, Toit G. and Weinberg, E. G. Egg Allergy and MMR Vaccination. S Afr.Med.J 2003, 93 (2): 113­114. Dyer, O. UK Government Denies That Smallpox Vaccination Plans Have Fallen Short of Target. BMJ. 327 (7422): 1010; November 1, 2003. Dym, M. Questions Vaccination Protocols. J Am Vet.Med Assoc. 223 (10): 1416­1417; November 15, 2003. Earle, C. C. Influenza Vaccination in Elderly Patients With Advanced Colorectal Cancer. J Clin.Oncol. 3­15­2003, 21 (6): 1161­1166. Egede, L. E. and Zheng, D. Racial/Ethnic Differences in Adult Vaccination Among Individuals With Diabetes Am.J Public Health 2003, 93 (2): 324­329. Egede, L. E. Association Between Number of Physician Visits and Influenza Vaccination Coverage Among Diabetic Adults With Access to Care. Diabetes Care. 26 (9): 2562­2567; September, 2003. Ehreth, J. The Global Value of Vaccination Vaccine 1­30­2003, 21 (7­8): 596­600. Ehreth, J. The Value of Vaccination: A Global Perspective. Vaccine. 21 (27­28): 4105­4117; October 1, 2003. Eichner, M. Analysis of Historical Data Suggests Long­Lasting Protective Effects of Smallpox Vaccination. Am J Epidemiol. 158 (8): 717­723; October 15, 2003. Eilertson, L. Vaccination Available. Nurs.Manage. 34 (6): 9; June 2003. Eko, F. O., Lubitz, W., McMillan, L., Ramey, K., Moore, T. T., Ananaba, G. A., Lyn, D., Black, C. M., and Igietseme, J. U. Recombinant Vibrio Cholerae Ghosts As a Delivery Vehicle for Vaccinating Against Chlamydia Trachomatis. Vaccine 4­2­2003, 21 (15): 1694­1703. Enquselassie, F.; Ayele, W.; Dejene, A.; Messele, T.; Abebe, A.; Cutts, F. T.; Nokes, D. J. Seroepidemiology of Measles in Addis Ababa, Ethiopia: Implications for Control Through Vaccination. Epidemiol.Infect. 130 (3): 507­519; June 2003. Enserink, M. Bioterrorism. New Look at Old Data Irks Smallpox­Eradication Experts Science 1­10­2003, 299 (5604): 181. Enserink, M. Infectious Diseases. Smallpox Vaccination Campaign in the Doldrums. Science 5­9­2003, 300 (5621): 880­881. Eriksson, J. C.; Davidsson, A.; Garberg, H.; Brokstad, K. A. Lymphocyte Distribution in the Tonsils Prior to and After Influenza Vaccination. Vaccine. 22 (1): 57­63; December 8, 2003. Esposito, S.; Marchisio, P.; Cavagna, R.; Gironi, S.; Bosis, S.; Lambertini, L.; Droghetti, R.; Principi, N. Effectiveness of Influenza Vaccination of Children With Recurrent Respiratory Tract Infections in Reducing Respiratory­Related Morbidity Within the Households. Vaccine. 21 (23): 3162­3168; July 4, 2003. Esposito, S.; Marchisio, P.; Cavagna, R.; Gironi, S.; Bosis, S.; Lambertini, L.; Droghetti, R.; Principi, N. Effectiveness of Influenza Vaccination of Children With Recurrent Respiratory Tract Infections in Reducing Respiratory­Related Morbidity Within the Households. Vaccine. 21 (23): 3162­3168; July 4, 2003. Evans, C. T.; Legro, M. W.; Weaver, F. M.; Goldstein, B. Influenza Vaccination Among Veterans With Spinal Cord Injury: Part 1. A Survey of Attitudes and Behavior. J.Spinal Cord.Med. 26 (3): 204­209; 2003. Everett, W. W.; Coffin, S. E.; Zaoutis, T.; Halpern, S. D.; Strom, B. L. Smallpox Vaccination: a National Survey of Emergency Health Care Providers. Acad.Emerg.Med. 10 (6): 606­611; June 2003. Farrington, C. P.; Kanaan, M. N.; Gay, N. J. Branching Process Models for Surveillance of Infectious Diseases Controlled by Mass Vaccination. Biostatistics. 4 (2): 279­295; April, 2003. Fedson, D. S. Pneumococcal Vaccination in Older Adults. N.Engl.J Med. 349 (7): 712­714; August 14, 2003. Fedson, D. S. Vaccination for Pandemic Influenza and Severe Acute Respiratory Syndrome: Common Issues and Concerns. Clin.Infect.Dis. 36 (12): 1562­
1563; June 15, 2003. Fernandez, S., Arreaza, L., Santiago, I., Malvar, A., Berron, S., Vazquez, J. A., and Hervada, X. Impact of Meningococcal Vaccination With Combined Serogroups A and C Polysaccharide Vaccine on Carriage of Neisseria Meningitidis C J Med.Microbiol. 2003, 52 (1): 75­77. Fett, J. D. Smallpox and Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1920­1925. Filipovic, T.; Grzetic, R.; Sviderek­Stalekar, D. Earlier Detection of Amblyopia and Strabismus by Ophthalmologic Screening Card Attached to the Vaccination Card. Can.J.Ophthalmol. 38 (7): 587­592; December, 2003. Fischer, D.; Reimann, J.; Schroder, R. [Macrophagic Myofasciitis: Inflammatory, Vaccination­Associated Muscular Disease]. Dtsch Med Wochenschr. 128 (44): 2305­2308; October 31, 2003. Fishman, J. A. Smallpox and Live­Virus Vaccination in Transplant Recipients. Am.J Transplant. 3 (7): 786­793; July 2003. Ford, E. S.; Mannino, D. M.; Williams, S. G. Asthma and Influenza Vaccination: Findings From the 1999­2001 National Health Interview Surveys. Chest. 124 (3): 783­789; September, 2003. Fox, A.; Lack, G. Egg Allergy and MMR Vaccination. Br.J Gen.Pract. 53 (495): 801­802; October, 2003. Foxwell, A. R.; Cripps, A. W.; Dear, K. B. Haemophilus Influenzae Oral Whole Cell Vaccination for Preventing Acute Exacerbations of Chronic Bronchitis. Cochrane Database Syst Rev.3): CD001958; 2003. Frazier, A. Support for Smallpox Vaccinations. Am.J Nurs. 103 (7): 116­117; July, 2003. Fredette, M. J.; De Serres, G.; Malenfant, M. Ophthalmological and Biological Features of the Oculorespiratory Syndrome After Influenza Vaccination. Clin Infect Dis. 37 (8): 1136­1138; October 15, 2003. Freed, G. L., Davis, M. M., and Clark, S. J. Variation in Public and Private Supply of Pneumococcal Conjugate Vaccine During a Shortage JAMA 2­5­2003, 289 (5): 575­578. Freeman, P. B. Smallpox Vaccination: A Shot in the Dark? Optometry. 2003, 74 (3): 141­142. Frey, C. R.; Sharp, M. A.; Min, A. S.; Schmid, D. S.; Loparev, V.; Arvin, A. M. Identification of CD8+ T Cell Epitopes in the Immediate Early 62 Protein (IE62) of Varicella­Zoster Virus, and Evaluation of Frequency of CD8+ T Cell Response to IE62, by Use of IE62 Peptides After Varicella Vaccination. J Infect.Dis. 188 (1): 40­52; July 1, 2003. Frey, C. R.; Sharp, M. A.; Min, A. S.; Schmid, D. S.; Loparev, V.; Arvin, A. M. Identification of CD8+ T Cell Epitopes in the Immediate Early 62 Protein (IE62) of Varicella­Zoster Virus, and Evaluation of Frequency of CD8+ T Cell Response to IE62, by Use of IE62 Peptides After Varicella Vaccination. J Infect.Dis. 188 (1): 40­52; July 1, 2003. Fringuelli, E.; Lepri, E.; Camilloni, B.; Neri, M.; Carrio, E.; Russano, A.; Spinozzi, F.; Iorio, A. M. Flow Cytometric Measurement of Intracellular IFN­
Gamma Induction in Aged Subjects Before and After Parenteral Influenza Vaccination. Dev.Biol.(Basel). 115:55­9; 2003. Fuessl, H. S. [How Do We Deal With Tick Bites­­Vaccination­­Antibiotica­­Immunotherapy?]. MMW.Fortschr.Med. 145 (15): 35; April 10, 2003. Fulginiti, V. A.; Papier, A.; Lane, J. M.; Neff, J. M.; Henderson, D. A. Smallpox Vaccination: A Review, Part II. Adverse Events. Clin.Infect.Dis. 37 (2): 251­
271; July 15, 2003. Fulginiti, V. A.; Papier, A.; Lane, J. M.; Neff, J. M.; Henderson, D. A. Smallpox Vaccination: A Review, Part I. Background, Vaccination Technique, Normal Vaccination and Revaccination, and Expected Normal Reactions. Clin.Infect.Dis. 37 (2): 241­250; July 15, 2003. Furth, S. L., Arbus, G. S., Hogg, R., Tarver, J., Chan, C., and Fivush, B. A. Varicella Vaccination in Children With Nephrotic Syndrome: A Report of the Southwest Pediatric Nephrology Study Group J Pediatr. 2003, 142 (2): 145­148. Furth, S. L., Hogg, R. J., Tarver, J., Moulton, L. H., Chan, C., and Fivush, B. A. Varicella Vaccination in Children With Chronic Renal Failure: A Report of the Southwest Pediatric Nephrology Study Group Pediatr.Nephrol. 2003, 18 (1): 33­38. Gallwitz, S.; Schutzbank, T.; Heberling, R. L.; Kalter, S. S.; Galpin, J. E. Smallpox: Residual Antibody After Vaccination. J Clin Microbiol. 41 (9): 4068­
4070; September, 2003. Gandjour, A. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 4­1­2003, 138 (7): 607­608. Gans, H.; DeHovitz, R.; Forghani, B.; Beeler, J.; Maldonado, Y.; Arvin, A. M. Measles and Mumps Vaccination As a Model to Investigate the Developing Immune System: Passive and Active Immunity During the First Year of Life. Vaccine. 21 (24): 3398­3405; July 28, 2003. Garcia­Lora, A.; Algarra, I.; Collado, A.; Garrido, F. Tumour Immunology, Vaccination and Escape Strategies. Eur.J Immunogenet. 30 (3): 177­183; June 2003. Garcia­Moll, X. Influenza Vaccination: a New Indication of an Old Therapy? Rev Esp.Cardiol. 56 (10): 944­946; October, 2003. Garner, D. and Weston, V. Effectiveness of Vaccination for Haemophilus Influenzae Type b Lancet 2­1­2003, 361 (9355): 395­396. Geier, M. R., Geier, D. A., and Zahalsky, A. C. Influenza Vaccination and Guillain Barre Syndrome Small Star, Filled. Clin Immunol. 2003, 107 (2): 116­121. Ghebrehewet, S.; Falconer, M.; McDonald, P.; Schlecht, B. MMR Vaccine Uptake Rates: A Data Validation Study. Commun Dis Public Health. 6 (2): 144­
146; June, 2003. Ghosh, T. K. Controversies in Rabies Vaccination. Indian J Pediatr. 70 (6): 495­498; June, 2003. Giammanco, A., Taormina, S., Chiarini, A., Dardanoni, G., Stefanelli, P., Salmaso, S., and Mastrantonio, P. Analogous IgG Subclass Response to Pertussis Toxin in Vaccinated Children, Healthy or Affected by Whooping Cough. Vaccine 5­16­2003, 21 (17­18): 1924­1931. Giles, S. G. A Home Based Health Check Combined With Influenza Vaccination Improved Uptake of Influenza Vaccination in People >/=75 Years of Age. Evid.Based.Nurs. 2003, 6 (2): 52­53. Gillet, A. M. [Is It Necessary to Vaccinate Against Variola?]. Med.Trop.(Mars.). 63 (6): 643­648; 2003. Giusti, R. J. An Outbreak of Varicella Despite Vaccination. N.Engl.J Med. 4­3­2003, 348 (14): 1405­1407. Givon­Lavi, N.; Fraser, D.; Dagan, R. Vaccination of Day­Care Center Attendees Reduces Carriage of Streptococcus Pneumoniae Among Their Younger Siblings. Pediatr.Infect.Dis J. 22 (6): 524­532; June 2003. Glaser, R.; Robles, T. F.; Sheridan, J.; Malarkey, W. B.; Kiecolt­Glaser, J. K. Mild Depressive Symptoms Are Associated With Amplified and Prolonged Inflammatory Responses After Influenza Virus Vaccination in Older Adults. Arch Gen.Psychiatry. 60 (10): 1009­1014; October, 2003. Glass, K. and Grenfell, B. T. Antibody Dynamics in Childhood Diseases: Waning and Boosting of Immunity and the Impact of Vaccination. J Theor.Biol. 3­7­
2003, 221 (1): 121­131. Gocke, K.; Baumann, U.; Hagemann, H.; Gabelsberger, J.; Hahn, H.; Freihorst, J.; von Specht, B. U. Mucosal Vaccination With a Recombinant OprF­I Vaccine of Pseudomonas Aeruginosa in Healthy Volunteers: Comparison of a Systemic Vs. a Mucosal Booster Schedule. FEMS Immunol.Med.Microbiol. 37 (2­3): 167­171; July 15, 2003. Godreuil, S., Delhaume, O., Besset­Prat, L., Blayac, J. P., Peyriere, H., and Bonnet, P. [Acute Haemorrhagic Pericarditis Following Influenza Vaccination] Presse Med. 2­15­2003, 32 (6): 258­259. Goldstein, B.; Hammond, M. C. The Importance of Influenza Vaccinations in Persons With Spinal Cord Injury and Disease. J.Spinal Cord.Med. 26 (3): 219­
220; 2003. Gomez­Lus, M. L., Gimenez, M. J., Vazquez, J. A., Aguilar, L., Anta, L., Berron, S., Laguna, B., and Prieto, J. Opsonophagocytosis Versus Complement Bactericidal Killing As Effectors Following Neisseria Meningitidis Group C Vaccination Infect. 2003, 31 (1): 51­54. Gordon, S. M. Pre­Event Smallpox Vaccination: Unresolved Issues. Cleve.Clin.J Med. 2003, 70 (2): 80­86. Grabenstein, J. D.; Winkenwerder, W., Jr. US Military Smallpox Vaccination Program Experience. JAMA. 289 (24): 3278­3282; June 25, 2003. Greenberg, N., Iversen, A., Hull, L., Unwin, C., Destrange, M., and Wessely, S. Vaccination Records in Gulf War Veterans. J Occup.Environ.Med. 2003, 45 (3): 219. Greene, J. To Be or Not to Be Vaccinated. The Smallpox Controversy Plays Out in California Hospitals. Trustee. 2003, 56 (5): 14­7, 1. Grist, N. R. Smallpox and Vaccination. Lancet 4­5­2003, 361 (9364): 1228. Gruber, C., Illi, S., Lau, S., Nickel, R., Forster, J., Kamin, W., Bauer, C. P., Wahn, V., and Wahn, U. Transient Suppression of Atopy in Early Childhood Is Associated With High Vaccination Coverage Pediatrics 2003, 111 (3): e282­e288. Gruchalla, R. S.; Jones, J. Combating High­Priority Biological Agents: What to Do With Drug­Allergic Patients and Those for Whom Vaccination Is Contraindicated? J Allergy Clin Immunol. 112 (4): 675­682; October, 2003. Gu, J. Beijing Centers for Disease Control and Prevention Emphasizes Cost­Effective Influenza Vaccination. Chin Med J (Engl.). 116 (11): 1686; November, 2003. Guala, A., Paoletti, R., Pastore, G., Sinaccio, C., and Pagani, L. Offering Rubella Vaccination to Sexually Active Adolescents. Vaccine 4­2­2003, 21 (15): 1561. Hak, E., Hoes, A. W., Grobbee, D. E., Lammers, J. W., Van Essen, G. A., Van Loon, A. M., and Verheij, T. J. Conventional Influenza Vaccination Is Not Associated With Complications in Working­Age Patients With Asthma or Chronic Obstructive Pulmonary Disease. Am.J Epidemiol. 4­15­2003, 157 (8): 692­700. Hak, E.; Bonten, M. J.; Hoes, A. W. Pneumococcal Vaccination in Older Adults. N.Engl.J Med. 349 (7): 712­714; August 14, 2003. Hall, A. J. Vaccination Politics Trop.Med.Int.Health 2003, 8 (1): 1­2. Halliday, L.; Thomson, J. A.; Roberts, L.; Bowen, S.; Mead, C. Influenza Vaccination of Staff in Aged Care Facilities in the ACT: How Can We Improve the Uptake of Influenza Vaccine? Aust.N.Z.J.Public Health. 27 (1): 70­75; 2003. Halperin, S. A.; Smith, B.; Nolan, C.; Shay, J.; Kralovec, J. Safety and Immunoenhancing Effect of a Chlorella­Derived Dietary Supplement in Healthy Adults Undergoing Influenza Vaccination: Randomized, Double­Blind, Placebo­Controlled Trial. CMAJ. 169 (2): 111­117; July 22, 2003. Halsell, J. S.; Riddle, J. R.; Atwood, J. E.; Gardner, P.; Shope, R.; Poland, G. A.; Gray, G. C.; Ostroff, S.; Eckart, R. E.; Hospenthal, D. R.; Gibson, R. L.; Grabenstein, J. D.; Arness, M. K.; Tornberg, D. N. Myopericarditis Following Smallpox Vaccination Among Vaccinia­Naive US Military Personnel. JAMA. 289 (24): 3283­3289; June 25, 2003. Hamidon, B. B.; Raymond, A. A. Acute Disseminated Encephalomyelitis (ADEM) Presenting With Seizures Secondary to Anti­Tetanus Toxin Vaccination. Med.J.Malaysia. 58 (5): 780­782; December, 2003. Hammarlund, E.; Lewis, M. W.; Hansen, S. G.; Strelow, L. I.; Nelson, J. A.; Sexton, G. J.; Hanifin, J. M.; Slifka, M. K. Duration of Antiviral Immunity After Smallpox Vaccination. Nat.Med. 9 (9): 1131­1137; September, 2003. Hanna, J. N.; Bullen, R. C.; Ziegler, C. L.; Akee, T.; Dostie, B. G.; Lort­Phillips, K. An Assessment of the Implementation of the Pneumococcal Conjugate Vaccination Program for Aboriginal and Torres Strait Infants in North Queensland. Commun Dis Intell. 27 (2): 262­266; 2003. Hanslik, T.; Boelle, P. Y.; Schwarzinger, M.; Carrat, F.; Freedberg, K. A.; Valleron, A. J.; Flahault, A. Varicella in French Adolescents and Adults: Individual Risk Assessment and Cost­Effectiveness of Routine Vaccination. Vaccine. 21 (25­26): 3614­3622; September 8, 2003. Hara, Y. [An Economic Evaluation of Strategy for Expanding Influenza Vaccination in Japan]. Nippon Rinsho. 61 (11): 2013­2018; November, 2003. Harmanci, H.; Gurbuz, Y.; Torun, S. D.; Tumerdem, N.; Erturk, T. Reasons for Non­Vaccination During National Immunization Days: a Case Study in Istanbul, Turkey. Public Health. 117 (1): 54­61; January 2003. Harper, S. A.; Fukuda, K.; Cox, N. J.; Bridges, C. B. Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza: Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm.Rep. 52 (RR­13): 1­8; September 26, 2003. Hassler, D.; Braun, R. [When Should Vaccination of Phenprocoumon Patients Take Place?]. Dtsch Med Wochenschr. 128 (36): 1854; September 5, 2003. Heath, P. T., Booy, R., McVernon, J., Bowen­Morris, J., Griffiths, H., Slack, M. P., Moloney, A. C., Ramsay, M. E., and Moxon, E. R. Hib Vaccination in Infants Born Prematurely Arch.Dis.Child 2003, 88 (3): 206­210. Hehn, J.; Hartmann, K.; Brocker, E. B.; Goebeler, M. [Influenza Vaccination and Skin Disease­­Coincidence or Causal Association?]. J Dtsch Dermatol Ges; 1 (2): 99­104; February, 2003. Henke, A.; Jarasch, N.; Wutzler, P. Vaccination Procedures Against Coxsackievirus­Induced Heart Disease. Expert.Rev.Vaccines. 2 (6): 805­815; December, 2003. Herzog, N. S.; Bratzler, D. W.; Houck, P. M.; Jiang, H.; Nsa, W.; Shook, C.; Weingarten, S. R. Effects of Previous Influenza Vaccination on Subsequent Readmission and Mortality in Elderly Patients Hospitalized With Pneumonia. Am J Med. 115 (6): 454­461; October 15, 2003. Heurter, H., Breen­Reid, K., Aronson, L., Lingard, L., Manning, D., and Ford­Jones, E. L. Childhood Immunization. How Knowledgeable Are We? Can Nurse 2003, 99 (4): 27­31. Hill, A. N. and Longini, I. M. The Critical Vaccination Fraction for Heterogeneous Epidemic Models Math.Biosci. 2003, 181 (1): 85­106 Hirsch, R. L. Vaccination Rates: Supply, Demand, and Tracking. Arch.Intern.Med. 4­14­2003, 163 (7): 849­850. Hirschmann, J. V. Pneumococcal Vaccination in Older Adults. N.Engl.J Med. 349 (7): 712­714; August 14, 2003. Holloway, B. Support for Smallpox Vaccinations. Am.J Nurs. 103 (7): 116­117; July, 2003. Holt, P. G. Functionally Mature Virus­Specific CD8(+) T Memory Cells in Congenitally Infected Newborns: Proof of Principle for Neonatal Vaccination? J Clin.Invest. 111 (11): 1645­1647; June 2003. Hostler, D., Milspaw, J., and Paris, P. M. Pneumococcal Vaccination: An Opportunity for Emergency Medical Services Prehosp.Emerg.Care 2003, 7 (1): 125­
135. Hoveyda, N. and Behrens, R. More Travel Advice and Fewer Vaccinations Are Needed BMJ 1­4­2003, 326 (7379): 52A. Howard­Ruben, J. Ongoing Debate Over Smallpox Vaccinations Continues. ONS.News. 18 (6): 12, 16; June 2003. Hsu, H. C.; Lin, R. S.; Tung, T. H.; Chen, T. H. Cost­Benefit Analysis of Routine Childhood Vaccination Against Chickenpox in Taiwan: Decision From Different Perspectives. Vaccine. 21 (25­26): 3982­3987; September 8, 2003. Huerta, M., Balicer, R. D., and Leventhal, A. SWOT Analysis: Strengths, Weaknesses, Opportunities and Threats of the Israeli Smallpox Revaccination Program Isr.Med.Assoc.J 2003, 5 (1): 42­46. Hull, H. F.; Danila, R.; Ehresmann, K. Smallpox and Bioterrorism: Public­Health Responses. J Lab Clin Med. 142 (4): 221­228; October, 2003. Hurley, D. Support for Smallpox Vaccinations. Am.J Nurs. 103 (7): 116­117; July, 2003. Iglesias, Berengue J., Lopez, Espinosa J., Campins, Marti M., Ortega, Lopez J., and Moraga, Llop F. [Vaccinations and Solid­Organ Transplantation: Review and Recommendations]. An Pediatr.(Barc.) 2003, 58 (4): 364­375. Isik, N.; Uzel, N.; Gokcay, G.; Kilic, A.; Yilmaz, G.; Sadikoglu, B.; Diri, S. Seroconversion After Measles Vaccination at Nine and Fifteen Months of Age. Pediatr Infect Dis J. 22 (8): 691­695; August 2003. Iyngkaran, P.; Limaye, V.; Hill, C.; Henderson, D.; Pile, K. D.; Rischmueller, M. Rheumatoid Vasculitis Following Influenza Vaccination. Rheumatology (Oxford). 42 (7): 907­909; July, 2003. Iyngkaran, P.; Limaye, V.; Hill, C.; Henderson, D.; Pile, K. D.; Rischmueller, M. Rheumatoid Vasculitis Following Influenza Vaccination. Rheumatology.(Oxford). 42 (7): 907­909; July 2003. Jalba, M. S. Atypical Mycobacterial Infection, Starvation and Effect of BCG Vaccination on Tuberculin Skin Test. Thorax 2003, 58 (4): 367­368. Janaszek, W., Gay, N. J., and Gut, W. Measles Vaccine Efficacy During an Epidemic in 1998 in the Highly Vaccinated Population of Poland Vaccine 1­17­
2003, 21 (5­6): 473­478. Janda, J.; Skovrankova, J. [What Did the Campaigns Against Childhood Vaccination Accomplish in Developed Countries?]. Cas Lek Cesk. 142 (7): 437­441; 2003. Jansen, V. A.; Stollenwerk, N.; Jensen, H. J.; Ramsay, M. E.; Edmunds, W. J.; Rhodes, C. J. Measles Outbreaks in a Population With Declining Vaccine Uptake. Science. 301 (5634): 804; August 8, 2003. Jautova, J.; Dorko, E.; Pilipcinec, E.; Tkacikova, L. Effect of Vaccination Therapy for Acne, Using a Staphylococci Antigenic Complex in Combination With Clindamycin. Folia Microbiol.(Praha). 48 (2): 249­252; 2003. Jefferson, T. and Demicheli, V. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 4­1­2003, 138 (7): 607­609. Jefferson, T. and Demicheli, V. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 4­1­2003, 138 (7): 607. Jensen, P. H. [Vaccination Against Alzheimer Disease]. Ugeskr.Laeger. 165 (43): 4124­4125; October, 2003. Jha, N.; Khan, J.; Prasad, R.; George, K.; Shrestha, B. K.; Acharya, B. Measles Outbreak in a Vaccinated Population in Dhankutta. Nepal Med Coll J; 5 (1): 16­17; June, 2003. Jimenez, R.; Larrauri, A.; Carrasco, P.; Esteban, J.; Gomez­Lopez, L. I.; Gil, A. Influenza Coverages in Spain and Vaccination­Related Factors in the Subgroup Aged 50­64 Years. Vaccine. 21 (25­26): 3550­3555; September 8, 2003. Jonkers, R. E. and Boersma, W. G. [Pneumococcal Vaccination in Adults]. Ned.Tijdschr.Geneeskd. 3­8­2003, 147 (10): 437­441. Josefson, D. Smallpox Vaccination Confers Long Lasting Immunity. BMJ 5­31­2003, 326 (7400): 1164. Jungbauer­Gans, M.; Kriwy, P. [Influence Exercised by Physicians on the Vaccination Rate]. Gesundheitswesen. 65 (7): 464­470; July 2003. Kabir, Z., Long, J., Reddaiah, V. P., Kevany, J., and Kapoor, S. K. Non­Specific Effect of Measles Vaccination on Overall Child Mortality in an Area of Rural India With High Vaccination Coverage: a Population­Based Case­Control Study. Bull.World Health Organ 2003, 81 (4): 244­250. Kang, N. G.; Oh, C. W. Gianotti­Crosti Syndrome Following Japanese Encephalitis Vaccination. J Korean Med.Sci. 18 (3): 459­461; June 2003. Karima, T. M., Bukhari, S. Z., Fatani, M. I., Yasin, K. A., Al Afif, K. A., and Hafiz, F. H. Clinical and Microbiological Spectrum of Meningococcal Disease in Adults During Hajj 2000: An Implication of Quadrivalent Vaccination Policy. J Pak.Med.Assoc. 2003, 53 (1): 3­7. Karima, T. M., Bukhari, S. Z., Fatani, M. I., Yasin, K. A., Al Afif, K. A., and Hafiz, F. H. Clinical and Microbiological Spectrum of Meningococcal Disease in Adults During Hajj 2000: An Implication of Quadrivalent Vaccination Policy. J Pak.Med.Assoc. 2003, 53 (1): 3­7. Karlsen, T. H.; Sommerfelt, H.; Klomstad, S.; Andersen, P. K.; Strand, T. A.; Ulvik, R. J.; Ahren, C.; Grewal, H. M. Intestinal and Systemic Immune Responses to an Oral Cholera Toxoid B Subunit Whole­Cell Vaccine Administered During Zinc Supplementation. Infect.Immun. 71 (7): 3909­3913; July, 2003. Kassianos, G. Influenza Vaccination of Patients Receiving Cytotoxic Chemotherapy: Can We Do Better? Int J Clin Pract. 57 (6): 457­458; July 2003. Kaufman, Z.; Green, M. S. Compliance With Influenza and Pneumococcal Vaccinations in Israel, 1999­2002. Public Health Rev. 31 (1): 71­79; 2003. Kawai, N.; Ikematsu, H.; Iwaki, N.; Satoh, I.; Kawashima, T.; Tsuchimoto, T.; Kashiwagi, S. A Prospective, Internet­Based Study of the Effectiveness and Safety of Influenza Vaccination in the 2001­2002 Influenza Season. Vaccine. 21 (31): 4507­4513; November 7, 2003. Keely, J. Support for Smallpox Vaccinations. Am.J Nurs. 103 (7): 116­117; July, 2003. Kermode, M.; Yong, K.; Hurley, S.; Marmion, B. An Economic Evaluation of Increased Uptake in Q Fever Vaccination Among Meat and Agricultural Industry Workers Following Implementation of the National Q Fever Management Program. Aust.N.Z.J.Public Health. 27 (4): 390­398; 2003. Ki, M., Park, T., Yi, S. G., Oh, J. K., and Choi, B. Risk Analysis of Aseptic Meningitis After Measles­Mumps­Rubella Vaccination in Korean Children by Using a Case­Crossover Design Am.J Epidemiol. 1­15­2003, 157 (2): 158­165. Kiang, K. M.; Krathwohl, M. D. Rates and Risks of Transmission of Smallpox and Mechanisms of Prevention. J Lab Clin Med. 142 (4): 229­238; October, 2003. Kimmel, S. R. A Mother Who Refuses to Vaccinate Her Child Am.Fam.Physician 2­1­2003, 67 (3): 651, 655­651, 656. Kmetzsch, C. I.; Schermann, M. T.; Santana, J. C.; Estima, C. L.; Faraco, F. J.; Silva, C. M.; Conceicao, R. [Occurrence of Haemophylus Influenzae B Meningitis After the Implementation of a Mass Vaccination Program]. J Pediatr (Rio J). 79 (6): 530­536; November, 2003. Kobayashi, M.; Hirakawa, K.; Sawada, M.; Suzuki, C.; Saikawa, S.; Ando, H.; Nakane, M.; Nakano, T. Vaccination Coverage of Poliomyelitis Among Less Than 5­Year­Old Children in the Markets of Niger. Jpn.J Infect Dis. 56 (4): 175­177; August, 2003. Kohrt, A. E. Child and Adolescent Immunizations: New Recommendations, New Standards, New Opportunities. Pediatrics. 112 (4): 978­981; October, 2003. Korobeinikov, A.; Maini, P. K.; Walker, W. J. Estimation of Effective Vaccination Rate: Pertussis in New Zealand As a Case Study. J Theor.Biol. 224 (2): 269­275; September 21, 2003. Korotkova, E. A.; Park, R.; Cherkasova, E. A.; Lipskaya, G. Y.; Chumakov, K. M.; Feldman, E. V.; Kew, O. M.; Agol, V. I. Retrospective Analysis of a Local Cessation of Vaccination Against Poliomyelitis: APossible Scenario for the Future. J Virol. 77 (23): 12460­12465; December, 2003. Krause, T. G., Hviid, A., Koch, A., Friborg, J., Hjuler, T., Wohlfahrt, J., Olsen, O. R., Kristensen, B., and Melbye, M. BCG Vaccination and Risk of Atopy JAMA 2­26­2003, 289 (8): 1012­1015. Kuhles, D. J.; Ackman, D. M. The Federal Smallpox Vaccination Program: Where Do We Go From Here? Health Aff.(Millwood.). Suppl Web Exclusives:W3­503­10; July, 2003. Kula, S. Smallpox Vaccination. Arch Dis Child. 88 (10): 841; October, 2003. Kuno, G. Serodiagnosis of Flaviviral Infections and Vaccinations in Humans. Adv.Virus Res. 61:3­65; 2003. Kunter, E., Cerrahoglu, K., Ilvan, A., Isitmangil, T., Turken, O., Okutan, O., Kartaloglu, Z., and Cavuslu, S. The Value of Pleural Fluid Anti­A60 IgM in BCG­Vaccinated Tuberculous Pleurisy Patients. Clin.Microbiol.Infect. 2003, 9 (3): 212­220. Kunz, C. TBE Vaccination and the Austrian Experience. Vaccine 4­1­2003, 21 Suppl 1:S50­5. (): S50­S55. Kuroiwa, C., Xayyavong, P., Vongphrachanh, P., Khampapongpane, B., Yamanaka, M., and Nakamura, S. Difficulties in Measles Elimination: Prevalence of Measles Antibodies Before and After Mass Vaccination Campaign in Laos Vaccine 1­17­2003, 21 (5­6): 479­484. Kwon, N.; Raven, M. C.; Chiang, W. K.; Moran, G. J.; Jui, J.; Carter, R. A.; Goldfrank, L. Emergency Physicians' Perspectives on Smallpox Vaccination. Acad.Emerg.Med. 10 (6): 599­605; June 2003. Kyaw, M. H.; Christie, P.; Clarke, S. C.; Mooney, J. D.; Ahmed, S.; Jones, I. G.; Campbell, H. Invasive Pneumococcal Disease in Scotland, 1999­2001: Use of Record Linkage to Explore Associations Between Patients and Disease in Relation to Future Vaccination Policy. Clin Infect Dis. 37 (10): 1283­1291; November 15, 2003. Lajeunesse, M. An Overview of Vaccination Against Infectious Disease in Children in 2003. Expert.Rev.Vaccines. 2 (5): 611­614; October, 2003. Lakshman, R., Murdoch, C., Race, G., Burkinshaw, R., Shaw, L., and Finn, A. Pneumococcal Nasopharyngeal Carriage in Children Following Heptavalent Pneumococcal Conjugate Vaccination in Infancy Arch.Dis.Child 2003, 88 (3): 211­214. Landi, F.; Onder, G.; Cesari, M.; Gravina, E. M.; Lattanzio, F.; Russo, A.; Bernabei, R. Effects of Influenza Vaccination on Mortality Among Frail, Community­Living Elderly Patients: an Observational Study. Aging Clin Exp Res. 15 (3): 254­258; June, 2003. Lane, J. M. and Goldstein, J. Evaluation of 21st­Century Risks of Smallpox Vaccination and Policy Options. Ann.Intern.Med. 3­18­2003, 138 (6): 488­493. Lane, J. M.; Goldstein, J. Adverse Events Occurring After Smallpox Vaccination. Semin Pediatr Infect Dis. 14 (3): 189­195; July 2003. Lawrence, G. L.; MacIntyre, C. R.; Hull, B. P.; McIntyre, P. B. Measles Vaccination Coverage Among Five­Year­Old Children: Implications for Disease Elimination in Australia. Aust.N.Z.J.Public Health. 27 (4): 413­418; 2003. Lee, J. S.; Kawakubo, K. Influenza Vaccination Coverage in Japan. Lancet. 362 (9397): 1767; November 22, 2003. Lee, P. P. Prevention and Control of Influenza. South Med J. 96 (8): 751­757; August, 2003. Lee, P. Y. and Peterson, E. D. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 4­1­2003, 138 (7): 608­609. Leggat, P. A. The Traveller's Pocket Medical Guide and International Certificate of Vaccination. J Travel.Med. 10 (4): 251; July 2003. Leon, De La Fuente; Gurfinkel, E. P.; Toledo, D.; Mautner, B. Flu Vaccination in Patients With Acute Coronary Syndromes: Treatment Benefit in Prespecified Subgroups. Rev Esp.Cardiol. 56 (10): 949­954; October, 2003. Lesho, E. P.; Schissel, D. J.; Harris, M. D. Vaccinating Health Care Workers Against Smallpox in an Isolated Primary Care Facility. Am J Med. 115 (7): 570­
572; November, 2003. Letai, A. G. Smallpox and Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1920­1925. Levine, M. M. Use of Vaccines for the Prevention of Typhoid Fever. Indian Pediatr. 40 (11): 1029­1034; November, 2003. Levy, C.; Carter, S.; Priloutskaya, G.; Gallegos, G. Critical Elements in the Design of Culturally Appropriate Interventions Intended to Reduce Health Disparities: Immunization Rates Among Hispanic Seniors in New Mexico. J.Health Hum.Serv.Adm. 26 (2): 199­238; 2003. Levy, J. [The Safety of Vaccination]. J Pharm.Belg. 58 (3): 75­78; 2003. Lim, C. S., Chan, K. P., Goh, K. T., and Chow, V. T. Hemagglutinin­Neuraminidase Sequence and Phylogenetic Analyses of Mumps Virus Isolates From a Vaccinated Population in Singapore. J Med.Virol. 2003, 70 (2): 287­292. Linton, L. S., Peddecord, K. M., Seidman, R. L., Edwards, C., Ross, S., Gustafson, K., Averhoff, F., and Fishbein, D. B. Implementing a Seventh Grade Vaccination Law: School Factors Associated With Completion of Required Immunizations. Prev.Med. 2003, 36 (4): 510­517. Litt, J.; Burgess, M. Varicella and Varicella Vaccination. An Update. Aust.Fam.Physician. 32 (8): 583­587; August, 2003. Lloyd, J. C.; Haber, P.; Mootrey, G. T.; Braun, M. M.; Rhodes, P. H.; Chen, R. T. Adverse Event Reporting Rates Following Tetanus­Diphtheria and Tetanus Toxoid Vaccinations: Data From the Vaccine Adverse Event Reporting System (), 1991­1997. Vaccine. 21 (25­26): 3746­3750; September 8, 2003. Lo, P. US Smallpox Vaccination Off to Slow Start Nat.Med. 2003, 9 (3): 249. Lofquist, J. M., Weimert, N. A., and Hayney, M. S. Smallpox: A Review of Clinical Disease and Vaccination. Am J Health Syst Pharm. 4­15­2003, 60 (8): 749­756. Long, S. S. Smallpox Vaccination and Pregnancy. J Pediatr. 143 (4): 476; October, 2003. Lonks, J. R. One Response to the Threat of Bioterror: Smallpox Vaccination. Med Health R.I. 86 (11): 347­350; November, 2003. Loo, M. K.; Sabahi, F.; Soleimanjdahi, H.; Kazemnejad, A.; Roustai, M. H. Seroprevalence of Neutralizing Antibodies to Measles Virus in a Vaccinated Population in Iran, 1998. Eur J Epidemiol. 18 (11): 1085­1089; 2003. Lucas, A. H.; McLean, G. R.; Reason, D. C.; O'Connor, A. P.; Felton, M. C.; Moulton, K. D. Molecular Ontogeny of the Human Antibody Repertoire to the Haemophilus Influenzae Type b Polysaccharide: Expression of Canonical Variable Regions and Their Variants in Vaccinated Infants. Clin Immunol. 108 (2): 119­127; August 2003. MacIntyre, C. R.; Chu, C. P.; Burgess, M. A. Use of Hospitalization and Pharmaceutical Prescribing Data to Compare the Prevaccination Burden of Varicella and Herpes Zoster in Australia. Epidemiol Infect. 131 (1): 675­682; August, 2003. Madar, R.; Repkova, L.; Baska, T.; Straka, S. Influenza Vaccination­­Knowledge, Attitudes, Coverage­­Can They Be Improved? Bratisl.Lek.Listy. 104 (7­8): 232­235; 2003. Mahmoodi, M.; Khamesipour, A.; Dowlati, Y.; Rafati, S.; Momeni, A. Z.; Emamjomeh, M.; Hejazi, H.; Modabber, F. Immune Response Measured in Human Volunteers Vaccinated With Autoclaved Leishmania Major Vaccine Mixed With Low Dose of BCG. Clin Exp Immunol. 134 (2): 303­308; November, 2003. Maier, G. Smallpox: What Every Nurse Should Know. Ohio.Nurses Rev. 78 (3): 4­6; March, 2003. Maier, T., Tun­Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R., and Nestle, F. O. Vaccination of Cutaneous T­Cell Lymphoma Patients Using Intranodal Injection of Autologous Tumor Lysate Pulsed Dendritic Cells. Blood 4­24­2003, . (. Marks, G. B., Ng, K., Zhou, J., Toelle, B. G., Xuan, W., Belousova, E. G., Mapplsc, and Britton, W. J. The Effect of Neonatal BCG Vaccination on Atopy and Asthma at Age 7 to 14 Years: An Historical Cohort Study in a Community With a Very Low Prevalence of Tuberculosis Infection and a High Prevalence of Atopic Disease. J Allergy Clin.Immunol. 2003, 111 (3): 541­549. Marras, T. K. Pneumococcal Vaccination in Older Adults. N.Engl.J Med. 349 (7): 712­714; August 14, 2003. Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu­Bobie, J., Arico, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., Serruto, D., Litt, D., Kroll, S., Welsch, J. A., Granoff, D. M., Rappuoli, R., and Pizza, M. Vaccination Against Neisseria Meningitidis Using Three Variants of the Lipoprotein GNA1870. J Exp.Med. 3­17­2003, 197 (6): 789­799. Massoudi, M. S.; Barker, L.; Schwartz, B. Effectiveness of Postexposure Vaccination for the Prevention of Smallpox: Results of a Delphi Analysis. J Infect Dis. 188 (7): 973­976; October 1, 2003. May, T.; Aulisio, M. P.; Silverman, R. D. The Smallpox Vaccination of Health Care Workers: Professional Obligations and Defense Against Bioterrorism. Hastings Cent.Rep. 33 (5): 26­33; September, 2003. May, T.; Silverman, R. D.; Aulisio, M. P. Do Healthcare Professionals Have an Obligation to Be Vaccinated Against Smallpox? APA.Newsl.Philos.Med. 2 (2): 209­212; 2003. McIntyre, P. B., Williams, A. H., and Leask, J. E. Refusal of Parents to Vaccinate: Dereliction of Duty or Legitimate Personal Choice? Med.J Aust. 2­17­2003, 178 (4): 150­151. Mehra, N. K.; Kaur, G. MHC­Based Vaccination Approaches: Progress and Perspectives. Expert.Rev.Mol.Med. 2003:1­17; February 24, 2003. Meltzer, M. I. and Bridges, C. B. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 4­1­2003, 138 (7): 608. Meltzer, M. I. Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination. Emerg.Infect.Dis. 9 (11): 1363­1370; November, 2003. Mercado, U. Antibody Responses Following Vaccination in Lupus Patients. Rev.Invest Clin. 2003, 55 (1): 93­94. Mercier, E.; Serie, M.; Gissot, V.; Dequin, P. F. [Tetanus Vaccination. Re­Vaccination Is Necessary but Not Always Sufficient]. Presse Med. 32 (30): 1418; September, 2003. Mermel, L. A. Risk of Cutaneous Vaccinia From Health Care Workers Who Receive Smallpox Vaccine JAMA 2003, 289 (7): 844­845. Meyers, D. G. Could Influenza Vaccination Prevent Myocardial Infarction, Stroke and Sudden Cardiac Death? Am.J.Cardiovasc.Drugs. 3 (4): 241­244; 2003. Meyers, D. G. Myocardial Infarction, Stroke, and Sudden Cardiac Death May Be Prevented by Influenza Vaccination Curr.Atheroscler.Rep. 2003, 5 (2): 146­
149. Millock, P. J. Legal Implications of the Smallpox Vaccination Program. J.Public Health Manag.Pract. 9 (5): 411­417; September, 2003. Mills, A. E.; Murdolo, V.; Webb, S. P. A Rare Local Granulomatous Complication of Q Fever Vaccination. Med J Aust. 179 (3): 166; August 4, 2003. Milton, D. K. Smallpox and Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1920­1925. Minor, P. D. Polio Vaccines and the Cessation of Vaccination. Expert.Rev Vaccines. 2 (1): 99­104; February, 2003. Miravalle, A.; Roos, K. L. Encephalitis Complicating Smallpox Vaccination. Arch.Neurol. 60 (7): 925­928; July, 2003. Molendini, L. O.; Zanetti, A.; Buzzi, F. [Mandatory or Voluntary Vaccinations? Juridical and Medico­Legal Aspects]. Ann.Ig. 15 (5): 559­566; September, 2003. Montella, M., Crispo, A., Grimaldi, M., Tridente, V., and Fusco, M. Assessment of Iatrogenic Transmission of HCV in Southern Italy: Was the Cause the Salk Polio Vaccination? J Med.Virol. 2003, 70 (1): 49­50. Moorhouse, M. Smallpox Vaccination Program Update: April 2003. Colo.Nurse. 103 (2): 21; June 2003. Moorthy, V. S.; Pinder, M.; Reece, W. H.; Watkins, K.; Atabani, S.; Hannan, C.; Bojang, K.; McAdam, K. P.; Schneider, J.; Gilbert, S.; Hill, A. V. Safety and Immunogenicity of DNA/Modified Vaccinia Virus Ankara Malaria Vaccination in African Adults. J Infect Dis. 188 (8): 1239­1244; October 15, 2003. Moran, G. J., Everett, W. W., Karras, D. J., Pesik, N. T., and Sztajnkrycer, M. D. Smallpox Vaccination for Emergency Physicians: Joint Statement of the AAEM and the SAEM. J Emerg.Med. 2003, 24 (3): 351­352. Morgan, O. W.; Meltzer, M.; Muir, D.; Hogan, H.; Seng, C.; Hill, J.; Beckford, J. Specialist Vaccination Advice and Pockets of Resistance to MMR Vaccination: Lessons From an Outbreak of Measles. Commun.Dis.Public Health. 6 (4): 330­333; December, 2003. Mortimer, P. P. Can Postexposure Vaccination Against Smallpox Succeed? Clin.Infect.Dis. 3­1­2003, 36 (5): 622­629. Mossong, J.; Muller, C. P. Modelling Measles Re­Emergence As a Result of Waning of Immunity in Vaccinated Populations. Vaccine. 21 (31): 4597­4603; November 7, 2003. Moverare, R. Immunological Mechanisms of Specific Immunotherapy With Pollen Vaccines: Implications for Diagnostics and the Development of Improved Vaccination Strategies. Expert.Rev Vaccines. 2 (1): 85­97; February, 2003. Moynihan, R. Health Professionals Challenge US Smallpox Vaccination Plan BMJ 1­25­2003, 326 (7382): 179. Muniz, A. E. Lymphocytic Vasculitis Associated With the Anthrax Vaccine: Case Report and Review of Anthrax Vaccination. J Emerg.Med. 25 (3): 271­276; October, 2003. Murphy, J. G.; Wright, R. S.; Bruce, G. K.; Baddour, L. M.; Farrell, M. A.; Edwards, W. D.; Kita, H.; Cooper, L. T. Eosinophilic­Lymphocytic Myocarditis After Smallpox Vaccination. Lancet. 362 (9393): 1378­1380; October 25, 2003. Murray, C. J.; Shengelia, B.; Gupta, N.; Moussavi, S.; Tandon, A.; Thieren, M. Validity of Reported Vaccination Coverage in 45 Countries. Lancet. 362 (9389): 1022­1027; September 27, 2003. Muszkat, M.; Friedman, G.; Dannenberg, H. D.; Greenbaum, E.; Lipo, M.; Heymann, Y.; Zakay­Rones, Z.; Ben Yehuda, A. Response to Influenza Vaccination in Community and in Nursing Home Residing Elderly: Relation to Clinical Factors. Exp Gerontol. 38 (10): 1199­1203; October, 2003. Nace, D. A. Improving Pneumococcal Vaccination Rates. J Am.Med.Dir.Assoc. 4 (2): 121­122; March 2003. Nakajima, H.; Ohtsuka, S.; Nishina, T.; Sugino, M.; Kimura, F.; Hanafusa, T.; Ikemoto, T.; Shimizu, A. Multiple Sclerosis After Allergen­Specific Immunotherapy and Influenza Vaccination. Eur Neurol. 50 (4): 248­249; 2003. Nakamura, N., Nokura, K., Zettsu, T., Koga, H., Tachi, M., Terada, M., Katoh, H., Itoh, Y., Osawa, H., Ozeki, T., and Yamamoto, H. Neurologic Complications Associated With Influenza Vaccination: Two Adult Cases. Intern.Med. 2003, 42 (2): 191­194. Naleway, A. L.; Belongia, E. A.; Greenlee, R. T.; Kieke, B. A., Jr.; Chen, R. T.; Shay, D. K. Eczematous Skin Disease and Recall of Past Diagnoses: Implications for Smallpox Vaccination. Ann.Intern.Med. 139 (1): 1­7; July 1, 2003. Nardelli­Haefliger, D.; Wirthner, D.; Schiller, J. T.; Lowy, D. R.; Hildesheim, A.; Ponci, F.; De Grandi, P. Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus­Like Particles. J Natl Cancer Inst. 95 (15): 1128­1137; August 6, 2003. Nascimento­Carvalho, C. M.; Moreno­Carvalho, O. A. Frequency of Lymphocytic Meningitis Associated With Mumps Before and After a Mass Campaign for Mumps Vaccination in Children From Salvador, Northeast Brazil. Arq Neuropsiquiatr. 61 (3B): 728­730; September, 2003. Nass, M. Safety of the Smallpox Vaccine Among Military Recipients. JAMA. 290 (16): 2123­2124; October 22, 2003. Nassauer, A. [Legal Security in Respect of Vaccination Procedures]. Gesundheitswesen 2003, 65 Suppl 1:41­2. (): 41­42. Neff, J. M., Lane, J. M., and Fulginiti, V. A. Smallpox and Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1920­1925. Newman, F. K.; Frey, S. E.; Blevins, T. P.; Mandava, M.; Bonifacio, A., Jr.; Yan, L.; Belshe, R. B. Improved Assay to Detect Neutralizing Antibody Following Vaccination With Diluted or Undiluted Vaccinia (Dryvax) Vaccine. J Clin.Microbiol. 41 (7): 3154­3157; July, 2003. Nichol, K. L. First Do No Harm: Ensuring That Healthcare Workers Vaccinate and Are Vaccinated. Infect Control Hosp.Epidemiol. 24 (11): 799­800; November, 2003. Nichol, K. L., Mallon, K. P., and Mendelman, P. M. Cost Benefit of Influenza Vaccination in Healthy, Working Adults: an Economic Analysis Based on the Results of a Clinical Trial of Trivalent Live Attenuated Influenza Virus Vaccine. Vaccine 5­16­2003, 21 (17­18): 2216­2226. Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., and Iwane, M. Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke Among the Elderly. N.Engl.J Med. 4­3­2003, 348 (14): 1322­1332. Niemann, T. Vaccination Information Reaches Audience J Am.Vet.Med.Assoc. 2­1­2003, 222 (3): 283. Nilsson, L.; Kjellman, N. I.; Bjorksten, B. Allergic Disease at the Age of 7 Years After Pertussis Vaccination in Infancy: Results From the Follow­Up of a Randomized Controlled Trial of 3 Vaccines. Arch Pediatr Adolesc.Med. 157 (12): 1184­1189; December, 2003. Norrby, R.; Tull, P. [Receding Adherence to Child Vaccination Programs Must Be Interrupted. Take Parents' Anxiety Seriously, Establish Regional Vaccination Centers]. Lakartidningen. 100 (40): 3110­3111; October 2, 2003. Novakova, E., Kosecka, G., Gajdos, J., Olear, V., and Hudeckova, H. Evaluation of Antibody Response After Vaccination With Conjugate Haemophilus Influenzae Type b Vaccine in Infants and Toddlers in Slovakia Eur.J Pediatr. 2003, 162 (2): 110­111. Odiit, A. and Amuge, B. Comparison of Vaccination Status of Children Born in Health Units and Those Born at Home. East Afr.Med.J 2003, 80 (1): 3­6. Ohkusa, Y. [An Analysis of the Demand for Influenza Vaccination Among the Elderly in Japan]. Nippon Koshu Eisei Zasshi 2003, 50 (1): 27­38. Okuno, Y. [Examination and Vaccination Against Influenza]. Rinsho Byori 2003, 51 (3): 268­273. Olesen, A. B.; Juul, S.; Thestrup­Pedersen, K. Atopic Dermatitis Is Increased Following Vaccination for Measles, Mumps and Rubella or Measles Infection. Acta Derm.Venereol. 83 (6): 445­450; 2003. Ortiz, De Lejarazu and Eiros, J. M. [Heading for Systematic Flu Vaccination?]. Med.Clin.(Barc.) 3­15­2003, 120 (9): 340­341. Ortolon, K. Take Your Best Shot. TMA, Specialty Societies Launch Efforts to Boost Vaccinations. Tex.Med. 2003, 99 (3): 40­43. Osborne, G. E., Mallon, E., and Mayou, S. C. Juvenile Sarcoidosis After BCG Vaccination. J Am Acad Dermatol. 2003, 48 (5 Suppl): S99­S102. Ostbye, T.; Taylor, D. H., Jr.; Lee, A. M.; Greenberg, G.; Van Scoyoc, L. Racial Differences in Influenza Vaccination Among Older Americans 1996­2000: Longitudinal Analysis of the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Survey. BMC Public Health. 3 (1): 41; December 16, 2003. Pafford­Failor, M. Smallpox Vaccinations: A Volunteer Program in the Volunteer State. Tenn.Nurse. 66 (2): 14­15; 2003. Pantosti, A.; Boccia, D.; D'Ambrosio, F.; Recchia, S.; Orefici, G.; Moro, M. L. Inferring the Potential Success of Pneumococcal Vaccination in Italy: Serotypes and Antibiotic Resistance of Streptococcus Pneumoniae Isolates From Invasive Diseases. Microb Drug Resist. 9 (Suppl 1): S61­S68, 2003. Parini, S. Vaccination Do's and Don'Ts. Nursing. 33 (12): 58­63; December, 2003. Parlato, A.; Marinelli, A.; Alfieri, R.; Albano, L.; Liguori, G. [The Tetanus in Italy and in the Campania Region: Retrospective Analysis. The Importance of Vaccinations]. Ig Sanita Pubbl. 59 (6): 383­392; November, 2003. Parmiani, G.; Pilla, L.; Castelli, C.; Rivoltini, L. Vaccination of Patients With Solid Tumours. Ann.Oncol. 14 (6): 817­824; June 2003. Pasquarella, A.; Perria, C.; D'Amato, M.; Billi, P.; Marceca, M.; Volpe, E.; Guasticchi, G. [Management of Vaccination Practices in Adults: the Influenza Vaccination Campaign in Lazio Region, Italy]. Ann.Ig. 15 (6): 871­879; November, 2003. Pastor Climent, M. A.; Schwarz, Chavarri H.; Pedrera, Carbonell, V; Pascual, De La Torre [Anti­Flu Vaccination in Health Staff: Problem of Consciousness­
Raising or of Conscience?]. Aten.Primaria. 32 (6): 395­396; October 15, 2003. Pavelka, M. S., Jr.; Chen, B.; Kelley, C. L.; Collins, F. M.; Jacobs, Jr WR, Jr. Vaccine Efficacy of a Lysine Auxotroph of Mycobacterium Tuberculosis. Infect.Immun. 71 (7): 4190­4192; July, 2003. Pena­Rey, I., Perez­Farinos, N., and Sarria­Santamera, A. [Determinants of Flu Vaccination in Galician Women Over 65 Years Old]. Aten Primaria 4­30­
2003, 31 (7): 462. Pennachio, D.; Terry, K. Have You Been Vaccinated? Med.Econ. 80 (8): 57­60, 66; April 25, 2003. Perez, E. E.; Bokszczanin, A.; McDonald­McGinn, D.; Zackai, E. H.; Sullivan, K. E. Safety of Live Viral Vaccines in Patients With Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome). Pediatrics. 112 (4): e325; October, 2003. Pericas, Bosch J. [Immunisation: Leaps into the Future. Foreseeable Changes in Childrens Vaccination Calendar in the Coming Years]. Aten.Primaria 3­30­
2003, 31 (5): 327­333. Piedra, P. A. Clinical Experience With Respiratory Syncytial Virus Vaccines. Pediatr.Infect.Dis.J 2003, 22 (2 Suppl): S94­S99. Piotrowski, J. Vaccination Hesitation. Congress, HHS Look to Tackle Safety Worries About Smallpox Vaccinations. Mod.Healthc. 2­17­2003, 33 (7): 18. Platonov, A. E.; Vershinina, I. V.; Kuijper, E. J.; Borrow, R.; Kayhty, H. Long Term Effects of Vaccination of Patients Deficient in a Late Complement Component With a Tetravalent Meningococcal Polysaccharide Vaccine. Vaccine. 21 (27­28): 4437­4447; October 1, 2003. Plaut, M.; Tinkle, S. S. Risks of Smallpox Vaccination: 200 Years After Jenner. J Allergy Clin Immunol. 112 (4): 683­685; October, 2003. Plotkin, S. A. Vaccines, Vaccination, and Vaccinology. J Infect.Dis. 5­1­2003, 187 (9): 1349­1359. Poccia, F.; Gioia, C.; Montesano, C.; Martini, F.; Horejsh, D.; Castilletti, C.; Pucillo, L.; Capobianchi, M. R.; Ippolito, G. Flow Cytometry and T­Cell Response Monitoring After Smallpox Vaccination. Emerg.Infect.Dis. 9 (11): 1468­1470; November, 2003. Polk, B. [Who Should Get an Influenza Vaccination?]. Med.Monatsschr.Pharm. 26 (12): 429; December, 2003. Ponte, C. F. [Vaccination, Quality Control, and Vaccine Production in Brazil Since 1960]. Hist Cienc.Saude Manguinhos. 10 (Suppl 2): 619­653; 2003. Postma, M. J.; Heijnen, M. L.; Beutels, P.; Jager, J. C. Pharmacoeconomics of Elderly Vaccination Against Invasive Pneumococcal Infections: Cost­
Effectiveness Analyses and Implications for The Netherlands. Expert.Rev.Vaccines. 2 (4): 477­482; August, 2003. Preziosi, M. P. and Halloran, M. E. Effects of Pertussis Vaccination on Transmission: Vaccine Efficacy for Infectiousness. Vaccine 5­16­2003, 21 (17­18): 1853­1861. Preziosi, M. P.; Halloran, M. E. Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity. Clin Infect Dis. 37 (6): 772­779; September 15, 2003. Prier, J. E.; Prier, S. G. Believe Epidemiology Key to Vaccination Protocols. J Am Vet.Med Assoc. 223 (7): 948­949; October 1, 2003. Prinz, C., Hafsi, N., and Voland, P. Helicobacter Pylori Virulence Factors and the Host Immune Response: Implications for Therapeutic Vaccination. Trends Microbiol. 2003, 11 (3): 134­138. Pukhalsky, A. L.; Shmarina, G. V.; Bliacher, M. S.; Fedorova, I. M.; Toptygina, A. P.; Fisenko, J. J.; Alioshkin, V. A. Cytokine Profile After Rubella Vaccine Inoculation: Evidence of the Immunosuppressive Effect of Vaccination. Mediators.Inflamm. 12 (4): 203­207; 2003. Puvacic, S.; Mulaomerovic, M.; Karakas, S.; Tandir, S.; Nada, E. [Expected Incidence of Post­Vaccination Complications in Vaccination Programs]. Med.Arh. 57 (5­6): 269­272; 2003. Quian, J. W. An Outbreak of Varicella Despite Vaccination. N.Engl.J Med. 4­3­2003, 348 (14): 1405­1407. Rahman, M., Takahashi, O., Goto, M., and Fukui, T. BCG Vaccination and Tuberculosis in Japan. J Epidemiol. 2003, 13 (3): 127­135. Rainer, S. R. Smallpox Vaccination Program Implementation Raises Concerns and Questions. N.J Nurse 2003, 33 (2): 8. Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., and Miller, E. Herd Immunity From Meningococcal Serogroup C Conjugate Vaccination in England: Database Analysis BMJ 2­15­2003, 326 (7385): 365­366. Raufu, A. Polio Vaccine Plans May Run into Problems in Nigeria. BMJ. 327 (7410): 380; August 9, 2003. Reinert, P. [Purulent Meningitis in Children: Special Considerations for Developing Countries]. Med.Trop.(Mars.). 63 (4­5): 481­485; 2003. Reinert, P.; Soubeyrand, B.; Gauchoux, R. [35­Year Measles, Mumps, Rubella Vaccination Assessment in France]. Arch Pediatr. 10 (11): 948­954; November, 2003. Richardson, V. A New Approach to Childhood Vaccination. Nurse Pract. 28 (11): 14,54; November, 2003. Riley, C.; Riley, S. Influenza and Pneumococcal Disease in the Community. Nurs.Stand. 18 (4): 45­51; October 8, 2003. Ring, A.; Marx, G.; Steer, C.; Prendiville, J.; Ellis, P. Poor Uptake of Influenza Vaccinations in Patients Receiving Cytotoxic Chemotherapy. Int J Clin Pract. 57 (6): 542­543; July 2003. Ringler, M., Gobel, G., Most, J., and Weithaler, K. Fully Vaccinated Children Are Rare: Immunization Coverage and Seroprevalence in Austrian School Children. Eur J Epidemiol. 2003, 18 (2): 161­170. Ritter, O.; Bonz, A.; Strotmann, J.; Langenfeld, H. [Myocardial Infarction After Influenza Vaccination]. Z.Kardiol. 92 (11): 962­965; November, 2003. Robbins, J. B.; Schneerson, R.; Gotschlich, E. C.; Mohammed, I.; Nasidi, A.; Chippaux, J. P.; Bernardino, L.; Maiga, M. A. Meningococcal Meningitis in Sub­
Saharan Africa: the Case for Mass and Routine Vaccination With Available Polysaccharide Vaccines. Bull.World Health Organ. 81 (10): 745­750; 2003. Roberts, R. J. Tuberculin Testing Before BCG Vaccination: Effect of Age on Adverse Effects Has Not Been Made Clear. BMJ. 327 (7420): 932; October 18, 2003. Roth, Y., Chapnik, J. S., and Cole, P. Feasibility of Aerosol Vaccination in Humans. Ann.Otol.Rhinol.Laryngol. 2003, 112 (3): 264­270. Rubins, K. and Relman, D. A. Images in Clinical Medicine. Progression of the Lesion at the Site of Inoculation After Smallpox Vaccination N.Engl.J Med. 1­
30­2003, 348 (5): 414. Saika, S.; Suzuki, K.; Ichinohe, S. [Measles Antibody Followed After Measles Vaccination: Comparison With Gelatin Beads Agglutination (PA) Antibody, Hemagglutination Inhibition (HI) Antibody and IgG­Avidity]. Kansenshogaku Zasshi. 77 (10): 809­814; October, 2003. Salleras, L., Dominguez, A., and Cardenosa, N. Dramatic Decline of Serogroup C Meningococcal Disease in Catalonia (Spain) After a Mass Vaccination Campaign With Meningococcal C Conjugated Vaccine Vaccine 1­30­2003, 21 (7­8): 729­733. Salleras, L., Dominguez, A., and Cardenosa, N. Impact of Mass Vaccination With Polysaccharide Conjugate Vaccine Against Serogroup C Meningococcal Disease in Spain Vaccine 1­30­2003, 21 (7­8): 725­728. Samoilovich, E.; Roivainen, M.; Titov, L. P.; Hovi, T. Serotype­Specific Mucosal Immune Response and Subsequent Poliovirus Replication in Vaccinated Children. J Med Virol. 71 (2): 274­280; October, 2003. Samuelsson, K.; Blennow, M. [Parents Rely on Child Vaccinations. But at the Same Time They Distrust the Medical Establishment As Shown in a Qualitative Study of Attitudes]. Lakartidningen. 100 (40): 3132­3135; October 2, 2003. Sankar, P.; Schairer, C.; Coffin, S. Public Mistrust: The Unrecognized Risk of the CDC Smallpox Vaccination Program. Am.J.Bioeth. 3 (4): 22­25; 2003. Santiago, E. M.; Lawson, E.; Gillenwater, K.; Kalangi, S.; Lescano, A. G.; Du, Quella G.; Cummings, K.; Cabrera, L.; Torres, C.; Gilman, R. H. A Prospective Study of Bacillus Calmette­Guerin Scar Formation and Tuberculin Skin Test Reactivity in Infants in Lima, Peru. Pediatrics. 112 (4): e298; October, 2003. Santoli, J. M.; Peter, G.; Arvin, A. M.; Davis, J. P.; Decker, M. D.; Fast, P.; Guerra, F. A.; Helms, C. M.; Hinman, A. R.; Katz, R.; Klein, J. O.; Koslap­
Petraco, M. B.; Paradiso, P. R.; Schaffner, W.; Whitley­Williams, P. N.; Williamson, D. E.; Gellin, B. Strengthening the Supply of Routinely Recommended Vaccines in the United States: Recommendations From the National Vaccine Advisory Committee. JAMA. 290 (23): 3122­3128; December 17, 2003. Sanz, J. C.; Fernandez, M.; Sagues, M. J.; Ramirez, R. [Laboratory Diagnosis of Parotiditis in the Post­Vaccination Era: New Strategies]. Enferm.Infecc.Microbiol Clin. 21 (7): 383­384; August, 2003. Sarria­Santamera, A.; Timoner, J. Influenza Vaccination in Old Adults in Spain. Eur.J Public Health. 13 (2): 133­137; June 2003. Sauerbrei, A.; Uebe, B.; Wutzler, P. Molecular Diagnosis of Zoster Post Varicella Vaccination. J Clin.Virol. 27 (2): 190­199; July, 2003. Saurina, G.; Shirazi, S.; Lane, J. M.; Daniel, B.; DiEugenia, L. Myocarditis After Smallpox Vaccination: A Case Report. Clin.Infect.Dis. 37 (1): 145­146; July 1, 2003. Saurina, G.; Shirazi, S.; Lane, J. M.; Daniel, B.; DiEugenia, L. Myocarditis After Smallpox Vaccination: a Case Report. Clin.Infect.Dis. 37 (1): 145­146; July 1, 2003. Scheibner, V. Response to Leask and McIntyre's Attack on Myself As a Public Opponent of Vaccination. Vaccine. 22 (1): vi­ix; December 8, 2003. Schlagenhauf, P. Focus Topic This Issue­­Accidents and Travel. Check Your Insurance!; Focus Topic This Issue­­W135 Meningococcal Disease and Travel; MalariaBioterrorism: Policy Considerations; Travel Medicine; Travelers' Diarrhea; Other Travel­Associated Infectious Diseases; Vaccines and Vaccinations. J Travel.Med. 10 (6): 364­367; November, 2003. Schmidt, K. and Ernst, E. MMR Vaccination Advice Over the Internet Vaccine 3­7­2003, 21 (11­12): 1044­1047. Schmitt, H. J., Booy, R., Weil­Olivier, C., Van Damme, P., Cohen, R., and Peltola, H. Child Vaccination Policies in Europe: A Report From the Summits of Independent European Vaccination Experts Lancet Infect.Dis. 2003, 3 (2): 103­108. Schneider, C. P.; McDonald, M. D. "The King of Terrors" Revisited: the Smallpox Vaccination Campaign and Its Lessons for Future Biopreparedness. J.Law Med.Ethics. 31 (4): 580­589; 2003. Schneider, J. Protection Against Infectious Diseases by DNA­Based Vaccination Strategies­­Lessons for Allergy Treatment? Arb.Paul Ehrlich Inst.Bundesamt Sera Impfstoffe Frankf A M. (94): 300­303; 2003. Schoenewald, C., Hughes, C., and Bohnert, L. Vaccine Information Statements. Are Federal Guidelines Being Followed? Adv.Nurse Pract. 2003, 11 (2): 63­
70. Schott, M. and Seissler, J. Dendritic Cell Vaccination: New Hope for the Treatment of Metastasized Endocrine Malignancies. Trends Endocrinol.Metab 2003, 14 (4): 156­162. Schroeder, B. M. ACIP Issues Guidelines on the Use of Smallpox Vaccine in a Pre­Event Vaccination Program. Am Fam.Physician. 68 (3): 554, 557­554, 558; August 1, 2003. Schwartz, M. D. The United States Civilian Smallpox Vaccination Program: Have We Thought Through the Whole Issue? Pharmacotherapy 2003, 23 (3): 271­273. Shaikh, I.; Omair, A.; Inam, S. N.; Safdar, S.; Kazmi, T.; Anjum, Q. National Polio Day Campaign in a Squatter Settlement Through Medical Students. J Pak.Med.Assoc. 53 (3): 98­101; March 2003. Shapiro, Y.; Shemer, J.; Heymann, A.; Shalev, V.; Maharshak, N.; Chodik, G.; Green, M. S.; Kokia, E. Influenza Vaccination: Reduction in Hospitalizations and Death Rates Among Members of "Maccabi Healthcare Services" During the 2000­2001 Influenza Season. Isr.Med.Assoc.J. 5 (10): 706­708; October, 2003. Shoji, H. and Kaji, M. The Influenza Vaccination and Neurological Complications. Intern.Med. 2003, 42 (2): 139. Sibbald, B. US Hospitals Balking at Smallpox Vaccination. CMAJ. 4­15­2003, 168 (8): 1034. Silverman, R. D.; May, T. Terror and Triage: Prioritizing Access to Mass Smallpox Vaccination. Creighton.Law Rev. 36 (3): 359­374; April, 2003. Singh, M. B. and Bhalla, P. L. Hypoallergenic Derivatives of Major Grass Pollen Allergens for Allergy Vaccination Immunol.Cell Biol. 2003, 81 (1): 86­91. Sipetic, S.; Vlajinac, H.; Kocev, N.; Radmanovic, S. The Belgrade Childhood Diabetes Study: Association of Infections and Vaccinations on Diabetes in Childhood. Ann.Epidemiol. 13 (9): 645­651; October, 2003. Sisk, J. E.; Whang, W.; Butler, J. C.; Sneller, V. P.; Whitney, C. G. Cost­Effectiveness of Vaccination Against Invasive Pneumococcal Disease Among People 50 Through 64 Years of Age: Role of Comorbid Conditions and Race. Ann.Intern.Med. 138 (12): 960­968; June 17, 2003. Skegg, D. C. Autism and Measles­Mumps­Rubella (MMR) Vaccination: a Challenge for Pharmacoepidemiology. Pharmacotherapy. 23 (12): 1521­1523; December, 2003. Skidmore, S. L. Support for Smallpox Vaccinations. Am.J Nurs. 103 (7): 116­117; July, 2003. Skledar, S. J.; Hess, M. M.; Ervin, K. A.; Gross, P. R.; Nowalk, M. P.; Carter, H.; Zimmerman, R. K.; Middleton, D. Designing a Hospital­Based Pneumococcal Vaccination Program. Am J Health Syst Pharm. 60 (14): 1471­1476; July 15, 2003. Skowronski, D. M.; De Serres, G.; Scheifele, D.; Russell, M. L.; Warrington, R.; Davies, H. D.; Dionne, M.; Duval, B.; Kellner, J.; MacDonald, J. Randomized, Double­Blind, Placebo­Controlled Trial to Assess the Rate of Recurrence of Oculorespiratory Syndrome Following Influenza Vaccination Among Persons Previously Affected. Clin Infect Dis. 37 (8): 1059­1066; October 15, 2003. Skowronski, D. M.; Remple, V. P.; Macnabb, J.; Pielak, K.; Patrick, D. M.; Halperin, S. A.; Scheifele, D. Injection­Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact. Pediatrics. 112 (6 Pt 1): e453; December, 2003. Smith, D. J.; Bot, S.; Dellamary, L.; Bot, A. Evaluation of Novel Aerosol Formulations Designed for Mucosal Vaccination Against Influenza Virus. Vaccine. 21 (21­22): 2805­2812; June 20, 2003. Smithers, P.; Murray, S. B.; Stewart, S.; Skull, S. Hospital Health Care Worker (HCW) Vaccination Coverage After Implementation of an HCW Vaccination Policy. Aust.Health Rev. 26 (1): 76­83; March, 2003. Smits, W.; Inglefield, J. T.; Letz, K.; Lee, R.; Craig, T. J. Improved Immunotherapy With a Rapid Allergen Vaccination Schedule: a Study of 137 Patients. Ear Nose Throat J. 82 (11): 881­887; November, 2003. Snyder, K. M. Smallpox and Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1920­1925. Soriano Faura, F. J.; Bras, Marquillas J.; Delgado Dominguez, J. J.; Galbe Sanchez­Ventura, J.; Merino, Moina M.; Sanchez­Ruiz Cabello, F. J.; Pallas Alonso, C. R.; Colomer, Revuelta J. [Prevention in Childhood and Adolescence]. Aten.Primaria. 32 Suppl 2:143­58; December, 2003. Stephenson, J. Smallpox Vaccine Program Launched Amid Concerns Raised by Expert Panel, Unions JAMA 2­12­2003, 289 (6): 685­686. Straetemans, M.; Sanders, E. A.; Veenhoven, R. H.; Schilder, A. G.; Damoiseaux, R. A.; Zielhuis, G. A. Review of Randomized Controlled Trials on Pneumococcal Vaccination for Prevention of Otitis Media. Pediatr.Infect.Dis J. 22 (6): 515­524; June 2003. Strine, T. W.; Mokdad, A. H.; Barker, L. E.; Groom, A. V.; Singleton, R.; Wilkins, C. S.; Chu, S. Y. Vaccination Coverage of American Indian/Alaska Native Children Aged 19 to 35 Months: Findings From the National Immunization Survey, 1998­2000. Am J Public Health. 93 (12): 2046­2049; December, 2003. Stringer, C. Post­Exposure Rabies Vaccination. Nurs.Stand. 2­5­2003, 17 (21): 41­42. Strongin, R. J. and Salinsky, E. Who Will Pay for the Adverse Events Resulting From Smallpox Vaccination? Liability and Compensation Issues. NHPF.Issue.Brief. 3­12­2003, 788): 1­15. Stuck, B. [Vaccination Complacency. How to Overcome Your Patient's Skepticism and Strengthen His Motivation]. MMW.Fortschr.Med. 145 (45): 25; November 6, 2003. Subias Loren, P. J.; Perula, de Torres; Moreno, Martin J.; Martin­Rabadan, Muro M.; Llergo, Munoz A.; Iglesias, Rodal M.; Garcia, Mata, Jr.; Bauza, Nicolay K. [Population Survey to Determine Perceptions on Preventive Activities]. Aten.Primaria. 32 Suppl 2:5­14; December, 2003. Sullivan, P. Cardiac Cases Trigger Advisory About Smallpox Vaccination. CMAJ. 4­29­2003, 168 (9): 1167. Sun, W.; Edelman, R.; Kanesa­Thasan, N.; Eckels, K. H.; Putnak, J. R.; King, A. D.; Houng, H. S.; Tang, D.; Scherer, J. M.; Hoke, C. H., Jr.; Innis, B. L. Vaccination of Human Volunteers With Monovalent and Tetravalent Live­Attenuated Dengue Vaccine Candidates. Am.J.Trop.Med.Hyg. 69 (6 Suppl): 24­
31; December, 2003. Svenson, M., Jacobi, H. H., Bodtger, U., Poulsen, L. K., Rieneck, K., and Bendtzen, K. Vaccination for Birch Pollen Allergy. Induction of Affinity­Matured or Blocking IgG Antibodies Does Not Account for the Reduced Binding of IgE to Bet v 1 Mol.Immunol. 2003, 39 (10): 603­612 Swartz, T. A.; Saliou, P.; Catznelson, E.; Blondeau, C.; Gil, I.; Peled, T.; Havkin, O.; Fletcher, M. Immune Response to a Diphtheria and Tetanus Toxoid Administration in a Three­Dose Diphtheria Tetanus Whole­Cell Pertussis/Enhanced Inactivated Poliovirus Vaccination Schedule: A 7­Year Follow Up. Eur J Epidemiol. 18 (8): 827­833; 2003. Szenborn, L.; Tischer, A.; Pejcz, J.; Rudkowski, Z.; jcik, W. Passive Acquired Immunity Against Measles in Infants Born to Naturally Infected and Vaccinated Mothers. Med Sci Monit. 9 (12): CR541­CR546; December, 2003. Szilagyi, P. G., Iwane, M. K., Humiston, S. E., Schaffer, S., McInerny, T., Shone, L., Jennings, J., Washington, M. L., and Schwartz, B. Time Spent by Primary Care Practices on Pediatric Influenza Vaccination Visits: Implications for Universal Influenza Vaccination Arch.Pediatr.Adolesc.Med. 2003, 157 (2): 191­195. Szilagyi, P. G.; Iwane, M. K.; Schaffer, S.; Humiston, S. G.; Barth, R.; McInerny, T.; Shone, L.; Schwartz, B. Potential Burden of Universal Influenza Vaccination of Young Children on Visits to Primary Care Practices. Pediatrics. 112 (4): 821­828; October, 2003. Takahashi, O., Noguchi, Y., Rahman, M., Shimbo, T., Goto, M., Matsui, K., Asai, A., Onishi, M., Koyama, H., Sawada, I., Yoshinaka, T., and Fukui, T. Influence of Family on Acceptance of Influenza Vaccination Among Japanese Patients. Fam.Pract. 2003, 20 (2): 162­166. Talbot, L. A. Biological Threats to America's Health. Biol.Res.Nurs. 2003, 4 (4): 241­243. Talbot, T. R.; Bredenberg, H. K.; Smith, M.; LaFleur, B. J.; Boyd, A.; Edwards, K. M. Focal and Generalized Folliculitis Following Smallpox Vaccination Among Vaccinia­Naive Recipients. JAMA. 289 (24): 3290­3294; June 25, 2003. Tamimi, W.; Hajeer, A.; Qasem, L.; Alkhashan, A.; Alsohabani, A.; Bernvil, S.; Balkhy, H.; Memish, Z. Expansion of Saudi Blood Donor Pool by Better Screening and Vaccination Practices. Clin Diagn Lab Immunol. 10 (6): 1159­1160; November, 2003. Tanaka, M.; Vitek, C. R.; Pascual, F. B.; Bisgard, K. M.; Tate, J. E.; Murphy, T. V. Trends in Pertussis Among Infants in the United States, 1980­1999. JAMA. 290 (22): 2968­2975; December 10, 2003. Taneja, V. Hib Vaccination Controversy and the Declaration of Commercial Interest Indian Pediatr. 2003, 40 (1): 75­76. Tata, L. J.; West, J.; Harrison, T.; Farrington, P.; Smith, C.; Hubbard, R. Does Influenza Vaccination Increase Consultations, Corticosteroid Prescriptions, or Exacerbations in Subjects With Asthma or Chronic Obstructive Pulmonary Disease? Thorax. 58 (10): 835­839; October, 2003. Tavadia, S., Drummond, A., Evans, C. D., and Wainwright, N. J. Leucocytoclastic Vasculitis and Influenza Vaccination. Clin.Exp.Dermatol. 2003, 28 (2): 154­156. Taylor, J. L., Turner, O. C., Basaraba, R. J., Belisle, J. T., Huygen, K., and Orme, I. M. Pulmonary Necrosis Resulting From DNA Vaccination Against Tuberculosis. Infect.Immun. 2003, 71 (4): 2192­2198. Teichmann, D.; Gobels, K.; Niedrig, M.; Grobusch, M. P. Clinical and Laboratory Features of Dengue Virus­Infected Travellers Previously Vaccinated Against Yellow Fever. Scand.J Infect Dis. 35 (6­7): 427­429; 2003. Telford, R.; Rogers, A. What Influences Elderly Peoples' Decisions About Whether to Accept the Influenza Vaccination? A Qualitative Study. Health Educ.Res. 18 (6): 743­753; December, 2003. Terada, K.; Niizuma, T.; Ogita, S.; Kataoka, N. [Survey of the Past History of Measles and Rubella and Advocacy for Vaccination and Certificates of Vaccination at Entry to Kindergarten, Primary School and Junior High School in Kurashiki City­­to Improve the Vaccination Rate]. Kansenshogaku Zasshi. 77 (9): 667­672; September, 2003. Thirlaway, K.; Lukman, H. Meningitis C Vaccine Uptake by British Undergraduates. Commun Dis Public Health. 6 (2): 157­160; June, 2003. Thiry, N., Beutels, P., Van Damme, P., and Van Doorslaer, E. Economic Evaluations of Varicella Vaccination Programmes: A Review of the Literature Pharmacoeconomics. 2003, 21 (1): 13­38. Thomas, D. M., Ray, S. M., Morton, F. J., Drew, J. S., Offutt, G., Whitney, C. G., and Jacobson, T. A. Patient Education Strategies to Improve Pneumococcal Vaccination Rates: Randomized Trial. J Investig.Med. 2003, 51 (3): 141­148. Thorne, C. D.; Hirshon, J. M.; Himes, C. D.; McDiarmid, M. A. Emergency Medicine Tools to Manage Smallpox (Vaccinia) Vaccination Complications: Clinical Practice Guideline and Policies and Procedures. Ann Emerg.Med. 42 (5): 665­680; November, 2003. Tidmarsh, L. There Is Little Evidence That Combined Vaccination Against Measles, Mumps, and Rubella Is Associated With Autism. Evid.Based.Ment.Health 2003, 6 (2): 62. Tieman, J. Vaccination Solutions. IOM Suggests Providers Be Reimbursed. Mod.Healthc. 33 (32): 12­13; August 11, 2003. Tomar, R. P. Pulse Polio Immunization: a Need for More Inputs. Indian J.Pediatr. 70 (11): 930; November, 2003. Torvaldsen, S., Simpson, J. M., and McIntyre, P. B. Effectiveness of Pertussis Vaccination in New South Wales, Australia, 1996­1998. Eur.J Epidemiol. 2003, 18 (1): 63­69. Toscani, L., Gauthey, L., and Robert, C. F. The Information Network of Senior Citizens in Geneva, Switzerland, and Progress in Flu Vaccination Coverage Between 1991 and 2000 Vaccine 1­17­2003, 21 (5­6): 393­398. Tozzi, A. E.; Rava, L.; Ciofi degli Atti, M. L.; Salmaso, S. Clinical Presentation of Pertussis in Unvaccinated and Vaccinated Children in the First Six Years of Life. Pediatrics. 112 (5): 1069­1075; November, 2003. Traynor, K. More Than 100,000 Troops Receive Smallpox Vaccination. Early Data Reveal Few Serious Adverse Events. Am.J Health Syst.Pharm. 4­1­2003, 60 (7): 644­645. Trossman, S. The Return of the Smallpox Vaccination. Nurses Report on Plans, Concerns. Am.Nurse. 35 (2): 1­2, 12; March 2003. Trotter, C. L., McVernon, J., Andrews, N. J., Burrage, M., and Ramsay, M. E. Antibody to Haemophilus Influenzae Type b After Routine and Catch­Up Vaccination. Lancet 5­3­2003, 361 (9368): 1523­1524. Trotter, C. L., Ramsay, M. E., and Slack, M. P. Rising Incidence of Haemophilus Influenzae Type b Disease in England and Wales Indicates a Need for a Second Catch­Up Vaccination Campaign. Commun Dis Public Health 2003, 6 (1): 55­58. Trotter, C., Borrow, R., Andrews, N., and Miller, E. Seroprevalence of Meningococcal Serogroup C Bactericidal Antibody in England and Wales in the Pre­
Vaccination Era Vaccine 3­7­2003, 21 (11­12): 1094­1098. Trzonkowski, P.; Mysliwska, J.; Szmit, E.; Wieckiewicz, J.; Lukaszuk, K.; Brydak, L. B.; Machala, M.; Mysliwski, A. Association Between Cytomegalovirus Infection, Enhanced Proinflammatory Response and Low Level of Anti­Hemagglutinins During the Anti­Influenza Vaccination­an Impact of Immunosenescence. Vaccine. 21 (25­26): 3826­3836; September 8, 2003. Tuckwell, H. C.; Hanslik, T.; Valleron, A. J.; Flahault, A. A Mathematical Model for Evaluating the Impact of Vaccination Schedules: Application to Neisseria Meningitidis. Epidemiol.Infect. 130 (3): 419­429; June 2003. Turner, C., Boyle, F., and O'Rourke, P. Mothers' Health Post­Partum and Their Patterns of Seeking Vaccination for Their Infants. Int.J Nurs.Pract. 2003, 9 (2): 120­126. Uzonna, J. E.; Chilton, P.; Whitlock, R. H.; Habecker, P. L.; Scott, P.; Sweeney, R. W. Efficacy of Commercial and Field­Strain Mycobacterium Paratuberculosis Vaccinations With Recombinant IL­12 in a Bovine Experimental Infection Model. Vaccine. 21 (23): 3101­3109; July 4, 2003. Valdmanis, V.; Walker, D.; Fox­Rushby, J. Are Vaccination Sites in Bangladesh Scale Efficient? Int.J.Technol.Assess.Health Care. 19 (4): 692­697; 2003. Van Den Hoven, M. A.; Verweij, M. F. Should We Promote Influenza Vaccination of Health Care Workers in Nursing Homes? Some Ethical Arguments in Favour of Immunization. Age Ageing. 32 (5): 487­489; September, 2003. van den, Hof S., Wallinga, J., Widdowson, M. A., and Conyn­van Spaendonck, M. A. Options for Improvement of the Dutch Measles Vaccination Schedule Vaccine 1­30­2003, 21 (7­8): 721­724. Van Der, Aa A., Hellings, N., Medaer, R., Gelin, G., Palmers, Y., Raus, J., and Stinissen, P. T Cell Vaccination in Multiple Sclerosis Patients With Autologous CSF­Derived Activated T Cells: Results From a Pilot Study Clin.Exp.Immunol. 2003, 131 (1): 155­168. Van Dijk, G. W., van Leeuwen, H. J., van Gijn, J., and Hoepelman, I. M. [Missing Spleen: Indication for Pneumococcal Vaccination]. Ned.Tijdschr.Geneeskd. 3­8­2003, 147 (10): 425­428. Van Essen, G. A., Palache, A. M., Forleo, E., and Fedson, D. S. Influenza Vaccination in 2000: Recommendations and Vaccine Use in 50 Developed and Rapidly Developing Countries. Vaccine 5­1­2003, 21 (16): 1780­1785. van Oirschot, J. T. Emergency Vaccination Against Classical Swine Fever. Dev.Biol (Basel). 114:259­67; 2003. van Turennout, C., Vandelanotte, J., van den, Akker M., and Depoorter, A. M. A Mass Campaign Too Often? Results of a Vaccination Coverage Survey in the Dikgale­Soekmekaar District S Afr.Med.J 2003, 93 (1): 65­68. Vazquez, S.; Valdes, O.; Pupo, M.; Delgado, I.; Alvarez, M.; Pelegrino, J. L.; Guzman, M. G. MAC­ELISA and ELISA Inhibition Methods for Detection of Antibodies After Yellow Fever Vaccination. J Virol.Methods. 110 (2): 179­184; June 2003. Vedhara, K.; Bennett, P. D.; Clark, S.; Lightman, S. L.; Shaw, S.; Perks, P.; Hunt, M. A.; Philip, J. M.; Tallon, D.; Murphy, P. J.; Jones, R. W.; Wilcock, G. K.; Shanks, N. M. Enhancement of Antibody Responses to Influenza Vaccination in the Elderly Following a Cognitive­Behavioural Stress Management Intervention. Psychother.Psychosom. 72 (5): 245­252; September, 2003. Verstraeten, T.; Jumaan, A. O.; Mullooly, J. P.; Seward, J. F.; Izurieta, H. S.; DeStefano, F.; Black, S. B.; Chen, R. T. A Retrospective Cohort Study of the Association of Varicella Vaccine Failure With Asthma, Steroid Use, Age at Vaccination, and Measles­Mumps­Rubella Vaccination. Pediatrics. 112 (2): e98­103; August 2003. Visser, M., Hogeman, P. H., van Vught, A. J., Revesz, T., and Wolfs, T. F. [Fulminating Pneumococcal Septicemia in a 2 Year Old Child With Sickle Cell Anemia]. Ned.Tijdschr.Geneeskd. 3­8­2003, 147 (10): 454­456. Voordouw, B. C., van der Linden, P. D., Simonian, S., van der, Lei J., Sturkenboom, M. C., and Stricker, B. H. Influenza Vaccination in Community­Dwelling Elderly: Impact on Mortality and Influenza­Associated Morbidity. Arch Intern Med. 5­12­2003, 163 (9): 1089­1094. Vynnycky, E.; Gay, N. J.; Cutts, F. T. The Predicted Impact of Private Sector MMR Vaccination on the Burden of Congenital Rubella Syndrome. Vaccine. 21 (21­22): 2708­2719; June 20, 2003. Wack, R. P. An Outbreak of Varicella Despite Vaccination. N.Engl.J Med. 4­3­2003, 348 (14): 1405­1407. Waecker, N. J., Jr. and Hale, B. R. Smallpox Vaccination. What the Pediatrician Needs to Know. Pediatr.Ann. 2003, 32 (3): 178­181. Wagner, C.; Popp, W.; Posch, M.; Vlasich, C.; Rosenberger­Spitzy, A. Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: a Case­Controlled Study. Gerontology. 49 (4): 246­250; July 2003. Wahlberg, J.; Fredriksson, J.; Vaarala, O.; Ludvigsson, J. Vaccinations May Induce Diabetes­Related Autoantibodies in One­Year­Old Children. Ann N Y.Acad Sci. 1005:404­8; November, 2003. Wallinga, J., Teunis, P., and Kretzschmar, M. Reconstruction of Measles Dynamics in a Vaccinated Population. Vaccine 6­2­2003, 21 (19­20): 2643­2650. Wasunna, A. Contribution of Vaccinations Towards Reducing Morbidity and Mortality Among Children in Developing Countries. East Afr Med J 2003, 80 (1): 1­2. Wathne, K. O.; Fjaerli, H. O.; Flaegstad, T.; Abrahamsen, T. G. [More Children Should Be Vaccinated Against Pneumococcal Disease]. Tidsskr.Nor Laegeforen. 123 (9): 1198­1200; May 1, 2003. Weaver, F. M.; Goldstein, B.; Evans, C. T.; Legro, M. W.; LaVela, S.; Smith, B.; Miskevics, S.; Hammond, M. C. Influenza Vaccination Among Veterans With Spinal Cord Injury: Part 2. Increasing Vaccination Rates. J.Spinal Cord.Med. 26 (3): 210­218; 2003. Wedege, E.; Kuipers, B.; Bolstad, K.; van Dijken, H.; Froholm, L. O.; Vermont, C.; Caugant, D. A.; van den, Dobbelsteen G. Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine. Infect.Immun. 71 (7): 3775­3781; July, 2003. Weightman, N. C.; Walters, A. Missed Opportunities in Vaccination of Patients With Subsequent Pneumococcal Bacteraemia. Br.J Gen.Pract. 53 (492): 547­
549; July, 2003. Weiner, B. and Irwin, M. Current Initiatives for Emergency Preparedness Response: Commentary on "New Challenges for Public Health Care: Biological and Chemical Weapons Awareness, Surveillance, and Response". Biol.Res.Nurs. 2003, 4 (4): 255­257. Wharton, M., Strikas, R. A., Harpaz, R., Rotz, L. D., Schwartz, B., Casey, C. G., Pearson, M. L., and Anderson, L. J. Recommendations for Using Smallpox Vaccine in a Pre­Event Vaccination Program. Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm.Rep. 4­4­2003, 52 (RR­7): 1­16. Whitham, M.; Blannin, A. K. The Effect of Exercise Training on the Kinetics of the Antibody Response to Influenza Vaccination. J.Sports Sci. 21 (12): 991­
1000; December, 2003. Whitman, T. J.; Ferguson, M. A.; Decker, C. F. Cardiac Dysrhythmia Following Smallpox Vaccination. Clin Infect Dis. 37 (11): 1579­1580; December 1, 2003. Willcox, A. Ready for Vaccination. Nurs.Stand. 18 (3): 19; October 1, 2003. Windorfer, A. [Vaccination. Tasks and Obligations for Surgeons]. Chirurg 2003, 74 (1): 73­80. Wong, S. J.; Boyle, R. H.; Demarest, V. L.; Woodmansee, A. N.; Kramer, L. D.; Li, H.; Drebot, M.; Koski, R. A.; Fikrig, E.; Martin, D. A.; Shi, P. Y. Immunoassay Targeting Nonstructural Protein 5 to Differentiate West Nile Virus Infection From Dengue and St. Louis Encephalitis Virus Infections and From Flavivirus Vaccination. J Clin Microbiol. 41 (9): 4217­4223; September, 2003. Wong­Beringer, A., Brodetsky, E., and Quist, R. Pneumococcal Vaccination in Hospitalized Elderly Patients: Role of the Pharmacist Pharmacotherapy 2003, 23 (2): 199­208. Wongsurakiat, P.; Lertakyamanee, J.; Maranetra, K. N.; Jongriratanakul, S.; Sangkaew, S. Economic Evaluation of Influenza Vaccination in Thai Chronic Obstructive Pulmonary Disease Patients. J Med Assoc Thai. 86 (6): 497­508; June, 2003. Wood, D. L. Increasing Immunization Coverage. American Academy of Pediatrics Committee on Community Health Services. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine. Pediatrics. 112 (4): 993­996; October, 2003. Woodberry, T., Gardner, J., Elliott, S. L., Leyrer, S., Purdie, D. M., Chaplin, P., and Suhrbier, A. Prime Boost Vaccination Strategies: CD8 T Cell Numbers, Protection, and Th1 Bias J Immunol. 3­1­2003, 170 (5): 2599­2604. Worthington, M. G. and Ross, J. J. Smallpox and Smallpox Vaccination. N Engl J Med. 5­8­2003, 348 (19): 1920­1925. Yih, W. K.; Lieu, T. A.; Rego, V. H.; O'Brien, M. A.; Shay, D. K.; Yokoe, D. S.; Platt, R. Attitudes of Healthcare Workers in U.S. Hospitals Regarding Smallpox Vaccination. BMC.Public Health. 3 (1): 20; June 11, 2003. Yung, B. Influenza Vaccination Reduces Risk of Hospitalisation for Heart Disease and CVD in Subjects Aged >/=65 Years. Thorax. 58 (7): 572; July, 2003. Zielinski, A.; Kwon, C. B.; Tomaszunas­Blaszczyk, J.; Magdzik, W.; Bennett, J. V. Risk of Haemophilus Influenzae Type b Meningitis in Polish Children Varies Directly With Number of Siblings: Possible Implications for Vaccination Strategies. Eur J Epidemiol. 18 (9): 917­922; 2003. Zimmerman, R. K. Recommended Childhood and Adolescent Immunization Schedule, United States, 2003 and Update on Childhood Immunizations Am.Fam.Physician 1­1­2003, 67 (1): 188­6. Zimmerman, R. K., Santibanez, T. A., Janosky, J. E., Fine, M. J., Raymund, M., Wilson, S. A., Bardella, I. J., Medsger, A. R., and Nowalk, M. P. What Affects Influenza Vaccination Rates Among Older Patients? An Analysis From Inner­City, Suburban, Rural, and Veterans Affairs Practices Am.J Med. 2003, 114 (1): 31­38. Zimmerman, R. K.; Nowalk, M. P.; Raymund, M.; Tabbarah, M.; Hall, D. G.; Wahrenberger, J. T.; Wilson, S. A.; Ricci, E. M. Tailored Interventions to Increase Influenza Vaccination in Neighborhood Health Centers Serving the Disadvantaged. Am J Public Health. 93 (10): 1699­1705; October, 2003. Zuckerman, J. N. Vaccination Priorities in Travel. BioDrugs. 17 (Suppl. 1) :1­6; 2003. 2004 Aaby, P.; Jensen, H.; Rodrigues, A.; Garly, M. L.; Benn, C. S.; Lisse, I. M.; Simondon, F. Divergent Female­Male Mortality Ratios Associated With Different Routine Vaccinations Among Female­Male Twin Pairs. Int.J.Epidemiol. 33 (2): 367­373; April, 2004. Aaby, P.; Rodrigues, A.; Biai, S.; Martins, C.; Veirum, J. E.; Benn, C. S.; Jensen, H. Oral Polio Vaccination and Low Case Fatality at the Paediatric Ward in Bissau, Guinea­Bissau. Vaccine. 22 (23­24): 3014­3017; August 13, 2004. Abadoglu, O.; Mungan, D.; Pasaoglu, G.; Celik, G.; Misirligil, Z. Influenza Vaccination in Patients With Asthma: Effect on the Frequency of Upper Respiratory Tract Infections and Exacerbations. J.Asthma. 41 (3): 279­283; 2004. Abel, R. L.; McGaha, P.; Young, R.; Bing, M.; Foran, T.; Oaks, B. Understanding Differences in Influenza Immunization Rates: a Survey of African­
American and Caucasian Medicare Beneficiaries in Texas. J.Health Hum.Serv.Adm. 26 (2): 174­198; 2003. Ackermann, D.; Chapman, S.; Leask, J. Media Coverage of Anthrax Vaccination Refusal by Australian Defence Force Personnel. Vaccine. 23 (3): 411­417; December 2, 2004. Ada, G. L. Vaccination and the Immune Response. Curr.Biol. 1 (4): 221­223; August, 1991. Ahmad, K. Kano to Recommence Vaccination Against Poliomyelitis. Lancet Neurol. 3 (7): 388; July, 2004. Ahmad, K. Polio Vaccination to Restart in Kenya. Lancet Infect.Dis. 4 (7): 391; July, 2004. Ahmad, K. Vaccination Halts Meningitis Outbreak in Burkina Faso. Lancet. 363 (9417): 1290; April 17, 2004. Akano, Y.; Ando, H.; Tanaka, A.; Uchida, H.; Fujii, K.; Takayanagi, M.; Magagi, A.; Nakane, M.; Nakano, T. Oral Polio Vaccines Have Not Yet Covered West Africa: Survey of Immunization Coverage Conducted in Niger. Jpn.J.Infect.Dis. 57 (3): 121­123; June, 2004. Aldrete, J. A. Smallpox Vaccination in the Early 19th Century Using Live Carriers: the Travels of Francisco Xavier De Balmis. South.Med.J. 97 (4): 375­378; April, 2004. Alexander, L. N.; Seward, J. F.; Santibanez, T. A.; Pallansch, M. A.; Kew, O. M.; Prevots, D. R.; Strebel, P. M.; Cono, J.; Wharton, M.; Orenstein, W. A.; Sutter, R. W. Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United States. JAMA. 292 (14): 1696­1701; October 13, 2004. Alexander, L.; Birkhead, G.; Guerra, F.; Helms, C.; Hinman, A.; Katz, S.; LeBaron, C. W.; Modlin, J.; Murphy, T. V. Ensuring Preparedness for Potential Poliomyelitis Outbreaks: Recommendations for the US Poliovirus Vaccine Stockpile From the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP). Arch Pediatr Adolesc Med; 158 (12): 1106­1112; December, 2004. Alfredsson, R.; Svensson, E.; Trollfors, B.; Borres, M. P. Why Do Parents Hesitate to Vaccinate Their Children Against Measles, Mumps and Rubella? Acta Paediatr. 93 (9): 1232­1237; September, 2004. Ali, T.; Scott, N.; Kallas, W.; Halliwell, M. E.; Savino, C.; Rosenberg, E.; Ferraro, M.; Hohmann, E. Detection of Influenza Antigen With Rapid Antibody­
Based Tests After Intranasal Influenza Vaccination (FluMist). Clin.Infect.Dis. 38 (5): 760­762; March 1, 2004. Allen, U. Reply to Measles Vaccination in Canada. J.Pediatr. 144 (1): 141; January, 2004. Allsup, S.; Haycox, A.; Regan, M.; Gosney, M. Is Influenza Vaccination Cost Effective for Healthy People Between Ages 65 and 74 Years? A Randomised Controlled Trial. Vaccine. 23 (5): 639­645; December 16, 2004. Altinkaynak, S.; Ertekin, V.; Guraksin, A.; Kilic, A. Effect of Several Sociodemographic Factors on Measles Immunization in Children of Eastern Turkey. Public Health. 118 (8): 565­569; December, 2004. Andersen, T. [Influenza Vaccination­­One More Time]. Ugeskr.Laeger. 166 (7): 611­612; February 9, 2004. Andrews N.; Miller E.; Grant A.; Stowe J; Osborne V.; Taylor B Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association. Pediatrics; 114 (3): 584­591; October, 2004. Andrews, R. M.; Counahan, M. L.; Hogg, G. G.; McIntyre, P. B. Effectiveness of a Publicly Funded Pneumococcal Vaccination Program Against Invasive Pneumococcal Disease Among the Elderly in Victoria, Australia. Vaccine. 23 (2): 132­138; November 25, 2004. Andrus, J. K. Rotavirus Vaccines. Lancet. 364 (9430): 246; July 17, 2004. Apple, J.; Hare, P.; Crerar, C.; Walker, E.; Wilson, J.; Brown, C.; Moses, K.; Hendrickson, T.; Field, D.; Hoffman, F.; Pedrus, P.; Miller, J.; Smith, B. Implementing a Smallpox Vaccination Program Aboard an Aircraft Carrier. Mil.Med. 169 (6): 455­460; June, 2004. Armstrong, B. G.; Mangtani, P.; Fletcher, A.; Kovats, S.; McMichael, A.; Pattenden, S.; Wilkinson, P. Effect of Influenza Vaccination on Excess Deaths Occurring During Periods of High Circulation of Influenza: Cohort Study in Elderly People. BMJ. August 15, 2004. Arness, M. K.; Eckart, R. E.; Love, S. S.; Atwood, J. E.; Wells, T. S.; Engler, R. J.; Collins, L. C.; Ludwig, S. L.; Riddle, J. R.; Grabenstein, J. D.; Tornberg, D. N. Myopericarditis Following Smallpox Vaccination. Am.J.Epidemiol. 160 (7): 642­651; October 1, 2004. Aronson, N. E.; Santosham, M.; Comstock, G. W.; Howard, R. S.; Moulton, L. H.; Rhoades, E. R.; Harrison, L. H. Long­Term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60­Year Follow­Up Study. JAMA. 291 (17): 2086­2091; May 5, 2004. Arribas, J. L.; Hernandez­Navarrete, M. J.; Solano, V. M. [Adult Vaccination Update]. Enferm.Infecc.Microbiol.Clin. 22 (6): 342­354; June, 2004. Arshi, S.; Sadeghi­Bazargani, H.; Ojaghi, H.; Savadi­Oskouei, D.; Hekmat, S.; Jastan, M.; Majidpour, A.; Shahizareh, F. The First Rapid Onset Optic Neuritis After Measles­Rubella Vaccination: Case Report. Vaccine. 22 (25­26): 3240­3242; September 3, 2004. Arya, S. C.; Agarwal, N. Rubella Immunity and Immunization of Male Hospital Personnel. J Hosp Infect. 58 (4): 306­307; December, 2004. Ashraf, H. WHO Regroups Efforts Against Polio Resurgence in Africa. Lancet Infect.Dis. 4 (8): 477; August, 2004. Assendelf, W. J.; Scholten, R. J.; Offringa, M. Pneumococcal Vaccination for the Elderly in The Netherlands? Assessment of the Quality and Content of Available Comparative Studies. Neth.J.Med. 62 (2): 36­44; February, 2004. Auranen, K.; Eichner, M.; Leino, T.; Takala, A. K.; Makela, P. H.; Takala, T. Modelling Transmission, Immunity and Disease of Haemophilus Influenzae Type b in a Structured Population. Epidemiol.Infect. 132 (5): 947­957; October, 2004. Aylward, R. B.; Cochi, S. L. Framework for Evaluating the Risks of Paralytic Poliomyelitis After Global Interruption of Wild Poliovirus Transmission. Bull.World Health Organ. 82 (1): 40­46; January, 2004. Bachmann, M. F.; Dyer, M. R. Opinion: Therapeutic Vaccination for Chronic Diseases: a New Class of Drugs in Sight. Nat.Rev Drug Discov. 3 (1): 81­88; January, 2004. Bahl, R.; Sinha, A.; Poulos, C.; Whittington, D.; Sazawal, S.; Kumar, R.; Mahalanabis, D.; Acosta, C. J.; Clemens, J. D.; Bhan, M. K. Costs of Illness Due to Typhoid Fever in an Indian Urban Slum Community: Implications for Vaccination Policy. J Health Popul Nutr; 22 (3): 304­310; September, 2004. Bale, J. F., Jr. Neurologic Complications of Immunization. J.Child Neurol. 19 (6): 405­412; June, 2004. Balicer, R. D.; Huerta, M.; Grotto, I. [Vaccination Policy in the IDF­­Past, Present and Future]. Harefuah. 143 (8): 609­13, 620; August, 2004. Balkhy, H. H.; Memish, Z. A.; Bafaqeer, S.; Almuneef, M. A. Influenza a Common Viral Infection Among Hajj Pilgrims: Time for Routine Surveillance and Vaccination. J.Travel.Med. 11 (2): 82­86; March, 2004. Ball, F.; Britton, T.; Lyne, O. Stochastic Multitype Epidemics in a Community of Households: Estimation and Form of Optimal Vaccination Schemes. Math.Biosci. 191 (1): 19­40; September, 2004. Banerjee, S.; Nandyala, A.; Podili, R.; Katoch, V. M.; Murthy, K. J.; Hasnain, S. E. Mycobacterium Tuberculosis (Mtb) Isocitrate Dehydrogenases Show Strong B Cell Response and Distinguish Vaccinated Controls From TB Patients. Proc.Natl.Acad.Sci.U.S.A. 101 (34): 12652­12657; August 24, 2004. Barale, A.; Malaspina, S.; Rivetti, D.; Demicheli, V.; Moiraghi, R. A. [Patient's Satisfaction Survey About the Quality of Immunization Services]. Ann Ig. 16 (1­2): 179­186; January, 2004. Barata, R. B. [The Impact of Mass Vaccination on Meningococcal Disease in the 1970s Epidemic in Brazil.]. Cad Saude Publica; 20 (6): 1762­1763; November, 2004. Bardin, P. G. Vaccination for Asthma Exacerbations. Intern.Med.J. 34 (6): 358­360; June, 2004. Barker, L. E.; Chu, S. Y.; Smith, P. J. Disparities in Immunizations. Am.J.Public Health. 94 (6): 906; June, 2004. Barouni, A. S.; Augusto, C.; Queiroz, M. V.; Lopes, M. T.; Zanini, M. S.; Salas, C. E. BCG Lymphadenopathy Detected in a BCG­Vaccinated Infant. Braz.J.Med.Biol.Res. 37 (5): 697­700; May, 2004. Bar­Oz, B.; Levichek, Z.; Moretti, M. E.; Mah, C.; Andreou, S.; Koren, G. Pregnancy Outcome Following Rubella Vaccination: a Prospective Controlled Study. Am.J.Med.Genet. 130A (1): 52­54; September 15, 2004. Barthelemy, M.; Barrat, A.; Pastor­Satorras, R.; Vespignani, A. Velocity and Hierarchical Spread of Epidemic Outbreaks in Scale­Free Networks. Phys.Rev.Lett. 92 (17): 178701; April 30, 2004. Barwick, R. History of Thymoma and Yellow Fever Vaccination. Lancet. 364 (9438): 936; September 11, 2004. Bateson, T. But What About Mercury in Vaccinations? Br.J.Nurs. 13 (16): 955; September 9, 2004. Bauch, C. T.; Earn, D. J. Vaccination and the Theory of Games. Proc.Natl.Acad.Sci.U.S.A. 101 (36): 13391­13394; September 7, 2004. Baydur, A. Influenza Vaccination in Vulnerable Populations. Chest. 125 (6): 1971­1972; June, 2004. Bechir, M.; Schelling, E.; Wyss, K.; Daugla, D. M.; Daoud, S.; Tanner, M.; Zinsstag, J. [An Innovative Approach Combining Human and Animal Vaccination Campaigns in Nomadic Settings of Chad: Experiences and Costs]. Med Trop (Mars); 64 (5): 497­502; 2004. Bedford, H. Measles and the Importance of Maintaining Vaccination Levels. Nurs.Times. 100 (26): 52­55; June 29, 2004. Belshe, R. B.; Newman, F. K.; Cannon, J.; Duane, C.; Treanor, J.; Van Hoecke, C.; Howe, B. J.; Dubin, G. Serum Antibody Responses After Intradermal Vaccination Against Influenza. N Engl J Med. 351 (22): 2286­2294; November 25, 2004. Bender, A.; Jager, G.; Scheuerer, W.; Feddersen, B.; Kaiser, R.; Pfister, H. W. Two Severe Cases of Tick­Borne Encephalitis Despite Complete Active Vaccination­the Significance of Neutralizing Antibodies. J.Neurol. 251 (3): 353­354; March, 2004. Beran, J.; Douda, P.; Gniel, D.; Zent, O. Long­Term Immunity After Vaccination Against Tick­Borne Encephalitis With Encepur Using the Rapid Vaccination Schedule. Int.J.Med.Microbiol. 293 Suppl 37:130­3; April, 2004. Bergthornorsson, G. I.; Matthiasson, T.; Guethnason, T.; Briem, H. [Cost­Effectiveness Analysis on Meningococca Serogroup C Vaccination.]. Laeknabladid; 90 (5): 379­383; May, 2004. Berrington, J.; Fenton, A. Immunization Responses in Preterm Infants Who Receive Postnatal Steroid Treatment. Pediatrics. 114 (4): 1127­1128; October, 2004. Bertley, F. M.; Ibrahim, S. A.; Libman, M.; Ward, B. J. Measles Vaccination in the Presence of Maternal Antibodies Primes for a Balanced Humoral and Cellular Response to Revaccination. Vaccine. 23 (4): 444­449; December 9, 2004. Beske, F. [Active Vaccination Current Status and Required Action]. Gesundheitswesen. 66 (5): 352­354; May, 2004. Beutels, P. Potential Conflicts of Interest in Vaccine Economics Research: a Commentary With a Case Study of Pneumococcal Conjugate Vaccination. Vaccine. 22 (25­26): 3312­3322; September 3, 2004. Beyer, W. E.; Palache, A. M.; Luchters, G.; Nauta, J.; Osterhaus, A. D. Seroprotection Rate, Mean Fold Increase, Seroconversion Rate: Which Parameter Adequately Expresses Seroresponse to Influenza Vaccination? Virus Res. 103 (1­2): 125­132; July, 2004. Blanco, Quiros A.; Gimenez, Sanchez F.; Asensi, Botet F.; Bernaola, Iturbe E.; De Juan, Martin F.; Garcia, Perez J.; Garces, Sanchez M.; Gomez Campdera, J. A.; Picazo, J. J.; Pineda, Solas, V [Vaccination Schedule of the Spanish Association of Pediatrics. Recommendations 2004]. An.Pediatr.(Barc.). 60 (5): 468­
472; May, 2004. Blasiole, D. A.; Metzgar, D.; Daum, L. T.; Ryan, M. A.; Wu, J.; Wills, C.; Le, C. T.; Freed, N. E.; Hansen, C. J.; Gray, G. C.; Russell, K. L. Molecular Analysis of Adenovirus Isolates From Vaccinated and Unvaccinated Young Adults. J.Clin.Microbiol. 42 (4): 1686­1693; April, 2004. Block, S. L.; Hedrick, J.; Harrison, C. J.; Tyler, R.; Smith, A.; Findlay, R.; Keegan, E. Community­Wide Vaccination With the Heptavalent Pneumococcal Conjugate Significantly Alters the Microbiology of Acute Otitis Media. Pediatr.Infect.Dis.J. 23 (9): 829­833; September, 2004. Bonito, A. J.; Lenfestey, N. F.; Eicheldinger, C.; Iannacchione, V. G.; Campbell, L. Disparities in Immunizations Among Elderly Medicare Beneficiaries, 2000 to 2002. Am.J.Prev.Med. 27 (2): 153­160; August, 2004. Bonu, S.; Rani, M.; Razum, O. Global Public Health Mandates in a Diverse World: the Polio Eradication Initiative and the Expanded Programme on Immunization in Sub­Saharan Africa and South Asia. Health Policy. 70 (3): 327­345; December, 2004. Boyce, T. G.; Weaver, A. L.; St Sauver, J. L.; Woodward­Lee, A. E.; Stancl, J. K.; Park, J. Y.; Jacobsen, S. J.; Jacobson, R. M.; Poland, G. A. Pertussis Vaccination and the Risk of Respiratory Syncytial Virus­Associated Hospitalization. Pediatr Infect Dis J; 23 (10): 897­901; October, 2004. Bozza, S.; Montagnoli, C.; Gaziano, R.; Rossi, G.; Nkwanyuo, G.; Bellocchio, S.; Romani, L. Dendritic Cell­Based Vaccination Against Opportunistic Fungi. Vaccine. 22 (7): 857­864; February 17, 2004. Bradbury, J. Predicting Vaccination Behaviour. Lancet Infect.Dis. 4 (10): 600; October, 2004. Brandao, A. P.; Oliveira, T. C.; Brandileone, M. C.; Goncalves, J. E.; Yara, T. I.; Simonsen, V. Persistence of Antibody Response to Pneumococcal Capsular Polysaccharides in Vaccinated Long Term­Care Residents in Brazil. Vaccine. 23 (6): 762­768; November 16, 2004. Bredin, C. P. Tuberculosis in the Ireland of 2003: It Hasn't Gone Away. Ir.Med.J. 97 (1): 6­7; January, 2004. Breeze, E.; Mangtani, P.; Price, G. M.; Kovats, S.; Roberts, J.; Fletcher, A. E. Trends in Influenza Vaccination Uptake Among People Aged Over 74 Years, 1997­2000: Survey of 73 General Practices in Britain. BMC.Fam.Pract. 5 (1): 8; April, 2004. Bricaire, F. [The Risk of Non­Vaccination]. Presse Med; 33 (18): 1229­1230; October 23, 2004. Bricks, L. F.; Mendes, C. M.; Lucarevschi, B. R.; Oplustil, C. P.; Zanella, R. C.; Bori, A.; Bertoli, C. J. Oropharyngeal Colonization by Haemophilus Influenzae in Healthy Children From Taubate (Sao Paulo), Prior to the Haemophilus Influenzae Type b Vaccination Program in Brazil. Rev Hosp Clin Fac Med Sao Paulo. 59 (5): 236­243; November 16, 2004. Brimnes, N. Variolation, Vaccination and Popular Resistance in Early Colonial South India. Med.Hist. 48 (2): 199­228; April, 2004. Brookmeyer, R.; Johnson, E.; Bollinger, R. Public Health Vaccination Policies for Containing an Anthrax Outbreak. Nature; 432 (7019): 901­904; December 16, 2004. Brotherton, J.; McIntyre, P.; Puech, M.; Wang, H.; Gidding, H.; Hull, B.; Lawrence, G.; MacIntyre, R.; Wood, N.; Armstrong, D. Vaccine Preventable Diseases and Vaccination Coverage in Australia 2001 to 2002. Commun Dis Intell; 28 (Suppl 2): vii­S116; December, 2004. Broutin, H.; Simondon, F.; Guegan, J. F. Whooping Cough Metapopulation Dynamics in Tropical Conditions: Disease Persistence and Impact of Vaccination. Proc.R.Soc.Lond B Biol.Sci. 271 Suppl 5:S302­5; August 7, 2004. Bryant, K. A.; Stover, B.; Cain, L.; Levine, G. L.; Siegel, J.; Jarvis, W. R. Improving Influenza Immunization Rates Among Healthcare Workers Caring for High­Risk Pediatric Patients. Infect Control Hosp Epidemiol. 25 (11): 912­917; November, 2004. Brydak, L. B.; Machala, M.; LAguna, P.; Rokicka­Milewska, R. Antibody Response to Influenza Vaccination in Splenectomized Patients in Poland. J.Clin.Immunol. 24 (3): 225­236; May, 2004. Buescher, J. J. Vaccinations Containing Thimerosal Do Not Increase Rates of Autism. J.Fam.Pract. 53 (2): 94­96; February, 2004. Bueving, H. J.; Bernsen, R. M.; de Jongste, J. C.; Suijlekom­Smit, L. W.; Rimmelzwaan, G. F.; Osterhaus, A. D.; Rutten­van Molken, M. P.; Thomas, S.; van der Wouden, J. C. Does Influenza Vaccination Exacerbate Asthma in Children? Vaccine. 23 (1): 91­96; November 15, 2004. Bueving, H. J.; van der Wouden, J. C.; Raat, H.; Bernsen, R. M.; de Jongste, J. C.; Suijlekom­Smit, L. W.; Osterhaus, A. D.; Rimmelzwaan, G. F.; Molken, M. R.; Thomas, S. Influenza Vaccination in Asthmatic Children: Effects on Quality of Life and Symptoms. Eur Respir J; 24 (6): 925­931; December, 2004. Buff, A. M.; Welch, F. J.; Tapia, R. A. A Review of Varicella Vaccine and Louisiana Vaccination Requirements. J.La State Med.Soc. 156 (1): 50­55; January, 2004. Bundt, T. S.; Hu, H. M. National Examination of Compliance Predictors and the Immunization Status of Children: Precursor to a Developmental Model for Health Systems. Mil Med. 169 (10): 795­803; October, 2004. Butler, D. Nigerian States Disrupt Campaign to Eradicate Polio. Nature. 428 (6979): 109; March 11, 2004. Butler, J. R.; McIntyre, P.; MacIntyre, C. R.; Gilmour, R.; Howarth, A. L.; Sander, B. The Cost­Effectiveness of Pneumococcal Conjugate Vaccination in Australia. Vaccine. 22 (9­10): 1138­1149; March 12, 2004. Caidi, H.; Bennis, I. F.; Mouan, N.; El, Aouad R. Evaluation of the Response to Vaccination Against Poliomyelitis and Measles in Malnourished Children in Morocco. East Mediterr Health J; 10 (4­5): 474­481; July, 2004. Calain, P.; Chaine, J. P.; Johnson, E.; Hawley, M. L.; O'Leary, M. J.; Oshitani, H.; Chaignat, C. L. Can Oral Cholera Vaccination Play a Role in Controlling a Cholera Outbreak? Vaccine. 22 (19): 2444­2451; June 23, 2004. Calandrillo, S. P. Vanishing Vaccinations: Why Are So Many Americans Opting Out of Vaccinating Their Children? Univ Mich J Law Reform; 37 (2): 353­
440; 2004. Calvo, N.; Morice, A.; Saenz, E.; Navas, L. [Using Surveys of Schoolchildren to Evaluate Coverage With and Opportunity for Vaccination in Costa Rica]. Rev.Panam.Salud Publica. 16 (2): 118­124; August, 2004. Campos, J.; Hernando, M.; Roman, F.; Perez­Vazquez, M.; Aracil, B.; Oteo, J.; Lazaro, E.; de Abajo, F. Analysis of Invasive Haemophilus Influenzae Infections After Extensive Vaccination Against H. Influenzae Type b. J.Clin.Microbiol. 42 (2): 524­529; February, 2004. Capua, I.; Marangon, S. Vaccination for Avian Influenza in Asia. Vaccine. 22 (31­32): 4137­4138; October 22, 2004. Carrier, J. Routine Childhood Vaccinations Did Not Increase the Risk of Incident Type 1 Diabetes in Danish Children. Evid.Based.Nurs. 7 (4): 121; October, 2004. Cassimatis, D. C.; Atwood, J. E.; Engler, R. M.; Linz, P. E.; Grabenstein, J. D.; Vernalis, M. N. Smallpox Vaccination and Myopericarditis: a Clinical Review. J.Am.Coll.Cardiol. 43 (9): 1503­1510; May 5, 2004. Castro, L.; Goncalves, G.; Catarino, J. [Reported Cases of Tetanus in the North of Portugal (1993­2002). Missed Opportunities for Vaccination]. Acta Med Port; 17 (3): 225­230; May, 2004. Cengiz, A. B.; Kanra, G.; Kara, A.; Ozen, M.; Konu, M.; Erdogan, I.; Cetin, M. Back to the Basics: Hemorrhage After Vaccination: a Case Report. Turk.J.Pediatr. 46 (3): 259­261; July, 2004. Chabot, I.; Goetghebeur, M. M.; Gregoire, J. P. The Societal Value of Universal Childhood Vaccination. Vaccine. 22 (15­16): 1992­2005; May 7, 2004. Check, E. Side Effects Leave Smallpox Vaccine in Limbo. Nature. 428 (6985): 789; April 22, 2004. Chen, Y. H.; Liou, S. H.; Chou, C. C.; Su, W. L.; Loh, C. H.; Lin, S. H. Influenza and Pneumococcal Vaccination of the Elderly in Taiwan. Vaccine. 22 (21­
22): 2806­2811; July 29, 2004. Chernesky, M.; O'neill, D.; Pickard, L.; Castriciano, S.; Kraftcheck, D.; Sellors, J.; McLean, D.; Flett, N.; Mahony, J. Immunogenicity and Adverse Reactions of Influenza Vaccination in Elderly Patients Given Acetaminophen or Placebo. Clin Diagn Virol. 1 (2): 129­136; November 30, 2004. Cherry, J. D.; Xing, D. X.; Newland, P.; Patel, K.; Heininger, U.; Corbel, M. J. Determination of Serum Antibody to Bordetella Pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults With Pertussis. Clin.Infect.Dis. 38 (4): 502­507; February 15, 2004. Cheuvart, B.; Burgess, M.; Zepp, F.; Mertsola, J.; Wolter, J.; Schuerman, L. Anti­Diphtheria Antibody Seroprotection Rates Are Similar 10 Years After Vaccination With DTpa or DTPa Using a Mathematical Model. Vaccine. 23 (3): 336­342; December 2, 2004. Chez, M. G.; Chin, K.; Hung, P. C. Immunizations, Immunology, and Autism. Semin Pediatr Neurol; 11 (3): 214­217; September, 2004. Chi, R. C.; Neuzil, K. M. The Association of Sociodemographic Factors and Patient Attitudes on Influenza Vaccination Rates in Older Persons. Am.J.Med.Sci. 327 (3): 113­117; March, 2004. Chiba, H.; Ohrui, T.; Matsui, T.; Fukushima, T.; Sasaki, H. Benefits of Pneumococcal Vaccination for Bedridden Patients. J.Am.Geriatr.Soc. 52 (8): 1410; August, 2004. Childhood Flue Vaccine­­Changing Recommendations...but There's Not Enough Vaccine to Go Around. Child Health Alert; 22:1­2; November, 2004. Ching, P.; Tynan, W. P.; Raymond, D.; Bresnitz, E.; Craig, A. S. Hospital Recruitment for the Smallpox Pre­Event Vaccination Program: Experiences From Florida, Nebraska, New Jersey, and Tennessee, December 2002­June 2003. Public Health Rep. 119 (6): 552­556; November, 2004. Chodaczek, G. [Adjuvants As Factors Improving Efficiency of Vaccination]. Postepy Hig.Med.Dosw. 58:47­59; March 2, 2004. Chong, C. Y.; Lim, S. H.; Ng, W. Y.; Tee, N.; Lin, R. V. Varicella Screening and Vaccination for Healthcare Workers at KK Women's and Children's Hospital. Ann.Acad.Med.Singapore. 33 (2): 243­247; March, 2004. Chopra, A.; Drage, L. A.; Hanson, E. M.; Touchet, N. L. Stevens­Johnson Syndrome After Immunization With Smallpox, Anthrax, and Tetanus Vaccines. Mayo Clin.Proc. 79 (9): 1193­1196; September, 2004. Chu, S. Y.; Barker, L. E.; Smith, P. J. Racial/Ethnic Disparities in Preschool Immunizations: United States, 1996­2001. Am.J.Public Health. 94 (6): 973­977; June, 2004. Cilla, G.; Dorronsoro, M.; Saenz­Dominguez, J. R.; Serrano, E.; Perez­Trallero, E. Increase of Immunity to Rubella and Interruption of Rubella Transmission in Gipuzkoa (Basque Country, Spain) After an Enhanced Vaccination Programme. Epidemiol.Infect. 132 (4): 685­692; August, 2004. Ciofi Degli Atti, M. L.; Rota, M. C.; Bella, A.; Salmaso, S. Do Changes in Policy Affect Vaccine Coverage Levels? Results of a National Study to Evaluate Childhood Vaccination Coverage and Reasons for Missed Vaccination in Italy. Vaccine. 22 (31­32): 4351­4357; October 22, 2004. Clemetson, C. A. Elevated Blood Histamine Caused by Vaccinations and Vitamin C Deficiency May Mimic the Shaken Baby Syndrome. Med.Hypotheses. 62 (4): 533­536; 2004. Clemetson, C. A. Individual Reactions Following Vaccinations or Inoculations Are Highly Variable. Mil.Med. 169 (2): v; February, 2004. Clover, R. D.; Young, H. F. Recommended Childhood and Adolescent Immunization Schedule, United States, July to December, 2004. Am.Fam.Physician. 69 (10): 2471­2472; May 15, 2004. Cohen, J. Vaccine Policy. Immunizing Kids Against Flu May Prevent Deaths Among the Elderly. Science. 306 (5699): 1123; November 12, 2004. Colgrove, J. The Power of Persuasion: Diphtheria Immunization, Advertising, and the Rise of Health Education. Public Health Rep. 119 (5): 506­509; September, 2004. Combadiere, B.; Boissonnas, A.; Carcelain, G.; Lefranc, E.; Samri, A.; Bricaire, F.; Debre, P.; Autran, B. Distinct Time Effects of Vaccination on Long­Term Proliferative and IFN­{Gamma}­Producing T Cell Memory to Smallpox in Humans. J.Exp.Med. 199 (11): 1585­1593; June 7, 2004. Conrad, D. A. Can Vaccination Prevent Sinusitis? Postgrad.Med. 115 (1): 33­34; January, 2004. Cooper, B. W. Smallpox Vaccination Risks and Public Policy. Ann.Intern.Med. 140 (1): 67; January 6, 2004. Cooper, C. L.; Davis, H.; Cameron, D. W. Influenza Vaccination With 1/10th the Full Dose. N Engl J Med. 351 (22): 2339­2340; November 25, 2004. Cortesi, E.; Briani, S. [Health­Care Workers Vaccination Coverage: Such a Long Way to Run]. Ann Ig. 16 (5): 633­638; September, 2004. Couch, R. B. Nasal Vaccination, Escherichia Coli Enterotoxin, and Bell's Palsy. N.Engl.J.Med. 350 (9): 860­861; February 26, 2004. Cox, R. J.; Brokstad, K. A.; Ogra, P. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines. Scand.J.Immunol. 59 (1): 1­15; January, 2004. Coyle, C. M.; Currie, B. P. Improving the Rates of Inpatient Pneumococcal Vaccination: Impact of Standing Orders Versus Computerized Reminders to Physicians. Infect Control Hosp Epidemiol. 25 (11): 904­907; November, 2004. Crittenton, E.; Davis, A.; Hoffmann, K. K.; Rutala, W. A.; Weber, D. J. Semipermeable Dressing Used to Cover Smallpox Vaccination Sites As a Cause of Skin Damage. Infect.Control Hosp.Epidemiol. 25 (2): 96; February, 2004. Cunha, S. C.; Dourado, I. MMR Mass Vaccination Campaigns, Vaccine­Related Adverse Events, and the Limits of the Decision Making Process, in Brazil. Health Policy. 67 (3): 323­328; March, 2004. Czajka, H. [Alternative Immunization Schedule and Combined Vaccines in Paediatric Practice]. Przegl Epidemiol; 58 Suppl 1:112­6; 2004. D'Alessandro, D.; Ciriminna, S.; Rossini, A.; Bossa, M. C.; Fara, G. M. Requests of Medical Examinations After Pneumococcal & Influenza Vaccination in the Elderly. Indian J.Med.Res. 119 Suppl:108­14; May, 2004. Daley, M. F.; Barrow, J.; Pearson, K.; Crane, L. A.; Gao, D.; Stevenson, J. M.; Berman, S.; Kempe, A. Identification and Recall of Children With Chronic Medical Conditions for Influenza Vaccination. Pediatrics. 113 (1 Pt 1): e26­e33; January, 2004. Danek, J.; Czajka, H.; Jawor­Bugajska, M.; Kruk, W. [Vaccinations As a Cause of Children Hospitalisation in Neuroinfection Department of the John Paul 2nd Hospital in Cracow Between 2002­­2004]. Przegl Epidemiol; 58 Suppl 1:117­22; 2004. Daniels, N. A.; Juarbe, T.; Rangel­Lugo, M.; Moreno­John, G.; Perez­Stable, E. J. Focus Group Interviews on Racial and Ethnic Attitudes Regarding Adult Vaccinations. J Natl Med Assoc; 96 (11): 1455­1461; November, 2004. Dannetun, E.; Tegnell, A.; Hermansson, G.; Torner, A.; Giesecke, J. Timeliness of MMR Vaccination­Influence on Vaccination Coverage. Vaccine. 22 (31­
32): 4228­4232; October 22, 2004. Das, P. Fragile Lives­Immunization at Risk. Lancet Infect Dis. 4 (12): 789; December, 2004. Davies, P.; Nwokoro, C.; Leigh, M. Vaccinations Against Influenza and Pneumococcus in Children With Diabetes: Telephone Questionnaire Survey. BMJ. 328 (7433): 203; January 24, 2004. Davis, M. M. Race­Based Immunization Recommendations and the Potential to Reduce Health Disparities. JAMA. 291 (18): 2253­2255; May 12, 2004. Dawson, A. Vaccination and the Prevention Problem. Bioethics; 18 (6): 515­530; November, 2004. Dayan, G. H.; Cairns, L.; Sangrujee, N.; Mtonga, A.; Nguyen, V.; Strebel, P. Cost­Effectiveness of Three Different Vaccination Strategies Against Measles in Zambian Children. Vaccine. 22 (3­4): 475­484; January 2, 2004. Dayan, G. H.; Orellana, L. C.; Forlenza, R.; Ellis, A.; Chaui, J.; Kaplan, S.; Strebel, P. Vaccination Coverage Among Children Aged 13 to 59 Months in Buenos Aires, Argentina, 2002. Rev.Panam.Salud Publica. 16 (3): 158­167; September, 2004. Dayan, G. H.; Rodriguez, R.; Vinje, J.; Vasconez, N.; Caceres, V.; Gregoricus, N.; Sobsey, M.; Landaverde, M. Assessment of Areas at Increased Risk for Poliovirus Circulation in Ecuador. Epidemiol.Infect. 132 (5): 787­795; October, 2004. De Bruijn, I. A.; Nauta, J.; Gerez, L.; Palache, A. M. Virosomal Influenza Vaccine: a Safe and Effective Influenza Vaccine With High Efficacy in Elderly and Subjects With Low Pre­Vaccination Antibody Titers. Virus Res. 103 (1­2): 139­145; July, 2004. de la, H. F.; Higuera, A. B.; Di Fabio, J. L.; Luna, M.; Naranjo, A. G.; de, lL; Pastor, D.; Hall, A. J. Effectiveness of Haemophilus Influenzae Type b Vaccination Against Bacterial Pneumonia in Colombia. Vaccine. 23 (1): 36­42; November 15, 2004. De Serres, G.; Skowronski, D. M.; Guay, M.; Rochette, L.; Jacobsen, K.; Fuller, T.; Duval, B. Recurrence Risk of Oculorespiratory Syndrome After Influenza Vaccination: Randomized Controlled Trial of Previously Affected Persons. Arch Intern Med. 164 (20): 2266­2272; November 8, 2004. de Vrese, M.; Rautenberg, P.; Laue, C.; Koopmans, M.; Herremans, T.; Schrezenmeir, J. Probiotic Bacteria Stimulate Virus­Specific Neutralizing Antibodies Following a Booster Polio Vaccination. Eur J Nutr; December 1, 2004. De Wals, P.; Deceuninck, G.; Boulianne, N.; De Serres, G. Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine. JAMA. 292 (20): 2491­2494; November 24, 2004. Dean, H. J.; Chen, D. Epidermal Powder Immunization Against Influenza. Vaccine. 23 (5): 681­686; December 16, 2004. Deng, Y.; Jing, Y.; Campbell, A. E.; Gravenstein, S. Age­Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture in Vitro, and Blunted Response to Influenza Vaccination in Vivo in the Elderly. J.Immunol. 172 (6): 3437­3446; March 15, 2004. Deshpande, S. A. Ethnic Differences in the Rates of BCG Vaccination. Arch.Dis.Child. 89 (1): 48­49; January, 2004. DeStefano, F.; Bhasin, T. K.; Thompson, W. W.; Yeargin­Allsopp, M.; Boyle, C. Age at First Measles­Mumps­Rubella Vaccination in Children With Autism and School­Matched Control Subjects: a Population­Based Study in Metropolitan Atlanta. Pediatrics. 113 (2): 259­266; February, 2004. Deubzer, H. E.; Obaro, S. K.; Newman, V. O.; Adegbola, R. A.; Greenwood, B. M.; Henderson, D. C. Colostrum Obtained From Women Vaccinated With Pneumococcal Vaccine During Pregnancy Inhibits Epithelial Adhesion of Streptococcus Pneumoniae. J.Infect.Dis. 190 (10): 1758­1761; November 15, 2004. Dexter, P. R.; Perkins, S. M.; Maharry, K. S.; Jones, K.; McDonald, C. J. Inpatient Computer­Based Standing Orders Vs Physician Reminders to Increase Influenza and Pneumococcal Vaccination Rates: a Randomized Trial. JAMA. 292 (19): 2366­2371; November 17, 2004. D'Heilly, S. J.; Lockman, J. L.; Nichol, K. L. Adherence of Mass Vaccinators to Timing Guidelines for Influenza Vaccination. Am.J.Prev.Med. 26 (1): 46­50; January, 2004. D'Heilly, S. J.; Nichol, K. L. Work­Site­Based Influenza Vaccination in Healthcare and Non­Healthcare Settings. Infect Control Hosp Epidemiol. 25 (11): 941­945; November, 2004. Diaz­Mitoma, F.; Alvarez­Maya, I.; Dabrowski, A.; Jaffey, J.; Frost, R.; Aucoin, S.; Kryworuchko, M.; Lapner, M.; Tadesse, H.; Giulivi, A. Transcriptional Analysis of Human Peripheral Blood Mononuclear Cells After Influenza Immunization. J.Clin.Virol. 31 (2): 100­112; October, 2004. Dine, M. S.; Hutchins, S. S.; Thomas, A.; Williams, I.; Bellini, W. J.; Redd, S. C. Persistence of Vaccine­Induced Antibody to Measles 26­33 Years After Vaccination. J.Infect.Dis. 189 Suppl 1:123­30; May 1, 2004. Dixon­Woods, M.; Brown, H.; Arthur, A.; Matthews, R.; Jagger, C. Organising Services for Influenza Vaccination for Older People. J.Health Serv.Res.Policy. 9 (2): 85­90; April, 2004. Dobson, R. J. Why Parents Claim Immunization Exemptions, and the Role of School Nurses. School Nurse News; 21 (5): 40­42; November, 2004. Dombkowski, K. J.; Lantz, P. M.; Freed, G. L. Risk Factors for Delay in Age­Appropriate Vaccination. Public Health Rep. 119 (2): 144­155; March, 2004. Dombkowski, K. J.; Lantz, P. M.; Freed, G. L. Role of Health Insurance and a Usual Source of Medical Care in Age­Appropriate Vaccination. Am.J.Public Health. 94 (6): 960­966; June, 2004. Dominguez, S. R.; Parrott, J. S.; Lauderdale, D. S.; Daum, R. S. On­Time Immunization Rates Among Children Who Enter Chicago Public Schools. Pediatrics; 114 (6): e741­e747; December, 2004. Dong­won, S. Western Medicine, Korean Government, and Imperialism in Late Nineteenth­Century Korea: The Cases of the Choson Government Hospital and Smallpox Vaccination. Hist Sci.(Tokyo). 13 (3): 164­175; March, 2004. Donlin, J. New Recommendation for Childhood Influenza Vaccine. NCSL.Legisbrief. 12 (34): 1­2; August, 2004. Dye, C. A Booster for Tuberculosis Vaccines. JAMA. 291 (17): 2127­2128; May 5, 2004. Dyer, O. US Health Workers Who Give Flu Jabs to Healthy People Could Face Fines or Imprisonment. BMJ. 329 (7472): 939; October 23, 2004. Dyer, O. US Judge Halts Compulsory Anthrax Vaccination for Soldiers. BMJ. 329 (7474): 1062; November 6, 2004. Eckart, R. E.; Love, S. S.; Atwood, J. E.; Arness, M. K.; Cassimatis, D. C.; Campbell, C. L.; Boyd, S. Y.; Murphy, J. G.; Swerdlow, D. L.; Collins, L. C.; Riddle, J. R.; Tornberg, D. N.; Grabenstein, J. D.; Engler, R. J. Incidence and Follow­Up of Inflammatory Cardiac Complications After Smallpox Vaccination. J.Am.Coll.Cardiol. 44 (1): 201­205; July 7, 2004. Edelman, K. J.; He, Q.; Makinen, J. P.; Haanpera, M. S.; Nguyen Tran, Minh N.; Schuerman, L.; Wolter, J.; Mertsola, J. A. Pertussis­Specific Cell­Mediated and Humoral Immunity in Adolescents 3 Years After Booster Immunization With Acellular Pertussis Vaccine. Clin.Infect.Dis. 39 (2): 179­185; July 15, 2004. Elkayam, O.; Caspi, D.; Reitblatt, T.; Charboneau, D.; Rubins, J. B. The Effect of Tumor Necrosis Factor Blockade on the Response to Pneumococcal Vaccination in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis. Semin.Arthritis Rheum. 33 (4): 283­288; February, 2004. Escribano, Montaner A.; De, Juanes Pardo, Jr. Infection by Influenza Virus in Childhood: a Call for Broader Influenza Vaccination. Arch.Bronconeumol. 40 (5): 231­235; May, 2004. Estimated Influenza Vaccination Coverage Among Adults and Children­­United States, September 1­November 30, 2004. MMWR Morb Mortal Wkly Rep; 53 (49): 1147­1153; December 17, 2004. Everett, W. W.; Zaoutis, T. L.; Halpern, S. D.; Strom, B. L.; Coffin, S. E. Preevent Vaccination Against Smallpox: a Survey of Pediatric Emergency Health Care Providers. Pediatr.Infect.Dis.J. 23 (4): 332­337; April, 2004. Fadrowski, J. J.; Furth, S. L. Varicella Zoster Virus: Vaccination and Implications in Children With Renal Failure. Expert.Rev.Vaccines. 3 (3): 291­298; June, 2004. Farrington, C. P. Re: "Risk Analysis of Aseptic Meningitis After Measles­Mumps­Rubella Vaccination in Korean Children by Using a Case­Crossover Design". Am.J.Epidemiol. 159 (7): 717­718; April 1, 2004. Fawcett, P. T.; Rose, C. D.; Maduskuie, V. Long­Term Effects of Immunization With Recombinant Lipoprotein Outer Surface Protein a on Serologic Test for Lyme Disease. Clin.Diagn.Lab Immunol. 11 (4): 808­810; July, 2004. Fedson, D. S. Vaccination for Pandemic Influenza: a Six Point Agenda for Interpandemic Years. Pediatr.Infect.Dis.J. 23 (1): S74­S77; January, 2004. Filippis, A. M.; Nogueira, R. M.; Jabor, A. V.; Schatzmayr, H. G.; Oliveira, J. C.; Dinis, S. C.; Galler, R. Isolation and Characterization of Wild Type Yellow Fever Virus in Cases Temporally Associated With 17DD Vaccination During an Outbreak of Yellow Fever in Brazil. Vaccine. 22 (9­10): 1073­1078; March 12, 2004. Fillmore, G. L.; Ward, T. P.; Bower, K. S.; Dudenhoefer, E. J.; Grabenstein, J. D.; Berry, G. K.; Madigan, W. P. Ocular Complications in the Department of Defense Smallpox Vaccination Program. Ophthalmology. 111 (11): 2086­2093; November, 2004. Fine, M. The Rhode Island Adult Vaccination Experience 1995­2003: Public Health, Marketplace Values, and Lessons Learned About the Integrity of Medicine As a Profession. Med.Health R.I. 87 (3): 75­76; March, 2004. Fine, M. The Rhode Island Influenza Vaccine Experience 1995­2003: Influenza Vaccine Price, Reimbursement, Availability, and Rhode Island's Influenza Vaccination Rate. Med.Health R.I. 87 (3): 79­80; March, 2004. Fine, P. E. Non­Specific "Non­Effects" of Vaccination. BMJ; 329 (7478): 1297­1298; December 4, 2004. Fitch, P.; Racine, A. Parental Beliefs About Vaccination Among an Ethnically Diverse Inner­City Population. J.Natl.Med.Assoc. 96 (8): 1047­1050; August, 2004. Fitzner, J.; Coulibaly, D.; Ekra, K. D.; Claude, Y. J.; Loukou, Y. G.; Odehouri, K. P.; Coulombier, D. Safety of the Yellow Fever Vaccine During the September 2001 Mass Vaccination Campaign in Abidjan, Ivory Coast. Vaccine. 23 (2): 156­162; November 25, 2004. Flannery, B.; Schrag, S.; Bennett, N. M.; Lynfield, R.; Harrison, L. H.; Reingold, A.; Cieslak, P. R.; Hadler, J.; Farley, M. M.; Facklam, R. R.; Zell, E. R.; Whitney, C. G. Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus Pneumoniae Infections. JAMA. 291 (18): 2197­2203; May 12, 2004. Fleck, F. Nigerian President Holds Key to Global Polio Eradication. BMJ. 328 (7439): 544; March 6, 2004. Fleck, F. Nigerian State of Kano Resumes Polio Vaccination. BMJ. 329 (7457): 70; July 10, 2004. Flynn, M.; Ogden, J. Predicting Uptake of MMR Vaccination: a Prospective Questionnaire Study. Br.J.Gen.Pract. 54 (504): 526­530; July, 2004. Folio, L. R.; Lahti, R. L.; Cockrum, D. S.; Bills, S.; Younker, M. R. Initial Experience With Mass Immunization As a Bioterrorism Countermeasure. J.Am.Osteopath.Assoc. 104 (6): 240­243; June, 2004. Fontanesi, J.; Shefer, A. M.; Fishbein, D. B.; Bennett, N. M.; De Guire, M.; Kopald, D.; Holcomb, K.; Stryker, D. W.; Coleman, M. S. Operational Conditions Affecting the Vaccination of Older Adults. Am.J.Prev.Med. 26 (4): 265­270; May, 2004. Ford, E. S.; Williams, S. G.; Mannino, D. M.; Redd, S. C. Influenza Vaccination Coverage Among Adults With Asthma: Findings From the 2000 Behavioral Risk Factor Surveillance System. Am.J.Med. 116 (8): 555­558; April 15, 2004. Forsyth, K. D.; Campins­Marti, M.; Caro, J.; Cherry, J. D.; Greenberg, D.; Guiso, N.; Heininger, U.; Schellekens, J.; Tan, T.; von Konig, C. H.; Plotkin, S. New Pertussis Vaccination Strategies Beyond Infancy: Recommendations by the Global Pertussis Initiative. Clin Infect Dis; 39 (12): 1802­1809; December 15, 2004. Foster, B. S.; Agahigian, D. D. Central Serous Chorioretinopathy Associated With Anthrax Vaccination. Retina. 24 (4): 624­625; August, 2004. Franco, E.; Giambi, C.; Ialacci, R.; Maurici, M. Pertussis Vaccination for Adolescents and Adults. Expert.Opin.Biol.Ther. 4 (10): 1669­1676; October, 2004. Frederiksen, M. S.; Brenoe, E.; Trier, J. Erythema Multiforme Minor Following Vaccination With Paediatric Vaccines. Scand.J.Infect.Dis. 36 (2): 154­155; 2004. Frederiksen, M. S.; Tofte, H. Immunisation With Aluminium­Containing Vaccine of a Child With Itching Nodule Following Previous Vaccination. Vaccine. 23 (1): 1­2; November 15, 2004. Fredrickson, D. D.; Davis, T. C.; Arnould, C. L.; Kennen, E. M.; Hurniston, S. G.; Cross, J. T.; Bocchini, J. A., Jr. Childhood Immunization Refusal: Provider and Parent Perceptions. Fam.Med. 36 (6): 431­439; June, 2004. Freed, G. L. Criteria for Choosing a Specific Vaccine. Arch.Pediatr.Adolesc.Med. 158 (4): 311; April, 2004. Frenkel, L. D. Immunization Issues in the 21st Century, Part II. Pediatr.Ann. 33 (9): 565, 567­565, 568; September, 2004. Frenkel, L. D. Immunization Issues of the 21st Century, Part I. Pediatr.Ann. 33 (8): 490­493; August, 2004. Frick, K. D.; Colchero, M. A.; Dean, D. Modeling the Economic Net Benefit of a Potential Vaccination Program Against Ocular Infection With Chlamydia Trachomatis. Vaccine. 22 (5­6): 690­697; January 26, 2004. Frick, K. D.; Scanlon, D. P.; Bandeen­Roche, K.; Kasper, J. D.; Simonsick, E. M.; Sullivan, E. M. Influenza Vaccination by Race Among Disabled Community Dwelling Older Women. J.Health Care Poor Underserved. 15 (2): 220­236; May, 2004. Friman, V.; Hahn­Zoric, M.; Bjorkander, J.; Oxelius, V. A.; Hanson, L. A. Aberrant IgG2 Antibody Response to Neisseria Meningitidis Polysaccharide A After Vaccination in Frequently Infected Compared to Healthy IgA­Deficient Individuals. Scand.J.Immunol. 60 (3): 292­298; September, 2004. Frosch, M. New Vaccination Strategies. Int J Med Microbiol. 294 (5): 267; October, 2004. Gabutti, G.; Guido, M.; Quattrocchi, M.; Zizza, A.; De, Donno A.; Gasparini, R.; Donatelli, I.; Prato, R.; Germinario, C.; Crovari, P. Surveillance of Influenza in Apulia, Italy, 1999­2000, 2000­2001, 2001­2002, and 2002­2003 Seasons. Med Mal Infect; 34 (10): 469­476; October, 2004. Gaertner, E. M.; Groo, S.; Kim, J. Papular Spongiotic Dermatitis of Smallpox Vaccination: Report of 2 Cases With Review of the Literature. Arch.Pathol.Lab Med. 128 (10): 1173­1175; October, 2004. Gans, H. A.; Yasukawa, L. L.; Alderson, A.; Rinki, M.; Dehovitz, R.; Maldonado, Y.; Arvin, A. M. T Cell Immunity to Measles Viral Proteins in Infants and Adults After Measles Immunization. Viral Immunol. 17 (2): 298­307; 2004. Gans, H. A.; Yasukawa, L. L.; Alderson, A.; Rinki, M.; DeHovitz, R.; Beeler, J.; Audet, S.; Maldonado, Y.; Arvin, A. M. Humoral and Cell­Mediated Immune Responses to an Early 2­Dose Measles Vaccination Regimen in the United States. J.Infect.Dis. 190 (1): 83­90; July 1, 2004. Garcia, dC; Arrazola Martinez, M. P.; de, J. P.; Sanz Gallardo, M. I.; Jaen, H. F.; Lago, L. E. [Influenza Vaccination in Healthcare Workers. Strategies to Achieve Compliance in a General Hospital.]. Med Clin (Barc.). 123 (14): 532­534; October 23, 2004. Geier, D.; Geier, M. R. Neurodevelopmental Disorders Following Thimerosal­Containing Childhood Immunizations: a Follow­Up Analysis. Int J Toxicol; 23 (6): 369­376; November, 2004. Geier, M. R.; Geier, D. A. Gastrointestinal Adverse Reactions Following Anthrax Vaccination: an Analysis of the Vaccine Adverse Events Reporting System () Database. Hepatogastroenterology. 51 (57): 762­767; May, 2004. Getsios, D.; Caro, I.; El Hadi, W.; Caro, J. J. Assessing the Economics of Vaccination for Neisseria Meningitidis in Industrialized Nations: a Review and Recommendations for Further Research. Int.J.Technol.Assess.Health Care. 20 (3): 280­288; 2004. Gibson, W. A. Mass Smallpox Immunization Program in a Deployed Military Setting. Am.J.Emerg.Med. 22 (4): 267­269; July, 2004. Gigli, L.; Graziano, M.; Manetta, G.; Palombino, R. [Measles in the Local Health Unit Naples 4: Vaccination Coverage, Epidemic 2001­2002 and Prevention Strategies]. Ann Ig. 16 (5): 627­632; September, 2004. Ginsberg, G. M.; Somekh, E. Cost Containment Analysis of Childhood Vaccination Against Varicella in Israel. J.Infect. 48 (2): 119­133; February, 2004. Glass, K.; Kappey, K.; Grenfell, B. T. The Effect of Heterogeneity in Measles Vaccination on Population Immunity. Epidemiol.Infect. 132 (4): 675­683; August, 2004. Glass, R. I.; Bresee, J. S.; Parashar, U. D.; Jiang, B.; Gentsch, J. The Future of Rotavirus Vaccines: a Major Setback Leads to New Opportunities. Lancet. 363 (9420): 1547­1550; May 8, 2004. Glazner, J. E.; Beaty, B. L.; Pearson, K. A.; Berman, S. The Cost of Giving Childhood Vaccinations: Differences Among Provider Types. Pediatrics. 113 (6): 1582­1587; June, 2004. Glik, D.; Macpherson, F.; Todd, W.; Stone, K.; Ang, A.; Connell, Jones M. Impact of an Immunization Education Program on Middle School Adolescents. Am J Health Behav; 28 (6): 487­497; November, 2004. Goel, N. K.; Swami, H. M. Cold Chain System in Chandigarh During Intensified Pulse Polio Immunization 2001­2002. Indian Pediatr. 41 (7): 750­751; July, 2004. Goldstein, A. O.; Kincade, J. E.; Gamble, G.; Bearman, R. S. Policies and Practices for Improving Influenza Immunization Rates Among Healthcare Workers. Infect Control Hosp Epidemiol. 25 (11): 908­911; November, 2004. Gomes, M. G.; White, L. J.; Medley, G. F. Infection, Reinfection, and Vaccination Under Suboptimal Immune Protection: Epidemiological Perspectives. J.Theor.Biol. 228 (4): 539­549; June 21, 2004. Gong, Z. Y.; Weng, J. Q.; Zhao, Z. Y.; Chen, Y. T.; Zhu, A. G.; Fu, G. M.; Fang, C. F.; Zhu, Z. Y.; Chen, E. F.; Wang, C. Z.; Wang, W.; Lei, L. H.; Wang, Z. [Serological Surveillance on Hemorrhagic Fever Renal Syndrome After Vaccination]. Zhonghua Liu Xing.Bing.Xue.Za Zhi. 25 (5): 400­402; May, 2004. Gowda, R.; Cartwright, K.; Bremner, J. A.; Green, S. T. Yellow Fever Vaccine: a Successful Vaccination of an Immunocompromised Patient. Eur.J.Haematol. 72 (4): 299­301; April, 2004. Grabenstein, J. D.; Winkenwerder, W., Jr. Bioterrorism and Compulsory Vaccination: United States Continues Vaccinating to Keep Troops Healthy. BMJ. 329 (7472): 977; October 23, 2004. Greenberg, H. B.; Piedra, P. A. Immunization Against Viral Respiratory Disease: a Review. Pediatr Infect Dis J; 23 (11 Suppl): S254­S261; November, 2004. Greenberg, R. N.; Schosser, R. H.; Plummer, E. A.; Roberts, S. E.; Caldwell, M. A.; Hargis, D. L.; Rudy, D. W.; Evans, M. E.; Hopkins, R. J. Urticaria, Exanthems, and Other Benign Dermatologic Reactions to Smallpox Vaccination in Adults. Clin.Infect.Dis. 38 (7): 958­965; April 1, 2004. Grenier, J. L.; Toth, E.; De Serres, G.; Menard, S.; Roussel, R.; Tremblay, M.; Landry, M.; Robert, Y.; Skowronski, D. M. Safety of Revaccination of Patients Affected by the Oculo­Respiratory Syndrome (ORS) Following Influenza Vaccination. Can.Commun.Dis.Rep. 30 (2): 9­16; January 15, 2004. Griffith, R. Childhood Immunization: Public Health or Parental Choice? Br.J.Community Nurs. 9 (9): 379­382; September, 2004. Griffiths, R. Giving the Influenza Jab: a Review of the Law. Br J Community Nurs; 9 (10): 442­445; October, 2004. Grondin, M. A.; Gerbaud, L.; Taillandier, S.; Jalenques, I.; Glanddier, P. Y. [Measurement of the Prevention Policy in the Hospital]. Presse Med. 33 (6): 373­
377; March 27, 2004. Gunn, S. W. Vaccination. World J.Surg. March 17, 2004. Gupta, V.; Bandyopadhyay, S.; Bapuraj, J. R.; Gupta, A. Bilateral Optic Neuritis Complicating Rabies Vaccination. Retina. 24 (1): 179­181; February, 2004. Gurfinkel, E. P.; de la Fuente, R. L. Two­Year Follow­Up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex.Heart Inst.J. 31 (1): 28­32; 2004. Gurfinkel, E. P.; Leon, de la Fuente; Mendiz, O.; Mautner, B. Flu Vaccination in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions (FLUVACS) Study. One­Year Follow­Up. Eur Heart J. 25 (1): 25­31; January, 2004. Gust, D. A.; Gangarosa, P.; Hibbs, B.; Pollard, R.; Wallach, G.; Chen, R. T. National Immunization Information Hotline: Calls Concerning Adverse Events, 1998­2000. J.Health Commun. 9 (5): 387­394; September, 2004. Gust, D. A.; Gangarosa, P.; Hibbs, B.; Wilkins, C.; Ford, K.; Stuart, M.; Brown­Bryant, R.; Wallach, G.; Chen, R. T. The National Immunization Information Hotline. J.Health Commun. 9 (4): 371­379; July, 2004. Guthrie, T.; Hobbs, C. G.; Davenport, V.; Horton, R. E.; Heyderman, R. S.; Williams, N. A. Parenteral Influenza Vaccination Influences Mucosal and Systemic T Cell­Mediated Immunity in Healthy Adults. J Infect Dis. 190 (11): 1927­1935; December 1, 2004. Gutteling, B. M.; de, Weerth C.; Buitelaar, J. K. Maternal Prenatal Stress and 4­6 Year Old Children's Salivary Cortisol Concentrations Pre­ and Post­
Vaccination. Stress; 7 (4): 257­260; December, 2004. Guy, B.; Chanthavanich, P.; Gimenez, S.; Sirivichayakul, C.; Sabchareon, A.; Begue, S.; Yoksan, S.; Luxemburger, C.; Lang, J. Evaluation by Flow Cytometry of Antibody­Dependent Enhancement (ADE) of Dengue Infection by Sera From Thai Children Immunized With a Live­Attenuated Tetravalent Dengue Vaccine. Vaccine. 22 (27­28): 3563­3574; September 9, 2004. Guy, R. J.; Di Natale, R.; Kelly, H. A.; Lambert, S. B.; Tobin, S.; Robinson, P. M.; Tallis, G.; Hampson, A. W. Influenza Outbreaks in Aged­Care Facilities: Staff Vaccination and the Emerging Use of Antiviral Therapy. Med.J.Aust. 180 (12): 640­642; June 21, 2004. Haber, P.; DeStefano, F.; Angulo, F. J.; Iskander, J.; Shadomy, S. V.; Weintraub, E.; Chen, R. T. Guillain­Barre Syndrome Following Influenza Vaccination. JAMA. 292 (20): 2478­2481; November 24, 2004. Hahn, B. J.; Erogul, M.; Sinert, R. Case Report of Tetanus in an Immunized, Healthy Adult and No Point of Entry. J.Emerg.Med. 27 (3): 257­260; October, 2004. Hainsworth, T. The Value of Cholera Vaccination in Promoting Travel Health. Nurs.Times. 100 (22): 30­31; June 1, 2004. Hak, E.; Bonten, M. J. MMR Vaccination and Febrile Seizures. JAMA. 292 (17): 2083­2084; November 3, 2004. Hak, E.; Wei, F.; Grobbee, D. E.; Nichol, K. L. A Nested Case­Control Study of Influenza Vaccination Was a Cost­Effective Alternative to a Full Cohort Analysis. J.Clin.Epidemiol. 57 (9): 875­880; September, 2004. Hall, A. J. Vaccination and Child Mortality. Lancet; 364 (9452): 2156­2157; December 18, 2004. Halvorsen, R.; Pettersen, M. [Vaccination of Patients With Allergy]. Tidsskr.Nor Laegeforen. 124 (3): 396; February 5, 2004. Hamilton, M.; Corwin, P.; Gower, S.; Rogers, S. Why Do Parents Choose Not to Immunise Their Children? N.Z.Med.J. 117 (1189): U768; February, 2004. Hammer, S. J.; Backer, H.; Schechter, R. Immunization Injections. Arch.Pediatr.Adolesc.Med. 158 (7): 708; July, 2004. Hammerschmidt, T.; Banz, K.; Wagenpfeil, S.; Neiss, A.; Wutzler, P. Economic Evaluation of Varicella Vaccination Programmes: a Review of the Literature. Pharmacoeconomics. 22 (2): 133­138; 2004. Hanania, N. A.; Sockrider, M.; Castro, M.; Holbrook, J. T.; Tonascia, J.; Wise, R.; Atmar, R. L. Immune Response to Influenza Vaccination in Children and Adults With Asthma: Effect of Corticosteroid Therapy. J.Allergy Clin.Immunol. 113 (4): 717­724; April, 2004. Hanna, J. N.; Bullen, R. C.; Andrews, D. E. The Acceptance of Three Simultaneous Vaccine Injections Recommended at 12 Months of Age. Commun Dis Intell; 28 (4): 493­496; 2004. Hanna, J. N.; Morgan, A. K.; McCulloch, B. G. Uptake of Influenza Vaccine Among Aboriginal and Torres Strait Island Adults in North Queensland, 2003. Commun.Dis.Intell. 28 (1): 80­82; 2004. Hannoun, C.; Megas, F.; Piercy, J. Immunogenicity and Protective Efficacy of Influenza Vaccination. Virus Res. 103 (1­2): 133­138; July, 2004. Harper, S. A.; Fukuda, K.; Uyeki, T. M.; Cox, N. J.; Bridges, C. B. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm.Rep. 53 (RR­6): 1­40; May 28, 2004. Hasan, A. S.; Malik, A.; Shukla, I.; Malik, M. A. Antibody Levels Against Polioviruses in Children Following Pulse Polio Immunization Program. Indian Pediatr. 41 (10): 1040­1044; November 4, 2004. Hasselhorn, H. M.; Hofmann, F.; Nubling, M. Effect of a Diphtheria Booster Vaccination in Adults With a Documented History of an Incomplete Primary Series Vaccination. Infection; 32 (5): 282­286; October, 2004. Hayney, M. S. Influenza Vaccine: Basis for Expanded Pharmacy­Based Immunization Services. J.Am.Pharm.Assoc.(Wash.DC.). 44 (3): 411­413; May, 2004. Hayney, M. S. Off to College: Tuition, Textbooks, Dormitory Gear, and Immunization. J.Am.Pharm.Assoc.(Wash.DC.). 44 (4): 524­525; July, 2004. Hays, J. P.; Eadie, K.; Veenhoven, R.; Verduin, C. M.; Verbrugh, H.; Van Belkum, A. Pneumococcal Vaccination Does Not Affect the Genetic Diversity of Moraxella Catarrhalis Isolates in Children. Eur.J.Clin.Microbiol.Infect.Dis. September 21, 2004. Heininger, U. [Complications of Infectious Diseases and Benefits of Immunization.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 47 (12): 1129­1135; December, 2004. Hemingway, C. O.; Poehling, K. A. Change in Recommendation Affects Influenza Vaccinations Among Children 6 to 59 Months of Age. Pediatrics. 114 (4): 948­952; October, 2004. Hempstead, K.; Bresnitz, E.; Howell­White, S.; Crabtree, D.; Scotto, Rosato N. Use of a State Regulation for Adult Vaccination. Am.J.Prev.Med. 26 (4): 311­
314; May, 2004. Hepburn, M. J.; Dooley, D. P.; Murray, C. K.; Hospenthal, D. R.; Hill, B. L.; Nauschuetz, W. N.; Davis, K. A.; Crouch, H. K.; McAllister, C. K. Frequency of Vaccinia Virus Isolation on Semipermeable Versus Nonocclusive Dressings Covering Smallpox Vaccination Sites in Hospital Personnel. Am.J.Infect.Control. 32 (3): 126­130; May, 2004. Hethcote, H. W.; Horby, P.; McIntyre, P. Using Computer Simulations to Compare Pertussis Vaccination Strategies in Australia. Vaccine. 22 (17­18): 2181­
2191; June 2, 2004. Heymann, A. D.; Shapiro, Y.; Chodick, G.; Shalev, V.; Kokia, E.; Kramer, E.; Shemer, J. Reduced Hospitalizations and Death Associated With Influenza Vaccination Among Patients With and Without Diabetes. Diabetes Care. 27 (11): 2581­2584; November, 2004. Heymann, D. L. Polio Eradication: Finishing the Job and Protecting the Investment. Bull.World Health Organ. 82 (1): 1; January, 2004. Hinkle, J. L. The New Adult Immunization Schedule. J.Neurosci.Nurs. 36 (3): 167­172; June, 2004. Hinman, A. R. Tracking Immunization. Pediatr.Ann. 33 (9): 609­615; September, 2004. Hoover, D. R.; Sambamoorthi, U.; Crystal, S. Characteristics of Community Dwelling Elderly Not Vaccinated for Pneumococcus in 1998 and 2001. Prev.Med. 39 (3): 517­527; September, 2004. Hopkins, R.; Bonow, J. School Entry Immunization: 15% of Students Lack Complete Vaccination Protection. J.Ark.Med.Soc. 101 (1): 18­19; July, 2004. Howard, D. H.; Roy, K. Private Care and Public Health: Do Vaccination and Prenatal Care Rates Differ Between Users of Private Versus Public Sector Care in India? Health Serv Res. 39 (6 Pt 2): 2013­2026; December, 2004. Hubicki, L.; Czech, E.; Kowalska, M.; Zejda, J. E. [Childhood Immunization Rate in Families of Various Social­Economical Status in Town of Bytom]. Przegl Epidemiol; 58 (4): 713­723; 2004. Huebner, R. E.; Mbelle, N.; Forrest, B.; Madore, D. V.; Klugman, K. P. Long­Term Antibody Levels and Booster Responses in South African Children Immunized With Nonavalent Pneumococcal Conjugate Vaccine. Vaccine. 22 (21­22): 2696­2700; July 29, 2004. Hull, B. P.; McIntyre, P. B. What Do We Know About 7vPCV Coverage in Aboriginal and Torres Strait Islander Children? Commun.Dis.Intell. 28 (2): 238­
243; 2004. Hull, J. H.; Mead, S. H.; Foster, O. J.; Modarres­Sadeghi, H. Severe Vasculitic Neuropathy Following Influenza Vaccination. J.Neurol.Neurosurg.Psychiatry. 75 (10): 1507­1508; October, 2004. Humiston, S. G.; Szilagyi, P. G.; Iwane, M. K.; Schaffer, S. J.; Santoli, J.; Shone, L.; Barth, R.; McInerny, T.; Schwartz, B. The Feasibility of Universal Influenza Vaccination for Infants and Toddlers. Arch.Pediatr.Adolesc.Med. 158 (9): 867­874; September, 2004. Hunter, D.; Zoutman, D.; Whitehead, J.; Hutchings, J.; MacDonald, K. Health Effects of Anthrax Vaccination in the Canadian Forces. Mil Med. 169 (10): 833­838; October, 2004. Husain, S.; Slobodkin, D.; Weinstein, R. A. Corrections to Table. Arch.Intern.Med. 164 (5): 573; March 8, 2004. Hussain, R.; Shahid, F.; Zafar, S.; Dojki, M.; Dockrell, H. M. Immune Profiling of Leprosy and Tuberculosis Patients to 15­Mer Peptides of Mycobacterium Leprae and M. Tuberculosis GroES in a BCG Vaccinated Area: Implications for Development of Vaccine and Diagnostic Reagents. Immunology. 111 (4): 462­471; April, 2004. Hussein, A. A.; Musa, A. O. Experiencing Service Learning: Students of a New Medical School As Vaccinators and Independent Monitors. Educ Health (Abingdon); 17 (3): 385­387; November, 2004. Hutchins, S. S.; Baughman, A. L.; Orr, M.; Haley, C.; Hadler, S. Vaccination Levels Associated With Lack of Measles Transmission Among Preschool­Aged Populations in the United States, 1989­1991. J.Infect.Dis. 189 Suppl 1:108­15; May 1, 2004. Hviid, A.; Melbye, M. Impact of Routine Vaccination With a Conjugate Haemophilus Influenzae Type b Vaccine. Vaccine. 22 (3­4): 378­382; January 2, 2004. Hviid, A.; Stellfeld, M.; Andersen, P. H.; Wohlfahrt, J.; Melbye, M. Impact of Routine Vaccination With a Pertussis Toxoid Vaccine in Denmark. Vaccine. 22 (27­28): 3530­3534; September 9, 2004. Hviid, A.; Stellfeld, M.; Wohlfahrt, J.; Melbye, M. Childhood Vaccination and Type 1 Diabetes. N.Engl.J.Med. 350 (14): 1398­1404; April 1, 2004. Influenza and Pneumococcal Vaccination Coverage Among Persons Aged >=65 Years and Persons Aged 18­64 Years With Diabetes or Asthma­­United States, 2003. JAMA; 292 (22): 2715­2716; December 8, 2004. Inoue, T.; Hayashi, N.; Tsuda, K. [Improvement of Tuberculin Test Results With BCG Vaccination in Set­City Primary School Children From 2000 to 2002]. Nippon Koshu Eisei Zasshi. 51 (2): 103­108; February, 2004. Ipp, M.; Cohen, E.; Goldbach, M.; Macarthur, C. Effect of Choice of Measles­Mumps­Rubella Vaccine on Immediate Vaccination Pain in Infants. Arch.Pediatr.Adolesc.Med. 158 (4): 323­326; April, 2004. Ipp, M.; Taddio, A.; Goldbach, M.; Ben David, S.; Stevens, B.; Koren, G. Effects of Age, Gender and Holding on Pain Response During Infant Immunization. Can.J.Clin.Pharmacol. 11 (1): e2­e7; 2004. Is It True That Vaccines May Not Be Safe for People With Rheumatoid Arthritis (Which I Have)? Does That Mean I Shouldn't Get a Flu Shot? Johns Hopkins Med Lett Health After 50; 17 (8): 8; October, 2004. Isaacs, D.; Kilham, H. A.; Marshall, H. Should Routine Childhood Immunizations Be Compulsory? J.Paediatr.Child Health. 40 (7): 392­396; July, 2004. Ismail, A. A.; Harris, S. L.; Granoff, D. M. Serum Group a Anticapsular Antibodies in a Sudanese Population Immunized With Meningococcal Polysaccharide Vaccine During a Group A Epidemic. Pediatr.Infect.Dis.J. 23 (8): 748­755; August, 2004. Ivers, L. C.; Ryan, E. T. Vaccination Strategies. Clin.Occup.Environ.Med. 4 (1): 27­43; February, 2004. Iwarson, S. [Great Changes in the Panorama of Infections During the 20th Century. Better Living Conditions More Important Than Vaccines and Antibiotics]. Lakartidningen. 101 (1­2): 82­86; January 8, 2004. Jack, S. Review: Existing Epidemiological Evidence Does Not Show an Association Between Mumps, Measles, and Rubella Vaccination and Autism. Evid.Based.Nurs. 7 (1): 25; January, 2004. Jacobs, L. M.; Emanuelsen, K.; McKay, C.; Burns, K. Bioterrorism Preparedness­­Part II. Smallpox Vaccination in a Hospital Setting. Conn.Med. 68 (1): 27­
35; January, 2004. Jahnz­Rozyk, K.; Brydak, L. B.; Targowski, T.; Machala, M.; Plusa, T. Effect of Influenza Vaccinations on Immune Response and Serum Eotaxin Level in Patients With Allergic Bronchial Asthma. Mediators.Inflamm. 13 (3): 195­199; June, 2004. Jedrychowski, W.; Maugeri, U.; Jedrychowska­Bianchi, I. Prospective Epidemiologic Study on Respiratory Diseases in Children and Immunization Against Measles. Int.J.Occup.Med.Environ.Health. 17 (2): 255­261; 2004. Jee, Y. M.; Cheon, D. S.; Kim, K. S.; Lee, S. H.; Yoon, J. D.; Lee, S. W.; Go, U.; Yang, B. K.; Ki, M. R.; Choi, B. Y.; Cho, H. W. A Seroprevalence Study of Poliovirus Antibody Among Primary Schoolchildren in Korea. Epidemiol.Infect. 132 (2): 351­355; April, 2004. Jefferson, T. Bioterrorism and Compulsory Vaccination. BMJ. 329 (7465): 524­525; September 4, 2004. Jelleyman, T.; Ure, A. Attitudes to Immunisation: a Survey of Health Professionals in the Rotorua District. N.Z.Med.J. 117 (1189): U769; February, 2004. Jick, H.; Kaye, J. A. Autism and DPT Vaccination in the United Kingdom. N.Engl.J.Med. 350 (26): 2722­2723; June 24, 2004. Johansen, H.; Nguyen, K.; Mao, L.; Marcoux, R.; Gao, R. N.; Nair, C. Influenza Vaccination. Health Rep. 15 (2): 33­43; March, 2004. Johansson, E. L.; Bergquist, C.; Edebo, A.; Johansson, C.; Svennerholm, A. M. Comparison of Different Routes of Vaccination for Eliciting Antibody Responses in the Human Stomach. Vaccine. 22 (8): 984­990; February 25, 2004. John, S.; Lalitha, G.; George, K.; Joseph, A. Serological Response to Early Measles Vaccination. J.Trop.Pediatr. 50 (3): 175­177; June, 2004. John, T. J. The Golden Jubilee of Vaccination Against Poliomyelitis. Indian J.Med.Res. 119:1­17; January, 2004. Jokhdar, H.; Borrow, R.; Sultan, A.; Adi, M.; Riley, C.; Fuller, E.; Baxter, D. Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A Following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia. Clin.Diagn.Lab Immunol. 11 (1): 83­88; January, 2004. Jones, T. F.; Ingram, L. A.; Craig, A. S.; Schaffner, W. Determinants of Influenza Vaccination, 2003­2004: Shortages, Fallacies and Disparities. Clin Infect Dis; 39 (12): 1824­1828; December 15, 2004. Kalaca, S.; Yalcin, M.; Simsek, Yavuz S. Missed Opportunities for Tetanus Vaccination in Pregnant Women, and Factors Associated With Seropositivity. Public Health. 118 (5): 377­382; July, 2004. Kaplan, S. L.; Mason, E. O., Jr.; Wald, E. R.; Schutze, G. E.; Bradley, J. S.; Tan, T. Q.; Hoffman, J. A.; Givner, L. B.; Yogev, R.; Barson, W. J. Decrease of Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States After the Introduction of the 7­Valent Pneumococcal Conjugate Vaccine. Pediatrics. 113 (3 Pt 1): 443­449; March, 2004. Kapp, C. Nigerian States Again Boycott Polio­Vaccination Drive. Muslim Officials Have Rejected Assurances That the Polio Vaccine Is Safe­­Leaving Africa on the Brink of Reinfection. Lancet. 363 (9410): 709; February 28, 2004. Katow, S. Surveillance of Congenital Rubella Syndrome in Japan, 1978­2002: Effect of Revision of the Immunization Law. Vaccine. 22 (29­30): 4084­4091; September 28, 2004. Katz, S. L. Measles Vaccination in Canada. J.Pediatr. 144 (1): 141; January, 2004. Keegan, R.; Bilous, J. Current Issues in Global Immunizations. Semin.Pediatr.Infect.Dis. 15 (3): 130­136; July, 2004. Keles, E.; Kaygusuz, I.; Karlidag, T.; Yalcin, S.; Acik, Y.; Alpay, H. C.; lu, O. Prevalence of Otitis Media With Effusion in First and Second Grade Primary School Students and Its Correlation With BCG Vaccination. Int.J.Pediatr.Otorhinolaryngol. 68 (8): 1069­1074; August, 2004. Kelly, C. D.; Egan, C.; Davis, S. W.; Samsonoff, W. A.; Musser, K. A.; Drabkin, P.; Miller, J. R.; Taylor, J.; Cirino, N. M. Laboratory Confirmation of Generalized Vaccinia Following Smallpox Vaccination. J.Clin.Microbiol. 42 (3): 1373­1375; March, 2004. Kelly, H.; Attia, J.; Andrews, R.; Heller, R. F. The Number Needed to Vaccinate (NNV) and Population Extensions of the NNV: Comparison of Influenza and Pneumococcal Vaccine Programmes for People Aged 65 Years and Over. Vaccine. 22 (17­18): 2192­2198; June 2, 2004. Kelly, H.; Worth, L.; Karapanagiotidis, T.; Riddell, M. Interruption of Rubella Virus Transmission in Australia May Require Vaccination of Adult Males: Evidence From a Victorian Sero­Survey. Commun.Dis.Intell. 28 (1): 69­73; 2004. Kempe, A.; Beaty, B. L.; Steiner, J. F.; Pearson, K. A.; Lowery, N. E.; Daley, M. F.; Crane, L. A.; Berman, S. The Regional Immunization Registry As a Public Health Tool for Improving Clinical Practice and Guiding Immunization Delivery Policy. Am.J.Public Health. 94 (6): 967­972; June, 2004. Kennedy, J. S.; Frey, S. E.; Yan, L.; Rothman, A. L.; Cruz, J.; Newman, F. K.; Orphin, L.; Belshe, R. B.; Ennis, F. A. Induction of Human T Cell­Mediated Immune Responses After Primary and Secondary Smallpox Vaccination. J.Infect.Dis. 190 (7): 1286­1294; October 1, 2004. Kennedy, R. C.; Byers, V. S.; Marchalonis, J. J. Measles Virus Infection and Vaccination: Potential Role in Chronic Illness and Associated Adverse Events. Crit Rev Immunol; 24 (2): 129­156; 2004. Kiel, R. J. Review: Pneumococcal Vaccination Does Not Prevent Pneumonia or Death in Adults. ACP J.Club. 141 (1): 16; July, 2004. Kiros, G. E.; White, M. J. Migration, Community Context, and Child Immunization in Ethiopia. Soc.Sci.Med. 59 (12): 2603­2616; December, 2004. Kissam, S.; Gifford, D. R.; Patry, G.; Bratzler, W. Is Signed Consent for Influenza or Pneumococcal Polysaccharide Vaccination Required? Arch.Intern.Med. 164 (1): 13­16; January 12, 2004. Kitchener, S. Viscerotropic and Neurotropic Disease Following Vaccination With the 17D Yellow Fever Vaccine, ARILVAX((R)). Vaccine. 22 (17­18): 2103­2105; June 2, 2004. Klugman, K. P. Vaccination: a Novel Approach to Reduce Antibiotic Resistance. Clin.Infect.Dis. 39 (5): 649­651; September 1, 2004. Knuf, M.; Schmitt, H. J.; Mohnike, K.; Zepp, F.; Habermehl, P.; Kampmann, C.; Herden, P. Tolerability of the Biken Acellular Pertussis Vaccine in Adults With or Without Previous Vaccination Against Pertussis in Childhood. Med.Klin.(Munich). 99 (9): 495­499; September 15, 2004. Koca, R.; Altinyazar, H. C.; Numanoglu, G.; Unalacak, M. Guttate Psoriasis­Like Lesions Following BCG Vaccination. J.Trop.Pediatr. 50 (3): 178­179; June, 2004. Kohl, K. S.; Marcy, S. M.; Blum, M.; Connell, Jones M.; Dagan, R.; Hansen, J.; Nalin, D.; Rothstein, E. Fever After Immunization: Current Concepts and Improved Future Scientific Understanding. Clin.Infect.Dis. 39 (3): 389­394; August 1, 2004. Komatsu, N.; Shichijo, S.; Nakagawa, M.; Itoh, K. New Multiplexed Flow Cytometric Assay to Measure Anti­Peptide Antibody: a Novel Tool for Monitoring Immune Responses to Peptides Used for Immunization. Scand.J.Clin.Lab Invest. 64 (6): 535­545; 2004. Koppen, S.; De Groot, R.; Neijens, H. J.; Nagelkerke, N.; Van Eden, W.; Rumke, H. C. No Epidemiological Evidence for Infant Vaccinations to Cause Allergic Disease. Vaccine. 22 (25­26): 3375­3385; September 3, 2004. Korczowski, B. Procalcitonin and C­Reactive Protein in Vaccination­Associated Adverse Reactions. Pediatr.Infect.Dis.J. 23 (3): 283; March, 2004. Kositanont, U.; Kanyok, R.; Wasi, C.; Wongsurakiat, P.; Suthamsmai, T.; Maranetra, N. Occurrence and Protective Level of Influenza Infections Using Serology in Patients With COPD in Vaccination Study. J.Med.Assoc.Thai. 87 (8): 964­969; August, 2004. Krantz, I.; Sachs, L.; Nilstun, T. Ethics and Vaccination. Scand.J.Public Health. 32 (3): 172­178; 2004. Kretzschmar, M.; van den, Hof S.; Wallinga, J.; van Wijngaarden, J. Ring Vaccination and Smallpox Control. Emerg.Infect.Dis. 10 (5): 832­841; May, 2004. Krueger, M.; Fluegge, K.; Krause, M. F.; Berner, R. Fatal Haemophilus Influenzaetype b Sepsis in a 10­Month­Old Infant Despite Complete Vaccination and Adequate Hib Antibodies. Eur.J.Pediatr. April 15, 2004. Kulkarni, V.; Nadgir, D.; Tapiawala, S.; Malabari, A.; Kalgikar, A.; Kela, R.; Nadkar, M.; Kamath, S.; Shah, A. Biphasic Demyelination of the Nervous System Following Anti­Rabies Vaccination. Neurol.India. 52 (1): 106­108; March, 2004. Kumagai, T.; Nagai, K.; Okui, T.; Tsutsumi, H.; Nagata, N.; Yano, S.; Nakayama, T.; Okuno, Y.; Kamiya, H. Poor Immune Responses to Influenza Vaccination in Infants. Vaccine. 22 (25­26): 3404­3410; September 3, 2004. Kutlesa, N. J. Creating a Sustainable Immunization System in Canada­­the Case for a Vaccine­Related Injury Compensation Scheme. Health Law J; 12: 201­
242; 2004. Kuula, A.; Bell, S. E.; Allen, R. Public Health Nurses' Views on Voluntary Smallpox Vaccination. J N Y State Nurses Assoc; 35 (1): 4­7; 2004. La Montagne, J. R.; Fauci, A. S. Intradermal Influenza Vaccination­­Can Less Be More? N Engl J Med. 351 (22): 2330­2332; November 25, 2004. Lackmann, G. M. Comparative Investigation of the Safety of Hexavalent Vaccines for Primary Scheduled Infant Immunizations in Germany Over a Time Period of 2 Years. Med.Sci.Monit. 10 (9): PI96­PI98; August, 2004. Lambert, S.; O'Grady, K. A.; Gabriel, S.; Carter, R.; Nolan, T. The Cost of Seasonal Respiratory Illnesses in Australian Children: the Dominance of Patient and Family Costs and Implications for Vaccine Use. Commun Dis Intell; 28 (4): 510­516; 2004. Lang, A. B.; Rudeberg, A.; Schoni, M. H.; Que, J. U.; Furer, E.; Schaad, U. B. Vaccination of Cystic Fibrosis Patients Against Pseudomonas Aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection. Pediatr.Infect.Dis.J. 23 (6): 504­510; June, 2004. Langue, J.; Matisse, N.; Pacoret, P.; Undreiner, F.; Boisnard, F.; Soubeyrand, B. Persistence of Antibodies at 5­6 Years of Age for Children Who Had Received a Primary Series Vaccination With a Pentavalent Whole­Cell Pertussis Vaccine and a First Booster With a Pentavalent Acellular Pertussis Vaccine: Immunogenicity and Tolerance of Second Booster With a Tetravalent Acellular Vaccine at 5­6 Years of Age. Vaccine. 22 (11­12): 1406­1414; March 29, 2004. Larkin, M. Flu Vaccine: Will Scarcity Improve Compliance in USA. Lancet Infect Dis; 4 (12): 715; December, 2004. LaVela, S. L.; Legro, M. W.; Weaver, F. M.; Smith, B. Staff Influenza Vaccination: Lessons Learned. SCI Nurs. 21 (3): 153­157; 2004. LaVela, S. L.; Smith, B.; Weaver, F. M.; Legro, M. W.; Goldstein, B.; Nichol, K. Attitudes and Practices Regarding Influenza Vaccination Among Healthcare Workers Providing Services to Individuals With Spinal Cord Injuries and Disorders. Infect Control Hosp Epidemiol. 25 (11): 933­940; November, 2004. Lawrence, G. L.; Burgess, M. A.; Kass, R. B. Age­Related Risk of Adverse Events Following Yellow Fever Vaccination in Australia. Commun.Dis.Intell. 28 (2): 244­248; 2004. Lawrence, G.; Boyd, I. Surveillance of Adverse Events Following Immunisation for Children Aged Less Than 7 Years, 1 January to 30 June 2004. Commun Dis Intell; 28 (4): 490­492; 2004. Le, T.; Cherry, J. D.; Chang, S. J.; Knoll, M. D.; Lee, M. L.; Barenkamp, S.; Bernstein, D.; Edelman, R.; Edwards, K. M.; Greenberg, D.; Keitel, W.; Treanor, J.; Ward, J. I. Immune Responses and Antibody Decay After Immunization of Adolescents and Adults With an Acellular Pertussis Vaccine: the APERT Study. J.Infect.Dis. 190 (3): 535­544; August 1, 2004. LeBaron, C. W.; Starnes, D. M.; Rask, K. J. The Impact of Reminder­Recall Interventions on Low Vaccination Coverage in an Inner­City Population. Arch.Pediatr.Adolesc.Med. 158 (3): 255­261; March, 2004. Lee, K. C.; Finkelstein, J. A.; Miroshnik, I. L.; Rusinak, D.; Santoli, J. M.; Lett, S. M.; Lieu, T. A. Pediatricians' Self­Reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine. Arch.Pediatr.Adolesc.Med. 158 (7): 695­701; July, 2004. Leino, T.; Takala, T.; Auranen, K.; Makela, P. H.; Takala, A. K. Indirect Protection Obtained by Haemophilus Influenzae Type b Vaccination: Analysis in a Structured Population Model. Epidemiol.Infect. 132 (5): 959­966; October, 2004. Leissner, K. B.; Holzman, R. S.; McCann, M. E. Bioterrorism and Children; Unique Concerns With Infection Control and Vaccination. Anesthesiol.Clin.North America. 22 (3): 563­577; September, 2004. Lemon, S. C.; Rakowski, W.; Clark, M. A.; Roy, J.; Friedmann, P. D. Variations in Influenza Vaccination Among the Elderly. Am.J.Health Behav. 28 (4): 352­360; July, 2004. Lesser, D. Risk of Contact Vaccinia From Immunization Sites. JAMA. 291 (19): 2313­2314; May, 2004. Letonturier, D. [Influenza Can Hide Other Infections]. Soins.Gerontol. (46): 42­45; March, 2004. Levenson, D. Institute of Medicine Rejects Vaccine­Autism Link. Rep.Med.Guidel.Outcomes.Res. 15 (11): 9­10, 12; June 11, 2004. Levine, O. S.; Cherian, T.; Shah, R.; Batson, A. PneumoADIP: an Example of Translational Research to Accelerate Pneumococcal Vaccination in Developing Countries. J Health Popul Nutr; 22 (3): 268­274; September, 2004. Levitt, C.; Shaw, E.; Wong, S.; Kaczorowski, J.; Springate, R.; Sellors, J.; Enkin, M. Systematic Review of the Literature on Postpartum Care: Selected Contraception Methods, Postpartum Papanicolaou Test, and Rubella Immunization. Birth. 31 (3): 203­212; September, 2004. Li, S. T.; Davis, R. L.; Weiss, N. S. Intussusception and Oral Poliovirus Vaccination: Is There an Association? Am.J.Epidemiol. 160 (6): 576­581; September 15, 2004. Li, Y. C.; Norton, E. C.; Dow, W. H. Influenza and Pneumococcal Vaccination Demand Responses to Changes in Infectious Disease Mortality. Health Serv.Res. 39 (4 Pt 1): 905­925; August, 2004. Lim, S.; Park, S.; Choi, H.; Kim, D.; Kim, H.; Yang, B.; Lee, J. Transverse Myelitis After Measles and Rubella Vaccination. J.Paediatr.Child Health. 40 (9­
10): 583­584; September, 2004. Lindberg, A. [Vaccinations­­Primary Prevention With Problems]. Lakartidningen. 101 (28­29): 2352­2354; July 8, 2004. Lindholm, C.; Naylor, A.; Johansson, E. L.; Quiding­Jarbrink, M. Mucosal Vaccination Increases Endothelial Expression of Mucosal Addressin Cell Adhesion Molecule 1 in the Human Gastrointestinal Tract. Infect.Immun. 72 (2): 1004­1009; February, 2004. Liu, Y. H.; Huang, L. M.; Wang, J. D. Reduction of Acute Respiratory Illness (ARI) Due to a Voluntary Workplace Influenza Vaccination Program: Who Are More Likely to Get the Benefit? J Occup Health; 46 (6): 455­460; November, 2004. Loeb, M.; Stevenson, K. B. Pneumococcal Immunization in Older Adults: Implications for the Long­Term­Care Setting. Infect Control Hosp Epidemiol. 25 (11): 985­994; November, 2004. Lu, L.; Jin, S. G.; Yu, J. J.; Ze, W. Y.; Ling, L. Y.; Wang, S. L.; Su, H.; Yan, B.; Liu, H.; Song, Q. F. [Study on the Cost of Expanded Programme on Immunization in Areas With Different Economic Levels]. Zhonghua Liu Xing Bing Xue Za Zhi. 25 (8): 684­687; August, 2004. Luca, L.; Morisset, M.; Kanny, G.; Moneret­Vautrin, D. A. Pancolitis After Influenza Vaccination. Allergy. 59 (3): 367; March, 2004. MacMahon, E.; Brown, L. J.; Bexley, S.; Snashall, D. C.; Patel, D. Identification of Potential Candidates for Varicella Vaccination by History: Questionnaire and Seroprevalence Study. BMJ. July 23, 2004. Madhavan, S. S.; Borker, R. D.; Fernandes, A. W.; Amonkar, M. M.; Rosenbluth, S. A. Assessing Predictors of Influenza and Pneumonia Vaccination in Rural Senior Adults. J.Health Soc.Policy. 18 (4): 13­38; 2004. Madhavan, S. S.; Borker, R. D.; Fernandes, A. W.; Amonkar, M. M.; Rosenbluth, S. A. Assessing Predictors of Influenza<Br />and Pneumonia Vaccination<Br />in Rural Senior Adults. J.Health Soc.Policy. 18 (2): 71­93; 2004. Madjid, M.; Casscells, W. Influenza As a Bioterror Threat: the Need for Global Vaccination. Expert.Opin.Biol.Ther. 4 (3): 265­267; March, 2004. Madsen, F. [Allergen Vaccination]. Ugeskr Laeger; 166 (48): 4391­4392; November 22, 2004. Madsen, K. M.; Vestergaard, M. MMR Vaccination and Autism : What Is the Evidence for a Causal Association? Drug Saf. 27 (12): 831­840; 2004. Mahan, C. M.; Kang, H. K.; Dalager, N. A.; Heller, J. M. Anthrax Vaccination and Self­Reported Symptoms, Functional Status, and Medical Conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Ann.Epidemiol. 14 (2): 81­88; February, 2004. Mahmoud, A. The Global Vaccination Gap. Science. 305 (5681): 147; July 9, 2004. Maho, A.; Ndeledje, Gondje N.; Mopate, L. Y.; Ganda, Kana S. [Newcastle Disease in Southern Chad: Peak Epidemic Periods and the Impact of Vaccination]. Rev Sci Tech; 23 (3): 777­782; December, 2004. Maitra, A.; Sherriff, A.; Griffiths, M.; Henderson, J.; Avon Longitudinal Study Of Parents And Children Study Team Pertussis Vaccination in Infancy and Asthma or Allergy in Later Childhood: Birth Cohort Study. BMJ. March, 2004. Mallet, E.; Matisse, N.; Mathieu, N.; Langue, J.; Boisnard, F.; Soubeyrand, B. Antibody Persistence Against Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus Influenzae Type b (Hib) in 5­6­Year­Old Children After Primary Vaccination and First Booster With a Pentavalent Combined Acellular Pertussis Vaccine: Immunogenicity and Tolerance of a Tetravalent Combined Acellular Pertussis Vaccine Given As a Second Booster. Vaccine. 22 (11­12): 1415­1422; March 29, 2004. Manthey, D. E.; Stopyra, J.; Askew, K. Referral of Emergency Department Patients for Pneumococcal Vaccination. Acad.Emerg.Med. 11 (3): 271­275; March, 2004. March, J. B. DNA Vaccination ­ Research Tool or a Practical Reality? Expert.Rev.Vaccines. 3 (2): 113­117; April, 2004. Mari, A. Is There a Causative Role for Tetanus Toxoid Vaccination in the Development of Allergy­Like Symptoms and in the Increasing Prevalence of Atopic Diseases? Med.Hypotheses. 63 (5): 875­886; 2004. Markey, C. S. Healthcare Worker Influenza Vaccination: Personal Choice or Professional Responsibility? Home.Healthc.Nurse. 22 (9): 643­644; September, 2004. Marti, J.; Anton, E. Polymyalgia Rheumatica Complicating Influenza Vaccination. J.Am.Geriatr.Soc. 52 (8): 1412; August, 2004. Martin, J. F. The Immunization Imperative. Expert.Rev.Vaccines. 3 (3): 225­227; June, 2004. Martin, J. Travel Vaccination: an Update. Nurs.Stand. 18 (34): 47­53; May 5, 2004. Mayer, M. [Commentary: Vaccination Coverage in Adults and Health Professionals: an Unresolved Issue in Primary Care.]. Aten.Primaria. 34 (7): 343­344; October 31, 2004. Mays, R. M.; Sturm, L. A.; Zimet, G. D. Parental Perspectives on Vaccinating Children Against Sexually Transmitted Infections. Soc.Sci.Med. 58 (7): 1405­
1413; April, 2004. Mazzone, P. J.; Mossad, S. B.; Mawhorter, S. D.; Mehta, A. C.; Mauer, J. R. Cell­Mediated Immune Response to Influenza Vaccination in Lung Transplant Recipients. J.Heart Lung Transplant. 23 (10): 1175­1181; October, 2004. McCall, B. J.; Davison, R. P.; Nissen, M. D.; Nourse, C. B. Pertussis Vaccination for New Parents? Med J Aust. 181 (10): 578; November 15, 2004. McIntyre, P. B.; Turnbull, F. M.; Egan, A. M.; Burgess, M. A.; Wolter, J. M.; Schuerman, L. M. High Levels of Antibody in Adults Three Years After Vaccination With a Reduced Antigen Content Diphtheria­Tetanus­Acellular Pertussis Vaccine. Vaccine. 23 (3): 380­385; December 2, 2004. McIntyre, P. Vaccines for Other Neonatal Infections: Vaccination Strategies for the Prevention of Neonatal Pertussis. Expert.Rev.Vaccines. 3 (4): 375­378; August, 2004. McKeever, T. M.; Lewis, S. A.; Smith, C.; Hubbard, R. Vaccination and Allergic Disease: a Birth Cohort Study. Am.J.Public Health. 94 (6): 985­989; June, 2004. McLaughlin, M. A. Thoughts on Rabies Vaccination Enforcement. J.Am.Vet.Med.Assoc. 224 (6): 834­835; March 15, 2004. McMurray, R.; Cheater, F. M.; Weighall, A.; Nelson, C.; Schweiger, M.; Mukherjee, S. Managing Controversy Through Consultation: a Qualitative Study of Communication and Trust Around MMR Vaccination Decisions. Br.J.Gen.Pract. 54 (504): 520­525; July, 2004. McVernon, J.; Howard, A. J.; Slack, M. P.; Ramsay, M. E. Long­Term Impact of Vaccination on Haemophilus Influenzae Type b (Hib) Carriage in the United Kingdom. Epidemiol.Infect. 132 (4): 765­767; August, 2004. McVernon, J.; Mitchison, N. A.; Moxon, E. R. T Helper Cells and Efficacy of Haemophilus Influenzae Type b Conjugate Vaccination. Lancet Infect.Dis. 4 (1): 40­43; January, 2004. McVernon, J.; Morgan, P.; Mallaghan, C.; Biswas, T.; Natarajan, M.; Griffiths, D.; Slack, M.; Moxon, R. Outbreak of Haemophilus Influenzae Type b Disease Among Fully Vaccinated Children in a Day­Care Center. Pediatr.Infect.Dis.J. 23 (1): 38­41; January, 2004. Melegaro, A.; Edmunds, W. J. Cost­Effectiveness Analysis of Pneumococcal Conjugate Vaccination in England and Wales. Vaccine. 22 (31­32): 4203­4214; October 22, 2004. Menzies, R.; McIntyre, P.; Beard, F. Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 1999 to 2002. Commun Dis Intell; 28 Suppl 1:S1­45; June, 2004. Mercado, U.; Acosta, H.; Avendano, L. Influenza Vaccination of Patients With Systemic Lupus Erythematosus. Rev.Invest Clin. 56 (1): 16­20; January, 2004. Metersky, M.; Ho, S. Y.; Petrillo, M. K. Does Hospital­Based Influenza Vaccination Result in Unintended Revaccination? Am.J.Med. 116 (12): 854­855; June 15, 2004. Meyerhoff, A.; Jacobs, R. J.; Greenberg, D. P.; Yagoda, B.; Castles, C. G. Clinician Satisfaction With Vaccination Visits and the Role of Multiple Injections, Results From the COVISE Study (Combination Vaccines Impact on Satisfaction and Epidemiology). Clin.Pediatr.(Phila). 43 (1): 87­93; January, 2004. Micco, E.; Gurmankin, A. D.; Armstrong, K. Differential Willingness to Undergo Smallpox Vaccination Among African­American and White Individuals. J.Gen.Intern.Med. 19 (5 Pt 1): 451­455; May, 2004. Milani, V.; Endres, M.; Kuppner, M. C.; Issels, R. D.; Noessner, E. [Heat Shock Proteins, Immune Competence and Vaccination]. Dtsch.Med.Wochenschr. 129 (1­2): 31­35; January 2, 2004. Militao de Albuquerque, Mde F.; Ximenes, R. A.; Campelo, A. R.; Sarinho, E.; Cruz, M.; Maia, Filho, V Neonatal BCG Vaccine and Response to the Tuberculin Test in BCG Vaccinated Children in Contact With Tuberculosis Patients in Recife, Brazil. J.Trop.Pediatr. 50 (1): 32­36; February, 2004. Miller, G. E.; Cohen, S.; Pressman, S.; Barkin, A.; Rabin, B. S.; Treanor, J. J. Psychological Stress and Antibody Response to Influenza Vaccination: When Is the Critical Period for Stress, and How Does It Get Inside the Body? Psychosom.Med. 66 (2): 215­223; March, 2004. Millett, P. D. Proliferation of Biological Weapons: Challenges and Responses. Med.Confl.Surviv. 20 (1): 4­18; January, 2004. Minor, P. D. Polio Eradication, Cessation of Vaccination and Re­Emergence of Disease. Nat.Rev.Microbiol. 2 (6): 473­482; June, 2004. Mishra, D. Typhoid Vaccination After Enteric Fever. Indian J.Pediatr. 71 (8): 767­768; August, 2004. Mitchell, D.; Pollari, C.; Swart, B. CARE Approach to Immunization Counselling. Can Nurse; 100 (9): 12­13; November, 2004. Mitka, M. Improvement Seen in US Immunization Rates. JAMA. 292 (10): 1167; September 8, 2004. Miura, M.; Katada, Y.; Ishihara, J. Time Interval of Measles Vaccination in Patients With Kawasaki Disease Treated With Additional Intravenous Immune Globulin. Eur J Pediatr. 163 (1): 25­29; January, 2004. Modlin, J. F. Poliomyelitis in the United States: the Final Chapter? JAMA. 292 (14): 1749­1751; October 13, 2004. Molinari, J. A. Vaccines: the Conflict Between Efficacy and Public Concerns­­Part 2. Compend.Contin.Educ.Dent. 25 (5): 396­399; May, 2004. Molloy, E. S.; Powell, F. C.; Doran, M. F.; Ryan, J. G.; Mulligan, N. J.; McCarthy, C. J.; Keogan, M. T.; McCarthy, G. M. An Unusual Case of Behcet's Syndrome: Triggered by Typhoid Vaccination? Clin Exp Rheumatol. 22 (4 Suppl 34): S71­S74; July, 2004. Mommers, M.; Weishoff­Houben, M.; Swaen, G. M.; Creemers, H.; Freund, H.; Dott, W.; Van Schayck, C. P. Infant Immunization and the Occurrence of Atopic Disease in Dutch and German Children: A Nested Case­Control Study. Pediatr.Pulmonol. 38 (4): 329­334; October, 2004. Montaner, M.; Canton, E.; Diosdado, N.; Moreno, R.; Ramos, P.; Igual, R.; Gonzalez­Granda, D.; Garcia­Aguayo, J. M.; Canos, M.; Gobernado, M. [Coverage of the 23­Valent Pneumococcal Vaccine in Those Older Than 64 Years of Age in the Region of Castellon and Valencia, Spain]. Rev.Esp.Quimioter. 17 (2): 155­160; June, 2004. Monto, A. S.; Rotthoff, J.; Teich, E.; Herlocher, M. L.; Truscon, R.; Yen, H. L.; Elias, S.; Ohmit, S. E. Detection and Control of Influenza Outbreaks in Well­
Vaccinated Nursing Home Populations. Clin.Infect.Dis. 39 (4): 459­464; August 15, 2004. Moore, S. E.; Jalil, F.; Ashraf, R.; Chen, Szu S.; Prentice, A. M.; Hanson, L. A. Birth Weight Predicts Response to Vaccination in Adults Born in an Urban Slum in Lahore, Pakistan. Am.J.Clin.Nutr. 80 (2): 453­459; August, 2004. Moorthy, V. S.; Imoukhuede, E. B.; Keating, S.; Pinder, M.; Webster, D.; Skinner, M. A.; Gilbert, S. C.; Walraven, G.; Hill, A. V. Phase 1 Evaluation of 3 Highly Immunogenic Prime­Boost Regimens, Including a 12­Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men. J.Infect.Dis. 189 (12): 2213­2219; June 15, 2004. Mor, M.; Harel, L.; Kahan, E.; Amir, J. Efficacy of Postexposure Immunization With Live Attenuated Varicella Vaccine in the Household Setting­a Pilot Study. Vaccine. 23 (3): 325­328; November 9, 2004. Moraga Llop, F. A. [Current Status of Combined Vaccines]. Rev.Esp.Quimioter. 17 (2): 127­130; June, 2004. Morales, A.; Martinez, M. M.; Tasset­Tisseau, A.; Rey, E.; Baron­Papillon, F.; Follet, A. Costs and Benefits of Influenza Vaccination and Work Productivity in a Colombian Company From the Employer's Perspective. Value.Health. 7 (4): 433­441; July, 2004. Mormile, R.; D'Alterio, V.; Treccagnoli, G.; Sorrentino, P. Henoch­Schonlein Purpura With Antiphospholipid Antibodies After Influenza Vaccination: How Fearful Is It in Children? Vaccine. 23 (5): 567­568; December 16, 2004. Morris, K. Influenza Immunization Among Health Care Workers. Ohio.Nurses Rev. 79 (8): 16, 15; September, 2004. Mortimer, P. P. Why, Which, How, Who, When? A Personal View of Smallpox Vaccination for the 2000s. Commun.Dis.Public Health. 7 (2): 145­150; June, 2004. Moynihan, J. A.; Larson, M. R.; Treanor, J.; Duberstein, P. R.; Power, A.; Shore, B.; Ader, R. Psychosocial Factors and the Response to Influenza Vaccination in Older Adults. Psychosom Med. 66 (6): 950­953; November, 2004. Mukherjee, A.; Ahluwalia, T. P.; Gaur, L. N.; Mittal, R.; Kambo, I.; Saxena, N. C.; Singh, P. Assessment of Vaccine Wastage During a Pulse Polio Immunization Programme in India. J.Health Popul.Nutr. 22 (1): 13­18; March, 2004. Mullooly, J. P.; Maher, J. E.; Drew, L.; Schuler, R.; Hu, W. Evaluation of the Impact of an HMO's Varicella Vaccination Program on Incidence of Varicella. Vaccine. 22 (11­12): 1480­1485; March 29, 2004. Muraskin, W. The Global Alliance for Vaccines and Immunization: Is It a New Model for Effective Public­Private Cooperation in International Public Health? Am.J.Public Health. 94 (11): 1922­1925; November, 2004. Musana, K. A.; Yale, S. H.; Mazza, J. J.; Reed, K. D. Practical Considerations to Influenza Vaccination. Clin Med Res; 2 (4): 256­259; November, 2004. Mysliwska, J.; Trzonkowski, P.; Szmit, E.; Brydak, L. B.; Machala, M.; Mysliwski, A. Immunomodulating Effect of Influenza Vaccination in the Elderly Differing in Health Status. Exp.Gerontol. 39 (10): 1447­1458; October, 2004. Naniche, D.; Garenne, M.; Rae, C.; Manchester, M.; Buchta, R.; Brodine, S. K.; Oldstone, M. B. Decrease in Measles Virus­Specific CD4 T Cell Memory in Vaccinated Subjects. J.Infect.Dis. 190 (8): 1387­1395; October 15, 2004. Napolitano, P. G.; Ryan, M. A.; Grabenstein, J. D. Pregnancy Discovered After Smallpox Vaccination: Is Vaccinia Immune Globulin Appropriate? Am J Obstet Gynecol; 191 (6): 1863­1867; December, 2004. Narula, D.; Tiwari, L.; Puliyel, J. M. Rotavirus Vaccines. Lancet. 364 (9430): 245­246; July 17, 2004. Neuhaus, T. J. Immunization in Children With Chronic Renal Failure: a Practical Approach. Pediatr.Nephrol. October 21, 2004. Nichol, K. L.; Mendelman, P. Influence of Clinical Case Definitions With Differing Levels of Sensitivity and Specificity on Estimates of the Relative and Absolute Health Benefits of Influenza Vaccination Among Healthy Working Adults and Implications for Economic Analyses. Virus Res. 103 (1­2): 3­8; July, 2004. Nicholls, S.; Carroll, K.; Crofts, J.; Ben­Eliezer, E.; Paul, J.; Zambon, M.; Joseph, C. A.; Verlander, N. Q.; Goddard, N. L.; Watson, J. M. Outbreak of Influenza A (H3N2) in a Highly­Vaccinated Religious Community: a Retrospective Cohort Study. Commun Dis Public Health; 7 (4): 272­277; December, 2004. Nishiura, H.; Tang, I. M. Modeling for a Smallpox­Vaccination Policy Against Possible Bioterrorism in Japan: the Impact of Long­Lasting Vaccinal Immunity. J.Epidemiol. 14 (2): 41­50; March, 2004. Nokleby, H. [Vaccination of Persons With Allergy]. Tidsskr.Nor Laegeforen. 123 (23): 3400­3401; January 9, 2004. Nolan, P. The Rhode Island Meningitis Vaccine Experience­­Mass Vaccination Campaigns, Politics and Health Policy. Med.Health R.I. 87 (3): 65­67; March, 2004. Nookala, S.; Srinivasan, S.; Kaliraj, P.; Narayanan, R. B.; Nutman, T. B. Impairment of Tetanus­Specific Cellular and Humoral Responses Following Tetanus Vaccination in Human Lymphatic Filariasis. Infect.Immun. 72 (5): 2598­2604; May, 2004. Nowalk, M. P.; Zimmerman, R. K.; Feghali, J. Missed Opportunities for Adult Immunization in Diverse Primary Care Office Settings. Vaccine. 22 (25­26): 3457­3463; September 3, 2004. Nowalk, M. P.; Zimmerman, R. K.; Shen, S.; Jewell, I. K.; Raymund, M. Barriers to Pneumococcal and Influenza Vaccination in Older Community­Dwelling Adults (2000­2001). J Am Geriatr.Soc. 52 (1): 25­30; January, 2004. Obaro, S. K.; Deubzer, H. E.; Newman, V. O.; Adegbola, R. A.; Greenwood, B. M.; Henderson, D. C. Serotype­Specific Pneumococcal Antibodies in Breast Milk of Gambian Women Immunized With a Pneumococcal Polysaccharide Vaccine During Pregnancy. Pediatr Infect Dis. 23 (11): 1023­1029; November, 2004. O'Brien, L.; Taddio, A.; Ipp, M.; Goldbach, M.; Koren, G. Topical 4% Amethocaine Gel Reduces the Pain of Subcutaneous Measles­Mumps­Rubella Vaccination. Pediatrics; 114 (6): e720­e724; December, 2004. Odio, C. Vaccines and Vaccination Strategies. Expert.Rev.Vaccines. 3 (4): 391­396; August, 2004. Okada, K.; Ueda, K.; Morokuma, K.; Kino, Y.; Tokugawa, K.; Nishima, S. Seroepidemiologic Study on Pertussis, Diphtheria, and Tetanus in the Fukuoka Area of Southern Japan: Seroprevalence Among Persons 0­80 Years Old and Vaccination Program. Jpn.J.Infect.Dis. 57 (2): 67­71; April, 2004. Olusanya, B. Polio­Vaccination Boycott in Nigeria. Lancet. 363 (9424): 1912; June 5, 2004. Oppermann, H.; Borrmann, M.; Thriene, B.; Grafe, L.; Wilhelms, E.; Herrmann, C.; Weise, H.; Hennig, E.; Claus, H. [Experiences and Difficulties in Implementing Immunization Registries in Saxony­Anhalt.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 47 (12): 1189­1195; December, 2004. Ovsyannikova, I. G.; Jacobson, R. M.; Vierkant, R. A.; Jacobsen, S. J.; Pankratz, V. S.; Poland, G. A. The Contribution of HLA Class I Antigens in Immune Status Following Two Doses of Rubella Vaccination. Hum Immunol; 65 (12): 1506­1515; December, 2004. Ovsyannikova, I. G.; Jacobson, R. M.; Vierkant, R. A.; Shane, Pankratz, V; Jacobsen, S. J.; Poland, G. A. Associations Between Human Leukocyte Antigen (HLA) Alleles and Very High Levels of Measles Antibody Following Vaccination. Vaccine. 22 (15­16): 1914­1920; May 7, 2004. Padgett, D. A. Maternal Vaccination: Is It Effective in the Face of Stress? Brain Behav.Immun. 18 (1): 13­14; January, 2004. Papadimitropoulos, V.; Vergidis, P. I.; Bliziotis, I.; Falagas, M. E. Vaccination Against Typhoid Fever in Travellers: a Cost­Effectiveness Approach. Clin.Microbiol.Infect. 10 (8): 681­683; August, 2004. Pappano, D.; Humiston, S.; Goepp, J. Efficacy of a Pediatric Emergency Department­Based Influenza Vaccination Program. Arch Pediatr Adolesc Med. 158 (11): 1077­1083; November, 2004. Parker, N. R. Positive Q Fever Skin Test After Vaccination. Med.J.Aust. 180 (1): 45­46; January 5, 2004. Parry, M. F.; Grant, B.; Iton, A.; Parry, P. D.; Baranowsky, D. Influenza Vaccination: a Collaborative Effort to Improve the Health of the Community. Infect Control Hosp Epidemiol. 25 (11): 929­932; November, 2004. Parve, J. Remove Vaccination Barriers for Children 12 to 24 Months. Nurse Pract. 29 (4): 35­38; April, 2004. Pastor, Climent M.; Schwarz, Chavarri H.; Pedrera, Carbonell, V; De La Torre, M. P. [Flu Vaccination Status of Primary Care Staff]. Aten.Primaria. 33 (3): 161; February 28, 2004. Paul, Y. Setback in Polio Eradication in India in 2002: Reasons and Remedies. Indian Pediatr. 41 (2): 202­203; February, 2004. Pazdiora, P.; Januska, J. [Dynamics of Antibody Formation After Vaccination Against Tick­Borne Encephalitis]. Epidemiol.Mikrobiol.Imunol. 53 (1): 17­21; February, 2004. Pelton, S. I. Modifying Acute Otitis Media: Implications of Immunization With Pneumococcal Conjugate Vaccine. Pediatr.Infect.Dis.J. 23 (9): 839­841; September, 2004. Pelton, S. I.; Loughlin, A. M.; Marchant, C. D. Seven Valent Pneumococcal Conjugate Vaccine Immunization in Two Boston Communities: Changes in Serotypes and Antimicrobial Susceptibility Among Streptococcus Pneumoniae Isolates. Pediatr Infect Dis J. 23 (11): 1015­1022; November, 2004. Pena­Rey, I.; Perez­Farinos, N.; Cortes­Garcia, M.; Amela­Heras, C. [Cost­Effectiveness of Varicella Vaccination in Spanish Adolescents]. Gac.Sanit. 18 (4): 287­294; July, 2004. Pena­Rey, I.; Perez­Farinos, N.; Sarria­Santamera, A. Factors Associated With Influenza Vaccination Among Elderly Spanish Women. Public Health. 118 (8): 582­587; December, 2004. Perriol, M. P.; Devos, D.; Hurtevent, J. F.; Gautier, S.; Caron, J.; Destee, A. [Flaccid Tetraplegia Following Anti­Tetanus Vaccination.]. Rev.Neurol.(Paris). 160 (10): 942­944; October, 2004. Peterson, C. Smallpox Vaccination Update. Am.J.Nurs. 104 (7): 104; July, 2004. Petrie, K. J.; Moss­Morris, R.; Grey, C.; Shaw, M. The Relationship of Negative Affect and Perceived Sensitivity to Symptom Reporting Following Vaccination. Br.J.Health Psychol. 9 (Pt 1): 101­111; February, 2004. Pfister, R. E.; Aeschbach, V.; Niksic­Stuber, V.; Martin, B. C.; Siegrist, C. A. Safety of DTaP­Based Combined Immunization in Very­Low­Birth­Weight Premature Infants: Frequent but Mostly Benign Cardiorespiratory Events. J.Pediatr. 145 (1): 58­66; July, 2004. Pierrynowski­Gallant, D. M.; Vollman, A. R. Influenza Vaccination Choices. Can.Nurse. 100 (2): 16­21; February, 2004. Plotkin, S. A. Of Vaccination and Infectious Diseases in 2003. Adv.Exp.Med.Biol. 549:1­4; 2004. Porco, T. C.; Holbrook, K.; Fernyak, S. E.; Portnoy, D.; Reiter, R.; Aragon, T. J. Logistics of Smallpox Control Through Ring Vaccination: a Stochastic Network Model. BMC.Public Health. 4 (1): 34; August 6, 2004. Portaels, F.; Aguiar, J.; Debacker, M.; Guedenon, A.; Steunou, C.; Zinsou, C.; Meyers, W. M. Mycobacterium Bovis BCG Vaccination As Prophylaxis Against Mycobacterium Ulcerans Osteomyelitis in Buruli Ulcer Disease. Infect Immun. 72 (1): 62­65; January, 2004. Posthouwer, D.; Voorbij, H. A.; Grobbee, D. E.; Numans, M. E.; van der Bom, J. G. Influenza and Pneumococcal Vaccination As a Model to Assess C­
Reactive Protein Response to Mild Inflammation. Vaccine. 23 (3): 362­365; December 2, 2004. Postma, M. J.; Bos, J. M.; Welte, R.; De Groot, R.; Luytjes, W.; Rumke, H. C.; Beutels, P. Do Costs of Varicella Justify Routine Infant Vaccination? Pharmacoeconomic and Clinical Considerations. Eur.J.Health Econ. 5 (1): 54­57; 2004. Poulos, C.; Bahl, R.; Whittington, D.; Bhan, M. K.; Clemens, J. D.; Acosta, C. J. A Cost­Benefit Analysis of Typhoid Fever Immunization Programmes in an Indian Urban Slum Community. J Health Popul Nutr; 22 (3): 311­321; September, 2004. Poyrazoglu, H. M.; Dusunsel, R.; Gunduz, Z.; Patiroglu, T.; Koklu, S. Antibody Response to Influenza A Vaccination in Children With Nephrotic Syndrome. Pediatr Nephrol. 19 (1): 57­60; January, 2004. Premenko­Lanier, M.; Rota, P.; Rhodes, G.; Bellini, W.; McChesney, M. Prior DNA Vaccination Does Not Interfere With the Live­Attenuated Measles Vaccine. Vaccine. 22 (5­6): 763­766; January 26, 2004. Principi, N.; Esposito, S. Are We Ready for Universal Influenza Vaccination in Paediatrics? Lancet Infect.Dis. 4 (2): 75­83; February, 2004. Puig­Barbera, J. [(Vaccines and Pregnancy). Part 2: Protection of the New­Born by Vaccinating Pregnant Women]. Aten.Primaria. 33 (3): 154­160; February 28, 2004. Puig­Barbera, J. [Vaccinations and Pregnancy (I): Vaccines That Are Indicated for Pregnant Women]. Aten.Primaria. 33 (1): 38­43; January, 2004. Puricelli, R. C.; Kupek, E.; Bertoncini, Rde C. [Control of a Community Outbreak of Group C Meningococcal Meningitis in Corupa, Santa Catarina State, Brazil, Based on Rapid and Effective Epidemiological Surveillance and Immunization]. Cad.Saude Publica. 20 (4): 959­967; July, 2004. Quinlivan, M. L.; Gershon, A. A.; Steinberg, S. P.; Breuer, J. Rashes Occurring After Immunization With a Mixture of Viruses in the Oka Vaccine Are Derived From Single Clones of Virus. J.Infect.Dis. 190 (4): 793­796; August 15, 2004. Qureshi, A. M.; Hughes, N. J.; Murphy, E.; Primrose, W. R. Factors Influencing Uptake of Influenza Vaccination Among Hospital­Based Health Care Workers. Occup.Med.(Lond). 54 (3): 197­201; May, 2004. Rager­Zisman, B.; Bazarsky, E.; Skibin, A.; Tam, G.; Chamney, S.; Belmaker, I.; Shai, I.; Kordysh, E.; Griffin, D. E. Differential Immune Responses to Primary Measles­Mumps­Rubella Vaccination in Israeli Children. Clin.Diagn.Lab Immunol. 11 (5): 913­918; September, 2004. Rahbek, S.; Krog, E.; Heilbuth, L.; Lindahl, H.; Bak, A. M.; Lomholdt, I.; Vincents, G. [Easy­Going Attitude to Influenza Vaccination]. Ugeskr.Laeger. 166 (3): 179; January 12, 2004. Raman, S.; Siddiq, T. O.; Joseph, A.; Jones, A. H.; Haray, P. N.; Masoud, A. G. Vaccination Metastasis Following Percutaneous Endoscopic Gastrostomy. Hosp.Med. 65 (4): 246­247; April, 2004. Raufu, A. Traditional Rulers in Northern Nigeria Call for Halt to Polio Vaccination. BMJ. 328 (7435): 306; February 7, 2004. Reading, R.; Surridge, H.; Adamson, R. Infant Immunization and Family Size. J Public Health (Oxf); 26 (4): 369­371; December, 2004. Ready, T. US Soldiers Refuse to Fall in Line With Anthrax Vaccination Scheme. Nat.Med. 10 (2): 112; February, 2004. Redd, S. C.; King, G. E.; Heath, J. L.; Forghani, B.; Bellini, W. J.; Markowitz, L. E. Comparison of Vaccination With Measles­Mumps­Rubella Vaccine at 9, 12, and 15 Months of Age. J.Infect.Dis. 189 Suppl 1:116­22; May 1, 2004. Reed, K.; Ilardi, D. Designed to Expedite: Immunization Registry Information Systems. School Nurse News; 21 (5): 18­21; November, 2004 Reiter, S. [Vaccination Coverage in Germany.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 47 (12): 1144­1150; December, 2004. Rendi­Wagner, P.; Kundi, M.; Zent, O.; Banzhoff, A.; Jaehnig, P.; Stemberger, R.; Dvorak, G.; Grumbeck, E.; Laaber, B.; Kollaritsch, H. Immunogenicity and Safety of a Booster Vaccination Against Tick­Borne Encephalitis More Than 3 Years Following the Last Immunisation. Vaccine. 23 (4): 427­434; December 9, 2004. Rendi­Wagner, P.; Kundi, M.; Zent, O.; Dvorak, G.; Jaehnig, P.; Holzmann, H.; Mikolasek, A.; Kollaritsch, H. Persistence of Protective Immunity Following Vaccination Against Tick­Borne Encephalitis­Longer Than Expected? Vaccine. 22 (21­22): 2743­2749; July 29, 2004. Rentier, B.; Gershon, A. A. Consensus: Varicella Vaccination of Healthy Children­­a Challenge for Europe. Pediatr.Infect.Dis.J. 23 (5): 379­389; May, 2004. Revello, M. G.; Gorini, G.; Zavattoni, M.; Furione, M.; Gerna, G. Congenital Rubella Infection Following Rubella Outbreak in Northern Italy, 2002: Need for an Effective Vaccination Programme. Eur.J.Clin.Microbiol.Infect.Dis. September 10, 2004. Robinson, J. Efficacy of Pneumococcal Immunization in Patients With Renal Disease ­ What Is the Data? Am.J.Nephrol. 24 (4): 402­409; July, 2004. Roost, H. P.; Gassner, M.; Grize, L.; Wuthrich, B.; Sennhauser, F. H.; Varonier, H. S.; Zimmermann, H.; Braun­Fahrlander, Ch Influence of MMR­
Vaccinations and Diseases on Atopic Sensitization and Allergic Symptoms in Swiss Schoolchildren. Pediatr.Allergy Immunol. 15 (5): 401­407; October, 2004. Rose, M.; Hey, C.; Kujumdshiev, S.; Gall, V.; Schubert, R.; Zielen, S. Immunogenicity of Pneumococcal Vaccination of Patients With Cochlear Implants. J.Infect.Dis. 190 (3): 551­557; August 1, 2004. Rosen, J. B.; Breman, J. G. Malaria Intermittent Preventive Treatment in Infants, Chemoprophylaxis, and Childhood Vaccinations. Lancet. 363 (9418): 1386­
1388; April 24, 2004. Roth, A.; Jensen, H.; Garly, M. L.; Djana, Q.; Martins, C. L.; Sodemann, M.; Rodrigues, A.; Aaby, P. Low Birth Weight Infants and Calmette­Guerin Bacillus Vaccination at Birth: Community Study From Guinea­Bissau. Pediatr.Infect.Dis.J. 23 (6): 544­550; June, 2004. Rothberg, M. Prioritizing Influenza Vaccination. JAMA; 292 (21): 2582­2583; December 1, 2004. Rottem, M.; Shoenfeld, Y. Vaccination and Allergy. Curr.Opin.Otolaryngol.Head Neck Surg. 12 (3): 223­231; June, 2004. Rubin, G. L.; Baird, J. H. New Recommendation on Japanese Encephalitis Vaccination for Travellers to Papua New Guinea. Med.J.Aust. 181 (5): 283; September 6, 2004. Rubinstein, E. Vaccination and Autoimmune Diseases: the Argument Against. Isr.Med.Assoc.J. 6 (7): 433­435; July, 2004. Rudis, M. I.; Stone, S. C.; Goad, J. A.; Lee, V. W.; Chitchyan, A.; Newton, K. I. Pneumococcal Vaccination in the Emergency Department: an Assessment of Need. Ann.Emerg.Med. 44 (4): 386­392; October, 2004. Russell, M.; Pool, V.; Kelso, J. M.; Tomazic­Jezic, V. J. Vaccination of Persons Allergic to Latex: a Review of Safety Data in the Vaccine Adverse Event Reporting System (). Vaccine. 23 (5): 664­667; December 16, 2004. Salerno­Goncalves, R.; Fernandez­Vina, M.; Lewinsohn, D. M.; Sztein, M. B. Identification of a Human HLA­E­Restricted CD8+ T Cell Subset in Volunteers Immunized With Salmonella Enterica Serovar Typhi Strain Ty21a Typhoid Vaccine. J Immunol. 173 (9): 5852­5862; November 1, 2004. Salmon, D. A.; Moulton, L. H.; Omer, S. B.; Chace, L. M.; Klassen, A.; Talebian, P.; Halsey, N. A. Knowledge, Attitudes, and Beliefs of School Nurses and Personnel and Associations With Nonmedical Immunization Exemptions. Pediatrics. 113 (6): e552­e559; June, 2004. Sands, B. E.; Cuffari, C.; Katz, J.; Kugathasan, S.; Onken, J.; Vitek, C.; Orenstein, W. Guidelines for Immunizations in Patients With Inflammatory Bowel Disease. Inflamm.Bowel.Dis. 10 (5): 677­692; September, 2004. Santibanez, T. A.; Zimmerman, R. K.; Nowalk, M. P.; Jewell, I. K.; Bardella, I. J. Physician Attitudes and Beliefs Associated With Patient Pneumococcal Polysaccharide Vaccination Status. Ann.Fam.Med. 2 (1): 41­48; January, 2004. Saravana, S. Uptake of Influenza Vaccination in Rheumatology Patients. Rheumatology.(Oxford). 43 (8): 1055; August, 2004. Sartor, C.; Tissot­Dupont, H.; Zandotti, C.; Martin, F.; Roques, P.; Drancourt, M. Use of a Mobile Cart Influenza Program for Vaccination of Hospital Employees. Infect Control Hosp Epidemiol. 25 (11): 918­922; November, 2004. Scala­Foley, M. A.; Caruso, J. T.; Archer, D.; Reinhard, S. C. Medicare's Preventive Services. Am.J.Nurs. 104 (4): 73­75; April, 2004. Schattenfroh, C. [Acute Disseminated Encephalomyelitis After Immunization Against Tick­Borne Encephalitis]. Nervenarzt. 75 (8): 776­779; August, 2004. Schattner, A.; Berrebi, A. Several Possible Causes for Multiple Myeloma Including a Vaccination in a Single Case Study. Vaccine. 22 (20): 2509­2510; June 30, 2004. Schetgen, M. [General Practitioners and Vaccination Coverage]. Rev Med Brux. 25 (4): A209­A211; September, 2004. Schlenker, T. Anti­Vaccinationists and Their Impact on Vaccination Coverage in Wisconsin. WMJ. 103 (5): 79­83; 2004. Schumm, W. R. Bioterrorism and Compulsory Vaccination: Arguments for Current Vaccines Are Based on Inadequate Support for Older Vaccines. BMJ. 329 (7472): 977­978; October 23, 2004. Schwab, J.; Ryan, M. Varicella Zoster Virus Meningitis in a Previously Immunized Child. Pediatrics. 114 (2): e273­e274; August, 2004. Schwartz, M. Protective Autoimmunity and Prospects for Therapeutic Vaccination Against Self­Perpetuating Neurodegeneration. Ernst.Schering.Res.Found.Workshop.47): 133­154; 2004. Schwarz, Chavarri H.; Ortuno Lopez, J. L.; Pedrera, Carbonell, V; Orozco, Beltran D. [Flu Vaccination During Pregnancy: at Present, Utopian.]. Aten.Primaria. 34 (6): 328; October 15, 2004. Schwarz, Chavarri H.; Pedrera, Carbonell, V; Ortuno Lopez, J. L.; Orozco, Beltran D.; Gil, Guillen, V; Pastor Climent, M. A. [Influence of Physician and Physician List Characteristics on Influenza Vaccination Rates in Older People in a Health Care Area in the Community of Valencia, Spain.]. Aten.Primaria. 34 (7): 336­342; October 31, 2004. Scuffham, P. A.; McIntyre, P. B. Pertussis Vaccination Strategies for Neonates­an Exploratory Cost­Effectiveness Analysis. Vaccine. 22 (21­22): 2953­2964; July 29, 2004. Selekman, J. Immunization Schedule 2004. Pediatr.Nurs. 30 (2): 156­157; March, 2004. Selgelid, M. J. Bioterrorism and Smallpox Planning: Information and Voluntary Vaccination. J Med Ethics; 30 (6): 558­560; December, 2004. Sendi, P.; Locher, R.; Bucheli, B.; Battegay, M. The Decision to Get Vaccinated Against Influenza. Am.J.Med. 116 (12): 856­858; June 15, 2004. Sengupta, S.; Strauss, R. P.; Corbie­Smith, G.; Thrasher, A. What Can the Elderly Do to Protect Themselves From the Flu in Addition to Getting a Flu Vaccination? Am.J.Public Health. 94 (6): 905­906; June, 2004. Senterre, J. [Varicella Vaccination]. Rev Med Brux. 25 (4): A223­A226; September, 2004. Sepkowitz, K. A. The 1947 Smallpox Vaccination Campaign in New York City, Revisited. Emerg.Infect.Dis. 10 (5): 960­961; May, 2004. Serrano, I.; Ramirez, M.; Melo­Cristino, J. Invasive Streptococcus Pneumoniae From Portugal: Implications for Vaccination and Antimicrobial Therapy. Clin.Microbiol.Infect. 10 (7): 652­656; July, 2004. Sharma, M. K.; Bhatia, V.; Swami, H. M. Outbreak of Measles Amongst Vaccinated Children in a Slum of Chandigarh. Indian J.Med.Sci. 58 (2): 47­53; February, 2004. Shefer, A.; Smith, P. J. Improving the Immunization and Health Status of Children in the Women, Infants, and Children (WIC) Program. J.Health Care Poor Underserved. 15 (1): 127­140; February, 2004. Shetty, P. Weapons of Mass Vaccination. Lancet Infect.Dis. 4 (3): 129; March, 2004. Shulman, S. T. Immunizations: the Greatest Good. Pediatricians Must Advocate for Children at the National, State, and Local Levels. Pediatr.Ann. 33 (8): 489; August, 2004. Siedler, A.; Leitmeyer, K. [Relevance of Sentinel Surveillance Systems for the Implementation and Evaluation of Vaccination Strategies.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 47 (12): 1136­1143; December, 2004. Singleton, J. A.; Wortley, P.; Lu, P. J. Influenza Vaccination of Persons With Cardiovascular Disease in the United States. Tex.Heart Inst.J. 31 (1): 22­27; 2004. Skowronski, D. M.; Pielak, K.; Remple, V. P.; Halperin, B. A.; Patrick, D. M.; Naus, M.; McIntyre, C. Adult Tetanus, Diphtheria and Pertussis Immunization: Knowledge, Beliefs, Behavior and Anticipated Uptake. Vaccine. 23 (3): 353­361; December 2, 2004. Slater, P. E.; Leventhal, A. Immunization Saves Lives. Isr.Med.Assoc.J. 6 (10): 646­647; October, 2004. Slominski, J. M.; Kubiak, A. [Pharmacoeconomics of Vaccinations in Chronic Obstructive Pulmonary Disease]. Pol Merkuriusz Lek. 16 Suppl 1: 83­85; May, 2004. Smeeth, L.; Cook, C.; Fombonne, E.; Heavey, L.; Rodrigues, L. C.; Smith, P. G.; Hall, A. J. MMR Vaccination and Pervasive Developmental Disorders: a Case­Control Study. Lancet. 364 (9438): 963­969; September 11, 2004. Smeeth, L.; Thomas, S. L.; Hall, A. J.; Hubbard, R.; Farrington, P.; Vallance, P. Risk of Myocardial Infarction and Stroke After Acute Infection or Vaccination. N Engl J Med; 351 (25): 2611­2618; December 16, 2004. Smith, J. A.; Casey, C. G.; Tierney, B. C. The Ocular Complications of Smallpox and Smallpox Immunization. Arch.Ophthalmol. 122 (9): 1407­1408; September, 2004. Soeung, S. C.; Grundy, J.; Biggs, B. A.; Boreland, M.; Cane, J.; Samnang, C.; Maynard, J. Management Systems Response to Improving Immunization Coverage in Developing Countries: a Case Study From Cambodia. Rural Remote Health; 4 (2): 263; April, 2004. Southern, J.; Deane, S.; Ashton, L.; Borrow, R.; Goldblatt, D.; Andrews, N.; Balmer, P.; Morris, R.; Kroll, J. S.; Miller, E. Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults. Clin Diagn Lab Immunol. 11 (6): 1100­1104; November, 2004. Speers, T.; Lewis, J. Journalists and Jabs: Media Coverage of the MMR Vaccine. Commun Med; 1 (2): 171­181; 2004. Spoulou, V.; Giannaki, M.; Vounatsou, M.; Bakoula, C.; Grafakos, S. Long­Term Immunity to Measles, Mumps and Rubella After MMR Vaccination Among Children With Bone Marrow Transplants. Bone Marrow Transplant. April 12, 2004. Staines, D. R. Is Osteoporosis Linked to Vaccinations and Gulf War Syndrome? Med.Hypotheses. 62 (5): 670­673; 2004. Stanwyck, C. A.; Kolasa, M. S.; Shaw, K. M. Immunization Requirements for Childcare Programs; Are They Enough? Am.J.Prev.Med. 27 (2): 161­163; August, 2004. Staszewski, V.; Boulinier, T. Vaccination: a Way to Address Questions in Behavioral and Population Ecology? Trends Parasitol. 20 (1): 17­22; January, 2004. Stephenson, L. Vaccinating Health Care Workers for Influenza­­a Real Patient Safety Issue. Iowa Med. 94 (5): 24­26; September, 2004. Steyer, T. E.; Ragucci, K. R.; Pearson, W. S.; Mainous, A. G., III The Role of Pharmacists in the Delivery of Influenza Vaccinations. Vaccine. 22 (8): 1001­
1006; February 25, 2004. Stipic­Markovic, A.; Pevec, B.; Radulovic, Pevec M.; Custovic, A.; Predovic, J. Allergic Diseases in Relationship With Environmental Factors in a Population of School Children in Zagreb, Croatia. Arh.Hig.Rada Toksikol. 55 (2­3): 221­228; June, 2004. Strid, J.; Hourihane, J.; Kimber, I.; Callard, R.; Strobel, S. Disruption of the Stratum Corneum Allows Potent Epicutaneous Immunization With Protein Antigens Resulting in a Dominant Systemic Th2 Response. Eur.J.Immunol. 34 (8): 2100­2109; August, 2004. Sulsky, S. I.; Grabenstein, J. D.; Delbos, R. G. Disability Among U.S. Army Personnel Vaccinated Against Anthrax. J Occup Environ Med; 46 (10): 1065­
1075; October, 2004. Tacken, M. A.; Braspenning, J. C.; Berende, A.; Hak, E.; De Bakker, D. H.; Groenewegen, P. P.; Grol, R. P. Vaccination of High­Risk Patients Against Influenza: Impact on Primary Care Contact Rates During Epidemics; Analysis of Routinely Collected Data. Vaccine. 22 (23­24): 2985­2992; August 13, 2004. Talbot, T. R.; Stapleton, J. T.; Brady, R. C.; Winokur, P. L.; Bernstein, D. I.; Germanson, T.; Yoder, S. M.; Rock, M. T.; Crowe, J. E., Jr.; Edwards, K. M. Vaccination Success Rate and Reaction Profile With Diluted and Undiluted Smallpox Vaccine: a Randomized Controlled Trial. JAMA. 292 (10): 1205­
1212; September 8, 2004. Talbot, T. R.; Ziel, E.; Doersam, J. K.; LaFleur, B.; Tollefson, S.; Edwards, K. M. Risk of Vaccinia Transfer to the Hands of Vaccinated Persons After Smallpox Immunization. Clin.Infect.Dis. 38 (4): 536­541; February 15, 2004. Tam, T.; Langley, J. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: Statement on Influenza Vaccination for the 2003­04 Season. Can.Commun.Dis.Rep. 30:1­5; March 1, 2004. Tanabe, T.; Awaya, Y.; Matsuishi, T.; Nagai, T.; Yamamoto, K.; Kurihara, M.; Iyoda, K.; Maekawa, K. [Survey of Vaccination and Viral Infections for Children With Severe Myoclonic Epilepsy in Infancy]. No To Hattatsu. 36 (4): 318­323; July, 2004. Temime, L.; Guillemot, D.; Boelle, P. Y. Short­ and Long­Term Effects of Pneumococcal Conjugate Vaccination of Children on Penicillin Resistance. Antimicrob.Agents Chemother. 48 (6): 2206­2213; June, 2004. Texier, S.; Dermu, M. [Tetanus in a Man Presenting With a Chronic Wound]. Presse Med. 33 (11): 759­760; June, 2004. Thiry, N.; Beutels, P.; Tancredi, F.; Romano, L.; Zanetti, A.; Bonanni, P.; Gabutti, G.; Damme, P. V. An Economic Evaluation of Varicella Vaccination in Italian Adolescents. Vaccine. 22 (27­28): 3546­3562; September 9, 2004. Thiry, N.; Beutels, P.; Van Damme, P.; Van Doorslaer, E. Economic Evaluation of Varicella Vaccination Programmes: a Review of the Literature. The Authors' Reply. Pharmacoeconomics. 22 (2): 136­138; 2004. Thomas, M. Prevention of Group B Meningococcal Disease by Vaccination: a Difficult Task. N.Z.Med.J. 117 (1200): U1016; August, 2004. Thomas, M.; Kohli, V.; King, D. Barriers to Childhood Immunization:Findings From a Needs Assessment Study. Home.Health Care Serv.Q. 23 (2): 19­39; 2004. Thorpe, L. E.; Mostashari, F.; Karpati, A. M.; Schwartz, S. P.; Manning, S. E.; Marx, M. A.; Frieden, T. R. Mass Smallpox Vaccination and Cardiac Deaths, New York City, 1947. Emerg.Infect.Dis. 10 (5): 917­920; May, 2004. Thwaites, C. L.; Yen, L. M.; Nga, N. T.; Parry, J.; Binh, N. T.; Loan, H. T.; Thuy, T. T.; Bethell, D.; Parry, C. M.; White, N. J.; Day, N. P.; Farrar, J. J. Impact of Improved Vaccination Programme and Intensive Care Facilities on Incidence and Outcome of Tetanus in Southern Vietnam, 1993­
2002.Trans.R.Soc.Trop.Med.Hyg. 98 (11): 671­677; November, 2004. Tishler, M.; Shoenfeld, Y. Vaccination May Be Associated With Autoimmune Diseases. Isr.Med.Assoc.J. 6 (7): 430­432; July, 2004. Titchner, P. Did Immunizations Kill My Babies? Midwifery Today Int Midwife. 71: 42­43; Autumn 2004. Toole, K.; Perry, C. S. Increasing Immunization Compliance. J.Sch Nurs. 20 (4): 203­208; August, 2004. Tracy, G. E. Immunization 2004­­Medicare Reimbursement and Coding. S D J Med; 57 (10): 447; October, 2004. Trautner, B. W.; Atmar, R. L.; Hulstrom, A.; Darouiche, R. O. Inactivated Influenza Vaccination for People With Spinal Cord Injury. Arch Phys Med Rehabil. 85(11): 1886­1889; November, 2004. Tuckwell, H. C. A Note on Vaccination Against Meningococcal Meningitis in Infants. Epidemiol.Infect. 132 (5): 999­1000; October, 2004. Tugwell, B. D.; Lee, L. E.; Gillette, H.; Lorber, E. M.; Hedberg, K.; Cieslak, P. R. Chickenpox Outbreak in a Highly Vaccinated School Population. Pediatrics. 113 (3 Pt 1): 455­459; March, 2004. Turner, N. Concerns of Health Providers and Parents Affect Immunisation Coverage. N.Z.Med.J. 117 (1189): U766; February, 2004. Uiterwyk, S. H. Pneumococcal Vaccine: to Vaccinate or to Revaccinate­­That Is the Question. Med.Health R.I. 87 (3): 68­71; March, 2004. Updated Interim Influenza Vaccination Recommendations­­2004­05 Influenza Season. MMWR Morb Mortal Wkly Rep; 53 (50): 1183­1184; December 24, 2004. Upfal, M. J.; Cinti, S. Smallpox Vaccination and Adverse Cardiac Events. Emerg.Infect.Dis. 10 (5): 961­962; May, 2004. Utz, S.; Richard, J. L.; Capaul, S.; Matter, H. C.; Hrisoho, M. G.; Muhlemann, K. Phylogenetic Analysis of Clinical Mumps Virus Isolates From Vaccinated and Non­Vaccinated Patients With Mumps During an Outbreak, Switzerland 1998­2000. J.Med.Virol. 73 (1): 91­96; May, 2004. Uzicanin, A.; Zhou, F.; Eggers, R.; Webb, E.; Strebel, P. Economic Analysis of the 1996­1997 Mass Measles Immunization Campaigns in South Africa. Vaccine. 22 (25­26): 3419­3426; September 3, 2004. van den Bosch, W. J. Pneumococcal Vaccination for Healthy Elderly: a Comment. Neth.J.Med. 62 (2): 66­68; February, 2004. van Neerven, R. J.; Arvidsson, M.; Ipsen, H.; Sparholt, S. H.; Rak, S.; Wurtzen, P. A. A Double­Blind, Placebo­Controlled Birch Allergy Vaccination Study: Inhibition of CD23­Mediated Serum­Immunoglobulin E­Facilitated Allergen Presentation. Clin.Exp.Allergy. 34 (3): 420­428; March, 2004. Vandermeulen, C.; Roelants, M.; Vermoere, M.; Roseeuw, K.; Goubau, P.; Hoppenbrouwers, K. Outbreak of Mumps in a Vaccinated Child Population: a Question of Vaccine Failure? Vaccine. 22 (21­22): 2713­2716; July 29, 2004. Vargas, M. H.; Bernal­Alcantara, D. A.; Vaca, M. A.; Franco­Marina, F.; Lascurain, R. Effect of BCG Vaccination in Asthmatic Schoolchildren. Pediatr.Allergy Immunol. 15 (5): 415­420; October, 2004. Vaugelade, J.; Pinchinat, S.; Guiella, G.; Elguero, E.; Simondon, F. Non­Specific Effects of Vaccination on Child Survival: Prospective Cohort Study in Burkina Faso. BMJ. 329 (7478): 1309; December 4, 2004. Vazquez, M.; LaRussa, P. S.; Gershon, A. A.; Niccolai, L. M.; Muehlenbein, C. E.; Steinberg, S. P.; Shapiro, E. D. Effectiveness Over Time of Varicella Vaccine. JAMA. 291 (7): 851­855; February 18, 2004. Veenhoven, R. H.; Bogaert, D.; Schilder, A. G.; Rijkers, G. T.; Uiterwaal, C. S.; Kiezebrink, H. H.; van Kempen, M. J.; Dhooge, I. J.; Bruin, J.; Ijzerman, E. P.; de Groot, R.; Kuis, W.; Hermans, P. W.; Sanders, E. A. Nasopharyngeal Pneumococcal Carriage After Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Children With a History of Recurrent Acute Otitis Media. Clin.Infect.Dis. 39 (7): 911­919; October 1, 2004. Vellozzi, C.; Averhoff, F.; Lane, J. M.; Wen, X.; Moore, A. C.; Santibanez, S.; Kroger, A.; Hasbrouck, L. M.; Kennedy, A.; Casey, C. G. Superinfection Following Smallpox Vaccination (Vaccinia), United States: Surveillance January 2003 Through January 2004. Clin Infect Dis; 39 (11): 1660­1666; December 1, 2004. Verschuur, M.; Van Der Beek, M. T.; Tak, H. S.; Visser, L. G.; De Maat, M. P. Interindividual Variation in the Response by Fibrinogen, C­Reactive Protein and Interleukin­6 to Yellow Fever Vaccination. Blood Coagul.Fibrinolysis. 15 (5): 399­404; July, 2004. Vestergaard, M.; Hviid, A.; Madsen, K. M.; Wohlfahrt, J.; Thorsen, P.; Schendel, D.; Melbye, M.; Olsen, J. MMR Vaccination and Febrile Seizures: Evaluation of Susceptible Subgroups and Long­Term Prognosis. JAMA. 292 (3): 351­357; July 21, 2004. Vial, T.; Descotes, J. Autoimmune Diseases and Vaccinations. Eur.J.Dermatol. 14 (2): 86­90; March, 2004. Vila, Corcoles A.; Ochoa, Gondar O.; Hospital, Guardiola, I; Bria, Ferre, X; Llor, Vila C.; Montanes, Boncompte D.; Estudio EVAN, Gd G. [EVAN­65 Project: Evaluation of the Effectiveness of Pneumococcus Vaccination in the Over­65s]. Aten.Primaria. 33 (3): 149­153; February 28, 2004. Vincents, G. [Influenza Vaccination]. Ugeskr.Laeger. 166 (7): 612; February 9, 2004. Vogtlander, N. P.; Brown, A.; Valentijn, R. M.; Rimmelzwaan, G. F.; Osterhaus, A. D. Impaired Response Rates, but Satisfying Protection Rates to Influenza Vaccination in Dialysis Patients. Vaccine. 22 (17­18): 2199­2201; June 2, 2004. Wagenpfeil, S.; Neiss, A.; Banz, K.; Wutzler, P. Empirical Data on the Varicella Situation in Germany for Vaccination Decisions. Clin.Microbiol.Infect. 10 (5): 425­430; May, 2004. Wagenpfeil, S.; Neiss, A.; Wutzler, P. Effects of Varicella Vaccination on Herpes Zoster Incidence. Clin Microbiol Infect. 10 (11): 954­960; November, 2004. Waibel, K. H.; Ager, E. P.; Topolski, R. L.; Walsh, D. S. Randomized Trial Comparing Vaccinia on the External Surfaces of 3 Conventional Bandages Applied to Smallpox Vaccination Sites in Primary Vaccinees. Clin.Infect.Dis. 39 (7): 1004­1007; October 1, 2004. Wakefield, A. J.; Harvey, P.; Linnell, J. MMR­­Responding to Retraction. Lancet. 363 (9417): 1327­1328; April 17, 2004. Walker, R. I.; Blanchard, T.; Braun, J. M.; Cebra, J. J.; Cross, A. S.; Fattom, A.; Giannasca, P. J.; Holder, I. A.; Huebner, J.; Matthews, R.; Pier, G. B.; Romani, L.; von Specht, B. U.; Trautmann, M. Meeting Summary: Possibilities for Active and Passive Vaccination Against Opportunistic Infections. Vaccine. 22 (7): 801­804; February 17, 2004. Wallis, D. H.; Chin, J. L.; Sur, D. K. Influenza Vaccination in Pregnancy: Current Practices in a Suburban Community. J.Am.Board Fam.Pract. 17 (4): 287­
291; July, 2004. Wang, C. S.; Wang, S. T.; Lai, C. T.; Lin, L. J.; Lee, C. T.; Chou, P. Reducing Major Cause­Specific Hospitalization Rates and Shortening Hospital Stays After Influenza Vaccination. Clin Infect Dis; 39 (11): 1604­1610; December 1, 2004. Warner, E. A.; Seleznick, M. J. Using Medical Record Reminders to Improve Pneumococcal Vaccination Rates. Jt.Comm J.Qual.Saf. 30 (6): 331­334; June, 2004. Wasfy, J. H. Childhood Vaccination and Type 1 Diabetes. N.Engl.J.Med. 351 (3): 298; July 15, 2004. Watson, M.; Roche, P.; Bayley, K.; Bell, J. M.; Collignon, P.; Gilbert, G. L.; Hogg, G.; Keil, A. D.; Krause, V.; Murphy, D.; Smith, H. V.; Brown, M.; Stylianopoulos, J.; Turnidge, J. Laboratory Surveillance of Invasive Pneumococcal Disease in Australia, 2003 Predicting the Future Impact of the Universal Childhood Conjugate Vaccine Program. Commun Dis Intell; 28 (4): 455­464; 2004. Way, A. B. Choices About Meningococcal Vaccination. N.Engl.J.Med. 350 (11): 1156; March 11, 2004. Weaver, F. M.; Goldstein, B.; Hammond, M. Improving Respiratory Vaccination Rates in Veterans With Spinal Cord Injury/Disorders: Lessons Learned. SCI Nurs. 21 (3): 143­148; 2004. Weaver, F. M.; Hatzakis, M.; Evans, C. T.; Smith, B.; LaVela, S. L.; Wallace, C.; Legro, M. W.; Goldstein, B. A Comparison of Multiple Data Sources to Identify Vaccinations for Veterans With Spinal Cord Injuries and Disorders. J.Am.Med.Inform.Assoc. June 7, 2004. Weber, C. J. Update on Immunizations for Older Adults. Urol.Nurs. 24 (4): 352­353; August, 2004. Welte, R.; Dobbelsteen, G. V.; Bos, J. M.; Melker, H. D.; Alphen, L. V.; Spanjaard, L.; Rumke, H. C.; Postma, M. J. Economic Evaluation of Meningococcal Serogroup C Conjugate Vaccination Programmes in The Netherlands and Its Impact on Decision­Making. Vaccine. 23 (4): 470­479; December 9, 2004. Wharton, M. Prevention of Pertussis Among Adolescents by Vaccination: Taking Action on What We Know and Acknowledging What We Do Not Know. Clin.Infect.Dis. 39 (1): 29­30; July 1, 2004. Whitehill, J.; Raucci, J.; Sandritter, T. Childhood Immunizations (Part Two). J.Pediatr.Health Care. 18 (4): 192­197; July, 2004. Wiertsema, S. P.; Sanders, E. A.; Veenhoven, R. H.; Heerbeek, N. V.; Hof, S. V.; Berbers, G. A.; Rijkers, G. T. Antibody Levels After Regular Childhood Vaccinations in the Immunological Screening of Children With Recurrent Otitis Media. J.Clin.Immunol. 24(4): 354­360; July, 2004. Wilde, H.; Khawplod, P.; Hemachudha, T. Simulated Post­Exposure Rabies Vaccination: Comments on Article by Madhusudana Et Al. Int.J.Infect.Dis. 8 (6): 374­375; November, 2004. Wilson, K.; Mills, E.; Boon, H.; Tomlinson, G.; Ritvo, P. A Survey of Attitudes Towards Paediatric Vaccinations Amongst Canadian Naturopathic Students. Vaccine. 22 (3­4): 329­334; January 2, 2004. Wirrell, E.; Hill, M. D.; Jadavji, T.; Kirton, A.; Barlow, K. Stroke After Varicella Vaccination. J Pediatr; 145 (6): 845­847; December, 2004. Wollenberg, A.; Engler, R. Smallpox, Vaccination and Adverse Reactions to Smallpox Vaccine. Curr.Opin.Allergy Clin.Immunol. 4 (4): 271­275; August, 2004. Wongsurakiat, P.; Maranetra, K. N.; Gulprasutdilog, P.; Aksornint, M.; Srilum, W.; Ruengjam, C.; Sated, W. Adverse Effects Associated With Influenza Vaccination in Patients With COPD: a Randomized Controlled Study. Respirology; 9 (4): 550­556; November, 2004. Wongsurakiat, P.; Maranetra, K. N.; Wasi, C.; Kositanont, U.; Dejsomritrutai, W.; Charoenratanakul, S. Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination: a Randomized Controlled Study. Chest. 125 (6): 2011­2020; June, 2004. Woo, E. J.; Ball, R.; Bostrom, A.; Shadomy, S. V.; Ball, L. K.; Evans, G.; Braun, M. Vaccine Risk Perception Among Reporters of Autism After Vaccination: Vaccine Adverse Event Reporting System 1990­2001. Am.J.Public Health. 94 (6): 990­995; June, 2004. Wood, C.; Baeyer, C. L.; Bourrillon, A.; Dejos­Conant, V.; Clyti, N.; Abitbol, V. Self­Assessment of Immediate Post­Vaccination Pain After Two Different MMR Vaccines Administered As a Second Dose in 4­ to 6­Year­Old Children. Vaccine. 23 (2): 127­131; November 25, 2004. Wright, S. A.; Taggart, A. J. Pneumococcal Vaccination for RA Patients on TNF­{Alpha} Antagonists. Rheumatology.(Oxford). 43 (4): 523; April, 2004. Wu, H. M.; Abrutyn, E. Influenza and Pneumococcal Vaccination: How Far We Have Come and How to Go Farther. Infect Control Hosp Epidemiol. 25 (11): 901­903; November, 2004. Wu, H. X.; Chen, Q.; Li, J. D.; Huang, X. F. Dynamics of Intestinal Flora After Oral Vaccination With Inactivated Whole­Cell/Recombinant B Subunit O139 Cholera Vaccine. Di Yi.Jun.Yi.Da.Xue.Xue.Bao. 24 (2): 220­222; February, 2004. Yavuz, T.; Arbak, P.; Ozturk, C. E.; Kocabay, K. [BCG Vaccination: Where Are We Now?]. Tuberk.Toraks. 52 (1): 47­51; 2004. Yohannes, K.; Roche, P.; Hampson, A.; Miller, M.; Spencer, J. Annual Report of the National Influenza Surveillance Scheme, 2003. Commun.Dis.Intell. 28 (2): 160­168; 2004. Young, D. C.; Bleyl, K.; Clark, T.; Oderda, G.; Liou, T. G. Increasing Pneumococcal Vaccination Rates Among Adults With Cystic Fibrosis. Am.J.Health Syst.Pharm. 61 (14): 1490­1493; July 15, 2004. Zambon, M. C. Ethics Versus Evidence in Influenza Vaccination. Lancet; 364 (9452): 2161­2163; December 18, 2004. Zangwill, K. M.; Belshe, R. B. Safety and Efficacy of Trivalent Inactivated Influenza Vaccine in Young Children: a Summary for the New Era of Routine Vaccination. Pediatr.Infect.Dis.J. 23 (3): 189­197; March, 2004. Zarocostas, J. UNICEF Taps Religious Leaders in Vaccination Push. Lancet. 363 (9422): 1709; May 22, 2004. Zent, O.; Plentz, A.; Schwarz, T. F.; Fruhwein, N.; Kuhr, H. B.; Broeker, M.; Banzhoff, A.; Jilg, W. TBE Booster Immunization According to the Rapid Immunization Schedule: Are 3­Year Booster Intervals Really Necessary? Vaccine. 23 (3): 312­315; December 2, 2004. Zetterstrom, R. Flawed Reports of Immunization Complications: Consequences for Child Health. Acta Paediatr. 93 (9): 1140­1143; September, 2004. Zhao, Z.; Mokdad, A. H.; Barker, L. Impact of Health Insurance Status on Vaccination Coverage in Children 19­35 Months Old, United States, 1993­1996. Public Health Rep. 119 (2): 156­162; March, 2004. Zhou, F.; Reef, S.; Massoudi, M.; Papania, M. J.; Yusuf, H. R.; Bardenheier, B.; Zimmerman, L.; McCauley, M. M. An Economic Analysis of the Current Universal 2­Dose Measles­Mumps­Rubella Vaccination Program in the United States. J.Infect.Dis. 189 Suppl 1:131­45; May 1, 2004. Zielinski, A.; Rosinska, M.; Czarkowski, M.; Rudowska, J. The Effectiveness of Vaccination With Whole­Cell Pertussis Vaccine by Age Group in Poland 1996­2001. Scand.J.Infect.Dis. 36 (2): 114­118; 2004. Zimmerman, R. K. Recommended Childhood and Adolescent Immunization Schedule, United States, January to June, 2004 and Update on Childhood Immunizations. Am.Fam.Physician. 69 (1): 206­211; January 1, 2004. Zimmerman, R. K.; Hoberman, A.; Nowalk, M. P.; Lin, C. J.; Greenberg, D. P.; Weinberg, S. T.; Bemm, C. W.; Block, B. Feasibility of Influenza Immunization for Inner­City Children Aged 6 to 23 Months. Am J Prev Med. 27 (5): 397­403; November 24, 2004. Zweiman, B.; Rothenberg, M. E. Sisk Et Al. Cost­Effectiveness of Vaccination Against Invasive Pneumococcal Disease Among People 50 Through 64 Years of Age: Role of Comorbid Conditions and Race. Ann Intern Med 2003 17;138:960­8. J.Allergy Clin.Immunol. 113 (1): 186; January, 2004. 2005 Aaby, P.; Jensen, H.; Benn, C. S.; Lisse, I. M. Non­Specific Effects of Vaccination: Survival Bias May Explain Findings. BMJ; 330 (7495): 844­845; April 9, 2005. Acosta­Ramirez; .; Duran­Arenas, L. G.; Eslava­Rincon, J. I.; Campuzano­Rincon, J. C. Determinants of Vaccination After the Colombian Health System Reform. Rev Saude Publica; 39 (3): 421­429; June, 2005. Ada, G. Overview of Vaccines and Vaccination. Mol Biotechnol; 29 (3): 255­272; March, 2005. Adler, U. C. The Influence of Childhood Infections and Vaccination on the Development of Atopy: a Systematic Review of the Direct Epidemiological Evidence. Homeopathy; 94 (3): 182­195; July, 2005. Afridi, N. K.; Hatcher, J.; Mahmud, S.; Nanan, D. Coverage and Factors Associated With Tetanus Toxoid Vaccination Status Among Females of Reproductive Age in Peshawar. J Coll Physicians Surg Pak; 15 (7): 391­395; July, 2005. Agarwal, S.; Bhanot, A.; Goindi, G. Understanding and Addressing Childhood Immunization Coverage in Urban Slums. Indian Pediatr; 42 (7): 653­663; July, 2005. Agol, V. I.; Chumakov, K.; Ehrenfeld, E.; Wimmer, E. Don't Drop Current Vaccine Until We Have New Ones. Nature; 435 (7044): 881; June 16, 2005. Ahmad, K. Polio Vaccination Campaign Starts in Yemen. Lancet Neurol; 4 (7): 398; July, 2005. Ajani, U. A.; Ford, E. S.; Mokdad, A. H. Examining the Coverage of Influenza Vaccination Among People With Cardiovascular Disease in the United States. Am Heart J; 149 (2): 254­259; February, 2005. Alexander, M. E.; Moghadas, S. M.; Rohani, P.; Summers, A. R. Modelling the Effect of a Booster Vaccination on Disease Epidemiology. J Math Biol; November 10, 2005. Alfageme, I.; Vazquez, R.; Reyes, N.; Munoz, J.; Fernandez, A.; Hernandez, M.; Merino, M.; Perez, J.; Lima, J. Clinical Efficacy of Anti­Pneumococcal Vaccination in Patients With COPD. Thorax; October 14, 2005. Alp, H.; Altinkaynak, S.; Arikan, D.; Ozyazicioglu, N. Adolescent Immunization Rates and the Effect of Socio­Demographic Factors on Immunization in a Cosmopolitan City (ERZURUM) in the Eastern Turkey. Health Policy; July 28, 2005. Amanna, I.; Slifka, M. K. Public Fear of Vaccination: Separating Fact From Fiction. Viral Immunol; 18 (2): 307­315; 2005. Andersson, N.; Cockcroft, A.; Ansari, N.; Omer, K.; Losos, J.; Ledogar, B.; Tugwell, P.; Shea, B. Household Cost­Benefit Equations and Sustainable Universal Childhood Immunization: a Randomised Cluster Controlled Trial in South Pakistan [ISRCTN12421731]. BMC Public Health; 5 (1): 72; June 28, 2005. Arenz, S.; Schmitt, H. J.; Tischer, A.; von, Kries R. Effectiveness of Measles Vaccination After Household Exposure During a Measles Outbreak: a Household Contact Study in Coburg, Bavaria. Pediatr Infect Dis J; 24 (8): 697­699; August, 2005. Arya, S. C.; Agarwal, N. Extended Adult Vaccination Coverage in Switzerland. Swiss Med Wkly; 135 (27­28): 415; July 9, 2005. Arya, S. C.; Agarwal, N. Vaccinated but Not Immunized: Healthcare Personnel in Developing Countries. J Hosp Infect; 60 (3): 290­291; July, 2005. Atabek, M. E.; Pirgon, O. Tetanus in a Fully Immunized Child. J Emerg Med; 29 (3): 345­346; October, 2005. Auckland, C.; Cowlishaw, A.; Morgan, D.; Miller, E. Reactions to Small Pox Vaccine in Naive and Previously­Vaccinated Individuals. Vaccine; April 15, 2005. Autran, B. [Vaccination: Recall or Second Dose, Semantic Difference or Immunologic Reality?]. Arch Pediatr; 12 (Spec No 4): 2­4; December, 2005. Awaya, Y.; Nagai, T. [Proposed Immunization Program for Children With Epilepsy or Severe Motor and Intellectual Disabilities]. No To Hattatsu; 37 (3): 251­256; May, 2005. Bae, G. R.; Lim, H. S.; Goh, U. Y.; Yang, B. G.; Kim, Y. T.; Lee, J. K. Seroprevalence of Measles Antibody and Its Attributable Factors in Elementary Students of Routine 2­Dose Schedule Era With Vaccination Record. J Prev Med Pub Health; 38 (4): 431­436; November, 2005. Baggs, J.; Chen, R. T.; Damon, I. K.; Rotz, L.; Allen, C.; Fullerton, K. E.; Casey, C.; Nordenberg, D.; Mootrey, G. Safety Profile of Smallpox Vaccine: Insights From the Laboratory Worker Smallpox Vaccination Program. Clin Infect Dis; 40 (8): 1133­1140; April 15, 2005. Baleta, A. African Conference Highlights Gaps in Vaccination. Lancet Infect Dis; 5 (8): 472­473; August, 2005. Banning, M. Influenza: Incidence, Symptoms and Treatment. Br J Nurs; 14 (22): 1192­1197; December 8, 2005. Bardenheier, B. H.; Shefer, A.; Barker, L.; Winston, C. A.; Sionean, C. K. Public Health Application Comparing Multilevel Analysis With Logistic Regression: Immunization Coverage Among Long­Term Care Facility Residents. Ann Epidemiol; May 25, 2005. Bardenheier, B. H.; Shefer, A.; McKibben, L.; Roberts, H.; Rhew, D.; Bratzler, D. Factors Predictive of Increased Influenza and Pneumococcal Vaccination Coverage in Long­Term Care Facilities: The CMS­CDC Standing Orders Program Project. J Am Med Dir Assoc; 6 (5): 291­299; September, 2005. Bardenheier, B.; Shefer, A.; Tiggle, R.; Marsteller, J.; Remsburg, R. E. Nursing Home Resident and Facility Characteristics Associated With Pneumococcal Vaccination: National Nursing Home Survey, 1995­1999. J Am Geriatr Soc; 53 (9): 1543­1551; September, 2005. Barnett, E. D. Immunizations and Infectious Disease Screening for Internationally Adopted Children. Pediatr Clin North Am; 52 (5): 1287­1309; October, 2005. Bartell, J. C. Operation Immunization 2004: Prevent, Protect, Immunize. J Am Pharm Assoc (Wash DC); 45 (4): 521­523; July, 2005. Barzilay, E. J.; O'brien, K. L.; Kwok, Y. S.; Hoekstra, R. M.; Zell, E. R.; Reid, R.; Santosham, M.; Whitney, C. G.; Feikin, D. R. Could a Single Dose of Pneumococcal Conjugate Vaccine in Children Be Effective? Modeling the Optimal Age of Vaccination. Vaccine; September 30, 2005. Baskan, E. B.; Tunali, S.; Kacar, S. D.; Adim, S. B.; Saricaoglu, H. A Case of Granuloma Annulare in a Child Following Tetanus and Diphtheria Toxoid Vaccination. J Eur Acad Dermatol Venereol; 19 (5): 639­640; September, 2005. Bauch, C. T. Imitation Dynamics Predict Vaccinating Behaviour. Proc Biol Sci; 272 (1573): 1669­1675; August 22, 2005. Bearden, D. T.; Holt, T. Statewide Impact of Pharmacist­Delivered Adult Influenza Vaccinations. Am J Prev Med; 29 (5): 450­452; December, 2005. Beaujean, D. J.; Verweij, M. F.; van Steenbergen, J. E. [Pneumococcal Vaccination; Arguments for Informing Parents About the Options Available]. Ned Tijdschr Geneeskd; 149 (17): 909­911; April 23, 2005. Bedford, H. Mumps: Current Outbreaks and Vaccination Recommendations. Nurs Times; 101 (39): 53­4, 56; September 27, 2005. Bellini, W. J.; Rota, J. S.; Lowe, L. E.; Katz, R. S.; Dyken, P. R.; Zaki, S. R.; Shieh, W. J.; Rota, P. A. Subacute Sclerosing Panencephalitis: More Cases of This Fatal Disease Are Prevented by Measles Immunization Than Was Previously Recognized. J Infect Dis; 192 (10): 1686­1693; November 15, 2005. Bennett, A. R.; Gorak­Stolinska, P.; Ben­Smith, A.; Floyd, S.; de Lara, C. M.; Weir, R. E.; Lalor, M. K.; Makamo, K.; Msiska, G. K.; Crampin, A. C.; Fine, P. E.; Dockrell, H. M.; Beverley, P. C. The PPD­Specific T­Cell Clonal Response in UK and Malawian Subjects Following BCG Vaccination: A New Repertoire Evolves Over 12 Months. Vaccine; December 27, 2005. Berard, F. [Can Vaccination of an Atopic Child Influence the Course of the Disease? Should One Recommend or Contraindicate Vaccines in Children With Atopic Dermatitis?]. Ann Dermatol Venereol; 132 (Spec No 1): 1S225­1S227; January, 2005. Bernsen, R. M.; de Jongste, J. C.; Koes, B. W.; Aardoom, H. A.; van der Wouden, J. C. Diphtheria Tetanus Pertussis Poliomyelitis Vaccination and Reported Atopic Disorders in 8­12­Year­Old Children. Vaccine; November 28, 2005. Best, J. M.; Castillo­Solorzano, C.; Spika, J. S.; Icenogle, J.; Glasser, J. W.; Gay, N. J.; Andrus, J.; Arvin, A. M. Reducing the Global Burden of Congenital Rubella Syndrome: Report of the World Health Organization Steering Committee on Research Related to Measles and Rubella Vaccines and Vaccination, June 2004. J Infect Dis; 192 (11): 1890­1897; December 1, 2005. Bijlenga, G. Proposal for Vaccination Against SARS Coronavirus Using Avian Infectious Bronchitis Virus Strain H From The Netherlands. J Infect; July 18, 2005. Bilukha, O. O.; Rosenstein, N. Prevention and Control of Meningococcal Disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 54 (RR­7): 1­21; May 27, 2005. Blume, S. Anti­Vaccination Movements and Their Interpretations. Soc Sci Med; July, 2005. Bocsan, I. S.; Gocan, G.; Ursu, L.; Brumboiu, M. I.; Sosa, I.; Simionca, L.; Sava, A.; Olaru, O.; Pastina, I. [How Protective Is the Immunization Against Viral Hepatitis B Prospectively? Seroprevalence Study on Viral Hepatitis B Infection]. Rev Med Chir Soc Med Nat Iasi; 109 (1): 124­130; January, 2005. Bogaert, D.; Veenhoven, R. H.; Ramdin, R.; Luijendijk, I. H.; Rijkers, G. T.; Sanders, E. A.; de, Groot R.; Hermans, P. W. Pneumococcal Conjugate Vaccination Does Not Induce a Persisting Mucosal IgA Response in Children With Recurrent Acute Otitis Media. Vaccine; 23 (20): 2607­2613; April 8, 2005. Bompart, F. Vaccination Strategies for the Last Stages of Global Polio Eradication. Indian Pediatr; 42 (2): 163­169; February, 2005. Bonnez, W. Immunization Against Genital Human Papillomaviruses. Pediatr Infect Dis J; 24 (11): 1005­1006; November, 2005. Booy, R.; Haworth, E. A.; Ali, K. A.; Chapel, H. M.; Moxon, E. R. Immunogenicity of Routine Vaccination Against Diphtheria, Tetanus, and Haemophilus Influenzae Type b in Asian Infants Born in the United Kingdom. Arch Dis Child; 90 (6): 589­591; June, 2005. Bork, K. H.; Heegaard, E. D.; Nielsen, J.; Kogutowska, E.; Heegaard, N. H. [Evaluation of Anthrax Vaccination in Denmark]. Ugeskr Laeger; 167 (36): 3390­
3393; September 5, 2005. Bovier, P. A.; Bouvier, Gallacdhi M.; Chamot, E. Swiss Primary Care Physicians Reporting of Utility and Use of Recommended Vaccinations for Adults. Swiss Med Wkly; 135 (13­14): 192­199; April 2, 2005. Breuer, J. Commentary on Varicella Vaccination of Children in the United States: Assessment After the First Decade 1995­2005. J Clin Virol; 33 (2): 96­98; June, 2005. Bronstein, D. E.; Cotliar, J.; Votava­Smith, J. K.; Powell, M. Z.; Miller, M. J.; Cherry, J. D. Recurrent Papular Urticaria After Varicella Immunization in a Fifteen­Month­Old Girl. Pediatr Infect Dis J; 24 (3): 269­270; March, 2005. Brotherton, J. M.; Hull, B. P.; Hayen, A.; Gidding, H. F.; Burgess, M. A. Probability of Coincident Vaccination in the 24 or 48 Hours Preceding Sudden Infant Death Syndrome Death in Australia. Pediatrics; 115 (6): e643­e646; June, 2005. Broutin, H.; Guegan, J. F.; Elguero, E.; Simondon, F.; Cazelles, B. Large­Scale Comparative Analysis of Pertussis Population Dynamics: Periodicity, Synchrony, and Impact of Vaccination. Am J Epidemiol; 161 (12): 1159­1167; June 15, 2005. Broutin, H.; Mantilla­Beniers, N. B.; Simondon, F.; Aaby, P.; Grenfell, B. T.; Guegan, J. F.; Rohani, P. Epidemiological Impact of Vaccination on the Dynamics of Two Childhood Diseases in Rural Senegal. Microbes Infect; April 4, 2005. Brownstein, J. S.; Kleinman, K. P.; Mandl, K. D. Identifying Pediatric Age Groups for Influenza Vaccination Using a Real­Time Regional Surveillance System. Am J Epidemiol; August 17, 2005. Brunton, C.; Weir, R.; Jennings, L. Knowledge and Attitudes About Influenza Vaccination Amongst General Practitioners, Practice Nurses, and People Aged 65 and Over. N Z Med J; 118 (1214): U1434; May 6, 2005. Buchta, C.; Kormoczi, G.; Heinze, G.; Puhr, R.; Kompatscher, M.; Jungling, G.; List, J.; Macher, M.; Hocker, P.; Watkins­Riedel, T.; Dettke, M. Lack of Impact of ABO Blood Group or Corresponding Isoantibodies on the Immune Response After Rabies Vaccination. Wien Klin Wochenschr; 117 (11­12): 412­416; June, 2005. Bueving, H. J.; Thomas, S.; van der Wouden, J. C. Influenza Vaccination in Children With Asthma: No Reason to Change Current Recommendations. Am J Respir Crit Care Med; 171 (8): 931­932; April 15, 2005. Burns, I. T.; Zimmerman, R. K. Immunization Barriers and Solutions. J Fam Pract; 54 (1): S58­S62; January, 2005. Burns, R. Immunization Strategies for Antibody Production. Methods Mol Biol; 295: 1­12; 2005. Burns, V. E.; Ring, C.; Carroll, D. Factors Influencing Influenza Vaccination Uptake in an Elderly, Community­Based Sample. Vaccine; 23 (27): 3604­3608; May, 2005. Bursztyn, M. Vascular Events After Acute Infection or Vaccination. N Engl J Med; 352 (11): 1151­1153; March 17, 2005. Butcher, G. A. The Role of the Spleen and Immunization Against Malaria. Trends Parasitol; June 16, 2005. Butler, D. Drugs Could Head Off a Flu Pandemic­­but Only If We Respond Fast Enough. Nature; 436 (7051): 614­615; August 4, 2005. Campbell, A. L.; Herold, B. C. Immunization of Pediatric Solid­Organ Transplantation Candidates: Immunizations in Transplant Candidates. Pediatr Transplant; 9 (5): 652­661; October, 2005. Canning, H. S.; Phillips, J.; Allsup, S. Health Care Worker Beliefs About Influenza Vaccine and Reasons for Non­Vaccination­­a Cross­Sectional Survey. J Clin Nurs; 14 (8): 922­925; September, 2005. Caramia, G.; Ruffini, E.; Cuzzolin, L.; Atzei, A.; Fanos, V. News on Vaccinations. Pediatr Med Chir; 27 (5): 42­47; September, 2005. Carels, T.; Flamaing, J. Vaccination of the Elderly: an Update. Tijdschr Gerontol Geriatr; 36 (5): 203­208; November, 2005. Carlsson, R. M.; Ekholm, L.; Gothefors, L.; Granstrom, M.; Trolin, I.; Tegnell, A. [Time for Booster Doses Against Whooping Cough for 10­Year­Old Children]. Lakartidningen; 102 (35): 2394­2398; August 29, 2005. Caro, J. J.; Getsios, D.; El­Hadi, W.; Payne, K.; O'Brien, J. A. Pertussis Immunization of Adolescents in the United States: an Economic Evaluation. Pediatr Infect Dis J; 24 (5 Suppl): S75­S82; May, 2005. Caro, J. J.; Getsios, D.; Payne, K.; Annemans, L.; Neumann, P. J.; Trindade, E. Economic Burden of Pertussis and the Impact of Immunization. Pediatr Infect Dis J; 24 (5 Suppl): S48­S54; May, 2005. Casey, C. G.; Iskander, J. K.; Roper, M. H.; Mast, E. E.; Wen, X. J.; Torok, T. J.; Chapman, L. E.; Swerdlow, D. L.; Morgan, J.; Heffelfinger, J. D.; Vitek, C.; Reef, S. E.; Hasbrouck, L. M.; Damon, I.; Neff, L.; Vellozzi, C.; McCauley, M.; Strikas, R. A.; Mootrey, G. Adverse Events Associated With Smallpox Vaccination in the United States, January­October 2003. JAMA; 294 (21): 2734­2743; December 7, 2005. Castiglione, F.; Liso, A. The Role of Computational Models of the Immune System in Designing Vaccination Strategies. Immunopharmacol Immunotoxicol; 27 (3): 417­432; 2005. Castillo­Febres, O.; Lopez, G.; Ortegal, F.; Estopinan, M.; Casanova­Escalona, L.; Sanchez­Naveda, M.; Decker, M.; Edwards, K. M. [Oropharyngeal Carriers in Venezuelan Children in Two Child Care Settings, Vaccinated or Not With Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine (PRP­T)]. Invest Clin; 46 (1): 15­24; March, 2005. Cavailler, P.; Lucas, M.; Perroud, V.; McChesney, M.; Ampuero, S.; Guerin, P. J.; Legros, D.; Nierle, T.; Mahoudeau, C.; Lab, B.; Kahozi, P.; Deen, J. L.; von, Seidlein L.; Wang, X. Y.; Puri, M.; Ali, M.; Clemens, J. D.; Songane, F.; Baptista, A.; Ismael, F.; Barreto, A.; Chaignat, C. L. Feasibility of a Mass Vaccination Campaign Using a Two­Dose Oral Cholera Vaccine in an Urban Cholera­Endemic Setting in Mozambique. Vaccine; October 21, 2005. Cazzola, M.; Salzillo, A.; De, Giglio C.; Piccolo, A.; Califano, C.; Noschese, P. Treatment of Acute Exacerbation of Severe­to­Very Severe COPD With Azithromycin in Patients Vaccinated Against Streptococcus Pneumoniae. Respir Med; 99 (6): 663­669; June, 2005. Cesaro, S. Which Immunization for Children After Chemotherapy? Eur J Haematol; 75 (2): 174; August, 2005. Cherif, H.; Landgren, O.; Konradsen, H. B.; Kalin, M.; Bjorkholm, M. Poor Antibody Response to Pneumococcal Polysaccharide Vaccination Suggests Increased Susceptibility to Pneumococcal Infection in Splenectomized Patients With Hematological Diseases. Vaccine; August 15, 2005. Chhabra, M.; Ichhpujani, R. L.; Bhardwaj, M.; Tiwari, K. N.; Panda, R. C.; Lal, S. Safety and Immunogenicity of the Intradermal Thai Red Cross (2­2­2­0­1­
1) Post Exposure Vaccination Regimen in the Indian Population Using Purified Chick Embryo Cell Rabies Vaccine. Indian J Med Microbiol; 23 (1): 24­28; January, 2005. Chodick, G.; Ashkenazi, S.; Livni, G.; Lerman, Y. Cost­Effectiveness of Varicella Vaccination of Healthcare Workers. Vaccine; July 15, 2005. Cizman, M.; Pokorn, M.; Osredkar, D. Re: Transverse Myelitis After Measles and Rubella Vaccination. J Paediatr Child Health; 41 (8): 460; August, 2005. Claesson, B. A.; Trollfors, B.; Lagergard, T.; Knutsson, N.; Schneerson, R.; Robbins, J. B. Antibodies Against Haemophilus Influenzae Type b Capsular Polysaccharide and Tetanus Toxoid Before and After a Booster Dose of the Carrier Protein Nine Years After Primary Vaccination With a Protein Conjugate Vaccine. Pediatr Infect Dis J; 24 (5): 463­464; May, 2005. Coates, A. L.; Tipples, G.; Leung, K.; Gray, M.; Louca, E. How Many Infective Viral Particles Are Necessary for Successful Mass Measles Immunization by Aerosol? Vaccine; October 18, 2005. Coffin, C. S.; Saunders, C.; Thomas, C. M.; Loewen, A. H.; Ghali, W. A.; Campbell, N. R. Validity of ICD­9­CM Administrative Data for Determining Eligibility for Pneumococcal Vaccination Triggers. Am J Med Qual; 20 (3): 158­163; May, 2005. Cohn, A. C.; Broder, K. R.; Pickering, L. K. Immunizations in the United States: a Rite of Passage. Pediatr Clin North Am; 52 (3): 669­693; June, 2005. Coleman, M. S.; Fontanesi, J.; Meltzer, M. I.; Shefer, A.; Fishbein, D. B.; Bennett, N. M.; Stryker, D. Estimating Medical Practice Expenses From Administering Adult Influenza Vaccinations. Vaccine; 23 (7): 915­923; January 4, 2005. Colgrove, J. "Science in a Democracy": the Contested Status of Vaccination in the Progressive Era and the 1920s. Isis; 96 (2): 167­191; June, 2005. Colombet, I.; Saguez, C.; Sanson­Le Pors, M. J.; Coudert, B.; Chatellier, G.; Espinoza, P. Diagnosis of Tetanus Immunization Status: Multicenter Assessment of a Rapid Biological Test. Clin Diagn Lab Immunol; 12 (9): 1057­1062; September, 2005. Colombo, G. L.; Serra, G.; Morlotti, L.; Fara, G. M. [The Role of Economic Evaluation for the Implementation of Vaccination Strategies]. Ann Ig; 17 (6): 479­490; November, 2005. Cook, I. F.; Murtagh, J. Ventrogluteal Area­a Suitable Site for Intramuscular Vaccination of Infants and Toddlers. Vaccine; December, 2005. Coudeville, L.; Brunot, A.; Szucs, T. D.; Dervaux, B. The Economic Value of Childhood Varicella Vaccination in France and Germany. Value Health; 8 (3): 209­222; May, 2005. Cunha, S. S. No Epidemiological Evidence for Infant Vaccinations to Cause Allergic Disease [Vaccine 2004;22:3375­85]. Vaccine; 23 (30): 3875; June 10, 2005. Czaja, C.; Crossette, L.; Metlay, J. P. Accuracy of Adult Reported Pneumococcal Vaccination Status of Children. Ann Epidemiol; 15 (4): 253­256; April, 2005. Dabas, P.; Agarwal, C. M.; Kumar, R.; Taneja, D. K.; Ingle, G. K.; Saha, R. Knowledge of General Public and Health Professionals About Tetanus Immunization. Indian J Pediatr; 72 (12): 1035­1037; December, 2005. Daems, R.; Del, Giudice G.; Rappuoli, R. Anticipating Crisis: Towards a Pandemic Flu Vaccination Strategy Through Alignment of Public Health and Industrial Policy. Vaccine; 23 (50): 5732­5742; December 30, 2005. Dalal, A.; Silveira, M. P. Immunization Status of Children in Goa. Indian Pediatr; 42 (4): 401­402; April 7, 2005. Daley, M. F.; Beaty, B. L.; Barrow, J.; Pearson, K.; Crane, L. A.; Berman, S.; Kempe, A. Missed Opportunities for Influenza Vaccination in Children With Chronic Medical Conditions. Arch Pediatr Adolesc Med; 159 (10): 986­991; October, 2005. Damoiseaux, R.; van der Wouden, J. C.; Bueving, H. Influenza Vaccination Effectiveness Is Not Proven in Younger Individuals at Risk. Arch Intern Med; 165 (16): 1921­1922; September 12, 2005. Dannetun, E.; Tegnell, A.; Hermansson, G.; Giesecke, J. Parents' Reported Reasons for Avoiding MMR Vaccination. Scand J Prim Health Care; 23 (3): 149­
153; September, 2005. Dasgupta, S.; Karmakar, P. R.; Mandal, N. K.; Roy, R. P.; Mallik, S.; Mandal, A. K. Routine Primary Immunization: Status in Two District of West Bengal. Indian J Public Health; 49 (4): 223­226; October, 2005. Davis, M. M. Effect of Pneumococcal Vaccination on Quality of Life in Children With Recurrent Acute Otitis Media: A Randomized, Controlled Trial. J Pediatr; 147 (1): 124­125; July, 2005. Davis, M. M. Varicella Vaccine, Cost­Effectiveness Analyses, and Vaccination Policy. JAMA; 294 (7): 845­846; August 17, 2005. Davis, M. M.; Gaglia, M. A. Associations of Daycare and School Entry Vaccination Requirements With Varicella Immunization Rates. Vaccine; 23 (23): 3053­3060; April 27, 2005. Davis, M. M.; Halasyamani, L. K.; Sneller, V. P.; Bishop, K. R.; Clark, S. J. Provider Response to Different Formats of the Adult Immunization Schedule. Am J Prev Med; 29 (1): 34­40; July, 2005. Dawson, A. The Determination of 'Best Interests' in Relation to Childhood Vaccinations. Bioethics; 19 (2): 188­205; April, 2005. de Greeff, S. C.; Schellekens, J. F.; Mooi, F. R.; de Melker, H. E. [Effect of Vaccination Against Pertussis on the Incidence of Pertussis in The Netherlands, 1996­2003]. Ned Tijdschr Geneeskd; 149 (17): 937­943; April 23, 2005. De, Marco G.; Ummarino, D.; Giannetti, E.; Magurno, T.; Guarino, A. Impact of Mass Communication in the Implementation of Influenza Vaccination for Infants. Arch Pediatr Adolesc Med; 159 (6): 596­597; June, 2005. De, Roux A.; Lode, H. Pneumococcal Vaccination. Eur Respir J; 26 (6): 982­983; December, 2005. De, Serres G.; Duval, B. Pertussis Vaccination Beyond Childhood. Lancet; 365 (9464): 1015­1016; March 16, 2005. De, Serres G.; Toth, E.; Menard, S.; Grenier, J. L.; Roussel, R.; Tremblay, M.; Landry, M.; Robert, Y.; Rochette, L.; Skowronski, D. M. Oculo­Respiratory Syndrome After Influenza Vaccination: Trends Over Four Influenza Seasons. Vaccine; 23 (28): 3726­3732; May 25, 2005. Deepe, G. S., Jr.; Wuthrich, M.; Klein, B. S. Progress in Vaccination for Histoplasmosis and Blastomycosis: Coping With Cellular Immunity. Med Mycol; 43 (5): 381­389; August, 2005. Dehart, M. P.; Salinas, S. K.; Barnette, L. J., Jr.; Lewis, K. D.; Mustin, H. D.; Corbett, C.; Green, P. K. Project Protect: Pneumococcal Vaccination in Washington State Nursing Homes. J Am Med Dir Assoc; 6 (2): 91­96; March, 2005. Delamonica, E.; Minujin, A.; Gulaid, J. Monitoring Equity in Immunization Coverage. Bull World Health Organ; 83 (5): 384­391; May, 2005. Denis, F. [Prospectives and Issues of HPV Vaccination in France.]. Med Mal Infect; 35 (Suppl 2): S140; June, 2005. Dennis, C. Polio Fight Falters As Yemen and Java Report Fresh Cases. Nature; 435 (7039): 133; May 12, 2005. Desai, M. R.; Holtz, T. H.; Helfand, R.; Terlouw, D. J.; Wannemuehler, K. A.; Kariuki, S. K.; Shi, Y. P.; Nahlen, B. L.; Ter Kuile, F. O. Relationship of Measles Vaccination With Anaemia and Malaria in Western Kenya. Trop Med Int Health; 10 (11): 1099­1107; November, 2005. Desjeux, G.; Galoisy­Guibal, L.; Colin, C. Cost­Benefit Analysis of Vaccination Against Tick­Borne Encephalitis Among French Troops. Pharmacoeconomics; 23 (9): 913­926; 2005. Dexheimer, J. W.; Gregg, W.; Talbot, T. R.; Aronsky, D. Creating and Validating a Pneumococcal Vaccination Registry. AMIA Annu Symp Proc; 201­205; 2005. Dhiman, N.; Ovsyannikova, I. G.; Jacobson, R. M.; Vierkant, R. A.; Pankratz, V. S.; Jacobsen, S. J.; Poland, G. A. Correlates of Lymphoproliferative Responses to Measles, Mumps, and Rubella (MMR) Virus Vaccines Following MMR­II Vaccination in Healthy Children. Clin Immunol; 115 (2): 154­161; May, 2005. Dhiman, N.; Ovsyannikova, I. G.; Oberg, A. L.; Grill, D. E.; Jacobson, R. M.; Poland, G. A. Immune Activation at Effector and Gene Expression Levels After Measles Vaccination in Healthy Individuals: a Pilot Study. Hum Immunol; 66 (11): 1125­1136; November, 2005. Dhiman, N.; Ovsyannikova, I. G.; Ryan, J. E.; Jacobson, R. M.; Vierkant, R. A.; Pankratz, V. S.; Jacobsen, S. J.; Poland, G. A. Correlations Among Measles Virus­Specific Antibody, Lymphoproliferation and Th1/Th2 Cytokine Responses Following Measles­Mumps­Rubella­II (MMR­II) Vaccination. Clin Exp Immunol; 142 (3): 498­504; December, 2005. Diekema, D. S. Responding to Parental Refusals of Immunization of Children. Pediatrics; 115 (5): 1428­1431; May, 2005. Dominguez, A.; Salleras, L.; Fedson, D. S.; Izquierdo, C.; Ruiz, L.; Ciruela, P.; Fenoll, A.; Casal, J. Effectiveness of Pneumococcal Vaccination for Elderly People in Catalonia, Spain: a Case­Control Study. Clin Infect Dis; 40 (9): 1250­1257; May 1, 2005. Dominguez, D. The Reemergence of Pertussis in Immunized Populations: a Case Study. Clin Lab Sci; 18 (4): 233­237; 2005. Doner, A. The Role of an Immunization Coordinator in a Tertiary Care Setting. J Pediatr Nurs; 20 (3): 225; June, 2005. Doroshenko, A. US Study Suggests Universal Vaccination of Children With Pneumococcal Conjugate Vaccine Is Beneficial for Adults. Euro Surveill; 10 (11): E051124; November 24, 2005. Drake, M. The Vaccination Registers: What Are They and What Can We Learn From Them? Local Popul Stud; 74: 36­53; 2005. Eckart, R. E.; Shry, E. A.; Jones, S. O.; Atwood, J. E.; Grabenstein, J. D. Comparison of Clinical Presentation of Acute Myocarditis Following Smallpox Vaccination to Acute Coronary Syndromes in Patients <40 Years of Age. Am J Cardiol; 95 (10): 1252­1255; May 15, 2005. Eckert, T.; Bartels, C.; Mawrin, C.; Feistner, H.; Welte, T. A Case of Influenza Vaccination Induced Guillain Barre Syndrome With Normal Cerebrospinal Fluid Protein and Improvement on Treatment With Corticosteroids. Scand J Infect Dis; 37 (8): 621­623; 2005. Edwards, K. M. Overview of Pertussis: Focus on Epidemiology, Sources of Infection, and Long Term Protection After Infant Vaccination. Pediatr Infect Dis J; 24 (6 Suppl): S104­S108; June, 2005. Ehreth, J. The Economics of Vaccination From a Global Perspective: Present and Future. Expert Rev Vaccines; 4 (1): 19­21; February, 2005. Elguero, E.; Simondon, K. B.; Vaugelade, J.; Marra, A.; Simondon, F. Non­Specific Effects of Vaccination on Child Survival? A Prospective Study in Senegal. Trop Med Int Health; 10 (10): 956­960; October, 2005. Elkayam, O.; Paran, D.; Burke, M.; Zakut, V.; Ben­Yitshak, R.; Litinsky, I.; Caspi, D. Pneumococcal Vaccination of Patients With Systemic Lupus Erythematosus: Effects on Generation of Autoantibodies. Autoimmunity; 38 (7): 493­496; November, 2005. Enserink, M. Avian Influenza. 'Pandemic Vaccine' Appears to Protect Only at High Doses. Science; 309 (5737): 996; August 12, 2005. Ercan, T. E.; Soycan, L. Y.; Apak, H.; Celkan, T.; Ozkan, A.; Akdenizli, E.; Kasapcopur, O.; Yildiz, I. Antibody Titers and Immune Response to Diphtheria­
Tetanus­Pertussis and Measles­Mumps­Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol; 27 (5): 273­
277; May, 2005. Erickson, L. J.; De, Wals P.; Farand, L. An Analytical Framework for Immunization Programs in Canada. Vaccine; 23 (19): 2470­2476; March 31, 2005. Eskinazi, D. Vaccinations: for or Against. Homeopathy; 94 (4): 252­253; October, 2005. Esposito, S.; Marchisio, P.; Bosis, S.; Lambertini, L.; Claut, L.; Faelli, N.; Bianchi, C.; Colombo, G. L.; Principi, N. Clinical and Economic Impact of Influenza Vaccination on Healthy Children Aged 2­5 Years. Vaccine; September 9, 2005. Fairweather, P.; O'rourke, T.; Strutton, G. Rare Complication of Q Fever Vaccination. Australas J Dermatol; 46 (2): 124­125; May, 2005. Farris, J. R. When Insurance Is Not Enough: Racial and Ethnic Disparities in Immunizations for the Medicare Population. Ethn Dis; 15 (2 Suppl 3): S3; 2005. Fatovic­Ferencic, S.; Buklijas, T. Vaccination: Fascination and Poetry. Croat Med J; 46 (1): 148­149; February, 2005. Fedson, D. S. Preparing for Pandemic Vaccination: an International Policy Agenda for Vaccine Development. J Public Health Policy; 26 (1): 4­29; April, 2005. Feldon, K.; Bahl, S.; Bhatnagar, P.; Wenger, J. Severe Vitamin A Deficiency in India During Pulse Polio Immunization. Indian J Med Res; 122 (3): 265­267; September, 2005. Ferguson, S. The Importance Of Timely Childhood Immunizations. J Ark Med Soc; 102 (1): 5; July, 2005. Ferrer, A.; Formiga, F.; Lombarte, I.; Marques, M. [High Percentage of Influenza Vaccination in Nonagenarian Patients After an Educational Programme.]. Med Clin (Barc); 124 (14): 557­558; April 16, 2005. Fineberg, H. V. We Must Not Lose the Wonders of Vaccination. MedGenMed; 7 (3): 53; July 15, 2005. Fiscella, K. Commentary­Anatomy of Racial Disparity in Influenza Vaccination. Health Serv Res; 40 (2): 539­550; April, 2005. Fischer, T. K.; Anh, D. D.; Antil, L.; Cat, N. D.; Kilgore, P. E.; Thiem, V. D.; Rheingans, R.; Tho, le H.; Glass, R. I.; Bresee, J. S. Health Care Costs of Diarrheal Disease and Estimates of the Cost­Effectiveness of Rotavirus Vaccination in Vietnam. J Infect Dis; 192 (10): 1720­1726; November 15, 2005. Fitzgerald, M.; Canny, M.; O'Flanagan, D. Vaccination Catch­Up Campaign in Response to Recent Increase in Hib Infection in Ireland. Euro Surveill; 10 (9): E050929; September 29, 2005. Fleming, D. M.; Monto, A. S. Influenza Vaccination in Children With Asthma: No Reason to Change Current Recommendations. Am J Respir Crit Care Med; 171 (8): 931; April 15, 2005. Fomin, I.; Caspi, D.; Levy, V.; Varsano, N.; Shalev, Y.; Paran, D.; Levartovsky, D.; Litinsky, I.; Kaufman, I.; Wigler, I.; Mendelson, E.; Elkayam, O. Vaccination Against Influenza in Rheumatoid Arthritis: the Effect of Disease Modifying Drugs, Including TNF a Blockers. Ann Rheum Dis; July 13, 2005. Forsyth, K.; Nagai, M.; Lepetic, A.; Trindade, E. Pertussis Immunization in the Global Pertussis Initiative International Region: Recommended Strategies and Implementation Considerations. Pediatr Infect Dis J; 24 (5 Suppl): S93­S97; May, 2005. Foster, S. L.; Hogue, M. D. Advisory Committee on Immunization Practices: Working to Improve Vaccine Use in the United States. J Am Pharm Assoc (Wash DC); 45 (3): 408­411; May, 2005. Fowler, R. A.; Sanders, G. D.; Bravata, D. M.; Nouri, B.; Gastwirth, J. M.; Peterson, D.; Broker, A. G.; Garber, A. M.; Owens, D. K. Cost­Effectiveness of Defending Against Bioterrorism: a Comparison of Vaccination and Antibiotic Prophylaxis Against Anthrax. Ann Intern Med; 142 (8): 601­610; April, 2005. Fox, N. C.; Black, R. S.; Gilman, S.; Rossor, M. N.; Griffith, S. G.; Jenkins, L.; Koller, M. Effects of A{Beta} Immunization (AN1792) on MRI Measures of Cerebral Volume in Alzheimer Disease. Neurology; April 7, 2005. Francesca, V.; Schiava, F.; Gnesutta, D.; Brianti, G.; Barbone, F. [Evaluation of the Effectiveness of Influenza Vaccination Among the Elderly in Friuli­
Venezia Giulia (Italy)]. Epidemiol Prev; 29 (3­4): 195­203; May, 2005. Franco­Paredes, C.; Lammoglia, L.; Santos­Preciado, J. I. The Spanish Royal Philanthropic Expedition to Bring Smallpox Vaccination to the New World and Asia in the 19th Century. Clin Infect Dis; 41 (9): 1285­1289; November 1, 2005. Franco­Paredes, C.; Rouphael, N.; Del, Rio C.; Santos­Preciado, J. I. Vaccination Strategies to Prevent Tuberculosis in the New Millennium: From BCG to New Vaccine Candidates. Int J Infect Dis; December 21, 2005. Frayha, H. H.; Al Mazrou, Y. Y. Vaccination Against Invasive Pneumococcal Disease in Saudi Arabia: Where Do We Stand? Ann Saudi Med; 25 (2): 90­93; March, 2005. Frech, S. A.; Kenney, R. T.; Spyr, C. A.; Lazar, H.; Viret, J. F.; Herzog, C.; Gluck, R.; Glenn, G. M. Improved Immune Responses to Influenza Vaccination in the Elderly Using an Immunostimulant Patch. Vaccine; 23 (7): 946­950; January 4, 2005. Freedman, S. B.; Reed, J.; Burwen, D. R.; Wise, R. P.; Weiss, A.; Ball, R. Transient Bulging Fontanelle After Vaccination: Case Report and Review of the Vaccine Adverse Event Reporting System. J Pediatr; 147 (5): 640­644; November, 2005. Fruhwein, N. [No All­Clear Signal for Early Summer Meningoencephalitis. Whom Do You Have to Vaccinate?]. MMW Fortschr Med; 147 (18): 14; May 5, 2005. Furton, E. J. Catholic Refusals of Immunization: Such Actions Are Often Unjustified. Ethics Medics; 30 (12): 1­2; December, 2005. Gaash, B.; Bhan, R. Immunization Status of Infants in Kargil. Indian Pediatr; 42 (8): 841­842; August, 2005. Gall, S. A. Maternal Immunization to Protect the Mother and Neonate. Expert Rev Vaccines; 4 (6): 813­818; December, 2005. Garcia, Callejo F.; Costa, Alcacer, I; de, Paula, V; Marco, Algarra J. [Sudden Bilateral Deafness After Measles, Mumps and Rubella Vaccination.]. An Pediatr (Barc); 62 (5): 482­483; May, 2005. Garcia, D. P. Living Without Immunizations­­a New Growing Trend. J Ky Med Assoc; 103 (3): 109­111; March, 2005. Gardner, E. M.; Gonzalez, E. W.; Nogusa, S.; Murasko, D. M. Age­Related Changes in the Immune Response to Influenza Vaccination in a Racially Diverse, Healthy Elderly Population. Vaccine; October 14, 2005. Gardner, H. B. Immunizations, Retinal and Subdural Hemorrhages: Are They Related? Med Hypotheses; 64 (3): 663; 2005. Gaudelus, J. [Elimination of Measles and Congenital Rubella: What Vaccination Strategy for the Future?]. Arch Pediatr; 12 (Spec No 4): 11­13; December, 2005. Gaudin, S.; Yazbeck, A. S. Immunization in India 1993­1999: Wealth, Gender, and Regional Inequalities Revisited. Soc Sci Med; August 4, 2005. Geel, A.; Zuidema, W.; van, Gelder T.; van, Doornum G.; Weimar, W. Successful Vaccination Against Varicella Zoster Virus Prior to Kidney Transplantation. Transplant Proc; 37 (2): 952­953; March, 2005. Gerace, T. M. Review: Vaccination Reduces the Incidence of Serologically Confirmed Influenza in Healthy Adults. Evid Based Nurs; 8 (2): 47; April, 2005. Ghendon, Y. Z.; Kaira, A. N.; Elshina, G. A. The Effect of Mass Influenza Immunization in Children on the Morbidity of the Unvaccinated Elderly. Epidemiol Infect; November 29, 2005. Giacchino, R.; Losurdo, G.; Castagnola, E. Decline in Mortality With Varicella Vaccination. N Engl J Med; 352 (17): 1819; April 28, 2005. Gidron, Y.; Hassid, A.; Yisrael, H.; Biderman, A. Do Psychological Factors Predict Occurrence of Influenza­Like Symptoms in Vaccinated Elderly Residents of a Sheltered Home? Br J Health Psychol; 10 (Pt 3): 411­420; September, 2005. Gil, H.; Bailly, P.; Meaux­Ruault, N.; Clement, I.; Floret, N.; Guiot, A.; Manteaux, C.; Talon, D.; Magy, N.; Dupond, J. L. [Influenza Vaccination Among Health­Care Workers. Vaccination Rates in Universitary Hospital of Besancon, Winter 2003­2004.]. Rev Med Interne; October 24, 2005. Gill, T.; Taylor, A. W.; Kempe, A.; Pickering, S.; Watson, M. Prevalence of Influenza Vaccination in South Australian Aged Care Homes. Aust N Z J Public Health; 29 (1): 38­43; February, 2005. Gindi, M.; Oravitz, P.; Sexton, R.; Shpak, M.; Eisenhart, A. Unreliability of Reported Tetanus Vaccination Histories. Am J Emerg Med; 23 (2): 120­122; March, 2005. Girard, D. Z. The Cost of Epidemiological Transition: A Study of a Decrease in Pertussis Vaccination Coverage. Health Policy; June 9, 2005. Glismann, S. Danish Supreme Court Rules That Child With Autism Developed in Temporal Relation With MMR Vaccination Is Not Entitled to Compensation. Euro Surveill; 10 (4): E050428; April 28, 2005. Gockel, C. M.; Russell, M. W. Induction and Recall of Immune Memory by Mucosal Immunization With a Non­Toxic Recombinant Enterotoxin­Based Chimeric Protein. Immunology; 116 (4): 477­486; December, 2005. Godfroid, F.; Denoel, P.; Poolman, J. Are Vaccination Programs and Isolate Polymorphism Linked to Pertussis Re­Emergence? Expert Rev Vaccines; 4 (5): 757­778; October, 2005. Golay, M.; Sudre, P. [Immunization of 28 Months Old Children in Geneva, Switzerland: Trend Over a 6­Year Period, 1995­2000]. Soz Praventivmed; 50 (5): 319­323; 2005. Goldman, G. S. Cost­Benefit Analysis of Universal Varicella Vaccination in the U.S. Taking into Account the Closely Related Herpes­Zoster Epidemiology. Vaccine; 23 (25): 3349­3355; May 9, 2005. Goldman, G. S. Universal Varicella Vaccination: Efficacy Trends and Effect on Herpes Zoster. Int J Toxicol; 24 (4): 205­213; July, 2005. Goldstein, A. O.; Kincade, J. E.; Resnick, J. E.; Gamble, G.; Bearman, R. S. Policies to Increase Influenza and Pneumococcal Immunizations in Chronically Ill and Institutionalized Settings. Am J Infect Control; 33 (8): 463­468; October, 2005. Goldstein, B.; Weaver, F. M.; Hammond, M. C. New CDC Recommendations: Annual Influenza Vaccination Recommended for Individuals With Spinal Cord Injuries. J Spinal Cord Med; 28 (5): 383­384; 2005. Goodwin, K.; Viboud, C.; Simonsen, L. Antibody Response to Influenza Vaccination in the Elderly: A Quantitative Review. Vaccine; October 3, 2005. Grabowsky, M.; Farrell, N.; Hawley, W.; Chimumbwa, J.; Hoyer, S.; Wolkon, A.; Selanikio, J. Integrating Insecticide­Treated Bednets into a Measles Vaccination Campaign Achieves High, Rapid and Equitable Coverage With Direct and Voucher­Based Methods. Trop Med Int Health; 10 (11): 1151­1160; November, 2005. Grabowsky, M.; Nobiya, T.; Ahun, M.; Donna, R.; Lengor, M.; Zimmerman, D.; Ladd, H.; Hoekstra, E.; Bello, A.; Baffoe­Wilmot, A.; Amofah, G. Distributing Insecticide­Treated Bednets During Measles Vaccination: a Low­Cost Means of Achieving High and Equitable Coverage. Bull World Health Organ; 83 (3): 195­201; March, 2005. Grau, A. J.; Fischer, B.; Barth, C.; Ling, P.; Lichy, C.; Buggle, F. Influenza Vaccination Is Associated With a Reduced Risk of Stroke. Stroke; 36 (7): 1501­
1506; July, 2005. Gravenstein, S. Commentary: Impact of Influenza Vaccination on Seasonal Mortality in the U.S. Population. Consult Pharm; 20 (6): 530­531; June, 2005. Gravenstein, S.; Drinka, P.; Osterweil, D.; Schilling, M.; Krause, P.; Elliott, M.; Shult, P.; Ambrozaitis, A.; Kandel, R.; Binder, E.; Hammond, J.; McElhaney, J.; Flack, N.; Daly, J.; Keene, O. Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long­Term Care Population. J Am Med Dir Assoc; 6 (6): 359­366; November, 2005. Greci, L. S.; Katz, D. L.; Jekel, J. Vaccinations in Pneumonia (VIP): Pneumococcal and Influenza Vaccination Patterns Among Patients Hospitalized for Pneumonia. Prev Med. 40 (4): 384­388; April, 2005. Greenberg, D. P. Pertussis in Adolescents: Increasing Incidence Brings Attention to the Need for Booster Immunization of Adolescents. Pediatr Infect Dis J; 24 (8): 721­728; August, 2005. Greig, J. E.; Patel, M. S.; Clements, M. S.; Taylor, N. K. Control Strategies for Q Fever Based on Results of Pre­Vaccination Screening in Victoria, 1988 to 2001. Aust N Z J Public Health; 29 (1): 53­57; February, 2005. Grilc, E.; Pirnat, N. Pertussis Outbreak in Recently Vaccinated Children in a Kindergarten in Ljubljana During a Resurgence in Pertussis Incidence. Euro Surveill; 10 (8): E050818; August 18, 2005. Grimprel, E. [Whooping Cough in Older Children and Adults]. Arch Pediatr; 12 (Spec No 4): 5­7; December, 2005. Grimprel, E.; von, Sonnenburg F.; Sanger, R.; Abitbol, V.; Wolter, J. M.; Schuerman, L. M. Combined Reduced­Antigen­Content Diphtheria­Tetanus­
Acellular Pertussis and Polio Vaccine (DTpa­IPV) for Booster Vaccination of Adults. Vaccine; 23 (28): 3657­3667; May 25, 2005. Grose, C. Varicella Vaccination of Children in the United States: Assessment After the First Decade 1995­2005. J Clin Virol; 33 (2): 89­95; June, 2005. Guigonis, V.; Debiec, H.; Deschenes, G.; Bensman, A.; Ronco, P. [Tissular Maternofetal Immunization: New Antigenic Targets, New Ideas.]. Arch Pediatr; November 3, 2005. Gupta, P.; Choudhury, P. Meningococcemia Update Vaccination and Chemoprophylaxis. Indian Pediatr; 42 (7): 641­644; July, 2005. Gupta, R. K.; Best, J.; MacMahon, E. Mumps and the UK Epidemic 2005. BMJ; 330 (7500): 1132­1135; May 14, 2005. Gust, D. A.; Kennedy, A.; Shui, I.; Smith, P. J.; Nowak, G.; Pickering, L. K. Parent Attitudes Toward Immunizations and Healthcare Providers the Role of Information. Am J Prev Med; 29 (2): 105­112; August, 2005. Gust, D.; Brown, C.; Sheedy, K.; Hibbs, B.; Weaver, D.; Nowak, G. Immunization Attitudes and Beliefs Among Parents: Beyond a Dichotomous Perspective. Am J Health Behav; 29 (1): 81­92; January, 2005. Gutierrez, Hernando R.; Alvarez, Pasquin M.; Sesmero, Lillo M.; Martin, Martin S. [Vaccination of Immigrant Children: How Do They Reach Our Clinics?]. Aten Primaria; 35 (3): 164; February 28, 2005. Haas, D. M.; Flowers, C. A.; Congdon, C. L. Rubella, Rubeola, and Mumps in Pregnant Women: Susceptibilities and Strategies for Testing and Vaccinating. Obstet Gynecol; 106 (2): 295­300; August, 2005. Hadeler, K. P.; Muller, J. Optimal Harvesting and Optimal Vaccination. Math Biosci; November 11, 2005. Hagan, P. Routine Vaccination for Tuberculosis Ends in UK. BMJ; 331 (7509): 128; July 16, 2005. Hall, J. L.; Katz, B. Z. Cost of Influenza Hospitalization at a Tertiary Care Children's Hospital and Its Impact on the Cost­Benefit Analysis of the Recommendation for Universal Influenza Immunization in Children Age 6 to 23 Months. J Pediatr; 147 (6): 807­811; December, 2005. Hallander, H. O.; Advani, A.; Donnelly, D.; Gustafsson, L.; Carlsson, R. M. Shifts of Bordetella Pertussis Variants in Sweden From 1970 to 2003, During Three Periods Marked by Different Vaccination Programs. J Clin Microbiol; 43 (6): 2856­2865; June, 2005. Hallander, H. O.; Gustafsson, L.; Ljungman, M.; Storsaeter, J. Pertussis Antitoxin Decay After Vaccination With DTPa Response to a First Booster Dose 312­
612 Years After the Third Vaccine Dose. Vaccine; July 25, 2005. Hallauer, J. F.; Neuschaefer­Rube, N. Influenza Vaccination of Hospital Staff in Germany: a Five­Year Survey on Vaccination Coverage and Policies: Identified Deficits in Influenza Immunisation Campaigns for Hospital Employees. Soz Praventivmed; 50 (1): 38­44; 2005. Hammarlund, E.; Lewis, M. W.; Carter, S. V.; Amanna, I.; Hansen, S. G.; Strelow, L. I.; Wong, S. W.; Yoshihara, P.; Hanifin, J. M.; Slifka, M. K. Multiple Diagnostic Techniques Identify Previously Vaccinated Individuals With Protective Immunity Against Monkeypox. Nat Med; August 7, 2005. Hannah, K. L.; Schade, C. P.; Cochran, R.; Brehm, J. G. Promoting Influenza and Pneumococcal Immunization in Older Adults. Jt Comm J Qual Patient Saf; 31 (5): 286­293; May, 2005. Hansen, O. [Acute Brachial Neuropathy Following Influenza Vaccination]. Ugeskr Laeger; 167 (11): 1297­1298; March 14, 2005. Harnos, A.; Reiczigel, J.; Solymosi, N.; Vattay, G. Analysis of the Effect of Immunization in Rabies Time Series. J Theor Biol; September 30, 2005. Harper, S. A.; Fukuda, K.; Uyeki, T. M.; Cox, N. J.; Bridges, C. B. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 54 (RR­8): 1­40; July 29, 2005. Hatakeyama, S.; Moriya, K.; Saijo, M.; Morisawa, Y.; Kurane, I.; Koike, K.; Kimura, S.; Morikawa, S. Persisting Humoral Antiviral Immunity Within the Japanese Population After the Discontinuation in 1976 of Routine Smallpox Vaccinations. Clin Diagn Lab Immunol; 12 (4): 520­524; April, 2005. Hatcher, M.; Heetebry, I.; Tabriziani, H. Mini Medical Record Application: Annual Register for Flu Shot Vaccinations. J Med Syst; 29 (3): 233­239; June, 2005. Hay, J. W.; Ward, J. I. Economic Considerations for Pertussis Booster Vaccination in Adolescents. Pediatr Infect Dis J; 24 (6 Suppl): S127­S133; June, 2005. Hayney, M. S.; Bartell, J. C. An Immunization Education Program for Childcare Providers. J Sch Health; 75 (4): 147­149; April, 2005. Hazlehurst, B.; Mullooly, J.; Naleway, A.; Crane, B. Detecting Possible Vaccination Reactions in Clinical Notes. AMIA Annu Symp Proc; 306­310; 2005. Heath, P. T.; Feldman, R. G. Vaccination Against Group B Streptococcus. Expert Rev Vaccines; 4 (2): 207­218; April, 2005. Hebert, P. L.; Frick, K. D.; Kane, R. L.; McBean, A. M. The Causes of Racial and Ethnic Differences in Influenza Vaccination Rates Among Elderly Medicare Beneficiaries. Health Serv Res; 40 (2): 517­538; April, 2005. Heegaard, E. D.; Fomsgaard, A. [Smallpox Preparedness in Denmark]. Ugeskr Laeger; 167 (36): 3384­3387; September 5, 2005. Heikkinen, T.; Booy, R.; Campins, M.; Finn, A.; Olcen, P.; Peltola, H.; Rodrigo, C.; Schmitt, H. J.; Schumacher, F.; Teo, S.; Weil­Olivier, C. Should Healthy Children Be Vaccinated Against Influenza? A Consensus Report of the Summits of Independent European Vaccination Experts. Eur J Pediatr; December 21, 2005. Heitz, R. Wisconsin's Immunization Registry. WMJ; 104 (5): 83­86; July, 2005. Hellebrand, E.; Mautner, J.; Reisbach, G.; Nimmerjahn, F.; Hallek, M.; Mocikat, R.; Hammerschmidt, W. Epstein­Barr Virus Vector­Mediated Gene Transfer into Human B Cells: Potential for Antitumor Vaccination. Gene Ther; September 1, 2005. Helms, C. M.; Guerra, F. A.; Klein, J. O.; Schaffner, W.; Arvin, A. M.; Peter, G. Strengthening the Nation's Influenza Vaccination System A National Vaccine Advisory Committee Assessment. Am J Prev Med; 29 (3): 221­226; October, 2005. Hendricks, J. W. Does Immunization Refusal Warrant Discontinuing a Physician­Patient Relationship? Arch Pediatr Adolesc Med; 159 (10): 994; October, 2005. Hewlett, E. L.; Edwards, K. M. Clinical Practice. Pertussis­­Not Just for Kids. N Engl J Med; 352 (12): 1215­1222; March 24, 2005. Heymann, D. L.; Sutter, R. W.; Aylward, R. B. A Global Call for New Polio Vaccines. Nature; 434 (7034): 699­700; April 7, 2005. HHS NEWS: Influenza and Pneumococcal Vaccination Coverage Among Persons Aged >=65 Years and Persons Aged 18­64 Years With Diabetes or Asthma­
­US, 2003. Ann Pharmacother; 39 (1): 217; January, 2005. HHS NEWS: Influenza Vaccination and Self­Reported Reasons for Not Receiving Influenza Vaccination Among Medicare Beneficiaries Aged >=65 Years­­
US, 1991­2002. Ann Pharmacother; 39 (1): 217­218; January, 2005 Hill, K. Schering­Plough Manufactures Do­It­Yourself Vaccinations. Can Vet J; 46 (12): 1071; December, 2005. Hoffmann, C. J.; Perl, T. M. The Next Battleground for Patient Safety: Influenza Immunization of Healthcare Workers. Infect Control Hosp Epidemiol; 26 (11): 850­851; November, 2005. Hofmann, F. Environmentally and Occupationally Acquired Diseases in Adolescents and Adulthood: Control of Diphtheria, Tetanus, Pertussis, and Poliomyelitis Through Regular Booster Vaccinations­­a European Perspective. Rev Environ Health; 20 (4): 303­317; October, 2005. Hogh, B.; Ronn, A. M. [Pregnant Women, Children and International Travel]. Ugeskr Laeger; 167 (42): 3992­3997; October 17, 2005. Holvast, B.; Huckriede, A. L.; Wilschut, J.; Horst, G.; De, Vries J.; Benne, R.; Kallenberg, C.; Bijl, M. Safety and Efficacy of Influenza Vaccination in Systemic Lupus Erythematosus Patients With Quiescent Disease. Ann Rheum Dis; December 1, 2005. Holzman, G. S.; Harwell, T. S.; Johnson, E. A.; Goldbaum, G.; Helgerson, S. D. A Media Campaign to Promote Pneumococcal Vaccinations: Is a Telephone Survey an Effective Evaluation Strategy? J Public Health Manag Pract; 11 (3): 228­234; May, 2005. Hong, R.; Banta, J. E. Effects of Extra Immunization Efforts on Routine Immunization at District Level in Pakistan. East Mediterr Health J; 11 (4): 745­752; July, 2005. Horby, P. W.; Williams, A.; Burgess, M. A.; Wang, H. Prevalence and Determinants of Influenza Vaccination in Australians Aged 40 Years and Over­­a National Survey. Aust N Z J Public Health; 29 (1): 35­37; February, 2005. Howard, R. S. Poliomyelitis and the Postpolio Syndrome. BMJ; 330 (7503): 1314­1318; June 4, 2005. Hoyle, T. What Information Should Be Integrated With the Childhood Immunization Registry? Mich Med; 104 (1): 18­19; January, 2005. Huang, C. L.; Yang, Y. H.; Wang, L. C.; Lin, Y. T.; Tsai, Y. Y.; Chiang, B. L. Humoral and Cellular Immune Response After Measles Vaccination in Taiwan. J Microbiol Immunol Infect; 38 (3): 169­175; June, 2005. Hughes, N. L. Increasing Influenza Vaccination of Health Care Workers. Am J Nurs; 105 (12): 96; December, 2005. Huhn, G. D.; Brown, J.; Perea, W.; Berthe, A.; Otero, H.; Libeau, G.; Maksha, N.; Sankoh, M.; Montgomery, S.; Marfin, A.; Admassu, M. Vaccination Coverage Survey Versus Administrative Data in the Assessment of Mass Yellow Fever Immunization in Internally Displaced Persons­Liberia, 2004. Vaccine; September, 2005. Humiston, S. G.; Rosenthal, S. L. Challenges to Vaccinating Adolescents: Vaccine Implementation Issues. Pediatr Infect Dis J; 24 (6 Suppl): S134­S140; June, 2005. Hurwitz, E. L.; Morgenstern, H. Vaccination and Risk of Allergic Disease. Am J Public Health; 95 (1): 6; January, 2005. Hviid, A.; Stellfeld, M.; Wohlfahrt, J.; Andersen, P. H.; Melbye, M. The Impact of Pre­School Booster Vaccination of 4­6­Year­Old Children on Pertussis in 0­1­Year­Old Children. Vaccine; September, 2005. Hviid, A.; Wohlfahrt, J.; Stellfeld, M.; Melbye, M. Childhood Vaccination and Nontargeted Infectious Disease Hospitalization. JAMA; 294 (6): 699­705; August 10, 2005. Hyatt, R. R., Jr.; Allen, S. M. Disability As a "Family Affair": Parental Disability and Childhood Immunization. Med Care; 43 (6): 600­606; June, 2005. Hyderi, A.; Kiran, U. BCG Under Universal Immunization Programme. Indian J Pediatr; 72 (10): 897­898; October, 2005. Hyla­Klekot, L.; Kucharska, G.; Cieslak, W. [Necrotizing Glomerulonephritis in Decursu Vasculitis After Vaccination Against Influenza]. Pol Merkuriusz Lek; 19 (109): 75­77; July, 2005. Iannelli, M.; Martcheva, M.; Li, X. Z. Strain Replacement in an Epidemic Model With Super­Infection and Perfect Vaccination. Math Biosci; 195 (1): 23­46; May, 2005. Ifezulike, C. C.; Ezechukwu, C. C.; Egbonu, I.; Chukwuka, J. O. Tuberculin Reaction Among Healthy BCG Vaccinated Primary School, Children in Nnewi, South Eastern Nigeria. Niger J Clin Pract; 8 (1): 4­9; June, 2005. Ikone, N.; Pyhala, R.; Toivonen, M.; Korpela, H. Influenza A/Fujian/411/02(H3N2)­Lineage Viruses in Finland: Genetic Diversity, Epidemic Activity and Vaccination­Induced Antibody Response. Arch Virol; September 30, 2005. Ikonen, N.; Pyhala, R.; Axelin, T.; Kleemola, M.; Korpela, H. Reappearance of Influenza B/Victoria/2/87­Lineage Viruses: Epidemic Activity, Genetic Diversity and Vaccination Efficacy in the Finnish Defence Forces. Epidemiol Infect; 133 (2): 263­271; April, 2005. Isaacs, D. Should All Australian Children Be Vaccinated Against Influenza? Med J Aust; 182 (11): 553­554; June 6, 2005. Isaacs, D.; Lawrence, G.; Boyd, I.; Ronaldson, K.; McEwen, J. Reporting of Adverse Events Following Immunization in Australia. J Paediatr Child Health; 41 (4): 163­166; April, 2005. Jackson, L. A.; Neuzil, K. M.; Whitney, C. G.; Starkovich, P.; Dunstan, M.; Yu, O.; Nelson, J. C.; Feikin, D. R.; Shay, D. K.; Baggs, J.; Carste, B.; Nahm, M. H.; Carlone, G. Safety of Varying Dosages of 7­Valent Pneumococcal Protein Conjugate Vaccine in Seniors Previously Vaccinated With 23­Valent Pneumococcal Polysaccharide Vaccine. Vaccine; 23 (28): 3697­3703; May 25, 2005. Jedrychowski, W.; Basa­Cierpialek, Z.; Maugeri, U.; Jedrychowska­Bianchi, I. [Measles Incidence in the Cohort of Schoolchildren and Vaccination Effectiveness]. Przegl Lek; 62 (12): 1352­1354; 2005. Jensen, H.; Benn, C. S.; Aaby, P. DTP in Low Income Countries: Improved Child Survival or Survival Bias? BMJ; 330 (7495): 845­846; April 9, 2005. Jimenez­Garcia, R.; Mayo­Montero, E.; Hernandez­Barrera, V.; Garrido, P. C.; Martinez­Hernandez, D.; de Miguel, A. G. Influenza Vaccination Among Diabetic Adults: Related Factors and Trend From 1993 to 2001 in Spain. Diabetes Care; 28 (8): 2031­2033; August, 2005. Jimenez­Garcia, R.; Mayo­Montero, E.; Hernandez­Barrera, V.; Sierra­Moros, M. J.; Pachon, del Amo, I; Carrasco­Garrido, P.; Martinez­Hernandez, D.; de Miguel, A. G. Evolution of Anti­Influenza Vaccination Coverage in Spain From 1993 to 2001. Vaccine; 23 (22): 2844­2850; April 22, 2005. Jimenez­Garcia, R.; rinez­Fernandez, M. C.; Garcia­Carballo, M.; Hernandez­Barrera, V.; Miguel, A. G.; Carrasco­Garrido, P. Influenza Vaccination Coverage and Related Factors Among Spanish Patients With Chronic Obstructive Pulmonary Disease. Vaccine; 23 (28): 3679­3686; May 25, 2005. Johnson, B. W.; Kosoy, O.; Martin, D. A.; Noga, A. J.; Russell, B. J.; Johnson, A. A.; Petersen, L. R. West Nile Virus Infection and Serologic Response Among Persons Previously Vaccinated Against Yellow Fever and Japanese Encephalitis Viruses. Vector Borne Zoonotic Dis; 5 (2): 137­145; 2005. Johnson, I. S. Coordinating Vaccine Use Is Best Way to Combat Polio. Nature; 435 (7044): 881; June 16, 2005. Jordan, R.; Connock, M.; Albon, E.; Fry­Smith, A.; Olowokure, B.; Hawker, J.; Burls, A. Universal Vaccination of Children Against Influenza: Are There Indirect Benefits to the Community? A Systematic Review of the Evidence. Vaccine; September 26, 2005. Joshi, A. B.; Banjara, M. R.; Wierzba, T. Should Vaccination Be a Priority Approach for Japanese Encephalitis Prevention in Nepal? JNMA J Nepal Med Assoc; 44 (157): 31; January, 2005. Jumaan, A. O.; Yu, O.; Jackson, L. A.; Bohlke, K.; Galil, K.; Seward, J. F. Incidence of Herpes Zoster, Before and After Varicella­Vaccination­Associated Decreases in the Incidence of Varicella, 1992­2002. J Infect Dis; 191 (12): 2002­2007; June 15, 2005. Kabir, Z.; Aaby, P. Non­Specific Effect of Measles Vaccination on All­Cause Child Mortality: Revisited. Indian Pediatr; 42 (6): 541­544; June, 2005. Kadam, P. Y.; Daniel, E. E. Comparative Study of Knowledge About Different Child Survival and Safe Motherhood Intervention in Two Groups of Mothers. Indian J Public Health; 49 (2): 99, 101; April, 2005. Kaiser, J. Biodefense. Report Faults Smallpox Vaccination. Science; 307 (5715): 1540; March 11, 2005. Kanbur, N. O.; Derman, O.; Kutluk, T. Measles Seroprevalence of an Adolescent Population Vaccinated With a Single Dose of Measles Vaccine Before Their First Birthday. Int J Adolesc Med Health; 17 (4): 337­341; October, 2005. Kaphengst, K. J. Best Timing of Pneumococcal Revaccination in COPD. Postgrad Med; 118 (2): 3; August, 2005. Karakas, M.; Durdu, M.; Uzun, S.; Karakas, P.; Tuncer, I.; Cevlik, F. Lichen Striatus Following HBV Vaccination. J Dermatol; 32 (6): 506­508; June, 2005. Karim, F.; Rafi, M.; Begum, S. A. Inequitable Access to Immunization and Vitamin A Capsule Services: a Case of Ethnic Minorities in Three Hill Districts of Bangladesh. Public Health; 119 (8): 743­746; August, 2005. Kavukcu, S. Deliberate Infection of Unimmunized Children by Children Immunized With Attentuated Vaccines May Be a Cheaper Preventive Strategy. Med Hypotheses; June 9, 2005. Keane, M. T.; Walter, M. V.; Patel, B. I.; Moorthy, S.; Stevens, R. B.; Bradley, K. M.; Buford, J. F.; Anderson, E. L.; Anderson, L. P.; Tibbals, K.; Vernon, T. M. Confidence in Vaccination: a Parent Model. Vaccine; 23 (19): 2486­2493; March 31, 2005. Keita, M. M.; Sylla, M.; Togo, B.; Bougoudogo, F. [Meningococcal Meningitis Epidemic in Africa: Case Management and Emergency Vaccination.]. Arch Pediatr; 12 (6): 758­760; June, 2005. Kelly, D. F.; Pollard, A. J.; Moxon, E. R. Immunological Memory: the Role of B Cells in Long­Term Protection Against Invasive Bacterial Pathogens. JAMA; 294 (23): 3019­3023; December 21, 2005. Kelly, H.; Vu, T.; Smith, D. Influenza Vaccination and Mortality in the United States. Arch Intern Med; 165 (17): 2037­2038; September 26, 2005. Kemper, A. R.; Cowan, A. E.; Ching, P. L.; Davis, M. M.; Kennedy, E. J.; Clark, S. J.; Freed, G. L. Hospital Decision­Making Regarding the Smallpox Pre­
Event Vaccination Program. Biosecur Bioterror; 3 (1): 23­30; 2005. Kendall, M. Engineering of Needle­Free Physical Methods to Target Epidermal Cells for DNA Vaccination. Vaccine; September 12, 2005. Kennedy, A. M.; Brown, C. J.; Gust, D. A. Vaccine Beliefs of Parents Who Oppose Compulsory Vaccination. Public Health Rep; 120 (3): 252­258; May, 2005. Kicera, T. J.; Douglas, M.; Guerra, F. A. Best­Practice Models That Work: the CDC's Racial and Ethnic Adult Disparities Immunization Initiative (READII) Programs. Ethn Dis; 15 (2 Suppl 3): S3; 2005. Kilbourne, E. D. Intradermal Vaccination Against Influenza. N Engl J Med; 352 (10): 1044­1046; March 10, 2005. Kim, S. H.; Yeo, S. G.; Jang, H. C.; Park, W. B.; Lee, C. S.; Lee, K. D.; Kim, H. B.; Kim, N. J.; Kim, Y. T.; Jee, Y.; Cho, H.; Oh, M. D.; Choe, K. W. Clinical Responses to Smallpox Vaccine in Vaccinia­Naive and Previously Vaccinated Populations: Undiluted and Diluted Lancy­Vaxina Vaccine in a Single­Blind, Randomized, Prospective Trial. J Infect Dis; 192 (6): 1066­1070; September 15, 2005. King, J. C., Jr.; Cummings, G. E.; Stoddard, J.; Readmond, B. X.; Magder, L. S.; Stong, M.; Hoffmaster, M.; Rubin, J.; Tsai, T.; Ruff, E. A Pilot Study of the Effectiveness of a School­Based Influenza Vaccination Program. Pediatrics; 116 (6): e868­e873; December, 2005. Klote, M. M.; Ludwig, G. V.; Ulrich, M. P.; Black, L. A.; Hack, D. C.; Engler, R. J.; Martin, B. L. Absence of Oropharyngeal Vaccinia Virus After Vaccinia (Smallpox) Vaccination. Ann Allergy Asthma Immunol; 94 (6): 682­685; June, 2005. Knuf, M.; Zepp, F.; Meyer, C.; Grzegowski, E.; Wolter, J.; Riffelmann, M.; Wirsing von Konig, C. H. Immunogenicity of a Single Dose of Reduced­Antigen Acellular Pertussis Vaccine in a Non­Vaccinated Adolescent Population. Vaccine; November 28, 2005. Koch, C. [Pretravel Vaccination]. Ugeskr Laeger; 167 (42): 3976­3983; October 17, 2005. Koch, D.; Thompson, L.; Swart, B. Looking Ahead to Successful Immunization Programs. Can Nurse; 101 (2): 14­15; February, 2005. Kolasa, M. S.; Cherry, J. E.; Chilkatowsky, A. P.; Reyes, D. P.; Lutz, J. P. Practice­Based Electronic Billing Systems and Their Impact on Immunization Registries. J Public Health Manag Pract; 11 (6): 493­499; November, 2005. Kondo, S.; Miyagawa, T. [Clinical Characteristics in Non­Symptomatic Infants With Tuberculosis Whose Diagnostic Clue Was Regular Tuberculin Skin Test Prior to BCG Vaccination]. Kekkaku; 80 (8): 565­569; August, 2005. Kriz, P.; Lebedova, V.; Benes, C. Large Decrease in Incidence of Invasive Haemophilus Influenzae b Disease Following Introduction of Routine Vaccination in the Czech Republic. Euro Surveill; 10 (7): E050728; July 28, 2005. Krizova, P. [Present Possibilities of Anti­Meningococcal Vaccination]. Klin Mikrobiol Infekc Lek; 11 (1): 25­29; February, 2005. Kroneman, M.; van Essen, G. A.; John, Paget W. Influenza Vaccination Coverage and Reasons to Refrain Among High­Risk Persons in Four European Countries. Vaccine; September 15, 2005. Kudva, I. T.; Griffin, R. W.; Garren, J. M.; Calderwood, S. B.; John, M. Identification of a Protein Subset of the Anthrax Spore Immunome in Humans Immunized With the Anthrax Vaccine Adsorbed Preparation. Infect Immun; 73 (9): 5685­5696; September, 2005. Kumar, A.; Murray, D. L.; Havlichek, D. H. Immunizations for the College Student: a Campus Perspective of an Outbreak and National and International Considerations. Pediatr Clin North Am; 52 (1): 229­41, xi; February, 2005. Laassri, M.; Lottenbach, K.; Belshe, R.; Wolff, M.; Rennels, M.; Plotkin, S.; Chumakov, K. Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains. J Infect Dis; 192 (12): 2092­2098; December 15, 2005. Labelle, C.; Macpherson, D. W. Evaluation of Yellow Fever Vaccination Centers in Canada. J Travel Med; 12 (4): 180­183; July, 2005. Lafer, M. M.; de Moraes­Pinto, M. I.; Weckx, L. Y. Prevalence of IgG Varicella Zoster Virus Antibodies in the Kuikuro and Kaiabi Indigenous Communities in Xingu National Park, Brazil, Before Varicella Vaccination. Rev Inst Med Trop Sao Paulo; 47 (3): 139­142; May, 2005. Laigret, J. [The Backstage Story of the Discovery of the Yellow Fever Vaccination. 1966]. Med Trop (Mars); 65 (3): 290­292; July, 2005. Lancaster, C. J.; Mauldin, M. P.; Gilbertson, B. O.; Darden, P. M.; Kittredge, D. How We Changed From Paper to Online Education: Teaching Immunization Delivery and Evaluation. Med Teach; 27 (8): 682­685; December, 2005. Landa, G.; Marcovich, A.; Leiba, H.; Springer, A.; Bukelman, A.; Pollack, A. Multiple Branch Retinal Arteriolar Occlusions Associated With Smallpox Vaccination. J Infect; June 1, 2005. Landi, F.; Onder, G.; Carpenter, I.; Garms­Homolova, V.; Bernabei, R. Prevalence and Predictors of Influenza Vaccination Among Frail, Community­Living Elderly Patients: An International Observational Study. Vaccine; 23 (30): 3896­3901; June 10, 2005. Lane, L.; Reynolds, A.; Ramsay, M. When Should Vaccination Be Contraindicated in Children? Drug Saf; 28 (9): 743­752; 2005. Laribiere, A.; Miremont­Salame, G.; Reyre, H.; Abouelfath, A.; Liege, L.; Moore, N.; Haramburu, F. Surveillance of Adverse Effects During a Vaccination Campaign Against Meningitis C. Eur J Clin Pharmacol; 61 (12): 907­911; December, 2005. Larsen, C. S.; Krolner, B. K. [Medical Advice for the Traveller]. Ugeskr Laeger; 167 (42): 3963­3968; October 17, 2005. Lau, C. Y.; Wahl, B.; Foo, W. K. Ring Vaccination Versus Mass Vaccination in Event of a Smallpox Attack. Hawaii Med J; 64 (2): 34­6, 53; February, 2005. Lee, C. W.; Suarez, D. L. Avian Influenza Virus: Prospects for Prevention and Control by Vaccination. Anim Health Res Rev; 6 (1): 1­15; June, 2005. Lee, G. M.; Lebaron, C.; Murphy, T. V.; Lett, S.; Schauer, S.; Lieu, T. A. Pertussis in Adolescents and Adults: Should We Vaccinate? Pediatrics; 115 (6): 1675­1684; June, 2005. Lehman, T. J. Juvenile Idiopathic Arthritis and HSP60 Vaccination: Selective Down­Regulation? Lancet; 366 (9479): 9­10; July 2, 2005. Lehtinen, M. Preparations for Implementing Human Papillomavirus Vaccination Should Begin. Euro Surveill; 10 (9): E050915; September 15, 2005. Letonturier, P. [Vaccination Against Infectious Threats]. Presse Med; 34 (19 Pt 1): 1403; November 5, 2005. Levi, B. H.; Brown, G. Description of the Immunization Information Database: a Tool for Investigating Allegations Made Against Childhood Immunizations. Vaccine; 23 (16): 2009­2015; March 14, 2005. Levy­Bruhl, D. [Estimation of the Epidemiological Impact of Various BCG Vaccination Scenarios in France]. Rev Epidemiol Sante Publique; 53 (5): 501­508; November, 2005. Levy­Bruhl, D. [Vaccination: Choosing Between Individual Desire and Public Policy.] Rev Epidemiol Sante Publique; 53 (4): 337­339; September, 2005. Lexau, C. A.; Lynfield, R.; Danila, R.; Pilishvili, T.; Facklam, R.; Farley, M. M.; Harrison, L. H.; Schaffner, W.; Reingold, A.; Bennett, N. M.; Hadler, J.; Cieslak, P. R.; Whitney, C. G. Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine. JAMA; 294 (16): 2043­2051; October 26, 2005. Lo, B.; Katz, M. H. Clinical Decision Making During Public Health Emergencies: Ethical Considerations. Ann Intern Med; 143 (7): 493­498; October 4, 2005. Long, S. S. Transient Bulging Fontanelle After Immunization. J Pediatr; 147 (5): A3; November, 2005. Longini, I. M., Jr.; Nizam, A.; Xu, S.; Ungchusak, K.; Hanshaoworakul, W.; Cummings, D. A.; Halloran, M. E. Containing Pandemic Influenza at the Source. Science; 309 (5737): 1083­1087; August 12, 2005. Lu, P. J.; Singleton, J. A.; Rangel, M. C.; Wortley, P. M.; Bridges, C. B. Influenza Vaccination Trends Among Adults 65 Years or Older in the United States, 1989­2002. Arch Intern Med; 165 (16): 1849­1856; September 12, 2005. Luman, E. T.; Barker, L. E.; McCauley, M. M.; Drews­Botsch, C. Timeliness of Childhood Immunizations: a State­Specific Analysis. Am J Public Health; 95 (8): 1367­1374; August, 2005. Luz, P. M.; Codeco, C. T.; Werneck, G. L.; Struchiner, C. J. A Modelling Analysis of Pertussis Transmission and Vaccination in Rio De Janeiro, Brazil. Epidemiol Infect; November 29, 2005. Macartney, K.; Mcintyre, P. Universal Varicella Vaccination. Comment. Med J Aust; 183 (5): 278­279; September 5, 2005. MacDonald, M. Parents' Decisions on MMR Vaccination for Their Children Were Based on Personal Experience Rather Than Scientific Evidence. Evid Based Nurs; 8 (2): 60; April, 2005. Machado, C. M.; Cardoso, M. R.; da, Rocha, I; Boas, L. S.; Dulley, F. L.; Pannuti, C. S. The Benefit of Influenza Vaccination After Bone Marrow Transplantation. Bone Marrow Transplant; September, 2005. Machado, C. M.; de, Souza, V; Sumita, L. M.; da, Rocha, I; Dulley, F. L.; Pannuti, C. S. Early Measles Vaccination in Bone Marrow Transplant Recipients. Bone Marrow Transplant; 35 (8): 787­791; March 7, 2005. Mackenzie, G. A. Universal Varicella Vaccination. Med J Aust; 183 (5): 277­279; September 5, 2005. Madar, R.; Strakova, J.; Baska, T.; Kavcova, E.; Straka, S. Pneumococcal Vaccination­­Current Situation and Perspectives. Bratisl Lek Listy; 106 (3): 119­
122; 2005. Magnani, G.; Falchetti, E.; Pollini, G.; Reggiani, L. B.; Grigioni, F.; Coccolo, F.; Potena, L.; Magelli, C.; Sambri, V.; Branzi, A. Safety and Efficacy of Two Types of Influenza Vaccination in Heart Transplant Recipients: a Prospective Randomised Controlled Study. J Heart Lung Transplant; 24 (5): 588­592; May, 2005. Mah, M. W.; Hagen, N. A.; Pauling­Shepard, K.; Hawthorne, J. S.; Mysak, M.; Lye, T.; Louie, T. J. Understanding Influenza Vaccination Attitudes at a Canadian Cancer Center. Am J Infect Control; 33 (4): 243­250; May, 2005. Malgras, B.; Petit, L.; Boutin, J. P. [International Conference on Tropical Medicine "Medicine and Health in the Tropics" September 11 to 15 2005. Acceptability of Vaccination Programs in Developing Countries: Sociocultural Aspects]. Med Trop (Mars); 65 (5): 428­430; November, 2005. Mandell, B. F. A Syringe in the Hand Is Worth Two Birds in the Bush. Cleve Clin J Med; 72 (11): 962; November, 2005. Manian, F. A. Intradermal Vaccination Against Influenza. N Engl J Med; 352 (10): 1044­1046; March 10, 2005. Marchetti, M.; Colombo, G. L. Cost­Effectiveness of Universal Pneumococcal Vaccination for Infants in Italy. Vaccine; 23 (37): 4565­4576; August 31, 2005. Marco, Hernandez M. [Reasons for the 2003­2004 Meningitis C Vaccination Campaign in Castilla­La Mancha.]. An Pediatr (Barc); 62 (4): 381­382; April, 2005. Marin, M.; Nguyen, H. Q.; Keen, J.; Jumaan, A. O.; Mellen, P. M.; Hayes, E. B.; Gensheimer, K. F.; Gunderman­King, J.; Seward, J. F. Importance of Catch­
Up Vaccination: Experience From a Varicella Outbreak, Maine, 2002­2003. Pediatrics; 115 (4): 900­905; April, 2005. Martignon, G.; Oryszczyn, M. P.; nnesi­Maesano, I. Does Childhood Immunization Against Infectious Diseases Protect From the Development of Atopic Disease? Pediatr Allergy Immunol; 16 (3): 193­200; May, 2005. Mascarenas, A.; Salinas, J.; Tasset­Tisseau, A.; Mascarenas, C.; Khan, M. M. Polio Immunization Policy in Mexico: Economic Assessment of Current Practice and Future Alternatives. Public Health; 119 (6): 542­549; June, 2005. Massad, E.; Coutinho, F. A.; Burattini, M. N.; Lopez, L. F.; Struchiner, C. J. Yellow Fever Vaccination: How Much Is Enough? Vaccine; 23 (30): 3908­3914; June 10, 2005. Matsumura, T.; Nakayama, T.; Okamoto, S.; Ito, H. Measles Vaccine Coverage and Factors Related to Uncompleted Vaccination Among 18­Month­Old and 36­Month­Old Children in Kyoto, Japan. BMC Public Health; 5 (1): 59; June 4, 2005. Matyasova, I. [Poliomyelitis Surveillance in the Czech Republic From the Start of Vaccination to the Certification of Eradication in the European Region]. Epidemiol Mikrobiol Imunol; 54 (1): 16­20; February, 2005. Maubec, E.; Pinquier, L.; Viguier, M.; Caux, F.; Amsler, E.; Aractingi, S.; Chafi, H.; Janin, A.; Cayuela, J. M.; Dubertret, L.; Authier, F. J.; Bachelez, H. Vaccination­Induced Cutaneous Pseudolymphoma. J Am Acad Dermatol; 52 (4): 623­629; April, 2005. Maurer, W. Death Following Hexavalent Vaccination. Vaccine; August 9, 2005. Mavimbe, J. C.; Braa, J.; Bjune, G. Assessing Immunization Data Quality From Routine Reports in Mozambique. BMC Public Health; 5:108; October 11, 2005. May, S. A.; Netto, G.; Domiati­Saad, R.; Kasper, C. Cutaneous Lymphoid Hyperplasia and Marginal Zone B­Cell Lymphoma Following Vaccination. J Am Acad Dermatol; 53 (3): 512­516; September, 2005. May, T. Public Communication, Risk Perception, and the Viability of Preventive Vaccination Against Communicable Diseases. Bioethics; 19 (4): 407­421; August, 2005. McInerny, T. K.; Cull, W. L.; Yudkowsky, B. K. Physician Reimbursement Levels and Adherence to American Academy of Pediatrics Well­Visit and Immunization Recommendations. Pediatrics; 115 (4): 833­838; April, 2005. Meltzer, M. I.; Neuzil, K. M.; Griffin, M. R.; Fukuda, K. An Economic Analysis of Annual Influenza Vaccination of Children. Vaccine; 23 (8): 1004­1014; January 11, 2005. Menzel, M.; Muellinger, B.; Weber, N.; Haeussinger, K.; Ziegler­Heitbrock, L. Inhalative Vaccination With Pneumococcal Polysaccharide in Healthy Volunteers. Vaccine; July 16, 2005. Metlay, J. P.; Fishman, N. O.; Joffe, M.; Edelstein, P. H. Impact of Pediatric Vaccination With Pneumococcal Conjugate Vaccine on the Risk of Bacteremic Pneumococcal Pneumonia in Adults. Vaccine; August 24, 2005. Meyerhoff, A. S.; Jacobs, R. J. Do Too Many Shots Due Lead to Missed Vaccination Opportunities? Does It Matter? Prev Med; 41 (2): 540­544; August, 2005. Michel, R.; Garnotel, E.; Spiegel, A.; Morillon, M.; Saliou, P.; Boutin, J. P. Outbreak of Typhoid Fever in Vaccinated Members of the French Armed Forces in the Ivory Coast. Eur J Epidemiol; 20 (7): 635­642; 2005. Middleton, D. B.; Fox, D. E.; Nowalk, M. P.; Skledar, S. J.; Sokos, D. R.; Zimmerman, R. K.; Ervin, K. A.; Lin, C. J. Overcoming Barriers to Establishing an Inpatient Vaccination Program for Pneumococcus Using Standing Orders. Infect Control Hosp Epidemiol; 26 (11): 874­881; November, 2005. Milgrom, H.; Palmer, E.; Leung, D. Smallpox Vaccination: a Conundrum of Risks and Outcomes. Curr Opin Allergy Clin Immunol; 5 (3): 207­209; June, 2005. Mills, E.; Jadad, A. R.; Ross, C.; Wilson, K. Systematic Review of Qualitative Studies Exploring Parental Beliefs and Attitudes Toward Childhood Vaccination Identifies Common Barriers to Vaccination. J Clin Epidemiol; 58 (11): 1081­1088; November, 2005. Milman, U.; Ben­Moshe, S.; Hermoni, D. The Role of the Patient Care Team in Elderly People Decision on Influenza Vaccination. Patient Educ Couns; 58 (2): 203­208; August, 2005. Miron, D.; Lavi, I.; Kitov, R.; Hendler, A. Vaccine Effectiveness and Severity of Varicella Among Previously Vaccinated Children During Outbreaks in Day­
Care Centers With Low Vaccination Coverage. Pediatr Infect Dis J; 24 (3): 233­236; March, 2005. Mitchell, V.; Walker, D.; Zuber, P.; Lydon, P.; Ahun, M. Evidenced­Based Decision Making About Hib Vaccination. Lancet; 365 (9463): 936­937; March 9, 2005. Mitragotri, S. Immunization Without Needles. Nat Rev Immunol; October, 2005. Mood, B. S.; Naini, R. N.; Salehi, M.; Kouhpayeh, H. R.; Azad, T. M.; Poor, T. N. Immunity Against Measles Among Vaccinated School Going Children in Zahedan, Southeast of Iran. Indian J Med Microbiol; 23 (4): 274­275; October, 2005. Morgenroth, H.; Hellenbrand, W.; Dreja, I.; Kahl, J.; Terhardt, M.; Vogel, M.; Schroten, H. [The Vaccination Coverage Among Children Aged 24 ­ 30 Months in Pediatric Offices November 1999 ­ May 2001. The Influence of Socio­Demographic Characteristics.]. Gesundheitswesen; 67 (11): 788­794; November, 2005. Moss, A. L. Lessons in Giving Vaccines: Soft Tissue Complications of Vaccinations. J Public Health (Oxf); 27 (2): 236­237; April 8, 2005. Motlova, J. [Disribution of Streptococcus Pneumoniae Serotypes and Serogroups Among Patients With Invasive Pneumococcal Diseases in the Czech Republic in 1996­2003: Background Data for Vaccination Strategy]. Epidemiol Mikrobiol Imunol; 54 (1): 3­10; February, 2005. Moulton, L. H.; Rahmathullah, L.; Halsey, N. A.; Thulasiraj, R. D.; Katz, J.; Tielsch, J. M. Evaluation of Non­Specific Effects of Infant Immunizations on Early Infant Mortality in a Southern Indian Population. Trop Med Int Health; 10 (10): 947­955; October, 2005. Mrozek­Budzyn, D. [Vaccination Coverage Among Children and Adolescents in Malopolskie Voivodeship in Period 1999­2004]. Przegl Epidemiol; 59 (4): 823­832; 2005. Mudur, G. Funds for Vaccination Over Next Decade May Fall Short by 10bn Dollars. BMJ; 331 (7530): 1426; December 17, 2005. Muller, D.; Saliou, P.; Szucs, T. D. [Coverage Rates of Influenza Vaccination in France: a Population­Based Cross­Sectional Analysis of Seasons 2001­2002 and 2002­2003.]. Med Mal Infect; November 29, 2005. Munoz, F. M.; Greisinger, A. J.; Wehmanen, O. A.; Mouzoon, M. E.; Hoyle, J. C.; Smith, F. A.; Glezen, W. P. Safety of Influenza Vaccination During Pregnancy. Am J Obstet Gynecol; 192 (4): 1098­1106; April, 2005. Munoz­Lope, F. Vaccination. Yes or No? Allergol Immunopathol (Madr); 33 (1): 1­6; January, 2005. Murphy, J. F. Is It Time to Introduce Varicella Vaccination? Ir Med J; 98 (3): 68; March, 2005. Music, S. Towards Universal Childhood Immunization: Why We Must and How We Might. Vaccine; August 22, 2005. Nabeshima, S.; Murata, M.; Kashiwagi, K.; Fujita, M.; Furusyo, N.; Hayashi, J. Serum Antibody Response to Tuberculosis­Associated Glycolipid Antigen After BCG Vaccination in Adults. J Infect Chemother; 11 (5): 256­258; October, 2005. Nakhla, I.; Frenck, R. W., Jr.; Teleb, N. A.; Oun, S. E.; Sultan, Y.; Mansour, H.; Mahoney, F. The Changing Epidemiology of Meningococcal Meningitis After Introduction of Bivalent A/C Polysaccharide Vaccine into School­Based Vaccination Programs in Egypt. Vaccine; 23 (25): 3288­3293; May 9, 2005. Narimah, A. Rubella Immunization in Malaysia­­20 Years on, and the Challenges Ahead. Med J Malaysia; 60 (3): 267­268; August, 2005. Narkeviciute, I.; Kavaliunaite, E.; Bernatoniene, G.; Eidukevicius, R. Clinical Presentation of Pertussis in Fully Immunized Children in Lithuania. BMC Infect Dis; 5 (1): 40; May 27, 2005. Navas, E.; Salleras, L.; Gisbert, R.; Dominguez, A.; Timoner, E.; Ibanez, D.; Prat, A. Cost­Benefit and Cost­Effectiveness of the Incorporation of the Pneumococcal 7­Valent Conjugated Vaccine in the Routine Vaccination Schedule of Catalonia (Spain). Vaccine; 23 (17­18): 2342­2348; March 18, 2005. Ndiaye, S. M.; Hopkins, D. P.; Smith, S. J.; Hinman, A. R.; Briss, P. A. Methods for Conducting Systematic Reviews of Targeted Vaccination Strategies for the Guide to Community Preventive Services. Am J Prev Med; 28 (5 Suppl): 238­247; June, 2005. Newport, M. J.; Goetghebuer, T.; Marchant, A. Hunting for Immune Response Regulatory Genes: Vaccination Studies in Infant Twins. Expert Rev Vaccines; 4 (5): 739­746; October, 2005. Nichol, K. L. Influenza Vaccination in the Elderly : Impact on Hospitalisation and Mortality. Drugs Aging; 22 (6): 495­515; 2005. Nichol, K. L.; Nordin, J.; Mullooly, J. Influence of Clinical Outcome and Outcome Period Definitions on Estimates of Absolute Clinical and Economic Benefits of Influenza Vaccination in Community Dwelling Elderly Persons. Vaccine; October 18, 2005. Niederhauser, V. P.; Stark, M. Narrowing the Gap in Childhood Immunization Disparities. Pediatr Nurs; 31 (5): 380­386; September, 2005. Nielsen, O. H.; Skinhoj, P. [Travel Medicine­­an Important Field in the Globalization]. Ugeskr Laeger; 167 (42): 3961; October 17, 2005. Nigro, G.; Adler, S. P.; La, Torre R.; Best, A. M. Passive Immunization During Pregnancy for Congenital Cytomegalovirus Infection. N Engl J Med; 353 (13): 1350­1362; September 29, 2005. Nilsson, L.; Faldella, G.; Jacquet, J. M.; Storsaeter, J.; Silfverdal, S. A.; Ekholm, L. A Fourth Dose of DTPa­IPV Vaccine Given to 4­6 Year Old Children in Italy and Sweden Following Primary Vaccination at 3, 5 and 11­12 Months of Age. Scand J Infect Dis; 37 (3): 221­229; 2005. Norrby, R. [Time to Change Child Vaccination Programs. Swedish Children Can Get Better Protection­­but It Costs More]. Lakartidningen; 102 (35): 2376­
2378; August 29, 2005. Nowalk, M. P.; Lin, C. J.; Zimmerman, R. K.; Troy, J. A.; Hoberman, A.; Kearney, D. H.; Cleary, S. M. Tailored Interventions to Introduce Influenza Vaccination Among 6­ to 23­Month­Old Children at Inner­City Health Centers. Am J Manag Care; 11 (11): 717­724; November, 2005. Nowalk, M. P.; Zimmerman, R. K.; Lin, C. J.; Ko, F. S.; Raymund, M.; Hoberman, A.; Kearney, D. H.; Greenberg, D. P. Parental Perspectives on Influenza Immunization of Children Aged 6 to 23 Months. Am J Prev Med; 29 (3): 210­214; October, 2005. Offit, P. A. The Cutter Incident, 50 Years Later. N Engl J Med; 352 (14): 1411­1412; April 7, 2005. Oglesby, A. Staying Healthy. Prevention Through Immunization. Diabetes Self Manag; 22 (4): 48­50; July, 2005. Oh, R. C. Folliculitis After Smallpox Vaccination: a Report of Two Cases. Mil Med; 170 (2): 133­136; February, 2005. Ohkusa, Y. Policy Evaluation for the Subsidy for Influenza Vaccination in Elderly. Vaccine; 23 (17­18): 2256­2260; March 18, 2005. Ohrui, T.; Nakayama, K.; Fukushima, T.; Chiba, H.; Sasaki, H. [Prevention of Elderly Pneumonia by Pneumococcal, Influenza and BCG Vaccinations]. Nippon Ronen Igakkai Zasshi; 42 (1): 34­36; January, 2005. Ohuabunwo, C.; Perevoscikovs, J.; Griskevica, A.; Gargiullo, P.; Brilla, A.; Viksna, L.; Glismann, S.; Wharton, M.; Vitek, C. Respiratory Diphtheria Among Highly Vaccinated Military Trainees in Latvia: Improved Protection From DT Compared With Td Booster Vaccination. Scand J Infect Dis; 37 (11): 813­
820; 2005. Olaguibel, J. M.; varez Puebla, M. J. Efficacy of Sublingual Allergen Vaccination for Respiratory Allergy in Children. Conclusions From One Meta­Analysis. J Investig Allergol Clin Immunol; 15 (1): 9­16; 2005. Olsen, G. W.; Steinberg, M. E.; Ley, C. A. Worksite Influenza Immunization Programs. Insight into the Implementation and Cost­Benefit. AAOHN J; 53 (3): 105­110; March, 2005. Orenstein, W. A.; Douglas, R. G.; Rodewald, L. E.; Hinman, A. R. Immunizations in the United States: Success, Structure, and Stress. Health Aff (Millwood); 24 (3): 599­610; May, 2005. Ottaviani, G.; Lavezzi, A. M.; Matturri, L. Sudden Infant Death Syndrome (SIDS) Shortly After Hexavalent Vaccination: Another Pathology in Suspected SIDS? Virchows Arch; :1­5; October 18, 2005. Pachon, del Amo, I [Impact of Vaccination Programmes in Spain.]. Aten Primaria; 35 (6): 314­317; April 15, 2005. Pack, R.; Wang, Y.; Singh, A.; Seidlein, L. V.; Pach, A.; Kaljee, L.; Butraporn, P.; Youlong, G.; Blum, L.; Bhutta, Z.; Santoso, S. S.; Trach, D. D.; Waluyo, I.; Nyamete, A.; Clemens, J.; Stanton, B. Willingness to Be Vaccinated Against Shigella and Other Forms of Dysentery: A Comparison of Three Regions in Asia. Vaccine; August 30, 2005. Pallin, D. J.; Muennig, P. A.; Emond, J. A.; Kim, S.; Camargo, C. A., Jr. Vaccination Practices in U.S. Emergency Departments, 1992­2000. Vaccine; 23 (8): 1048­1052; January 11, 2005. Panhotra, B. R.; Saxena, A. K. Negative Attitude of Health Care Workers Towards Childhood Vaccination Program. Vaccine; August 23, 2005. Parashar, S. Moving Beyond the Mother­Child Dyad: Women's Education, Child Immunization, and the Importance of Context in Rural India. Soc Sci Med; 61 (5): 989­1000; September, 2005. Paredes, J. L.; Diaz, D. Improving Immunization of Programmable Logic Controllers Using Weighted Median Filters. ISA Trans; 44 (2): 225­241; April, 2005. Park, J. H.; Na, K. S.; Paik, S. S.; Yoo, D. H. Macrophagic Myofasciitis Unrelated to Vaccination. Scand J Rheumatol; 34 (1): 65­67; 2005. Parry, J. Vaccinating Poultry Against Avian Flu Is Contributing to Spread. BMJ; 331 (7527): 1223; November 26, 2005. Partidos, C. D.; Muller, S. Decision­Making at the Surface of the Intact or Barrier Disrupted Skin: Potential Applications for Vaccination or Therapy. Cell Mol Life Sci; April 7, 2005. Patel, R.; Longini, I. M., Jr.; Halloran, M. E. Finding Optimal Vaccination Strategies for Pandemic Influenza Using Genetic Algorithms. J Theor Biol; 234 (2): 201­212; May 21, 2005. Paulussen, T. G.; Hoekstra, F.; Lanting, C. I.; Buijs, G. B.; Hirasing, R. A. Determinants of Dutch Parents' Decisions to Vaccinate Their Child. Vaccine; September 9, 2005. Pawelec, G. Immunosenescence and Vaccination. Immun Ageing; 2 (1): 16; November 24, 2005. Pebody, R. G. Universal Varicella­Zoster Vaccination: Is Europe Ready? Int J Clin Pract; 59 (11): 1248­1250; November, 2005. Pepersack, T.; Turneer, M.; De, Breucker S.; Stubbe, M.; Beyer, I. Tetanus Immunization Among Geriatric Hospitalized Patients. Eur J Clin Microbiol Infect Dis; June 16, 2005. Petersen, J. E. [Traveller's Medicine on the Internet]. Ugeskr Laeger; 167 (42): 3971­3973; October 17, 2005. Phillips, A. C.; Burns, V. E.; Carroll, D.; Ring, C.; Drayson, M. The Association Between Life Events, Social Support, and Antibody Status Following Thymus­Dependent and Thymus­Independent Vaccinations in Healthy Young Adults. Brain Behav Immun; 19 (4): 325­333; July, 2005. Phillips, A. C.; Carroll, D.; Burns, V. E.; Drayson, M. Neuroticism, Cortisol Reactivity, and Antibody Response to Vaccination. Psychophysiology; 42 (2): 232­238; March, 2005. Phillips, A. C.; Carroll, D.; Burns, V. E.; Ring, C.; Macleod, J.; Drayson, M. Bereavement and Marriage Are Associated With Antibody Response to Influenza Vaccination in the Elderly. Brain Behav Immun; September 26, 2005. Pinot de, Moira A.; Edmunds, W. J.; Breuer, J. The Cost­Effectiveness of Antenatal Varicella Screening With Post­Partum Vaccination of Susceptibles. Vaccine; October 3, 2005. Plans, P. [Evaluation of Vaccination Programs Through Serological Studies and Distributed Vaccines]. Gac Sanit; 19 (6): 456­462; November, 2005. Platonov, A. E.; Griffiths, U. K.; Voeykova, M. V.; Platonova, O. V.; Shakhanina, I. L.; Chistyakova, G. G.; Robertson, S. E. Economic Evaluation of Haemophilus Influenzae Type b Vaccination in Moscow, Russian Federation. Vaccine; December 15, 2005. Plescia, M.; Leach, L.; Meriwether, R. Clinical Inquiries: What Illnesses Contraindicate Immunization? J Fam Pract; 54 (7): 621­623; July, 2005. Podewils, L. J.; Antil, L.; Hummelman, E.; Bresee, J.; Parashar, U. D.; Rheingans, R. Projected Cost­Effectiveness of Rotavirus Vaccination for Children in Asia. J Infect Dis; 192 Suppl 1:S133­45; September 1, 2005. Poland, G. A.; Grabenstein, J. D.; Neff, J. M. The US Smallpox Vaccination Program: a Review of a Large Modern Era Smallpox Vaccination Implementation Program. Vaccine; 23 (17­18): 2078­2081; March 18, 2005. Poland, G. A.; Jacobson, R. M.; Koutsky, L. A.; Tamms, G. M.; Railkar, R.; Smith, J. F.; Bryan, J. T.; Cavanaugh, P. F., Jr.; Jansen, K. U.; Barr, E. Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: a 2­Year Randomized Controlled Clinical Trial. Mayo Clin Proc; 80 (5): 601­610; May, 2005. Poland, G. A.; Tosh, P.; Jacobson, R. M. Requiring Influenza Vaccination for Health Care Workers: Seven Truths We Must Accept. Vaccine; 23 (17­18): 2251­2255; March 18, 2005. Poltorak, M.; Leach, M.; Fairhead, J.; Cassell, J. 'MMR Talk' and Vaccination Choices: An Ethnographic Study in Brighton. Soc Sci Med; 61 (3): 709­719; August, 2005. Pons, Sempere J.; Beltran, Redondo B.; Riera, Mestre A.; Bella, Cueto F. [Influenza Vaccination and Pneumococcal Vaccination in Patients Cared in an Internal Medicine Department.]. Rev Clin Esp; 205 (6): 302; June, 2005. Popp, W. [Immunization in the Elderly­­Necessary, Helpful, Superfluous?]. MMW Fortschr Med; 147 (41): 34, 36; October 13, 2005. Potin, S. M.; Valencia, B. MA [Vaccination in Premature Infants: An Issue Many Times Forgotten.]. Rev Chilena Infectol; 22 (4): 339­344; December, 2005. Pounder, D. Avoiding Rabies. BMJ; 331 (7515): 469­470; September 3, 2005. Praditsuwan, R.; Assantachai, P.; Wasi, C.; Puthavatana, P.; Kositanont, U. The Efficacy and Effectiveness of Influenza Vaccination Among Thai Elderly Persons Living in the Community. J Med Assoc Thai; 88 (2): 256­264; February, 2005. Prendergast, H. M.; Graneto, J.; Kelley, G. D. Child Immunization Status in an Urban ED. Am J Emerg Med; 23 (5): 704­705; September, 2005. Pressman, S. D.; Cohen, S.; Miller, G. E.; Barkin, A.; Rabin, B. S.; Treanor, J. J. Loneliness, Social Network Size, and Immune Response to Influenza Vaccination in College Freshmen. Health Psychol; 24 (3): 297­306; May, 2005. Puig­Barbera, J. [Measurement of Efficacy of Influenza Vaccination in Elderly Individuals. How and Why.] Med Clin (Barc); 125 (18): 695­696; November, 2005. Putz, M. M.; Alberini, I.; Midgley, C. M.; Manini, I.; Montomoli, E.; Smith, G. L. Prevalence of Antibodies to Vaccinia Virus After Smallpox Vaccination in Italy. J Gen Virol; 86 (Pt 11): 2955­2960; November, 2005. Rajshekhar, V. BCG Vaccination and Severity of Childhood Tuberculous Meningitis. J Neurol Neurosurg Psychiatry; 76 (11): 1470; November, 2005. Ramet, J.; Weil­Olivier, C.; Sedlak, W. Is Europe Ready to Embrace a Policy of Universal Varicella Vaccination?*. Int J Clin Pract; 59 (11): 1326­1333; November, 2005. Ras, Vidal E.; Babio, Pazos M. [Dont Forget to Vaccinate Me.]. Aten Primaria; 36 (4): 226; September 15, 2005. Revello, M. G. Passive Immunization Against Cytomegalovirus During Pregnancy. N Engl J Med; 353 (26): 2818­2820; December 29, 2005. Richards, S. One Jab Benefits All. Assessing the Impact of Extending the Vaccination Programme. Nurs Stand; 19 (29): 19; March 30, 2005. Riedel, S. Edward Jenner and the History of Smallpox and Vaccination. Proc (Bayl Univ Med Cent); 18 (1): 21­25; January, 2005. Riel­Romero, R. M. Acute Transverse Myelitis in a 7­Month­Old Boy After Diphtheria­Tetanus­Pertussis Immunization. Spinal Cord; November 29, 2005. Rinaldo, C. R., Jr. Passive Immunization Against Poliomyelitis: the Hammon Gamma Globulin Field Trials, 1951­1953. Am J Public Health; 95 (5): 790­799; May, 2005. Risser, N.; Murphy, M. Immunization Against Meningococcal Disease. Nurse Pract; 30 (11): 65­66; November, 2005. Rivest, P.; Grenier, L.; Lonergan, G.; Bedard, L. Varicella Vaccination for Grades 4 and 5 Students: From Theory to Practice. Can J Public Health; 96 (3): 197­200; May, 2005. Rock, M. T.; Yoder, S. M.; Wright, P. F.; Talbot, T. R.; Edwards, K. M.; Crowe, J. E., Jr. Differential Regulation of Granzyme and Perforin in Effector and Memory T Cells Following Smallpox Immunization. J Immunol; 174 (6): 3757­3764; March 15, 2005. Rodrigues, L. C.; Pereira, S. M.; Cunha, S. S.; Genser, B.; Ichihara, M. Y.; de Brito, S. C.; Hijjar, M. A.; Dourado, I.; Cruz, A. A.; Sant'Anna, C.; Bierrenbach, A. L.; Barreto, M. L. Parental Refusal of Childhood VaccinationsREVAC Cluster­Randomised Trial. Lancet; 366 (9493): 1290­1295; October 8, 2005. Ronveaux, O.; Rickert, D.; Hadler, S.; Groom, H.; Lloyd, J.; Bchir, A.; Birmingham, M. The Immunization Data Quality Audit: Verifying the Quality and Consistency of Immunization Monitoring Systems. Bull World Health Organ; 83 (7): 503­510; July, 2005. Root­Bernstein, R. S. Vaccination Markers: Designing Unique Antigens to Be Added to Vaccines to Differentiate Between Natural Infection and Vaccination. Vaccine; 23 (17­18): 2057­2059; March 18, 2005. Rosenthal, S. L. Protecting Their Adolescents From Harm: Parental Views on STI Vaccination. J Adolesc Health; 37 (3): 177­178; September, 2005. Ross, A.; McLean, T. W.; Farber, R.; Weaver, R. G., Jr.; Chauvenet, A.; Givner, L. B.; Shetty, A. K. Retinitis Following Varicella in a Vaccinated Child With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer; May 3, 2005. Ross, G. Vaccinate Schoolchildren to Reduce Influenza Toll. Arch Intern Med; 165 (17): 2038­2040; September 26, 2005. Rota, M. C.; D'Ancona, F.; Massari, M.; Mandolini, D.; Giammanco, A.; Carbonari, P.; Salmaso, S.; Atti, M. L. How Increased Pertussis Vaccination Coverage Is Changing the Epidemiology of Pertussis in Italy. Vaccine; August 17, 2005. Roth, A.; Sodemann, M.; Jensen, H.; Poulsen, A.; Gustafson, P.; Gomes, J.; Djana, Q.; Jakobsen, M.; Garly, M. L.; Rodrigues, A.; Aaby, P. Vaccination Technique, PPD Reaction and BCG Scarring in a Cohort of Children Born in Guinea­Bissau 2000­2002. Vaccine; 23 (30): 3991­3998; June 10, 2005. Rov, S. Role of the Indian Medical Association (IMA) in Polio Eradication. J Indian Med Assoc; 103 (12): 653; December, 2005. Russell, M. L.; Verhoef, M. J.; Injeyan, H. S. Are Chiropractors Interested in Participating in Immunization Awareness and Promotion Activities? Can J Public Health; 96 (3): 194­196; May, 2005. Russell, M. L.; Yau, A.; Baptiste, B.; Rowntree, C.; Robb, J.; Hill, S. Improving the Public Health/Physician Partnership for Influenza Vaccination. Can J Public Health; 96 (2): 155­158; March, 2005. Rust, G. Summary: Take­Home Points From the Eliminating Adult Immunization Disparities Symposium. Ethn Dis; 15 (2 Suppl 3): S3; 2005. Rust, G.; Strothers, H. S., III; Zimmerman, R. K. Re­Engineering the Primary Care Practice to Eliminate Adult Immunization Disparities. Ethn Dis; 15 (2 Suppl 3): S3; 2005. Sacks, H. S. Review: Vaccination Reduces the Incidence of Serologically Confirmed Influenza in Healthy Adults. ACP J Club; 142 (3): 70; May, 2005. Saito, W.; Nagai, H.; Suzuki, J.; Masuda, K.; Tamura, A.; Nagayama, N.; Akagawa, S.; Kawabe, Y.; Machida, K.; Kurashima, A.; Yotsumoto, H.; Saito, T.; Arai, T.; Okabe, N. [Capsular Polysaccharide Antibodies After Pneumococcal Polysaccharide Vaccination in Patients With Chronic Respiratory Disease]. Nihon Kokyuki Gakkai Zasshi; 43 (5): 277­282; May, 2005. Salama, P.; McFarland, J.; Mulholland, K. Reaching the Unreached With Measles Vaccination. Lancet; 366 (9488): 787­788; September 3, 2005. Salinsky, E. Clinical Preventive Services: When Is the Juice Worth the Squeeze? NHPF Issue Brief;806): 1­30; August 24, 2005. Saliou, P.; Girard, M. [From Jenner and Pasteur to Vaccinology]. Therapie; 60 (3): 201­204; May, 2005. Salisbury, D. M. Development of Immunization Policy and Its Implementation in the United Kingdom. Health Aff (Millwood); 24 (3): 744­754; May, 2005. Salmon, D. A.; Moulton, L. H.; Omer, S. B.; Dehart, M. P.; Stokley, S.; Halsey, N. A. Factors Associated With Refusal of Childhood Vaccines Among Parents of School­Aged Children: a Case­Control Study. Arch Pediatr Adolesc Med; 159 (5): 470­476; May, 2005. Salmon, D. A.; Sapsin, J. W.; Teret, S.; Jacobs, R. F.; Thompson, J. W.; Ryan, K.; Halsey, N. A. Public Health and the Politics of School Immunization Requirements. Am J Public Health; 95 (5): 778­783; May, 2005. Salo, H.; Sintonen, H.; Pekka, Nuorti J.; Linna, M.; Nohynek, H.; Verho, J.; Kilpi, T. Economic Evaluation of Pneumococcal Conjugate Vaccination in Finland. Scand J Infect Dis; 37 (11): 821­832; November, 2005. Sambamoorthi, U.; Findley, P. A. Who Are the Elderly Who Never Receive Influenza Immunization? Prev Med. 40 (4): 469­478; April, 2005. Sambamoorthi, U.; Findley, P. A. Who Are the Elderly Who Never Receive Influenza Immunization? Prev Med. 40 (4): 469­478; April, 2005. Santibanez, T. A.; Barker, L. E.; Shaw, K. M. Measurement of Vaccination Coverage at Age 24 and 19­35 Months: A Case Study of Multiple Imputation in Public Health. Popul Health Metr; 3 (1): 6; July 5, 2005. Santos, A. P.; Bertho, A. L.; Dias, D. C.; Santos, J. R.; Marcovistz, R. Lymphocyte Subset Analyses in Healthy Adults Vaccinated With Yellow Fever 17DD Virus. Mem Inst Oswaldo Cruz; 100 (3): 331­337; May, 2005. Saponi Cortes, J. M.; Sanchez Munoz­Torrero, J. F.; Sanchez, Sanchez T.; Costo, Campoamor A. [Use and Effectivity of Influenza Vaccination for the Prevention of Hospital Admissions of High Risk Patients With Cardiopulmonary Decompensation.]. Rev Clin Esp; 205 (6): 302­303; June, 2005. Satcher, D. Adult Immunization Disparities: a Challenge for the Public Health/Primary Care Partnership. Ethn Dis; 15 (2 Suppl 3): S3; 2005. Sato, M.; Saito, R.; Tanabe, N.; Nishikawa, M.; Sasaki, A.; Gejyo, F.; Suzuki, H. Antibody Response to Influenza Vaccination in Nursing Home Residents and Healthcare Workers During Four Successive Seasons in Niigata, Japan. Infect Control Hosp Epidemiol; 26 (11): 859­866; November, 2005. Sauri, M. A. The Politics of Vaccine Production. Md Med; 6 (1): 19­22; 2005. Schellekens, J.; von Konig, C. H.; Gardner, P. Pertussis Sources of Infection and Routes of Transmission in the Vaccination Era. Pediatr Infect Dis J; 24 (5 Suppl): S19­S24; May, 2005. Schetgen, M. [Current Vaccines]. Rev Med Brux; 26 (5): S455­S458; September, 2005. Schierup, M. H.; Mordhorst, C. H.; Muller, C. P.; Christensen, L. S. Evidence of Recombination Among Early­Vaccination Era Measles. Virus Strains. BMC Evol Biol; 5:52; October 6, 2005. Schleiss, M. R. Acquisition of Human Cytomegalovirus Infection in Infants Via Breast Milk: Natural Immunization or Cause for Concern? Rev Med Virol; November 15, 2005. Schleiss, M. Selective Versus Universal Vaccination for Varicella Zoster Virus Infection: What Holds the Key to Successful Disease Control? Herpes; 12 (2): 32; September, 2005. Schmitt, H. J.; Siegrist, C. A.; Salmaso, S.; Law, B.; Booy, R. B. Zinka Et Al., Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination. Vaccine; August 3, 2005. Schouls, L. M.; van der, Ende A.; van, de Pol, I; Schot, C.; Spanjaard, L.; Vauterin, P.; Wilderbeek, D.; Witteveen, S. Increase in Genetic Diversity of Haemophilus Influenzae Serotype b (Hib) Strains After Introduction of Hib Vaccination in The Netherlands. J Clin Microbiol; 43 (6): 2741­2749; June, 2005. Schwartz, B.; Gellin, B. Vaccination Strategies for an Influenza Pandemic. J Infect Dis; 191 (8): 1207­1209; April 15, 2005. Schwarz, Chavarri H.; Ortuno Lopez, J. L.; Lattur, Vilchez A.; Pedrera, Carbonell, V; Orozco, Beltran D.; Gil, Guillen, V [Can We Improve Influenza Vaccination Rates in Older People With Chronic Diseases?]. Aten Primaria; 35 (4): 178­182; March 15, 2005. Schwarz, Chavarri H.; Ortuno, Lopez J.; Lattur, Vilchez A.; Pedrera, Carbonell, V; Orozco, Beltran D.; Gil, Guillen, V. [Flu Vaccination in Primary Care: Analysis of the Process and Proposals for Increasing Coverage.]. Aten Primaria; 36 (7): 390­396; October 31, 2005. Sejvar, J. J.; Labutta, R. J.; Chapman, L. E.; Grabenstein, J. D.; Iskander, J.; Lane, J. M. Neurologic Adverse Events Associated With Smallpox Vaccination in the United States, 2002­2004. JAMA; 294 (21): 2744­2750; December 7, 2005. Sekawi, Z.; Muizatul, W. M.; Marlyn, M.; Jamil, M. A.; Ilina, I. Rubella Vaccination Programme in Malaysia: Analysis of a Seroprevalence Study in an Antenatal Clinic. Med J Malaysia; 60 (3): 345­348; August, 2005. Senn, N.; Genton, B. [Pre­ and Post­Exposure Rabies Prophylaxis: Who to Vaccinate and How?]. Rev Med Suisse; 1 (19): 1280­1283; May 11, 2005. Shah, N. K. Adolescent Vaccination. J Indian Med Assoc; 103 (11): 626, 628; November, 2005. Shann, F. Non­Specific Effects of Vaccination: Vaccines Have Non­Specific (Heterologous) Effects. BMJ; 330 (7495): 844; April 9, 2005. Sharifi, N.; Mofrad, P. S. Vascular Events After Acute Infection or Vaccination. N Engl J Med; 352 (11): 1151­1153; March 17, 2005. Shatz, D. V. Vaccination Considerations in the Asplenic Patient. Expert Rev Vaccines; 4 (1): 27­34; February, 2005. Shefer, A.; McKibben, L.; Bardenheier, B.; Bratzler, D.; Roberts, H. Characteristics of Long­Term Care Facilities Associated With Standing Order Programs to Deliver Influenza and Pneumococcal Vaccinations to Residents in 13 States. J Am Med Dir Assoc; 6 (2): 97­104; March, 2005. Shenson, D.; Dimartino, D.; Bolen, J.; Campbell, M.; Lu, P. J.; Singleton, J. A. Validation of Self­Reported Pneumococcal Vaccination in Behavioral Risk Factor Surveillance Surveys: Experience From the Sickness Prevention Achieved Through Regional Collaboration (SPARC) Program. Vaccine; 23 (8): 1015­1020; January 11, 2005. Shepard, C. W.; Ortega­Sanchez, I. R.; Scott, R. D.; Rosenstein, N. E. Cost­Effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States. Pediatrics; 115 (5): 1220­1232; May, 2005. Sherpa, T. Y.; Leaf, H. L. Pneumococcal Vaccination in Adults. Curr Infect Dis Rep; 7 (3): 211­217; May, 2005. Shui, I.; Kennedy, A.; Wooten, K.; Schwartz, B.; Gust, D. Factors Influencing African­American Mothers' Concerns About Immunization Safety: a Summary of Focus Group Findings. J Natl Med Assoc; 97 (5): 657­666; May, 2005. Siddiqui, A.; Usmani, R. I.; Anwer, S.; Afsar, S. Guillain­Barre Syndrome Occurring After Rabies Vaccination. J Pak Med Assoc; 55 (2): 87­88; February, 2005. Simondon, F.; Vaugelade, J. Beneficial and Adverse Side Effects of Vaccination: Perception in Developing Countries. Expert Rev Vaccines; 4 (6): 785­787; December, 2005. Simonsen, L.; Viboud, C.; Elixhauser, A.; Taylor, R. J.; Kapikian, A. Z. More on RotaShield and Intussusception: The Role of Age at the Time of Vaccination. J Infect Dis; 192 Suppl 1:S36­43; September 1, 2005. Simonsen, L.; Viboud, C.; Taylor, R. Influenza Vaccination in Elderly People. Lancet; 366 (9503): 2086; December 17, 2005. Singleton, J. A.; Poel, A. J.; Lu, P. J.; Nichol, K. L.; Iwane, M. K. Where Adults Reported Receiving Influenza Vaccination in the United States. Am J Infect Control; 33 (10): 563­570; December, 2005. Singleton, J. A.; Santibanez, T. A.; Wortley, P. M. Influenza and Pneumococcal Vaccination of Adults Aged >/=65 Racial/Ethnic Differences. Am J Prev Med; 29 (5): 412­420; December, 2005. Sinha, A.; Lieu, T. A.; Paoletti, L. C.; Weinstein, M. C.; Platt, R. The Projected Health Benefits of Maternal Group B Streptococcal Vaccination in the Era of Chemoprophylaxis. Vaccine; 23 (24): 3187­3195; May 2, 2005. Skeet, J. A Checklist for Planning Flu Vaccination Clinics for 2006. Nurs Times; 101 (48): 45; November 29, 2005. Slifka, M. K. The Future of Smallpox Vaccination: Is MVA the Key? Med Immunol; 4 (1): 2; March 1, 2005. Smith, P. J.; Hoaglin, D. C.; Battaglia, M. P.; Khare, M.; Barker, L. E. Statistical Methodology of the National Immunization Survey, 1994­2002. Vital Health Stat 2;(138): 1­55; March, 2005. Snopov, S. A.; Kharit, S. M.; Norval, M.; Ivanova, V. V. Circulating Leukocyte and Cytokine Responses to Measles and Poliovirus Vaccination in Children After Ultraviolet Radiation Exposures. Arch Virol; June 28, 2005. Sokos, D. R. Pharmacists' Role in Increasing Pneumococcal and Influenza Vaccination. Am J Health Syst Pharm; 62 (4): 367­377; February 15, 2005. Soleimanjahi, H.; Bamdad, T.; Fotouhi, F.; Roustai, M. H.; Faghihzadeh, S. Prevalence of HI Antibody Titer Against Rubella Virus to Determine the Effect of Mass Vaccination in Tehran. J Clin Virol; July 30, 2005. Solomon, A. W.; Mabey, D. C. Modeling the Economic Net Benefit of a Potential Vaccination Program Against Ocular Infection With Chlamydiatrachomatis. Vaccine; August 22, 2005. Soltani, M. S.; Bchir, A.; Amri, F.; Gueddiche, N.; Sfar, T.; Sahloul, S.; Garbouj, M. [Epidemiology of Haemophilus Influenzae Meningitis in Tunisia]. East Mediterr Health J; 11 (1­2): 14­27; January, 2005. Sotiropoulos, A.; Merkouris, P.; Gikas, A.; Skourtis, S.; Skliros, E.; Lanaras, L.; Nikolaou, T.; Pappas, S. Influenza and Pneumococcal Vaccination Rates Among Greek Diabetic Patients in Primary Care. Diabet Med; 22 (1): 110­111; January, 2005. Southern, J.; Crowley­Luke, A.; Borrow, R.; Andrews, N.; Miller, E. Immunogenicity of One, Two or Three Doses of a Meningococcal C Conjugate Vaccine Conjugated to Tetanus Toxoid, Given As a Three­Dose Primary Vaccination Course in UK Infants at 2, 3 and 4 Months of Age With Acellular Pertussis­
Containing DTP/Hib Vaccine. Vaccine; August 17, 2005. Soysal, A.; Millington, K. A.; Bakir, M.; Dosanjh, D.; Aslan, Y.; Deeks, J. J.; Efe, S.; Staveley, I.; Ewer, K.; Lalvani, A. Effect of BCG Vaccination on Risk of Mycobacterium Tuberculosis Infection in Children With Household Tuberculosis Contact: Prospective Community­Based Study. Lancet; 366 (9495): 1443­
1451; October 22, 2005. Spector, N. D.; Kelly, S. F. Sleep Disorders, Immunizations, Sports Injuries, Autism. Curr Opin Pediatr; 17 (6): 773­786; December, 2005. Speroni, K. G.; Dawson, E.; Atherton, M.; Corriher, J. Influenza Vaccination: Incidence of Symptoms and Resulting Absenteeism in Hospital Employees. AAOHN J; 53 (11): 477­483; November, 2005. Srinivasan, R.; Stevens, P. Selective Neonatal BCG Vaccination: Specialist BCG Clinics Are an Alternative. Acta Paediatr; 94 (5): 634­635; May, 2005. St­Amour, M.; Guay, M.; Perron, L.; Clement, P.; Baron, G.; Petit, G.; Lemaire, J. Are Vaccination Information Leaflets Useful for Vaccinators and Parents? Vaccine; (; December 29, 2005. Stanford, E. A.; Chambers, C. T.; Craig, K. D.; McGrath, P. J.; Cassidy, K. L. "Ow!": Spontaneous Verbal Pain Expression Among Young Children During Immunization.. Clin J Pain; 21 (6): 499­502; November, 2005. Stefanacci, R. G. Creating Artificial Barriers to Vaccinations. J Am Med Dir Assoc; 6 (5): 357­358; September, 2005. Steffen, R.; Castelli, F.; Dieter, Nothdurft H.; Rombo, L.; Jane, Zuckerman N. Vaccination Against Enterotoxigenic Escherichia Coli, a Cause of Travelers' Diarrhea. J Travel Med; 12 (2): 102­107; March, 2005. Steffen, R.; Connor, B. A. Vaccines in Travel Health: From Risk Assessment to Priorities. J Travel Med; 12 (1): 26­35; January, 2005. Steiner, I. Can Vaccinating Older Adults Against Varicella Zoster Virus Prevent Herpes Zoster and Postherpetic Neuralgia? Nat Clin Pract Neurol; 1 (1): 18­
19; November, 2005. Steinsvag, S. K.; Florvaag, E. [Vaccination Against Allergy­­Why and How]. Tidsskr Nor Laegeforen; 125 (11): 1489­1490; June 2, 2005. Stephenson, I.; Bugarini, R.; Nicholson, K. G.; Podda, A.; Wood, J. M.; Zambon, M. C.; Katz, J. M. Cross­Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses After Vaccination With Nonadjuvanted and MF59­Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy. J Infect Dis; 191 (8): 1210­1215; April 15, 2005. Stern, A. M.; Markel, H. The History of Vaccines and Immunization: Familiar Patterns, New Challenges. Health Aff (Millwood); 24 (3): 611­621; May, 2005. Stiehm, E. R.; Roberts, R. L.; Kaplan, M. S.; Corren, J.; Jaracz, E.; Rico, M. J. Pneumococcal Seroconversion After Vaccination for Children With Atopic Dermatitis Treated With Tacrolimus Ointment. J Am Acad Dermatol; 53 (2 Suppl 2): S206­S213; August, 2005. Strunk, C. Innovative Workplace Influenza Program: Boosting Employee Immunization Rates. AAOHN J; 53 (10): 432­437; October, 2005. Sturm, L. A.; Mays, R. M.; Zimet, G. D. Parental Beliefs and Decision Making About Child and Adolescent Immunization: From Polio to Sexually Transmitted Infections. J Dev Behav Pediatr; 26 (6): 441­452; December, 2005. Sugaya, N.; Takeuchi, Y. Mass Vaccination of Schoolchildren Against Influenza and Its Impact on the Influenza­Associated Mortality Rate Among Children in Japan. Clin Infect Dis; 41 (7): 939­947; October 1, 2005. Sugishita, Y.; Maeda, H.; Mori, T. [Variation in Yield of Needle Scars With Multipuncture BCG Vaccination]. Nippon Koshu Eisei Zasshi; 52 (12): 1045­
1049; December, 2005. Suvedi, B. K. Twenty­Five Years of Immunization Program in Nepal. Kathmandu Univ Med J (KUMJ); 3 (1): 4; January, 2005. Suzano, C. E.; Amaral, E.; Sato, H. K.; Papaiordanou, P. M. The Effects of Yellow Fever Immunization (17DD) Inadvertently Used in Early Pregnancy During a Mass Campaign in Brazil. Vaccine; October 3, 2005. Svane, C.; Sonne, M.; Nissen, L. R. [Adverse Reactions to Anthrax Vaccination in Danish Military Personnel Deployed to Iraq]. Ugeskr Laeger; 167 (36): 3393­3396; September 5, 2005. Szilagyi, P. G.; Shone, L. P.; Barth, R.; Kouides, R. W.; Long, C.; Humiston, S. G.; Jennings, J.; Bennett, N. M. Physician Practices and Attitudes Regarding Adult Immunizations. Prev Med. 40 (2): 152­161; February, 2005. Szilagyi, P. G.; Shone, L. P.; Barth, R.; Kouides, R. W.; Long, C.; Humiston, S. G.; Jennings, J.; Bennett, N. M. Physician Practices and Attitudes Regarding Adult Immunizations. Prev Med. 40 (2): 152­161; February, 2005. Szucs, T. D. Health Economic Research on Vaccinations and Immunisation Practices­­an Introductory Primer. Vaccine; 23 (17­18): 2095­2103; March 18, 2005. Szucs, T. D. Meningococcal Vaccination: Cui Bono? Pharmacoeconomics; 23 (4): 315­316; 2005. Szucs, T. D.; Muller, D. Influenza Vaccination Coverage Rates in Five European Countries­a Population­Based Cross­Sectional Analysis of Two Consecutive Influenza Seasons. Vaccine; July 15, 2005. Tabbarah, M.; Zimmerman, R. K.; Nowalk, M. P.; Janosky, J. E.; Troy, J. A.; Raymund, M.; Jewell, I. K. What Predicts Influenza Vaccination Status in Older Americans Over Several Years? J Am Geriatr Soc; 53 (8): 1354­1359; August, 2005. Takayama, N. [Investigation Concerning Demand and Vaccination Applicants to Traveler's Vaccines (Typhoid Fever and Meningococcal Vaccines) Not Marketed in Japan]. Kansenshogaku Zasshi; 79 (4): 254­259; April, 2005. Takeda, K.; Hara, H. [Abeta Vaccination and Treatment of Alzheimer's Disease]. No To Shinkei; 57 (10): 867­876; October, 2005. Takeuchi, F. Effectiveness of Vaccination Strategies for Infectious Diseases According to Human Contact Networks. Jpn J Infect Dis; 58 (6): S16­S17; December, 2005. Talbot, T. R.; Bradley, S. E.; Cosgrove, S. E.; Ruef, C.; Siegel, J. D.; Weber, D. J. Influenza Vaccination of Healthcare Workers and Vaccine Allocation for Healthcare Workers During Vaccine Shortages. Infect Control Hosp Epidemiol; 26 (11): 882­890; November, 2005. Talbot, T. R.; Crocker, D. D.; Peters, J.; Doersam, J. K.; Ikizler, M. R.; Sannella, E.; Wright, P. E.; Edwards, K. M. Duration of Virus Shedding After Trivalent Intranasal Live Attenuated Influenza Vaccination in Adults. Infect Control Hosp Epidemiol; 26 (5): 494­500; May, 2005. Tan, T.; Halperin, S.; Cherry, J. D.; Edwards, K.; Englund, J. A.; Glezen, P.; Greenberg, D.; Rothstein, E.; Skowronski, D. Pertussis Immunization in the Global Pertussis Initiative North American Region: Recommended Strategies and Implementation Considerations. Pediatr Infect Dis J; 24 (5 Suppl): S83­
S86; May, 2005. Tapiainen, T.; Bar, G.; Schaad, U. B.; Heininger, U. Influenza Vaccination Among Healthcare Workers in a University Children's Hospital. Infect Control Hosp Epidemiol; 26 (11): 855­858; November, 2005. Tapiainen, T.; Heininger, U. Fever Following Immunization. Expert Rev Vaccines; 4 (3): 419­427; June, 2005. Taranger, J. [Why Was Whooping Cough Vaccination in Sweden Interrupted Between 1979­1996?]. Lakartidningen; 102 (39): 2788; September 26, 2005. Tassignon, J.; Burny, W.; Dahmani, S.; Zhou, L.; Stordeur, P.; Byl, B.; De, Groote D. Monitoring of Cellular Responses After Vaccination Against Tetanus Toxoid: Comparison of the Measurement of IFN­Gamma Production by ELISA, ELISPOT, Flow Cytometry and Real­Time PCR. J Immunol Methods; 35 (2): 188­198; September 9, 2005. Tavares, E. C.; Ribeiro, J. G.; Oliveira, L. A. [Active and Passive Immunization in the Extremely Preterm Infant]. J Pediatr (Rio J); 81 (1 Suppl): S89­S94; March, 2005. Taylor, L.; Tan, C. G.; Liu, S.; Miro, S.; Genese, C. A.; Bresnitz, E. A. New Jersey's Smallpox Vaccination Clinic Experiences, 2003. J Public Health Manag Pract; 11 (3): 216­221; May, 2005. Temime, L.; Boelle, P. Y.; Valleron, A. J.; Guillemot, D. Penicillin­Resistant Pneumococcal Meningitis: High Antibiotic Exposure Impedes New Vaccine Protection. Epidemiol Infect; 133 (3): 493­501; June, 2005. Tezel, A.; Paliwal, S.; Shen, Z.; Mitragotri, S. Low­Frequency Ultrasound As a Transcutaneous Immunization Adjuvant. Vaccine; 23 (29): 3800­3807; May 31, 2005. Thind, A. Determinants of Tetanus Toxoid Immunization in Pregnancy in Rural Bihar. Trop Doct; 35 (2): 75­77; April, 2005. Thomas, C. M.; Loewen, A.; Coffin, C.; Campbell, N. R. Improving Rates of Pneumococcal Vaccination on Discharge From a Tertiary Center Medical Teaching Unit: a Prospective Intervention. BMC Public Health; 5:110; October 14, 2005. Thomas, L. M.; Wood, A.; Shenton, S.; Ledingham, J. M. Uptake of Influenza Vaccination in Rheumatology Patients: Reply. Rheumatology (Oxford); 44 (1): 131; January, 2005. Thompson, W. W.; Shay, D. K.; Weintraub, E.; Brammer, L.; Cox, N. J.; Fukuda, K. Influenza Vaccination Among the Elderly in the United States. Arch Intern Med; 165 (17): 2038­2039; September 26, 2005. Timmermans, D. R.; Henneman, L.; Hirasing, R. A.; van der, Wal G. Attitudes and Risk Perception of Parents of Different Ethnic Backgrounds Regarding Meningococcal C Vaccination. Vaccine; 23 (25): 3329­3335; May 9, 2005. Tjalma, W. A.; Damme, P. V. Is the Public Enough Aware to Accept a Vaccination Program Against Human Papillomavirus? Vaccine; 23 (25): 3231; May 9, 2005. Toptygina, A. P.; Pukhalsky, A. L.; Alioshkin, V. A. Immunoglobulin G Subclass Profile of Antimeasles Response in Vaccinated Children and in Adults With Measles History. Clin Diagn Lab Immunol; 12 (7): 845­847; July, 2005. Toubi, E.; Shoenfeld, Y. Predictive and Protective Autoimmunity in Cardiovascular Diseases: Is Vaccination Therapy a Reality? Lupus; 14 (9): 665­669; 2005. Toussirot, E.; Wendling, D. Bacillus Calmette­Guerin Vaccination in a Patient Treated With Infliximab. J Rheumatol; 32 (12): 2500­2501; December, 2005. Toy, W. C.; Janosky, J. E.; Laird, S. B. Influenza Immunization of Medical Residents: Knowledge, Attitudes, and Behaviors. Am J Infect Control; 33 (8): 473­
475; October, 2005. Trevisan, A.; Morandin, M.; Frasson, C.; Paruzzolo, P.; Davanzo, E.; Marco, L. D.; Fabrello, A.; Borella­Venturini, M. Prevalence of Childhood Exanthematic Disease Antibodies in Paramedical Students: Need of Vaccination. Vaccine; September 7, 2005. Trmal, J.; Havlickova, M.; Bicova, R.; Bitterova, Z.; Kelerova, J. [Simultaneous Vaccination Against Influenza and Invasive Pneumococcal Disease in Chronic Dialysis Patients]. Epidemiol Mikrobiol Imunol; 54 (3): 123­128; August, 2005. Trottier, H.; Philippe, P. Scaling Properties of Childhood Infectious Diseases Epidemics Before and After Mass Vaccination in Canada. J Theor Biol; 235 (3): 326­337; August 7, 2005. Tseng, H. F.; Tan, H. F.; Chang, C. K. Varicella Epidemiology and Cost­Effectiveness Analysis of Universal Varicella Vaccination Program in Taiwan. Southeast Asian J Trop Med Public Health; 36 (6): 1450­1458; November, 2005. Tunc, B.; Filik, L. Should Leptospira Vaccination Be Encouraged? A Case Report. Ethiop Med J; 43 (2): 123; April, 2005. Turner, D. A.; Wailoo, A. J.; Cooper, N. J.; Sutton, A. J.; Abrams, K. R.; Nicholson, K. G. The Cost­Effectiveness of Influenza Vaccination of Healthy Adults 50­64 Years of Age. Vaccine; September 21, 2005. Uhnoo, I.; Linde, A. [Antiviral Agents in Influenza­­Current Recommendations. Anti­Influenza Agents Are Not a Substitution for but a Complement to Vaccination]. Lakartidningen; 102 (49): 3802­6, 3808; December 5, 2005. Uji, M.; Matsushita, H.; Iwata, S. Microscopic Polyangiitis After Influenza Vaccination. Intern Med; 44 (8): 892­896; August, 2005. Vahdani, P.; Aminzadeh, Z.; Alimardani, M.; Sharafi, A. Measles and Rubella Vaccination of Two Million Iranians: Complications in Vaccinees Aged 5­25 Years. Scand J Infect Dis; 37 (11): 913­915; 2005. Valli, L. Logical to Vaccinate Rather Than Risk Infection. Can Vet J; 46 (2): 108; February, 2005. van Amersfoorth, S. C.; Schouls, L. M.; van der Heide, H. G.; Advani, A.; Hallander, H. O.; Bondeson, K.; von Konig, C. H.; Riffelmann, M.; Vahrenholz, C.; Guiso, N.; Caro, V.; Njamkepo, E.; He, Q.; Mertsola, J.; Mooi, F. R. Analysis of Bordetella Pertussis Populations in European Countries With Different Vaccination Policies. J Clin Microbiol; 43 (6): 2837­2843; June, 2005. van Boven, M.; Mooi, F. R.; Schellekens, J. F.; de Melker, H. E.; Kretzschmar, M. Pathogen Adaptation Under Imperfect Vaccination: Implications for Pertussis. Proc Biol Sci; 272 (1572): 1617­1624; August 7, 2005. Van der Wal, M. F.; Diepenmaat, A. C.; Pel, J. M.; Hirasing, R. A. Vaccination Rates in a Multicultural Population. Arch Dis Child; 90 (1): 36­40; January, 2005. van, der, V; Claessen, A. M.; van Velzen­Blad, H.; Biesma, D. H.; Rijker, G. T. Development of Functional Haemophilus Influenzae Type b Antibodies After Vaccination. Haematologica; 90 (11): 1582­1584; November, 2005. Van, Houdt, I; Oudejans, J. J.; van den Eertwegh, A. J.; Baars, A.; Vos, W.; Bladergroen, B. A.; Rimoldi, D.; Muris, J. J.; Hooijberg, E.; Gundy, C. M.; Meijer, C. J.; Kummer, J. A. Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients With Stage III and IV Melanoma. Clin Cancer Res; 11 (17): 6400­6407; September 1, 2005. Vatansever, U.; Coplu, N.; Oner, N.; Sonmez, C.; Karasalihoglu, S.; Kurtoglu, D.; Esen, B.; Ekuklu, G. Seroprevalance of Bordetella Pertussis Antibodies Among Healthy Adolescent Girls in Edirne. Swiss Med Wkly; 135 (35­36): 531­536; September 3, 2005. Vellozzi, C.; Lane, J. M.; Averhoff, F.; Maurer, T.; Norton, S.; Damon, I.; Casey, C. Generalized Vaccinia, Progressive Vaccinia, and Eczema Vaccinatum Are Rare Following Smallpox (Vaccinia) Vaccination: United States Surveillance, 2003. Clin Infect Dis; 41 (5): 689­697; September 1, 2005. Verweij, M. F.; van den Hoven, M. A. Influenza Vaccination in Dutch Nursing Homes: Is Tacit Consent Morally Justified? Med Health Care Philos; 8 (1): 89­
95; 2005. Victora, C. G. Reaching the Underserved. Am J Public Health; 95 (2): 195; February, 2005. Vila, A.; Ochoa, O.; Ansa, X. Characteristics and Predictors for Non­Vaccination With PPV in the Elderly Population. Prev Med; December 14, 2005. Vila­Corcoles, A.; Ochoa­Gondar, O.; nsa­Echeverria, X.; Gomez­Sorribes, A.; Espelt­Aluja, P.; Pascual­Moron, I. [Influenza Vaccination and Mortality in the Elderly.]. Med Clin (Barc); 125 (18): 689­691; November, 2005. Vizzi, E.; Calvino, E.; Gonzalez, R.; Perez­Schael, I.; Ciarlet, M.; Kang, G.; Estes, M. K.; Liprandi, F.; Ludert, J. E. Evaluation of Serum Antibody Responses Against the Rotavirus Nonstructural Protein NSP4 in Children After Rhesus Rotavirus Tetravalent Vaccination or Natural Infection. Clin Diagn Lab Immunol; 12 (10): 1157­1163; October, 2005. Volpi, A. Varicella Immunization and Herpes Zoster. Herpes; 12 (3): 59; December, 2005. von, Kries R. Comment on B. Zinka Et Al., Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination. Vaccine; August 1, 2005. Wahid, R.; Cannon, M. J.; Chow, M. Virus­Specific CD4+ and CD8+ Cytotoxic T­Cell Responses and Long­Term T­Cell Memory in Individuals Vaccinated Against Polio. J Virol; 79 (10): 5988­5995; May, 2005. Walden, J. Travel Immunizations: Benefits and Precautions. Am Fam Physician; 71 (12): 2254; June 15, 2005. Wallinga, J.; Heijne, J. C.; Kretzschmar, M. A Measles Epidemic Threshold in a Highly Vaccinated Population. PLoS Med; 2 (11): e316; October 18, 2005. Wang, S. T.; Lee, L. T.; Chen, L. S.; Chen, T. H. Economic Evaluation of Vaccination Against Influenza in the Elderly: an Experience From a Population­
Based Influenza Vaccination Program in Taiwan. Vaccine; 23 (16): 1973­1980; March 14, 2005. Washington, M. L.; Humiston, S. G.; Fauerbach, P. B.; Glezen, W. P.; Black, S.; Shinefield, H.; Pulley, J. A Personnel Time­Motion Study of Intranasal Influenza Vaccination in Healthy Children. Vaccine; July 6, 2005. Washington, M. L.; Mason, J.; Meltzer, M. I. Maxi­Vac: Planning Mass Smallpox Vaccination Clinics. J Public Health Manag Pract; 11 (6): 542­549; November, 2005. Watanuki, Y.; Takahashi, H.; Yoshiike, Y.; Ogura, T.; Sato, M.; Miyazawa, N.; Kakemizu, N. [Understanding of Pneumococcal Vaccination in Patients With Chronic Respiratory Diseases]. Nihon Kokyuki Gakkai Zasshi; 43 (4): 209­215; April, 2005. Waugh, N. Commentary: Pneumococcal Immunization May Not Be Cost­Effective in the Elderly in Developed Countries. Int J Epidemiol; March 11, 2005. Webb, G. F. Being Prepared: Modeling the Response to an Anthrax Attack. Ann Intern Med; 142 (8): 667­668; April, 2005. Weber, C. J. Update on Childhood Immunizations. Urol Nurs; 25 (3): 214­215; June, 2005. Weil­Olivier, C. [Invasive Haemophilus Influenzae Type B Infection­­Importance of Recall]. Arch Pediatr; 12 (Spec No 4): 8­10; December, 2005. Weir, E. Vaccination Boosts Adult Immunity to Varicella Zoster Virus. CMAJ; 173 (3): 249; August 2, 2005. Welch, A. C.; Ferreri, S. P.; Blalock, S. J.; Caiola, S. M. North Carolina Family Practice Physicians' Perceptions of Pharmacists As Vaccinators. J Am Pharm Assoc (Wash DC); 45 (4): 486­491; July, 2005. Weller, T. H. Intradermal Vaccination Against Influenza. N Engl J Med; 352 (10): 1044­1046; March 10, 2005. Wendelboe, A. M.; Van, Rie A.; Salmaso, S.; Englund, J. A. Duration of Immunity Against Pertussis After Natural Infection or Vaccination. Pediatr Infect Dis J; 24 (5 Suppl): S58­S61; May, 2005. Wharton, M.; Hogan, R.; Segal­Freeman, P. Childhood Immunization: Exemptions and Vaccine Safety. J Law Med Ethics; 33 (4 Suppl): 34­37; 2005. While, A.; George, C.; Murgatroyd, B. Promoting Influenza Vaccination in Older People: Rationale and Reality. Br J Community Nurs; 10 (9): 427­430; September, 2005. Whitley, R. J. Changing Dynamics of Varicella­Zoster Virus Infections in the 21st Century: the Impact of Vaccination. J Infect Dis; 191 (12): 1999­2001; June 15, 2005. Widera, G.; Johnson, J.; Kim, L.; Libiran, L.; Nyam, K.; Daddona, P. E.; Cormier, M. Effect of Delivery Parameters on Immunization to Ovalbumin Following Intracutaneous Administration by a Coated Microneedle Array Patch System. Vaccine; October 6, 2005. Wiese­Posselt, M.; Leitmeyer, K.; Hamouda, O.; Bocter, N.; Zollner, I.; Haas, W.; Ammon, A. Influenza Vaccination Coverage in Adults Belonging to Defined Target Groups, Germany, 2003/2004. Vaccine; December 27, 2005. Wilson, K.; Mills, E. J.; Norman, G.; Tomlinson, G. Changing Attitudes Towards Polio Vaccination: a Randomized Trial of an Evidence­Based Presentation Versus a Presentation From a Polio Survivor. Vaccine; 23 (23): 3010­3015; April 27, 2005. Wilson, S. J. Factors Affecting Implementation of the U.S. Smallpox Vaccination Program, 2003. Public Health Rep; 120 (1): 3­5; January, 2005. Wirsing von Konig, C. H.; Campins­Marti, M.; Finn, A.; Guiso, N.; Mertsola, J.; Liese, J. Pertussis Immunization in the Global Pertussis Initiative European Region: Recommended Strategies and Implementation Considerations. Pediatr Infect Dis J; 24 (5 Suppl): S87­S92; May, 2005. Wishner, A.; Aronson, J.; Kohrt, A.; Norton, G. Best Practices: Applying Management Analysis of Excellence to Immunization. J Med Pract Manage; 20 (5): 275­278; March, 2005. Wodi, A. P.; Samy, S.; Ezeanolue, E.; Lamour, R.; Patel, R.; Budnick, L. D.; Dashefsky, B. Influenza Vaccine: Immunization Rates, Knowledge, and Attitudes of Resident Physicians in an Urban Teaching Hospital. Infect Control Hosp Epidemiol; 26 (11): 867­873; November, 2005. Wolfe, R. M.; Sharp, L. K. Vaccination or Immunization? The Impact of Search Terms on the Internet. J Health Commun; 10 (6): 537­551; September, 2005. Wolfe, S.; Bhatt, A. Evolving Recommendations for Vaccinating the Immunocompromised Patient. J Public Health Manag Pract; 11 (6): 566­570; November, 2005. Wong, S. S.; Yuen, K. Y. Influenza Vaccination: Options and Issues. Hong Kong Med J; 11 (5): 381­390; October, 2005. Wong­Chew, R. M.; Islas­Romero, R.; Garcia­Garcia, M. D.; Beeler, J. A.; Audet, S.; Santos­Preciado, J. I.; Gans, H.; Lew­Yasukawa, L.; Maldonado, Y. A.; Arvin, A. M.; Valdespino­Gomez, J. L. Immunogenicity of Aerosol Measles Vaccine Given As the Primary Measles Immunization to Nine­Month­Old Mexican Children. Vaccine; September 7, 2005. Woo, E. J.; Ball, R.; Braun, M. M. Fatal Syncope­Related Fall After Immunization. Arch Pediatr Adolesc Med; 159 (11): 1083; November, 2005. Wood, N.; Menzies, R.; McIntyre, P. Epiglottitis in Sydney Before and After the Introduction of Vaccination Against Haemophilus Influenzae Type b Disease. Intern Med J; 35 (9): 530­535; September, 2005. Woringer, V. [Vaccination Status in Children: Positive Effects of Introducing Preschools Visits by an Attending Physician.] Rev Med Suisse; 1 (42): 2756­
2758; November 23, 2005. Wortley, P. Who's Getting Shots and Who's Not: Racial/Ethnic Disparities in Immunization Coverage. Ethn Dis; 15 (2 Suppl 3): S3; 2005. Wright, J. A.; Polack, C. Understanding Variation in Measles­Mumps­Rubella Immunization Coverage­­a Population­Based Study. Eur J Public Health; October 5, 2005. Wu, T. H.; Hutt, J. A.; Garrison, K. A.; Berliba, L. S.; Zhou, Y.; Lyons, C. R. Intranasal Vaccination Induces Protective Immunity Against Intranasal Infection With Virulent Francisella Tularensis Biovar A. Infect Immun; 73 (5): 2644­2654; May, 2005. Wuorimaa, T. K.; Dagan, R.; Bailleux, F.; Haikala, R.; Ekstrom, N.; Eskola, J.; Yaich, M.; Kayhty, H. Functional Activity of Antibodies After Immunization of Finnish and Israeli Infants With an 11­Valent Pneumococcal Conjugate Vaccine. Vaccine; August, 2005. Xakellis, G. C. Predictors of Influenza Immunization in Persons Over Age 65. J Am Board Fam Pract; 18 (5): 426­433; September, 2005. Xie, J.; Dow, W. H. Longitudinal Study of Child Immunization Determinants in China. Soc Sci Med; 61 (3): 601­611; August, 2005. Xu, Q.; Xu, A. Q.; Song, L. Z.; Zhang, L.; Xiao, Z. K.; Wang, C. Y.; Li, M. S.; Wang, A. L.; Li, Z. [Analysis on the Changing of Age Patterns Among Rubella Patients After Rubella Vaccine Immunization for Children in Shandong Province, China]. Zhonghua Liu Xing Bing Xue Za Zhi; 26 (11): 861­863; November, 2005. Yamshchikov, G.; Borisevich, V.; Kwok, C. W.; Nistler, R.; Kohlmeier, J.; Seregin, A.; Chaporgina, E.; Benedict, S.; Yamshchikov, V. The Suitability of Yellow Fever and Japanese Encephalitis Vaccines for Immunization Against West Nile Virus. Vaccine; June 3, 2005. Yanagihara, D. M.; Taira, D. A.; Davis, J.; Gronley, K. A.; Marciel, C.; Lee, E.; Tice, A. A Health Plan Intervention to Improve Pneumococcal Vaccination in the Elderly. Manag Care Interface; 18 (9): 25­30; September, 2005. Yang, J.; Acosta, C. J.; Si, G.; Zeng, J.; Li, C. Y.; Liang, D. B.; Ochiai, R. L.; Page, A. L.; novaro­Holliday, M. C.; Zhang, J.; Zhou, B. D.; Liao, H. Z.; Wang, M. L.; Tan, D. M.; Tang, Z. Z.; Gong, J.; Park, J. K.; Ali, M.; Ivanoff, B.; Liang, G. C.; Yang, H. H.; Pang, T.; Xu, Z. Y.; Donner, A.; Galindo, C. M.; Dong, B. Q.; Clemens, J. D. A Mass Vaccination Campaign Targeting Adults and Children to Prevent Typhoid Fever in Hechi; Expandin the Use of Vi Polysaccharide Vaccine in Southeast China: A Cluster­Randomized Trial. BMC Public Health; 5 (1): 49; May 18, 2005. Yeung, L. F.; Lurie, P.; Dayan, G.; Eduardo, E.; Britz, P. H.; Redd, S. B.; Papania, M. J.; Seward, J. F. A Limited Measles Outbreak in a Highly Vaccinated US Boarding School. Pediatrics; 116 (6): 1287­1291; December, 2005. Yousfi, M. E.; Mercier, S.; Breuille, D.; Denis, P.; Papet, I.; Mirand, P. P.; Obled, C. The Inflammatory Response to Vaccination Is Altered in the Elderly. Mech Ageing Dev; April 26, 2005. Zhang, L.; Johnson, W. D.; Armstrong, M. G. Influenza Vaccination in Mississippi, 1992­2003: Trends, Subgroup Comparisons, and Forecast. J Miss State Med Assoc; 46 (11): 337­343; November, 2005. Zhou, F.; Harpaz, R.; Jumaan, A. O.; Winston, C. A.; Shefer, A. Impact of Varicella Vaccination on Health Care Utilization. JAMA; 294 (7): 797­802; August 17, 2005. Zhou, H.; Deem, M. W. Sculpting the Immunological Response to Dengue Fever by Polytopic Vaccination. Vaccine; December 28, 2005. Zimmerman, R. K. If Pneumonia Is the "Old Man's Friend", Should It Be Prevented by Vaccination? An Ethical Analysis. Vaccine; 23 (29): 3843­3849; May 31, 2005. Zimmerman, R. K. Recent Changes in Influenza Epidemiology and Vaccination Recommendations. J Fam Pract; 54 (1): S1­S8; January, 2005. Zimmerman, R. K.; Nowalk, M. P.; Lin, C. J.; Ko, F. S.; Block, B.; Anderson, G.; Wahrenberger, J. T.; Fox, D. E. Interventions Over 2 Years to Increase Influenza Vaccination of Children Aged 6­23 Months in Inner­City Family Health Centers. Vaccine; November 15, 2005. Zimmerman, R. K.; Tabbarah, M.; Bardenheier, B.; Janosky, J. E.; Troy, J. A.; Raymund, M.; Yawn, B. P. The 2002 United States Varicella Vaccine Shortage and Physician Recommendations for Vaccination. Prev Med; 41 (2): 575­582; August, 2005. Zimmerman, R. K.; Tabbarah, M.; Nowalk, M. P.; Raymund, M.; Jewell, I. K.; Block, B.; Hall, D. G. Predictors of Pneumococcal Polysaccharide Vaccination Among Patients at Three Inner­City Neighborhood Health Centers. Am J Geriatr Pharmacother; 3 (3): 149­159; September, 2005. Zinka, B.; Rauch, E.; Buettner, A.; Rueff, F.; Penning, R. Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination. Vaccine; May 18, 2005. 2006 Aaby, P.; Biai, S.; Veirum, J. E.; Sodemann, M.; Lisse, I.; Garly, M. L.; Ravn, H.; Benn, C. S.; Rodrigues, A.DTP With or After Measles Vaccination Is Associated With Increased in­Hospital Mortality in Guinea­Bissau. Vaccine; October 18, 2006. Aaby, P.; Ibrahim, S. A.; Libman, M. D.; Jensen, H. The Sequence of Vaccinations and Increased Female Mortality After High­Titre Measles Vaccine: Trials From Rural Sudan and Kinshasa. Vaccine; January, 2006. Aaby, P.; Jensen, H.; Walraven, G. Age­Specific Changes in the Female­Male Mortality Ratio Related to the Pattern of Vaccinations: An Observational Study From Rural Gambia. Vaccine; March 31, 2006. Aaby, P.; Vessari, H.; Nielsen, J.; Maleta, K.; Benn, C. S.; Jensen, H.; Ashorn, P. Sex Differential Effects of Routine Immunizations and Childhood Survival in Rural Malawi. Pediatr Infect Dis J; 25 (8): 721­727; August, 2006. Aaby, P.[International Health at Home: Bringing the Experiences Back Home With You].Ugeskr Laeger; 168 (36): 3015­3018; September 4, 2006. Aavitsland, P. [Vaccination­­the Story About That's What Did Not Happen]. Tidsskr Nor Laegeforen; 126 (19): 2504; October 5, 2006. Abramson, J. S.; Neuzil, K. M.; Tamblyn, S. E. Annual Universal Influenza Vaccination: Ready or Not? Clin Infect Dis; 42 (1): 132­135; January 1, 2006. ACOG Committee Opinion No. 344: Human Papillomavirus Vaccination. Obstet Gynecol; 108 (3 Pt 1): 699­705; September, 2006. Adler, U. C.Effects of Childhood Infections and Vaccination on Development of Atopy. Homeopathy; 95 (2): 116­117; April, 2006. Afzal, M. A.; Ozoemena, L. C.; O'hare, A.; Kidger, K. A.; Bentley, M. L.; Minor, P. D. Absence of Detectable Measles Virus Genome Sequence in Blood of Autistic Children Who Have Had Their MMR Vaccination During the Routine Childhood Immunization Schedule of UK. J Med Virol; 78 (5): 623­630; May, 2006. Agtini, M. D.; Ochiai, R. L.; Soeharno, R.; Lee, H. J.; Sundoro, J.; Hadinegoro, S. R.; Han, O. P.; Tana, L.; Halim, F. X.; Ghani, L.; Delima; Lestari, W.; Sintawati, F. X.; Kusumawardani, N.; Malik, R.; Santoso, T. S.; Nadjib, M.; Soeroso, S.; Wangsasaputra, F.; Ali, M.; Ivanoff, B.; Galindo, C. M.; Pang, T.; Clemens, J. D.; Suwandono, A.; Acosta, C. J.Introducing Vi Polysaccharide Typhoid Fever Vaccine to Primary School Children in North Jakarta, Indonesia, Via an Existent School­Based Vaccination Platform. Public Health; September 25, 2006. Aksiutina, L. P. [The Use of Factorial Correlation­Regression Analysis in the Evaluation of the Efficiency of BCG Immunization in Children]. Probl Tuberk Bolezn Legk; 3: 35­37; 2006. Aldis, J. W.; Kortepeter, M. G.; Rusnak, J. M. Reaction After Smallpox Vaccination. Am Fam Physician; 74 (1): 145­147; July 1, 2006. Ambrosio, A. M.; Riera, L. M.; Saavedra, Mdel C.; Sabattini, M. S. Immune Response to Vaccination Against Argentine Hemorrhagic Fever in an Area Where Different Arenaviruses Coexist. Viral Immunol; 19 (2): 196­201; 2006. Ambrozaitis, A.; Laiskonis, A.; Balciuniene, L.; Banzhoff, A.; Malerczyk, C. Rabies Post­Exposure Prophylaxis Vaccination With Purified Chick Embryo Cell Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV) in a Four­Site Intradermal Schedule (4­0­2­0­1­1): An Immunogenic, Cost­Effective and Practical Regimen. Vaccine; February 28, 2006. Anderson, W. Immunization and Hygiene in the Colonial Philippines. J Hist Med Allied Sci; July 28, 2006. Andre, J. B.; Gandon, S. Vaccination, Within­Host Dynamics, and Virulence Evolution. Evolution Int J Org Evolution; 60 (1): 13­23; January, 2006. Andreae, M. C.; Freed, G. L.; Katz, S. L. Safety Concerns Regarding Combination Vaccines. Perspective of Select European Countries. Hum Vaccin; 1 (1): 1­
5; January, 2005. Appel, A.; Everhart, R.; Mehler, P. S.; Mackenzie, T. D. Lack of Ethnic Disparities in Adult Immunization Rates Among Underserved Older Patients in an Urban Public Health System. Med Care; 44 (11): 1054­1058; November, 2006. Arguedas, A.; Soley, C. Pneumococcal Vaccination for Acute Otitis Media. Lancet; 367 (9526): 1897­1898; June 10, 2006. Arinez­Fernandez, M. C.; Carrasco­Garrido, P.; Garcia­Carballo, M.; Hernandez­Barrera, V.; de Miguel, A. G.; Jimenez­Garcia, R. Determinants of Pneumococcal Vaccination Among Patients With Chronic Obstructive Pulmonary Disease in Spain. Hum Vaccin; 2 (3): 99­104; May, 2006. Arita, I.; Nakane, M.; Fenner, F. Public Health. Is Polio Eradication Realistic? Science; 312 (5775): 852­854; May 12, 2006. Arnedo­Pena, A.; Puig­Barbera, J.; Aznar­Orenga, M. A.; Ballester­Albiol, M.; Pardo­Serrano, F.; Bellido­Blasco, J. B.; Romeu­Garcia, M. A. Varicella Vaccine Effectiveness During an Outbreak in a Partially Vaccinated Population in Spain. Pediatr Infect Dis J; 25 (9): 774­778; September, 2006. Arya, S. C.; Agarwal, N. Military Personnel Are Regularly Immunized With Vi Polysaccharide Typhoid Vaccines. Mil Med; 171 (7): x; July, 2006. Arya, S. C.; Agarwal, N. Re: Outbreak of Typhoid Fever in Vaccinated Members of the French Armed Forces in the Ivory Coast. Eur J Epidemiol; May 23, 2006. Arya, S. C.; Agarwal, N.Re: Seroepidemiology Study of Rubella Antibodies Among Pregnant Women From Seven Asian Countries: Evaluation of the Rubella Vaccination Program in Taiwan.Vaccine; August 14, 2006. Asakawa, J.; Kobayashi, S.; Kaneda, K.; Ogasawara, H.; Sugawara, M.; Yasuda, M.; Hashimoto, H. Reactive Arthritis After Influenza Vaccination: Report of a Case. Mod Rheumatol; 15 (4): 283­285; August, 2005. Ashwell, G. K.; Aslam, A. A.; Griffin, J. L.; Horsnell, K.; Rashid, N.; Shahzad, N.; Jubb, A. M. Audit of Influenza Vaccination in Primary Care. Br J Gen Pract; 56 (527): 461; June, 2006. Auewarakul, P.; Kositanont, U.; Sornsathapornkul, P.; Tothong, P.; Kanyok, R.; Thongcharoen, P. Antibody Responses After Dose­Sparing Intradermal Influenza Vaccination. Vaccine; September 1, 2006. Aydin, K.; Elmas, S.; Guzes, E. A.Reversible Posterior Leukoencephalopathy and Adie's Pupil After Measles Vaccination.J Child Neurol; 21 (6): 525­527; June, 2006. Babiuk, S.; Babiuk, L. A.; van Drunen Littel­van den Hurk Editorial: DNA Vaccination: a Simple Concept With Challenges Regarding Implementation. Int Rev Immunol; 25 (3): 51­81; May, 2006. Babl, F. E.; Lewena, S.; Brown, L. Vaccination­Related Adverse Events. Pediatr Emerg Care; 22 (7): 514­519; July, 2006. Bakke, H.; Samdal, H. H.; Holst, J.; Oftung, F.; Haugen, I. L.; Kristoffersen, A. C.; Haugan, A.; Janakova, L.; Korsvold, G. E.; Krogh, G.; Andersen, E. A.; Djupesland, P.; Holand, T.; Rappuoli, R.; Haneberg, B. Oral Spray Immunization May Be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies but Not Nasal Mucosal or Cellular Immunity. Scand J Immunol; 63 (3): 223­231; March, 2006. Ball, F.; Lyne, O.Optimal Vaccination Schemes for Epidemics Among a Population of Households, With Application to Variola Minor in Brazil. Stat Methods Med Res; 15 (5): 481­497; October, 2006. Ballet, C.; Roussey­Kesler, G.; Aubin, J. T.; Brouard, S.; Giral, M.; Miqueu, P.; Louis, S.; van der, Werf S.; Soulillou, J. P. Humoral and Cellular Responses to Influenza Vaccination in Human Recipients Naturally Tolerant to a Kidney Allograft. Am J Transplant; 6 (11): 2796­2801; November, 2006. Bansal, S.; Pourbohloul, B.; Meyers, L. A. A Comparative Analysis of Influenza Vaccination Programs. PLoS Med; 3 (10); October 3, 2006. Barker, L. E.; Chu, S. Y.; Li, Q.; Shaw, K. M.; Santoli, J. M. Disparities Between White and African­American Children in Immunization Coverage. J Natl Med Assoc; 98 (2): 130­135; February, 2006. Barnabas, R. V.; Laukkanen, P.; Koskela, P.; Kontula, O.; Lehtinen, M.; Garnett, G. P. Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses. PLoS Med; 3 (5): e138; April 4, 2006. Bartlett, D. L.; Molinari, N. A.; Ortega­Sanchez, I. R.; Urquhart, G. A. Economics of Immunization Information Systems in the United States: Assessing Costs and Efficiency. Cost Eff Resour Alloc; 4 (1): 15; August 22, 2006. Bass, S. B.; Ruzek, S. B.; Gordon, T. F.; Hanlon, A. L.Preparedness for a Smallpox Outbreak: Comparing Metrics for Assessing Levels of Vaccination Among Health­Care Workers by State. Epidemiol Infect; 1­12; September 6, 2006. Bateman, C. Polio Vaccination 'Gaps'­­Namibia Pays the Price. S Afr Med J; 96 (8): 668, 670; August, 2006. Bedford, H.; Lane, L. Pneumococcal Vaccine and the New Child Vaccination Schedule. Nurs Times; 102 (39): 44, 46­44, 47; September 26, 2006. Benin, A. L.; Wisler­Scher, D. J.; Colson, E.; Shapiro, E. D.; Holmboe, E. S. Qualitative Analysis of Mothers' Decision­Making About Vaccines for Infants: the Importance of Trust. Pediatrics; 117 (5): 1532­1541; May, 2006. Benn, C. S.; Aaby, P.[Gender Differences in Response to Preventive Health Care Interventions. Do We Have to Treat Girls and Boys Differently, If We Treat Them at All?].Ugeskr Laeger; 168 (36): 3045­3046; September 4, 2006. Bergsaker, M. A.; Feiring, B. Introduction of Pneumococcal Conjugate Vaccine into the Norwegian Childhood Vaccination Programme. Euro Surveill; 11 (2): E060202; February 2, 2006. Bergsaker, M.; Hungnes, O.; Iversen, B.[Vaccination Against Influenza, Why, for Whom and With Which Vaccine?]. Tidsskr Nor Laegeforen; 126 (21): 2814­2817; November 2, 2006. Bernsen, R. M.; Koes, B. W.; de Jongste, J. C.; van der Wouden, J. C. Haemophilus Influenzae Type b Vaccination and Reported Atopic Disorders in 8­12­
Year­Old Children. Pediatr Pulmonol; 41 (5): 463­469; March 17, 2006. Berrington, J. E.; Cant, A. J.; Matthews, J. N.; O'keeffe, M.; Spickett, G. P.; Fenton, A. C. Haemophilus Influenzae Type b Immunization in Infants in the United Kingdom: Effects of Diphtheria/Tetanus/Acellular Pertussis/Hib Combination Vaccine, Significant Prematurity, and a Fourth Dose. Pediatrics; March, 2006. Bigham, M.; Remple, V. P.; Pielak, K.; McIntyre, C.; White, R.; Wu, W. Uptake and Behavioural and Attitudinal Determinants of Immunization in an Expanded Routine Infant Hepatitis B Vaccination Program in British Columbia. Can J Public Health; 97 (2): 90­95; March, 2006. Bishai, D.; McQuestion, M.; Chaudhry, R.; Wigton, A. The Costs Of Scaling Up Vaccination In The World's Poorest Countries. Health Aff (Millwood); 25 (2): 348­ 356; March, 2006. Bjorklund, J.; Strand, M.; Blennow, M. [Ambitious Measles Vaccination Program in Vietnam]. Lakartidningen; 103 (17): 1325­1327; April 26, 2006. Bloom, S. A.; Trepka, M. J.; Nobles, R. E.; Becerra, M. A.; Reef, S.; Zhang, G. Low Postpartum Rubella Vaccination Rates in High­Risk Women, Miami, Florida, 2001. Am J Prev Med; 30 (2): 119­124; February, 2006. Bodor, M.; Montalvo, E. Vaccination­Related Shoulder Dysfunction. Vaccine; September 8, 2006. Bogdanovic, G.; Lindekrantz, E.; Bennet, R.; Eriksson, M. [Influenza in Children Demanding for Health Care. Effect of Vaccination Is Still Uncertain­­There Is Probably a Lower Protection Rate in Children Than in Adults]. Lakartidningen; 103 (7): 446­449; February 15, 2006. Boncz, I.; Sebestyen, A. Compensation for Vaccine Injury in Hungary. Lancet; 367 (9517): 1144; April 8, 2006. Bonifachich, E.; Chort, M.; Astigarraga, A.; Diaz, N.; Brunet, B.; Pezzotto, S. M.; Bottasso, O. Protective Effect of Bacillus Calmette­Guerin (BCG) Vaccination in Children With Extra­Pulmonary Tuberculosis, but Not the Pulmonary Disease A Case­Control Study in Rosario, Argentina. Vaccine; January 6, 2006. Bonney, L. E.; Lally, M.; Williams, D. R.; Stein, M.; Flanigan, T. Where to Begin Human Papillomavirus Vaccination? Lancet Infect Dis; 6 (7): 389­390; July, 2006. Boot, H. J.; de Melker, H. E.; Stolk, E. A.; de Wit, G. A.; Kimman, T. G. Assessing the Introduction of Universal Varicella Vaccination in the Netherlands. Vaccine; June 8, 2006. Bou­Mias, C.; Zwart­Salmeron, M.; Calvet­Freixas, E.; Bunuel­Alvarez, J. [Telephone Recruitment for Flu Vaccination.]. Aten Primaria; 37 (3): 176­177; February 28, 2006. Boulay, B. R.; Murray, C. J.; Ptak, J.; Kirkland, K. B.; Montero, J.; Talbot, E. A. An Outbreak of Pertussis in a Hematology­Oncology Care Unit: Implications for Adult Vaccination Policy. Infect Control Hosp Epidemiol; 27 (1): 92­95; January, 2006. Brady, M. T. Immunization Recommendations for Children With Metabolic Disorders: More Data Would Help. Pediatrics; 118 (2): 810­813; August, 2006. Branger, B.; Winer, N. [Epidemiology of Anti­D Allo­Immunization During Pregnancy]. J Gynecol Obstet Biol Reprod (Paris); 35 (Suppl 1): 87­92; February, 2006. Brewer, N. T.; Hallman, W. K.Subjective and Objective Risk As Predictors of Influenza Vaccination During the Vaccine Shortage of 2004­2005. Clin Infect Dis; 43 (11): 1379­1386; December 1, 2006. Brisson, M.; Edmunds, W. J.Impact of Model, Methodological, and Parameter Uncertainty in the Economic Analysis of Vaccination Programs. Med Decis Making; 26 (5): 434­446; September, 2006. Broder, K. R.; Cortese, M. M.; Iskander, J. K.; Kretsinger, K.; Slade, B. A.; Brown, K. H.; Mijalski, C. M.; Tiwari, T.; Weston, E. J.; Cohn, A. C.; Srivastava, P. U.; Moran, J. S.; Schwartz, B.; Murphy, T. V. Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 55 (RR­3): 1­34; March 24, 2006. Brodin­Sartorius, A.; Guebre­Egziabher, F.; Fouque, D.; Cozon, G.; Villar, E.; Laville, M.; Juillard, L. Recurrent Idiopathic Thrombotic Thrombocytopenic Purpura: a Role for Vaccination in Disease Relapse? Am J Kidney Dis; 48 (3): e31­e34; September, 2006. Brook, I.; Foote, P. A.; Hausfeld, J. N. Frequency of Recovery of Pathogens Causing Acute Maxillary Sinusitis in Adults Before and After Introduction of Vaccination of Children With the 7­Valent Pneumococcal Vaccine. J Med Microbiol; 55 (Pt 7): 943­946; July, 2006. Brooks, D. A.; Clover, R.Pertussis Infection in the United States: Role for Vaccination of Adolescents and Adults. J Am Board Fam Med; 19 (6): 603­611; November, 2006. Bryant­Genevier, M.; Sommer, S.; McMahon, A.; Ball, R.; Braun, M. M. Correlates of Public Health Workforce Acceptance of Smallpox Immunization in Virginia. Public Health Nurs; 23 (4): 339­346; July, 2006. Bueving, H. J. Is Influenza Vaccination in Asthmatic Children Helpful? Clin Exp Allergy; 36 (1): 21­25; January, 2006. Bueving, H. J.; van der Wouden, J. C. Influenza Vaccination in Healthy Children. Vaccine; April 21, 2006. Burgess, D. C.; Burgess, M. A.; Leask, J. The MMR Vaccination and Autism Controversy in United Kingdom 1998­2005: Inevitable Community Outrage or a Failure of Risk Communication? Vaccine; March 3, 2006. Burls, A.; Jordan, R.; Barton, P.; Olowokure, B.; Wake, B.; Albon, E.; Hawker, J. Vaccinating Healthcare Workers Against Influenza to Protect the Vulnerable­Is It a Good Use of Healthcare Resources? A Systematic Review of the Evidence and an Economic Evaluation. Vaccine; January 9, 2006. Butler, A. Lyon Playfair (1818­1898) and Compulsory Vaccination. Scott Med J; 51 (3): 43­46; August, 2006. Byington, C. L.; Ampofo, K.; Pavia, A. T.; Korgenski, K.; Daly, J. Pneumococcal Empyema: Impact of Immunization. Pediatr Infect Dis J; 25 (9): 854; September, 2006. Byington, C. L.; Ampofo, K.; Pavia, A. T.; Korgenski, K.; Daly, J. Pneumococcal Empyema: Impact of Immunization. Pediatr Infect Dis J; 25 (9): 854; September, 2006. Byrnes, P.; Fulton, B.; Crawford, M. An Audit of Influenza Vaccination Rates. Aust Fam Physician; 35 (7): 551­552; July, 2006. Cai, L.; Uchiyama, H.; Yanagisawa, S.; Kamae, I. Cost­Effectiveness Analysis of Influenza and Pneumococcal Vaccinations Among Elderly People in Japan. Kobe J Med Sci; 52 (4): 97­109; 2006. Calugar, A.; Ortega­Sanchez, I. R.; Tiwari, T.; Oakes, L.; Jahre, J. A.; Murphy, T. V. Nosocomial Pertussis: Costs of an Outbreak and Benefits of Vaccinating Health Care Workers. Clin Infect Dis; 42 (7): 981­988; April 1, 2006. Calvert, J.; Shors, A. R.; Hornung, R. L.; Poorsattar, S. P.; Sidbury, R. Relapse of Wells' Syndrome in a Child After Tetanus­Diphtheria Immunization. J Am Acad Dermatol; 54 (5 Suppl): S232­S233; May, 2006. Camargos, P.; Ribeiro, Y.; Teixeira, A.; Menezes, L.Tuberculin Skin Reactivity After Neonatal BCG Vaccination in Preterm Infants in Minas Gerais, Brazil, 2001­ 2002. Rev Panam Salud Publica; 19 (6): 403­407; June, 2006. Cameron, J. C.; Walsh, D.; Finlayson, A. R.; Boyd, J. H. Oral Polio Vaccine and Intussusception: A Data Linkage Study Using Records for Vaccination and Hospitalization. Am J Epidemiol; February 8, 2006. Campins, Marti M.[[Vaccination of Health­Care Personnel.].Enferm Infecc Microbiol Clin; 24 (7): 411­412; August, 2006. Campos­Outcalt, D Are You Up to Date With New Immunization Recommendations? J Fam Pract; 55 (3): 232­234; March, 2006. Capolongo, M. J.; Dibonaventura, M. D.; Chapman, G. B. Physician Vaccinate Thyself: Why Influenza Vaccination Rates Are Higher Among Clinicians Than Among Nonclinicians. Ann Behav Med; 31 (3): 288­296; June, 2006. Caramia, G.; Ruffini, E.; Cuzzolin, L.; Atzei, A.; Fanos, V. News on Vaccinations. Pediatr Med Chir; 27 (5): 42­47; September, 2005. Carbonne, B.; Goffinet, F.; Marpeau, L. [Prevention of Fetomaternal Anti­D Allo­Immunization: Methods Used and Topics Discussed]. J Gynecol Obstet Biol Reprod (Paris); 35 (Suppl 1): 85­86; February, 2006. Carrat, F.; Lavenu, A.; Cauchemez, S.; Deleger, S. Repeated Influenza Vaccination of Healthy Children and Adults: Borrow Now, Pay Later? Epidemiol Infect; 134 (1): 63­70; February, 2006. Carty, C. L.; Heagerty, P.; Nakayama, K.; McClung, E. C.; Lewis, J.; Lum, D.; Boespflug, E.; Cloud­Gehring, C.; Soleimani, B. R.; Ranchalis, J.; Bacus, T.; Furlong, C.; Jarvik, G. P. Inflammatory Response After Influenza Vaccination in Men With and Without Carotid Artery Disease. Arterioscler Thromb Vasc Biol; October 5, 2006. Cassell, J.; Leach, M.; Fairhead, J.; Small, M.; Mercer, C. The Social Shaping of Childhood Vaccination Practice in Rural and Urban Gambia. Health Policy Plan; 21 (5): 373­391; September, 2006. Castilla, J.; Arregui, L.; Baleztena, J.; Brugos, A.; Barricarte, A.; Carpintero, M.; Cherrez, C.; Diez, J.; Fernandez, Alonso M.; Figuerido, E.; Franco, T.; Gil, A.; Guijarro, J.; Iceta, A.; Lacalle, T.; Martin, C.; Martinez, Mazo M.; Moran, J.; Moreno, M.; Palau, J.; Perez, Afonso F.; Ruiz, I.; Senosiain, M.; Sota, M.; Virto, T.; Vizcay, J.; Yoldi, C. [Influenza Outbreaks in Highly­Vaccinated Older Institutionalised People in the 2004­2005 Season]. Med Clin (Barc); 126 (1): 35­36; January 14, 2006. Castro­Rodriguez, J. A.; Mallol, J.; Andrade, R.; Munoz, M.; Azzini, I.Comparison of Tuberculin Skin Test Response After Three Modalities of Neonatal BCG Vaccination. Trans R Soc Trop Med Hyg; September 22, 2006. CDC's Advisory Committee Recommends Human Papillomavirus Virus Vaccination. J Med Assoc Ga; 95 (2): 26; 2006. Cella, M. T.; Corona, G.; Tuccillo, E.; Franco, G.[Assessment of Efficacy and Economic Impact of an Influenza Vaccination Campaign in the Personnel of a Health Care Setting]. Med Lav; 96 (6): 483­489; November, 2005. Chaithongwongwatthana, S.; Yamasmit, W.; Limpongsanurak, S.; Lumbiganon, P.; Desimone, J.; Baxter, J.; Tolosa, J. Pneumococcal Vaccination During Pregnancy for Preventing Infant Infection. Cochrane Database Syst Rev;1: CD004903; January 25, 2006. Challenges of Vaccination.Vet Rec; 159 (17): 540­541; October 21, 2006. Chamoux, A.; is­Porret, M.; Rouffiac, K.; Baud, O.; Millot­Theis, B.; Souweine, B. [Impact Study of an Active Antiflu Vaccination Programme on the Clermont­ Ferrand Teaching Hospital Staff.]. Med Mal Infect; March 31, 2006. Chanthavanich, P.; Luxemburger, C.; Sirivichayakul, C.; Lapphra, K.; Pengsaa, K.; Yoksan, S.; Sabchareon, A.; Lang, J. Short Report: Immune Response and Occurrence of Dengue Infection in Thai Children Three to Eight Years After Vaccination With Live Attenuated Tetravalent Dengue Vaccine. Am J Trop Med Hyg; 75 (1): 26­28; July, 2006. Chantler, T.; Newton, S.; Lees, A.; Diggle, L.; Mayon­White, R.; Pollard, A. J.; Fitzpatrick, R.Parental Views on the Introduction of an Infant Pneumococcal Vaccine. Community Pract; 79 (7): 213­216; July, 2006. Chapman, G. B.; Coups, E. J. "Emotion and Preventive Health Behavior: Worry, Regret, and Influenza Vaccination": Correction. Health Psychol; 25 (3): 444; April, 2006. Chapman, G. B.; Coups, E. J. Emotions and Preventive Health Behavior: Worry, Regret, and Influenza Vaccination. Health Psychol; 25 (1): 82­90; January, 2006. Chatterjee, S.; Perignon, J. L.; Marck, E. V.; Druilhe, P.How Reliable Are Models for Malaria Vaccine Development? Lessons From Irradiated Sporozoite Immunizations. J Postgrad Med; 52 (4): 321­324; October, 2006. Cheater, F. M. Mothers' Decisions About MMR Vaccination Were Framed by Their Children's Vulnerabilities and Wider Social Trends. Evid Based Nurs; 9 (1): 27; January, 2006. Chen, F. H. A Susceptible­Infected Epidemic Model With Voluntary Vaccinations. J Math Biol; June 7, 2006. Chen, S. C.; Chang, C. F.; Jou, L. J.; Liao, C. M. Modelling Vaccination Programmes Against Measles in Taiwan. Epidemiol Infect; October 26, 2006. Chen, Y. H.; Yang, G. Y.; Loh, C. H.; Liou, S. H.; Su, W. L.; Lin, S. H.; Chou, C. C.Cost Benefits of Targeting the Pneumococcal Vaccination Program to the Elderly Population in Taiwan. Am J Infect Control; 34 (9): 597­599; November, 2006. Chi, R. C.; Reiber, G. E.; Neuzil, K. M. Influenza and Pneumococcal Vaccination in Older Veterans: Results From the Behavioral Risk Factor Surveillance System. J Am Geriatr Soc; 54 (2): 217­223; February, 2006. Childhood Influenza Vaccination Coverage­­United States, 2004­05 Influenza Season. MMWR Morb Mortal Wkly Rep; 55 (39): 1062­1065; October 6, 2006. Chiu, Y. K.; Huang, C. C.; Jeng, J.; Shiea, J.; Chen, W. J. Foreign Body Granuloma Caused by Monosodium Glutamate After BCG Vaccination. J Am Acad Dermatol; 55 (2 Suppl): S1­S5; August, 2006. Chodick, G.; Heymann, A. D.; Green, M. S.; Kokia, E.; Shalev, V. Late Influenza Vaccination Is Associated With Reduced Effectiveness. Prev Med; April 2, 2006. Choi, J. Y.; Lee, S. H. Does Prenatal Care Increase Access to Child Immunization? Gender Bias Among Children in India. Soc Sci Med; January 26, 2006. Choi, M. J.; Kim, J. H.; Maibach, H. I. Topical DNA Vaccination With DNA/Lipid Based Complex. Curr Drug Deliv; 3 (1): 37­45; January, 2006. Chou, C. H.; Liou, W. P.; Hu, K. I.; Loh, C. H.; Chou, C. C.; Chen, Y. H.Bell's Palsy Associated With Influenza Vaccination: Two Case Reports. Vaccine; October, 2006. Chowdhury, F.; Khan, A. I.; Hossain, M. I.; Malek, M. A.; Faruque, A. S.; Ahmed, T.; Salam, M. A. Young Children Non­Immunized Against Measles: Characteristics and Programmatic Implications. Acta Paediatr; 95 (1): 44­49; January, 2006. Christenson, B. Spanish Royal Philanthropic Expedition and Smallpox Vaccination. Clin Infect Dis; 42 (5): 731­732; March 1, 2006. Cohen, A. L.; Veenstra, D. Economic Analysis of Prevaccination Serotesting Compared With Presumptive Immunization for Polio, Diphtheria, and Tetanus in Internationally Adopted and Immigrant Infants. Pediatrics; 117 (5): 1650­1655; May, 2006. Cohen, D.; Muhsen, K.; Aboudy, Y.; Harari, H.; Mendelson, E.; Green, M. S. Use of Rubella Seroepidemiological Data for Assessment of Previous Vaccination Policy and for Decision Making in Response to Epidemics in Israel. Vaccine; May 2, 2006. Cohen, H. W.; Gould, R. M.; Sidel, V. W. Smallpox Vaccinations and Adverse Events. JAMA; 295 (16): 1897­1898; April 26, 2006. Cohen, L. L.; Maclaren, J. E.; Fortson, B. L.; Friedman, A.; Demore, M.; Lim, C. S.; Shelton, E.; Gangaram, B. Randomized Clinical Trial of Distraction for Infant Immunization Pain. Pain; June 13, 2006. Coleman, M. S.; Washington, M. L.; Orenstein, W. A.; Gazmararian, J. A.; Prill, M. M. Interdisciplinary Epidemiologic and Economic Research Needed to Support a Universal Childhood Influenza Vaccination Policy. Epidemiol Rev; June 1, 2006. College National des Gynecologues Et Obstetriciens Francais Cngof [Recommendations for Clinical Practice. Prevention in Maternofetal Rh Immunization (December 2005).]. Gynecol Obstet Fertil; April 24, 2006. Corsini, E.; Vismara, L.; Lucchi, L.; Viviani, B.; Govoni, S.; Galli, C. L.; Marinovich, M.; Racchi, M. High Interleukin­10 Production Is Associated With Low Antibody Response to Influenza Vaccination in the Elderly. J Leukoc Biol; May 17, 2006. Cox, R. J.; Haaheim, L. R.; Ericsson, J. C.; Madhun, A. S.; Brokstad, K. A. The Humoral and Cellular Responses Induced Locally and Systemically After Parenteral Influenza Vaccination in Man. Vaccine; June 8, 2006. Crampton, P.; Carr, J. Socially or Materially Marginal Children Are Less Likely to Be Fully Immunised­­a Systems Response. BMJ; 332 (7553): 1314; June 3, 2006. Cripps, A. W.; Leach, A. J.; Lehmann, D. Pneumococcal Vaccination in Developing Countries. Lancet; 368 (9536): 644; August, 2006. Crosbie, E. J.; Kitchener, H. C. Human Papillomavirus in Cervical Screening and Vaccination. Clin Sci (Lond); 110 (5): 543­552; May, 2006. Cruces, R. P.; Donoso, F. A.; Camacho, A. J.; Llorente, H. M. [Invasive Infections Caused by Haemophilus Influenzae Type b After the Institution of the Conjugated Vaccine on the Expanded Programm on Immunization in Chile]. Rev Chilena Infectol; 23 (1): 50­54; March, 2006. Cui, F. Q.; Gofin, R. Immunization Coverage and Its Determinants in Children Aged 12­23 Months in Gansu, China. Vaccine; September 1, 2006. Cui, Z.; Dierling, A.; Foldvari, M. Non­Invasive Immunization on the Skin Using DNA Vaccine. Curr Drug Deliv; 3 (1): 29­35; January, 2006. Currie, G. P.; Douglas, J. G. ABC of Chronic Obstructive Pulmonary Disease.Non­Pharmacological Management. BMJ; 332 (7554): 1379­1381; June 10, 2006. Currie, J. Vaccination: Is It a Real Problem for Anesthesia and Surgery? Paediatr Anaesth; 16 (5): 501­503; May, 2006. D'Heilly, S. J.; Blade, M. A.; Nichol, K. L Safety of Influenza Vaccinations Administered in Nontraditional Settings. Vaccine; February 9, 2006. Da Silva e Sa GR; Camacho, L. A.; Siqueira, M. M.; Stavola, M. S.; Ferreira, D. A.Seroepidemiological Profile of Pregnant Women After Inadvertent Rubella Vaccination in the State of Rio De Janeiro, Brazil, 2001­2002. Rev Panam Salud Publica; 19 (6): 371­378; June, 2006. Daley, M. F.; Crane, L. A.; Chandramouli, V.; Beaty, B. L.; Barrow, J.; Allred, N.; Berman, S.; Kempe, A. Influenza Among Healthy Young Children: Changes in Parental Attitudes and Predictors of Immunization During the 2003 to 2004 Influenza Season. Pediatrics; 117 (2): e268­e277; February, 2006. Damoiseaux, J.; Rijkers, G.; Tervaert, J. W. Pneumococcal Vaccination Does Not Increase Circulating Levels of IgM Antibodies to Oxidized LDL in Humans and Therefore Precludes an Anti­Atherogenic Effect. Atherosclerosis; June 13, 2006. Dannetun, E.; Tegnell, A.; Torner, A.; Giesecke, J. Coverage of Hepatitis B Vaccination in Swedish Healthcare Workers. J Hosp Infect; April 16, 2006. Davids, V.; Hanekom, W. A.; Mansoor, N.; Gamieldien, H.; Gelderbloem, S. J.; Hawkridge, A.; Hussey, G. D.; Hughes, E. J.; Soler, J.; Murray, R. A.; Ress, S. R.; Kaplan, G. The Effect of Bacille Calmette­Guerin Vaccine Strain and Route of Administration on Induced Immune Responses in Vaccinated Infants. J Infect Dis; 193 (4): 531­536; February 15, 2006. Davis, M. M. Successes and Remaining Challenges After 10 Years of Varicella Vaccination in the USA. Expert Rev Vaccines; 5 (2): 295­302; April, 2006. Davis, M. M.; Taubert, K.; Benin, A. L.; Brown, D. W.; Mensah, G. A.; Baddour, L. M.; Dunbar, S.; Krumholz, H. M.Influenza Vaccination As Secondary Prevention for Cardiovascular Disease. A Science Advisory From the American Heart Association/ American College of Cardiology.J Am Coll Cardiol; September 18, 2006. Davis, M. M.; Taubert, K.; Benin, A. L.; Brown, D. W.; Mensah, G. A.; Baddour, L. M.; Dunbar, S.; Krumholz, H. M. Influenza Vaccination As Secondary Prevention for Cardiovascular Disease: a Science Advisory From the American Heart Association/American College of Cardiology.I. J Am Coll Cardiol; 48 (7): 1498­1502; October 3, 2006. Day, M. Body Consults to Balance Public Health Against Private Rights. BMJ; 332 (7551): 1176; May, 2006. de Andres, A. L.; Garrido, P. C.; Hernandez­Barrera, V.; Del Pozo, S. V.; de Miguel, A. G.; Jimenez­Garcia, R. Influenza Vaccination Among the Elderly Spanish Population: Trend From 1993 to 2003 and Vaccination­Related Factors*. Eur J Public Health; October 27, 2006. De Greeff, S. C.; de Melker, H. E.; Spanjaard, L.; Schouls, L. M.; van, Derende A. Protection From Routine Vaccination at the Age of 14 Months With Meningococcal Serogroup C Conjugate Vaccine in the Netherlands. Pediatr Infect Dis J; 25 (1): 79­80; January, 2006. de Juanes, J.R.; Garcia de Codes, A.; Arrazola, M. P.; Jaen, F.; Sanz, M. I.; Gonzalez, A. Influenza Vaccination Coverage Among Hospital Personnel Over Three Consecutive Vaccination Campaigns (2001­2002 to 2003­2004). Vaccine; December 1, 2005. de Timoteo Mavimbe, J. C.; Muquingue, H. N.; Braa, J.; Bjune, G. Immunization Coverage in Mozambique: From Concepts to Decision­Making. Health Policy; January 4, 2006. De, Juanes, Jr.; Cisterna, R.; Sanz, J.; Magaz, S.; Badia, X. [Efficiency of Influenza Vaccination in the Working Population in Spain.]. Gac Sanit; 20 (2): 101­
107; March, 2006. De, Wals P. Immunization Strategies for the Control of Serogroup C Meningococcal Disease in Developed Countries. Expert Rev Vaccines; 5 (2): 269­275; April, 2006. De, Wals P.; Trottier, P.; Pepin, J. Relative Efficacy of Different Immunization Schedules for the Prevention of Serogroup C Meningococcal Disease: A Model­ Based Evaluation. Vaccine; 24 (17): 3500­3504; April 24, 2006. Delacourt, C.[Prevention of Childhood Tuberculosis: a Powerful Strategy for Contact Investigation Must Accompany Any Change in BCG Vaccination.]. Arch Pediatr; September 18, 2006. Dempsey, A. F.; Zimet, G. D.; Davis, R. L.; Koutsky, L. Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: a Randomized Intervention Study of Written Information About HPV. Pediatrics; 117 (5): 1486­1493; May, 2006. Derancourt, C.; Timsit, F. J.; Verraes­Derancourt, S.; Janier, M.; Dupin, N.; Chartier, C. [Vaccinations.]. Ann Dermatol Venereol; 133 (8­9­C2): 66; September, 2006. Deshmukh, V. MMR Vaccination: New Thought. Indian Pediatr; 43 (6): 555­556; June, 2006. Dexheimer, J. W.; Jones, I.; Chen, Q.; Talbot, T. R.; Mason, D.; Aronsky, D.Providers' Beliefs, Attitudes, and Behaviors Before Implementing a Computerized Pneumococcal Vaccination Reminder.Acad Emerg Med; November 13, 2006. Di, Martino, V; Monnet, E. [Can We Improve Hepatitis B Vaccination Coverage in HIV­Infected Persons?]. Gastroenterol Clin Biol; 30 (3): 443­445; March, 2006. Diez­Domingo, J.; Gil, A.; San­Martin, M.; Gonzalez, A.; Esteban, J.; Baldo, J. M.; Planelles, M. V.; Ubeda, M. I.; Graullera, M.; Peris, A.; Martinez, M.; Anton, V.; Gallego, D.; Alvarez, T.; Villarroya, J. V.; Jubert, A.; Casani, C.; Peidro, C.; Garcia, M.; Ballester, A. Seroprevalence of Varicella Among Children and Adolescents in Valencia, Spain. Reliability of the Parent's Reported History and the Medical File for Identification of Potential Candidates for Vaccination. Hum Vaccin; 1 (5): 204­206; September, 2005. Diggle, L. Childhood Immunisation (1): Planned Changes to the Routine Schedule. Community Pract; 79 (7): 231­232; July, 2006. Diggle, L. The WHO Technique for Intramuscular Thigh Vaccination in Infants and Toddlers Had Fewer Adverse Reactions Than 2 Other Techniques. Evid Based Nurs; 9 (1): 9; January, 2006. Dillner, J. HPV Type Replacement in the Post­Vaccination Era What Is Meant and Is It Likely? Eur J Obstet Gynecol Reprod Biol; August 11, 2006. Dinelli, M. I.; Fisberg, M.; de Moraes­Pinto, M. I. Role of Routine and Mass Vaccination Campaigns in Immunization Status of Adolescents. Eur J Pediatr; October 28, 2006. Distribution of Insecticide­Treated Bednets During a Polio Immunization Campaign­­Niger, 2005. MMWR Morb Mortal Wkly Rep; 55 (33): 913­916; August 25, 2006. Dixon, B. Vaccination and the Placebo Effect. Lancet Infect Dis; 6 (7): 393; July, 2006. Dombkowski, K. J.; Davis, M. M.; Cohn, L. M.; Clark, S. J.Effect of Missed Opportunities on Influenza Vaccination Rates Among Children With Asthma. Arch Pediatr Adolesc Med; 160 (9): 966­971; September, 2006. Dominguez, S. R.; Daum, R. S. Physician Knowledge and Perspectives Regarding Influenza and Influenza Vaccination. Hum Vaccin; 1 (2): 74­79; March, 2005. Donalisio, M. R.; Ruiz, T.; Cordeiro, R. [Factors Associated With Influenza Vaccination Among Elderly Persons in Southeastern Brazil]. Rev Saude Publica; 40 (1): 115­119; February, 2006. Doshi, P.Influenza Vaccination: Policy Versus Evidence: Policy Is in the Lead. BMJ; 333 (7576): 1020­1021; November 11, 2006. Dubray, C.; Gervelmeyer, A.; Djibo, A.; Jeanne, I.; Fermon, F.; Soulier, M. H.; Grais, R. F.; Guerin, P. J. Late Vaccination Reinforcement During a Measles Epidemic in Niamey, Niger (2003­2004). Vaccine; February 8, 2006. Dunais, B.; Saccomano, C.; Mousnier, A.; Roure, M. C.; Dellamonica, P.; Roger, P. M. Influenza Vaccination: Impact of an Intervention Campaign Targeting Hospital Staff. Infect Control Hosp Epidemiol; 27 (5): 529­531; May, 2006. Ebrahim, G. J.Vaccination Against Tuberculosis. J Trop Pediatr; 52 (5): 305­306; October, 2006. Edwards, K. M.; Griffin, M. R.Influenza Vaccination of Children: Can It Be Accomplished? J Infect Dis; 194 (8): 1027­1029; October 15, 2006. Ek, T.; Mellander, L.; Hahn­Zoric, M.; Abrahamsson, J. Avidity of Tetanus and Hib Antibodies After Childhood Acute Lymphoblastic Leukaemia ­ Implications for Vaccination Strategies. Acta Paediatr; 95 (6): 701­706; June, 2006. Elliott, C.; Farmer, K. Immunization Status of Children Under 7 Years in the Vikas Nagar Area, North India. Child Care Health Dev; 32 (4): 415­421; July, 2006. Elomaa, A.; Advani, A.; Donnelly, D.; Antila, M.; Mertsola, J.; He, Q.; Hallander, H. Population Dynamics of Bordetella Pertussis in Finland and Sweden, Neighbouring Countries With Different Vaccination Histories. Vaccine; September, 2006. Emanuel, E. J.; Wertheimer, A. Public Health. Who Should Get Influenza Vaccine When Not All Can? Science; 312 (5775): 854­855; May 12, 2006. Emir, S.; Buyukpamukcu, M.; Koseoglu, V.; Hascelik, G.; Akyuz, C.; Kutluk, T.; Varan, A.Varicella Vaccination in Children With Lymphoma and Solid Tumours. Postgrad Med J; 82 (973): 760­762; November, 2006. Englund, J. A.; Walter, E. B.; Gbadebo, A.; Monto, A. S.; Zhu, Y.; Neuzil, K. M.Immunization With Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers. Pediatrics; 118 (3): e579­e585; September, 2006. Erkek, E.; Tuncez, F.; Sanli, C.; Duman, D.; Kurtipek, G. S.; Bagci, Y.; Ayaslioglu, E. Nicolau's Syndrome in a Newborn Caused by Triple DTP (Diphtheria­ Tetanus­Pertussis) Vaccination. J Am Acad Dermatol; 54 (5 Suppl): S241­S242; May, 2006. Esposito, S.; Marchisio, P.; Droghetti, R.; Lambertini, L.; Faelli, N.; Bosis, S.; Tosi, S.; Begliatti, E.; Principi, N. Influenza Vaccination Coverage Among Children With High­Risk Medical Conditions. Vaccine; March 31, 2006. Facilities Pressed to Vaccinate Staff. Nursing; 36 (8): 34; August, 2006. Fahy, W. A.; Farnworth, E.; Yeldrem, K. P.; Melling, G. S.; Grennan, D. M. Pneumococcal and Influenza Vaccination in Patients With Rheumatic Conditions and Receiving DMARD Therapy. Rheumatology (Oxford); April 25, 2006. Falkenstein, K. Immunization Update: New Recommendations and Choices. Adv Nurse Pract; 14 (3): 63­5, 79; March, 2006. Famularo, G.; Nicotra, G. C.; Minisola, G.; De, Simone C. Leukocytoclastic Vasculitis After Influenza Vaccination. J Clin Rheumatol; 12 (1): 48­50; February, 2006. Fedson, D. S.; Nichol, K. L.Influenza Vaccination: Policy Versus Evidence: No Gap Between Policy and Evidence.BMJ; 333 (7576): 1020; November 11, 2006. Feijo, R. B.; Safadi, M. A. Immunizations: Three Centuries of Success and Ongoing Challenges. J Pediatr (Rio J); 82 (3 Suppl): S1­S3; July, 2006. Ferdman, R. M.; Church, J. A.Denial of insurance authorization at a subspecialty office as a cause of missed opportunities for influenza vaccination in children with asthma. Arch Pediatr Adolesc Med; 160 (9): 987­988; September, 2006. Fernandez, Barrio B.; Santos­Juanes, Jimenez J.; Suarez, Saavedra S.; Medina, Villanueva A.; Concha, Torre A.; Sanchez Del, Rio J.; Rey, Galan C. [Complications of Varicella for Which Dermatologists Are Rarely Consulted, Another Argument in Favor of Systematic Immunization.]. Actas Dermosifiliogr; 97 (4): 291­292; May, 2006. Ferrer, A.; Formiga, F.; Lombarte, I. [Flu Vaccination of Patients Over 90. High Compliance.]. Aten Primaria; 37 (4): 243; March 15, 2006. Fiander, A. N.; Tristram, A. J.; Davidson, E. J.; Tomlinson, A. E.; Man, S.; Baldwin, P. J.; Sterling, J. C.; Kitchener, H. C. Prime­Boost Vaccination Strategy in Women With High­Grade, Noncervical Anogenital Intraepithelial Neoplasia: Clinical Results From a Multicenter Phase II Trial. Int J Gynecol Cancer; 16 (3): 1075­1081; May, 2006. Fielder, M.; Lewis, D. J. Vaccination Against Bacterial Gut Infections. Curr Opin Infect Dis; 11 (5): 591­596; October, 1998. Fiks, A. G.; Alessandrini, E. A.; Luberti, A. A.; Ostapenko, S.; Zhang, X.; Silber, J. H.Identifying Factors Predicting Immunization Delay for Children Followed in an Urban Primary Care Network Using an Electronic Health Record. Pediatrics; November 6, 2006. Finch, M. Point: Mandatory Influenza Vaccination for All Heath Care Workers? Seven Reasons to Say "No". Clin Infect Dis; 42 (8): 1141­1143; April 15, 2006. Findley, S. E.; Irigoyen, M.; Sanchez, M.; Guzman, L.; Mejia, M.; Sajous, M.; Levine, D. A.; Chen, S.; Chimkin, F. Community­Based Strategies to Reduce Childhood Immunization Disparities. Health Promot Pract; June 7, 2006. Fine, A. M.; Goldmann, D. A.; Forbes, P. W.; Harris, S. K.; Mandl, K. D. Incorporating Vaccine­Preventable Disease Surveillance into the National Health Information Network: Leveraging Children's Hospitals. Pediatrics; 118 (4): 1431­1438; October, 2006. Finger, R.; Shoemaker, J. Preventing Pertussis in Infants by Vaccinating Adults. Am Fam Physician; 74 (3): 382; August 1, 2006. Fisman, D. N.; Abrutyn, E.; Spaude, K. A.; Kim, A.; Kirchner, C.; Daley, J. Prior Pneumococcal Vaccination Is Associated With Reduced Death, Complications, and Length of Stay Among Hospitalized Adults With Community­Acquired Pneumonia. Clin Infect Dis; 42 (8): 1093­1101; April 15, 2006. Fleming, D. M.; Elliot, A. J. Estimating the Risk Population in Relation to Influenza Vaccination Policy. Vaccine; March 15, 2006. Fletcher, M. A.; Laufer, D. S.; McIntosh, E. D.; Cimino, C.; Malinoski, F. J. Controlling Invasive Pneumococcal Disease: Is Vaccination of at­Risk Groups Sufficient? Int J Clin Pract; 60 (4): 450­456; April, 2006. Floret, D. [Mandatory Immunizations in Children: Should We Give Up?]. Arch Pediatr; February 16, 2006. Foldvari, M.; Babiuk, S.; Badea, I. DNA Delivery for Vaccination and Therapeutics Through the Skin. Curr Drug Deliv; 3 (1): 17­28; January, 2006. Fombonne, E.; Zakarian, R.; Bennett, A.; Meng, L.; Lean­Heywood, D. Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations. Pediatrics; 118 (1): e139­e150; July, 2006. Fontanesi, J.; Hill, L.; Olson, R.; Bennett, N. M.; Kopald, D. Mass Vaccination Clinics Versus Appointments. J Med Pract Manage; 21 (5): 288­294; March, 2006. Fowler, G. L.; Baggs, J. M.; Weintraub, E. S.; Martin, S. W.; McNeil, M. M.; Gust, D. A. Factors Influencing Laboratory Workers' Decisions to Accept or Decline Anthrax Vaccine Adsorbed (AVA): Results of a Decision­Making Study in CDC's Anthrax Vaccination Program. Pharmacoepidemiol Drug Saf; August 21, 2006. Foxwell, A. R.; Cripps, A. W.; Dear, K. B. Haemophilus Influenzae Oral Whole Cell Vaccination for Preventing Acute Exacerbations of Chronic Bronchitis. Cochrane Database Syst Rev; (4): CD001958; October 18, 2006. Frampton, J. E.; Keam, S. J. Reduced­Antigen, Combined Diphtheria­Tetanus­Acellular Pertussis Vaccine, Adsorbed (Boostrix((R)) US Formulation) : Use As a Single­Dose Booster Immunization in Adolescents Aged 10­18 Years. Paediatr Drugs; 8 (3): 189­195; 2006. Francisco, P. M.; Donalisio, M. R.; Barros, M. B.; Cesar, C. L.; Carandina, L.; Goldbaum, M. [Factors Associated With Vaccination Against Influenza in the Elderly.]. Rev Panam Salud Publica; 19 (4): 259­264; April, 2006. Frey, H. S. The Ethics of Influenza Vaccination. Science; 313 (5788): 758­760; August 11, 2006. Frink, M.; Muller, C. W.; Ziesing, S.; Krettek, C. [Tetanus Vaccination in the Accident and Emergency Department.]. Unfallchirurg; October 5, 2006. Fuchs, F. [Immunization in France: High Quality Regulation.]. Arch Pediatr; May 11, 2006. Fuller, C. L.; Brittingham, K. C.; Hepburn, M. J.; Martin, J. W.; Petitt, P. L.; Pittman, P. R.; Bavari, S. Dominance of Human Innate Immune Responses in Primary Francisella Tularensis Live Vaccine Strain Vaccination. J Allergy Clin Immunol; 117 (5): 1186­1188; May, 2006. Galanis, E.; King, A. S.; Varughese, P.; Halperin, S. A. Changing Epidemiology and Emerging Risk Groups for Pertussis. CMAJ; 174 (4): 451­452; February 14, 2006. Galicia­Garcia, M. D.; Gonzalez­Torga, A.; Garcia­Gonzalez, C.; Fuster­Perez, M.; Garrigos­Gordo, I.; Lopez­Fresnena, N.; Gracia­Rodriguez, R. M.; Sanchez­ Paya, J.[Influenza Vaccination in Healthcare Workers. Why Are Some Vaccinated Whereas Others Are Not?]. Enferm Infecc Microbiol Clin; 24 (7): 413­417; August, 2006. Gallagher, S.; Povey, R. Determinants of Older Adults' Intentions to Vaccinate Against Influenza: a Theoretical Application. J Public Health (Oxf); April 26, 2006. Galvani, A. P.; Medlock, J.; Chapman, G. B. The Ethics of Influenza Vaccination. Science; 313 (5788): 758­760; August 11, 2006. Gao, L.; Hethcote, H. Simulations of Rubella Vaccination Strategies in China. Math Biosci; April 5, 2006. Gao, S.; Chen, L.; Nieto, J. J.; Torres, A. Analysis of a Delayed Epidemic Model With Pulse Vaccination and Saturation Incidence. Vaccine; June 5, 2006. Gao, S.; Chen, L.; Teng, Z. Impulsive Vaccination of an SEIRS Model With Time Delay and Varying Total Population Size. Bull Math Biol; August 11, 2006. Garcia­Doval, I.; Mayo, E.; Nogueira, Farina J.; Cruces, M. J.Bullous Pemphigoid Triggered by Influenza Vaccination? Ecological Study in Galicia, Spain. Br J Dermatol; 155 (4): 820­823; October, 2006. Garcia­Sancho, F. M.; Garcia­Garcia, L.; Jimenez­Corona, M. E.; Palacios­Martinez, M.; Ferreyra­Reyes, L. D.; Canizales­Quintero, S.; Cano­Arellano, B.; Poncede­ Leon, A.; Sifuentes­Osornio, J.; Small, P.; Deriemer, K.Is Tuberculin Skin Testing Useful to Diagnose Latent Tuberculosis in BCG­Vaccinated Children? Int J Epidemiol; September 28, 2006. Garcia, S.; Levine, O. S.; Cherian, T.; Gabastou, J. M.; Andrus, J. Pneumococcal Disease and Vaccination in the Americas: an Agenda for Accelerated Vaccine Introduction. Rev Panam Salud Publica; 19 (5): 340­348; May, 2006. Gargiullo, P. M.; Murphy, T. V.; Davis, R. L.Is There a Safe Age for Vaccinating Infants With Tetravalent Rhesus­Human Reassortant Rotavirus Vaccine? J Infect Dis; 194 (12): 1793­1794; December 15, 2006. Gasink, L. B.; Wurcell, A. G.; Kotloff, R. M.; Lautenbach, E.; Blumberg, E. A. Low Prevalence of Prior Streptococcus Pneumoniae Vaccination Among Potential Lung Transplant Candidates. Chest; 130 (1): 218­221; July, 2006. Gatell, J. M. Immune­Based Therapies: Clinical Experience With Immunomodulators and Therapeutic Immunization. J Acquir Immune Defic Syndr; 42 (Suppl 1): S6­S7; July, 2006. Gatewood, S.; Goode, J. V.; Stanley, D. Keeping Up­to­Date on Immunizations: a Framework and Review for Pharmacists. J Am Pharm Assoc (Wash DC); 46 (2): 183­192; March, 2006. Gemmill, I. Mandatory Immunization of Health Care Providers: the Time Has Come. Can J Public Health; 97 (2): 86­89; March, 2006. Gendrel, D.[BCG Vaccination: Typically French Quarrel or Real Debate?]. Presse Med; 35 (11 Pt 2): 1723­1724; November, 2006. Gentile, D.; Trecki, J.; Patel, A.; Fausnight, T.; Angelini, B.; Skoner, D. Effect of Tetanus Immunization on T­Helper Cytokine Production in Adults With and Without Allergic Rhinitis. Allergy Asthma Proc; 27 (3): 197­201; May, 2006. Gerdes, J.; Thorsen, T.[So Dangerous Are Not Measles, Mumps and Rubella...A Qualitative Survey of Causes of MMR Vaccination Refusal in the County of Vejle]. Ugeskr Laeger; 168 (33): 2670­2674; August 14, 2006. Gilkeson, G. S.Vaccinations in Patients With Systemic Lupus Erythematosus­­Safe, but Not Always Effective. Nat Clin Pract Rheumatol; 2 (11): 590­591; November, 2006. Gillon, H. J.; Armstrong, B. G.; Fiese, M. A.Before You Give That Vaccination. Nursing; 36 (11): 54­57; November, 2006. Gimenez, Sanchez F.; Martinon, Torres F.; Bernaola, Iturbe E.; Baca, Cots M.; De Juan, Martin F.; Diez, Delgado J.; Garces, Sanchez M.; Gomez Campdera, J. A.; Picazo, J.; Pineda, Solas, V [The Role of the Rotavirus Vaccine in Childhood Vaccination Schedules.]. An Pediatr (Barc); 64 (6): 573­577; June, 2006. Gjersvik, P. [Vaccination Against Rotavirus in Uzbekistan?]. Tidsskr Nor Laegeforen; 126 (20): 2694; October, 2006. Gjersvik, P. [Very Good Effect of Hib Vaccination in Kenya]. Tidsskr Nor Laegeforen; 126 (19): 2554; October 5, 2006. Glenn, G. M.; Kenney, R. T.Mass Vaccination: Solutions in the Skin. Curr Top Microbiol Immunol; 304: 247­268; 2006. Gluck, T. Vaccinate Your Immunocompromised Patients! Rheumatology (Oxford); 45 (1): 9­10; January, 2006. Gnanasekaran, S. K.; Finkelstein, J. A.; Hohman, K.; O'Brien, M.; Kruskal, B.; Lieu, T. Parental Perspectives on Influenza Vaccination Among Children With Asthma. Public Health Rep; 121 (2): 181­188; March, 2006. Gnanasekaran, S. K.; Finkelstein, J. A.; Lozano, P.; Farber, H. J.; Chi, F. W.; Lieu, T. A. Influenza Vaccination Among Children With Asthma in Medicaid Managed Care. Ambul Pediatr; 6 (1): 1­7; January 1, 2006. Goebel, L. J.; Mufson, M. A. Influenza Season Triggers Pneumococcal Vaccination. J Am Geriatr Soc; 54 (8): 1261­1264; August, 2006. Goncalves, G.; Nascimento, M. S.; Reu, C.; Cutts, F. T. Levels of Rubella Antibody Among Vaccinated and Unvaccinated Portuguese Mothers and Their Newborns. Vaccine; July 12, 2006. Goodman, M. J.; Nordin, J. D.; Harper, P.; Defor, T.; Zhou, X. The Safety of Trivalent Influenza Vaccine Among Healthy Children 6 to 24 Months of Age. Pediatrics; 117 (5): e821­e826; May, 2006. Goodman, M. J.; Nordin, J. Vaccine Adverse Event Reporting System Reporting Source: a Possible Source of Bias in Longitudinal Studies. Pediatrics; 117 (2): 387­ 390; February, 2006. Goodyear­Smith, F.; Wong, F.; Petousis­Harris, H.; Wilson, E.; Turner, N. Follow­Up of MMR Vaccination Status in Children Referred to a Pediatric Immunization Clinic on Account of Egg Allergy. Hum Vaccin; 1 (3): 118­122; May, 2005. Gordon, S. M.Health Care Worker, Vaccinate Thyself: Toward Better Compliance With Influenza Vaccination. Cleve Clin J Med; 73 (11): 965­966; November, 2006. Gorse, G. J.; O'connor, T. Z.; Young, S. L.; Habib, M. P.; Wittes, J.; Neuzil, K. M.; Nichol, K. L. Impact of a Winter Respiratory Virus Season on Patients With COPD and Association With Influenza Vaccination. Chest; 130 (4): 1109­1116; October, 2006. Gostin, L. O. Medical Countermeasures for Pandemic Influenza: Ethics and the Law. JAMA; 295 (5): 554­556; February 1, 2006. Grabenstein, J. D.; Nevin, R. L.Mass Immunization Programs: Principles and Standards. Curr Top Microbiol Immunol; 304: 31­51; 2006. Grabenstein, J. D.; Pittman, P. R.; Greenwood, J. T.; Engler, R. J. Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects. Epidemiol Rev; June 8, 2006. Grabenstein, J. D.Immunization 1967­2006: Implementation Keeping Pace With Invention? (December). Ann Pharmacother; November 21, 2006. Grabenstein, J. D.The Value of Immunization for God's People. Natl Cathol Bioeth Q; 6 (3): 433­442; 2006. Grace, J. A. Adolescent Immunization: Challenges and Opportunities. J Sch Nurs; 22 (2): 87­93; April, 2006. Grais, R. F.; DE, Radigues, X; Dubray, C.; Fermon, F.; Guerin, P. J. Exploring the Time to Intervene With a Reactive Mass Vaccination Campaign in Measles Epidemics. Epidemiol Infect; 1­5; January 26, 2006. Granerod, J.; Davison, K. L.; Ramsay, M. E.; Crowcroft, N. S. Investigating the Aetiology of and Evaluating the Impact of the Men C Vaccination Programme on Probable Meningococcal Disease in England and Wales. Epidemiol Infect; February 22, 2006. Grau, A. J.; Marquardt, L.; Lichy, C. The Effect of Infections and Vaccinations on Stroke Risk. Expert Rev Neurother; 6 (2): 175­183; February, 2006. Griffiths, U. K.; Botham, L.; Schoub, B. D. The Cost­Effectiveness of Alternative Polio Immunization Policies in South Africa. Vaccine; May 26, 2006. Grijalva, C. G.; Poehling, K. A.; Nuorti, J. P.; Zhu, Y.; Martin, S. W.; Edwards, K. M.; Griffin, M. R.National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States. Pediatrics; 118 (3): 865­873; September, 2006. Groll, D. L.; Thomson, D. J. Incidence of Influenza in Ontario Following the Universal Influenza Immunization Campaign. Vaccine; April 5, 2006. Gronim, S. S. Imagining Inoculation: Smallpox, the Body, and Social Relations of Healing in the Eighteenth Century. Bull Hist Med; 80 (2): 247­268; 2006. Gronvall, G. K.; Borio, L. L. Removing Barriers to Global Pandemic Influenza Vaccination. Biosecur Bioterror; 4 (2): 168­175; 2006. Groves, M. G. Seeks to Clear Up Misunderstandings on Human Rabies Vaccinations. J Am Vet Med Assoc; 228 (11): 1676; June 1, 2006. Gruich, M., Jr. Life­Changing Experiences of a Private Practicing Pediatrician: Perspectives From a Private Pediatric Practice. Pediatrics; 117 (5 Pt 3): S359­
S364; May, 2006. Guerin, N.; Sorge, F.; Imbert, P.; Laurent, C.; Banerjee, A.; Khelfaoui­Ladraa, F.; Gendrel, D. [Vaccinations for Traveler Child.]. Arch Pediatr; October 12, 2006. Gustafsson, L.; Hessel, L.; Storsaeter, J.; Olin, P.Long­Term Follow­Up of Swedish Children Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age Indicates the Need for a Booster Dose at 5 to 7 Years of Age. Pediatrics; 118 (3): 978­984; September, 2006. Guttmann, A.; Manuel, D.; Dick, P. T.; To, T.; Lam, K.; Stukel, T. A. Volume Matters: Physician Practice Characteristics and Immunization Coverage Among Young Children Insured Through a Universal Health Plan. Pediatrics; 117 (3): 595­602; March, 2006. Hak, E.; Buskens, E.; Nichol, K. L.; Verheij, T. J. Do Recommended High­Risk Adults Benefit From a First Influenza Vaccination? Vaccine; January 18, 2006. Hall, A. J Polysaccharide Pneumococcal Vaccination: New Evidence. Thorax; 61 (3): 183­184; March, 2006. Hall, G. H.Influenza Vaccination: Policy Versus Evidence: Vested Interests Will Always Trump Evidence. BMJ; 333 (7576): 1021; November 11, 2006. Halperin, S. A.; Sweet, L.; Baxendale, D.; Neatby, A.; Rykers, P.; Smith, B.; Zelman, M.; Maus, D.; Lavigne, P.; Decker, M. D. How Soon After a Prior Tetanus­ Diphtheria Vaccination Can One Give Adult Formulation Tetanus­Diphtheria­Acellular Pertussis Vaccine? Pediatr Infect Dis J; 25 (3): 195­200; March, 2006. Hamilton­West, K. Factors Influencing MMR Vaccination Decisions Following a Mumps Outbreak on a University Campus. Vaccine; April 18, 2006. Hamkar, R.; Jalilvand, S.; Abdolbaghi, M. H.; Esteghamati, A. R.; Hagh­Goo, A.; Jelyani, K. N.; Mohktari­Azad, T.; Zahraei, M.; Nategh, R. Inadvertent Rubella Vaccination of Pregnant Women: Evaluation of Possible Transplacental Infection With Rubella Vaccine. Vaccine; 24 (17): 3558­3563; April 24, 2006. Hamkar, R.; Jalilvand, S.; Mokhtari­Azad, T.; Jelyani, K. N.; Nategh, R.Evaluation of Immunity Against Rubella in Iranian After Mass Campaign for Measles­ Rubella Vaccination on December 2003. Am J Infect Control; 34 (9): 588­592; November, 2006. Hancock, D. Influenza Vaccinations: Should They Be Mandatory for Nurses? CON. MCN Am J Matern Child Nurs; 31 (2): 77; March, 2006. Hanslik, T. [Immunizations: a Matter for All Physicians.]. Rev Med Interne; June 22, 2006. Hanson, J. F.; Taft, S. C.; Weiss, A. A. Neutralizing Antibodies and Persistence of Immunity Following Anthrax Vaccination. Clin Vaccine Immunol; 13 (2): 208­ 213; February, 2006. Hara, M.; Sakamoto, T.; Tanaka, K. Effectiveness of Influenza Vaccination in Preventing Influenza­Like Illness Among Community­Dwelling Elderly: Population­ Based Cohort Study in Japan. Vaccine; May 5, 2006. Harris, L. M.; Chin, N. P.; Fiscella, K.; Humiston, S. Barrier to Pneumococcal and Influenza Vaccinations in Black Elderly Communities: Mistrust. J Natl Med Assoc; 98 (10): 1678­1684; October, 2006. Haynes, L.; Swain, S. L. Why Aging T Cells Fail: Implications for Vaccination. Immunity; 24 (6): 663­666; June, 2006. Hayney, M. S. Management of Syncope Following Immunization. J Am Pharm Assoc (Wash DC); 46 (3): 407­408; May, 2006. Healy, C. M.; Baker, C. J. Prospects for Prevention of Childhood Infections by Maternal Immunization. Curr Opin Infect Dis; 19 (3): 271­276; June, 2006. Heffelfinger, J. D.; Heckbert, S. R.; Psaty, B. M.; Weiss, N. S.; Thompson, W. W.; Bridges, C. B.; Jackson, L. A. Influenza Vaccination and Risk of Incident Myocardial Infarction. Hum Vaccin; 2 (4): 161­166; July, 2006. Heilmann, C.; Grandjean, P.; Weihe, P.; Nielsen, F.; Budtz­Jorgensen, E.Reduced Antibody Responses to Vaccinations in Children Exposed to Polychlorinated Biphenyls. PLoS Med; 3 (8); August 22, 2006. Heininger, U. An Internet­Based Survey on Parental Attitudes Towards Immunization. Vaccine; June 5, 2006. Heininger, U.; Cherry, J. D. Pertussis Immunisation in Adolescents and Adults­­Bordetella Pertussis Epidemiology Should Guide Vaccination Recommendations. Expert Opin Biol Ther; 6 (7): 685­697; July, 2006. Heininger, U.; Zuberbuhler, M. Immunization Rates and Timely Administration in Pre­School and School­Aged Children. Eur J Pediatr; 165 (2): 124­129; February, 2006. Henderson, J. W.; Arbor, S. A.; Broich, S. L.; Mohr, Peterson J.; Hutchinson, J. E. Immunization Initiation Among Infants in the Oregon Health Plan. Am J Public Health; March 29, 2006. Hepburn, M. J.; Kortepeter, M. G.; Pittman, P. R.; Boudreau, E. F.; Mangiafico, J. A.; Buck, P. A.; Norris, S. L.; Anderson, E. L. Neutralizing Antibody Response to Booster Vaccination With the 17d Yellow Fever Vaccine. Vaccine; January 18, 2006. Hepburn, M. J.; Purcell, B. K.; Lawler, J. V.; Coyne, S. R.; Petitt, P. L.; Sellers, K. D.; Norwood, D. A.; Ulrich, M. P. Live Vaccine Strain Francisella Tularensis Is Detectable at the Inoculation Site but Not in Blood After Vaccination Against Tularemia. Clin Infect Dis; 43 (6): 711­716; September 15, 2006. Herman, C.; McIntyre, C.; Pielak, K. Mass Immunization Clinics. Nurs BC; 38 (4): 20­21; October, 2006. Hernan, M. A.; Alonso, A.; Hernandez­Diaz, S. Tetanus Vaccination and Risk of Multiple Sclerosis: a Systematic Review. Neurology; 67 (2): 212­215; July 25, 2006. Herndler­Brandstetter, D.; Cioca, D. P.; Grubeck­Loebenstein, B. Immunizations in the Elderly: Do They Live Up to Their Promise? Wien Med Wochenschr; 156 (5­6): 130­141; March, 2006. Heymann, D. L.; Aylward, R. B.Mass Vaccination: When and Why. Curr Top Microbiol Immunol; 304: 1­16; 2006. Hirdes, J. P.; Dalby, D. M.; Steel, R. K.; Carpenter, G. I.; Bernabei, R.; Morris, J. N.; Fries, B. E.Predictors of Influenza Immunization Among Home Care Clients in Ontario. Can J Public Health; 97 (4): 335­339; July, 2006. Hitchcock, W. P. Rationale for Use of Tdap Booster Vaccines for Adolescent Immunization: Overview of Efficacy, Safety, and Clinical Use. Clin Pediatr (Phila); 45 (9): 785­794; November, 2006. Hofman, T.; Cranswick, N.; Kuna, P.; Boznanski, A.; Latos, T.; Gold, M.; Murell, D.; Gebauer, K.; Behre, U.; Machura, E.; Oacutelafsson, J.; Szalai, Z. Tacrolimus Ointment Does Not Affect the Immediate Response to Vaccination, the Generation of Immune Memory, or Humoral and Cell­Mediated Immunity in Children. Arch Dis Child; June 23, 2006. Hofmann, F.; Ferracin, C.; Marsh, G.; Dumas, R. Influenza Vaccination of Healthcare Workers: a Literature Review of Attitudes and Beliefs. Infection; 34 (3): 142­ 147; June, 2006. Hogue, M. D.; Grabenstein, J. D.; Foster, S. L.; Rothholz, M. C. Pharmacist Involvement With Immunizations: a Decade of Professional Advancement. J Am Pharm Assoc (Wash DC); 46 (2): 168­179; March, 2006. Holodniy, M.Prevention of Shingles by Varicella Zoster Virus Vaccination. Expert Rev Vaccines; 5 (4): 431­443; August, 2006. Hong, J. M.; Jung, K. Y. An Adult Case of Mumps Brainstem Meningoencephalitis With a Past Measles­Mumps­Rubella (MMR) Vaccination. Korean J Intern Med; 21 (2): 154­157; June, 2006. Honkanen, P.; Laara, E.; Pyhala, R.; Kivela, S. L.; Helena, Makela P. Comparison of Two Vaccination Programmes in Preventing Influenza­Related Hospitalization Among the Elderly During Two Consecutive Seasons. Scand J Infect Dis; 38 (6): 506­511; 2006. Hoover, D. R.; Sambamoorthi, U.; Crystal, S. On Characteristics of Community Dwelling Elderly Not Vaccinated for Pneumococcus in 1998 and 2001. Prev Med; February 7, 2006. Hopkins, R. Call to Action: Adult Immunization. J Ark Med Soc; 102 (9): 237; March, 2006. Huerta, M.; Balicer, R. D.; Mimouni, D.; Goldberg, A.; Furman, M. M.; Klement, E.; Hourvitz, A.; Grotto, I. Validity of Self­Assessment of Skin Reaction After Smallpox Vaccination. Public Health Rep; 121 (1): 45­50; January, 2006. Hughes, R. A.; Charlton, J.; Latinovic, R.; Gulliford, M. C. No Association Between Immunization and Guillain­Barre Syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med; 166 (12): 1301­1304; June 26, 2006. Hui, S. L.; Chu, L. W.; Peiris, J. S.; Chan, K. H.; Chu, D.; Tsui, W. Immune Response to Influenza Vaccination in Community­Dwelling Chinese Elderly Persons. Vaccine; May 3, 2006. Hutton, G.; Tediosi, F. The Costs of Introducing a Malaria Vaccine Through the Expanded Program on Immunization in Tanzania. Am J Trop Med Hyg; 75 (2 Suppl): 119­130; August, 2006. Ichim, T. E.; Popov, I. A.; Riordan, N. H.; Izadi, H.; Zhong, Z.; Yijian, L.; Sher, S.; Oleinik, E. K. A Novel Method of Modifying Immune Responses by Vaccination With Lipiodol­SiRNA Mixtures. J Transl Med; 4: 2; January 3, 2006. Ikegame, K.; Kaida, K.; Fujioka, T.; Kawakami, M.; Hasei, H.; Inoue, T.; Taniguchi, Y.; Yoshihara, S.; Hayashi, S.; Kurata, Y.; Ogawa, H. Idiopathic Thrombocytopenic Purpura After Influenza Vaccination in a Bone Marrow Transplantation Recipient. Bone Marrow Transplant; 38 (4): 323­324; August, 2006. Immunization practices in pediatric liver transplant patients at studies of pediatric liver and transplant (split) centers. Transplantation; 82 (1 Suppl 2): 981­982; July 15, 2006. Influenza and Pneumococcal Vaccination Coverage Among Persons Aged > or = 65 Years­­United States, 2004­2005. MMWR Morb Mortal Wkly Rep; 55 (39): 1065­1068; October 6, 2006. Injeyan, H. S.; Russell, M. L.; Verhoef, M. J.; Mutasingwa, D. Canadian Chiropractors' Perception of Educational Preparation to Counsel Patients on Immunization. J Manipulative Physiol Ther; 29 (8): 643­650; October, 2006. Iorio, A. M.; Camilloni, B.; Basileo, M.; Guercini, F.; Conti, S.; Ferrante, F.; Paccamiccio, E.; Iaboni, S.; Vecchioli, M.; Iorio, A. Influenza Vaccination in Patients on Long­Term Anticoagulant Therapy. Vaccine; June 8, 2006. Iorio, A. M.; Neri, M.; Lepri, E.; Camilloni, B.; Basileo, M.; Sigismondi, N.; Fabiani, C.; Calzoletti, L.; Puzelli, S.; Donatelli, I. An Influenza A/H3 Outbreak During the 2004/2005 Winter in Elderly Vaccinated People Living in a Nursing Home. Vaccine; June 5, 2006. Ipp, M.; Cohen, E.; Goldbach, M.; Macarthur, C.Pain Response to M­M­R Vaccination in 4 ­ 6 Year Old Children. Can J Clin Pharmacol; 13 (3): e296­e299; 2006. Ipp, M.; Sam, J.; Parkin, P. C. Needle Aspiration and Intramuscular Vaccination. Arch Pediatr Adolesc Med; 160 (4): 451; April, 2006. Irigoyen, M. M.; Findley, S.; Wang, D.; Chen, S.; Chimkin, F.; Pena, O.; Mendonca, E. Challenges and Successes of Immunization Registry Reminders at Inner­ City Practices. Ambul Pediatr; 6 (2): 100­104; March, 2006. Isaacman, D. J.; Fletcher, M. A.; Fritzell, B.; Ciuryla, V.; Schranz, J. Indirect Effects Associated With Widespread Vaccination of Infants With Heptavalent Pneumococcal Conjugate Vaccine (PCV7; Prevnar). Vaccine; September 18, 2006. Ito, Y.; Sumi, H.; Kato, T. Evaluation of Influenza Vaccination in Health­Care Workers, Using Rapid Antigen Detection Test. J Infect Chemother; 12 (2): 70­
72; April, 2006. Jackson, L. A.; Dunstan, M.; Starkovich, P.; Dunn, J.; Yu, O.; Nelson, J. C.; Rees, T.; Zavitkovsky, A. Prophylaxis With Acetaminophen or Ibuprofen for Prevention of Local Reactions to the Fifth Diphtheria­Tetanus Toxoids­Acellular Pertussis Vaccination: a Randomized, Controlled Trial. Pediatrics; 117 (3): 620­625; March, 2006. Jain, S.; Sharma, R. K.; Vyas, S. P. Chitosan Nanoparticles Encapsulated Vesicular Systems for Oral Immunization: Preparation, in­Vitro and in­Vivo Characterization. J Pharm Pharmacol; 58 (3): 303­310; March, 2006. JCAHO Targets Resistance to Flu Vaccinations. Hosp Peer Rev; 31 (11): 157­160; November, 2006. Jefferson, T. Influenza Vaccination: Policy Versus Evidence. BMJ; 333 (7574): 912­915; October 28, 2006. Jennings, L. Influenza Vaccination Among New Zealand Healthcare Workers: Low Rates Are Concerning. N Z Med J; 119 (1233): U1961; May 5, 2006. Jhaveri, R. Pneumococcal Empyema: Impact of Immunization. Pediatr Infect Dis J; 25 (9): 854; September, 2006. Jia, H.; Link, M.; Holt, J.; Mokdad, A. H.; Li, L.; Levy, P. S.Monitoring County­Level Vaccination Coverage During the 2004­2005 Influenza Season. Am J Prev Med; 31 (4): 275­280; October, 2006. Jimenez­Garcia, R.; Arinez­Fernandez, M. C.; Hernandez­Barrera, V.; Garcia­Carballo, M. M.; de Miguel, A. G.; Carrasco­Garrido, P. Compliance With Influenza and Pneumococcal Vaccination Among Patients With Chronic Obstructive Pulmonary Disease Consulting Their Medical Practitioners in Catalonia, Spain. J Infect; October 13, 2006. Jimenez­Garcia, R.; Hernandez­Barrera, V.; Carrasco­Garrido, P.; Sierra­Moros, M. J.; Martinez­Hernandez, D.; de Miguel, A. G. Influenza Vaccination Coverages Among Spanish Children, Adults and Health Care Workers. Infection; 34 (3): 135­141; June, 2006. Jimenez­Garcia, R.; Hernandez­Barrera, V.; Carrasco, Garrido P.; Del Pozo, S. V.; de Miguel, A. G. Influenza Vaccination Among Cardiovascular Disease Sufferers in Spain: Related Factors and Trend, 1993­2003. Vaccine; March 29, 2006. Johnston, B. D.; Huebner, C. E.; Anderson, M. L.; Tyll, L. T.; Thompson, R. S. Healthy Steps in an Integrated Delivery System: Child and Parent Outcomes at 30 Months. Arch Pediatr Adolesc Med; 160 (8): 793­800; August, 2006. Joos, T. J.; Miller, W. C.; Murdoch, D. M.Tuberculin Reactivity in Bacille Calmette­Guerin Vaccinated Populations: a Compilation of International Data. Int J Tuberc Lung Dis; 10 (8): 883­891; August, 2006. Juurlink, D. N.; Stukel, T. A.; Kwong, J.; Kopp, A.; McGeer, A.; Upshur, R. E.; Manuel, D. G.; Moineddin, R.; Wilson, K.Guillain­Barre Syndrome After Influenza Vaccination in Adults: a Population­Based Study. Arch Intern Med; 166 (20): 2217­2221; November 13, 2006. Kaic, B.Aseptic Meningitis After Vaccination With L­Zagreb Mumps Strain­Virologically Confirmed Cases Faulty Calculation of Rates. Vaccine; October 25, 2006. Kairys, S. W.; Gubernick, R. S.; Millican, A.; Adams, W. G. Using a Registry to Improve Immunization Delivery. Pediatr Ann; 35 (7): 500­506; July, 2006. Kamadjeu, R. M.; Tolentino, H. Web­Based Public Health GIS for Resources­Constrained Environment Using SVG Technology: a Proof of Concept Applied to the Expanded Program on Immunization Data. Int J Health Geogr; 5 (1): 24; June 3, 2006. Kamin, W.; Staubach, P.; Klar­Hlawatsch, B.; Erdnuss, F.; Knuf, M. [Anaphylaxis After Vaccination Due to Hypersensitivity to Gelatin]. Klin Padiatr; 218 (2): 92­ 94; March, 2006. Kaml, M.; Weiskirchner, I.; Keller, M.; Luft, T.; Hoster, E.; Hasford, J.; Young, L.; Bartlett, B.; Neuner, C.; Fischer, K. H.; Neuman, B.; Wurzner, R.; Grubeck­ Loebenstein, B. Booster Vaccination in the Elderly: Their Success Depends on the Vaccine Type Applied Earlier in Life As Well As on Pre­
Vaccination Antibody Titers. Vaccine; July 10, 2006. Kapetanovic, M. C.; Saxne, T.; Nilsson, J. A.; Geborek, P.Influenza Vaccination As Model for Testing Immune Modulation Induced by Anti­TNF and Methotrexate Therapy in Rheumatoid Arthritis Patients. Rheumatology (Oxford); November 18, 2006. Karthikeyan, B. V.; Pradeep, A. R. Immunization Against Periodontal Disease: Current Strategy and Future Prospects. J Int Acad Periodontol; 8 (4): 106­108; October, 2006. Kato, M. [Influence of Time and Sequence of Vaccination on Completion Ratio]. Nippon Koshu Eisei Zasshi; 53 (2): 105­111; February, 2006. Kaufmann, S. H. Envisioning Future Strategies for Vaccination Against Tuberculosis. Nat Rev Immunol; 6 (9): 699­704; September, 2006. Kennedy, R. D.; Cullamar, K.Immunizations for the Older Adult. Medsurg Nurs; 15 (4): 253­254; August, 2006. Ketterhenry, S.; Martineau, D.; Whittington, A.; Zahn, J. Smallpox. Okla Nurse; 51 (2): 8­9; June, 2006. Keylock, K. T.; Lowder, T.; Leifheit, K. A.; Cook, M.; Mariani, R. A.; Ross, K.; Kim, K.; Chapman­Novakofski, K.; McAuley, E.; Woods, J. A.higher antibody, but not cell­mediated, responses to vaccination in high physically fit elderly. J Appl Physiol; November 9, 2006. Khan, F. N.; Lin, M.; Hinkle, C. J.; Franklin, P.; Luther, R.; Woodruff, F.; Henson, K.; Lukenbill, M.; Gutierrez, M.; Zhu, B. P.Case­Control Study of Vaccination History in Relation to Pertussis Risk During an Outbreak Among School Students. Pediatr Infect Dis J; 25 (12): 1132­1136; December, 2006. Khan, M. N.; Rahman, M. L.; Awal, Miah A.; Islam, M. S.; Musa, S. A.; Tofail, F.Vaccination Coverage Survey in Dhaka District. Bangladesh Med Res Counc Bull; 31 (2): 46­53; August, 2005. Khan, S.; Erlichman, J.; Rand, E. B. Live Virus Immunization After Orthotopic Liver Transplantation. Pediatr Transplant; 10 (1): 78­82; February, 2006. Khare, M.; Piccinino, L.; Barker, L. E.; Linkins, R. W. Assessment of Immunization Registry Databases As Supplemental Sources of Data to Improve Ascertainment of Vaccination Coverage Estimates in the National Immunization Survey. Arch Pediatr Adolesc Med; 160 (8): 838­842; August, 2006. Kim, S. H.; Yeo, S. G.; Cho, J. H.; Kim, H. B.; Kim, N. J.; Oh, M. D.; Choe, K. W.; Jee, Y.; Cho, H. Cell­Mediated Immune Responses to Smallpox Vaccination. Clin Vaccine Immunol; 13 (10): 1172­1174; October, 2006. Kimman, T. G.; Boot, H. J.; Berbers, G. A.; Vermeer­de Bondt, P. E.; rdine de, Wit G.; de Melker, H. E. Developing a Vaccination Evaluation Model to Support Evidence­Based Decision Making on National Immunization Programs. Vaccine; March 27, 2006. King, W. D.; Woolhandler, S. J.; Brown, A. F.; Jiang, L.; Kevorkian, K.; Himmelstein, D. U.; Bor, D. H. Brief Report: Influenza Vaccination and Health Care Workers in the United States. J Gen Intern Med; 21 (2): 181­184; February, 2006. Kingsley, J. D.; Varman, M.; Chatterjee, A.; Kingsley, R. A.; Roth, K. S. Immunizations for Patients With Metabolic Disorders. Pediatrics; June 30, 2006. Kitaichi, N.; Ariga, T.; Ohno, S.; Shimizu, T. Acute Unilateral Conjunctivitis After Rubella Vaccination: the Detection of the Rubella Genome in the Inflamed Conjunctiva by Reverse Transcriptase­Polymerase­Chain Reaction. Br J Ophthalmol; 90 (11): 1436­1437; November, 2006. Klote, M. M.; Engler, R. J.; Martin, B. L.; Cummings, J. F.; Wortmann, G. W.; Ludwig, G. V.Vaccinia DNA in Blood After Smallpox Vaccination. JAMA; 296 (11): 1350­1351; September, 2006. Knuf, M.; Neiss, A.; Wutzler, P. [Impact of Universal Varicella Vaccination in Germany: An Epidemiological and Economic Analysis.]. Klin Padiatr; 218 (4): 203­ 212; July, 2006. Knutsson, N.; Jansson, U. B.; Alm, B. Immediate Injection Pain in Infants Aged 18 Months During Vaccination Against Measles, Mumps and Rubella With Either Priorix((R)) or MMR­II((R)). Vaccine; 24 (31­32): 5800­5805; July 26, 2006. Kochethu, G.; Clark, F. J.; Craddock, C. F. Pertussis: Should We Vaccinate Post Transplant? Bone Marrow Transplant; March 6, 2006. Kolasa, M. S.; Chilkatowsky, A. P.; Clarke, K. R.; Lutz, J. P. How Complete Are Immunization Registries? The Philadelphia Story. Ambul Pediatr; 6 (1): 21­
24; January, 2006. Kollaritsch, H.; Maurer, W. [Rabies: Epidemiology, Pre­ and Postexposure Immunization.]. Wien Klin Wochenschr; 118 (11­12): 312­320; June, 2006. Kolos, V.; Menzies, R.; McIntyre, P.Higher Pertussis Hospitalization Rates in Indigenous Australian Infants, and Delayed Vaccination. Vaccine;August 31, 2006. Kordsmeier, J. Influenza Vaccinations: Should They Be Mandatory for Nurses? PRO. MCN Am J Matern Child Nurs; 31 (2): 76; March, 2006. Krause, G.; Siedler, A.; Schenkel, K.; Steffens, I. Measles Vaccination Advised Before Travel to World Cup in Germany, but Risk of Measles Infection Low. Euro Surveill; 11 (6): E060615; June 15, 2006. Kretzschmar, M.; Wallinga, J.; Teunis, P.; Xing, S.; Mikolajczyk, R. Frequency of Adverse Events After Vaccination With Different Vaccinia Strains. PLoS Med; August 22, 2006. Krief, I.; Goldblatt, J. G.; Paz, A.; Potasman, I. Late Vaccination Against Yellow Fever of Travelers Visiting Endemic Countries. Travel Med Infect Dis; 4 (2): 94­ 98; March, 2006. Kuehn, B. M. CDC: Immunize More Children for Influenza. JAMA; 295 (23): 2709; June 21, 2006. Kwong, J. C.; Manuel, D. G.Using OHIP Physician Billing Claims to Ascertain Individual Influenza Vaccination Status. Vaccine; October, 2006. Kwong, J. C.; Sambell, C.; Johansen, H.; Stukel, T. A.; Manuel, D. G. The Effect of Universal Influenza Immunization on Vaccination Rates in Ontario. Health Rep; 17 (2): 31­40; May, 2006. Kwong, J. C.; Stukel, T. A.; McGeer, A. J.; Manuel, D. G. Appropriate Measures of Influenza Immunization Program Effectiveness. Vaccine; October 11, 2006. Kyaw, M. H.; Greene, C. M.; Schaffner, W.; Ray, S. M.; Shapiro, M.; Barrett, N. L.; Gershman, K.; Craig, A. S.; Roberson, A.; Zell, E. R.; Schuchat, A.; Bennett, N. M.; Whitney, C. G.Adults With Invasive Pneumococcal Disease Missed Opportunities for Vaccination. Am J Prev Med; 31 (4): 286­292; October, 2006. Lambert, Y.; Lombet, J.[Vaccination Against Rotavirus: an Old Challenge, an Ongoing Reality]. Rev Med Liege; 61 (9): 653­655; September, 2006. Landi, F.; Onder, G.; Cesari, M.; Russo, A.; Barillaro, C.; Bernabei, R.In a Prospective Observational Study, Influenza Vaccination Prevented Hospitalization Among Older Home Care Patients. J Clin Epidemiol; 59 (10): 1072­1077; October, 2006. Lane, J. M.Mass Vaccination and Surveillance/Containment in the Eradication of Smallpox. Curr Top Microbiol Immunol; 304: 17­29; 2006. Langley, J. M.Highlights of the National Advisory Committee on Immunization Statement on Influenza for the 2006­2007 Season. CMAJ; 175 (7): 742; September 26, 2006. Langmuir, A. D. Poliomyelitis Vaccination. 1955. Public Health Rep; 121 (Suppl 1): 243­245; 2006. Laria, C.; Alio, J.; Rodriguez, J. L.; Sanchez, J.; Galal, A. [Optic Neuritis After Meningococcal Vaccination.]. Arch Soc Esp Oftalmol; 81 (8): 479­482; August, 2006. Lau, J. T.; Yang, X.; Tsui, H. Y.; Kim, J. H. Prevalence of Influenza Vaccination and Associated Factors Among Community­Dwelling Hong Kong Residents of Age 65 or Above. Vaccine; May 3, 2006. Leask, J.; Chapman, S.; Hawe, P.; Burgess, M. What Maintains Parental Support for Vaccination When Challenged by Anti­Vaccination Messages? A Qualitative Study. 24(49­50): 7238­7245. Vaccine; May 23, 2006. LeBaron, C. W.; Bi, D.; Sullivan, B. J.; Beck, C.; Gargiullo, P. Evaluation of Potentially Common Adverse Events Associated With the First and Second Doses of Measles­Mumps­Rubella Vaccine. Pediatrics; 118 (4): 1422­1430; October, 2006. Lee, H. G.; Zhu, X.; Nunomura, A.; Perry, G.; Smith, M. A. Amyloid­{Beta} Vaccination: Testing the Amyloid Hypothesis?: Heads We Win, Tails You Lose! Am J Pathol; 169 (3): 738­739; September, 2006. Lee, J.; Robinson, J. L.; Spady, D. W. Frequency of Apnea, Bradycardia, and Desaturations Following First Diphtheria­Tetanus­Pertussis­Inactivated Polio­ Haemophilus Influenzae Type B Immunization in Hospitalized Preterm Infants. BMC Pediatr; 6 (1): 20; June, 2006. Lee, P. Y.; Scumpia, P. O.; Byars, J. A.; Kelly, K. M.; Zhuang, H.; Shuster, J. S.; Theriaque, D. W.; Segal, M. S.; Reeves, W. H.; Brantly, M. L. Short­Term Atorvastatin Treatment Enhances Specific Antibody Production Following Tetanus Toxoid Vaccination in Healthy Volunteers. Vaccine; January 9, 2006. Lee, V. J.; Wilder­Smith, A.Travel Characteristics and Health Practices Among Travellers at the Travellers' Health and Vaccination Clinic in Singapore. Ann Acad Med Singapore; 35 (10): 667­673; October, 2006. Leitmeyer, K.; Buchholz, U.; Kramer, M.; Schenkel, K.; Stahlhut, H.; Kollstadt, M.; Haas, W.; Meyer, C. Influenza Vaccination in German Health Care Workers: Effects and Findings After Two Rounds of a Nationwide Awareness Campaign. Vaccine; May 11, 2006. Lenne, X.; Diez, Domingo J.; Gil, A.; Ridao, M.; Lluch, J. A.; Dervaux, B. Economic Evaluation of Varicella Vaccination in Spain­Results From a Dynamic Model. Vaccine; May 4, 2006. Levidiotou, S.; Vrioni, G.; Tzanakaki, G.; Pappa, C.; Gesouli, H.; Gartzonika, C.; Papamichail, D.; Kremastinou, J. Serotype Distribution of Streptococcus Pneumoniae in North­Western Greece and Implications for a Vaccination Programme. FEMS Immunol Med Microbiol; 48 (2): 179­182; November, 2006. Levine, M. M.Mass Vaccination to Control Epidemic and Endemic Typhoid Fever. Curr Top Microbiol Immunol; 304: 231­246; 2006. Lewis, F. S.; Norton, S. A.; Bradshaw, R. D.; Lapa, J.; Grabenstein, J. D. Analysis of Cases Reported As Generalized Vaccinia During the US Military Smallpox Vaccination Program, December 2002 to December 2004. J Am Acad Dermatol; 55 (1): 23­31; July, 2006. Lewis, R. F.; Braka, F.; Mbabazi, W.; Makumbi, I.; Kasasa, S.; Nanyunja, M. Exposure of Ugandan Health Personnel to Measles and Rubella: Evidence of the Need for Health Worker Vaccination. Vaccine; 24(47­48): 6924­6929. June 28, 2006. Lichy, C.; Grau, A. J.Investigating the Association Between Influenza Vaccination and Reduced Stroke Risk. Expert Rev Vaccines; 5 (4): 535­540; August, 2006. Lin, C. J.; Nowalk, M. P.; Zimmerman, R. K.; Ko, F. S.; Zoffel, L.; Hoberman, A.; Kearney, D. H. Beliefs and Attitudes About Influenza Immunization Among Parents of Children With Chronic Medical Conditions Over a Two­Year Period. J Urban Health; June 13, 2006. Lin, C. J.; Zimmerman, R. K.; Nowalk, M. P.; Ko, F. S.; Raymund, M.; Hoberman, A.; Kearney, D. H.; Block, B. Parental Perspectives on Influenza Vaccination of Children With Chronic Medical Conditions. J Natl Med Assoc; 98 (2): 148­153; February, 2006. Lindemann, M.; Witzke, O.; Lutkes, P.; Fiedler, M.; Kreuzfelder, E.; Philipp, T.; Roggendorf, M.; Grosse­Wilde, H. ELISpot Assay As a Sensitive Tool to Detect Cellular Immunity Following Influenza Vaccination in Kidney Transplant Recipients. Clin Immunol; April, 2006. Lindley, M. C.; Wortley, P. M.; Winston, C. A.; Bardenheier, B. H.The Role of Attitudes in Understanding Disparities in Adult Influenza Vaccination. Am J Prev Med; 31 (4): 281­285; October, 2006. Link, M. W.; Ahluwalia, I. B.; Euler, G. L.; Bridges, C. B.; Chu, S. Y.; Wortley, P. M. Racial and Ethnic Disparities in Influenza Vaccination Coverage Among Adults During the 2004­2005 Season. Am J Epidemiol; January 27, 2006. Linkins, R. W.; Salmon, D. A.; Omer, S. B.; Pan, W. K.; Stokley, S.; Halsey, N. A.Support for Immunization Registries Among Parents of Vaccinated and Unvaccinated School­Aged Children: A Case Control Study. BMC Public Health; 6 (1): 236; September 22, 2006. Liu, W.; Clemens, J. D.; Yang, J. Y.; Xu, Z. Y. Immunization Against Japanese Encephalitis in China: A Policy Analysis. Vaccine; April 24, 2006. Llamas, Urrutia C.; Garcia, Pagador E.; Calderer Cardona, M. R.; Lopez, Martinez R.; Bueno Garcia, M. T.; De la Fuente Cadenas JA [Does Anti­Tetanus Vaccination Always Create Protective Immunity?]. Rev Enferm; 29 (1): 7­10; January, 2006. Llewellyn, M.Anaphylaxis Following Paediatric Immunization. Ir Med J; 99 (4): 125; April, 2006. Lo, B. HPV Vaccine and Adolescents' Sexual Activity. BMJ; 332 (7550): 1106­1107; May 13, 2006. Loevinsohn, B.; Hong, R.; Gauri, V. Will More Inputs Improve the Delivery of Health Services? Analysis of District Vaccination Coverage in Pakistan. Int J Health Plann Manage; 21 (1): 45­54; January, 2006. Looijmans­Van, den Akker, I; Verheij, T. J.; Buskens, E.; Nichol, K. L.; Rutten, G. E.; Hak, E. Clinical Effectiveness of First and Repeat Influenza Vaccination in Adult and Elderly Diabetic Patients. Diabetes Care; 29 (8): 1771­1776; August, 2006. Louie, J. K.; Schechter, R.; Honarmand, S.; Guevara, H. F.; Shoemaker, T. R.; Madrigal, N. Y.; Woodfill, C. J.; Backer, H. D.; Glaser, C. A. Severe Pediatric Influenza in California, 2003­2005: Implications for Immunization Recommendations. Pediatrics; 117 (4): e610­e618; April, 2006. Ludwig, B.; Kraus, F. B.; Allwinn, R.; Keim, S.; Doerr, H. W.; Buxbaum, S. Loss of Varicella Zoster Virus Antibodies Despite Detectable Cell Mediated Immunity After Vaccination. Infection; 34 (4): 222­226; August, 2006. Luman, E. T.; Ching, P. L.; Jumaan, A. O.; Seward, J. F. Uptake of Varicella Vaccination Among Young Children in the United States: a Success Story in Eliminating Racial and Ethnic Disparities. Pediatrics; 117 (4): 999­1008; April, 2006. Lyon, A. K.; Bardhan, M.; Barker, P.; Wilson, P.Computer Technology and the Childhood Immunization Programme: an Investigation of Low Uptake Rates in Coventry Primary Care Trust. J Public Health (Oxf); September 6, 2006. Ma, K. K.; Schaffner, W.; Colmenares, C.; Howser, J.; Jones, J.; Poehling, K. A. Influenza Vaccinations of Young Children Increased With Media Coverage in 2003. Pediatrics; 117 (2): e157­e163; February, 2006. Maciosek, M. V.; Solberg, L. I.; Coffield, A. B.; Edwards, N. M.; Goodman, M. J. Influenza Vaccination Health Impact and Cost Effectiveness Among Adults Aged 50 to 64 and 65 and Older. Am J Prev Med; 31 (1): 72­79; July, 2006. Mackenzie, G.; Carapetis, J.; Leach, A.; Hare, K.; Morris, P. Indirect Effects of Childhood Pneumococcal Vaccination on Pneumococcal Carriage Among Adults and Older Children in Australian Aboriginal Communities. Vaccine; September, 2006. Madani, T. A. Trend in Incidence of Hepatitis B Virus Infection During a Decade of Universal Childhood Hepatitis B Vaccination in Saudi Arabia. Trans R Soc Trop Med Hyg; April 4, 2006. Mahon, B. E.; Anah, K.; Kharasch, S. J.Screening Emergency Department Patients for Under­Immunized Adolescents. J Adolesc Health; 39 (4): 598­600; October, 2006. Mair, M.; Grow, R. W.; Mair, J. S.; Radonovich, L. J. Universal Influenza Vaccination: The Time to Act Is Now. Biosecur Bioterror; March 1, 2006. Maire, N.; Tediosi, F.; Ross, A.; Smith, T. Predictions of the Epidemiologic Impact of Introducing a Pre­Erythrocytic Vaccine into the Expanded Program on Immunization in Sub­Saharan Africa. Am J Trop Med Hyg; 75 (2 Suppl): 111­118; August, 2006. Mandl, C. W.Influenza Vaccination: Policy Versus Evidence: Protection From Disease Versus Disease Severity. BMJ; 333 (7576): 1020; November 11, 2006. Mansfield, P. R.; Phadke, A.; Kale, A. Blanket Hepatitis B Vaccination Is Questionable in India. BMJ; 332 (7547): 976; April 22, 2006. Marchetti, F.; Bua, J.; Ventura, A. Pneumococcal Vaccination for Acute Otitis Media. Lancet; 367 (9526): 1897; June 10, 2006. Marin, M.; Nguyen, H. Q.; Langidrik, J. R.; Edwards, R.; Briand, K.; Papania, M. J.; Seward, J. F.; LeBaron, C. W. Measles Transmission and Vaccine Effectiveness During a Large Outbreak on a Densely Populated Island: Implications for Vaccination Policy. Clin Infect Dis; 42 (3): 315­319; February 1, 2006. Marrero, W.; Hernandez, L.; Garcia, R.; Gutierrez, L. M. [Immunization Program Against Influenza for Adults 65 Years or Older at a Community Pharmacy in Puerto Rico]. P R Health Sci J; 25 (1): 35­42; March, 2006. Marshall, H. S.; Gold, M. S.; Gent, R.; Quinn, P. J.; Piotto, L.; Clarke, M. F.; Roberton, D. M. Ultrasound Examination of Extensive Limb Swelling Reactions After Diphtheria­Tetanus­Acellular Pertussis or Reduced­Antigen Content Diphtheria­Tetanus­Acellular Pertussis Immunization in Preschool­Aged Children. Pediatrics; 118 (4): 1501­1509; October, 2006. Marsteller, J. A.; Tiggle, R.; Remsburg, R.; Shefer, A.; Bardenheier, B. Influenza Immunization in Nursing Homes: Who Does Not Get Immunized and Whose Status Is Unknown? Infect Control Hosp Epidemiol; 27 (4): 388­396; April, 2006. Martin, E. Improving Influenza Vaccination Rates in a Pediatric Asthma Management Program by Utilization of an Electronic Medical Record. Clin Pediatr (Phila); 45 (3): 221­227; April, 2006. Martin, Fernandez J. [Analysis of a Economic Model of a Populational Influenza Immunization Strategy in Healthy Employees]. Rev Esp Salud Publica; 80 (3): 219­231; May, 2006. Martins, R. M.; Galler, R.; Freire, M. S.; Camacho, L. A.; Maia, M. D.; Homma, A. Yellow Fever Vaccination: Some Thoughts on How Much Is Enough [Vaccine 23 (2005) 3908­3914]. Vaccine; January 18, 2006. Matteson, L. M. Using Seasonal Influenza Clinics for Public Health Preparedness Exercises. Am J Nurs; 106 (10): 28­29; October, 2006. Maurer, D.; Fulton, C.; Doria, M. Factors That Influence the Decision of Military Dependents to Decline Smallpox Vaccination During an Outbreak. Mil Med; 171 (4): 321­324; April, 2006. May, T.; Silverman, R. D. Free­Riding, Fairness and the Rights of Minority Groups in Exemption From Mandatory Childhood Vaccination. Hum Vaccin; 1 (1): 12­ 15; January, 2005. McClelland, A.; Liamputtong, P. Knowledge and Acceptance of Human Papillomavirus Vaccination: Perspectives of Young Australians Living in Melbourne, Australia. Sex Health; 3 (2): 95­101; May, 2006. McKinney, B. A.; Reif, D. M.; Rock, M. T.; Edwards, K. M.; Kingsmore, S. F.; Moore, J. H.; Crowe, J. E., Jr. Cytokine Expression Patterns Associated With Systemic Adverse Events Following Smallpox Immunization. J Infect Dis; 194 (4): 444­453; August 15, 2006. McNeil, C. Coming Soon: Cervical Cancer Vaccines, and an Array of Public Health Issues. J Natl Cancer Inst; 98 (7): 432­434; April 5, 2006. Meissner, H. C.; Reef, S. E.; Cochi, S. Elimination of Rubella From the United States: a Milestone on the Road to Global Elimination. Pediatrics; 117 (3): 933­935; March, 2006. Melliez, H.; Boelle, P. Y.; Baron, S.; Mouton, Y.; Yazdanpanah, Y. Effectiveness of Childhood Vaccination Against Rotavirus in Sub­Saharan Africa: The Case of Nigeria. Vaccine; August 7, 2006. Mercado, U. Why Have Rheumatologists Been Reluctant to Vaccinate Patients With Systemic Lupus Erythematosus? J Rheumatol; 33 (8): 1469­1471; August, 2006. Merito, M.; Giorgi, Rossi P.; Mantovani, J.; Curtale, F.; Borgia, P.; Guasticchi, G. Cost­Effectiveness of Vaccinating for Invasive Pneumococcal Disease in the Elderly in the Lazio Region of Italy. Vaccine; August 18, 2006. Meyer, P.; Menzel, M.; Muellinger, B.; Weber, N.; Haeussinger, K.; Ziegler­Heitbrock, L. Inhalative Vaccination With Pneumococcal Polysaccharide in Patients With Chronic Obstructive Pulmonary Disease. Vaccine; 24 (31­32): 5832­5838; July 26, 2006. Michiels, B.; Philips, H.; Coenen, S.; Denekens, J.; Van, Royen P. Serum Antibodies Against Circulating Influenza Strains Among Vaccinated and Unvaccinated General Practitioners During Two Consecutive Years (2002­2003). Vaccine; February 3, 2006. Michiels, B.; Philips, H.; Coenen, S.; Yane, F.; Steinhauser, T.; Stuyck, S.; Denekens, J.; Van, Royen P. The Effect of Giving Influenza Vaccination to General Practitioners: a Controlled Trial [NCT00221676]. BMC Med; 4 (1): 17; July 10, 2006. Middleman, A. B. Immunization Update: Pertussis, Meningoccocus, and Human Papillomavirus. Adolesc Med Clin; 17 (3): 547­563; October, 2006. Minh, Thang N.; Bhushan, I.; Bloom, E.; Bonu, S. Child Immunization In Vietnam: Situation And Barriers To Coverage. J Biosoc Sci;1­18; January 27, 2006. Miranda, M. E.; Meslin, F. X. Human Rabies Prevention. Dev Biol (Basel); 125: 155­164; 2006. Mishra, D.; Dubey, V.; Asthana, A.; Saraf, D. K.; Jain, N. K. Elastic Liposomes Mediated Transcutaneous Immunization Against Hepatitis B. Vaccine; March 15, 2006. Mitka, M. Age Range Widens for Pertussis Vaccine: Boosters Advised for Adolescents and Adults. JAMA; 295 (8): 871­872; February 22, 2006. Miura, S.; Matsumoto, K.; Oki, A.; Satoh, T.; Tsunoda, H.; Yasugi, T.; Taketani, Y.; Yoshikawa, H. Do We Need a Different Strategy for HPV Screening and Vaccination in East Asia? Int J Cancer; August 23, 2006. Miyagawa, K. [Discussion on Simultaneous Administration of Required Childhood Vaccinations]. Nippon Koshu Eisei Zasshi; 53 (3): 208­209; March, 2006. Mmeje, O.; Davis, M. M. Will Coverage for Child and Adolescent Immunizations Be Mandated for Insurance Plans in 2006? Lessons Learned From the Newborns' and Mothers' Health Protection Act of 1996. Pediatrics; 118 (1): 388­392; July, 2006. Modlin, J. F.; Halsey, N. A. Excretion of Oral Poliovirus Vaccine Strains: Effect of Vaccination Schedule. J Infect Dis; 193 (11): 1614­1615; June 1, 2006. Mody, L.; Langa, K. M.; Malani, P. N. Impact of the 2004­2005 Influenza Vaccine Shortage on Immunization Practices in Long­Term Care Facilities. Infect Control Hosp Epidemiol; 27 (4): 383­387; April, 2006. Mohan, A.; Murhekar, M. V.; Wairagkar, N. S.; Hutin, Y. J.; Gupte, M. D.Measles Transmission Following the Tsunami in a Population With a High One­
Dose Vaccination Coverage, Tamilnadu, India 2004­2005. BMC Infect Dis; 6 (1): 143; September, 2006. Mok, E.; Yeung, S. H.; Chan, M. F.Prevalence of Influenza Vaccination and Correlates of Intention to Be Vaccinated Among Hong Kong Chinese. Public Health Nurs; 23 (6): 506­515; November, 2006. Montella, S.; De, Stefano S.; Sperli, F.; Barbarano, F.; Santamaria, F. Increased Risk of Chronic Suppurative Lung Disease After Measles or Pertussis in Non­ Vaccinated Children. Vaccine; September 27, 2006. Moon, J. S.; Souayah, N.Guillain­Barre Syndrome Triggered by Influenza Vaccination in a Recipient of Liver Transplant on FK506. Liver Transpl; 12 (10): 1537­ 1539; September 26, 2006. Moore, D. L.; Vaudry, W.; Scheifele, D. W.; Halperin, S. A.; Dery, P.; Ford­Jones, E.; Arishi, H. M.; Law, B. J.; Lebel, M.; Le, Saux N.; Grimsrud, K.; Tam, T.Surveillance for Influenza Admissions Among Children Hospitalized in Canadian Immunization Monitoring Program Active Centers, 2003­2004. Pediatrics; 118 (3): e610­e619; September, 2006. Moore, H. C.; Lehmann, D. Decline in Meningitis Admissions in Young Children: Vaccines Make a Difference. Med J Aust; 185 (7): 404; October 2, 2006. Moral, L.; Rubio, E. M. We Will Have to Vaccinate Healthy Children Against Influenza When We Know That It Is Helpful. Eur J Pediatr; May 25, 2006. Moraleda, G.; Barcena, R.; Del, Campo S.; Oton, E.; Moreno, J.; Foruni, J. R. De Novo HBV Infection Caused by an Anti­HBc Positive Donor in a Vaccinated Liver Transplant Recipient In Spite of Anti­HBs Response. Am J Transplant; 6 (2): 438­440; February, 2006. Moreira, E. D., Jr.; de Oliveira, B. G.; Neves, R. C.; Costa, S.; Karic, G.; Filho, J. O. Assessment of Knowledge and Attitudes of Young Uninsured Women Toward Human Papillomavirus Vaccination and Clinical Trials. J Pediatr Adolesc Gynecol; 19 (2): 81­87; April, 2006. Morita, J. Addressing Racial and Ethnic Disparities in Adult Immunization, Chicago. J Public Health Manag Pract; 12 (4): 321­329; July, 2006. Moscardino, U.; Axia, G.; Altoe, G.The Role of Maternal Depressed Mood and Behavioural Soothing on Infant Response to Routine Vaccination. Acta Paediatr; 95 (12): 1680­1684; December, 2006. Muhamed, G.; Greenbaum, E.; Zakay­Rones, Z. Neuraminidase Antibody Response to Inactivated Influenza Virus Vaccine Following Intranasal and Intramuscular Vaccination. Isr Med Assoc J; 8 (3): 155­158; March, 2006. Muller, D.; Nguyen­Van­Tam, J. S.; Szucs, T. D. Influenza Vaccination Coverage Rates in the UK: A Comparison of Two Monitoring Methods During the 2002­ 2003 and 2003­2004 Seasons. Public Health; 120 (11): 1074­1080; November, 2006. Munoz, M. A.; Abarca, V. K.; Luchsinger, F., V; Valenzuela, B. MT; Jimenez de la, J. J. [Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on Behalf of The Chilean Infectious Diseases Society: March 2006]. Rev Chilena Infectol; 23 (2): 124­127; June, 2006. Mupere, E.; Karamagi, C.; Zirembuzi, G.; Grabowsky, M.; de Swart, R. L.; Nanyunja, M.; Mayanja, H. Measles Vaccination Effectiveness Among Children Under 5 Years of Age in Kampala, Uganda. Vaccine; March 3, 2006. Murphy, D.; Dandeker, C.; Horn, O.; Hotopf, M.; Hull, L.; Jones, M.; Marteau, T.; Rona, R.; Wessely, S. UK Armed Forces Responses to an Informed Consent Policy for Anthrax Vaccination: A Paradoxical Effect? Vaccine; 24 (16): 3109­3114; April 12, 2006. Murphy, K.; Ververeli, K.; Harvey, B. M.; Duke, A. L.; Chapas­Crilly, J.; Uryniak, T.; Lyzell, E.; Mezzanotte, W.Antibody Response After Varicella Vaccination in Children Treated With Budesonide Inhalation Suspension or Non­Steroidal Conventional Asthma Therapy. Int J Clin Pract; 60 (12): 1548­
1557; December, 2006. Murray, R. A.; Mansoor, N.; Harbacheuski, R.; Soler, J.; Davids, V.; Soares, A.; Hawkridge, A.; Hussey, G. D.; Maecker, H.; Kaplan, G.; Hanekom, W. A. Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response. J Immunol; 177 (8): 5647­5651; October 15, 2006. Musa, O. I. Injection Safety Practice Among Health Workers in Static Immunization Centres in a Nigerian Urban Community. Trop Doct; 36 (3): 185­186; July, 2006. Musher, D. M.; Rueda­Jaimes, A. M.; Graviss, E. A.; Rodriguez­Barradas, M. C.Effect of Pneumococcal Vaccination: a Comparison of Vaccination Rates in Patients With Bacteremic and Nonbacteremic Pneumococcal Pneumonia. Clin Infect Dis; 43 (8): 1004­1008; October 15, 2006. Mykietiuk, A.; Carratala, J.; Dominguez, A.; Manzur, A.; Fernandez­Sabe, N.; Dorca, J.; Tubau, F.; Manresa, F.; Gudiol, F. Effect of Prior Pneumococcal Vaccination on Clinical Outcome of Hospitalized Adults With Community­Acquired Pneumococcal Pneumonia. Eur J Clin Microbiol Infect Dis; June 14, 2006. Nascimento­Carvalho, C. M.; de Andrade, A. L. Haemophilus Influenzae Type b Vaccination: Long­Term Protection. J Pediatr (Rio J); 82 (3 Suppl): S109­
S114; July, 2006. Navarro, D.; Escribano, A.; Cebrian, L.; Gimeno, C.; Garcia­Maset, L.; Garcia­de­Lomas, J. Type­Specific Antibodies to Pneumococcal Capsular Polysaccharide Acquired Either Naturally or After Vaccination With Prevenar in Children With Underlying Chronic or Recurrent Lung Diseases. Clin Vaccine Immunol; 13 (6): 665­670; June, 2006. Ndiaye, A. A.; De, Wals P.; Proulx, J. F.; Ouakki, M.; Jette, L.; Dery, S.Impact of a Mass Immunization Campaign to Control an Outbreak of Severe Respiratory Infections in Nunavik, Northern Canada. Int J Circumpolar Health; 65 (4): 297­304; September, 2006. Nichol, K. L.Improving Influenza Vaccination Rates Among Adults. Cleve Clin J Med; 73 (11): 1009­1015; November, 2006. Nicoll, J. A.; Barton, E.; Boche, D.; Neal, J. W.; Ferrer, I.; Thompson, P.; Vlachouli, C.; Wilkinson, D.; Bayer, A.; Games, D.; Seubert, P.; Schenk, D.; Holmes, C.Abeta Species Removal After Abeta42 Immunization. J Neuropathol Exp Neurol; 65 (11): 1040­1048; November, 2006. Nishiura, H.; Dietz, K.; Eichner, M. The Earliest Notes on the Reproduction Number in Relation to Herd Immunity: Theophil Lotz and Smallpox Vaccination. J Theor Biol; 241 (4): 964­967; August 21, 2006. Nishiura, H.; Eichner, M. Estimation of the Duration of Vaccine­Induced Residual Protection Against Severe and Fatal Smallpox Based on Secondary Vaccination Failure. Infection; 34 (5): 241­246; October, 2006. Nishiura, H.Analysis of a Previous Smallpox Vaccination Study: Estimation of the Time Period Required to Acquire Vaccine­Induced Immunity As Assessed by Revaccination. Southeast Asian J Trop Med Public Health; 37 (4): 673­680; July, 2006. Noakes, K.; Pebody, R. G.; Gungabissoon, U.; Stowe, J.; Miller, E. Pneumococcal Polysaccharide Vaccine Uptake in England, 1989­2003, Prior to the Introduction of a Vaccination Programme for Older Adults. J Public Health (Oxf); July 7, 2006. Noakes, K.; Salisbury, D.Immunization Campaigns in the UK. Curr Top Microbiol Immunol; 304: 53­70; 2006. Nokleby, H. Vaccination and Anaphylaxis. Curr Allergy Asthma Rep; 6 (1): 9­13; January, 2006. Nokleby, H.; Bergsaker, M. A. [Adverse Events After Vaccination]. Tidsskr Nor Laegeforen; 126 (19): 2541­2544; October 5, 2006. Nokleby, H.; Feiring, B. [The Norwegian Vaccination Program]. Tidsskr Nor Laegeforen; 126 (19): 2538­2540; October 5, 2006. Noller, K. L. HPV Vaccination: More Questions Than Answers. Obstet Gynecol; 107 (1): 4­5; January, 2006. Nowalk, M. P.; Zimmerman, R. K.; Tabbarah, M.; Raymund, M.; Jewell, I. K. Determinants of Adult Vaccination at Inner­City Health Centers: a Descriptive Study. BMC Fam Pract; 7: 2; January 10, 2006. O'Connor, M. E.; Matthews, B. S.; Gao, D.Effect of Open Access Scheduling on Missed Appointments, Immunizations, and Continuity of Care for Infant Well­ Child Care Visits. Arch Pediatr Adolesc Med; 160 (9): 889­893; September, 2006. O'malley, A. S.; Forrest, C. B. Immunization Disparities in Older Americans Determinants and Future Research Needs. Am J Prev Med; 31 (2): 150­158; August, 2006. Obaro, S. K.; Ota, M. O. Sense and the Science of Childhood Immunization: Can We Achieve More With Less? Vaccine; July 7, 2006. Obonyo, C. O.; Lau, J. Efficacy of Haemophilus Influenzae Type b Vaccination of Children: a Meta­Analysis. Eur J Clin Microbiol Infect Dis; February 21, 2006. Ohnson, N. G. Haemophilus Influenzae Type b Reemergence After Combination Immunization. Emerg Infect Dis; 12 (6): 937­941; June, 2006. Olawsky, A. South Carolina Prepares: Pandemic Influenza. S C Nurse; 13 (2): 22; April, 2006. Olender, L. Case Report: Adapting the HEICS Approach for Flu Vaccination Clinic. Disaster Manag Response; 4 (1): 28­30; January, 2006. Olmsted, S. S.; Grabenstein, J. D.; Jain, A. K.; Lurie, N. Patient Experience With, and Use of, an Electronic Monitoring System to Assess Vaccination Responses. Health Expect; 9 (2): 110­117; June, 2006. Olsen, D. P. Should RNs Be Forced to Get the Flu Vaccine? Am J Nurs; 106 (10): 76­79; October, 2006. Olusanya, B. O.; Okolo, A. A. Early Hearing Detection at Immunization Clinics in Developing Countries. Int J Pediatr Otorhinolaryngol; May 24, 2006. Omer, S. B.; Pan, W. K.; Halsey, N. A.; Stokley, S.; Moulton, L. H.; Navar, A. M.; Pierce, M.; Salmon, D. A. Nonmedical Exemptions to School Immunization Requirements: Secular Trends and Association of State Policies With Pertussis Incidence. JAMA; 296 (14): 1757­1763; October 11, 2006. Omiadze, K.; Telia, A.; Khechinashvili, G. Efforts of Identifying the Place of Tb Infection and Bcg Vaccination in the Hygiene Hypothesis of Allergy. Georgian Med News; 136: 61­65; July, 2006. Orenstein, W. A.The Role of Measles Elimination in Development of a National Immunization Program. Pediatr Infect Dis J; 25 (12): 1093­1101; December, 2006. Otsuka, T.; Fujinaka, H.; Kamimura, T.; Tanaka, Y.; Hayakawa, H.; Sato, M.; Syoubugawa, Y.; Saito, R.; Suzuki, H.; Tomizawa, S. Influenza Vaccination in Severely Multiply Handicapped Persons/Children. Vaccine; March 10, 2006. Ouedraogo, L. T.; Ouedraogo, S. M.; Ouedraogo, Z. T.; Traore­Ouedraogo, R.; Kam, L.; Sawadogo, A.; Sondo, B. [Factors for Non­Observance of the Extended Program Timetable for Vaccination in Health Districts: the Case of Bousse in Burkina Faso.]. Med Mal Infect; March 30, 2006. Page, S. A.; Russell, M. L.; Verhoef, M. J.; Injeyan, H. S. Immunization and the Chiropractor­Patient Interaction: a Western Canadian Study. J Manipulative Physiol Ther; 29 (2): 156­161; February, 2006. Parashar, U. D.; Alexander, J. P.; Glass, R. I. Prevention of Rotavirus Gastroenteritis Among Infants and Children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 55 (RR­12): 1­13; August 11, 2006. Parker, A. L.; England, R. W.; Nguyen, S. A.; Whisman, B. A.; Hagan, L. L. Generalized Cutaneous Reactions to the Anthrax Vaccine: Preliminary Results of Anthrax Vaccine­Specific Cell Mediated Immunity and Cytokine Profiles. Hum Vaccin; 2 (3): 105­109; May, 2006. Parker, J. Managing Tetanus. Emerg Nurse; 14 (4): 14­17; July, 2006. Parsons, H. K.; Metcalf, S. C.; Tomlin, K.; Read, R. C.; Dockrell, D. H. Invasive Pneumococcal Disease and the Potential for Prevention by Vaccination in the United Kingdom. J Infect; October 16, 2006. Parsons, H. K.; Tomlin, K.; Metcalf, S. C.; Brazier, J. E.; Dockrell, D. H. The Economic Cost of Invasive Pneumococcal Disease and the Potential for Reduction by Vaccination in an Adult Population in South Yorkshire. QJM; 99 (5): 348­349; May, 2006. Pascolo, S.Vaccination With Messenger RNA.Methods Mol Med; 127: 23­40; 2006. Patel, M. S.; Davis, M. M. Could a Federal Program to Promote Influenza Vaccination Among Elders Be Cost­Effective? Prev Med; February 7, 2006. Patten, S.; Vollman, A. R.; Manning, S. D.; Mucenski, M.; Vidakovich, J.; Davies, H. D. Vaccination for Group B Streptococcus During Pregnancy: Attitudes and Concerns of Women and Health Care Providers. Soc Sci Med; March 15, 2006. Paul, I. M.; Eleoff, S. B.; Shaffer, M. L.; Bucher, R. M.; Moyer, K. M.; Gusic, M. E. Improving Influenza Vaccination Rates for Children Through Year­
Round Scheduling. Ambul Pediatr; 6 (4): 230­234; July, 2006. Peakman, M.; Skowera, A.; Hotopf, M. Immunological Dysfunction, Vaccination and Gulf War Illness. Philos Trans R Soc Lond B Biol Sci; 361 (1468): 681­
687; April 29, 2006. Pearson, M. L.; Bridges, C. B.; Harper, S. A. Influenza Vaccination of Health­Care Personnel: Recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 55 (RR­2): 1­16; February 24, 2006. Pelletier­Fleury, N.; Le, Vaillant M.; Hebbrecht, G.; Boisnault, P. Determinants of Preventive Services in General Practice A Multilevel Approach in Cardiovascular Domain and Vaccination in France. Health Policy; July 31, 2006. Pelletier­Fleury, N.; Le, Vaillant M.; Hebbrecht, G.; Boisnault, P. Determinants of Preventive Services in General Practice A Multilevel Approach in Cardiovascular Domain and Vaccination in France. Health Policy; July 31, 2006. Penn, C. L. Vaccine Safety & Immunization Information. J Ark Med Soc; 102 (12): 322­324; June, 2006. Pertussis Outbreak in an Amish Community­­Kent County, Delaware, September 2004­February 2005. MMWR Morb Mortal Wkly Rep; 55 (30): 817­821; August 4, 2006. Phibbs, S. L.; Hambidge, S. J.; Steiner, J. F.; Davidson, A. J. The Impact of Inactive Infants on Clinic­Based Immunization Rates. Ambul Pediatr; 6 (3): 173­
177; May, 2006. Phillips­Tangum, C.; Rehm, B.; Hilton, O. Immunization Practices and Policies: a Survey of Health Insurance Plans. AHIP Cover; 47 (1): 32­37; January, 2006. Piccirillo, B.; Gaeta, T. Survey on Use of and Attitudes Toward Influenza Vaccination Among Emergency Department Staff in a New York Metropolitan Hospital. Infect Control Hosp Epidemiol; 27 (6): 618­622; June, 2006. Pichichero, M.; Papa, T.; Blatter, M.; Mitchell, D.; Kratz, R.; Sneed, J.; Bassily, E.; Casey, J.; Gilmet, G. Immune Memory in Children Previously Vaccinated With an Experimental Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine. Pediatr Infect Dis J; 25 (11): 995­1000; November, 2006. Pierrynowski Gallant, D. M.; Murray, M. A.; McNeil, S. Influenza Vaccination: a Call for a Multiple Intervention Approach. Can J Public Health; 97 (2): 136­
138; March, 2006. Piira, T.; Champion, G. D.; Bustos, T.; Donnelly, N.; Lui, K. Factors Associated With Infant Pain Response Following an Immunization Injection. Early Hum Dev; August 18, 2006. Pineda, Solas A.; Bernaola, Iturbe E.; Martinon­Torres, F.; Baca, Cots M.; De Juan, Martin F.; Gomez Campdera, J. A.; Diaz, Domingo J.; Garces, Sanchez M.; Gimenez, Sanchez F.; Picazo, J.[Recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics: Influenza Vaccination Campaign 2006­2007.]. An Pediatr (Barc ); 65 (3): 252­255; September, 2006. Pinto, L. A.; Viscidi, R.; Harro, C. D.; Kemp, T. J.; Garcia­Pineres, A. J.; Trivett, M.; Demuth, F.; Lowy, D. R.; Schiller, J. T.; Berzofsky, J. A.; Hildesheim, A. Cellular Immune Responses to HPV­18, ­31, and ­53 in Healthy Volunteers Immunized With Recombinant HPV­16 L1 Virus­Like Particles. Virology; July 21, 2006. Plogreen, P. M.; Pottinger, J.; Polygreen, L.; Diekema, D. J.; Herwaldt, L. A. Influenza Vaccination Rates, Feedback and the Hawthorne Effect. Infect Control Hosp Epidemiol; 27 (1): 98­99; January, 2006. Plotkin, S. A.The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis; 43 (Suppl 3): S164­S168; November 1, 2006. Pollabauer, E. M.; Petermann, R.; Ehrlich, H. J. Group C Meningococcal Polysaccharide­Tetanus Toxoid Conjugate Vaccine: a Meta­Analysis of Immunogenicity, Safety and Posology. Hum Vaccin; 1 (4): 131­139; July, 2005. Pool, V.; Iskander, J. Safety of Influenza Vaccination During Pregnancy. Am J Obstet Gynecol; 194 (4): 1200; April, 2006. Preserved Humoral and Celular Response to Influenza Vaccination in Human Recipients Naturally Tolerant to a Kidney Allograft.Transplantation; 82 (1 Suppl 2): 172; July 15, 2006. Principi, N.; Esposito, S.Influenza vaccination in healthy children.Vaccine; August 31, 2006. Putz, M. M.; Midgley, C. M.; Law, M.; Smith, G. L.Quantification of Antibody Responses Against Multiple Antigens of the Two Infectious Forms of Vaccinia Virus Provides a Benchmark for Smallpox Vaccination. Nat Med; 12 (11): 1310­1315; November, 2006. Quigley, R.; Hayes, B.Determinants of Influenza Vaccination Uptake Among Hospital Healthcare Workers. Ir Med J; 99 (7): 200­203; July, 2006. Rager, B. Vaccines and Vaccination Programs Revisited. Isr Med Assoc J; 8 (5): 299­300; May, 2006. Rahman, M.; Banerjee, M.; Rahman, M.; Akhter, F. U. Vaccination Status of Tribal Mothers and Their Under Five Children. Mymensingh Med J; 15 (1): 55­
57; January, 2006. Rajantie, J.; Zeller, B.; Treutiger, I.; Rosthoj, S.Vaccination Associated Thrombocytopenic Purpura in Children. Vaccine; November 9, 2006. Ramet, J.; Weil­Olivier, C.; Sedlak, W.Influenza Vaccination: The Paediatric Perspective. Vaccine; October 2, 2006. Ramirez, E.; Bulim, I. D.; Kraus, J. M.; Morita, J. Use of Public School Immunization Data to Determine Community­Level Immunization Coverage. Public Health Rep; 121 (2): 189­196; March, 2006. Ratzan, S. C.Time for a routine immunization communication effort. J Health Commun; 11 (6): 547­549; September, 2006. Ray, P.; Hayward, J.; Michelson, D.; Lewis, E.; Schwalbe, J.; Black, S.; Shinefield, H.; Marcy, M.; Huff, K.; Ward, J.; Mullooly, J.; Chen, R.; Davis, R. Encephalopathy After Whole­Cell Pertussis or Measles Vaccination: Lack of Evidence for a Causal Association in a Retrospective Case­Control Study. Pediatr Infect Dis J; 25 (9): 768­773; September, 2006. Re, F.; Donnini, A.; Provinciali, M. Induction of Alphadelta­ and Alphabeta­Mediated T Cell Responses in Healthy Elderly Subjects After Influenza Vaccination. Biogerontology; July 5, 2006. Rees, P. J.Pneumococcal Vaccination in Asthma. Int J Clin Pract; 60 (11): 1341­1342; November, 2006. Rein, D. B.; Honeycutt, A. A.; Rojas­Smith, L.; Hersey, J. C. Impact of the CDC's Section 317 Immunization Grants Program Funding on Childhood Vaccination Coverage. Am J Public Health; July 27, 2006. Rendi­Wagner, P.; Zent, O.; Jilg, W.; Plentz, A.; Beran, J.; Kollaritsch, H. Persistence of Antibodies After Vaccination Against Tick­Borne Encephalitis. Int J Med Microbiol; March 6, 2006. Renne, E. Perspectives on Polio and Immunization in Northern Nigeria. Soc Sci Med; June 8, 2006. Response to Vaccination Is Dependent on the Applied Immunosuppression. Transplantation; 82 (1 Suppl 2): 521; July 15, 2006. Revai, K.; McCormick, D. P.; Patel, J.; Grady, J. J.; Saeed, K.; Chonmaitree, T. Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Bacterial Colonization During Acute Otitis Media. Pediatrics; 117 (5): 1823­1829; May, 2006. Rheingans, R. D.; Heylen, J.; Giaquinto, C. Economics of Rotavirus Gastroenteritis and Vaccination in Europe: What Makes Sense? Pediatr Infect Dis J; 25 (1 Suppl): S48­S55; January, 2006. Rickert, D.; Santoli, J.; Shefer, A.; Myrick, A.; Yusuf, H. Influenza Vaccination of High­Risk Children What the Providers Say. Am J Prev Med; 30 (2): 111­
118; February, 2006. Rimple, D.; Weiss, S. J.; Brett, M.; Ernst, A. A. An Emergency Department­Based Vaccination Program: Overcoming the Barriers for Adults at High Risk for Vaccine­Preventable Diseases. Acad Emerg Med; 13 (9): 922­930; September, 2006. Rishpon, S. Recent Improvements in Polio and Pertussis Vaccination Policy in Israel, 2005. Isr Med Assoc J; 8 (5): 319­321; May, 2006. Rizzo, C. Improving Immunization Rates in Practice Settings. Pediatr Ann; 35 (7): 493­497; July, 2006. Rizzo, C. Linking Practices With Community Programs to Improve Immunization Rates. Pediatr Ann; 35 (7): 513­515; July, 2006. Rizzo, C. Maximizing Office­Based Immunization. Pediatr Ann; 35 (7): 480, 482­480, 484; July, 2006. Rizzo, C.; Viboud, C.; Montomoli, E.; Simonsen, L.; Miller, M. A. Influenza­Related Mortality in the Italian Elderly: No Decline Associated With Increasing Vaccination Coverage. Vaccine; July 7, 2006. Rizzuto, E.; Prete, A. M.; Virtuani, L.; Pompa, M. G.Effectiveness of Influenza Vaccination: A Survey Within the Italian Ministry of Health Personnel.Vaccine; June 21, 2006. Robb­Nicholson, C.By the Way, Doctor. I Was Vaccinated Against Lyme Disease in 2000. Do I Still Need to Be Careful About Tick Bites? Harv Womens Health Watch; 13 (12): 8; August, 2006. Roberts, L. Global Health. Polio Eradication: Is It Time to Give Up? Science; 312 (5775): 832­835; May 12, 2006. Roberts, L. Infectious Disease. Polio Experts Strive to Understand a Puzzling Outbreak. Science; 312 (5780): 1581; June 16, 2006. Roberts, S.; Hollier, L. M.; Sheffield, J.; Laibl, V.; Wendel, G. D., Jr. Cost­Effectiveness of Universal Influenza Vaccination in a Pregnant Population. Obstet Gynecol; 107 (6): 1323­1329; June, 2006. Robertson, S.; Newbigging, K.; Carman, W.; Jones, G.; Isles, C. Fulminating Varicella Despite Prophylactic Immune Globulin and Intravenous Acyclovir in a Renal Transplant Recipient: Should Renal Patients Be Vaccinated Against VZV Before Transplantation? Clin Transplant; 20 (1): 136­138; January, 2006. Rodrigues, A.; Fischer, T. K.; Valentiner­Branth, P.; Nielsen, J.; Steinsland, H.; Perch, M.; Garly, M. L.; Molbak, K.; Aaby, P. Community Cohort Study of Rotavirus and Other Enteropathogens: Are Routine Vaccinations Associated With Sex­Differential Incidence Rates? Vaccine; March 31, 2006. Rodriguez­Rodriguez, M. I.; Gaton Del, Amo M.; Robles­Marinas, V.; Rubio­Dominguez, J. [Factors Determining Flu Vaccination in the Over­65s]. Aten Primaria; 37 (7): 381­385; April 30, 2006. Rojas­Sotelo, J. C.; Prieto­Alvarado, F. E. [Pentavalent Vaccine and Vaccination Coverage in Children Aged Less Than One in Colombia 2000­2003]. Rev Salud Publica (Bogota); 8 (Suppl 1): 71­85; May, 2006. Rose, M. A.; Schubert, R.; Kujumdshiev, S.; Kitz, R.; Zielen, S.Immunoglobulins and Immunogenicity of Pneumococcal Vaccination in Preschool Asthma. Int J Clin Pract; 60 (11): 1425­1431; November, 2006. Rov, S. Role of the Indian Medical Association (IMA) in Polio Eradication. J Indian Med Assoc; 103 (12): 653; December, 2005. Rowland, K.; Guthmann, R.; Jamieson, B.; Malloy, D. How Should We Manage a Patient With a Positive PPD and Prior BCG Vaccination? J Fam Pract; 55 (8): 718­720; August, 2006. Rupp, R.; Rosenthal, S. L.; Middleman, A. B.Vaccination: an Opportunity to Enhance Early Adolescent Preventative Services. J Adolesc Health; 39 (4): 461­
464; October, 6 2006. Rupprecht, C. E. Additional Thoughts on Human Rabies Vaccination. J Am Vet Med Assoc; 229 (2): 206­207; July 15, 2006. Ruskamp­Hatz, J.; Hackney, E. Exemptions for Childhood Immunizations. NCSL Legisbrief; 14 (30): 1­2; June, 2006. Russell, M. N.; Cetron, M. S.; Eidex, R. B. The US­Certified Yellow Fever Vaccination Center Registry: A Tool for Travelers, State Health Departments, and Vaccine Providers. J Travel Med; 13 (1): 48­49; January, 2006. Ryan, A. M.; Bermingham, N.; Harrington, H. J.; Keohane, C.Atypical Presentation of Macrophagic Myofasciitis 10 Years Post Vaccination. Neuromuscul Disord; September 25, 2006. Saibara, T. Universal Vaccination and Thereafter. J Gastroenterol; 41 (4): 399­400; April, 2006. Salmon, D. A.; Omer, S. B.Individual Freedom Versus Collective Responsibility: Immunization Decision­Making in the Face of Occasionally Competing Values. Emerg Themes Epidemiol; 3 (1): 13; September 27, 2006. Salmon, D. A.; Smith, P. J.; Navar, A. M.; Pan, W. K.; Omer, S. B.; Singleton, J. A.; Halsey, N. A. Measuring Immunization Coverage Among Preschool Children: Past, Present, and Future Opportunities. Epidemiol Rev; June 1, 2006. Salmon, D. A.; Teret, S. P.; MacIntyre, C. R.; Salisbury, D.; Burgess, M. A.; Halsey, N. A. Compulsory Vaccination and Conscientious or Philosophical Exemptions: Past, Present, and Future. Lancet; 367 (9508): 436­442; February 4, 2006. Salmon, D. Vaccination in Australia. Lancet; 368 (9533): 364­365; July 29, 2006. Salo, H.; Kilpi, T.; Sintonen, H.; Linna, M.; Peltola, V.; Heikkinen, T. Cost­Effectiveness of Influenza Vaccination of Healthy Children. Vaccine; April 7, 2006. Samad, L.; Tate, A. R.; Dezateux, C.; Peckham, C.; Butler, N.; Bedford, H. Differences in Risk Factors for Partial and No Immunisation in the First Year of Life: Prospective Cohort Study. BMJ; 332 (7553): 1312­1313; June 3, 2006. Sanchez­Munoz, J. F.; Saponi­Cortes, J. M.; Costo­Campoamor, A. [Effectiveness of the Vaccination in High Risk Population.]. Med Clin (Barc); 127 (2): 77; June 10, 2006. Sanchez, Callejas A.; Campins, Marti M.; Martinez, Gomez, X; Pinos, Tella L.; Hermosilla, Perez E.; Vaque, Rafart J. [Influenza Vaccination in Patients Admitted to a Tertiary Hospital. Factors Associated With Coverage.]. An Pediatr (Barc ); 65 (4): 331­336; October, 2006. Santibanez, T. A.; Santoli, J. M.; Barker, L. E. Differential Effects of the DTaP and MMR Vaccine Shortages on Timeliness of Childhood Vaccination Coverage. Am J Public Health; 96 (4): 691­696; April, 2006. Santibanez, T. A.; Santoli, J. M.; Bridges, C. B.; Euler, G. L.Influenza Vaccination Coverage of Children Aged 6 to 23 Months: the 2002­2003 and 2003­2004 Influenza Seasons. Pediatrics; 118 (3): 1167­1175; September, 2006. Sanz, J. C.; de, Ory F. [Rubella: a New Scenario for an Old Disease]. Enferm Infecc Microbiol Clin; 24 (1): 36­44; January, 2006. Sanz, J. C.; Del Mar Mosquera, M.; Echevarria, J. E.; Fernandez, M.; Herranz, N.; Palacios, G.; DE Ory, F.Sensitivity and Specificity of Immunoglobulin G Titer for the Diagnosis of Mumps Virus in Infected Patients Depending on Vaccination Status. APMIS; 114 (11): 788­794; November, 2006. Sasaki, S.; Jaimes, M. C.; Holmes, T. H.; Dekker, C. L.; Mahmood, K.; Kemble, G. W.; Arvin, A. M.; Greenberg, H. B. Comparison of the influenza­specific effector and memory b cell responses to immunization of children and adults with live attenuated or inactivated influenza vaccines. J Virol; October 18, 2006. Savona, M. R.; la Cruz, W. P.; Jones, M. S.; Thornton, J. A.; Xia, D.; Hadfield, T. L.; Danaher, P. J. Detection of Vaccinia DNA in the Blood Following Smallpox Vaccination. JAMA; 295 (16): 1898­1900; April 26, 2006. Scalise, D. Save Lives Now. 30 Things You Can Do to Eliminate Infections. Hosp Health Netw; 80 (9): 32­40, 2; September, 2006. Schafer, S.; Gillette, H.; Hedberg, K.; Cieslak, P. A Community­Wide Pertussis Outbreak: An Argument for Universal Booster Vaccination. Arch Intern Med; 166 (12): 1317­1321; June 26, 2006. Schessl, J.; Luther, B.; Kirschner, J.; Mauff, G.; Korinthenberg, R. Infections and Vaccinations Preceding Childhood Guillain­Barre Syndrome: a Prospective Study. Eur J Pediatr; May 12, 2006. Scheurer, D. B. Improving Inpatient Vaccinations: a Long Road Ahead. South Med J; 99 (3): 203­204; March, 2006. Scheurer, D. B.; Cawley, P. J.; Brown, S. B.; Heffner, J. E. Overcoming Barriers to Pneumococcal Vaccination in Patients With Pneumonia. Am J Med Qual; 21 (1): 18­29; January, 2006. Schondorf, I.; Schonfeld, C.; Nicolay, U.; Zent, O.; Banzhoff, A. Response to Tick­Borne Encephalitis (TBE) Booster Vaccination After Prolonged Time Intervals to Primary Immunization With the Rapid Schedule. Int J Med Microbiol; March 9, 2006. Schroeder, S. D. Pneumococcal Vaccination Guidelines. S D Med; 59 (1): 19; January, 2006. Schulman, S.; Sveger, T. [Sweden Should Follow Norway and Introduce Vaccination Against Pneumococci]. Lakartidningen; 103 (7): 480; February 15, 2006. Schumm, W. R.Neurologic Adverse Events Associated With Smallpox Vaccination in the United States­­Response and Comment on Reporting of Headaches As Adverse Events After Smallpox Vaccination Among Military and Civilian Personnel. BMC Med; 4: 27; November 10, 2006. Schutt, M. A.; Parker, F. M.Influenza Vaccination Administration by Junior and Senior Nursing Students. J Nurs Educ; 45 (11): 480; November, 2006. Schutz, C.; Vaudaux, B. [Vaccinations During Adolescence: the Role of Physicians and School Health Services]. Rev Med Suisse; 2 (69): 1522­1525; June 7, 2006. Schwartz, B.; Wortley, P.Mass Vaccination for Annual and Pandemic Influenza. Curr Top Microbiol Immunol; 304: 131­152; 2006. Schwartz, K. L.; Neale, A. V.; Northrup, J.; Monsur, J.; Patel, D. A.; Tobar, R., Jr.; Wortley, P. M. Racial Similarities in Response to Standardized Offer of Influenza Vaccination. A MetroNet Study. J Gen Intern Med; 21 (4): 346­351; April, 2006. Sell, E.; Minassian, B. A. Demystifying Vaccination­Associated Encephalopathy. Lancet Neurol; 5 (6): 465­466; June, 2006. Serpell, L.; Green, J. Parental Decision­Making in Childhood Vaccination. Vaccine; February 28, 2006. Seward, J. F.; Orenstein, W. A. Commentary: the Case for Universal Varicella Immunization. Pediatr Infect Dis J; 25 (1): 45­46; January, 2006. Shafi, S.; Gatrad, A. R.; Quadri, S. M.; Sheikh, A. Vaccinations for Hajj. J R Soc Health; 126 (2): 68­69; March, 2006. Shahrabani, S.; Benzion, U. The Effects of Socioeconomic Factors on the Decision to Be Vaccinated: the Case of Flu Shot Vaccination. Isr Med Assoc J; 8 (9): 630­ 634; September, 2006. Shao, P. L.; Lu, C. Y.; Chang, L. Y.; Huang, F. Y.; Lee, C. Y.; Hsueh, P. R.; Huang, L. M. Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine Booster in Taiwanese Toddlers. J Formos Med Assoc; 105 (7): 542­549; July, 2006. Shao, Z.; Li, W.; Ren, J.; Liang, X.; Xu, L.; Diao, B.; Li, M.; Lu, M.; Ren, H.; Cui, Z.; Zhu, B.; Dai, Z.; Zhang, L.; Chen, X.; Kan, B.; Xu, J. Identification of a New Neisseria Meningitidis Serogroup C Clone From Anhui Province, China. Lancet; 367 (9508): 419­423; February 4, 2006. Shefer, A.; Santoli, J.; Wortley, P.; Evans, V.; Fasano, N.; Kohrt, A.; Fontanesi, J.; Szilagyi, P. Status of Quality Improvement Activities to Improve Immunization Practices and Delivery: Findings From the Immunization Quality Improvement Symposium, October 2003. J Public Health Manag Pract; 12 (1): 77­89; January, 2006. Shim, E.; Feng, Z.; Martcheva, M.; Castillo­Chavez, C. An Age­Structured Epidemic Model of Rotavirus With Vaccination. J Math Biol; 53 (4): 719­746; October, 2006. Shinefield, H. R.; Black, S. Prospects for Active and Passive Immunization Against Staphylococcus Aureus. Pediatr Infect Dis J; 25 (2): 167­168; February, 2006. Short, J. A.; van der Walt, J. H.; Zoanetti, D. C. Immunization and Anesthesia ­ an International Survey. Paediatr Anaesth; 16 (5): 514­522; May, 2006. Should HPV Vaccines Be Mandatory for All Adolescents? Lancet; 368 (9543): 1212; October 7, 2006. Shugarman, L. R.; Hales, C.; Setodji, C. M.; Bardenheier, B.; Lynn, J.The Influence of Staff and Resident Immunization Rates on Influenza­Like Illness Outbreaks in Nursing Homes. J Am Med Dir Assoc; 7 (9): 562­567; November, 2006. Shulman, S. T. Improving Immunization Rates: Practical Tips. Pediatr Ann; 35 (7): 465­466; July, 2006. Shulman, S. T. Rotavirus Immunization Again! It's Important! Pediatr Ann; 35 (1): 4­5; January, 2006. Sikora, J. P.; Chlebna­Sokol, D.; Ligenza, I.; Sikora, A. Haemophilus Influenzae Type b and Pertussis Vaccinations in Preterm Infants. Arch Immunol Ther Exp (Warsz); May 2, 2006. Silfverdal, S. A.; Gothefors, L. [Time to Vaccinate Infants and Small Children Against Pneumococci]. Lakartidningen; 103 (7): 477­478; February 15, 2006. Silverstein, R. P. The Ethics of Influenza Vaccination. Science; 313 (5788): 758­760; August 11, 2006. Silwal, R. C.; Jimba, M.; Poudyal, A. K.; Poudel, K. C.; Wakai, S. Improving Immunization Services Under the Armed Conflict in Rural Nepal. Public Health; 120 (9): 805­808; September, 2006. Sivasankaran, S.; Manickam, P.; Ramakrishnan, R.; Hutin, Y.; Gupte, M. D. Estimation of Measles Vaccination Coverage Using the Lot Quality Assurance Sampling (LQAS) Method­­Tamilnadu, India, 2002­2003. MMWR Morb Mortal Wkly Rep; 55 (Suppl 1): 16­19; April 28, 2006. Skinner, S. R.; Kang, M.Human Papillomavirus Prevalence in Canberra High School Students: Significance for Vaccination Strategies and Adolescent Health. Sex Health; 3 (4): 299­300; December, 2006. Skowronski, D. M.; Jacobsen, K.; Daigneault, J.; Remple, V. P.; Gagnon, L.; Daly, P.; Arsenault, G.; Landry, M.; Pielak, K.; Duval, B.; Tam, T.; De, Serres G. Solicited Adverse Events After Influenza Immunization Among Infants, Toddlers, and Their Household Contacts. Pediatrics; 117 (6): 1963­1971; June, 2006. Skowronski, D. M.; Woolcott, J. C.; Tweed, S. A.; Brunham, R. C.; Marra, F. Potential Cost­Effectiveness of Annual Influenza Immunization for Infants and Toddlers: Experience From Canada. Vaccine; January 4, 2006. Smith, C. Vaccination in Australia. Lancet; 367 (9522): 1575; May 13, 2006. Smith, J. M.; Craig, T. J. Strategies for Improving Pneumococcal Vaccination in Eligible Patients. Curr Infect Dis Rep; 8 (3): 231­237; May, 2006. Smith, N. M.; Bresee, J. S.; Shay, D. K.; Uyeki, T. M.; Cox, N. J.; Strikas, R. A. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 55 (RR­10): 1­42; July 28, 2006. Smith, N. M.; Shay, D. K.Influenza Vaccination for Elderly People and Their Care Workers. Lancet; 368 (9549): 1752­1753; November 18, 2006. Snape, M. D.; Kelly, D. F.; Salt, P.; Green, S.; Snowden, C.; Diggle, L.; Borkowski, A.; Yu, L. M.; Moxon, E. R.; Pollard, A. J.Serogroup C Meningococcal Glycoconjugate Vaccine in Adolescents: Persistence of Bactericidal Antibodies and Kinetics of the Immune Response to a Booster Vaccine More Than 3 Years After Immunization. Clin Infect Dis; 43 (11): 1387­1394; December 1, 2006. Soeung, S. C.; Grundy, B. M.; Ly, C. K.; Samnang, C.; Boreland, M.; Brooks, A.; Maynard, J.; Biggs, B. A. Improving Immunization Coverage Through Budgeted Microplans and Sub­National Performance Agreements: Early Experience From Cambodia. Asia Pac J Public Health; 18 (1): 29­38; 2006. Soeung, S. C.; Grundy, J.; Maynard, J.; Brooks, A.; Boreland, M.; Sarak, D.; Jenkinson, K.; Biggs, B. A. Financial Sustainability Planning for Immunization Services in Cambodia. Health Policy Plan; May 23, 2006. Sommerfelt, H.; Godal, T. [Vaccination in a Developmental Perspective]. Tidsskr Nor Laegeforen; 126 (20): 2674­2677; October, 2006. Song, J. Y.; Cheong, H. J.; Ha, S. H.; Kee, S. Y.; Jeong, H. W.; Kim, W. J. Active Influenza Immunization in Hemodialysis Patients: Comparison Between Single­ Dose and Booster Vaccination. Am J Nephrol; 26 (2): 206­211; 2006. Song, J. Y.; Park, C. W.; Jeong, H. W.; Cheong, H. J.; Kim, W. J.; Kim, S. R. Effect of a Hospital Campaign for Influenza Vaccination of Healthcare Workers. Infect Control Hosp Epidemiol; 27 (6): 612­617; June, 2006. Southern, J.; Gelb, D.; Andrews, N.; Waight, P. A.; Morris, R.; Cartwright, K.; Miller, E.Reactogenicity of Meningococcal C Conjugate Vaccines When Administered at the Same Time As, or a Month Prior to or After, Tetanus and Diphtheria Booster Vaccinations. Hum Vaccin; 2 (6); November 11, 2006. Spreng, S.; Dietrich, G.; Weidinger, G. Rational Design of Salmonella­Based Vaccination Strategies. Methods; January 13, 2006. Stadtlander, C. T.Explaining the Benefits of Vaccinations. Fam Pract Manag; 13 (9): 24; October, 2006. Steiner, I. Can Vaccinating Older Adults Against Varicella Zoster Virus Prevent Herpes Zoster and Postherpetic Neuralgia? Nat Clin Pract Neurol; 1 (1): 18­
19; November, 2005. Stenqvist, K.; Hellvin, M. A.; Hellke, P.; Hoglund, D.; von, Sydow H. Influenza Work on the Regional Level in Sweden: An Integrated Program for Vaccination of Risk Groups, Surveillance and Pandemic Planning Which Focuses on the Role of the Health Care Worker. Vaccine; June 14, 2006. Stoehr, G. A.; Rose, M. A.; Eber, S. W.; Heidemann, K.; Schubert, R.; Zielen, S. Immunogenicity of Sequential Pneumococcal Vaccination in Subjects Splenectomised for Hereditary Spherocytosis. Br J Haematol; 132 (6): 788­790; March, 2006. Straits­Troster, K. A.; Kahwati, L. C.; Kinsinger, L. S.; Orelien, J.; Burdick, M. B.; Yevich, S. J. Racial/Ethnic Differences in Influenza Vaccination in the Veterans Affairs Healthcare System. Am J Prev Med; 31 (5): 375­382; November, 2006. Studdiford, J.; Oppenheim, L.; McCann, E.; Altshuler, M. Erythema Multiforme After Meningitis Vaccine: Patient Safety Concerns With Repeat Immunization. Pharmacotherapy; 26 (11): 1658­1661; November, 2006. Sudarshan, M. K.; Madhusudana, S. N.; Mahendra, B. J.; Narayana, D. H.; Giri, M. S.; Muhamuda, K.; Ravish, H. S.; Venkatesh, G. M.Boosting Effect of Purified Chick Embryo Cell Rabies Vaccine Using the Intradermal Route in Persons Previously Immunized by the Intramuscular Route or Vice Versa. Natl Med J India; 19 (4): 192­194; July, 2006. Sugawara, T.; Ohkusa, Y.; Oikawa, K.; Haneda, N.; Kikuchi, K.; Kato, F.; Yamaguchi, S.; Okabe, N. [Cost­Effectiveness Analysis of Routine Immunization for Varicella in Japan]. Kansenshogaku Zasshi; 80 (3): 212­219; March, 2006. Sultana, R.; Rahman, M. M.; Hassan, Z.; Hassan, M. S.Prevalence of IgG Antibody Against Measles, Mumps and Rubella in Bangladeshi Children: a Pilot Study to Evaluate the Need for Integrated Vaccination Strategy. Scand J Immunol; 64 (6): 684­689; December, 2006. Sutter, R. W.; Maher, C.Mass Vaccination Campaigns for Polio Eradication: an Essential Strategy for Success. Curr Top Microbiol Immunol; 304: 195­220; 2006. Suwansrinon, K.; Wilde, H.; Benjavongkulchai, M.; Banjongkasaena, U.; Lertjarutorn, S.; Boonchang, S.; Suttisri, R.; Khowplod, P.; Daviratanasilpa, S.; Sitprija, V. Survival of Neutralizing Antibody in Previously Rabies Vaccinated Subjects: A Prospective Study Showing Long Lasting Immunity. Vaccine; February 28, 2006. Swain, G. R.; Ransom, J. Universal Influenza Vaccination Recommendations: Local Health Department Perspectives. J Public Health Manag Pract; 12 (4): 317­320; July, 2006. Swanepoel, D. W.; Hugo, R.; Louw, B. Infant Hearing Screening at Immunization Clinics in South Africa. Int J Pediatr Otorhinolaryngol; February 13, 2006. Szilagyi, P. G.; Griffin, M. R.; Shone, L. P.; Barth, R.; Zhu, Y.; Schaffer, S.; Ambrose, S.; Roy, J.; Poehling, K. A.; Edwards, K. M.; Walker, F. J.; Schwartz, B. The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties. Pediatrics; 118 (4): 1394­
1402; October, 2006. Szucs, T. D.; Wahle, K.; Muller, D. [Influenza Vaccination in Germany. A Population­Based Cross­Sectional Analysis of Three Seasons Between 2002 and 2005.]. Med Klin (Munich); 101 (7): 537­545; July 15, 2006. Tabira, T. [Therapeutic Strategies Including Vaccination]. Nippon Ronen Igakkai Zasshi; 43 (3): 306­308; May, 2006. Tafaghodi, M.; Jaafari, M. R.; Sajadi Tabassi, S. A. Nasal Immunization Studies Using Liposomes Loaded With Tetanus Toxoid and CpG­ODN. Eur J Pharm Biopharm; May, 2006. Tai, J. H.; Curns, A. T.; Parashar, U. D.; Bresee, J. S.; Glass, R. I. Rotavirus Vaccination and Intussusception: Can We Decrease Temporally Associated Background Cases of Intussusception by Restricting the Vaccination Schedule? Pediatrics; 118 (2): e258­e264; August, 2006. Takeuchi, F.; Yamamoto, K. Effectiveness of Realistic Vaccination Strategies for Contact Networks of Various Degree Distributions. J Theor Biol; June 12, 2006. Talbot, T. R.; Peters, J.; Yan, L.; Wright, P. F.; Edwards, K. M.Optimal Bandaging of Smallpox Vaccination Sites to Decrease the Potential for Secondary Vaccinia Transmission Without Impairing Lesion Healing. Infect Control Hosp Epidemiol; 27 (11): 1184­1192; November, 2006. Tambini, G.; Andrus, J. K.; Fitzsimmons, J. W.; Roses, Periago M. Regional Immunization Programs As a Model for Strengthening Cooperation Among Nations. Rev Panam Salud Publica; 20 (1): 54­59; July, 2006. Tarjan, P.; Sipka, S.; Lakos, G.; Kiss, E.; Ujj, G.; Szegedi, G. Influenza Vaccination and the Production of Anti­Phospholipid Antibodies in Patients With Systemic Lupus Erythematosus. Scand J Rheumatol; 35 (3): 241­243; May, 2006. Tediosi, F.; Hutton, G.; Maire, N.; Smith, T. A.; Ross, A.; Tanner, M. Predicting the Cost­Effectiveness of Introducing a Pre­Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Tanzania. Am J Trop Med Hyg; 75 (2 Suppl): 131­143; August, 2006. Temime, L.; Dab, W. [Pneumococcal Vaccination: Expected Benefits in Adults.]. Rev Med Interne; September 18, 2006. Temte, J. L. The 2006 Childhood and Adolescent Immunization Schedule: Reflections at the 50th Anniversary of the Polio Vaccine. Am Fam Physician; 73 (1): 37, 40; January 1, 2006. Tesovic, G.; Lesnikar, V. Aseptic Meningitis After Vaccination With L­Zagreb Mumps Strain­Virologically Confirmed Cases. Vaccine; June 30, 2006. The Topicality of Return to Smallpox Vaccination: Problems and Prospects]. Vestn Ross Akad Med Nauk; 7: 32­38; 2006. Thomas, R.; Jefferson, T.; Demicheli, V.; Rivetti, D. Influenza Vaccination for Healthcare Workers Who Work With the Elderly. Cochrane Database Syst Rev; 3: CD005187; July, 2006. Thomas, R.; Jefferson, T.; Demicheli, V.; Rivetti, D. Influenza Vaccination for Health­Care Workers Who Work With Elderly People in Institutions: a Systematic Review. Lancet Infect Dis; 6 (5): 273­279; May, 2006. Thornjoethleifsson, B.; Daviethsdottir, K.; Agnarsson, U.; Theodors, A.; Gunnarsdottir, A.; Moeller, E.; Jonsdottir, A.; Sigthornorsson, G.; Kjeld, M.; Bjarnason, I. [Effect of Pentavac and MMR Vaccination on the Intestine.]. Laeknabladid; 88 (6): 491­494; June, 2002. Thorpe, J. M.; Sleath, B. L.; Thorpe, C. T.; Van Houtven, C. H.; Blalock, S. J.; Landerman, L. R.; Campbell, W. H.; Clipp, E. C. Caregiver Psychological Distress As a Barrier to Influenza Vaccination Among Community­Dwelling Elderly With Dementia. Med Care; 44 (8): 713­721; August, 2006. Ting, A.; Aniruddhan, K.; Hallam, N.; Freeman, J.; McFadzean, J. Severe Influenza in Children With Neurodevelopmental Impairment­­Implications for Vaccination Policy. J Infect; 53 (2): 144­146; August, 2006. Tishler, M.; Levy, O.; mit­Vazina, M. Immune Thrombocytopenic Purpura Following Influenza Vaccination. Isr Med Assoc J; 8 (5): 322­323; May, 2006. Tjalma, W. A.; van Damme, P. Who Should Be Vaccinated Against Human Papillomavirus? Int J Gynecol Cancer; 16 (4): 1498­1499; July, 2006. Todd, B. Influenza Vaccination Update. Am J Nurs; 106 (10): 30­31; October, 2006. Tomita, N. [Analysis of an Adult Measles Outbreak in the Eastern Part of Ehime Prefecture in Japan]. Nippon Koshu Eisei Zasshi; 53 (6): 448­456; June, 2006. Topuzoglu, A.; Ay, P.; Hidiroglu, S.; Gurbuz, Y.The Barriers Against Childhood Immunizations: a Qualitative Research Among Socio­Economically Disadvantaged Mothers. Eur J Public Health; November 7, 2006. Torrelo, A.; Suarez, J.; Colmenero, I.; Azorin, D.; Perera, A.; Zambrano, A. Deep Morphea After Vaccination in Two Young Children. Pediatr Dermatol; 23 (5): 484­487; September, 2006. Torres, Borrego J.; Guzman, E. G. [Safety of MMR Immunization in Egg­Allergic Children.]. An Pediatr (Barc); 64 (5): 464­467; May, 2006. Torun, S. D.; Bakirci, N. Vaccination Coverage and Reasons for Non­Vaccination in a District of Istanbul. BMC Public Health; 6: 125; May 5, 2006. Tosh, P. K.; Jacobson, R. M.; Poland­Gregory, A. Mandatory Influenza Vaccination for Health Care Workers­­a Timely Step Forward. Md Med; 7 (1): 21­23; 2006. Traeger, M.; Thompson, A.; Dickson, E.; Provencio, A. Bridging Disparity: A Multidisciplinary Approach for Influenza Vaccination in an American Indian Community. Am J Public Health; March 29, 2006. Traynor, K. Vaccination Not Just for Kids Anymore, Experts Say. Am J Health Syst Pharm; 63 (17): 1582­1584; September 1, 2006. Treanor, J.; Wu, H.; Liang, H.; Topham, D. J. Immune Responses to Vaccinia and Influenza Elicited During Primary Versus Recent or Distant Secondary Smallpox Vaccination of Adults. Vaccine; 24(47­48): 6913­6923. June 21, 2006. Tregnaghi, M.; Lopez, P.; Rocha, C.; Rivera, L.; David, M. P.; Ruttimann, R.; Schuerman, L. A New DTPw­HB/Hib Combination Vaccine for Primary and Booster Vaccination of Infants in Latin America. Rev Panam Salud Publica; 19 (3): 179­188; March, 2006. Trivalle, C.; Okenge, E.; Hamon, B.; Taillandier, J.; Falissard, B.Factors That Influence Influenza Vaccination Among Healthcare Workers in a French Geriatric Hospital. Infect Control Hosp Epidemiol; 27 (11): 1278­1280; November, 2006. Trollfors, B. General Vaccination of Children Against Influenza? Acta Paediatr; 95 (7): 774­777; July, 2006. Trotter, C. L.; Edmunds, W. J.; Ramsay, M. E.; Miller, E. Modeling Future Changes to the Meningococcal Serogroup C Conjugate (MCC) Vaccine Program in England and Wales. Hum Vaccin; 2 (2): 68­73; March, 2006. Trottier, H.; Philippe, P.; Roy, R. Stochastic Modeling of Empirical Time Series of Childhood Infectious Diseases Data Before and After Mass Vaccination. Emerg Themes Epidemiol; 3 (1): 9; August 8, 2006. Tseng, H. F.; Chang, C. K.; Tan, H. F.; Yang, S. E.; Chang, H. W. Seroepidemiology Study of Rubella Antibodies Among Pregnant Women From Seven Asian Countries: Evaluation of the Rubella Vaccination Program in Taiwan. Vaccine; 24 (29­30): 5772­5777; July 17, 2006. Tseng, H. F.; Tan, H. F.; Chang, C. K. Use of National Health Insurance Database to Evaluate the Impact of Public Varicella Vaccination Program on Burden of Varicella in Taiwan. Vaccine; May 2, 2006. Tuck, R. H. Coding and Payment for Immunizations. Pediatr Ann; 35 (7): 507­512; July, 2006. Turgay, N.[Last Updates on Leishmania Vaccine Studies: When Are We Going to Be Vaccinated?]. Turkiye Parazitol Derg; 29 (4): 232­234; 2005. Ulm, S.; Hummel, M.; Emig, M.; Barreto­Miranda, M.; Back, W.; Reiter, A.; Hehlmann, R.; Willer, A. Leukocytoclastic Vasculitis and Acute Renal Failure After Influenza Vaccination in an Elderly Patient With Myelodysplastic Syndrome. Onkologie; 29 (10): 470­472; October, 2006. Understanding Vaccines. How Immunizations Help Fight Disease. Mayo Clin Womens Healthsource; 10 (12): 1­2; December, 2006. Vaccination Guidelines for Female Infertility Patients. Fertil Steril; 86 (Suppl 5): S28­S30; November, 2006. Vaccines: More Reasons to Immunize.Consum Rep; 71 (10): 62; October, 2006. Valdespino­Gomez, J. L.; de, Lourdes Garcia­Garcia; Fernandez­de­Castro, J.; Henao­Restrepo, A. M.; Bennett, J.; Sepulveda­Amor, J.Measles Aerosol Vaccination. Curr Top Microbiol Immunol; 304: 165­193; 2006. Valentiner­Branth, P.; Perch, M.; Nielsen, J.; Steinsland, H.; Garly, M. L.; Fischer, T. K.; Sommerfelt, H.; Molbak, K.; Aaby, P. Community Cohort Study of Cryptosporidium Parvum Infections: Sex­Differential Incidences Associated With BCG and Diptheria­Tetanus­Pertussis Vaccinations. Vaccine; February 2, 2006. van der Wouden, J. C.; Bernsen, R. M. Childhood Immunization and Atopic Disease. Pediatr Allergy Immunol; 17 (3): 234; May, 2006. van Tilburg, C. M.; Sanders, E. A.; Rovers, M. M.; Wolfs, T. F.; Bierings, M. B. Loss of Antibodies and Response to (Re­)Vaccination in Children After Treatment for Acute Lymphocytic Leukemia: a Systematic Review. Leukemia; August 3, 2006. van, der, V; Launay, O. [Vaccinations]. Rev Prat; 56 (5): 563­571; March 15, 2006. van, Heerbeek N.; Straetemans, M.; Wiertsema, S. P.; Ingels, K. J.; Rijkers, G. T.; Schilder, A. G.; Sanders, E. A.; Zielhuis, G. A. Effect of Combined Pneumococcal Conjugate and Polysaccharide Vaccination on Recurrent Otitis Media With Effusion. Pediatrics; 117 (3): 603­608; March, 2006. van, Ranst M. Influenza Viruses in General, Human Strains, Shift and Drift, Vaccination. Verh K Acad Geneeskd Belg; 68 (2): 77­80; 2006. van, Treeck U. Measles Outbreak in Germany: Over 1000 Cases Now Reported in Nordrhein Westfalen. Euro Surveill; 11 (5): E060511; May 11, 2006. Vazquez­Fernandez Del Pozo, S.; Hernandez­Barrera, V.; Carrasco­Garrido, P.; Alvarez­Martin, E.; Lopez­de, Andres A.; Gil de Miguel, A.; Jimenez­Garcia, R. Influenza Vaccination Coverage and Related Factors Among Spanish Children. J Infect; October 11, 2006. Vene, S.; Haglund, M.; Lundkvist, A.; Lindquist, L.; Forsgren, M.Study of the Serological Response After Vaccination Against Tick­Borne Encephalitis in Sweden. Vaccine; August 2, 2006. Venturi, G.; Mel, R.; Marchi, A.; Mancuso, S.; Russino, F.; Pra, G. D.; Papa, N.; Bertiato, G.; Fiorentini, C.; Ciufolini, M. G. Humoral Immunity and Correlation Between ELISA, Hemagglutination Inhibition, and Neutralization Tests After Vaccination Against Tick­Borne Encephalitis Virus in Children. J Virol Methods; February 1, 2006. Verma, A.; Wade, J. J. Immunization Issues Before and After Solid Organ Transplantation in Children. Pediatr Transplant; 10 (5): 536­548; August, 2006. Vermeer­de Bondt, P. E.; Dzaferagic, A.; David, S.; van der Maas, N. A. Performance of the Brighton Collaboration Case Definition for Hypotonic­
Hyporesponsive Episode (HHE) on Reported Collapse Reactions Following Infant Vaccinations in the Netherlands. Vaccine; July 24, 2006. Vickers, D.; Ross, A. G.; Mainar­Jaime, R. C.; Neudorf, C.; Shah, S.Whole­Cell and Acellular Pertussis Vaccination Programs and Rates of Pertussis Among Infants and Young Children. CMAJ; 175 (10): 1213­1217; November 7, 2006. Vila­Corcoles, A.; Ochoa­Gondar, O.; Ester, F.; Sarra, N.; Ansa, X.; Saun, N.; Evan, G. S.Evolution of Vaccination Rates After the Implementation of a Free Systematic Pneumococcal Vaccination in Catalonian Older Adults: 4­Years Follow­Up. BMC Public Health; 6: 231; September 18, 2006. Villoldo, P. Smallpox and Vaccination in Cuba. 1911. Public Health Rep; 121 (Suppl 1): 47­49; 2006. Voordouw, B. C.; Sturkenboom, M. C.; Dieleman, J. P.; Stijnen, T.; van der, Lei J.; Stricker, B. H. Annual Influenza Vaccination in Community­Dwelling Elderly Individuals and the Risk of Lower Respiratory Tract Infections or Pneumonia. Arch Intern Med; 166 (18): 1980­1985; October 9, 2006. Vora, G. J. Co­Infections of Adenovirus Species in Previously Vaccinated Patients. Emerg Infect Dis; 12 (6): 921­930; June, 2006. Vu, D. M.; de Boer, A. W.; Danzig, L.; Santos, G.; Canty, B.; Flores, B. M.; Granoff, D. M. Priming for Immunologic Memory in Adults by Meningococcal Group C Conjugate Vaccination. Clin Vaccine Immunol; 13 (6): 605­610; June, 2006. Vu, D. M.; Kelly, D.; Heath, P. T.; McCarthy, N. D.; Pollard, A. J.; Granoff, D. M. Effectiveness Analyses May Underestimate Protection of Infants After Group C Meningococcal Immunization. J Infect Dis; 194 (2): 231­237; July 15, 2006. Vu, D. M.; Welsch, J. A.; Zuno­Mitchell, P.; la Cruz, J. V.; Granoff, D. M. Antibody Persistence 3 Years After Immunization of Adolescents With Quadrivalent Meningococcal Conjugate Vaccine. J Infect Dis; 193 (6): 821­828; March 15, 2006. Waibel, K. H.; Walsh, D. S. Smallpox Vaccination Site Complications. Int J Dermatol; 45 (6): 684­688; June, 2006. Waibel, K. H.; Walsh, D. S. Smallpox Vaccination Site Reactions: Two Cases of Exaggerated Scarring and a Brief Review. Int J Dermatol; 45 (6): 764­765; June, 2006. Walker, V.; Selby, G.; Wacogne, I. Does Neonatal BCG Vaccination Protect Against Tuberculous Meningitis? Arch Dis Child; 91 (9): 789­791; September, 2006. Wallis, D. H.; Chin, J. L.; Sur, D. K.; Lee, M. Y. Increasing Rates of Influenza Vaccination During Pregnancy: a Multisite Interventional Study. J Am Board Fam Med; 19 (4): 345­349; July, 2006. Walter, E. B.; Neuzil, K. M.; Zhu, Y.; Fairchok, M. P.; Gagliano, M. E.; Monto, A. S.; Englund, J. A.Influenza Vaccine Immunogenicity in 6­ to 23­Month­
Old Children: Are Identical Antigens Necessary for Priming? Pediatrics; 118 (3): e570­e578; September, 2006. Wang, C. S.; Wang, S. T.; Lai, C. T.; Lin, L. J.; Chou, P.Impact of Influenza Vaccination on Major Cause­Specific Mortality. Vaccine; October 25, 2006. Wang, I. J.; Huang, L. M.; Chen, H. H.; Hwang, K. C.; Chen, C. J.Seroprevalence of Rubella Infection After National Immunization Program in Taiwan: Vaccination Status and Immigration Impact.J Med Virol; 79 (1): 97­103; November 28, 2006. Wang, I. J.; Hwang, K. C.; Tsai, Y. H.; Wu, Y. N.; Chao, S. J.; Chen, T. E.; Huang, L. M. Rubella Seroprevalence Among Young Women Taipei County After Routine Measles, Mumps and Rubella Immunization Program. Acta Paediatr Taiwan; 47 (1): 14­17; January, 2006. Wang, L. Y.; Hu, C. T.; Ho, T. Y.; Lin, H. H. Geographic and Ethnic Variations of Long­Term Efficacy and Immunogenicity of Hepatitis B Vaccination in Hualien, a HBV Hyperendemic Area. Vaccine; March 10, 2006. Wassen, L.; Jertborn, M. Influence of Exogenous Reproductive Hormones on Specific Antibody Production in Genital Secretions After Vaginal Vaccination With Recombinant Cholera Toxin B Subunit in Humans. Clin Vaccine Immunol; 13 (2): 202­207; February, 2006. Watanuki, Y.; Takahashi, H.; Ogura, T.; Miyazawa, N.; Nakamura, M.; Hashizume, T.; Kozawa, S.; Tagawa, A. [Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Patients With Chronic Respiratory Diseases]. Nihon Kokyuki Gakkai Zasshi; 44 (4): 305­311; April, 2006. Watson­Creed, G.; Saunders, A.; Scott, J.; Lowe, L.; Pettipas, J.; Hatchette, T. F. Two Successive Outbreaks of Mumps in Nova Scotia Among Vaccinated Adolescents and Young Adults. CMAJ; 175 (5): 483­488; August 29, 2006. Watson, J. T.; Ramirez, E.; Evens, A.; Bellini, W. J.; Johnson, H.; Morita, J. Measles Immunization Coverage Determined by Serology and Immunization Record From Children in Two Chicago Communities. Public Health Rep; 121 (3): 262­269; May, 2006. Webb, C. W.; Crowell, K.; Cravens, D. Which Vaccinations Are Indicated After Splenectomy? J Fam Pract; 55 (8): 711­712; August, 2006. Weil­Olivier, C.; Angoulvant, F.; Chevallier, B.; De, Montalembert M.; Gaudelus, J.; Quinet, B.; Labrune, P.; Duclos, A.; Dunais, B.; Maitre, M. [Influenza Vaccination Coverage Rate in Children With Underlying Chronic Disorders in 7 French Paediatric Wards.]. Arch Pediatr; August 17, 2006. Weil­Olivier, C.; Jacquet, A. [Immunization: Adverse Event Reporting System.]. Arch Pediatr; May 11, 2006. Weinke, T.; Liebold, I.; Burchard, G. D.; Fruhwein, N.; Grobusch, M. P.; Hatz, C.; Kollaritsch, H.; Nothdurft, H. D.; Reisinger, E.; Rieke, B.; Schonfeld, Ch; Steffen, R.; Stich, A. [Prophylactic Immunization Against Enterotoxin­Forming Escherichia Coli Strains As Cause of Travellers' Diarrhea: Does It Make Sense and for Whom?]. Dtsch Med Wochenschr; 131 (30): 1660­1664; July, 2006. Weir, E. Measles, Again­­and Its Implications for Occupational Health. CMAJ; 174 (9): 1259; April 25, 2006. Weir, R. E.; Black, G. F.; Nazareth, B.; Floyd, S.; Stenson, S.; Stanley, C.; Branson, K.; Sichali, L.; Chaguluka, S. D.; Donovan, L.; Crampin, A. C.; Fine, P. E.; Dockrell, H. M.The Influence of Previous Exposure to Environmental Mycobacteria on the Interferon­Gamma Response to Bacille Calmette­Guerin Vaccination in Southern England and Northern Malawi. Clin Exp Immunol; 146 (3): 390­399; December, 2006. Wells, T. S.; Sato, P. A.; Smith, T. C.; Wang, L. Z.; Reed, R. J.; Ryan, M. A. Military Hospitalizations Among Deployed US Service Members Following Anthrax Vaccination, 1998­2001. Hum Vaccin; 2 (2): 54­59; March, 2006. Weng, W. K.; Czerwinski, D.; Levy, R. Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype Are Associated With Better Clinical Outcome Following Idiotype Vaccination in Follicular Lymphoma Patients Regardless of Their Response to Induction Chemotherapy. Blood; October 10, 2006. Wertheim, M. S.; Keel, M.; Cook, S. D.; Tole, D. M. Corneal Transplant Rejection Following Influenza Vaccination. Br J Ophthalmol; 90 (7): 925; July, 2006. Westphall, J. S.Smallpox­­Inappropriate Vaccination Site. Aviat Space Environ Med; 77 (11): 1193­1195; November, 2006. Wheeler, A. W.; Woroniecki, S. R. Modern Approaches to Therapeutic Vaccination As Treatment for Type 1 Respiratory Hypersensitivity (Allergy) Treatment. Expert Rev Vaccines; 5 (1): 27­31; February, 2006. White­Williams, C.; Brown, R.; Kirklin, J.; St, Clair K.; Keck, S.; O'Donnell, J.; Pitts, D.; Van, Bakel A. Improving Clinical Practice: Should We Give Influenza Vaccinations to Heart Transplant Patients? J Heart Lung Transplant; 25 (3): 320­323; March, 2006. Whiteside, J.; Grover, M.; Hitchcock, K.; Kim, R.Clinical Inquiries. Should Patients Receive 23­Valent Pneumococcal Vaccination More Than Once? J Fam Pract; 55 (9): 809­812; September, 2006. Wiggs­Stayner, K. S.; Purdy, T. R.; Go, G. N.; McLaughlin, N. C.; Tryzynka, P. S.; Sines, J. R.; Hlaing, T. The Impact of Mass School Immunization on School Attendance. J Sch Nurs; 22 (4): 219­222; August, 2006. Wilson, F. L.; Brown, D. L.; Stephens­Ferris, M. Can Easy­to­Read Immunization Information Increase Knowledge in Urban Low­Income Mothers? J Pediatr Nurs; 21 (1): 4­12; February, 2006. Wilson, K.; Barakat, M.; Mills, E.; Ritvo, P.; Boon, H.; Vohra, S.; Jadad, A. R.; McGeer, A. Addressing the Emergence of Pediatric Vaccination Concerns: Recommendations From a Canadian Policy Analysis. Can J Public Health; 97 (2): 139­141; March, 2006. Wilson, T. R. Update on Adolescent Immunization: Review of Pertussis and the Efficacy, Safety, and Clinical Use of Vaccines That Contain Tetanus­
Diphtheria­ Acellular Pertussis. J Pediatr Health Care; 20 (4): 229­237; July, 2006. Winston, C. A.; Lindley, M. C.; Wortley, P. M. Lessons Learned From Inpatient Vaccination in Michigan. Am J Med Qual; 21 (2): 125­133; March, 2006. Winston, C. A.; Wortley, P. M.; Lees, K. A. Factors Associated With Vaccination of Medicare Beneficiaries in Five U.s. Communities: Results From the Racial and Ethnic Adult Disparities in Immunization Initiative Survey, 2003. J Am Geriatr Soc; 54 (2): 303­310; February, 2006. Wiser, I.; Balicer, R. D.; Cohen, D.An Update on Smallpox Vaccine Candidates and Their Role in Bioterrorism Related Vaccination Strategies. Vaccine; September 22, 2006. Wisloff, T.; Abrahamsen, T. G.; Bergsaker, M. A.; Lovoll, O.; Kristiansen, I. S. [Vaccination­­Value for Money?]. Tidsskr Nor Laegeforen; 126 (20): 2670­
2673; October, 2006. Wisloff, T.; Abrahamsen, T. G.; Bergsaker, M. A.; Lovoll, O.; Moller, P.; Pedersen, M. K.; Kristiansen, I. S. Cost Effectiveness of Adding 7­Valent Pneumococcal Conjugate (PCV­7) Vaccine to the Norwegian Childhood Vaccination Program. Vaccine; 24 (29­30): 5690­5699; July 17, 2006. Wiysonge, C. S.; Nomo, E.; Mawo, J. N.; Ticha, J. M. Accelerated Measles Control in Sub­Saharan Africa. Lancet; 367 (9508): 394­395; February 4, 2006. Wolicki, B.; Wolicki, J. What's New With Immunizations? Mich Nurse; 79 (5): 19, 21; September, 2006. Wood, N.; McIntyre, P.; Wong, M. Vaccination for the Paediatrician. J Paediatr Child Health; 42 (11): 665­673; November, 2006. Wortley, P. M.; Schwartz, B.; Levy, P. S.; Quick, L. M.; Evans, B.; Burke, B. Healthcare Workers Who Elected Not to Receive Smallpox Vaccination. Am J Prev Med; 30 (3): 258­265; March, 2006. Wu, P.; Griffin, M. R.; Richardson, A.; Gabbe, S. G.; Gambrell, M. A.; Hartert, T. V. Influenza Vaccination During Pregnancy: Opinions and Practices of Obstetricians in an Urban Community. South Med J; 99 (8): 823­828; August, 2006. Wu, S. J.; Sun, S.; Li, J. Y.; Hu, P. Y.; Chien, C. Y.Acute Fulminant Myocarditis After Diphtheria, Polio, and Tetanus Vaccination. Asian Cardiovasc Thorac Ann; 14 (6): e111­e112; December, 2006. Wutzler, P. [Prophylactic Influenza Vaccination: What Is the Situation in Germany?]. Dtsch Med Wochenschr; 131 (9): 453­457; March 3, 2006. Xing, Z.; Lichty, B. D. Use of Recombinant Virus­Vectored Tuberculosis Vaccines for Respiratory Mucosal Immunization. Tuberculosis (Edinb); February 24, 2006. Yang, L. C.; Yang, X. G. [Study on the Development of DNA Immunization Technique]. Wei Sheng Yan Jiu; 35 (1): 110­114; January, 2006. Yasuda, K.Immunization Information Systems. Pediatrics; 118 (3): 1293­1295; September, 2006. Yoder, J. S.; Dworkin, M. S.VACCINATION USAGE AMONG AN OLD­ORDER AMISH COMMUNITY IN ILLINOIS. Pediatr Infect Dis J; 25 (12): 1182­ 1183; December, 2006. Yoo, B. K.; Frick, K. D. The Instrumental Variable Method to Study Self­Selection Mechanism: a Case of Influenza Vaccination. Value Health; 9 (2): 114­
122; March, 2006. Yoo, B. K.; Grosse, S.; Frick, K. D. Self­Selection and Evaluation of Influenza Vaccination Effectiveness Among Elderly. Vaccine; June 30, 2006. Zarogiannis, S.; Gourgoulianis, K. Hospitalization Trends for Pneumonia Among Older Persons. JAMA; 295 (18): 2137; May 10, 2006. Zinka, B.; Penning, R. Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination. Vaccine; April 18, 2006. Zohrabian, A.; Hayes, E. B.; Petersen, L. R. Cost­Effectiveness of West Nile Virus Vaccination. Emerg Infect Dis; 12 (3): 375­380; March, 2006. Zuercher, A. W.; Horn, M. P.; Que, J. U.; Ruedeberg, A.; Schoeni, M. H.; Schaad, U. B.; Marcus, P.; Lang, A. B. Antibody Responses Induced by Long­Term Vaccination With an Octovalent Conjugate Pseudomonas Aeruginosa Vaccine in Children With Cystic Fibrosis. FEMS Immunol Med Microbiol; 47 (2): 302­ 308; July, 2006. 2007 Aaby, P.; Benn, C. S.; Nielsen, J.; Lisse, I. M.; Rodrigues, A.; Jensen, H. DTP Vaccination and Child Survival in Observational Studies With Incomplete Vaccination Data. Trop Med Int Health; 12 (1): 15­24; January, 2007. Aaby, P.; Garly, M. L.; Nielsen, J.; Ravn, H.; Martins, C.; Bale, C.; Rodrigues, A.; Benn, C. S.; Lisse, I. M. Increased Female­Male Mortality Ratio Associated With Inactivated Polio and Diphtheria­Tetanus­Pertussis Vaccines: Observations From Vaccination Trials in Guinea­Bissau. Pediatr Infect Dis J. 2007 Mar;26(3):247­ 52. Aballea, S.; Chancellor, J.; Martin, M.; Wutzler, P.; Carrat, F.; Gasparini, R.; Toniolo­Neto, J.; Drummond, M.; Weinstein, M. The Cost­Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: an International Model. Value Health; 10 (2): 98­116; March, 2007. Aballea, S.; De, Juanes, Jr.; Barbieri, M.; Martin, M.; Chancellor, J.; Oyaguez, I.; Verwee, B.; Largeron, N. The Cost Effectiveness of Influenza Vaccination for Adults Aged 50 to 64 Years: A Model­Based Analysis for Spain. Vaccine; 25 (39­40): 6900­6910; September 28, 2007. Abarca, V. K. [Influenza: Immunization to New Age Groups.]. Rev Chilena Infectol; 24 (3): 227­230; June, 2007. Abbas, M.; Fiala, L.; Tawfiq, L. Workplace Influenza Vaccination in Two Major Industries in Saudi Arabia: a Cost Benefit Analysis. J Egypt Public Health Assoc; 81 (1­2): 59­73; 2006. Abe, M.; Okada, K.; Hayashida, K.; Matsuo, F.; Shiosaki, K.; Miyazaki, C.; Ueda, K.; Kino, Y. Duration of Neutralizing Antibody Titer After Japanese Encephalitis Vaccination. Microbiol Immunol; 51 (6): 609­616; 2007. Abu­Shakra, M.; Press, J.; Buskila, D.; Sukenik, S. Influenza Vaccination of Patients With Systemic Lupus Erythematosus: Safety and Immunogenecity Issues. Autoimmun Rev; 6 (8): 543­546; September, 2007. Actions to Strengthen Adult and Adolescent Immunization Coverage in the United States: Policy Principles of the Infectious Diseases Society of America. Clin Infect Dis. 2007 Jun 15; 44 (12):e104­8. Epub 2007 May 14. Adamkovicova, E.; Jarcuska, P.; Schreter, I. [Travel During Pregnancy and Possibilities of Vaccination.]. Klin Mikrobiol Infekc Lek; 12 (6): 224­228; December, 2006. Afshar, Paiman S.; Siadati, A.; Mamishi, S.; Tabatabaie, P.; Khotaee, G. Disseminated Mycobacterium Bovis Infection After BCG Vaccination. Iran J Allergy Asthma Immunol; 5 (3): 133­137; September, 2006. Agampodi, S. B.; Amarasinghe, D. Private Sector Contribution to Childhood Immunization: Sri Lankan Experience. Indian J Med. 2007 Apr; 61(4):192­200. Aguilar, L.; Gimenez, M. J. [Immunization and Antimicrobials. Is There an Association Between the Effects Against Streptococcus Pneumoniae?]. Rev Esp Quimioter. 2007 Mar;(1): 125­7. Ahonkai, A.; Lechtzin, N. A Case for Vaccination. Am J Med. 2007 Apr; 120(4):319­21. Ahrens, J.; Heuft, H. G.; Goudeva, L.; Przemeck, M. Rhesus Immune Globulin Fails to Prevent Immunization After Rhesus Incompatible Blood Transfusion. Transfus Apher Sci; March 14, 2007. Akmatov, M. K.; Kretzschmar, M.; Kramer, A.; Mikolajczyk, R. T. Determinants of Childhood Vaccination Coverage in Kazakhstan in a Period of Societal Change: Implications for Vaccination Policies. Vaccine; 25(10): 1756­63; November 27, 2006. Aksakal, F.; Maral, I.; Yalinay, Cirak M.; Aygun, R. Rubella Seroprevalence Among Women of Childbearing Age Residing in a Rural Region: Is There a Need for Rubella Vaccination in Turkey? Jpn J Infect Dis; 60 (4): 157­160; August, 2007. Akumu, A. O.; English, M.; Scott, J. A.; Griffiths, U. K. Economic Evaluation of Delivering Haemophilus Influenzae Type b Vaccine in Routine Immunization Services in Kenya. Bull World Health Organ; 85 (7): 511­518; July, 2007. Al­Tawfiq, J. A.; Abukhamsin, A. Bordetella Pertussis Infection in a Highly Vaccinated Population in Saudi Arabia, 1996­2004. J Infect; June 11, 2007. Albrich, W. C.; Madhi, S. A.; Lafond, K. E.; Klugman, K. P. Herd Immunity After Pneumococcal Conjugate Vaccination. Lancet; 370 (9583): 218­219; July 21, 2007. Alfonsi, V.; Montomoli, E.; Manini, I.; Alberini, I.; Gentile, C.; Rota, M. C.; Ciofi Degli Atti, M. L. Susceptibility to Varicella in Childbearing Age Women, Central Italy: Is There a Need for Vaccinating This Population Group? Vaccine; 25 (32): 6086­6088; August 10, 2007. Alfonso, H. C.; Gomez, O. C.; Fonte, L. M.; Quintana, Q. P. [Isolation of a Strain From the Bataviae Pathogenic Complex in Patient Vaccinated Against Copenhageni, Canicola and Mozdok]. Rev Cubana Med Trop; 57 (1): 73­74; January, 2005. Allaert, F. A.; Baptiste, C. [Attitude of Adults at Work Towards Influenza Vaccination.]. Med Mal Infect; November 6, 2007. Almanzar, G.; Herndler­Brandstetter, D.; Chaparro, S. V.; Jenewein, B.; Keller, M.; Grubeck­Loebenstein, B. Immunodominant Peptides From Conserved Influenza Proteins ­ A Tool for More Efficient Vaccination in the Elderly? Wien Med Wochenschr. 2007 Mar; 157 (5­6): 116­121.. Altuzarra, H. R.; Valenzuela, B. MT; Trucco, A. O.; Inostroza, S. J.; Granata, S. P.; Fleiderman, V. J. [Nasal Carriage of Streptococcus Pneumoniae in Elderly Subjects According to Vaccination Status.]. Rev Med Chil. 2007 Feb; 135 (2): 160­166; Epub 2007 Mar 28. Anand, S.; Barnighausen, T. Health Workers and Vaccination Coverage in Developing Countries: an Econometric Analysis. Lancet; 2007 Apr 14; 369 (9569): 1277­ 85 Ancona, F.; Alfonsi, V.; Caporali, M.; Ranghiasci, A.; Ciofi Degli, Atti M. Pneumococcal Conjugate, Meningococcal C and Varicella Vaccination in Italy. Euro Surveill; 12 (2); February, 2007. Antunes, J. L.; Waldman, E. A.; Borrell, C.; Paiva, T. M. Effectiveness of Influenza Vaccination and Its Impact on Health Inequalities. Int J Epidemiol; 36(6): 1319­ 1326; October 31, 2007. Anuradha, B.; Santosh, C.; Hari, Sai Priya, V; Suman, Latha G.; Murthy, K.; Vijaya, Lakshmi, V Age­Related Waning of in Vitro Interferon­Gamma Levels Against R32kDaBCG in BCG Vaccinated Children. J Immune Based Ther Vaccines; 5: 8; June 7, 2007. Appel, S.; Chapman, J.; Shoenfeld, Y. Infection and Vaccination in Chronic Fatigue Syndrome: Myth or Reality? Autoimmunity; 40 (1): 48­53; February, 2007. Approved: New Requirement Allowing Administration of Flu and Pneumococcal Vaccines With Physician Order. Jt Comm Perspect; 26 (10): 4; October, 2006. Arah, O. A. Health Workers and Vaccination Coverage in Developing Countries. Lancet; 370 (9586): 480; August 11, 2007. Arbyn, M. Effects of Quadrivalent Human Papillomavirus Vaccination. Lancet; 370 (9592): 1031­1032; September 22, 2007. Arenas­Garcia, L.; Garcia­Corp; Martinez­Gurrion, L. A.; Martinez­Mendoza, L. A.; Cortina­Jacobo, S.; Noyola, D. E. Acceptance of Influenza Vaccination by Nursing Personnel in Mexico. J Hosp Infect; March 9, 2007. Arevshatian, L.; Clements, C.; Lwanga, S.; Misore, A.; Ndumbe, P.; Seward, J.; Taylor, P. An Evaluation of Infant Immunization in Africa: Is a Transformation in Progress? Bull World Health Organ; 85 (6): 449­457; June, 2007. Arnold, W.; Busch, R.; Arnold, A.; Ritscher, B.; Neiss, A.; Niedermeyer, H. P. The Influence of Measles Vaccination on the Incidence of Otosclerosis in Germany. Eur Arch Otorhinolaryngol; February 13, 2007. Arya, S. C.; Agarwal, N. Assessing the Safety of Post­Exposure Rabies Immunization in Pregnancy. Hum Vaccin; 3 (6); June 8, 2007. Arya, S. C.; Agarwal, N. Assessing the Safety of Post­Exposure Rabies Immunization in Pregnancy. Hum Vaccin; 3 (5): 155; September, 2007. Arya, S. C.; Agarwal, N. Baffling Measles Immunization Schedules for Young Infants. Vaccine; September 21, 2007. Arya, S. C.; Agarwal, N. Re: Determinants of Monovalent Oral Polio Vaccine Mutagenesis in Vaccinated Elderly People. Vaccine; 25 (34): 6295; August 21, 2007. Asano, T.; Aki, K.; Okada, T.; Hatori, T.; Kuwabara, K.; Hamada, H.; Imai, T.; Fujino, O. Usefulness of DNA Analysis of Tuberculosis With Ruptured Lymphadenitis in a Bacille Calmette­Guerin­Vaccinated Infant. Pediatr Int. 2007 Jun; 49(30):392­4 Asllani, A.; Dileepan, P.; Ettkin, L. A Methodology for Using Simulation to Optimize Emergency Mass Vaccination Parameters. J Med Syst; 31 (6): 453­459; December, 2007. Assessment of Immunity and Allergy After Vaccination With Dry Combined Anthrax Vaccine. Zh Mikrobiol Epidemiol Immunobiol;(5): 51­53; September, 2007. Assessment of Yellow Fever Epidemic Risk­­a Decision­Making Tool for Preventive Immunization Campaigns Wkly Epidemiol Rec. 2007 May 4;82 82(18):153­ 160. Astrand, R.; Sveger, T.; Nilsson, P. Haemophilus Meningitis in a Six­Month­Old Boy Vaccinated Against Hib. Scand J Infect Dis; 39 (8): 743­744; 2007. Aubin, F. [Human Papillomavirus Infection. Screening Treatment and Vaccination]. Rev Prat; 56 (17): 1875­1876; November 15, 2006. Avidity of Immunoglobulin G to Rubella Virus in Post­Vaccination and Post­Infection Immunity. Zh Mikrobiol Epidemiol Immunobiol; (4): 6­11; July, 2007. Avis, K.; Tan, L.; Anderson, C.; Tan, B.; Muhajarine, N. Taking a Closer Look: an Examination of Measles, Mumps, and Rubella Immunization Uptake in Saskatoon. Can J Public Health; 98 (5): 417­421; September, 2007. Babic, M. J. Eczema Vaccinatum: a Reaction to the Smallpox Vaccine. A Report of a Rare but Potentially Lethal Consequence. Am J Nurs; 107 (8): 30­31; August, 2007. Baccam, P.; Boechler, M. Public Health Response to an Anthrax Attack: an Evaluation of Vaccination Policy Options. Biosecur Bioterror. 2007 Mar; 5 (1): 26­34. Badilla, X.; Morice, A.; vila­Aguero, M. L.; Saenz, E.; Cerda, I.; Reef, S.; Castillo­Solorzano, C. Fetal Risk Associated With Rubella Vaccination During Pregnancy. Pediatr Infect Dis J; 26 (9): 830­835; September, 2007. Baicus, A.; Combiescu, M.; Persu, A.; ubert­Combiescu, A. Immune Status to Polioviruses in the Children Population of Romania Between 2002­2005 As Indicated by Serological Investigation in Cases of Acute Flaccid Paralysis (AFP) and Facial Paralysis (FP) and Its Use As a "National Reference Value" to Evaluate the Vaccination Coverage in Particular Groups of Healthy Children. Rev Med Chir Soc Med Nat Iasi. 2006 Oct­Dec;110 (4): 1004­11. Bakare, M.; Shrivastava, R.; Jeevanantham, V.; Navaneethan, S. D. Impact of Two Different Models on Influenza and Pneumococcal Vaccination in Hospitalized Patients. South Med J; 100 (2): 140­144; February, 2007. Baker, C. J.; Schaffner, W.; Zimmerman, R. K. Importance of Influenza Vaccination for Children. Am Fam Physician; 76 (3): 343­344; August 1, 2007. Baker, L. M.; Wilson, F. L.; Nordstrom, C. K.; Legwand, C. Mothers' Knowledge and Information Needs Relating to Childhood Immunizations. Issues Compr Pediatr Nurs; 30 (1­2): 39­53; January, 2007. Baldo, V.; Ferro, A.; Napoletano, G.; Milani, S.; Bertoncello, L.; Baldovin, T.; Trivello, R. Universal Varicella Vaccination in the Veneto Region, Italy: Launch of a Programme Targeting All Children Aged 14 Months and Susceptible Adolescents. Euro Surveill; 12 (11): E071101; November 1, 2007. Balicer, R. D.; Grotto, I.; Mimouni, M.; Mimouni, D. Is Childhood Vaccination Associated With Asthma? A Meta­Analysis of Observational Studies. Pediatrics; 120 (5): e1269­e1277; November, 2007. Banus, S.; Bottema, R. W.; Siezen, C. L.; Vandebriel, R. J.; Reimerink, J.; Mommers, M.; Koppelman, G. H.; Hoebee, B.; Thijs, C.; Postma, D. S.; Kimman, T. G.; Stelma, F. F. A Toll­Like Receptor 4 Polymorphism Is Associated With the Response to Whole­Cell Pertussis Vaccination in Children From the KOALA Study. Clin Vaccine Immunol; August 15, 2007. Baquero­Artigao, F. [Clinical and Therapeutic Changes in Otitis With Anti­Pneumococcal Vaccination.]. Rev Esp Quimioter. 2007 Mar; 20 (1): 122­4. Barr, F. Rabies Vaccination. Vet Rec; 160 (24): 850; June 16, 2007. Barreto, L.; Guasparini, R.; Meekison, W.; Noya, F.; Young, L.; Mills, E. Humoral Immunity 5 Years After Booster Immunization With an Adolescent and Adult Formulation Combined Tetanus, Diphtheria, and 5­Component Acellular Pertussis Vaccine. Vaccine; October 2, 2007. Bartlett, D. L.; Washington, M. L.; Bryant, A.; Thurston, N.; Perfili, C. A. Cost Savings Associated With Using Immunization Information Systems for Vaccines for Children Administrative Tasks. J Public Health Manag Pract; 13 (6): 559­566; November, 2007. Baudier, F.; Tarrapey, F.; Leboube, G. [Pilot Campaign to Promote Vaccination: Description Preliminary Results of a Regional French Program.]. Med Mal Infect; May 21, 2007. Baumgardner, D. J.; Halsmer, S. E.; Steber, D. L.; Shah, D. S.; Mundt, M. P. Does Proximity to Clinic Affect Immunization Rates and Blood Pressure? Int J Psychiatry Med; 36 (2): 199­209; 2006. Baxter, D. Immunization and Health Workers: Overview. Occup Med (Lond); 57 (8): 547; December, 2007. Bayas, J. M.; Gonzalez­Alvarez, R.; Guinovart, C. Herpes Zoster After Yellow Fever Vaccination. J Travel Med; 14 (1): 65­66; January, 2007. Beall, B. Vaccination With the Pneumococcal 7­Valent Conjugate: a Successful Experiment but the Species Is Adapting. Expert Rev Vaccines; 6 (3): 297­300; June, 2007. Beermann, B. [Some Corrections Concerning Vaccines Campaigns]. Lakartidningen. 2007 Mar 14­20;104 (11):885. Beigel, J.; Kohl, K. S.; Brinley, F.; Graham, P. L.; Khuri­Bulos, N.; Larussa, P. S.; Nell, P.; Norton, S.; Stoltman, G.; Tebaa, A.; Warschaw, K. Generalized Vaccinia As an Adverse Event Following Exposure to Vaccinia Virus: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data. Vaccine; May 2, 2007. Beigel, J.; Kohl, K. S.; Khuri­Bulos, N.; Bravo, L.; Nell, P.; Marcy, S. M.; Warschaw, K.; Ong­Lim, A.; Poerschke, G.; Weston, W.; Lindstrom, J. A.; Stoltman, G.; Maurer, T. Rash Including Mucosal Involvement: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data. Vaccine. 2007 March 13. Bellei, N. C.; Carraro, E.; Castelo, A.; Granato, C. F. Risk Factors for Poor Immune Response to Influenza Vaccination in Elderly People. Braz J Infect Dis; 10 (4): 269­273; August, 2006. Bennett, E. M.; Domachowske, J. B. New Immunization Strategies for Preventing Infectious Diseases in Adolescents. Pediatr Ann; 36 (6): 327­335; June, 2007. Bentsi­Enchill, A. D.; Zongo, I.; Khamassi, S.; Pless, R.; Thombiano, R.; Tiendrebeogo, S.; Nelson, C. B.; Duclos, P. Monitoring of Adverse Events During the 2003 Mass Vaccination Campaign With a Trivalent Meningococcal A/C/W135 Polysaccharide Vaccine in Burkina Faso. Vaccine; May 7, 2007. Bernaola Iturbe, E.; Gimenez Sanchez, F.; Baca Cots, M.; De Juan Martin, F.; Diez Domingo, J.; Garces Sanchez, M.; Gomez­Campdera, A.; Martinon­
Torres, F.; Picazo, J. J.; Pineda, Solas, V [Vaccination Schedule of the Spanish Association of Pediatrics: Recommendations 2007.]. An Pediatr (Barc ); 66 (1): 62­69; January, 2007. Bertin, M.; Scarpelli, M.; Proctor, A. W.; Sharp, J.; Robitson, E.; Donnelly, T.; Young, C.; Gordon, S. M. Novel Use of the Intranet to Document Health Care Personnel Participation in a Mandatory Influenza Vaccination Reporting Program. Am J Infect Control; 35 (1): 33­37; February, 2007. Berto, P.; Gallio, D.; Principi, N. [Budgetary Impact of Pneumococcal Conjugate Vaccination of Newborns]. Ann Ig; 19 (3): 281­291; May, 2007. Bettinger, J. A.; Scheifele, D. W.; Halperin, S. A.; Kellner, J. D.; Tyrrell, G. Invasive Pneumococcal Infections in Canadian Children, 1998­2003: Implications for New Vaccination Programs. Can J Public Health; 2007 Mar­Apr; 98 (2): 111­115. Beutels, P.; Thiry, N.; Van, Damme P. Convincing or Confusing? Economic Evaluations of Childhood Pneumococcal Conjugate Vaccination­a Review (2002­ 2006). Vaccine; 25 (8): 1355­1367; February 9, 2007. Bibliography. Current World Literature. Infectious Diseases and Immunization. Curr Opin Pediatr; 19 (1): 120­129; February, 2007. Billings, L.; Fiorillo, A.; Schwartz, I. B. Vaccinations in Disease Models With Antibody­Dependent Enhancement. Math Biosci; September 4, 2007. Bilukha, O.; Messonnier, N.; Fischer, M. Use of Meningococcal Vaccines in the United States. Pediatr Infect Dis J; 26 (5): 371­376; May, 2007. Birnbaum, A. D.; Tessler, H. H.; Schultz, K. A.; Farber, M. D.; Gao, W.; Lin, P.; Oh, F.; Goldstein, D. A. Epidemiologic Relationship Between Fuchs Heterochromic Iridocyclitis and the United States Rubella Vaccination Program. Am J Ophthalmol; July 12, 2007. Bittner, V.; Sanderson, B. K. Influenza Vaccination in Secondary Prevention­an Opportunity Missed. J Cardiopulm Rehabil Prev; 27 (4): 202­207; July, 2007. Blackburn, M.; Bellemare, S.; Gagne, G.; Gagnon, J.; Gagnon­Gervais, K.; Gaudet, C.; Messier, Fugere L. Overview of the Immunization Product Quality Control Practices of Vaccinators in Monteregie. Can Commun Dis Rep; 33 (1): 1­8; January 1, 2007. Block, S. L.; Vesikari, T.; Goveia, M. G.; Rivers, S. B.; Adeyi, B. A.; Dallas, M. J.; Bauder, J.; Boslego, J. W.; Heaton, P. M. Efficacy, Immunogenicity, and Safety of a Pentavalent Human­Bovine (WC3) Reassortant Rotavirus Vaccine at the End of Shelf Life. Pediatrics; 119 (1): 11­18; January, 2007. Boa, A. [Approaches of the Expanded Programme of Immunization (EPI) and Analysis of Its Failures in the Sanitary District of Bouna (Northeast of Cote D'Ivoire)]. Bull Soc Pathol Exot; 99 (5): 386­390; December, 2006. Bompart, F. [Vaccination Strategies for the Global Eradication of Poliomyelitis]. Bull Soc Pathol Exot; 97 (4): 288­292; November, 2004. Bonanni, P. Vaccination and Risk Groups: How Can We Really Protect the Weakest? Hum Vaccin; 3 (5); April 27, 2007. Bonhoeffer, J.; Heininger, U. Adverse Events Following Immunization: Perception and Evidence. Curr Opin Infect Dis; 20 (3): 237­246; June, 2007. Boom, J. A.; Dragsbaek, A. C.; Nelson, C. S. The Success of an Immunization Information System in the Wake of Hurricane Katrina. Pediatrics; 119 (6): 1213­ 1217; June, 2007. Boom, J. A.; Nelson, C. S.; Laufman, L. E.; Kohrt, A. E.; Kozinetz, C. A. Improvement in Provider Immunization Knowledge and Behaviors Following a Peer Education Intervention. Clin Pediatr (Phila); May 23, 2007. Boot, H. J.; Sonsma, J.; van, Nunen F.; Abbink, F.; Kimman, T. G.; Buisman, A. M. Determinants of Monovalent Oral Polio Vaccine Mutagenesis in Vaccinated Elderly People. Vaccine; 25 (24): 4706­4714; June 11, 2007. Borgmeyer, C. AAFP Encourages Use of Medical Home, New Immunization Policy at AMA Congress. Ann Fam Med; 5 (5): 464­466; September, 2007. Borlaug, G.; Newman, A.; Pfister, J.; Davis, J. P. Factors That Influenced Rates of Influenza Vaccination Among Employees of Wisconsin Acute Care Hospitals and Nursing Homes During the 2005­2006 Influenza Season. Infect Control Hosp Epidemiol; 28 (12); October, 2007. Borras, E.; Dominguez, A.; Batalla, J.; Torner, N.; Cardenosa, N.; Nebot, M.; Plasencia, A.; Salleras, L. Vaccination Coverage in Indigenous and Immigrant Children Under 3 Years of Age in Catalonia (Spain). Vaccine; January 22, 2007. Borrill, Z.; Woodhead, M. Universal Influenza Vaccination in the Elderly: Another Piece in the Jigsaw. Eur Respir J; 30 (3): 407­408; September, 2007. Borrow, R.; Miller, E. Long­Term Protection in Children With Meningococcal C Conjugate Vaccination: Lessons Learned. Expert Rev Vaccines; 5 (6): 851­
857; December, 2006. Bossenecker, W. [Tick­Borne Encephalitis: Infection Mechanisms, Clinical Picture and Vaccination Options]. MMW Fortschr Med; 149 (5): 29­33; February 1, 2007. Bouazzaoui, N. L. [Evolution of the Vaccination Timetable in Morocco]. Bull Acad Natl Med; 190 (4­5): 1017­1032; April, 2006. Boulanger, J. C. [About the Opinion of the French Comite Technique Des Vaccinations and Conseil Superieur D'Hygiene Publique (9th March 2007) Concerning Vaccination Against HPV Strains 6, 11, 16 and 18.]. Gynecol Obstet Fertil; 35 (6): 599­600; June, 2007. Bowerman, R. J. Community­Wide INH Treatment of Latent TB Infection in a BCG­Vaccinated Population: Experience in Rural Taiwan. Int J Tuberc Lung Dis; 11 (4): 470­472; April, 2007. Boyce, T. G. Vaccination Usage Among an Old­Order Amish Community in Illinois. Pediatr Infect Dis J. 2007 Apr; 26 (4): 370. Breban, R.; Vardavas, R.; Blower, S. Mean­Field Analysis of an Inductive Reasoning Game: Application to Influenza Vaccination. Phys Rev E Stat Nonlin Soft Matter Phys; 76 (3 Pt 1): 031127; September, 2007. Bremner, S. A.; Carey, I. M.; DeWilde, S.; Richards, N.; Maier, W. C.; Hilton, S. R.; Strachan, D. P.; Cook, D. G. Vaccinations, Infections and Antibacterials in the First Grass Pollen Season of Life and Risk of Later Hayfever. Clin Exp Allergy. 2007 Apr; 37 (4): 512­7. Bren, L. Influenza: Vaccination Still the Best Protection. FDA Consum; 40 (5): 12­19; September, 2006. Brewer, N. T.; Chapman, G. B.; Gibbons, F. X.; Gerrard, M.; McCaul, K. D.; Weinstein, N. D. Meta­Analysis of the Relationship Between Risk Perception and Health Behavior: the Example of Vaccination. Health Psychol; 26 (2): 136­145; March, 2007. Brewer, N. T.; Cuite, C. L.; Herrington, J. E.; Weinstein, N. D. RAPID COMMUNICATIONS: Risk Compensation and Vaccination: Can Getting Vaccinated Cause People to Engage in Risky Behaviors? Ann Behav Med; 34 (1): 95­99; August, 2007. Brook, I.; Gober, A. E. Frequency of Recovery of Pathogens From the Nasopharynx of Children With Acute Maxillary Sinusitis Before and After the Introduction of Vaccination With the 7­Valent Pneumococcal Vaccine. Int J Pediatr Otorhinolaryngol; 71(4): 575­579; January 30, 2007. Brotherton, J. HPV Vaccination. Aust Fam Physician; 36 (6): 391; June, 2007. Brotherton, J.; Wang, H.; Schaffer, A.; Quinn, H.; Menzies, R.; Hull, B.; Lawrence, G.; Wood, J.; Wood, N.; Rosewell, A.; Newall, A.; MacIntyre, R.; Macartney, K.; Gidding, H.; McIntyre, P.; Booy, R. Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005. Commun Dis Intell; 31 Suppl: S1­ 152; June, 2007. Brown, N. J.; Berkovic, S. F.; Scheffer, I. E. Vaccination, Seizures and 'Vaccine Damage'. Curr Opin Neurol; 20 (2): 181­187; April, 2007. Bruce, G. Paramedic Services Workplace Program Improves Influenza Immunization Rates Among Paramedics. Can J Infect Control; 22 (3): 156­1; 2007. Brueggemann, A. B.; Pai, R.; Crook, D. W.; Beall, B. Vaccine Escape Recombinants Emerge After Pneumococcal Vaccination in the United States. PLoS Pathog; 3 (11): e168; November 16, 2007. Buelow, V. H.; Van, Hook J. Timely Immunization Series Completion Among Children of Immigrants. J Immigr Minor Health; October, 2007. Buettcher, M.; Heininger, U.; Braun, M.; Bonhoeffer, J.; Halperin, S.; Heijbel, H.; de Menezes, Martins R.; Vermeer­de, Bondt P. Hypotonic­Hyporesponsive Episode (HHE) As an Adverse Event Following Immunization in Early Childhood: Case Definition and Guidelines for Data Collection, Analysis, and Presentation. Vaccine; May 8, 2007. Bueving, H. J.; van der Wouden, J. C. What Is the Role of Virus Vaccination in Patients With Asthma? Curr Allergy Asthma Rep; 7 (1): 72­76; April, 2007. Burwen, D. R.; La, Voie L.; Braun, M. M.; Houck, P.; Ball, R. Evaluating Adverse Events After Vaccination in the Medicare Population. Pharmacoepidemiol Drug Saf; March 27, 2007. Buttery, J. P. Routine Rotavirus Vaccinations of Infants Cost US$138 Per Case Averted and US$197,190 Per Life Year Saved From